Citrus Sinensis ID: 003481
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 816 | 2.2.26 [Sep-21-2011] | |||||||
| Q8GUH1 | 834 | U-box domain-containing p | yes | no | 0.928 | 0.908 | 0.399 | 1e-158 | |
| Q94A51 | 805 | U-box domain-containing p | no | no | 0.915 | 0.927 | 0.319 | 1e-106 | |
| Q9SW11 | 835 | U-box domain-containing p | no | no | 0.930 | 0.908 | 0.320 | 4e-99 | |
| Q9LU47 | 819 | Putative U-box domain-con | no | no | 0.928 | 0.925 | 0.314 | 1e-97 | |
| Q9FKG5 | 796 | U-box domain-containing p | no | no | 0.552 | 0.566 | 0.396 | 1e-91 | |
| Q8S8S7 | 801 | U-box domain-containing p | no | no | 0.534 | 0.544 | 0.411 | 1e-91 | |
| Q9FKG6 | 845 | U-box domain-containing p | no | no | 0.552 | 0.533 | 0.378 | 1e-86 | |
| Q0DR28 | 518 | U-box domain-containing p | no | no | 0.495 | 0.779 | 0.375 | 5e-79 | |
| Q9FGD7 | 765 | Putative U-box domain-con | no | no | 0.578 | 0.616 | 0.325 | 2e-59 | |
| C0LGU1 | 959 | Probable LRR receptor-lik | no | no | 0.344 | 0.293 | 0.394 | 1e-50 |
| >sp|Q8GUH1|PUB33_ARATH U-box domain-containing protein 33 OS=Arabidopsis thaliana GN=PUB33 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 558 bits (1437), Expect = e-158, Method: Compositional matrix adjust.
Identities = 327/819 (39%), Positives = 464/819 (56%), Gaps = 61/819 (7%)
Query: 23 EKVYVALGKCVEKGLSLLHWTLQRFGSSREICILHVHQPSPVIPTLLGKLPASQASAEVL 82
EK++VA+ K V K S L W LQ G ++IC++HVHQPS +IP + K P E +
Sbjct: 45 EKIFVAVDKHVAKSKSTLIWALQNTGG-KKICLIHVHQPSQMIPLMGAKFPVGAVKEEEV 103
Query: 83 SAFRAEERQKMKKLLDNYLRICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAF 142
FR +ER+K+ +LD+YLRIC + V+A + E + I+ IVQL++ GI+KLVMGA
Sbjct: 104 RVFREKEREKVHMILDDYLRICQQRGVRAEKMFIEMESIENGIVQLISELGIRKLVMGAA 163
Query: 143 PDNCMKVKMG---SRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPNSFLPFCGAETR 199
D +M SRKA + + AP C+IWF KG + T+EA+ E+
Sbjct: 164 ADRHYSRRMTDLKSRKAIFVRREAPTLCQIWFTCKGYLIHTREAT--------MDDTESE 215
Query: 200 SAKMLRSRSLENCNGTSLFNPESILSRSATTLTHVGITDWVQSDPVHMVFPSSPT----- 254
A S S + T PES ++ V TD VQ +V S T
Sbjct: 216 YASPRPSISASDLLQT-FSTPES----EHQHISRVQSTDSVQ----QLVSNGSSTEQSGR 266
Query: 255 ISCSDMNLFSPRSSSAGS------GYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEELR 308
+S +N S GS MS S S +D V+ R+ + +A +
Sbjct: 267 VSDGSLNTDEEERESDGSEVTGSATVMSSGHSSPSSFPDGVDDSFNVKIRKATSEAHSSK 326
Query: 309 NSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKA 368
AFAE LRR+K E A++AI + K ESAY+ E+ RK+ E A+ + +K E+
Sbjct: 327 QEAFAETLRRQKAEKNALDAIRRAKQSESAYSEELKRRKDTEIAVAKEKERFITIKNEQE 386
Query: 369 FVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVR 428
+ +EL M A+L S+ +++ ++ +L + + L+ E++ ++ ++ A+R
Sbjct: 387 VIMEELQSAMAQKAMLESQIAKSDGTMEKLNQKLDIAVKLLQKLRDEREELQTERDRALR 446
Query: 429 WLERWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYK 488
E RS + + +FS ++++ AT +F + K+G+GG+G +Y
Sbjct: 447 EAEELRSHAETSTLQLPQYF---------TDFSFSEIEEATNHFDSTLKIGEGGYGSIYV 497
Query: 489 GEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNG 548
G + VAIKML ++ QG +E+QQEV VLSK++HP+++TL+GACPE WSLVYEYLP G
Sbjct: 498 GLLRHTQVAIKMLNPNSSQGPVEYQQEVDVLSKMRHPNIITLIGACPEGWSLVYEYLPGG 557
Query: 549 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 608
SL+DRL K N PL W++R RIA EI + L FLHS+K +VHGDLKP NILLDS L S
Sbjct: 558 SLEDRLTCKDNSPPLSWQNRVRIATEICAALVFLHSNKAHSLVHGDLKPANILLDSNLVS 617
Query: 609 KICDFGICRLVTEDTLYLPSFHRS--TAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIIL 666
K+ DFG C L+ P+ +S T G+ Y DPE +G LTPKSD YSFG+I+L
Sbjct: 618 KLSDFGTCSLLH------PNGSKSVRTDVTGTVAYLDPEASSSGELTPKSDVYSFGIILL 671
Query: 667 QLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPD 726
+LLTGR + ++ EV+ A+ G L+ +LDPLAGDWP A +L L L+CCE RPD
Sbjct: 672 RLLTGRPALRISNEVKYALDNGTLNDLLDPLAGDWPFVQAEQLARLALRCCETVSENRPD 731
Query: 727 ITPSLVKELEQLHVA------------EERPVPSFFLCPILQEIMHDPQVAADGFTYEGK 774
+ + + LE + + E R P +F+CPI QE+M DP VAADGFTYE +
Sbjct: 732 LGTEVWRVLEPMRASSGGSSSFHLGRNEHRIAPPYFICPIFQEVMQDPHVAADGFTYEAE 791
Query: 775 AIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDWL 813
AIR WL++ +TSPMTN++LSH L NHALR AIQ+WL
Sbjct: 792 AIRAWLDSEHDTSPMTNVKLSHTSLIANHALRSAIQEWL 830
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q94A51|PUB32_ARATH U-box domain-containing protein 32 OS=Arabidopsis thaliana GN=PUB32 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 386 bits (992), Expect = e-106, Method: Compositional matrix adjust.
Identities = 265/830 (31%), Positives = 427/830 (51%), Gaps = 83/830 (10%)
Query: 23 EKVYVALGKCVEKGLSLLHWTLQRFGSSREICILHVHQPSPVIPTLLGKLPASQASAEVL 82
E ++VA+ + VE+ + + W + F S ++IC+L+VH+ + KL +
Sbjct: 15 ETIFVAVAEDVERSKTTVLWAARNF-SGKKICLLYVHRTARAASWTHKKLVGGSFKKHDV 73
Query: 83 SAFRAEERQKMKKLLDNYLRICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAF 142
E+ K+ +L+++YL++ E E++ + I++ IV+L+ H I+ LVMGA
Sbjct: 74 KVIERVEKPKVDELMNSYLQLLSETEIQTDKLCIAGQNIEECIVELIARHKIKWLVMGAA 133
Query: 143 PDNCMKVKMG---SRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPN---SFLPFC-- 194
D KM S+KA + K AP C IWF+ KG ++T+ +++ N + P
Sbjct: 134 SDKHYSWKMTDLKSKKAIFVCKKAPDSCHIWFLCKGYLIFTRASNDDSNNRQTMPPLVQL 193
Query: 195 --GAETRSAKMLRS----------RSLENCNG---TSLFNPESILSRSATTLTHVGITDW 239
ETR ++ L S RSL +G T E + R+ + +
Sbjct: 194 DSDNETRKSEKLESSYMRRRLRYWRSLLEQDGEKDTGQLEREKVEPRAPPLFSSGSSS-- 251
Query: 240 VQSDPVHMVFPSSPTISCSDMNLFSPRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHRE 299
+PV P SP + SD + + + EK D KV ++ +
Sbjct: 252 SFGEPVGPE-PVSPELVDSD---------TLNTSNVEEKEREGDVARKVH------RYDK 295
Query: 300 VSIKAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQD 359
+ + + E ++ + ++ EA+ K KA E +E RK E+ L+ +
Sbjct: 296 AMHDIGQSDRTVYGEAGKKWEEDASTTEALCKAKALEGLCIKESSQRKRLEELLEKEKLE 355
Query: 360 QEKLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRI 419
+ + ++ +EL L S+ ++ E + + + +Q++ I
Sbjct: 356 VKMVIEQNNGFMKELQMVQGRNLKLESQMRKLQDLEKEHGEKFDTAMELLKSFRQKRDEI 415
Query: 420 RRQKVEAVRWLERWRS--RGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFK 477
R AV+ + R +G+ G ++ E ++S ++ AT F S+K
Sbjct: 416 RIDHENAVKEVNALRRLVKGETGESSGS----------EMLDYSFMEINEATNEFDPSWK 465
Query: 478 VGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEA 537
+G+G +G VYKG + VA+KML S+ EF++ V +LS+++HP+LVTL+GACPE+
Sbjct: 466 LGEGKYGSVYKGNLQHLQVAVKMLPSYGSLNHFEFERRVEILSRVRHPNLVTLMGACPES 525
Query: 538 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKP 597
SL+Y+Y+PNGSL+D ++NV L W+ R RIA+EI S L FLHS+ P I+HG+LKP
Sbjct: 526 RSLIYQYIPNGSLEDCFSSENNVPALSWESRIRIASEICSALLFLHSNIP-CIIHGNLKP 584
Query: 598 QNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSD 657
ILLDS L +KI D+GI +L+ D L S P+ DP Y + +T +SD
Sbjct: 585 SKILLDSNLVTKINDYGISQLIPIDGL-----------DKSDPHVDPHYFVSREMTLESD 633
Query: 658 SYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCC 717
Y+FG+I+LQLLT R G+ +V+ A+ +S++LD AGDWP ++L ++ ++CC
Sbjct: 634 IYAFGIILLQLLTRRPVSGILRDVKCALENDNISAVLDNSAGDWPVARGKKLANVAIRCC 693
Query: 718 ELYGRERPDITPSLVKELEQLHVAE---------------ERPVPSFFLCPILQEIMHDP 762
+ RPD+ +++ ++++ E RP PS +LCPI QE+M DP
Sbjct: 694 KKNPMNRPDLA-VVLRFIDRMKAPEVPSSETSSYANQNVPRRP-PSHYLCPIFQEVMKDP 751
Query: 763 QVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDW 812
+AADGFTYE +AIR+WL NG +TSPMTNL++ +L PNHAL AIQDW
Sbjct: 752 LIAADGFTYEAEAIREWLANGHDTSPMTNLKMEDCNLIPNHALHLAIQDW 801
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q9SW11|PUB35_ARATH U-box domain-containing protein 35 OS=Arabidopsis thaliana GN=PUB35 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 363 bits (931), Expect = 4e-99, Method: Compositional matrix adjust.
Identities = 269/839 (32%), Positives = 420/839 (50%), Gaps = 80/839 (9%)
Query: 25 VYVALGKCVEKGLSLLHWTLQRFGSSREIC--ILHVHQPSPVIPTLLGK-LPASQASAEV 81
V VAL K ++ W +++F + + +LH+H +PT +G +P S+ +V
Sbjct: 22 VVVALSGS-SKSKYVVTWAIEKFATEGNVGFKLLHIHPMITSVPTPMGNAIPISEVRDDV 80
Query: 82 LSAFRAEERQKMKKLLDNYLRICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGA 141
++A+R E + +++L Y ++ V +V ++ E+D + AI + + I ++V+G
Sbjct: 81 VTAYRQEILWQSEEMLKPYTKLFVRRKVAVEVLVIESDNVAAAIAEEVTRDSIDRIVIGG 140
Query: 142 FPDNCMKVKMGSRKA---SYAAKNAPMFCEIWFVNKGKHVWTKEASESPNSFLPFCGAET 198
+ SRKA S + P FC ++ V+KGK + + N+ + G+E
Sbjct: 141 SSRSFF-----SRKADICSVISALMPNFCTVYVVSKGKLSCVRPSDSDGNATIREDGSER 195
Query: 199 RSAKMLRSRSLENCNG--TSLFNPES-ILSRSATTLTHVGITDWVQSDPVHMVFPSSPTI 255
++ S + + +S + +S LS + H S P+ S
Sbjct: 196 TNSSSGSSGPTSDSSDVMSSAHDSQSRPLSLPVRRMQHFPAIAGQASVPMETSSVGSDET 255
Query: 256 SCSDMNLFSPRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSAFAEF 315
C ++ R S S R STD+ S+ + R+ ++ + N + F
Sbjct: 256 RCMSLDAEEARDVS------SINRSSTDTTSRWTPRRRDYEERKEAMSSSS-SNREYGNF 308
Query: 316 LRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDAL--QTTIQDQEKLKQEKAFVTQE 373
R + +G ++ ++R DAL Q+ +Q L F ++
Sbjct: 309 GTRF-----SWSGMG----VDTTHSRASQQASNMSDALSEQSYTDNQVNLN----FEVEK 355
Query: 374 LHRTMRNVALLNSRAQ-----------EANRRR-DEATG--ELKLIQASIATL-QQEKQR 418
L +R+V + + AQ E N+RR +EA ELKL + L ++EKQ
Sbjct: 356 LRAELRHVQEMYAVAQTETFDASRKLGELNQRRLEEAIKLEELKLKEYEARELAEKEKQN 415
Query: 419 IRRQKVEAV-------------RWLERWRSRGQAGAANYDGFIGLVEDLPESAEFSLADL 465
+ + +A R ER +R +G +G + + F+ ++
Sbjct: 416 FEKARRDAESMRERAEREIAQRREAERKSARDTKEKEKLEGTLGSPQ--LQYQHFAWEEI 473
Query: 466 QTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP 525
AT +FSE K+G G +G VYK + T +K+L S Q +FQQE+ +LSK++HP
Sbjct: 474 MAATSSFSEELKIGMGAYGAVYKCNLHHTTAVVKVLQSAENQLSKQFQQELEILSKIRHP 533
Query: 526 HLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 585
HLV LLGACPE +LVYEY+ NGSL+DRLF+ +N PL W +R RIA E+A+ L FLH S
Sbjct: 534 HLVLLLGACPEQGALVYEYMENGSLEDRLFQVNNSPPLPWFERFRIAWEVAAALVFLHKS 593
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP-SFHRSTAPKGSFPYADP 644
KP+ I+H DLKP NILLD SK+ D G+ +V D L + ++ T+P G+ Y DP
Sbjct: 594 KPKPIIHRDLKPANILLDHNFVSKVGDVGLSTMVQVDPLSTKFTIYKQTSPVGTLCYIDP 653
Query: 645 EYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV-SCGKLSSILDPLAGDWPT 703
EY RTG ++ KSD YSFG+I+LQLLT + + L V A+ S + ILD AG+WP
Sbjct: 654 EYQRTGRISSKSDIYSFGMILLQLLTAKPAIALTHFVESAMDSNDEFLKILDQKAGNWPI 713
Query: 704 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPVPSF----------FLCP 753
R L L L C EL G++RPD+ ++ LE L E+ SF F+CP
Sbjct: 714 EETRELAALALCCTELRGKDRPDLKDQILPALENLKKVAEKARNSFSGVSTQPPTHFICP 773
Query: 754 ILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDW 812
+L+++M++P VAADG+TY+ AI +WL+ TSPMT+ L +L PN+ L AI +W
Sbjct: 774 LLKDVMNEPCVAADGYTYDRHAIEEWLKE-HNTSPMTDSPLHSKNLLPNYTLYTAIMEW 831
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LU47|PUB53_ARATH Putative U-box domain-containing protein 53 OS=Arabidopsis thaliana GN=PUB53 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 358 bits (918), Expect = 1e-97, Method: Compositional matrix adjust.
Identities = 267/849 (31%), Positives = 422/849 (49%), Gaps = 91/849 (10%)
Query: 7 AVPSQLPEIVEEEGGGEKVYVALGKCVE-KGLSLLHWTLQRFGSSREIC--ILHVHQPSP 63
AV +QLP+ + E + VAL K +++ W L +FGS + + ++H+H
Sbjct: 14 AVRAQLPKRADLAAPSEPMTVALAISGSIKSKNVIKWALNKFGSDKNVTFKLIHIHPKIT 73
Query: 64 VIPTLLGKLPA-SQASAEVLSAFRAEERQKMKK-LLDNYLRICVEAEVK----------- 110
+PT G + + S+ EV +A+R + Q+ K+ LL + ++C ++K
Sbjct: 74 TLPTASGNIVSISEELEEVAAAYRQKVMQETKETLLKPFKKMCERKKLKIDETRFESSLT 133
Query: 111 ---ARIITTEADKIQKAIVQLMNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFC 167
+ E++ + AI + +N H I L++G + AS +A + C
Sbjct: 134 KVAVELQVLESNSVAVAITKEVNQHLISNLIIGR-SSQAASSRNYDITASISA-SVSNLC 191
Query: 168 EIWFV-NKGKHVWTKEASESPNSFLPFCGAETRSAKMLRSRSLENCNGTSLFNPESILSR 226
++ V N G H+ K+ S++ + R++ S S N + ++S
Sbjct: 192 TVYVVSNGGVHILAKDTSDTERNDTSIESGFERTSSSCSSGSGANSD---------VMSN 242
Query: 227 SATTLTHVGITDWVQSDPVHMVFPSSPT-ISCSDMNLFSPRSSSAGSGYMSEKRESTDSD 285
+ + H +Q+ P + S P S ++ + RSS A + KR S ++
Sbjct: 243 ALKSNPHTLSNKRMQNLPTIVRGVSVPMETSSTESDETKKRSSDAAEE--ASKRSSPETS 300
Query: 286 SKVEEDPLYVQHREVSIKAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHL 345
V +P F +F RK +AM ++ + + H
Sbjct: 301 RSVSWNP------------------QFRDFDERK----DAMSSMSSNFEYGNVVTPLGHY 338
Query: 346 RKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEAT-GELKL 404
+ +D T+ + KL+ E L A+ +A+R+ +E EL L
Sbjct: 339 FTDNQD----TLNEISKLRAE-------LRHAHEMYAVAQVETLDASRKLNELKFEELTL 387
Query: 405 IQ---ASIATLQQEK--QRIRRQKVEAVRWLERWRSRGQAGAANYDGFIGLVEDLPESAE 459
++ IA + EK Q+ R ++ A R ++ +A LV + E
Sbjct: 388 LEHETKGIAKKETEKFEQKRREEREAAQRREAEMKATHEAKEKEKLEESSLVAPKLQYQE 447
Query: 460 FSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVL 519
F+ ++ AT +FSE K+G G +G VYK + A+K+L+S +F QE+ +L
Sbjct: 448 FTWEEIINATSSFSEDLKIGMGAYGDVYKCNLHHTIAAVKVLHSAESSLSKQFDQELEIL 507
Query: 520 SKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 579
SK++HPHLV LLGACP+ +LVYEY+ NGSL+DRLF+ ++ P+ W R RIA E+AS L
Sbjct: 508 SKIRHPHLVLLLGACPDHGALVYEYMENGSLEDRLFQVNDSQPIPWFVRLRIAWEVASAL 567
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV-TEDTLYLP-SFHRSTAPKG 637
FLH SKP I+H DLKP NILL+ SK+ D G+ ++ D L + ++ T+P G
Sbjct: 568 VFLHKSKPTPIIHRDLKPANILLNHNFVSKVGDVGLSTMIQAADPLSTKFTMYKQTSPVG 627
Query: 638 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCG---KLSSIL 694
+ Y DPEY RTG ++PKSD Y+FG+IILQLLTG+ + L V A+ +L IL
Sbjct: 628 TLCYIDPEYQRTGRISPKSDVYAFGMIILQLLTGQQAMALTYTVETAMENNNDDELIQIL 687
Query: 695 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH-----------VAEE 743
D AG+WP R+L L LQC EL ++RPD+ ++ LE L A
Sbjct: 688 DEKAGNWPIEETRQLAALALQCTELRSKDRPDLEDQILPVLESLKKVADKARNSLSAAPS 747
Query: 744 RPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNH 803
+P PS F CP+L+++M +P +AADG+TY+ +AI +W+EN R TSP+TN L +++L PNH
Sbjct: 748 QP-PSHFFCPLLKDVMKEPCIAADGYTYDRRAIEEWMENHR-TSPVTNSPLQNVNLLPNH 805
Query: 804 ALRHAIQDW 812
L AI +W
Sbjct: 806 TLYAAIVEW 814
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FKG5|PUB51_ARATH U-box domain-containing protein 51 OS=Arabidopsis thaliana GN=PUB51 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 338 bits (866), Expect = 1e-91, Method: Compositional matrix adjust.
Identities = 195/492 (39%), Positives = 280/492 (56%), Gaps = 41/492 (8%)
Query: 361 EKLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQA------SIATLQQ 414
EKLK E + V + + Q+ N+RR E LK + + +++
Sbjct: 300 EKLKIELRHIKGMYAVAQSEVIDASKKMQDLNQRRSEEATRLKNLTIREEEADEVVEMER 359
Query: 415 EKQRIRRQKVEAVR-WLERW---RSRGQAGAANYDGFIGLVEDLPESA--------EFSL 462
E+Q + E VR +ER R +A A +ED E +F
Sbjct: 360 ERQEDAENEAELVRECIERETEERLEAEARAEEVRKEKQRLEDALEGGPLQRQQYMKFEW 419
Query: 463 ADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL 522
++ AT +FS+ K+G GG+G VY+ + TVA+K+L+S +F QE+ +LSK+
Sbjct: 420 EEIVEATSSFSDELKIGVGGYGSVYRCNLHHTTVAVKVLHSDKSSLTKQFHQELEILSKI 479
Query: 523 QHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLF-RKSNVS-----PLLWKDRARIAAEIA 576
+HPHL+ LLGACPE SLVYEY+ NGSL++RL R+ NV PL W +R RIA EIA
Sbjct: 480 RHPHLLLLLGACPERGSLVYEYMHNGSLEERLMKRRPNVDTPQPPPLRWFERFRIAWEIA 539
Query: 577 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 636
S L FLH+++P IVH DLKP NILLD SKI D G+ ++V D + + T P
Sbjct: 540 SALYFLHTNEPRPIVHRDLKPANILLDRNNVSKIGDVGLSKMVNLDPSHASTVFNETGPV 599
Query: 637 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV--SCGKLSSIL 694
G+F Y DPEY RTGV+TP+SD Y+FG+I+LQL+T R +GLA + +A+ GK + IL
Sbjct: 600 GTFFYIDPEYQRTGVVTPESDIYAFGIILLQLVTARSAMGLAHSIEKALRDQTGKFTEIL 659
Query: 695 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH--------------V 740
D AGDWP A+ +V +GL+C E+ R+RPD+ ++ LE+L +
Sbjct: 660 DKTAGDWPVKEAKEMVMIGLRCAEMRKRDRPDLGKEILPVLERLKEVASIARNMFADNLI 719
Query: 741 AEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLT 800
P+ F CPI +++M +P VA+DG+TYE +AI++WL+ + SPMT+L L
Sbjct: 720 DHHHNAPTHFYCPITKDVMENPCVASDGYTYEKRAIKEWLQKNHK-SPMTDLPFPSDSLL 778
Query: 801 PNHALRHAIQDW 812
PNH+L AI++W
Sbjct: 779 PNHSLLSAIKEW 790
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8S8S7|PUB34_ARATH U-box domain-containing protein 34 OS=Arabidopsis thaliana GN=PUB34 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 338 bits (866), Expect = 1e-91, Method: Compositional matrix adjust.
Identities = 190/462 (41%), Positives = 265/462 (57%), Gaps = 26/462 (5%)
Query: 372 QELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVR-WL 430
+EL T V +L++ ++R + A E + +Q + A L++E+ ++VE + L
Sbjct: 334 EELFSTQNKVKMLSTEYLNESKRVNNAV-EKEELQRNTAALEKERYMKAVKEVETAKALL 392
Query: 431 ERWRSRGQAGAAN-----------YDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVG 479
R + Q N D +G ++++ ++ TAT FS +G
Sbjct: 393 AREFCQRQIAEVNALRTYLEKKKVIDQLLGTDH---RYRKYTIEEIVTATEGFSPEKVIG 449
Query: 480 QGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWS 539
+GG+G VY+ + A+K++ + + EF +EV VLS+L+HPH+V LLGACPE
Sbjct: 450 EGGYGKVYQCSLDSTPAAVKVVRLDTPEKKQEFLKEVEVLSQLRHPHVVLLLGACPENGC 509
Query: 540 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQN 599
LVYEYL NGSL++ +F + N PL W R R+ E+A GL FLHSSKPE IVH DLKP N
Sbjct: 510 LVYEYLENGSLEEYIFHRKNKPPLPWFIRFRVIFEVACGLAFLHSSKPEPIVHRDLKPGN 569
Query: 600 ILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSY 659
ILL+ SKI D G+ +LVT+ + +R++ G+ Y DPEYHRTG + PKSD Y
Sbjct: 570 ILLNRNYVSKIADVGLAKLVTDVAPDNVTMYRNSVLAGTLHYIDPEYHRTGTIRPKSDLY 629
Query: 660 SFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCEL 719
+FG+IILQLLT R P G+ V AV G L+ +LD DWP L +GL+C E
Sbjct: 630 AFGIIILQLLTARNPSGIVPAVENAVKKGTLTEMLDKSVTDWPLAETEELARIGLKCAEF 689
Query: 720 YGRERPDITPSLVKELEQLHVAEERPV---------PSFFLCPILQEIMHDPQVAADGFT 770
R+RPD+ ++ L++L V PS + CPIL+EIM +P++AADGFT
Sbjct: 690 RCRDRPDLKSEVIPVLKRLVETANSKVKKEGSNLRAPSHYFCPILREIMEEPEIAADGFT 749
Query: 771 YEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDW 812
YE KAI WLE SP+T +L H LTPNH LR AI+DW
Sbjct: 750 YERKAILAWLEK-HNISPVTRQKLDHFKLTPNHTLRSAIRDW 790
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FKG6|PUB52_ARATH U-box domain-containing protein 52 OS=Arabidopsis thaliana GN=PUB52 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 322 bits (824), Expect = 1e-86, Method: Compositional matrix adjust.
Identities = 181/478 (37%), Positives = 268/478 (56%), Gaps = 27/478 (5%)
Query: 361 EKLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLI----QASIATLQQEK 416
EKL+ E V + + + E N+RR E + +L + + + T +EK
Sbjct: 364 EKLRAELKHVQEMYAMAQTETVGASKKLTELNQRRFEESEKLVELKEKEEVAKDTASKEK 423
Query: 417 QRIRR-----QKVEAVRWLERWRSRGQAGAANYDGF------IGLVEDLPESAEFSLADL 465
QR +KV+ + E R A D LV + ++ ++
Sbjct: 424 QRYEEAMKEAEKVKELMMKEALHRREAEFKAERDAREKDKLQASLVSPGVQYQHYTWEEI 483
Query: 466 QTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP 525
AT +F+E+ K+G G +G VYK + T A+K+L++ Q +F QE+ +LSK++HP
Sbjct: 484 AAATSDFAENLKIGIGAYGSVYKCNLHHTTGAVKVLHAGETQLSKQFDQELEILSKIRHP 543
Query: 526 HLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 585
HLV LLGACPE LVYEY+ NGSL DRL ++ P+ W +R RIA E+AS L FLH S
Sbjct: 544 HLVLLLGACPERGCLVYEYMDNGSLDDRLMLVNDTPPIPWFERFRIALEVASALVFLHKS 603
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 645
KP I+H DLKP NILLD SK+ D G+ +V +D + + + T+P G+ Y DPE
Sbjct: 604 KPRPIIHRDLKPGNILLDHNFVSKLGDVGLSTMVNQDDVSSRTIFKQTSPVGTLCYIDPE 663
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV-SCGKLSSILDPLAGDWPTF 704
Y RTG+++PKSD YS G++ILQL+T + + + V A+ + +ILD AG WP
Sbjct: 664 YQRTGIISPKSDVYSLGVVILQLITAKPAIAITHMVEEAIGDDAEFMAILDKKAGSWPIS 723
Query: 705 VARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPV----------PSFFLCPI 754
R L LGL C E+ R+RPD+ ++ LE+L ++ PS F+CP+
Sbjct: 724 DTRELAALGLCCTEMRRRDRPDLKDQIIPALERLRKVADKAQNLLSRTPSGPPSHFICPL 783
Query: 755 LQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDW 812
L+ +M++P VAADG+TY+ +AI +WL ++TSP+TNL L + +L N+ L AI +W
Sbjct: 784 LKGVMNEPCVAADGYTYDREAIEEWLRQ-KDTSPVTNLPLPNKNLIANYTLYSAIMEW 840
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q0DR28|PUB57_ORYSJ U-box domain-containing protein 57 OS=Oryza sativa subsp. japonica GN=PUB57 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 296 bits (758), Expect = 5e-79, Method: Compositional matrix adjust.
Identities = 165/440 (37%), Positives = 247/440 (56%), Gaps = 36/440 (8%)
Query: 392 NRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRGQAGAANYDGFIGLV 451
+R+ E ++ +++ I TL+ + QK +AV ++ + D + V
Sbjct: 81 DRKTYEEVRKVHILEEEIVTLKHQADTYLVQKEKAVTAYDQLKHER-------DNAVQQV 133
Query: 452 EDLPESA-----EFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNM 506
+L + + +FS D++ AT +F + +VG +G YKG + V IK+ S +
Sbjct: 134 NELRDQSTHIILDFSRKDMEQATEHFKNAREVGDTEYGHTYKGMIHNMKVLIKLSSSQKL 193
Query: 507 QGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWK 566
FQQEV +L + +HP+++T +G C E +LVYE+LPNG+L+DR+ +N +PL W
Sbjct: 194 -----FQQEVSILRQWRHPNIITFIGVCSEVSALVYEWLPNGNLEDRIICTNNSAPLSWY 248
Query: 567 DRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626
+R +I EI L FLHS+K +VHGDL+P NIL+D+ SKIC+FG+ L + +
Sbjct: 249 NRTQIIGEICCALLFLHSNKSTALVHGDLRPCNILIDANYRSKICNFGMSNLFLQLGTFP 308
Query: 627 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS 686
P+ PY DPE++ TG LT SD YS G+IIL+LLTG P+ L+ +V A+
Sbjct: 309 PNL------TARLPYMDPEFNTTGELTTLSDVYSLGVIILRLLTGMPPLTLSEKVAEALG 362
Query: 687 CGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL-------- 738
L ++D AGDWP A++L +GL C + ++RPD+ + +E L
Sbjct: 363 SDSLHLLIDKSAGDWPYIEAKQLALIGLSCTGMTRKKRPDLLNEVWIVIEPLTRKPPAAT 422
Query: 739 -----HVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLR 793
+ + VP+ F+CPI EIM DPQVA+DGFTYE +AIR W + G SPMTNL
Sbjct: 423 WPYLQSASGDSSVPAAFICPISMEIMKDPQVASDGFTYEAEAIRCWFDRGISRSPMTNLA 482
Query: 794 LSHLHLTPNHALRHAIQDWL 813
L +L+L PN LR I +L
Sbjct: 483 LPNLNLVPNRVLRSFIHGYL 502
|
Possesses E3 ubiquitin-protein ligase in vitro. May be involved in cell death signaling. Oryza sativa subsp. japonica (taxid: 39947) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q9FGD7|PUB50_ARATH Putative U-box domain-containing protein 50 OS=Arabidopsis thaliana GN=PUB50 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 231 bits (589), Expect = 2e-59, Method: Compositional matrix adjust.
Identities = 184/565 (32%), Positives = 284/565 (50%), Gaps = 93/565 (16%)
Query: 287 KVEEDPLYV--QHREVSIKAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMH 344
KV E L + + REV + AE + +A L ++ FE A+ +E
Sbjct: 251 KVNEAKLMIDEKSREVKVNAERSNRAEWAISL-----------CNSRIGEFE-AWIKEES 298
Query: 345 LRKEAEDALQTTIQ-DQEKLKQEKAFVTQ---ELHRTMRNVALLNSRAQEANRRRDEATG 400
R+E LQ T+ D+E +++ K +V + +LH +L+S+ + + +A
Sbjct: 299 ERREK---LQATLDSDKECIEEAKNYVEKGKTKLHSLAELQEVLSSKVKTMMEAKSQAEV 355
Query: 401 ELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRGQAGAANYDGFIGLVEDLPESAEF 460
EL+ + + E +++R Q+ R +E + R G+ + + E E+
Sbjct: 356 ELERVVLQRGEMITEIEKLRSQRDVFNRRIEFCKEREVIGSVSKE------EVKCGYREY 409
Query: 461 SLADLQTATCNFSESFKVGQGG-FGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVL 519
D++ AT +S+ ++ GG + VY+G + TVA+K++ + F +V++L
Sbjct: 410 VAEDIRLATETYSDRLRLKSGGNWTNVYRGRIKHTTVAVKVI--GDSLSDEAFGAKVKLL 467
Query: 520 SKLQHPHLVTLLGACPE-AWSLVYEYLPNGSLQDRLF---RKSNVSPLL-WKDRARIAAE 574
++++HP+LV + G C + L++EY+ NG+L+D LF RKS S +L W DR RIA +
Sbjct: 468 NEIRHPNLVAIAGFCSQRPKCLLFEYMHNGNLRDNLFTSQRKSRRSKILKWHDRIRIAHQ 527
Query: 575 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 634
+ SGL FLHS KP+ IVHG L P ILLD L KI FG L + S T
Sbjct: 528 VCSGLGFLHSVKPKPIVHGRLTPSKILLDRNLVPKITGFG---------LIMHSDQSDTK 578
Query: 635 PKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSI- 693
P D +FG+++L LLTGR GL +A+S + S +
Sbjct: 579 P---------------------DVMAFGVLLLHLLTGRNWHGLL----KAMSMNQTSILR 613
Query: 694 -LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDI-TPSLVKELEQL------------- 738
LD AG WP +A+ L ++C + D T +++EL ++
Sbjct: 614 DLDQTAGKWPLELAKEFGALAVKCSSVNRGGNMDFSTKEIMEELGKIREKADEFKTKGGY 673
Query: 739 ------HVAEERP--VPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMT 790
++ E P +PS F+CPILQE+M +P VAADGF+YE +AI++WL G +TSPMT
Sbjct: 674 EEATNSNMDEGDPNDIPSVFMCPILQEVMKNPHVAADGFSYELEAIQEWLSMGHDTSPMT 733
Query: 791 NLRLSHLHLTPNHALRHAIQDWLCK 815
NLRL + LTPNH LR IQDW K
Sbjct: 734 NLRLDYQMLTPNHTLRSLIQDWHSK 758
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|C0LGU1|Y5374_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g37450 OS=Arabidopsis thaliana GN=At5g37450 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 201 bits (512), Expect = 1e-50, Method: Compositional matrix adjust.
Identities = 118/299 (39%), Positives = 178/299 (59%), Gaps = 18/299 (6%)
Query: 460 FSLADLQTATCNFSESFKVGQGGFGCVYKGEMLG-RTVAIKMLYSHNMQGQLEFQQEVRV 518
++ +L +AT +FS+ ++G+GG+G VYKG + G VA+K ++QGQ EF E+ +
Sbjct: 619 YNFTELDSATSSFSDLSQIGRGGYGKVYKGHLPGGLVVAVKRAEQGSLQGQKEFFTEIEL 678
Query: 519 LSKLQHPHLVTLLGACPEAWS--LVYEYLPNGSLQDRL---FRKSNVSPLLWKDRARIAA 573
LS+L H +LV+LLG C + LVYEY+PNGSLQD L FR+ PL R RIA
Sbjct: 679 LSRLHHRNLVSLLGYCDQKGEQMLVYEYMPNGSLQDALSARFRQ----PLSLALRLRIAL 734
Query: 574 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 633
A G+ +LH+ I+H D+KP NILLDS+++ K+ DFGI +L+ D + H +T
Sbjct: 735 GSARGILYLHTEADPPIIHRDIKPSNILLDSKMNPKVADFGISKLIALDGGGVQRDHVTT 794
Query: 634 APKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV----GLAGEVRRAVSCGK 689
KG+ Y DPEY+ + LT KSD YS G++ L++LTG P+ + EV A G
Sbjct: 795 IVKGTPGYVDPEYYLSHRLTEKSDVYSLGIVFLEILTGMRPISHGRNIVREVNEACDAGM 854
Query: 690 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH---VAEERP 745
+ S++D G + +R ++L ++CC+ RP + +V+ELE ++ EE+P
Sbjct: 855 MMSVIDRSMGQYSEECVKRFMELAIRCCQDNPEARPWML-EIVRELENIYGLIPKEEKP 912
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 816 | ||||||
| 359478641 | 836 | PREDICTED: U-box domain-containing prote | 0.973 | 0.949 | 0.667 | 0.0 | |
| 297746091 | 820 | unnamed protein product [Vitis vinifera] | 0.953 | 0.948 | 0.658 | 0.0 | |
| 356557439 | 780 | PREDICTED: U-box domain-containing prote | 0.950 | 0.994 | 0.622 | 0.0 | |
| 255587037 | 673 | receptor protein kinase, putative [Ricin | 0.816 | 0.989 | 0.694 | 0.0 | |
| 356541238 | 776 | PREDICTED: U-box domain-containing prote | 0.939 | 0.988 | 0.588 | 0.0 | |
| 356547247 | 659 | PREDICTED: U-box domain-containing prote | 0.805 | 0.996 | 0.639 | 0.0 | |
| 224059500 | 736 | predicted protein [Populus trichocarpa] | 0.672 | 0.745 | 0.749 | 0.0 | |
| 224106491 | 439 | predicted protein [Populus trichocarpa] | 0.537 | 1.0 | 0.806 | 0.0 | |
| 449450906 | 671 | PREDICTED: U-box domain-containing prote | 0.807 | 0.982 | 0.561 | 0.0 | |
| 449496721 | 650 | PREDICTED: U-box domain-containing prote | 0.779 | 0.978 | 0.549 | 0.0 |
| >gi|359478641|ref|XP_003632149.1| PREDICTED: U-box domain-containing protein 33-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1070 bits (2767), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 545/817 (66%), Positives = 645/817 (78%), Gaps = 23/817 (2%)
Query: 7 AVPSQLPEIVEEEGGGEKVYVALGKCVEKGLSLLHWTLQRFGSSREICILHVHQPSPVIP 66
AV S L IVEE GG++V+VA+GK VEK SLLHWT +RFGS EIC++HVHQPSP+IP
Sbjct: 36 AVASSLSGIVEE--GGDRVHVAVGKSVEKAESLLHWTFRRFGSC-EICLVHVHQPSPLIP 92
Query: 67 TLLGKLPASQASAEVLSAFRAEERQKMKKLLDNYLRICVEAEVKARIITTEADKIQKAIV 126
TLLGKLPASQA+ EV+SA R EE+++ KLL NY IC +VK IIT EAD +QK IV
Sbjct: 93 TLLGKLPASQANGEVVSAHRREEKKQTNKLLLNYSNICSRMKVKPSIITIEADHVQKGIV 152
Query: 127 QLMNIHGIQKLVMGA-FPDNCMKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASE 185
L+N HGI+KLVMG P+NCMKVKM S KA+YAAK AP FCEIWF++KGKHVWTKEA +
Sbjct: 153 DLVNRHGIRKLVMGGTVPENCMKVKMSSSKANYAAKKAPEFCEIWFIHKGKHVWTKEAFK 212
Query: 186 SPNSFLPFCGAETRSAKMLRSRSLENCNGTSLFNPESILSRSA-TTLTHVGITDWVQSDP 244
+P P +T + + L F PE + S S+ ++ G + V+S+
Sbjct: 213 APGFLPPISHPKTETGEDLG------------FQPECLPSGSSPVSVLSGGDRNGVESEL 260
Query: 245 VHMVFPSSPTISCSD-----MNLFSPRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHRE 299
V SSP +S S + S+ +G G +EKR S DS SK EE+ LY Q E
Sbjct: 261 VRTRVTSSPALSDSTSRNDPQFSPTSSSTFSGYGSSAEKR-SMDSYSKTEEESLYYQLAE 319
Query: 300 VSIKAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQD 359
+I+AE RN AF E L+R+KLESEAMEAI KVKAFESA+ARE+ LRK+AEDAL++TIQ+
Sbjct: 320 ATIEAEASRNEAFLELLKRQKLESEAMEAIAKVKAFESAHAREVELRKDAEDALRSTIQE 379
Query: 360 QEKLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRI 419
Q+KL +E+ +T+E+ +TMRNVALL+SRAQEANRR DEAT ELKLIQASIATLQ EKQ+I
Sbjct: 380 QDKLLEEREKLTREIQKTMRNVALLDSRAQEANRRCDEATEELKLIQASIATLQYEKQKI 439
Query: 420 RRQKVEAVRWLERWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVG 479
RRQK+EA+ WL+RWRSRGQAG ++ +GFIG+ EDLPE AEFSL+DL+TATCNFSESFK+G
Sbjct: 440 RRQKMEAMHWLDRWRSRGQAGTSHCNGFIGVFEDLPELAEFSLSDLETATCNFSESFKIG 499
Query: 480 QGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWS 539
QGG G VYKGEML +TVAIK L+ HNMQGQ EFQ+EV+VL K+QHPHLVTL+GA PEAWS
Sbjct: 500 QGGNGSVYKGEMLDKTVAIKKLHPHNMQGQSEFQREVQVLGKIQHPHLVTLIGASPEAWS 559
Query: 540 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQN 599
LVYEYLPNGSLQDRLFRKSN SPL WK RARI EI+S L FLHS KPEKIVHG+L+P+N
Sbjct: 560 LVYEYLPNGSLQDRLFRKSNNSPLTWKVRARIITEISSALLFLHSCKPEKIVHGNLRPEN 619
Query: 600 ILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSY 659
ILL S+L KICDFGICRLV+++TL PSF R+ PKG+FPY DPE +RTGVLT KSD Y
Sbjct: 620 ILLGSDLRCKICDFGICRLVSDETLRCPSFRRNAEPKGAFPYEDPELYRTGVLTTKSDIY 679
Query: 660 SFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCEL 719
SFG+IILQLLTGR PVGLA EVR+AVSCGKL+SILD AG WPT VA RL DL L+CCEL
Sbjct: 680 SFGVIILQLLTGRPPVGLASEVRKAVSCGKLASILDSSAGVWPTHVASRLADLALRCCEL 739
Query: 720 YGRERPDITPSLVKELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDW 779
R+RP++ P+LV+ELEQLHV+EE+PVPSFFLCPILQ+IMHDP VAADGFTYE +A+ W
Sbjct: 740 NSRDRPELKPTLVRELEQLHVSEEQPVPSFFLCPILQDIMHDPHVAADGFTYEKEALLGW 799
Query: 780 LENGRETSPMTNLRLSHLHLTPNHALRHAIQDWLCKS 816
LENGRETSPMTNLRLSHLHLTPNH+LR IQDWLCKS
Sbjct: 800 LENGRETSPMTNLRLSHLHLTPNHSLRSTIQDWLCKS 836
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297746091|emb|CBI16147.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1045 bits (2701), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 538/817 (65%), Positives = 634/817 (77%), Gaps = 39/817 (4%)
Query: 7 AVPSQLPEIVEEEGGGEKVYVALGKCVEKGLSLLHWTLQRFGSSREICILHVHQPSPVIP 66
AV S L IVEE GG++V+VA+GK VEK SLLHWT +RFGS EIC++HVHQPSP+IP
Sbjct: 36 AVASSLSGIVEE--GGDRVHVAVGKSVEKAESLLHWTFRRFGSC-EICLVHVHQPSPLIP 92
Query: 67 TLLGKLPASQASAEVLSAFRAEERQKMKKLLDNYLRICVEAEVKARIITTEADKIQKAIV 126
TLLGKLPASQA+ EV+SA R EE+++ KLL NY IC +VK IIT EAD +QK IV
Sbjct: 93 TLLGKLPASQANGEVVSAHRREEKKQTNKLLLNYSNICSRMKVKPSIITIEADHVQKGIV 152
Query: 127 QLMNIHGIQKLVMGA-FPDNCMKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASE 185
L+N HGI+KLVMG P+NCMKVKM S KA+YAAK AP FCEIWF++KGKHVWTKEA +
Sbjct: 153 DLVNRHGIRKLVMGGTVPENCMKVKMSSSKANYAAKKAPEFCEIWFIHKGKHVWTKEAFK 212
Query: 186 SPNSFLPFCGAETRSAKMLRSRSLENCNGTSLFNPESILSRSA-TTLTHVGITDWVQSDP 244
+P P +T + + L F PE + S S+ ++ G + V+S+
Sbjct: 213 APGFLPPISHPKTETGEDLG------------FQPECLPSGSSPVSVLSGGDRNGVESEL 260
Query: 245 VHMVFPSSPTISCSD-----MNLFSPRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHRE 299
V SSP +S S + S+ +G G +EKR S DS SK EE+ LY Q E
Sbjct: 261 VRTRVTSSPALSDSTSRNDPQFSPTSSSTFSGYGSSAEKR-SMDSYSKTEEESLYYQLAE 319
Query: 300 VSIKAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQD 359
+I+AE RN AF E L+R+KLESEAMEAI KVKAFESA+ARE+ LRK+AEDAL++TIQ+
Sbjct: 320 ATIEAEASRNEAFLELLKRQKLESEAMEAIAKVKAFESAHAREVELRKDAEDALRSTIQE 379
Query: 360 QEKLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRI 419
Q+KL +E+ +T+E+ +TMRNVALL+SRAQEANRR DEAT ELKLIQASIATLQ EKQ+I
Sbjct: 380 QDKLLEEREKLTREIQKTMRNVALLDSRAQEANRRCDEATEELKLIQASIATLQYEKQKI 439
Query: 420 RRQKVEAVRWLERWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVG 479
RRQK+EA+ WL+RWRSRGQAG ++ +GFIG+ EDLPE AEFSL+DL+TATCNFSESFK+G
Sbjct: 440 RRQKMEAMHWLDRWRSRGQAGTSHCNGFIGVFEDLPELAEFSLSDLETATCNFSESFKIG 499
Query: 480 QGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWS 539
QGG G VYKGEML +TVAIK L+ HNMQGQ EFQ+EV+VL K+QHPHLVTL+GA PEAWS
Sbjct: 500 QGGNGSVYKGEMLDKTVAIKKLHPHNMQGQSEFQREVQVLGKIQHPHLVTLIGASPEAWS 559
Query: 540 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQN 599
LVYEYLPNGSLQDRLFRKSN SPL WK RARI EI+S L FLHS KPEKIVHG+L+P+N
Sbjct: 560 LVYEYLPNGSLQDRLFRKSNNSPLTWKVRARIITEISSALLFLHSCKPEKIVHGNLRPEN 619
Query: 600 ILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSY 659
ILL S+L KICDFGICRL PKG+FPY DPE +RTGVLT KSD Y
Sbjct: 620 ILLGSDLRCKICDFGICRL----------------PKGAFPYEDPELYRTGVLTTKSDIY 663
Query: 660 SFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCEL 719
SFG+IILQLLTGR PVGLA EVR+AVSCGKL+SILD AG WPT VA RL DL L+CCEL
Sbjct: 664 SFGVIILQLLTGRPPVGLASEVRKAVSCGKLASILDSSAGVWPTHVASRLADLALRCCEL 723
Query: 720 YGRERPDITPSLVKELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDW 779
R+RP++ P+LV+ELEQLHV+EE+PVPSFFLCPILQ+IMHDP VAADGFTYE +A+ W
Sbjct: 724 NSRDRPELKPTLVRELEQLHVSEEQPVPSFFLCPILQDIMHDPHVAADGFTYEKEALLGW 783
Query: 780 LENGRETSPMTNLRLSHLHLTPNHALRHAIQDWLCKS 816
LENGRETSPMTNLRLSHLHLTPNH+LR IQDWLCKS
Sbjct: 784 LENGRETSPMTNLRLSHLHLTPNHSLRSTIQDWLCKS 820
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356557439|ref|XP_003547023.1| PREDICTED: U-box domain-containing protein 33-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 981 bits (2536), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 493/792 (62%), Positives = 593/792 (74%), Gaps = 16/792 (2%)
Query: 24 KVYVALGKCVEKGLSLLHWTLQRFGSSREICILHVHQPSPVIPTLLGKLPASQASAEVLS 83
KV+VA+GK ++K + LL WTL F ++ EI I+H +QPS IPTLLGKLPASQAS V+S
Sbjct: 4 KVHVAVGKSLDKAVPLLRWTLNHFRNA-EIVIVHAYQPSLTIPTLLGKLPASQASPAVVS 62
Query: 84 AFRAEERQKMKKLLDNYLRICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAFP 143
AFR ER++ KLLD YL IC A V+A +I TEAD++QK IV L+ H I+KLV+GA P
Sbjct: 63 AFRKAEREQTVKLLDKYLSICRAARVRASVIVTEADQVQKGIVDLVIKHNIEKLVIGAIP 122
Query: 144 DNCMKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPNSFLPFCGAETRSAKM 203
+NCMKVK S KA+Y AKNAP FCE+WF+ KGKH+WT+EASE+P E + +
Sbjct: 123 ENCMKVKRNSGKANYTAKNAPPFCEVWFIYKGKHIWTREASETPCYSSSCTQPEIATRES 182
Query: 204 LRSRSLENCNGTSLFNPESILSRSATTLTHVGITDWVQSDPVHMVFPSSPTISCSDMNLF 263
LR RS + G LF+ E + SA T T G WVQ + + + S S +
Sbjct: 183 LRCRSFQY--GNELFDSEYLQPNSARTTTGSGSRSWVQGE----IIETEAIFSSSCSSHC 236
Query: 264 SPRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSAFAEFLRRKKLES 323
SP++SS R D+ + E+ + Q E +AE + + AFAE L+ +KLE
Sbjct: 237 SPQNSS---------RAYLDTYLEAMEERINKQLIETKREAEAVTDEAFAELLKCEKLEV 287
Query: 324 EAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVAL 383
EAMEAI KV FESA+ RE+ LRKEAEDAL T+Q+Q+KL + EL TMRN+AL
Sbjct: 288 EAMEAIRKVNLFESAHVREVKLRKEAEDALTDTVQEQQKLLNASEEIAGELQMTMRNIAL 347
Query: 384 LNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRGQAGAAN 443
L+SRAQEA+RR DEA EL LIQ SI+TL QE+Q+IRRQK+EA+RWLERWRSRG+ GAA+
Sbjct: 348 LDSRAQEAHRRCDEAADELSLIQESISTLWQERQQIRRQKMEALRWLERWRSRGKVGAAH 407
Query: 444 YDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYS 503
+G IG E+LPE AEFSL+DLQ ATCNFS SF + QGG+ C+YKGEMLGRTVAIK +
Sbjct: 408 CNGVIGFAEELPELAEFSLSDLQNATCNFSNSFIIEQGGYVCIYKGEMLGRTVAIKKFHQ 467
Query: 504 HNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPL 563
HNMQG LEF+QEV+VL LQHPHL+TLLG CPEAWS+VYEYLPNG+LQD LFRKSN SPL
Sbjct: 468 HNMQGPLEFRQEVQVLGSLQHPHLITLLGVCPEAWSIVYEYLPNGTLQDYLFRKSNNSPL 527
Query: 564 LWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623
W RAR+ AEIAS LCFLHS +PE I+HGDLKP+ +LLDS L K+C FG CRLV+E++
Sbjct: 528 TWNTRARMIAEIASALCFLHSFRPESIIHGDLKPETVLLDSSLGCKMCGFGFCRLVSEES 587
Query: 624 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR 683
L PSF ST PKG+F Y DPE+ RTG+LT KSD YSFGLIILQLLTGR PVGLA VR
Sbjct: 588 LLRPSFRLSTEPKGAFTYTDPEFQRTGILTTKSDIYSFGLIILQLLTGRTPVGLAVLVRN 647
Query: 684 AVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE 743
A+SCGKLSSILD AG+WP+ VA RLV+LGLQCC+ Y R+RP++TP+LV+ELEQLH +EE
Sbjct: 648 AISCGKLSSILDSSAGEWPSAVAMRLVELGLQCCQQYRRDRPELTPTLVRELEQLHASEE 707
Query: 744 RPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNH 803
RPVPSFF C IL EIMHDPQVAADGFTYEG AIR+WLENG +TSPMTNL+LSHL LTPNH
Sbjct: 708 RPVPSFFSCQILLEIMHDPQVAADGFTYEGDAIREWLENGHDTSPMTNLKLSHLFLTPNH 767
Query: 804 ALRHAIQDWLCK 815
ALR AIQDWLCK
Sbjct: 768 ALRLAIQDWLCK 779
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255587037|ref|XP_002534109.1| receptor protein kinase, putative [Ricinus communis] gi|223525841|gb|EEF28277.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 946 bits (2446), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 469/675 (69%), Positives = 543/675 (80%), Gaps = 9/675 (1%)
Query: 145 NCMKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPNSFLPFCGAETRSAKML 204
+CMKVK S KA Y AK+AP FCEIWF+NKGKH+WTKEA E + + S L
Sbjct: 5 SCMKVKKSSDKADYVAKSAPYFCEIWFINKGKHIWTKEAFERSSH------SGGASDDTL 58
Query: 205 RSRSLENCNGTSLFNPESILSRSATTLTHVGITDWVQSDPVHMVFPSSPTISCSDMNLF- 263
S+SL PE + S SAT + ++DWVQ + + P T S + F
Sbjct: 59 GSKSLRYSKNIMPLYPEYLQSTSATGIPCASVSDWVQIESNNSEEPVLHTRSSTTNGCFP 118
Query: 264 --SPRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSAFAEFLRRKKL 321
+ S+S+ S +E+R S DSDSKVEE+ LY Q E I+AE RN AF E LRRKK+
Sbjct: 119 QSAFSSTSSSSRASTERRVSLDSDSKVEEESLYCQLAEARIEAEASRNEAFEELLRRKKI 178
Query: 322 ESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNV 381
E + +EAI KVK FESAY E+ LRKEAEDAL+ TI++Q KL +EK VT+EL RTMRN+
Sbjct: 179 EFQTLEAISKVKIFESAYENEVKLRKEAEDALRITIEEQVKLLKEKEEVTRELQRTMRNL 238
Query: 382 ALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRGQAGA 441
ALL++R +EANRR+DEA GELKLIQ SIA+L+QEKQRI+RQK+EAVRWLERWR+RG AGA
Sbjct: 239 ALLDNRGKEANRRQDEAAGELKLIQTSIASLRQEKQRIQRQKMEAVRWLERWRNRGPAGA 298
Query: 442 ANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKML 501
N +GF+G VE+LPE AEF L+DL+TATCNFSESFK+GQGG+GCVYKGEMLGRTVAIK L
Sbjct: 299 PNCNGFLGFVEELPELAEFLLSDLETATCNFSESFKLGQGGYGCVYKGEMLGRTVAIKKL 358
Query: 502 YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVS 561
+ HNMQGQ EFQ+EV+VL KLQHPHLVTLLG+CPEAWSLVYEYLPNGSL + LFR+SN+S
Sbjct: 359 HPHNMQGQSEFQKEVQVLGKLQHPHLVTLLGSCPEAWSLVYEYLPNGSLHECLFRRSNIS 418
Query: 562 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621
PL WK RARI AEI+S +CFLHSS PEKIVHGDLKPQNILLDSELS KIC+FGICRLVT+
Sbjct: 419 PLTWKVRARIIAEISSAVCFLHSSNPEKIVHGDLKPQNILLDSELSCKICEFGICRLVTD 478
Query: 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV 681
DTLY P FHR PKG+FPY DPE+HR GVLT KSD YSFG+IILQLLTGR PVGL GEV
Sbjct: 479 DTLYCPRFHRGNEPKGAFPYTDPEFHRVGVLTTKSDIYSFGVIILQLLTGRPPVGLVGEV 538
Query: 682 RRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVA 741
RR + CGKL+SILDP AG+WPTF+A RLVDLGLQ CEL RERP++TP+LV+ELEQLHV+
Sbjct: 539 RRTMLCGKLASILDPSAGEWPTFIASRLVDLGLQFCELNSRERPELTPALVRELEQLHVS 598
Query: 742 EERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTP 801
EERPVPSFFLCPILQEIMHDPQVAADGFTYEG+A+R WLENGRETSPMTNL+LSHL+LTP
Sbjct: 599 EERPVPSFFLCPILQEIMHDPQVAADGFTYEGEAMRGWLENGRETSPMTNLKLSHLYLTP 658
Query: 802 NHALRHAIQDWLCKS 816
NHALR AIQDWLCKS
Sbjct: 659 NHALRFAIQDWLCKS 673
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356541238|ref|XP_003539086.1| PREDICTED: U-box domain-containing protein 33-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 913 bits (2359), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/794 (58%), Positives = 572/794 (72%), Gaps = 27/794 (3%)
Query: 23 EKVYVALGKCVEKGLSLLHWTLQRFGSSREICILHVHQPSPVIPTLLGKLPASQASAEVL 82
E V+VA+GK ++K +LL W F S +I +LHVHQPS +IPTLLGKLPASQAS EV+
Sbjct: 10 EMVHVAVGKSLKKAATLLQWCFTHF-SKPQIFLLHVHQPSTMIPTLLGKLPASQASPEVV 68
Query: 83 SAFRAEERQKMKKLLDNYLRICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAF 142
SA+R EE++ K+LL+ YL +C A+VKA + EAD++QK IV L+ +H ++KLV+GA
Sbjct: 69 SAYRIEEKEDTKRLLEKYLSLCRAAKVKASSVIGEADQVQKGIVDLVTVHNVRKLVIGAI 128
Query: 143 PDNCMKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPNSFLPFCGAETRSAK 202
P+NCMK+K S KA+YAAKNAP FCEIWFV GKH+WT+EASE+P S ET +A+
Sbjct: 129 PENCMKIKRNSSKANYAAKNAPPFCEIWFVYNGKHIWTREASETPRSLSSRAQPETTTAE 188
Query: 203 MLRSRSLENCNGTSLFNPESILSRSATTLTHVGITDWVQSDPVHMVFPSSPTISCSDMNL 262
L RS + GT L ++T T VQS+ + + T S +
Sbjct: 189 SLSCRSFHD--GTKELLHSECLQLNSTKTTR----SMVQSE----IIEAEATFSSKSSSC 238
Query: 263 FSPRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSAFAEFLRRKKLE 322
S S +G+ D+ S+ EE+ + Q E +A+ + A AE L+ K+LE
Sbjct: 239 NSHCSPQHSAGWY------LDTHSEFEEETIDSQLIETKREAKAATDKALAELLKSKRLE 292
Query: 323 SEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVA 382
+A+EAI KV FESA+A E+ LRKEAEDAL+ TIQ+Q+ EK + +EL RT+R+++
Sbjct: 293 VKAIEAISKVNFFESAHAHEVKLRKEAEDALRATIQEQQMFLDEKEEIARELERTVRSIS 352
Query: 383 LLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRGQAGAA 442
LL + A E N +RDEA EL LIQASI+ L EKQ+IR+QK+EA+ WLERW+S GQ GA
Sbjct: 353 LLGNCAHETNHKRDEAENELSLIQASISNLWHEKQQIRQQKMEALHWLERWKSCGQVGAD 412
Query: 443 NYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLY 502
+ +G IG E+ PE AEFSL+DLQ ATCNFSESFKV +GG+G +YKGEMLGRTVAI+ L+
Sbjct: 413 HCNGVIGFAEEFPELAEFSLSDLQNATCNFSESFKVMEGGYGSIYKGEMLGRTVAIRKLH 472
Query: 503 SHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSP 562
HNMQG EF QE ++L LQHPHLVTLLG CPEAWS VYEYLP+GSLQD LFRKS+ P
Sbjct: 473 PHNMQGSSEFHQEAQILGSLQHPHLVTLLGVCPEAWSFVYEYLPSGSLQDYLFRKSSFLP 532
Query: 563 LLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622
L RA+ AEIA+ LCFLHSSKPE I+HG L + +LLDS LS KIC+FG RLV ED
Sbjct: 533 LTRNIRAQWIAEIATALCFLHSSKPETIIHGGLTLETVLLDSALSCKICEFGFSRLVKED 592
Query: 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR 682
T PKGSF Y DPE+ RTGVLTPKSD YSFG+IILQLLTGR PVGL GEVR
Sbjct: 593 ----------TEPKGSFTYTDPEFQRTGVLTPKSDIYSFGIIILQLLTGRTPVGLVGEVR 642
Query: 683 RAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAE 742
RAVSCGKL ILD AG+W + +A RL +LGLQCC+L R RP++TPSLV+EL+QL V E
Sbjct: 643 RAVSCGKLYPILDSSAGEWNSTMATRLAELGLQCCQLNSRVRPELTPSLVRELKQLLVLE 702
Query: 743 ERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPN 802
ERPVPSFFLCPI QEIMHDPQVAADGFTYEGKAI +WLENG ETSPMTNL+L+HL+LTPN
Sbjct: 703 ERPVPSFFLCPIFQEIMHDPQVAADGFTYEGKAISEWLENGHETSPMTNLKLTHLNLTPN 762
Query: 803 HALRHAIQDWLCKS 816
HALR AIQ WLCKS
Sbjct: 763 HALRLAIQGWLCKS 776
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547247|ref|XP_003542027.1| PREDICTED: U-box domain-containing protein 33-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 867 bits (2239), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 430/672 (63%), Positives = 509/672 (75%), Gaps = 15/672 (2%)
Query: 147 MKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPNSFLPFCGAETRSAKMLRS 206
MKVK S KA+Y AKNAP FCE+WF+ KGKH+WT+EASE+P S E + + LR
Sbjct: 1 MKVKRNSSKANYTAKNAPPFCEVWFIYKGKHIWTREASETPCSSSSCTQPEIATTESLRC 60
Query: 207 RSLENCNGTSLFNPESILSRSATTLTHVGITDWVQSDPVHM--VFPSSPTISCSDMNLFS 264
RS + LF+ E + SA T GI WVQ + + F S + CS S
Sbjct: 61 RSFQY-GKNELFDSEYLWPNSARTTAVSGIRSWVQGEIIETEATFSSKASSCCSHC---S 116
Query: 265 PRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSAFAEFLRRKKLESE 324
P++SS R D+ +V E+ + Q E +AE + + AF E L+ +KLE E
Sbjct: 117 PQNSS---------RAYFDTYLEVMEERINKQLIETKREAEAVTDEAFTELLKCEKLEVE 167
Query: 325 AMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALL 384
AMEAI KV FESA+ RE+ LRKEA+DAL+ T+Q+Q+KL E + EL TMRN+ALL
Sbjct: 168 AMEAIRKVNLFESAHVREVKLRKEADDALRDTVQEQQKLLNESEEIAGELQMTMRNIALL 227
Query: 385 NSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRGQAGAANY 444
+SRAQEANRRRDEA EL LIQ SI+TL QE+Q+IRRQK EA+RWLERWRSRGQ GAA+
Sbjct: 228 DSRAQEANRRRDEAADELSLIQESISTLWQERQQIRRQKTEALRWLERWRSRGQVGAAHC 287
Query: 445 DGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSH 504
+G IG E+LPE AEFSL+DLQ ATCNFS SFK+ QGG+ C+YKGEMLGRTVAIK + H
Sbjct: 288 NGVIGFAEELPELAEFSLSDLQNATCNFSNSFKIEQGGYSCIYKGEMLGRTVAIKKFHQH 347
Query: 505 NMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLL 564
NMQG LEF+QEV+VL LQHPHL+TLLG CPEAWS+VYEYLPNG+LQD LFRKSN SPL
Sbjct: 348 NMQGPLEFRQEVQVLGSLQHPHLITLLGVCPEAWSIVYEYLPNGTLQDYLFRKSNNSPLT 407
Query: 565 WKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624
W RAR+ AEIAS LCFLHS KPE I+HGDLKP+ +LLDS L K+C FG+CRLV+E++L
Sbjct: 408 WNTRARMIAEIASALCFLHSFKPETIIHGDLKPETVLLDSSLGCKMCGFGLCRLVSEESL 467
Query: 625 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA 684
PSF ST PKG+F Y DPE+ RTG+LT KSD YSFGLIILQLLTGR PVGLA VR A
Sbjct: 468 LRPSFRLSTEPKGAFTYTDPEFQRTGILTTKSDIYSFGLIILQLLTGRTPVGLAVLVRNA 527
Query: 685 VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER 744
VSCGKLSSILD AG+WP+ VA +LV+LGLQCC+ Y R+RP++TP+LV+ELEQLH +EER
Sbjct: 528 VSCGKLSSILDSSAGEWPSAVAMQLVELGLQCCQQYHRDRPELTPTLVRELEQLHASEER 587
Query: 745 PVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHA 804
PVPSFF CPILQEIMHDPQVAADGFTYEG AIR+WLENG +TSPMTNL+LSHL LTPN+A
Sbjct: 588 PVPSFFSCPILQEIMHDPQVAADGFTYEGDAIREWLENGHDTSPMTNLKLSHLFLTPNYA 647
Query: 805 LRHAIQDWLCKS 816
LR AIQDWLCKS
Sbjct: 648 LRLAIQDWLCKS 659
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224059500|ref|XP_002299877.1| predicted protein [Populus trichocarpa] gi|222847135|gb|EEE84682.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 838 bits (2164), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/554 (74%), Positives = 463/554 (83%), Gaps = 5/554 (0%)
Query: 263 FSPRSSSAGSGYMS-EKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSAFAEFLRRKKL 321
FS SS SG S E R S+ SD KVEE+ Y EVS++AE L N AF E L+ K L
Sbjct: 186 FSSTISSCASGCTSTEMRVSSGSDPKVEEESSYSHIEEVSLEAEALGNEAFEELLKCKTL 245
Query: 322 ESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNV 381
E EAMEA KVK +ESA E+ LRKEAEDAL TIQDQEKL +EK V ++L RTMRNV
Sbjct: 246 ELEAMEAFSKVKIYESALVHEVKLRKEAEDALNNTIQDQEKLLKEKDEVARKLERTMRNV 305
Query: 382 ALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRGQAGA 441
ALL+ RAQEANRR +EA+GELKLIQ SI +L+QE+QRIRRQK+EAV WLERWRS GQAG
Sbjct: 306 ALLDIRAQEANRRCEEASGELKLIQTSILSLRQEEQRIRRQKMEAVHWLERWRSPGQAGT 365
Query: 442 ANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKML 501
AN +GF+G+ E+LPE AEFSL+DLQTATCNFSESFK+GQGG G VYKGEMLGRTVAIK L
Sbjct: 366 ANCNGFLGITEELPELAEFSLSDLQTATCNFSESFKLGQGGCGQVYKGEMLGRTVAIKRL 425
Query: 502 YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVS 561
+ +NMQGQ EFQ+EV+VL KLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLF+K+N++
Sbjct: 426 HPNNMQGQSEFQKEVQVLGKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFQKNNIA 485
Query: 562 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621
PL WK R RI AEI+S LCFLHSSKPEKIVHGDLKPQNILL+SELS KIC+FGICRLVTE
Sbjct: 486 PLTWKIRTRIIAEISSALCFLHSSKPEKIVHGDLKPQNILLNSELSCKICEFGICRLVTE 545
Query: 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV 681
D+LY PSFH ST PKGSFPY DPE+ R GVLTPKSD Y+FG+IILQLLTG+ P GL GEV
Sbjct: 546 DSLYQPSFHWSTIPKGSFPYTDPEFQRIGVLTPKSDIYAFGVIILQLLTGKPPAGLVGEV 605
Query: 682 RRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVA 741
RR KL+SILDP + +WP VARRLVDL LQ CEL R RPD+TP+LV+ELE LHV+
Sbjct: 606 RRT---RKLTSILDP-SAEWPMIVARRLVDLALQFCELSSRGRPDLTPTLVRELEHLHVS 661
Query: 742 EERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTP 801
EERPVPSFFLCPILQEIMHDPQVAADGFTYEG+A+R WL NGRETSPMTNLRL HLHLTP
Sbjct: 662 EERPVPSFFLCPILQEIMHDPQVAADGFTYEGEALRGWLANGRETSPMTNLRLDHLHLTP 721
Query: 802 NHALRHAIQDWLCK 815
NHALR AIQDWLCK
Sbjct: 722 NHALRLAIQDWLCK 735
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106491|ref|XP_002314184.1| predicted protein [Populus trichocarpa] gi|222850592|gb|EEE88139.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1944), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/439 (80%), Positives = 397/439 (90%)
Query: 378 MRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRG 437
MRNVALL+SRAQEANRR +EA GELKLIQ SI++L+QEKQRIR+QK+EAV WLERWRS G
Sbjct: 1 MRNVALLDSRAQEANRRSEEAAGELKLIQTSISSLRQEKQRIRQQKIEAVHWLERWRSHG 60
Query: 438 QAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVA 497
QAGA+N +G +G+ E+LPE AEFSL+DLQTATCNFSESFK+GQGG GCVYKGEMLGRTVA
Sbjct: 61 QAGASNCNGILGITEELPELAEFSLSDLQTATCNFSESFKLGQGGCGCVYKGEMLGRTVA 120
Query: 498 IKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRK 557
IK L+ +N QGQLEFQ+EV+VL KLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLF+K
Sbjct: 121 IKRLHPNNTQGQLEFQKEVQVLGKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFQK 180
Query: 558 SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
SN+SPL WK R RI AEI+S LCFLHSSKPEKIVHGDLKPQNILL+SELS KIC+FGICR
Sbjct: 181 SNISPLTWKIRTRIIAEISSTLCFLHSSKPEKIVHGDLKPQNILLNSELSCKICEFGICR 240
Query: 618 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGL 677
LVTED+LY PS HRS PKGSFPY DPE+ R GVLTPKSD Y+FG+IILQLLTG+ PVGL
Sbjct: 241 LVTEDSLYCPSIHRSNEPKGSFPYTDPEFQRIGVLTPKSDIYAFGVIILQLLTGKPPVGL 300
Query: 678 AGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 737
G+VRR +SCGKL+SILDP AG+WP FVAR+LV L LQ CEL R+RPD+TP+LV+ELEQ
Sbjct: 301 VGKVRRTLSCGKLASILDPSAGEWPMFVARQLVYLSLQFCELRSRDRPDLTPTLVRELEQ 360
Query: 738 LHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHL 797
LHV+EERPVPS FLCPILQEIMHDPQVAADGFTYEG+A+R+WL NGRETSPMTNLRLSHL
Sbjct: 361 LHVSEERPVPSIFLCPILQEIMHDPQVAADGFTYEGEALREWLANGRETSPMTNLRLSHL 420
Query: 798 HLTPNHALRHAIQDWLCKS 816
LTPNHALR AIQDWLC++
Sbjct: 421 LLTPNHALRLAIQDWLCQT 439
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450906|ref|XP_004143203.1| PREDICTED: U-box domain-containing protein 33-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 747 bits (1929), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/680 (56%), Positives = 491/680 (72%), Gaps = 21/680 (3%)
Query: 147 MKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPNSFLPFCGAETRSAKMLRS 206
MKVK S KA YAA+N P+ CEIWFV+KG H+WT+EA E G+ + S +LR
Sbjct: 1 MKVKKSSSKADYAARNIPLPCEIWFVDKGNHIWTREAVE---------GSCSASPSLLRE 51
Query: 207 RSL--ENCNGTSLF-NPESILSRSATTLTHVGIT---DWVQSDPVHM--VFPSSPTISCS 258
++ ENC+ +SL N S + + + + GI + + +P H+ V SS I +
Sbjct: 52 LAITKENCSQSSLVDNSHSFNQQYSHSSSANGIIEGFNCIDKEPFHVEGVMSSSLDIHFT 111
Query: 259 ---DMNLFSPRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSAFAEF 315
++ S +SS E RE T SDSKVEE L + ++ ++ E RN A A
Sbjct: 112 YPLRISSSSASTSSDSGYSSVEGREPTSSDSKVEERGLNGELKDAILETEASRNEAIAMH 171
Query: 316 LRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQELH 375
L +K+E EA E+I K K F+ E+ LR+E E+ L+T I+ ++ L +E+ + +EL
Sbjct: 172 LICRKMEQEAAESIKKFKVFKCVNEHEIDLRRETEELLRTIIEKKQTLSEERTEIHEELE 231
Query: 376 RTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRS 435
TM+ +ALL+S+AQE N++ +EAT EL+ IQASIA L++EKQ ++ QK+ A+ WL +W+S
Sbjct: 232 STMKTLALLDSQAQEVNQKHEEATAELRNIQASIAALKKEKQTMQSQKMNALNWLSQWKS 291
Query: 436 RGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRT 495
+ +A NY+ I ++E + EF+ +LQ ATC+FSESFK+ GG+GC+YKGEMLG+T
Sbjct: 292 Q-EASLENYNASIRVMEHQTQLIEFTFLELQMATCDFSESFKISHGGYGCLYKGEMLGKT 350
Query: 496 VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLF 555
VAI+ L+ H + G EF++EV VL KLQHPHLVTLLG C EAWSL+YEYLP+G+LQ LF
Sbjct: 351 VAIRKLHPHYILGPAEFREEVEVLGKLQHPHLVTLLGVCTEAWSLIYEYLPHGNLQSHLF 410
Query: 556 RKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 615
+K N PL WK RARI AEI S LCFLHSSKPEKIVHGDLKP+NILLDSE SKICDFGI
Sbjct: 411 QKGNTPPLTWKTRARIIAEIGSALCFLHSSKPEKIVHGDLKPENILLDSEFISKICDFGI 470
Query: 616 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 675
RLV+E+TLY PSF RST PKG+F + DPE R GVLTPKSD YSFGLIILQLL+G+ V
Sbjct: 471 YRLVSEETLYCPSFRRSTEPKGAFSHTDPECQRDGVLTPKSDIYSFGLIILQLLSGKPIV 530
Query: 676 GLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735
GL E+R+A+S G+L S+LD AG+WP VARRLVD+GLQCCEL G +RP++TP++V+EL
Sbjct: 531 GLVIELRKAISFGRLESVLDLSAGEWPIDVARRLVDIGLQCCELKGSDRPELTPTIVREL 590
Query: 736 EQLHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLS 795
+QL EERPVPS+FLCPILQEIM DPQVAADGFTYEG+AIR+W NGRETSPMTNL+LS
Sbjct: 591 KQLQNFEERPVPSYFLCPILQEIMQDPQVAADGFTYEGEAIREWFNNGRETSPMTNLKLS 650
Query: 796 HLHLTPNHALRHAIQDWLCK 815
HLHLTPNHA+R AIQDWLC+
Sbjct: 651 HLHLTPNHAVRLAIQDWLCR 670
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449496721|ref|XP_004160207.1| PREDICTED: U-box domain-containing protein 33-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 721 bits (1861), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/682 (54%), Positives = 480/682 (70%), Gaps = 46/682 (6%)
Query: 147 MKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPNSFLPFCGAETRSAKMLRS 206
MKVK S KA YAA+N P+ CEIWFV+KG H+WT+EA E G+ + S +LR
Sbjct: 1 MKVKKSSSKADYAARNIPLPCEIWFVDKGNHIWTREAVE---------GSCSASPSLLRE 51
Query: 207 RSL--ENCNGTSL------FNPESILSRSATTLTHVGITDWVQSDPVHM--VFPSSPTIS 256
++ ENC+ +SL FN + S SA + + + + +P H+ V SS I
Sbjct: 52 LAITKENCSQSSLVDNSHSFNQQYSHSSSANGI--IEGFNCIDKEPFHVEGVMSSSLDIH 109
Query: 257 CS---DMNLFSPRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSAFA 313
+ ++ S +SS E RE T SDSKVEE L + ++ ++ E RN
Sbjct: 110 FTYPLRISSSSASTSSDSGYSSVEGREPTSSDSKVEERGLNGELKDAILETEASRN---- 165
Query: 314 EFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQE 373
EF K F+ E+ LR+E E+ L+T I+ ++ L +E+ + +E
Sbjct: 166 EF-----------------KVFKCVNEHEIDLRRETEELLRTIIEKKQTLSEERTEIHEE 208
Query: 374 LHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERW 433
L TM+ +ALL+S+AQE N++ +EAT EL+ IQASIA L++EKQ ++ QK+ A+ WL +W
Sbjct: 209 LESTMKTLALLDSQAQEVNQKHEEATAELRNIQASIAALKKEKQTMQSQKMNALNWLSQW 268
Query: 434 RSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLG 493
+S+ +A NY+ I ++E + EF+ +LQ ATC+FSESFK+ GG+GC+YKGEMLG
Sbjct: 269 KSQ-EASLENYNASIRVMEHQTQLIEFTFLELQMATCDFSESFKISHGGYGCLYKGEMLG 327
Query: 494 RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDR 553
+TVAI+ L+ H + G EF++EV VL KLQHPHLVTLLG C EAWSL+YEYLP+G+LQ
Sbjct: 328 KTVAIRKLHPHYILGPAEFREEVEVLGKLQHPHLVTLLGVCTEAWSLIYEYLPHGNLQSH 387
Query: 554 LFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 613
LF+K N PL WK RARI AEI S LCFLHSSKPEKIVHGDLKP+NILLDSE SKICDF
Sbjct: 388 LFQKGNTPPLTWKTRARIIAEIGSALCFLHSSKPEKIVHGDLKPENILLDSEFISKICDF 447
Query: 614 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRL 673
GI RLV+E+TLY PSF RST PKG+F + DPE R GVLTPKSD YSFGLIILQLL+G+
Sbjct: 448 GIYRLVSEETLYCPSFRRSTEPKGAFSHTDPECQRDGVLTPKSDIYSFGLIILQLLSGKP 507
Query: 674 PVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 733
VGL E+R+A+S G+L S+LD AG+WP VARRLVD+GLQCCEL G +RP++TP++V+
Sbjct: 508 IVGLVIELRKAISFGRLESVLDLSAGEWPIDVARRLVDIGLQCCELKGSDRPELTPTIVR 567
Query: 734 ELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLR 793
EL+QL EERPVPS+FLCPILQEIM DPQVAADGFTYEG+AIR+W NGRETSPMTNL+
Sbjct: 568 ELKQLQNFEERPVPSYFLCPILQEIMQDPQVAADGFTYEGEAIREWFNNGRETSPMTNLK 627
Query: 794 LSHLHLTPNHALRHAIQDWLCK 815
LSHLHLTPNHA+R AIQDWLC+
Sbjct: 628 LSHLHLTPNHAVRLAIQDWLCR 649
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8GUH1 | PUB33_ARATH | 2, ., 7, ., 1, 1, ., - | 0.3992 | 0.9289 | 0.9088 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 6.3.2 | 0.691 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 816 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-43 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-41 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-41 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-37 | |
| cd01989 | 146 | cd01989, STK_N, The N-terminal domain of Eukaryoti | 1e-36 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-32 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-31 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-25 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-21 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-21 | |
| smart00504 | 63 | smart00504, Ubox, Modified RING finger domain | 1e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-20 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 8e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-17 | |
| pfam04564 | 73 | pfam04564, U-box, U-box domain | 3e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 9e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 6e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-15 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-14 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-14 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-14 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 6e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 8e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 9e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-09 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-09 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 5e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 4e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-04 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 6e-04 | |
| cd00293 | 130 | cd00293, USP_Like, Usp: Universal stress protein f | 6e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.001 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.001 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.001 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.002 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 0.002 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.002 | |
| pfam13445 | 55 | pfam13445, zf-RING_LisH, RING-type zinc-finger, Li | 0.002 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 0.003 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.003 | |
| PRK01156 | 895 | PRK01156, PRK01156, chromosome segregation protein | 0.003 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 2e-48
Identities = 75/198 (37%), Positives = 104/198 (52%), Gaps = 18/198 (9%)
Query: 478 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGAC 534
+G+GGFG VY G+ VAIK++ + LE +E+ +L KL HP++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 535 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
LV EY GSL+D L K N L + RI +I GL +LHS I+H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 593 GDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR-TG 650
DLKP+NILLDS+ K+ DFG+ +L+T D L + G+ Y PE G
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI------VGTPAYMAPEVLLGKG 169
Query: 651 VLTPKSDSYSFGLIILQL 668
+ KSD +S G+I+ +L
Sbjct: 170 YYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 2e-43
Identities = 67/203 (33%), Positives = 100/203 (49%), Gaps = 18/203 (8%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 533
K+G+G FG VY G+ VAIK++ ++ E +E+++L KL+HP++V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 534 C--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591
+ LV EY G L D L ++ +S + +I S L +LHS + IV
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE---DEARFYLRQILSALEYLHS---KGIV 119
Query: 592 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 651
H DLKP+NILLD + K+ DFG+ R + T G+ Y PE
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-------TTFVGTPEYMAPEVLLGKG 172
Query: 652 LTPKSDSYSFGLIILQLLTGRLP 674
D +S G+I+ +LLTG+ P
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 3e-43
Identities = 76/211 (36%), Positives = 107/211 (50%), Gaps = 25/211 (11%)
Query: 477 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVT 529
K+G+G FG VYKG + G VA+K L + + EF +E ++ KL HP++V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 530 LLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 587
LLG C E +V EY+P G L D L + + L KD ++A +IA G+ +L S
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLESKN- 122
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADP 644
VH DL +N L+ L KI DFG+ R + ED Y G P A P
Sbjct: 123 --FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR------KRGGGKLPIKWMA-P 173
Query: 645 EYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 674
E + G T KSD +SFG+++ ++ T G P
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 6e-43
Identities = 73/205 (35%), Positives = 106/205 (51%), Gaps = 19/205 (9%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSH--NMQGQLEFQQEVRVLSKLQHPHLVTLLG 532
K+G G FG VYK + G+ VA+K+L + ++E+R+L +L HP++V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 533 AC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
A + LV EY G L D L R +S + +IA +I GL +LHS I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLS---EDEAKKIALQILRGLEYLHS---NGI 119
Query: 591 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 650
+H DLKP+NILLD KI DFG+ + + + + T G+ Y PE G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSS------SSLTTFVGTPWYMAPEVLLGG 173
Query: 651 VL-TPKSDSYSFGLIILQLLTGRLP 674
PK D +S G+I+ +LLTG+ P
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 2e-41
Identities = 75/210 (35%), Positives = 107/210 (50%), Gaps = 23/210 (10%)
Query: 477 KVGQGGFGCVYKGEMLGR------TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVT 529
K+G+G FG VYKG + G+ VA+K L + Q EF +E R++ KL HP++V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 530 LLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 587
LLG C E +V EY+P G L D L RK+ L D A +IA G+ +L S
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLES--- 121
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA--DPE 645
+ +H DL +N L+ L KI DFG+ R + +D Y + P PE
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGK-------LPIRWMAPE 174
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLT-GRLP 674
+ G T KSD +SFG+++ ++ T G P
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (385), Expect = 3e-41
Identities = 98/280 (35%), Positives = 136/280 (48%), Gaps = 39/280 (13%)
Query: 477 KVGQGGFGCVYKGEMLG-----RTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL 530
K+G+G FG VYKG++ G VA+K L + + + +F +E RV+ KL HP++V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 531 LGACPEA--WSLVYEYLPNGSLQDRL------FRKSNVSPLLWKDRARIAAEIASGLCFL 582
LG C E LV EY+ G L D L F S L KD A +IA G+ +L
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 583 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP-- 640
S +K VH DL +N L+ +L KI DFG+ R V +D Y G P
Sbjct: 122 AS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY------RKKTGGKLPIR 172
Query: 641 -YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGL-AGEVRRAVSCGKLSSILDP 696
A PE + G+ T KSD +SFG+++ ++ T G P GL EV + G L
Sbjct: 173 WMA-PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR---LPK 228
Query: 697 LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736
P + L +L L C +L +RP + LV+ LE
Sbjct: 229 -----PEYCPDELYELMLSCWQLDPEDRPTFS-ELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 6e-41
Identities = 73/210 (34%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 477 KVGQGGFGCVYKGEMLGR------TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVT 529
K+G+G FG VYKG++ G+ VA+K L + Q EF +E R++ KL HP++V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 530 LLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 587
LLG C E +V EY+ G L L + N L D A +IA G+ +L S
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLES--- 120
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA--DPE 645
+ +H DL +N L+ L KI DFG+ R + +D Y G P PE
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY-------RKRGGKLPIRWMAPE 173
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLT-GRLP 674
+ G T KSD +SFG+++ ++ T G P
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 7e-37
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLG 532
+G+G FG VY G +A+K + + ++E+R+LS LQHP++V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 533 AC----PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 588
+ ++ EY+ GSL L + + + + R +I GL +LHS
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTR---QILEGLAYLHS---N 120
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 648
IVH D+K NIL+DS+ K+ DFG + + D + +G+ + PE R
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRL-GDIETGEGTG---SVRGTPYWMAPEVIR 176
Query: 649 TGVLTPKSDSYSFGLIILQLLTGRLP 674
+D +S G ++++ TG+ P
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|238947 cd01989, STK_N, The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 1e-36
Identities = 59/154 (38%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 24 KVYVALGKCVEKGLSLLHWTLQRFGSSR-EICILHVHQPSPVIPTLLGKLPASQASAEVL 82
V VA+ K +K + L W L + I ++HVH P IP+ GKL EV
Sbjct: 1 SVAVAVDK-DKKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGKL-------EVA 52
Query: 83 SAFRAEERQKMKKLLDNYLRICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAF 142
SA++ EE ++ K+LL Y C V+ + E D + KAIV+ + HGI KLVMGA
Sbjct: 53 SAYKQEEDKEAKELLLPYRCFCSRKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGAS 112
Query: 143 PDNCMKVKM-GSRKASYAAKNAPMFCEIWFVNKG 175
DN +K S AS K AP FC ++ V+KG
Sbjct: 113 SDNHFSMKFKKSDVASSVLKEAPDFCTVYVVSKG 146
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. Length = 146 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-35
Identities = 76/277 (27%), Positives = 124/277 (44%), Gaps = 20/277 (7%)
Query: 477 KVGQGGFGCVYKGEMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHP-HLVTLLG 532
K+G+G FG VY + VA+K+L + F +E+++L+ L HP ++V L
Sbjct: 7 KLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 533 AC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
+ LV EY+ GSL+D L + PL + I A+I S L +LHS I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---I 122
Query: 591 VHGDLKPQNILLDSELS-SKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
+H D+KP+NILLD + K+ DFG+ +L+ + + G+ Y PE
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 650 GVL---TPKSDSYSFGLIILQLLTGRLPV------GLAGEVRRAVSCGKLSSILDPLAGD 700
L + SD +S G+ + +LLTG P + + + S+ PL+
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242
Query: 701 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 737
P +++ DL + + R + L +L
Sbjct: 243 NPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 16/202 (7%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA- 533
K+G+GGFG VYK G+ VAIK++ + + + + E+++L K +HP++V G+
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 534 -CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
+ +V E+ GSL+D L KS L A + E+ GL +LHS I+H
Sbjct: 67 LKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHS---NGIIH 121
Query: 593 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL 652
D+K NILL S+ K+ DFG+ ++ + R+T G+ + PE
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQLS------DTKARNT-MVGTPYWMAPEVINGKPY 174
Query: 653 TPKSDSYSFGLIILQLLTGRLP 674
K+D +S G+ ++L G+ P
Sbjct: 175 DYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 7e-31
Identities = 82/221 (37%), Positives = 114/221 (51%), Gaps = 22/221 (9%)
Query: 477 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC- 534
K+G G FG V+ G G T VA+K L M + F QE +++ KL+H LV L C
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 535 -PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 593
E +V EY+ GSL D L + L +AA+IA G+ +L S +H
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFL-KSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHR 127
Query: 594 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRTG 650
DL +NIL+ L KI DFG+ RL+ ED Y TA +G+ FP + PE G
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLI-EDDEY-------TAREGAKFPIKWTAPEAANYG 179
Query: 651 VLTPKSDSYSFGLIILQLLT-GRLPV-GLAG-EVRRAVSCG 688
T KSD +SFG+++ +++T GR+P G+ EV V G
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG 220
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 6e-30
Identities = 79/234 (33%), Positives = 118/234 (50%), Gaps = 39/234 (16%)
Query: 459 EFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLG-------RTVAIKMLY-SHNMQGQL 510
E L+ ++ F E ++G+G FG VYKGE+ G +VAIK L + + Q
Sbjct: 1 EIPLSAVR-----FLE--ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ 53
Query: 511 EFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVS------- 561
EF+QE ++S LQHP++V LLG C + +++EYL +G L + L R S S
Sbjct: 54 EFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113
Query: 562 ------PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 615
L D IA +IA+G+ +L S VH DL +N L+ L+ KI DFG+
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGL 170
Query: 616 CRLV-TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQL 668
R + + D Y +S P P PE G T +SD +SFG+++ ++
Sbjct: 171 SRDIYSAD--YYRVQSKSLLPVRWMP---PEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 4e-29
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 34/212 (16%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA 533
+GQG G VYK + G+ A+K ++ + + + + +E++ L + P++V GA
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 534 C--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591
S+V EY+ GSL D L + + A IA +I GL +LH+ + I+
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIPE---PVLAYIARQILKGLDYLHTKR--HII 122
Query: 592 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF----PYADPEYH 647
H D+KP N+L++S+ KI DFGI +++ + +F Y PE
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLE----------NTLDQCNTFVGTVTYMSPE-- 170
Query: 648 RTGVLTPKSDSY-----SFGLIILQLLTGRLP 674
R + +S SY S GL +L+ G+ P
Sbjct: 171 R---IQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 69/206 (33%), Positives = 113/206 (54%), Gaps = 22/206 (10%)
Query: 477 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 535
K+G G FG V++G R VAIK+L S ++ Q +FQ+EV+ L +L+H HL++L C
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 536 --EAWSLVYEYLPNGSLQDRLF----RKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
E ++ E + GSL L + V+ L+ +A ++A G+ +L +
Sbjct: 73 VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLID-----MACQVAEGMAYLEE---QN 124
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
+H DL +NIL+ +L K+ DFG+ RL+ ED +YL S K + + PE
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKED-VYLSSDK-----KIPYKWTAPEAASH 178
Query: 650 GVLTPKSDSYSFGLIILQLLT-GRLP 674
G + KSD +SFG+++ ++ T G++P
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 68/219 (31%), Positives = 107/219 (48%), Gaps = 25/219 (11%)
Query: 478 VGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEA 537
+G+G FG V G+ G+ VA+K L + Q F E V++ L+HP+LV LLG +
Sbjct: 14 IGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQG 72
Query: 538 WSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDL 595
L V EY+ GSL D L R + + + A ++ G+ +L + VH DL
Sbjct: 73 NPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDL 128
Query: 596 KPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP--YADPEYHRTGVLT 653
+N+L+ +L +K+ DFG L E + S G P + PE R +
Sbjct: 129 AARNVLVSEDLVAKVSDFG---LAKEASQGQDS--------GKLPVKWTAPEALREKKFS 177
Query: 654 PKSDSYSFGLIILQLLT-GRLP---VGLAGEVRRAVSCG 688
KSD +SFG+++ ++ + GR+P + L +V V G
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPHVEKG 215
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQL-EFQQEVRVLSKLQHPH 526
N+ +G+G FG VYKG L G VAIK + + + L QE+ +L L+HP+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 527 LVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 584
+V +G+ + SL + EY NGSL+ + + L A ++ GL +LH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL---VAVYVYQVLQGLAYLHE 117
Query: 585 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY-AD 643
+ ++H D+K NIL + K+ DFG+ + + + + G+ PY
Sbjct: 118 ---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS------KDDASVVGT-PYWMA 167
Query: 644 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
PE + SD +S G +++LLTG P
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-27
Identities = 72/214 (33%), Positives = 104/214 (48%), Gaps = 18/214 (8%)
Query: 477 KVGQGGFGCVYKGE---MLGRT--VAIKMLYSHNMQG-QLEFQQEVRVLSKLQHPHLVTL 530
K+G G FG V +GE G+ VA+K L S + +F +E ++ L H +L+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 531 LGAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
G +V E P GSL DRL RK + L A +IA+G+ +L S +
Sbjct: 62 YGVVLTHPLMMVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIANGMRYLESKR--- 117
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICR-LVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 648
+H DL +NILL S+ KI DFG+ R L + Y+ H K F + PE R
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL----KVPFAWCAPESLR 173
Query: 649 TGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAGE 680
T + SD + FG+ + ++ T G P GL+G
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS 207
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 478 VGQGGFGCVY--KGEMLGRTVAIKML-----YSHNMQGQLEFQQEVRVLSKLQHPHLVTL 530
+G+G FG V + + G+ A+K+L E +LS++ HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHT--LTERNILSRINHPFIVKL 58
Query: 531 LGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKP 587
A E LV EY P G L L ++ S +RAR AAEI L +LHS
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE----ERARFYAAEIVLALEYLHS--- 111
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 647
I++ DLKP+NILLD++ K+ DFG+ + ++ + R+ G+ Y PE
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE------GSRTNTFCGTPEYLAPEVL 165
Query: 648 RTGVLTPKSDSYSFGLIILQLLTGRLP 674
D +S G+++ ++LTG+ P
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 69/207 (33%), Positives = 110/207 (53%), Gaps = 23/207 (11%)
Query: 477 KVGQGGFGCVYK------GEMLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVT 529
++G+G FG V G+ G VA+K L +S Q + +F++E+ +L L H ++V
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 530 LLGACPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 585
G C + L+ EYLP+GSL+D L R + + K +++I G+ +L S
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGS- 127
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS--FPYAD 643
++ +H DL +NIL++SE KI DFG+ +++ ED Y + P S F YA
Sbjct: 128 --QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDY----YYVKEPGESPIFWYA- 180
Query: 644 PEYHRTGVLTPKSDSYSFGLIILQLLT 670
PE RT + SD +SFG+ + +L T
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 70/210 (33%), Positives = 105/210 (50%), Gaps = 23/210 (10%)
Query: 478 VGQGGFGCVYKGEMLGR-----TVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
+G G FG V KG L + VA+K L H G+ EF +E V+++L HP +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 532 GAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
G C E LV E P G L L ++ + D +A ++A G+ +L S
Sbjct: 63 GVCKGEPLMLVMELAPLGPLLKYLKKRREIPV---SDLKELAHQVAMGMAYLESK---HF 116
Query: 591 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEYH 647
VH DL +N+LL + +KI DFG+ R + + Y +R+T G +P YA PE
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY----YRATT-AGRWPLKWYA-PECI 170
Query: 648 RTGVLTPKSDSYSFGLIILQLLT-GRLPVG 676
G + KSD +S+G+ + + + G P G
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPYG 200
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 65/205 (31%), Positives = 108/205 (52%), Gaps = 20/205 (9%)
Query: 477 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 535
K+G G FG V++G T VA+K L M + +F E +++ KL+HP L+ L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 536 --EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 593
E +V E + GSL + L + L +AA++ASG+ +L + + +H
Sbjct: 72 LEEPIYIVTELMKYGSLLEYL-QGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHR 127
Query: 594 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRTG 650
DL +N+L+ K+ DFG+ R++ ED +Y A +G+ FP + PE
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKED-IY-------EAREGAKFPIKWTAPEAALYN 179
Query: 651 VLTPKSDSYSFGLIILQLLT-GRLP 674
+ KSD +SFG+++ +++T GR+P
Sbjct: 180 RFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 28/211 (13%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEF-QQEVRVLSKLQHPHLVTLLG 532
++G+G FG VY G+ +K + NM + + E EV++L KL HP+++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 533 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRA-RIAAEIASGLCFLHSSKPEK 589
+ E L V EY G L ++ ++ +++ ++ L +LHS K
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RK 123
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---- 645
I+H D+KPQNI L S K+ DFGI ++++ + G+ Y PE
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV------VGTPYYLSPELCQN 177
Query: 646 --YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
Y KSD +S G ++ +L T + P
Sbjct: 178 KPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 81/270 (30%), Positives = 126/270 (46%), Gaps = 39/270 (14%)
Query: 478 VGQGGFGCVYKGEMLG-------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVT 529
+GQG FG VY+G G VAIK + + +M+ ++EF E V+ + H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 530 LLGACPEAWS--LVYEYLPNGSLQDRLFRK-------SNVSPLLWKDRARIAAEIASGLC 580
LLG +V E + G L+ L + + P + ++AAEIA G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 581 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP 640
+L + +K VH DL +N ++ +L+ KI DFG+ R + E Y KG P
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG------GKGLLP 184
Query: 641 --YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAGE-VRRAVSCGKLSSILD 695
+ PE + GV T KSD +SFG+++ ++ T P GL+ E V + V G LD
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG---HLD 241
Query: 696 PLAGDWPTFVARRLVDLGLQCCELYGRERP 725
P +L++L C + + RP
Sbjct: 242 L-----PENCPDKLLELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 76/204 (37%), Positives = 108/204 (52%), Gaps = 19/204 (9%)
Query: 477 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 535
K+G G FG V+ G G T VAIK L +M + F E ++ +LQHP LV L
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 536 -EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 594
E ++ EY+ NGSL D L + L +AA+IA G+ F+ + +H D
Sbjct: 72 QEPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRD 127
Query: 595 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRTGV 651
L+ NIL+ L KI DFG+ RL+ ED Y TA +G+ FP + PE G
Sbjct: 128 LRAANILVSETLCCKIADFGLARLI-EDNEY-------TAREGAKFPIKWTAPEAINYGT 179
Query: 652 LTPKSDSYSFGLIILQLLT-GRLP 674
T KSD +SFG+++ +++T GR+P
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-23
Identities = 94/256 (36%), Positives = 123/256 (48%), Gaps = 27/256 (10%)
Query: 477 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 535
K+GQG FG V+ G G T VAIK L M + F QE +V+ KL+H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 536 E-AWSLVYEYLPNGSLQDRLFRKSNVSPLL-WKDRARIAAEIASGLCFLHSSKPEKIVHG 593
E +V EY+ GSL D F K + L +AA+IASG+ ++ VH
Sbjct: 72 EEPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 126
Query: 594 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRTG 650
DL+ NIL+ L K+ DFG+ RL+ ED Y TA +G+ FP + PE G
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLI-EDNEY-------TARQGAKFPIKWTAPEAALYG 178
Query: 651 VLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRL 709
T KSD +SFG+++ +L T GR+P G V R V L + P L
Sbjct: 179 RFTIKSDVWSFGILLTELTTKGRVP--YPGMVNREV----LDQVERGYRMPCPPECPESL 232
Query: 710 VDLGLQCCELYGRERP 725
DL QC ERP
Sbjct: 233 HDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 69/251 (27%), Positives = 111/251 (44%), Gaps = 36/251 (14%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLG 532
++G+G G V+K + G TVA+K + ++G + +E++ L QHP++V LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 533 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
+ LV EY+P L + L + PL + G+ ++H+ I
Sbjct: 67 VFPHGSGFVLVMEYMP-SDLSEVLRDEER--PLPEAQVKSYMRMLLKGVAYMHA---NGI 120
Query: 591 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST----APKGSFPYADPEY 646
+H DLKP N+L+ ++ KI DFG+ RL +E+ L S +T AP+ Y +Y
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE--LLYGARKY 178
Query: 647 HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILD----PLAGDWP 702
P D ++ G I +LL G P+ GE +L+ + P WP
Sbjct: 179 ------DPGVDLWAVGCIFAELLNGS-PL-FPGENDIE----QLAIVFRTLGTPNEETWP 226
Query: 703 TFVARRLVDLG 713
L D
Sbjct: 227 GL--TSLPDYN 235
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 76/272 (27%), Positives = 124/272 (45%), Gaps = 27/272 (9%)
Query: 471 NFSESFKVGQGGFGCVYKG--EMLGRTVAIKM--LYSHNMQGQLEFQQEVRVLSKLQHPH 526
+F K+G+G FG V+K + R A+K L N + + E E RVL+KL +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 527 LVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 584
++ + + L V EY NG L L + PL R +I GL LHS
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 585 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 644
+KI+H D+K N+ LD+ + KI D G+ +L++++T F + G+ Y P
Sbjct: 120 ---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN----FANTIV--GTPYYLSP 170
Query: 645 EYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTF 704
E KSD ++ G+++ + TG+ P + A+ + + P++ +
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--ALILKIIRGVFPPVSQMY--- 225
Query: 705 VARRLVDLGLQCCELYGRERPDIT-----PSL 731
+++L L QC R+RPD PSL
Sbjct: 226 -SQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 5e-22
Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 34/222 (15%)
Query: 478 VGQGGFGCVYKGEML--GRTVAIKML-----YSHNMQGQLEFQQEVRVLSKL-QHPHLVT 529
+G+G F V + + AIK+L + + E VL++L HP ++
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYV--KIEKEVLTRLNGHPGIIK 66
Query: 530 LLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSK 586
L + +L V EY PNG L + + ++ + R AAEI L +LHS
Sbjct: 67 LYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLD----EKCTRFYAAEILLALEYLHS-- 120
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF----------HRSTAPK 636
+ I+H DLKP+NILLD ++ KI DFG +++ ++ + ++
Sbjct: 121 -KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 637 GSF----PYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
SF Y PE SD ++ G II Q+LTG+ P
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 63/201 (31%), Positives = 106/201 (52%), Gaps = 20/201 (9%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
K+G G +G VY+G + TVA+K L M+ + EF +E V+ +++HP+LV LLG C
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 535 PE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
+ ++ E++ G+L D L R+ N + +A +I+S + +L + +H
Sbjct: 72 TREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIH 127
Query: 593 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRT 649
DL +N L+ K+ DFG+ RL+T DT TA G+ FP + PE
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY--------TAHAGAKFPIKWTAPESLAY 179
Query: 650 GVLTPKSDSYSFGLIILQLLT 670
+ KSD ++FG+++ ++ T
Sbjct: 180 NKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 3e-21
Identities = 69/223 (30%), Positives = 113/223 (50%), Gaps = 29/223 (13%)
Query: 478 VGQGGFGCVYKGEMLG-RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE 536
+G G FG V+ G+ G VAIKM+ M + +F +E +V+ KL HP+LV L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 537 AWSL--VYEYLPNGSLQDRLFR---KSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591
+ V EY+ NG L + L K LL + +++ + +L S+ +
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL-----DMCSDVCEAMEYLESN---GFI 122
Query: 592 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHR 648
H DL +N L+ + K+ DFG+ R V +D + T+ +G+ FP +A PE
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDD--------QYTSSQGTKFPVKWAPPEVFD 174
Query: 649 TGVLTPKSDSYSFGLIILQLLT-GRLPVG--LAGEVRRAVSCG 688
+ KSD +SFG+++ ++ + G++P EV +VS G
Sbjct: 175 YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 477 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 535
++G G FG V+ G L + VAIK + M + +F +E +V+ KL HP LV L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE-DFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 536 E--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 593
E LV+E++ +G L D + ++ + + ++ G+ +L SS ++H
Sbjct: 70 ERSPICLVFEFMEHGCLSD--YLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHR 124
Query: 594 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLT 653
DL +N L+ K+ DFG+ R V +D + ST K ++ PE +
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDD-----QYTSSTGTKFPVKWSSPEVFSFSKYS 179
Query: 654 PKSDSYSFGLIILQLLT-GRLP 674
KSD +SFG+++ ++ + G+ P
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 7e-21
Identities = 80/215 (37%), Positives = 113/215 (52%), Gaps = 21/215 (9%)
Query: 477 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 535
K+GQG FG V+ G G T VAIK L M + F QE +++ KL+H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 536 E-AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 594
E +V E++ GSL D L ++ + L +AA+IA G+ ++ +H D
Sbjct: 72 EEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRD 127
Query: 595 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRTGV 651
L+ NIL+ L KI DFG+ RL+ ED Y TA +G+ FP + PE G
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLI-EDNEY-------TARQGAKFPIKWTAPEAALYGR 179
Query: 652 LTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAV 685
T KSD +SFG+++ +L+T GR+P G V R V
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVP--YPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|128780 smart00504, Ubox, Modified RING finger domain | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 1e-20
Identities = 31/63 (49%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 750 FLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAI 809
FLCPI E+M DP + G TYE AI WL + T P+T L+H L PN AL+ AI
Sbjct: 2 FLCPISLEVMKDPVILPSGQTYERSAIEKWLLS-HGTDPVTGQPLTHEDLIPNLALKSAI 60
Query: 810 QDW 812
Q+W
Sbjct: 61 QEW 63
|
Modified RING finger domain, without the full complement of Zn2+-binding ligands. Probable involvement in E2-dependent ubiquitination. Length = 63 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 89/257 (34%), Positives = 127/257 (49%), Gaps = 29/257 (11%)
Query: 477 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 535
K+G G FG V+ G G T VA+K L M + F +E +++ KL+H LV L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 536 E-AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 594
E +V EY+ GSL D L + L + +AA++A+G+ ++ +H D
Sbjct: 72 EEPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRD 127
Query: 595 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRTGV 651
L+ NIL+ L KI DFG+ RL+ ED Y TA +G+ FP + PE G
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLI-EDNEY-------TARQGAKFPIKWTAPEAALYGR 179
Query: 652 LTPKSDSYSFGLIILQLLT-GRLPV-GLAG-EVRRAVSCGKLSSILDPLAGDWPTFVARR 708
T KSD +SFG+++ +L+T GR+P G+ EV V G P D P
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM----PCPQDCPI----S 231
Query: 709 LVDLGLQCCELYGRERP 725
L +L LQC + ERP
Sbjct: 232 LHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 72/214 (33%), Positives = 102/214 (47%), Gaps = 42/214 (19%)
Query: 478 VGQGGFGCVYKGEML------GRTVAIKMLYSHNM--QGQLE-FQQEVRVLSKLQHPHLV 528
+G G FG V ML G+ A+K+L + Q+E E R+L ++HP LV
Sbjct: 9 LGTGSFGRV----MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLV 64
Query: 529 TLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSS 585
L G+ + +L V EY+P G L L RKS P AR AA++ L +LHS
Sbjct: 65 NLYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPE---PVARFYAAQVVLALEYLHS- 119
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 645
IV+ DLKP+N+LLDS+ KI DFG + V T L G+ Y PE
Sbjct: 120 --LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC---------GTPEYLAPE 168
Query: 646 YHRTGVLTPK-----SDSYSFGLIILQLLTGRLP 674
++ K D ++ G++I ++L G P
Sbjct: 169 -----IILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-20
Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 30/202 (14%)
Query: 491 MLGRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLL--GACPEAWSL-VYEY 544
M G VAIK+L + + + + F++E + ++L HP++V LL G P V+EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL-- 602
+P +L++ L + L + R+ ++ L H+ + IVH DLKPQNI++
Sbjct: 61 VPGRTLREVL---AADGALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQ 114
Query: 603 -DSELSSKICDFGICRLVTEDTLYLPSFH--------RSTAPKGSFPYADPEYHRTGVLT 653
+K+ DFGI L LP R+T G+ Y PE R +T
Sbjct: 115 TGVRPHAKVLDFGIGTL-------LPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT 167
Query: 654 PKSDSYSFGLIILQLLTGRLPV 675
P SD Y++GLI L+ LTG+ V
Sbjct: 168 PNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 477 KVGQGGFGCVYKGEML----GRTVAIK-MLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
++G G G V K +L G+ +A+K + N Q + +E+ +L K P++V
Sbjct: 8 ELGAGNSGVVSK--VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 532 GAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
GA S+ EY+ GSL K + + +IA + GL +LH K
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDK--ILKEVQGRIPERILGKIAVAVLKGLTYLHEKH--K 121
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
I+H D+KP NIL++S K+CDFG+ + + G+ Y PE +
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--------AKTFVGTSSYMAPERIQG 173
Query: 650 GVLTPKSDSYSFGLIILQLLTGRLPVG 676
+ KSD +S GL +++L TGR P
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 478 VGQGGFGCVYKGEMLG-------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVT 529
+G+G FG V+ GE VA+K L + + + +F++E +L+ QH ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 530 LLGACPE--AWSLVYEYLPNGSLQDRLFR-----------KSNVSPLLWKDRARIAAEIA 576
G C E +V+EY+ +G L L S + L +IA +IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 577 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 636
SG+ +L S + VH DL +N L+ +L KI DFG+ R V Y H +
Sbjct: 133 SGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 637 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 674
+ PE T +SD +SFG+++ ++ T G+ P
Sbjct: 190 ----WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-20
Identities = 84/300 (28%), Positives = 135/300 (45%), Gaps = 56/300 (18%)
Query: 478 VGQGGFGCVYKG---EMLGR----TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVT 529
+G+G FG V K + GR TVA+KML + +L + E +L ++ HPH++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 530 LLGACP--EAWSLVYEYLPNGSLQD--RLFRK-------------------SNVSPLLWK 566
L GAC L+ EY GSL+ R RK + L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 567 DRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626
D A +I+ G+ +L K +VH DL +N+L+ KI DFG+ R V E+ Y+
Sbjct: 128 DLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 627 PSFHRSTAPKGSFP--YADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA 684
RS KG P + E + T +SD +SFG+++ +++T L G
Sbjct: 185 ---KRS---KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT------LGGNPYPG 232
Query: 685 VSCGKLSSILDP-LAGDWPTFVARRLVDLGLQCCELYGRERPDITPS---LVKELEQLHV 740
++ +L ++L + P + + +L L C ++ PD P+ + KELE++ V
Sbjct: 233 IAPERLFNLLKTGYRMERPENCSEEMYNLMLTCW----KQEPDKRPTFADISKELEKMMV 288
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 4e-20
Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 478 VGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLE---------FQQEVRVLSKLQHPH 526
+G G FG VY G G +A+K + ++ + +E+ +L +LQH +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 527 LVTLLGACPEAWSLVY--EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 584
+V LG+ +A L EY+P GS+ L L ++ R +I GL +LH+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR---QILKGLNYLHN 124
Query: 585 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 644
I+H D+K NIL+D++ KI DFGI + + ++L + + +GS + P
Sbjct: 125 ---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 645 EYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
E + T K+D +S G +++++LTG+ P
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-20
Identities = 70/213 (32%), Positives = 106/213 (49%), Gaps = 38/213 (17%)
Query: 478 VGQGGFG----CVYK--GEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
+G+G FG C Y + G VA+K L + +F++E+ +L LQH ++V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 532 GACPEA----WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI--------AAEIASGL 579
G C A LV EYLP GSL+D L K R R+ A++I G+
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRD----------YLQKHRERLDHRKLLLYASQICKGM 121
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS- 638
+L S ++ VH DL +NIL++SE KI DFG+ +++ +D Y ++ P S
Sbjct: 122 EYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY----YKVREPGESP 174
Query: 639 -FPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 670
F YA PE + SD +SFG+++ +L T
Sbjct: 175 IFWYA-PESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 478 VGQGGFGCVYKGEMLG-----RTVAIKMLYS-HNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
+G+G FGCVY G ++ A+K L +++ +F +E ++ HP++++LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 532 GAC--PEAWSLV-YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 588
G C E LV Y+ +G L++ R +P + KD ++A G+ +L S +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRN-FIRSETHNPTV-KDLIGFGLQVAKGMEYLAS---K 117
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 648
K VH DL +N +LD + K+ DFG+ R + + Y S H T K + E +
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY--SVHNHTGAKLPVKWMALESLQ 175
Query: 649 TGVLTPKSDSYSFGLIILQLLT 670
T T KSD +SFG+++ +L+T
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 479 GQGGFGCVYKG------EMLGRTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
G G FG VYKG E + VAIK+L + + E E V++ + HPH+V LL
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 532 GACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
G C L+ + +P G L D + +++ + + +IA G+ +L +++
Sbjct: 76 GICLSSQVQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRL 130
Query: 591 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 650
VH DL +N+L+ + KI DFG+ +L+ D + + K + E
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE----KEYHAEGGKVPIKWMALESILHR 186
Query: 651 VLTPKSDSYSFGLIILQLLT-GRLP 674
+ T KSD +S+G+ + +L+T G P
Sbjct: 187 IYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 477 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGAC 534
K+G+G FG VYKG + G T VA+K S F QE +L + HP++V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 535 PEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
+ + V E +P GSL L +K N + K +++ + A+G+ +L S + +H
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLES---KNCIH 116
Query: 593 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL 652
DL +N L+ KI DFG+ R E +Y S P + PE G
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIP---IKWTAPEALNYGRY 172
Query: 653 TPKSDSYSFGLIILQLLTG 671
T +SD +S+G+++ + +
Sbjct: 173 TSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 64/215 (29%), Positives = 94/215 (43%), Gaps = 42/215 (19%)
Query: 478 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLEFQ------QEVRVLSKLQHPHLVT 529
+G+G FG C+ + + A+K + N Q +E E R+L +L HP LV
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYM---NKQKCVEKGSVRNVLNERRILQELNHPFLVN 64
Query: 530 LLGACPEAWS---------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGL 579
L W LV + L G L+ L +K S +++ + EI L
Sbjct: 65 L-------WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS----EEQVKFWICEIVLAL 113
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 639
+LHS + I+H D+KP NILLD + I DF I VT DTL +T+ G+
Sbjct: 114 EYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-------TTSTSGTP 163
Query: 640 PYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
Y PE + D +S G+ + L G+ P
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 8e-19
Identities = 71/206 (34%), Positives = 105/206 (50%), Gaps = 22/206 (10%)
Query: 477 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 535
K+G G FG V+ G T VA+K L M Q F +E ++ LQH LV L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-AFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 536 --EAWSLVYEYLPNGSLQDRLFRKSNV-SPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
E ++ EY+ GSL D F KS+ +L +A+IA G+ ++ + +H
Sbjct: 72 KEEPIYIITEYMAKGSLLD--FLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIH 126
Query: 593 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRT 649
DL+ N+L+ L KI DFG+ R V ED Y TA +G+ FP + PE
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLAR-VIEDNEY-------TAREGAKFPIKWTAPEAINF 178
Query: 650 GVLTPKSDSYSFGLIILQLLT-GRLP 674
G T KSD +SFG+++ +++T G++P
Sbjct: 179 GSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 8e-19
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 49/218 (22%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQQ----EVRVLSKLQHPHLVTL 530
K+G+G +G VYK + G VA+K + + E+ +L +L+HP++V L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 531 LG--ACPEAWSLVYEYLPN--GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
L LV+EY D+ R +SP L K I ++ GL + HS
Sbjct: 64 LDVIHTERKLYLVFEYCDMDLKKYLDK--RPGPLSPNLIK---SIMYQLLRGLAYCHS-- 116
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED---------TLYLPSFHRSTAPK- 636
+I+H DLKPQNIL++ + K+ DFG+ R TL+ +R AP+
Sbjct: 117 -HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLW----YR--APEI 169
Query: 637 --GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 672
GS Y+ T V D +S G I +++TG+
Sbjct: 170 LLGSKHYS------TAV-----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 478 VGQGGFGCVYKGEMLGRT-------VAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVT 529
+G G FG VY+G GR VA+K L S + Q + +F E ++SK H ++V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 530 LLGACPEA--WSLVYEYLPNGSLQDRLF----RKSNVSPLLWKDRARIAAEIASGLCFLH 583
L+G E ++ E + G L+ L R S L KD A ++A G +L
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 584 SSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFP 640
+ +H D+ +N LL + KI DFG+ R +Y S++R + P
Sbjct: 134 EN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIYRASYYRKGG-RAMLP 184
Query: 641 --YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 674
+ PE G+ T K+D +SFG+++ ++ + G +P
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 4e-18
Identities = 62/205 (30%), Positives = 106/205 (51%), Gaps = 21/205 (10%)
Query: 477 KVGQGGFGCVYKGEMLGR-TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 535
++G G FG V G+ G+ VAIKM+ +M + EF +E +V+ KL H LV L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 536 EAWSL--VYEYLPNGSLQDRL---FRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
+ + V EY+ NG L + L ++ S LL + ++ G+ +L S ++
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLL-----EMCKDVCEGMAYLES---KQF 121
Query: 591 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 650
+H DL +N L+D + K+ DFG+ R V +D + S K ++ PE
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRWSPPEVLLYS 176
Query: 651 VLTPKSDSYSFGLIILQLLT-GRLP 674
+ KSD ++FG+++ ++ + G++P
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 477 KVGQGGFGCVYKGE----MLGRTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
++G G FG V GE M V +K L S QL F QEV+ +L HP+++ L
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 532 GACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDR---ARIAAEIASGLCFLHSSK 586
G C E+ + LV E+ P G L++ L R + + R+A E+ASGL +LH +
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGI--CR-----LVTEDTLYLPSFHRSTAPKGSF 639
+H DL +N L ++LS KI D+G+ + +T+D +P R AP+
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPL--RWLAPELVE 175
Query: 640 PYADPEYHRTGVLTPKSDSYSFGLIILQLLT 670
T KS+ +S G+ + +L T
Sbjct: 176 IRGQD--LLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 65/216 (30%), Positives = 96/216 (44%), Gaps = 35/216 (16%)
Query: 478 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 532
+ +G +G V+ K + G AIK++ +M + + Q E +LS+ Q P++V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 533 ACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLH 583
+S LV EYLP G L L +D ARI AEI L +LH
Sbjct: 60 -----YSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLD---EDVARIYIAEIVLALEYLH 110
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL-VTEDTLYLPSFHRSTAPK----GS 638
S+ I+H DLKP NIL+DS K+ DFG+ ++ + + L G+
Sbjct: 111 SNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND---DEKEDKRIVGT 164
Query: 639 FPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
Y PE + D +S G I+ + L G P
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 6e-18
Identities = 85/297 (28%), Positives = 131/297 (44%), Gaps = 39/297 (13%)
Query: 478 VGQGGFGCVY------KGEMLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTL 530
+G+G FG V + G VA+K L Q +++E+ +L L H ++V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 531 LGACPE----AWSLVYEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSS 585
G C E L+ EY+P GSL+D L + N++ LL A +I G+ +LHS
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL-----FAQQICEGMAYLHS- 125
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 645
+ +H DL +N+LLD++ KI DFG+ + V E Y +P F YA E
Sbjct: 126 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP--VFWYA-VE 180
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 705
+ + SD +SFG+ + +LLT + K ++ P G
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLTHCDS--------KQSPPKKFEEMIGPKQG---QMT 229
Query: 706 ARRLVDLGLQCCELYGRERPDITPSLVKEL-EQLHVAEERPVPSF-FLCPILQEIMH 760
RL++L + L P P V L + E + P+F L PIL+E+ H
Sbjct: 230 VVRLIELLERGMRL---PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 6e-18
Identities = 80/261 (30%), Positives = 121/261 (46%), Gaps = 34/261 (13%)
Query: 478 VGQGGFGCVYKGEML--GRTVAIK--MLYSHNMQGQL---EFQQEVRVLSKLQHPHLVTL 530
+G G FG VY+G L G A+K L GQ + +QE+ +LSKLQHP++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 531 LGACPEAWSL-VY-EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 588
LG E +L ++ E +P GSL L + + + + R +I GL +LH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR---QILLGLEYLHD---R 121
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY-H 647
VH D+K NIL+D+ K+ DFG+ + V E SF +S KGS + PE
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF-----SFAKSF--KGSPYWMAPEVIA 174
Query: 648 RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR---RAVSCGKLSSILDPLAGDWPTF 704
+ G +D +S G +L++ TG+ P V + +L I D L+ + F
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDF 234
Query: 705 VARRLVDLGLQCCELYGRERP 725
+ L+C + RP
Sbjct: 235 I--------LKCLQRDPSLRP 247
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 79/298 (26%), Positives = 132/298 (44%), Gaps = 43/298 (14%)
Query: 477 KVGQGGFGCVYKGEMLGRT-------VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 529
++G+G FG V+ E + VA+K L + + +FQ+E +L+ LQH H+V
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 530 LLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKD--------------RARIAA 573
G C + L V+EY+ +G L ++ R ++ D IA+
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 574 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 633
+IASG+ +L S + VH DL +N L+ + L KI DFG+ R V Y H +
Sbjct: 131 QIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH-TM 186
Query: 634 APKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSS 692
P P PE T +SD +SFG+I+ ++ T G+ P + C
Sbjct: 187 LPIRWMP---PESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-EVIECITQGR 242
Query: 693 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPVPSFF 750
+L+ P + + D+ L C + ++R +I KE+ ++ A + P +
Sbjct: 243 VLER-----PRVCPKEVYDIMLGCWQREPQQRLNI-----KEIYKILHALGKATPIYL 290
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 8e-18
Identities = 54/176 (30%), Positives = 80/176 (45%), Gaps = 34/176 (19%)
Query: 471 NFSESFKVGQGGFGCVYKGEMLG------------------RTVAIKMLY-SHNMQGQLE 511
NF E K+G+G FG V+ E G VA+K+L + + +
Sbjct: 8 NFVE--KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 512 FQQEVRVLSKLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFR--------KSNVS 561
F +EV++LS+L P++ LLG C L + EY+ NG L L + N
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 562 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
L + +A +IASG+ +L S VH DL +N L+ + KI DFG+ R
Sbjct: 126 SLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 8e-18
Identities = 68/270 (25%), Positives = 115/270 (42%), Gaps = 39/270 (14%)
Query: 478 VGQGGFGCVY------KGEMLGRTVAIKML---------YSHNMQGQLE-FQQEVRVLSK 521
+G+G +G VY GEM+ A+K + + + ++ + E+ L
Sbjct: 9 IGKGTYGRVYLALNVTTGEMM----AVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 522 LQHPHLVTLLG--ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 579
L H ++V LG E S+ EY+P GS+ L L + ++ GL
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE---QVLEGL 121
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 639
+LHS + I+H DLK N+L+D++ KI DFGI + D +Y ++ + +GS
Sbjct: 122 AYLHS---KGILHRDLKADNLLVDADGICKISDFGISK--KSDDIY--DNDQNMSMQGSV 174
Query: 640 PYADPE----YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILD 695
+ PE Y + + K D +S G ++L++ GR P + G S
Sbjct: 175 FWMAPEVIHSYSQG--YSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS-AP 231
Query: 696 PLAGDWPTFVARRLVDLGLQCCELYGRERP 725
P+ D ++ +D C + RP
Sbjct: 232 PIPPDVSMNLSPVALDFLNACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 12/151 (7%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIK-MLYSHNMQGQLEF-QQEVRVLSKLQHPHLVTLLG 532
VG+G +G V K G VAIK S + + + +EV+VL +L+H ++V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 533 ACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
A LV+EY+ L+ + P + ++ + + HS I
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVR---SYIWQLLQAIAYCHS---HNI 121
Query: 591 VHGDLKPQNILLDSELSSKICDFGICRLVTE 621
+H D+KP+NIL+ K+CDFG R +
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRA 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 61/206 (29%), Positives = 106/206 (51%), Gaps = 29/206 (14%)
Query: 477 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC-P 535
+G+G FG V +GE G+ VA+K + ++ Q F +E V++KL H +LV LLG
Sbjct: 13 IIGEGEFGAVLQGEYTGQKVAVKNIKC-DVTAQ-AFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 536 EAWSLVYEYLPNGSLQDRLFRKS----NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591
+V E + G+L + L + +V LL + + ++A G+ +L S +K+V
Sbjct: 71 NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLL-----QFSLDVAEGMEYLES---KKLV 122
Query: 592 HGDLKPQNILLDSELSSKICDFGICRLVTE--DTLYLPSFHRSTAPKGSFPYADPEYHRT 649
H DL +NIL+ + +K+ DFG+ R+ + D LP + PE +
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP-----------VKWTAPEALKH 171
Query: 650 GVLTPKSDSYSFGLIILQLLT-GRLP 674
+ KSD +S+G+++ ++ + GR P
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 70/225 (31%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 476 FKVGQGGFGCVYKGE----------MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP 525
+++G+G FG V+ E ML VA+K L + + +FQ+E +L+ LQH
Sbjct: 11 WELGEGAFGKVFLAECHNLLPEQDKML---VAVKALKEASESARQDFQREAELLTVLQHQ 67
Query: 526 HLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRAR 570
H+V G C E L V+EY+ +G L +R R L
Sbjct: 68 HIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 571 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 630
IA++IASG+ +L S VH DL +N L+ L KI DFG+ R + T Y
Sbjct: 127 IASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS-TDYYRVGG 182
Query: 631 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 674
R+ P P PE T +SD +SFG+++ ++ T G+ P
Sbjct: 183 RTMLPIRWMP---PESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 68/219 (31%), Positives = 106/219 (48%), Gaps = 34/219 (15%)
Query: 477 KVGQGGFGCVYKGEML------GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVT 529
++G+ FG +YKG + + VAIK L N Q EFQQE ++++L HP++V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 530 LLGACPEAWS--LVYEYLPNGSLQDRLFRKSN--------------VSPLLWKDRARIAA 573
LLG + +++EYL G L + L +S S L D IA
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 574 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 633
+IA+G+ +L S VH DL +NIL+ +L KI D G+ R +Y ++R
Sbjct: 132 QIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKISDLGLSR-----EIYSADYYR-V 182
Query: 634 APKGSFP--YADPEYHRTGVLTPKSDSYSFGLIILQLLT 670
PK P + PE G + SD +SFG+++ ++ +
Sbjct: 183 QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 33/217 (15%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLL 531
+G+G FG V K G+ + K + NM + E QQ EV +L +L+HP++V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK-EKQQLVSEVNILRELKHPNIVRYY 65
Query: 532 GAC--PEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIA--------AEIASGL 579
+L V EY G L +L +K K+R I ++ L
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLA-QLIQKCK------KERKYIEEEFIWRILTQLLLAL 118
Query: 580 --CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG 637
C S ++H DLKP NI LD+ + K+ DFG+ +++ D+ + ++ G
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY------VG 172
Query: 638 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
+ Y PE KSD +S G +I +L P
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 82/294 (27%), Positives = 141/294 (47%), Gaps = 44/294 (14%)
Query: 477 KVGQGGFGCVY--------KGEMLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHL 527
++GQG FG VY KGE R VA+K + S +++ ++EF E V+ H+
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71
Query: 528 VTLLGACPEAWS--LVYEYLPNGSLQD--RLFRKSNVS-----PLLWKDRARIAAEIASG 578
V LLG + +V E + +G L+ R R + P ++ ++AAEIA G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 579 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS 638
+ +L++ +K VH DL +N ++ + + KI DFG+ R + E Y KG
Sbjct: 132 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY------RKGGKGL 182
Query: 639 FP--YADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGK-LSSILD 695
P + PE + GV T SD +SFG+++ ++ + LA + + +S + L ++D
Sbjct: 183 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPYQGLSNEQVLKFVMD 236
Query: 696 PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPVPSF 749
D P R+ DL ++ C + P + P+ ++ + L ++ PSF
Sbjct: 237 GGYLDQPDNCPERVTDL-MRMCWQFN---PKMRPTFLEIVNLL---KDDLHPSF 283
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|203049 pfam04564, U-box, U-box domain | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-17
Identities = 26/70 (37%), Positives = 34/70 (48%)
Query: 746 VPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHAL 805
+P FL PI E+M DP + G TY+ I L + T P T L+H L PN L
Sbjct: 1 IPDEFLDPITLELMKDPVILPSGITYDRSTIERHLLSVDPTDPFTREPLTHDQLIPNLEL 60
Query: 806 RHAIQDWLCK 815
+ I WL +
Sbjct: 61 KEKIDAWLEE 70
|
This domain is related to the Ring finger pfam00097 but lacks the zinc binding residues. Length = 73 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 28/213 (13%)
Query: 477 KVGQGGFGCVYKGEMLG-------RTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLV 528
++GQG FG VY+G G VAIK + + +M+ ++EF E V+ + H+V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 529 TLLGACPEAWS--LVYEYLPNG-------SLQDRLFRKSNVSPLLWKDRARIAAEIASGL 579
LLG + ++ E + G SL+ + +P K ++A EIA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 639
+L+++K VH DL +N ++ + + KI DFG+ R + E Y KG
Sbjct: 133 AYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY------RKGGKGLL 183
Query: 640 P--YADPEYHRTGVLTPKSDSYSFGLIILQLLT 670
P + PE + GV T SD +SFG+++ ++ T
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 29/207 (14%)
Query: 478 VGQGGFGCVYKGEMLGR-----TVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVT 529
+G G FG V +G + VAIK L S + L+F E ++ + HP+++
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQR--LDFLTEASIMGQFDHPNIIR 69
Query: 530 LLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 587
L G ++ + + EY+ NGSL D+ R+ N + IASG+ +L
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSL-DKFLRE-NDGKFTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGICRLV--TEDTLYLPSFHRSTAPKGSFP--YAD 643
VH DL +NIL++S L K+ DFG+ R + +E T T G P +
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY--------TTKGGKIPIRWTA 176
Query: 644 PEYHRTGVLTPKSDSYSFGLIILQLLT 670
PE T SD +SFG+++ ++++
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 5e-17
Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 31/209 (14%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHPHLVTLL 531
K+GQG G VY G+ VAIK + N+Q Q + + E+ V+ + +HP++V L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQM---NLQQQPKKELIINEILVMRENKHPNIVNYL 82
Query: 532 GA---CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLCFLHSS 585
+ E W +V EYL GSL D V D +IAA E L FLHS+
Sbjct: 83 DSYLVGDELW-VVMEYLAGGSLTD-------VVTETCMDEGQIAAVCRECLQALEFLHSN 134
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 645
+ ++H D+K NILL + S K+ DFG C +T P + + G+ + PE
Sbjct: 135 Q---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT------PEQSKRSTMVGTPYWMAPE 185
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
PK D +S G++ ++++ G P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 5e-17
Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 19/204 (9%)
Query: 478 VGQGGFG----CVY--KGEMLGRTVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTL 530
+G+G FG C Y +G+ G VA+K L + + + ++E+ +L L H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 531 LGACPE----AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
G C E L+ E+LP+GSL++ L R N + + K + + A +I G+ +L S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLGS-- 127
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 646
+ VH DL +N+L++SE KI DFG+ + + D Y +P F YA PE
Sbjct: 128 -RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSP--VFWYA-PEC 183
Query: 647 HRTGVLTPKSDSYSFGLIILQLLT 670
SD +SFG+ + +LLT
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 28/208 (13%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKM--LYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 532
K+G+G G VYK G+ VAIK L N + + E+ ++ +HP++V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNIVDYYD 82
Query: 533 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDR--ARIAAEIASGLCFLHSSKPE 588
+ + +V EY+ GSL D + + + + A + E+ GL +LHS +
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDII----TQNFVRMNEPQIAYVCREVLQGLEYLHS---Q 135
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEY 646
++H D+K NILL + S K+ DFG +T++ R++ G+ PY A PE
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-----SKRNSV-VGT-PYWMA-PEV 187
Query: 647 HRTGVLTPKSDSYSFGLIILQLLTGRLP 674
+ PK D +S G++ +++ G P
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 5e-17
Identities = 72/237 (30%), Positives = 104/237 (43%), Gaps = 35/237 (14%)
Query: 515 EVRVLSKLQHPHLVTLLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI 571
E+ + KLQHP++V L+G C A+ L++EY+ +L + L N+S W+ R +I
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAY-LIHEYIEGKNLSEVL---RNLS---WERRRKI 785
Query: 572 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS-FH 630
A IA L FLH +V G+L P+ I++D + + L LP
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR------------LSLPGLLC 833
Query: 631 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--------R 682
T S Y PE T +T KSD Y FGLI+++LLTG+ P V R
Sbjct: 834 TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWAR 893
Query: 683 RAVSCGKLSSILDPLAGDWPTFVARRLV---DLGLQCCELYGRERPDITPSLVKELE 736
S L +DP + +V +L L C RP ++K LE
Sbjct: 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP-CANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-17
Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 25/204 (12%)
Query: 478 VGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEA 537
+G+G FG V G+ G VA+K + ++ Q F E V+++L+H +LV LLG E
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 538 WS---LVYEYLPNGSLQDRLFRKSNVSPLLWKDR-ARIAAEIASGLCFLHSSKPEKIVHG 593
+V EY+ GSL D L +S +L D + + ++ + +L ++ VH
Sbjct: 72 KGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 594 DLKPQNILLDSELSSKICDFGICRLV--TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 651
DL +N+L+ + +K+ DFG+ + T+DT LP + PE R
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----------VKWTAPEALREKK 175
Query: 652 LTPKSDSYSFGLIILQLLT-GRLP 674
+ KSD +SFG+++ ++ + GR+P
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 8e-17
Identities = 67/231 (29%), Positives = 110/231 (47%), Gaps = 34/231 (14%)
Query: 464 DLQTATCNFSESFKVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQGQL--EFQQ 514
++ +T F E ++G+ FG VYKG + G + VAIK L +G L EF+
Sbjct: 1 EINLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKH 57
Query: 515 EVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-- 570
E + S+LQHP++V LLG + S+++ Y + L + L +S S + D +
Sbjct: 58 EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 571 -----------IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 619
I +IA+G+ FL S +VH DL +N+L+ +L+ KI D G+ R V
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 620 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 670
Y S P + PE G + SD +S+G+++ ++ +
Sbjct: 175 YAAD-YYKLMGNSLLP---IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 9e-17
Identities = 69/260 (26%), Positives = 121/260 (46%), Gaps = 45/260 (17%)
Query: 478 VGQGGFGCVYKGEML--GRTVAIKMLY---SHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 532
+G G G V K + + G +A K+++ +++ Q+ +E++++ + + P++V+ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQI--LRELQIMHECRSPYIVSFYG 70
Query: 533 AC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
A + E++ GSL DR+++K P+ + +IA + GL +L++ +
Sbjct: 71 AFLNENNI-CMCMEFMDCGSL-DRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNV--HR 124
Query: 590 IVHGDLKPQNILLDSELSSKICDFGIC-RLVTE--DTLYLPSFHRSTAPKGSFPYADPEY 646
I+H D+KP NIL++S K+CDFG+ L+ DT G+ Y PE
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----------GTSTYMSPER 173
Query: 647 HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPL--------- 697
+ G T KSD +S G+ I++L G+ P + ILD L
Sbjct: 174 IQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD--DPMGILDLLQQIVQEPPP 231
Query: 698 ---AGDWPTFVARRLVDLGL 714
+ D+P R VD L
Sbjct: 232 RLPSSDFPE-DLRDFVDACL 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-16
Identities = 67/207 (32%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 478 VGQGGFGCVYKG------EMLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL 530
+G G FG VYKG E + VAIK+L + + +EF E +++ + HPHLV L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 531 LGAC-PEAWSLVYEYLPNGSLQDRLFR-KSNVSPLL---WKDRARIAAEIASGLCFLHSS 585
LG C LV + +P+G L D + K N+ L W +IA G+ +L
Sbjct: 75 LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE- 127
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP--YAD 643
++VH DL +N+L+ S KI DFG+ RL+ D A G P +
Sbjct: 128 --RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE------KEYNADGGKMPIKWMA 179
Query: 644 PEYHRTGVLTPKSDSYSFGLIILQLLT 670
E T +SD +S+G+ I +L+T
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 478 VGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQGQLE-FQQEVRVLSKL-QHPHLV 528
+G G FG V + G VA+KML + E E++++S L H ++V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 529 TLLGACPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
LLGAC ++ EY G L + L RK L D + ++A G+ FL S
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLE-DLLSFSYQVAKGMAFLAS-- 159
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS--FP--YA 642
+ +H DL +N+LL KICDFG+ R + D+ Y+ KG+ P +
Sbjct: 160 -KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV--------VKGNARLPVKWM 210
Query: 643 DPEYHRTGVLTPKSDSYSFGLIILQLLT 670
PE V T +SD +S+G+++ ++ +
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 33/227 (14%)
Query: 466 QTATCNFSESFKV---GQGGFGCVYK--GEMLGRTVAIKMLY-SHNMQGQLEFQQEVRVL 519
+A + SE +V G G G VYK GR A+K++Y +H + + +E+ +L
Sbjct: 67 PSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEIL 126
Query: 520 SKLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDR--ARIAAEI 575
+ HP++V + + E++ GSL+ + ++ A +A +I
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH---------IADEQFLADVARQI 177
Query: 576 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAP 635
SG+ +LH IVH D+KP N+L++S + KI DFG+ R++ + + +
Sbjct: 178 LSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ------TMDPCNSS 228
Query: 636 KGSFPYADPEYHRTGVLTPKSDSY-----SFGLIILQLLTGRLPVGL 677
G+ Y PE T + D Y S G+ IL+ GR P G+
Sbjct: 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275
|
Length = 353 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 3e-16
Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 22/199 (11%)
Query: 477 KVGQGGFGCVYKG--EML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTL 530
++G G FG V KG +M +TVA+K+L + N L E +E V+ +L +P++V +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 531 LGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
+G C E+W LV E G L L + +V+ K+ + +++ G+ +L +
Sbjct: 62 IGICEAESWMLVMELAELGPLNKFLQKNKHVTE---KNITELVHQVSMGMKYLEETN--- 115
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---Y 646
VH DL +N+LL ++ +KI DFG+ + + D Y + T K + PE Y
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY---YKAKTHGKWPVKWYAPECMNY 172
Query: 647 HRTGVLTPKSDSYSFGLII 665
++ + KSD +SFG+++
Sbjct: 173 YK---FSSKSDVWSFGVLM 188
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 71/235 (30%), Positives = 113/235 (48%), Gaps = 39/235 (16%)
Query: 478 VGQGGFGCVYKGEM----LGRTVAIKMLYSHNMQG-QLEFQQEVRVLSKL-QHPHLVTLL 531
+G+G FG V + + L AIKML + +F E+ VL KL HP+++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 532 GACPEAWSL--VYEYLPNGSLQDRLFRKSNV--------------SPLLWKDRARIAAEI 575
GAC L EY P G+L D L RKS V S L + + A+++
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 576 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAP 635
A+G+ +L ++ +H DL +N+L+ L+SKI DFG+ R + +Y+ + T
Sbjct: 129 ATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYV----KKTMG 178
Query: 636 KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKL 690
+ + E V T KSD +SFG+++ ++ V L G ++C +L
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI------VSLGGTPYCGMTCAEL 227
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 28/161 (17%)
Query: 478 VGQGGFGCVYKG--EMLGRTVAIK-MLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGA 533
+G+G +G VYK + G+ VAIK M + + E ++E +L K HP++ T GA
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE--EIKEEYNILRKYSNHPNIATFYGA 71
Query: 534 C---------PEAWSLVYEYLPNGSLQD--RLFRKSNVS---PLLWKDRARIAAEIASGL 579
+ W LV E GS+ D + RK + A I E GL
Sbjct: 72 FIKKNPPGNDDQLW-LVMELCGGGSVTDLVKGLRKKGKRLKEEWI----AYILRETLRGL 126
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 620
+LH +K ++H D+K QNILL K+ DFG+ +
Sbjct: 127 AYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 471 NFSESFKVGQGGFGCVYKGEM--LGRTVAIK-MLYSHNMQGQLEFQQEVRVLSKLQHPHL 527
E ++G+G G V K + G A+K + N Q + +E+ + + P++
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 528 VTLLGAC-PEAWSLVY---EYLPNGSLQDRLFRK--SNVSPLLWKDRARIAAEIASGLCF 581
V GA E+ S + EY GSL D +++K + K +IA + GL +
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 582 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC-RLVTEDTLYLPSFHRSTAPKGSFP 640
LHS KI+H D+KP NILL + K+CDFG+ LV S T SF
Sbjct: 121 LHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN-------SL-AGTFTGTSF- 168
Query: 641 YADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
Y PE + + SD +S GL +L++ R P
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-16
Identities = 65/219 (29%), Positives = 108/219 (49%), Gaps = 19/219 (8%)
Query: 477 KVGQGGFGCVYKGEMLGR-TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 535
++G G FG V+ G+ + VAIK + M + +F +E +V+ KL HP LV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE-DFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 536 EAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDR-ARIAAEIASGLCFLHSSKPEKIVH 592
+ L V E++ NG L + L ++ L KD + ++ G+ +L + +H
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQGK---LSKDMLLSMCQDVCEGMEYLERN---SFIH 123
Query: 593 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL 652
DL +N L+ S K+ DFG+ R V +D + S+ K ++ PE
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDD-----EYTSSSGAKFPVKWSPPEVFNFSKY 178
Query: 653 TPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCG 688
+ KSD +SFG+++ ++ T G++P EV +S G
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 5e-16
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 35/211 (16%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIK-MLYSHNMQGQLEFQQ----EVRVLSKLQHPHLVT 529
K+G+G +G VYK + G VAIK + +G + E+++L +L HP+++
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEG---IPKTALREIKLLKELNHPNIIK 62
Query: 530 LLGACPE--AWSLVYEYLPNGSLQ-----DRLFRKSNVSPLLWKDRARIAAEIASGLCFL 582
LL LV+E++ + R +S + L+ ++ GL F
Sbjct: 63 LLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLY--------QLLQGLAFC 114
Query: 583 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 642
HS I+H DLKP+N+L+++E K+ DFG+ R T + Y
Sbjct: 115 HSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY------THYVVTRWYR 165
Query: 643 DPE-YHRTGVLTPKSDSYSFGLIILQLLTGR 672
PE + D +S G I +LL+ R
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKM--LYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 532
K+G+G +G VYK + L + A+K L S + + + + E+R+L+ + HP++++
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 533 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRA--RIAAEIASGLCFLHSSKPE 588
A + L V EY P G L + K L ++ RI ++ GL LH +
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLS-KAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---Q 122
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 648
KI+H DLK NILL + KI D GI +++ ++ G+ Y PE +
Sbjct: 123 KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK--------TQIGTPHYMAPEVWK 174
Query: 649 TGVLTPKSDSYSFGLIILQLLTGRLP 674
+ KSD +S G ++ ++ T P
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 472 FSESFKVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEF-QQEVRVLSKLQHPHLV 528
F+ +G+G FG VYK + + VAIK++ + ++E QQE++ LS+ + P++
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 529 TLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
G+ + L + EY GS D L K L A I E+ GL +LH
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLL--KP--GKLDETYIAFILREVLLGLEYLHE-- 116
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADP 644
E +H D+K NILL E K+ DFG+ +T +F G+ P+ A P
Sbjct: 117 -EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF------VGT-PFWMA-P 167
Query: 645 EYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
E + K+D +S G+ ++L G P
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 6e-16
Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 478 VGQGGFGCVYKGEMLG--------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLV 528
+G G FG VY+G VA+K L Q + EF +E ++S HP++V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 529 TLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNV----SPLL-WKDRARIAAEIASGLCF 581
LLG C E ++ E + G L L R + V PLL K+ I ++A G +
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 582 LHSSKPEKIVHGDLKPQNILLDSELSS-----KICDFGICRLVTEDTLYLPSFHRSTAPK 636
L +H DL +N L+ + KI DFG+ R +Y ++R +
Sbjct: 122 LEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-----DIYKSDYYRKEG-E 172
Query: 637 GSFP--YADPEYHRTGVLTPKSDSYSFGLIILQLLT 670
G P + PE G T +SD +SFG+++ ++LT
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 6e-16
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 472 FSESFKVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLV 528
F++ K+G+G FG V+KG + VAIK++ + ++E QQE+ VLS+ P++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 529 TLLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 585
G+ + W ++ EYL GS D L PL A I EI GL +LHS
Sbjct: 66 KYYGSYLKDTKLW-IIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHS- 119
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 645
EK +H D+K N+LL K+ DFG+ +T+ + +F G+ + PE
Sbjct: 120 --EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF------VGTPFWMAPE 171
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
+ K+D +S G+ ++L G P
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 6e-16
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 31/208 (14%)
Query: 478 VGQGGFGCVYKG------EMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLV 528
+G G FG V+KG + + VAIK + + G+ FQ+ + + L H ++V
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 529 TLLGACPEA-WSLVYEYLPNGSLQDRLF-RKSNVSP---LLWKDRARIAAEIASGLCFLH 583
LLG CP A LV + P GSL D + + ++ P L W +IA G+ +L
Sbjct: 73 RLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLE 126
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV-TEDTLYLPSFHRSTAPKGSFPYA 642
++VH +L +NILL S+ +I DFG+ L+ +D Y S H K +
Sbjct: 127 E---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH-----KTPIKWM 178
Query: 643 DPEYHRTGVLTPKSDSYSFGLIILQLLT 670
E G T +SD +S+G+ + ++++
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-16
Identities = 60/226 (26%), Positives = 106/226 (46%), Gaps = 44/226 (19%)
Query: 478 VGQGGFGCVYKGEMLG-------RTVAIKMLYSH-NMQGQLEFQQEVRVLSKLQHPHLVT 529
+GQG FG V++ G VA+KML + Q +FQ+E ++++ HP++V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 530 LLGACPEA--WSLVYEYLPNGSLQDRLFRKS-------------------NVSPLLWKDR 568
LLG C L++EY+ G L + L +S N PL ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 569 ARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 628
IA ++A+G+ +L K VH DL +N L+ + KI DFG+ R +Y
Sbjct: 133 LCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSR-----NIYSAD 184
Query: 629 FHRSTA----PKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 670
+++++ P P Y+R T +SD +++G+++ ++ +
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 472 FSESFKVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLV 528
F++ ++G+G FG VYKG VAIK++ + ++E QQE+ VLS+ P++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 529 TLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
G+ + L + EYL GS D L PL A I EI GL +LHS
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHS-- 119
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 646
E+ +H D+K N+LL + K+ DFG+ +T+ + +F G+ + PE
Sbjct: 120 -ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF------VGTPFWMAPEV 172
Query: 647 HRTGVLTPKSDSYSFGLIILQLLTGRLP 674
+ K+D +S G+ ++L G P
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 9e-16
Identities = 68/235 (28%), Positives = 108/235 (45%), Gaps = 39/235 (16%)
Query: 478 VGQGGFGCVY----KGEMLGRTVAIKMLYSHNMQG-QLEFQQEVRVLSKL-QHPHLVTLL 531
+G+G FG V K + L AIK + + + +F E+ VL KL HP+++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 532 GACPEAWSL--VYEYLPNGSLQDRLFRKSNV--------------SPLLWKDRARIAAEI 575
GAC L EY P+G+L D L RKS V S L + AA++
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 576 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAP 635
A G+ +L ++ +H DL +NIL+ +KI DFG+ R +Y+ + T
Sbjct: 122 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV----KKTMG 171
Query: 636 KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKL 690
+ + E V T SD +S+G+++ ++ V L G ++C +L
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI------VSLGGTPYCGMTCAEL 220
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 9e-16
Identities = 54/161 (33%), Positives = 86/161 (53%), Gaps = 23/161 (14%)
Query: 478 VGQGGFGCVYKGEML--GRTVAIK-MLYSHNMQG-QLEFQQEVRVLSKLQ---HPHLVTL 530
+G+G +G VYK L GR VA+K + + +G L +E+ +L +L+ HP++V L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 531 LGAC--PEAW-----SLVYEYLPNGSLQD-RLFRKSNVSPLLWKDRAR-IAAEIASGLCF 581
L C P +LV+E++ QD + P L + + + ++ G+ F
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVD----QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 582 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622
LHS +IVH DLKPQNIL+ S+ KI DFG+ R+ + +
Sbjct: 123 LHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 80/287 (27%), Positives = 127/287 (44%), Gaps = 37/287 (12%)
Query: 471 NFSESFKVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQG-QLEFQQEVRVLSKL 522
N E +G+G FG V+ + G V +K L + Q EF++E+ + KL
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 523 QHPHLVTLLGACPEA--WSLVYEYLPNGSLQDRL------FRKSNVSPLLWKDRARIAAE 574
H ++V LLG C EA ++ EY G L+ L K PL K + + +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 575 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST- 633
IA G+ L ++ + VH DL +N L+ S+ K+ + + V Y R+
Sbjct: 126 IALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYK---LRNAL 179
Query: 634 APKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPV-GLAG-EVRRAVSCGKL 690
P PE + + KSD +SFG+++ ++ T G LP GL+ EV + GKL
Sbjct: 180 IPLRWLA---PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236
Query: 691 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 737
P+ P+ RL L +C + ++RP + LV L +
Sbjct: 237 EL---PVPEGCPS----RLYKLMTRCWAVNPKDRPSFS-ELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 29/208 (13%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHPHLVTLL 531
K+GQG G V+ G+ VAIK + N+Q Q + + E+ V+ +L++P++V L
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQI---NLQKQPKKELIINEILVMKELKNPNIVNFL 82
Query: 532 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLCFLHSSK 586
+ + +V EYL GSL D V D A+IAA E L FLH+++
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTD-------VVTETCMDEAQIAAVCRECLQALEFLHANQ 135
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 646
++H D+K N+LL + S K+ DFG C +T P + + G+ + PE
Sbjct: 136 ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT------PEQSKRSTMVGTPYWMAPEV 186
Query: 647 HRTGVLTPKSDSYSFGLIILQLLTGRLP 674
PK D +S G++ ++++ G P
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 73/258 (28%), Positives = 114/258 (44%), Gaps = 24/258 (9%)
Query: 478 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGA 533
VG+G FG V+ + + + V IK + M +L Q E +VL L HP+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 534 CPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591
E A +V EY P G+L + + ++ N LL D I L LH + I+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCN--SLL--DEDTILHFFVQILLALHHVHTKLIL 123
Query: 592 HGDLKPQNILLDS-ELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 650
H DLK QNILLD ++ KI DFGI ++ L S ++ G+ Y PE
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKI-------LSSKSKAYTVVGTPCYISPELCEGK 176
Query: 651 VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 710
KSD ++ G ++ +L + L A+ +S P+ D + R+L+
Sbjct: 177 PYNQKSDIWALGCVLYELAS--LKRAFEAANLPALVLKIMSGTFAPI-SDRYSPDLRQLI 233
Query: 711 DLGLQCCELYGRERPDIT 728
L L +RP ++
Sbjct: 234 ---LSMLNLDPSKRPQLS 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 2e-15
Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 64/227 (28%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQHPHLVTLLG 532
++G+G +G VYK G VA+K + N + +E+++L KL+HP++V L
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 533 ACPEAWS----LVYEYLP---NGSLQDRLFR------KSNVSPLLWKDRARIAAEIASGL 579
+V+EY+ G L + K ++ GL
Sbjct: 66 IVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKC------------YMKQLLEGL 113
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED----------TL-YLPS 628
+LHS+ I+H D+K NIL++++ K+ DFG+ R T+ TL Y P
Sbjct: 114 QYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRP- 169
Query: 629 FHRSTAPK---GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 672
P+ G+ Y P+ D +S G I+ +L G+
Sbjct: 170 ------PELLLGATRY-----------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 17/207 (8%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLG 532
K+G G FG VY L G +A+K + + + E E++VL L+HP+LV G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 533 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
E + EY G+L++ L + + + ++ GL +LHS I
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIR---VYTLQLLEGLAYLHSHG---I 120
Query: 591 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 650
VH D+KP NI LD K+ DFG + +T + +S A G+ Y PE G
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA--GTPAYMAPEVITGG 178
Query: 651 VLTPK---SDSYSFGLIILQLLTGRLP 674
+D +S G ++L++ TG+ P
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 39/224 (17%)
Query: 477 KVGQGGFG----CVYKG--EMLGRT----------VAIKMLYSH-NMQGQLEFQQEVRVL 519
K+G+G FG C +G E LG VA+KML + + +F +E++++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 520 SKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRL--------FRKSNVSPLL-WKDR 568
S+L++P+++ LLG C + ++ EY+ NG L L F +N P + +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 569 ARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 628
+A +IASG+ +L S VH DL +N L+ + + KI DFG+ R LY
Sbjct: 132 LYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSR-----NLYSGD 183
Query: 629 FHRSTAPKGSFP--YADPEYHRTGVLTPKSDSYSFGLIILQLLT 670
++R + P + E G T SD ++FG+ + ++ T
Sbjct: 184 YYRIQG-RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 35/219 (15%)
Query: 478 VGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHPHLV 528
+G+G FG V K E +G TVA+KML + L + E+ ++ + +H +++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 529 TLLGACPEAWSL--VYEYLPNGSLQDRLFRK-------------SNVSPLLWKDRARIAA 573
LLG C + L V EY +G+L+D L + L KD A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 574 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 633
++A G+ FL S +K +H DL +N+L+ + KI DFG+ R + Y R T
Sbjct: 140 QVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY-----RKT 191
Query: 634 APKGSFPYA--DPEYHRTGVLTPKSDSYSFGLIILQLLT 670
G P PE V T +SD +SFG+++ ++ T
Sbjct: 192 T-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 77/223 (34%), Positives = 115/223 (51%), Gaps = 27/223 (12%)
Query: 477 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 535
K+G G FG V+ T VA+K + +M + F E V+ LQH LV L
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 536 -EAWSLVYEYLPNGSLQDRLFRKS---NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591
E ++ E++ GSL D F KS + PL +A+IA G+ F+ +
Sbjct: 72 KEPIYIITEFMAKGSLLD--FLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQ---RNYI 124
Query: 592 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHR 648
H DL+ NIL+ + L KI DFG+ R++ ED Y TA +G+ FP + PE
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVI-EDNEY-------TAREGAKFPIKWTAPEAIN 176
Query: 649 TGVLTPKSDSYSFGLIILQLLT-GRLPV-GLAG-EVRRAVSCG 688
G T KSD +SFG+++++++T GR+P G++ EV RA+ G
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 219
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 5e-15
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 472 FSESFKVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLV 528
F++ ++G+G FG V+KG + VAIK++ + ++E QQE+ VLS+ P++
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 529 TLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
G+ + L + EYL GS D L P A + EI GL +LHS
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILKGLDYLHS-- 119
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 646
EK +H D+K N+LL + K+ DFG+ +T+ + +F G+ + PE
Sbjct: 120 -EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF------VGTPFWMAPEV 172
Query: 647 HRTGVLTPKSDSYSFGLIILQLLTGRLP 674
+ K+D +S G+ ++L G P
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 478 VGQGGFGCVYKGEMLG--RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 535
+G+G +G VY L +AIK + + + +E+ + S L+H ++V LG+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 536 EA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI--AAEIASGLCFLHSSKPEKIV 591
E + + E +P GSL L +S PL ++ I +I GL +LH +IV
Sbjct: 76 ENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIV 130
Query: 592 HGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 650
H D+K N+L+++ KI DFG + + +F G+ Y PE G
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF------TGTLQYMAPEVIDKG 184
Query: 651 V--LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV 685
+D +S G I+++ TG+ P GE + A+
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM 221
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 478 VGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQG-QLEFQQEVRVLSKLQHPHLVTLLGACP 535
+G+G FG V+KG + +T VA+K Q +++F E R+L + HP++V L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 536 EAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 593
+ +V E +P G L +K + L K + A + A+G+ +L S + +H
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLES---KNCIHR 117
Query: 594 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLT 653
DL +N L+ KI DFG+ R +D +Y S + K + PE G +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQ-EDDGIYSSSGLKQIPIK----WTAPEALNYGRYS 172
Query: 654 PKSDSYSFGLIILQLLT 670
+SD +S+G+++ + +
Sbjct: 173 SESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 49/160 (30%), Positives = 81/160 (50%), Gaps = 35/160 (21%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKML----YSHNMQGQLEFQ--QEVRVLSKLQHPHLV 528
K+G+G + VYK GR VAIK + G + F +E+++L +L+HP+++
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDG-INFTALREIKLLQELKHPNII 65
Query: 529 TLLGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI--AAEIAS------- 577
LL +LV+E++ L+ + KD++ + A+I S
Sbjct: 66 GLLDVFGHKSNINLVFEFME-TDLE-----------KVIKDKSIVLTPADIKSYMLMTLR 113
Query: 578 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
GL +LHS+ I+H DLKP N+L+ S+ K+ DFG+ R
Sbjct: 114 GLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 477 KVGQGGFGCVYKGEMLGRT-------VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 529
++G+G FG V+ E VA+K L + + +F +E +L+ LQH H+V
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 530 LLGACPEAWSL--VYEYLPNGSLQ--------DRLFRKSNVSP--LLWKDRARIAAEIAS 577
G C E L V+EY+ +G L D + P L IA +IA+
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 578 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG 637
G+ +L S + VH DL +N L+ L KI DFG+ R V Y H + P
Sbjct: 132 GMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH-TMLPIR 187
Query: 638 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 674
P PE T +SD +S G+++ ++ T G+ P
Sbjct: 188 WMP---PESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 36/215 (16%)
Query: 478 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-----FQQEVRVLSKLQHPHLVTL 530
+GQG FG VY + GR +A+K + + + + E+++L LQH +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 531 LGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 588
G E S+ EY+P GS++D+L ++ + + R +I G+ +LHS+
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR---QILEGVEYLHSNM-- 124
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGIC-RLVT--EDTLYLPSFHRSTAPKGSFPYADPE 645
IVH D+K NIL DS + K+ DFG RL T + S G+ + PE
Sbjct: 125 -IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT------GTPYWMSPE 177
Query: 646 ------YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
Y R K+D +S G ++++LT + P
Sbjct: 178 VISGEGYGR------KADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 63/215 (29%), Positives = 91/215 (42%), Gaps = 33/215 (15%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEF-QQEVRVLSKLQHPHLVTLLGA 533
+G G VY L VAIK + Q ++ ++EV+ +S+ HP++V +
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 534 CPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLCFLHSSKPE 588
L V YL GSL D + L D A IA E+ GL +LHS
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGL---DEAIIATVLKEVLKGLEYLHS---N 121
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK---GSFPYADPE 645
+H D+K NILL + S KI DFG+ +L K G+ + PE
Sbjct: 122 GQIHRDIKAGNILLGEDGSVKIADFGV-----SASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 646 YHRTGVLTP------KSDSYSFGLIILQLLTGRLP 674
V+ K+D +SFG+ ++L TG P
Sbjct: 177 -----VMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 60/207 (28%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 478 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL-EFQQEVRVLSKLQH---PHLVTLL 531
+G+G +G VY+G+ + GR VA+K++ + + Q+EV +LS+L+ P++
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 532 GAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 588
G+ P W ++ EY GS+ R K+ P+ K + I E+ L ++H
Sbjct: 69 GSYLKGPRLW-IIMEYAEGGSV--RTLMKA--GPIAEKYISVIIREVLVALKYIHKVG-- 121
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 648
++H D+K NIL+ + + K+CDFG+ L+ +++ RST G+ + PE
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-----KRSTF-VGTPYWMAPEVIT 174
Query: 649 TGVL-TPKSDSYSFGLIILQLLTGRLP 674
G K+D +S G+ I ++ TG P
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 3e-14
Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 31/209 (14%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHPHLVTLL 531
K+GQG G VY + G+ VAIK + N+Q Q + + E+ V+ + ++P++V L
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQM---NLQQQPKKELIINEILVMRENKNPNIVNYL 82
Query: 532 GAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLCFLHSS 585
+ E W +V EYL GSL D V D +IAA E L FLHS+
Sbjct: 83 DSYLVGDELW-VVMEYLAGGSLTD-------VVTETCMDEGQIAAVCRECLQALDFLHSN 134
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 645
+ ++H D+K NILL + S K+ DFG C +T P + + G+ + PE
Sbjct: 135 Q---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT------PEQSKRSTMVGTPYWMAPE 185
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
PK D +S G++ ++++ G P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 478 VGQGGFGCV--YKGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 532
+G+G FG V + + G+ A+K+L + + E E RVL +HP L +L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 533 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 589
+ + V EY+ G L L R+ S +DR R AEI S L +LHS K
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFS----EDRTRFYGAEIVSALDYLHSGK--- 115
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
IV+ DLK +N++LD + KI DFG+C+ D + +F G+ Y PE
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC------GTPEYLAPEVLED 169
Query: 650 GVLTPKSDSYSFGLIILQLLTGRLP 674
D + G+++ +++ GRLP
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 44/222 (19%)
Query: 471 NFSESFKVGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQQ------EVRVLSKL 522
+ VG G FG V+ + + A+K++ + + +Q E RVL ++
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVM---AIPEVIRLKQEQHVHNEKRVLKEV 58
Query: 523 QHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLF---RKSNVSPLLWKDRARIAAEIAS 577
HP ++ L + L + EY+P G L L R SN + L + A+EI
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFY------ASEIVC 112
Query: 578 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG 637
L +LHS ++IV+ DLKP+NILLD E K+ DFG + + + T L G
Sbjct: 113 ALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC---------G 160
Query: 638 SFPYADPEY-----HRTGVLTPKSDSYSFGLIILQLLTGRLP 674
+ Y PE H V D ++ G++I ++L G P
Sbjct: 161 TPEYLAPEVIQSKGHNKAV-----DWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 48/145 (33%), Positives = 79/145 (54%), Gaps = 15/145 (10%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTLLGA 533
K+G+G +G VYK + G+ VAIK++ ++ L E +E+ +L + P++V G+
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 534 C---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
+ W +V EY GS+ D + K L ++ A I + GL +LHS+K
Sbjct: 67 YFKNTDLW-IVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHSNK---K 120
Query: 591 VHGDLKPQNILLDSELSSKICDFGI 615
+H D+K NILL+ E +K+ DFG+
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGV 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 55/168 (32%), Positives = 85/168 (50%), Gaps = 21/168 (12%)
Query: 477 KVGQGGFGCVYKGEML-----GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
++G G FG V GE+ + V ++ S ++Q Q++F +E + LQH +L+ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 532 GACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDR---ARIAAEIASGLCFLHSSK 586
G C E + LV E+ P G L+ R + L+ D R+A EIA GL LH +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLK-GYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRL-------VTEDTLYLP 627
+H DL +N LL ++L+ KI D+G+ VT D L++P
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVP 165
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 55/203 (27%), Positives = 101/203 (49%), Gaps = 20/203 (9%)
Query: 477 KVGQGGFGCVYKGEMLGRT----VAIKMLYSHNMQG-QLEFQQEVRVLSKLQHPHLVTLL 531
++G G FGCV KG R VAIK+L + N + + E +E ++ +L +P++V ++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 532 GAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
G C EA LV E G L L K + + + + +++ G+ +L +
Sbjct: 62 GVCEAEALMLVMEMASGGPLNKFLSGKKDEITV--SNVVELMHQVSMGMKYLEG---KNF 116
Query: 591 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---YH 647
VH DL +N+LL ++ +KI DFG+ + + D Y + +A K + PE +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY---YKARSAGKWPLKWYAPECINFR 173
Query: 648 RTGVLTPKSDSYSFGLIILQLLT 670
+ + +SD +S+G+ + + +
Sbjct: 174 K---FSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 5e-14
Identities = 64/259 (24%), Positives = 111/259 (42%), Gaps = 21/259 (8%)
Query: 478 VGQGGFGCVYKGE--MLGRTVAIKML-YSHNMQGQLE-----FQQEVRVLSKLQHPHLVT 529
+G G F Y+ G +A+K + Y N + E ++E+R++++L HPH++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 530 LLGACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 587
+LGA E ++L E++ GS+ L S ++ GL +LH +
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLL---SKYGAFKEAVIINYTEQLLRGLSYLHEN-- 122
Query: 588 EKIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 646
+I+H D+K N+L+DS +I DFG + F G+ + PE
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL--GTIAFMAPEV 179
Query: 647 HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVA 706
R D +S G +I+++ T + P K++S P ++
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA--PSIPEHLS 237
Query: 707 RRLVDLGLQCCELYGRERP 725
L D+ L+C EL +RP
Sbjct: 238 PGLRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 6e-14
Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 40/225 (17%)
Query: 477 KVGQGGFGCVYKGEMLGRT------------------VAIKMLYSH-NMQGQLEFQQEVR 517
K+G+G FG V+ E G VA+KML N + +F +E++
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 518 VLSKLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFR--------KSNVSPLLWKD 567
++S+L+ P+++ LL C + L + EY+ NG L L R K++V + +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 568 RARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627
+A +IASG+ +L S VH DL +N L+ + KI DFG+ R LY
Sbjct: 132 LIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSR-----NLYSG 183
Query: 628 SFHRSTAPKGSFP--YADPEYHRTGVLTPKSDSYSFGLIILQLLT 670
++R + P + E G T SD ++FG+ + ++LT
Sbjct: 184 DYYRIQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 6e-14
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 31/209 (14%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHPHLVTLL 531
K+GQG G VY G+ VAI+ + N+Q Q + + E+ V+ + ++P++V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 532 GAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLCFLHSS 585
+ E W +V EYL GSL D V D +IAA E L FLHS+
Sbjct: 84 DSYLVGDELW-VVMEYLAGGSLTD-------VVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 645
+ ++H D+K NILL + S K+ DFG C +T P + + G+ + PE
Sbjct: 136 Q---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT------PEQSKRSTMVGTPYWMAPE 186
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
PK D +S G++ ++++ G P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 34/212 (16%)
Query: 478 VGQGGFGCVYKGEMLG--RTVAIKMLYSH--NMQGQLEF-QQEVRVLSKL-QHPHLVTLL 531
+G+G FG V E+ G A+K+L +E E RVL+ +HP L L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 532 GAC---PEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGLCFL 582
+C + V EY+ G L + F + RAR AAEI GL FL
Sbjct: 63 -SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP---------RARFYAAEIVLGLQFL 112
Query: 583 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 642
H I++ DLK N+LLDSE KI DFG+C+ E L ++ G+ Y
Sbjct: 113 HE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILG---GVTTSTFCGTPDYI 163
Query: 643 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
PE P D ++ G+++ ++L G+ P
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 8e-14
Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 26/207 (12%)
Query: 478 VGQGGFGCVYKGEM--LGR---TVAIKMLYS-HNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
+G G FG V +G + G+ VAIK L S + + + +F E ++ + HP+++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 532 G----ACPEAWSLVYEYLPNGSLQDRLFRKSN----VSPLLWKDRARIAAEIASGLCFLH 583
G + P ++ E++ NG+L D R+++ V L+ R IA+G+ +L
Sbjct: 72 GVVTKSRPVM--IITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRG-----IAAGMKYLS 123
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 643
VH DL +NIL++S L K+ DFG+ R + +DT P++ S K +
Sbjct: 124 EMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD-PTYTSSLGGKIPIRWTA 179
Query: 644 PEYHRTGVLTPKSDSYSFGLIILQLLT 670
PE T SD +S+G+++ ++++
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 478 VGQGGFGCV--YKGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 532
+G+G FG V K + GR A+K+L + + E E RVL +HP L L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 533 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 589
+ + V EY G L L R+ S +DRAR AEI S L +LHS K
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFS----EDRARFYGAEIVSALDYLHSEK--N 116
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
+V+ DLK +N++LD + KI DFG+C+ +D + +F G+ Y PE
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC------GTPEYLAPEVLED 170
Query: 650 GVLTPKSDSYSFGLIILQLLTGRLP 674
D + G+++ +++ GRLP
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 478 VGQGGFGCV--YKGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 532
+G+G FG V + + GR A+K+L + + E E RVL +HP L L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 533 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 589
A + V EY G L L R+ + ++RAR AEI S L +LHS
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERVFT----EERARFYGAEIVSALEYLHS---RD 115
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
+V+ D+K +N++LD + KI DFG+C+ D + +F G+ Y PE
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC------GTPEYLAPEVLED 169
Query: 650 GVLTPKSDSYSFGLIILQLLTGRLP 674
D + G+++ +++ GRLP
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 477 KVGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLE--FQQEVRVLSKLQHPHLVTLLG 532
K+G+G FG +Y K + IK + M + + ++EV +L+K++HP++VT
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 533 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 589
+ E L V EY G L R+ R+ V L +D+ +I+ GL +H K
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGV--LFSEDQILSWFVQISLGLKHIHD---RK 121
Query: 590 IVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 648
I+H D+K QNI L + +K+ DFGI R + + + G+ Y PE +
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM----ELAYTCV--GTPYYLSPEICQ 175
Query: 649 TGVLTPKSDSYSFGLIILQLLTGRLP 674
K+D +S G ++ +L T + P
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 85/292 (29%), Positives = 130/292 (44%), Gaps = 47/292 (16%)
Query: 478 VGQGGFGCVYKGEM----LGRTVAIKMLYSHNMQG-QLEFQQEVRVLSKL-QHPHLVTLL 531
+G+G FG V K + L AIK + + + +F E+ VL KL HP+++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 532 GACPEA--WSLVYEYLPNGSLQDRLFRKSNV--------------SPLLWKDRARIAAEI 575
GAC L EY P+G+L D L RKS V S L + AA++
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 576 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAP 635
A G+ +L ++ +H DL +NIL+ +KI DFG+ R +Y+ + T
Sbjct: 134 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV----KKTMG 183
Query: 636 KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILD 695
+ + E V T SD +S+G+++ ++ V L G ++C +L L
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI------VSLGGTPYCGMTCAELYEKL- 236
Query: 696 PLAG--DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL-HVAEER 744
P + P + DL QC RE+P PS + L L + EER
Sbjct: 237 PQGYRLEKPLNCDDEVYDLMRQCW----REKPYERPSFAQILVSLNRMLEER 284
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (174), Expect = 3e-13
Identities = 51/155 (32%), Positives = 67/155 (43%), Gaps = 27/155 (17%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKM----LYSHNMQGQLEFQQEVRVLSKLQ-HPHLVT 529
++G G FG VY G VAIK YS L +EV+ L KL HP++V
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL---REVKSLRKLNEHPNIVK 62
Query: 530 LLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSK 586
L E L V+EY+ G+L K + R I +I GL +H
Sbjct: 63 LKEVFRENDELYFVFEYM-EGNLYQ--LMKDRKGKPFSESVIRSIIYQILQGLAHIHK-- 117
Query: 587 PEKIVHG----DLKPQNILLDSELSSKICDFGICR 617
HG DLKP+N+L+ KI DFG+ R
Sbjct: 118 -----HGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 33/212 (15%)
Query: 478 VGQGGFGCVY-----KGEMLGRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTL 530
+GQG FG V+ G G+ A+K+L ++ ++ + E +L+++ HP +V L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 531 LGA--CPEAWSLVYEYLPNGSLQDRL-----FRKSNVSPLLWKDRARIAAEIASGLCFLH 583
A L+ ++L G L RL F + +V L AE+A L LH
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL--------AELALALDHLH 115
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 643
S I++ DLKP+NILLD E K+ DFG+ + + SF G+ Y
Sbjct: 116 SLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTVEYMA 166
Query: 644 PE-YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
PE +R G T +D +SFG+++ ++LTG LP
Sbjct: 167 PEVVNRRG-HTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 33/209 (15%)
Query: 478 VGQGGFGCVYKG------EMLGRTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVTL 530
+G G FG VYKG E + VAIK L + + + E E V++ + +PH+ L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 531 LGAC-PEAWSLVYEYLPNGSLQDRLFR-KSNVSP---LLWKDRARIAAEIASGLCFLHSS 585
LG C L+ + +P G L D + K N+ L W +IA G+ +L
Sbjct: 75 LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEE- 127
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA--- 642
++VH DL +N+L+ + KI DFG+ +L+ D +H A G P
Sbjct: 128 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE---KEYH---AEGGKVPIKWMA 179
Query: 643 -DPEYHRTGVLTPKSDSYSFGLIILQLLT 670
+ HR T +SD +S+G+ + +L+T
Sbjct: 180 LESILHRI--YTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-13
Identities = 55/180 (30%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 477 KVGQGGFGCV-----YKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
++G G FG V Y + R V ++ + + + Q EF Q+ LQHP+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 532 GACPEA--WSLVYEYLPNGSL------QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 583
G C EA + LV+EY G L + R S + L R+A EIA+G+ +H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLL-----QRMACEIAAGVTHMH 116
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGIC-------RLVTEDTLYLPSFHRSTAPK 636
+H DL +N L S+L+ K+ D+GI + TED +P R AP+
Sbjct: 117 K---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPL--RWLAPE 171
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 50/157 (31%), Positives = 80/157 (50%), Gaps = 31/157 (19%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQ---------QEVRVLSKLQHP 525
K+G+G +G VYK G VA+K + +LE + +E+ +L +L HP
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKI-------RLETEDEGVPSTAIREISLLKELNHP 58
Query: 526 HLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLC 580
++V LL LV+E+L D L + + SPL D I + ++ G+
Sbjct: 59 NIVRLLDVVHSENKLYLVFEFLD----LD-LKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 581 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
+ HS +++H DLKPQN+L+D E + K+ DFG+ R
Sbjct: 114 YCHS---HRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 59/219 (26%), Positives = 104/219 (47%), Gaps = 33/219 (15%)
Query: 478 VGQGGFGCVYKGEMLG---------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHPH 526
+G+G FG V E LG TVA+KML + L + E+ ++ + +H +
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 527 LVTLLGACPEAWSL--VYEYLPNGSLQDRL-----------FRKSNVS--PLLWKDRARI 571
++ LLGAC + L + EY G+L++ L + + V + +KD
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 572 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 631
++A G+ +L S +K +H DL +N+L+ KI DFG+ R D + + +
Sbjct: 143 TYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR----DVNNIDYYKK 195
Query: 632 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 670
+T + + PE V T +SD +SFG+++ ++ T
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 8e-13
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 478 VGQGGFGCVYKGEM--LGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLG 532
+G+GGFG V ++ G+ A K L + +G+ E ++L K+ +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 533 A--CPEAWSLVYEYLPNGSLQDRLFRKSNV-SPLLWKDRARI-AAEIASGLCFLHSSKPE 588
A + LV + G L+ + NV P + RA AA+I GL LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLK---YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---R 114
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 648
+IV+ DLKP+N+LLD + +I D G+ + L + G+ Y PE +
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGL-------AVELKGGKKIKGRAGTPGYMAPEVLQ 167
Query: 649 TGVLTPKSDSYSFGLIILQLLTGRLP 674
V D ++ G + +++ GR P
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 9e-13
Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 38/214 (17%)
Query: 478 VGQGGFGCVYKGEMLG--RTVAIKMLYSHNMQGQLEFQQ--------EVRVLSKLQHPHL 527
+G+G FG V E G AIK+L + + Q E RVL+ P
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKIL-----KKDVIIQDDDVECTMVEKRVLALPGKPPF 62
Query: 528 VTLLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 584
+T L +C + V EY+ G L ++ V AAEIA GL FLHS
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS 119
Query: 585 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 644
+ I++ DLK N++LD+E KI DFG+C+ + ++ R+ G+ Y P
Sbjct: 120 ---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK----ENIFGGKTTRTFC--GTPDYIAP 170
Query: 645 E---YHRTGVLTPKS-DSYSFGLIILQLLTGRLP 674
E Y G KS D ++FG+++ ++L G+ P
Sbjct: 171 EIIAYQPYG----KSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 9e-13
Identities = 53/222 (23%), Positives = 97/222 (43%), Gaps = 38/222 (17%)
Query: 478 VGQGGFGCVYKGEM-----LGRTVAIKMLYSHNM-QGQLE-FQQEVRVLSKLQHPHLVTL 530
+G+G FG V +G++ VA+K + ++E F E + HP+++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 531 LGACPEAWSL--------VYEYLPNGSLQDRLFR--------KSNVSPLLWKDRARIAAE 574
+G C EA SL + ++ +G L L K + LL + +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLL-----KFMVD 121
Query: 575 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST- 633
IA G+ +L + +H DL +N +L +++ + DFG+ + +Y ++R
Sbjct: 122 IALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSK-----KIYSGDYYRQGR 173
Query: 634 APKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 674
K + E V T KSD ++FG+ + ++ T G+ P
Sbjct: 174 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 54/149 (36%), Positives = 80/149 (53%), Gaps = 16/149 (10%)
Query: 478 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSK-LQHPHLVTLL 531
+G+G FG V K + G+ A+K+L + + E + E VL K ++HP LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 532 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPE 588
+ + V +Y+ G L L R+ + + RAR AAEIAS L +LHS
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFP----EPRARFYAAEIASALGYLHS---L 115
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICR 617
I++ DLKP+NILLDS+ + DFG+C+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 36/161 (22%)
Query: 477 KVGQGGFGCVYK--GEMLGRTVAIKMLYS---HNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
VG+G +G V K + G+ VAIK M ++ + E+R+L +L+H +LV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLI 66
Query: 532 GAC--PEAWSLVYEYL-----------PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASG 578
+ LV+E++ PNG L + RK L+ +I G
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-LDESRVRK-----YLF--------QILRG 112
Query: 579 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 619
+ F HS I+H D+KP+NIL+ K+CDFG R +
Sbjct: 113 IEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 77/275 (28%), Positives = 129/275 (46%), Gaps = 34/275 (12%)
Query: 478 VGQGGFGCVYKG--EMLGR---TVAIKMLYSHNMQGQ-LEFQQEVRVLSKLQHPHLVTLL 531
+G G FG V++G +M GR VAIK L + Q +F E ++ + H +++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 532 GACPE--AWSLVYEYLPNGSLQDRLFRKSN--VSPLLWKDRARIAAEIASGLCFLHSSKP 587
G + ++ EY+ NG+L D+ R + S R IA+G+ +L
Sbjct: 73 GVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSDMN- 127
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 647
VH DL +NIL++S L K+ DFG+ R++ +D + ++ K + PE
Sbjct: 128 --YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP---EGTYTTSGGKIPIRWTAPEAI 182
Query: 648 RTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCG-KLSSILDPLAGDWPT 703
T SD +SFG+++ ++++ G P EV +A++ G +L P D P+
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL-----PAPMDCPS 237
Query: 704 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738
V + L LQC + RP +V L++L
Sbjct: 238 AVYQ----LMLQCWQQDRARRPRF-VDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 478 VGQGGFGCVYKGEM-LGRTVAIKMLY---SHNMQGQLEF---QQEVRVLSKLQHPHLVTL 530
+G+G +G VY G G+ +A+K + S+ + + E+ Q+EV +L L+H ++V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 531 LGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 588
LG C + S+ E++P GS+ L R PL + +I G+ +LH++
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNN--- 121
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 648
+VH D+K N++L K+ DFG R + L+ + + G+ + PE
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 649 TGVLTPKSDSYSFGLIILQLLTGRLP 674
KSD +S G + ++ TG+ P
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 477 KVGQGGFGCVYKGEMLGR-----TVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTL 530
+G+G FG VY+G + VA+K + E F QE ++ + HPH+V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 531 LGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 588
+G E W +V E P G L+ L L + ++++ L +L S +
Sbjct: 73 IGVITENPVW-IVMELAPLGELRSYLQVNKYSLDLA--SLILYSYQLSTALAYLESKR-- 127
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP--YADPE- 645
VH D+ +N+L+ S K+ DFG+ R + +++ Y A KG P + PE
Sbjct: 128 -FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY-------KASKGKLPIKWMAPES 179
Query: 646 --YHRTGVLTPKSDSYSFGLIILQLL 669
+ R T SD + FG+ + ++L
Sbjct: 180 INFRR---FTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 69/208 (33%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 478 VGQGGFGCVY--KGEMLGRTVAIKMLYSH---NMQGQLEFQQEVRVLSK-LQHPHLVTLL 531
+G+G FG V K ++ G+ A+K+L N + Q E VL K ++HP LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 532 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPE 588
+ E V +++ G L L R+ + + RAR AAEIAS L +LHS
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFP----EPRARFYAAEIASALGYLHSIN-- 116
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICR--LVTEDTLYLPSFHRSTAPKGSFPYADPEY 646
IV+ DLKP+NILLDS+ + DFG+C+ + DT +T G+ Y PE
Sbjct: 117 -IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--------TTTFCGTPEYLAPEV 167
Query: 647 HRTGVLTPKSDSYSFGLIILQLLTGRLP 674
R D + G ++ ++L G P
Sbjct: 168 IRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 60/230 (26%), Positives = 104/230 (45%), Gaps = 35/230 (15%)
Query: 455 PESAEFSLADLQTATCNFSESFKVGQGGFG----CVYKGEMLGRTVAIKMLYSHN---MQ 507
P+++ + L+D + +G G FG +KG G AIK L M+
Sbjct: 10 PDTSSWKLSDFEMGE-------TLGTGSFGRVRIAKHKGT--GEYYAIKCLKKREILKMK 60
Query: 508 GQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLW 565
QE +L +L HP +V ++ + + + + E++ G L L RK+ P
Sbjct: 61 QVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL-RKAGRFP--- 116
Query: 566 KDRARI-AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624
D A+ AE+ +LHS + I++ DLKP+N+LLD++ K+ DFG + V + T
Sbjct: 117 NDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF 173
Query: 625 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
L G+ Y PE ++ D ++ G+++ + + G P
Sbjct: 174 TLC---------GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 68/215 (31%), Positives = 96/215 (44%), Gaps = 41/215 (19%)
Query: 479 GQGGFGCV----YKGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVL---SKLQHPHLV 528
G+G FG V YK G AIK L ++ + E + E R+ + +HP LV
Sbjct: 8 GRGHFGKVLLAEYKKT--GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 529 TLLGACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHS 584
L AC + V EY G L + P RA AA + GL +LH
Sbjct: 66 NLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-----RAVFYAACVVLGLQYLHE 119
Query: 585 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 644
+K IV+ DLK N+LLD+E KI DFG+C+ E + R++ G+ P
Sbjct: 120 NK---IVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGF---GDRTSTFCGT-----P 165
Query: 645 EYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 674
E+ VLT S D + G++I ++L G P
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 478 VGQGGFGCVYKG------EMLGRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTL 530
+G G FG VYKG E + VAIK+L + + E E V++ + P++ L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 531 LGAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
LG C LV + +P G L D + + N + +D +IA G+ +L +
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLDYV--RENKDRIGSQDLLNWCVQIAKGMSYLEEVR--- 129
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA----DPE 645
+VH DL +N+L+ S KI DFG+ RL+ D +H A G P +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE---TEYH---ADGGKVPIKWMALESI 183
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLT 670
HR T +SD +S+G+ + +L+T
Sbjct: 184 LHRR--FTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 46/165 (27%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ---------EVRVLSKLQHP 525
K+G+G +G VYKG G+ VA+K + +LE ++ E+ +L +LQHP
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKI-------RLESEEEGVPSTAIREISLLKELQHP 59
Query: 526 HLVTLLGAC--PEAWSLVYEYL-----------PNGSLQDRLFRKSNVSPLLWKDRARIA 572
++V L L++E+L P G D KS +
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLY----------- 108
Query: 573 AEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
+I G+ F HS +++H DLKPQN+L+D++ K+ DFG+ R
Sbjct: 109 -QILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 2e-12
Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 36/165 (21%)
Query: 478 VGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQ---------QEVRVLSKLQHPH 526
+G G +G V + GR VAIK + F +E+++L L+H +
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 527 LVTLLGAC-PEAWS------LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRARIAAEIAS 577
++ LL P + +V E + D ++ + PL +I
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMET----DLHKVIKSPQ--PLTDDHIQYFLYQILR 114
Query: 578 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622
GL +LHS+ ++H DLKP NIL++S KICDFG+ R V D
Sbjct: 115 GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 33/215 (15%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQQ--------EVRVLSKLQHPH 526
++G+G +G VYK G T+A+K + +LE + E+ +L K P+
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEI-------RLELDESKFNQIIMELDILHKAVSPY 60
Query: 527 LVTLLGACPEAWSLVY--EYLPNGSLQDRLFRKSNVSPLLWKDR-ARIAAEIASGLCFLH 583
+V GA ++ EY+ GSL D+L+ + + +D RI + GL FL
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFL- 118
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGIC-RLV---TEDTLYLPSFHRSTAPKGSF 639
+ I+H D+KP N+L++ K+CDFG+ LV + + S+ K
Sbjct: 119 -KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGG 177
Query: 640 PYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
P +P Y T +SD +S GL IL++ GR P
Sbjct: 178 PNQNPTY------TVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 33/214 (15%)
Query: 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHP 525
NF K+G+G F VYK L GR VA+K + M Q +E+ +L +L HP
Sbjct: 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHP 62
Query: 526 HLVTLLGACPEAWSL--VYEYLPNGSL---------QDRLFRKSNVSPLLWKDRARIAAE 574
+++ L + E L V E G L Q RL + +WK +
Sbjct: 63 NVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPE----RTIWK----YFVQ 114
Query: 575 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 634
+ S L +HS ++I+H D+KP N+ + + K+ D G+ R + T S
Sbjct: 115 LCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL----- 166
Query: 635 PKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQL 668
G+ Y PE KSD +S G ++ ++
Sbjct: 167 -VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 48/232 (20%)
Query: 477 KVGQGGFGCVYKGEML----------------GRT--VAIKMLYSH-NMQGQLEFQQEVR 517
K+G+G FG V+ E++ GR VA+K+L N + +F +EV+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 518 VLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLF------RKSNVSPLLWKDRA 569
+LS+L+ P+++ LLG C + ++ EY+ NG L L ++ N + +
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 570 ----------RIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 619
+A +IASG+ +L S VH DL +N L+ L+ KI DFG+ R
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSR-- 186
Query: 620 TEDTLYLPSFHRSTAPKGSFP--YADPEYHRTGVLTPKSDSYSFGLIILQLL 669
LY ++R + P + E G T SD ++FG+ + ++L
Sbjct: 187 ---NLYAGDYYRIQG-RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 478 VGQGGFGCVYKGEMLG--RTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHPHLVTLLG 532
+G+G FG V E G AIK+L + + + E RVL+ P +T L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 533 ACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
+C + +Y EY+ G L +++ V AAEIA GL FLHS +
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS---KG 121
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
I++ DLK N++LDSE KI DFG+C+ D + +F G+ Y PE
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC------GTPDYIAPEIIAY 175
Query: 650 GVLTPKSDSYSFGLIILQLLTGRLP 674
D ++FG+++ ++L G+ P
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 47/175 (26%), Positives = 82/175 (46%), Gaps = 30/175 (17%)
Query: 467 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEF--QQEVRVLSKL 522
+ ++ K+G+G FG VYK + GR VA+K + HN + +E+++L KL
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL 64
Query: 523 QHPHLVTLLGACPEAWSLVYEYLPNGSLQDRL-------FRKSNVSPLLWKDRAR----- 570
+HP++V L+ + E P+ S + R + ++S LL +
Sbjct: 65 KHPNVVPLI-------DMAVER-PDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQ 116
Query: 571 ---IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622
++ G+ +LH + I+H D+K NIL+D++ KI DFG+ R
Sbjct: 117 IKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 23/202 (11%)
Query: 478 VGQGGFGCVYKGEML--GRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA- 533
+G G G VYK L R +A+K++ ++ Q + E+ +L K P+++ GA
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 534 -CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
S+ E++ GSL ++RK +L RIA + GL +L S K I+H
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIP-EHVL----GRIAVAVVKGLTYLWSLK---ILH 118
Query: 593 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL 652
D+KP N+L+++ K+CDFG+ + + G+ Y PE
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--------AKTYVGTNAYMAPERISGEQY 170
Query: 653 TPKSDSYSFGLIILQLLTGRLP 674
SD +S G+ ++L GR P
Sbjct: 171 GIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 31/210 (14%)
Query: 478 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 532
+G+G FG V + + G+ A+K+L + + E E RVL +HP L L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 533 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 589
+ L V EY G L L R+ S +DRAR AEI S L +LHS
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFS----EDRARFYGAEIVSALGYLHS---CD 115
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
+V+ DLK +N++LD + KI DFG+C+ E S + +F PEY
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCK---EGI----SDGATMK---TF-CGTPEYLAP 164
Query: 650 GVLTPKS-----DSYSFGLIILQLLTGRLP 674
VL D + G+++ +++ GRLP
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 5e-12
Identities = 48/147 (32%), Positives = 75/147 (51%), Gaps = 17/147 (11%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEF---QQEVRVLSKLQHPHLVTLL 531
++G G +G VYK + G VAIK++ ++ +F QQE+ +L + +HP++V
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 532 GA---CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 588
G+ + W +V EY GSLQD + PL A + E GL +LH +
Sbjct: 67 GSYLRRDKLW-IVMEYCGGGSLQDIY--QVTRGPLSELQIAYVCRETLKGLAYLHETG-- 121
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGI 615
+H D+K NILL + K+ DFG+
Sbjct: 122 -KIHRDIKGANILLTEDGDVKLADFGV 147
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 50/171 (29%), Positives = 84/171 (49%), Gaps = 29/171 (16%)
Query: 514 QEVRVLSKLQHPHLVTLLGACPEAW-----SLVYEYLPNGSLQDRLFRKSNVSP--LLWK 566
+E++VL + P++V GA + S+ E++ GSL D++ +K+ P +L
Sbjct: 48 RELKVLHECNSPYIVGFYGA---FYSDGEISICMEHMDGGSL-DQVLKKAGRIPENIL-- 101
Query: 567 DRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626
+I+ + GL +L KI+H D+KP NIL++S K+CDFG+
Sbjct: 102 --GKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS---------- 147
Query: 627 PSFHRSTAPK--GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 675
S A G+ Y PE + T +SD +S GL ++++ GR P+
Sbjct: 148 GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 69/256 (26%), Positives = 107/256 (41%), Gaps = 52/256 (20%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQ---HPHLVT 529
++G G +G VYK G VA+K + + L +EV +L +L+ HP++V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 530 LLGACPEAWS-------LVYEYLPNGSLQD-RLFRKSNVSPLLWKDRAR-IAAEIASGLC 580
L+ C + + LV+E++ QD R + P L + + + + GL
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVD----QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 581 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAP-KGSF 639
FLH++ IVH DLKP+NIL+ S K+ DFG+ R+ S + P +
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY--------SCQMALTPVVVTL 171
Query: 640 PYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCG-----KLSSIL 694
Y PE D +S G I ++ R+ + CG +L I
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-----------RKPLFCGNSEADQLGKIF 220
Query: 695 D----PLAGDWPTFVA 706
D P DWP V
Sbjct: 221 DLIGLPPEDDWPRDVT 236
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 8e-12
Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 37/223 (16%)
Query: 478 VGQGGFGCVYKGEML-----GRTVAIKMLYS----HNMQGQLEFQQEVRVLSKLQHPHLV 528
+G+GG+G V++ + G+ A+K+L N + + E +L ++HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 529 TLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSS 585
L+ A L + EYL G L L R+ + +D A +EI+ L LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQ- 118
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 645
+ I++ DLKP+NILLD++ K+ DFG+C+ + +F G+ Y PE
Sbjct: 119 --QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC------GTIEYMAPE 170
Query: 646 Y-----HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR 683
H V D +S G ++ +LTG P E R+
Sbjct: 171 ILMRSGHGKAV-----DWWSLGALMYDMLTGAPP--FTAENRK 206
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 33/219 (15%)
Query: 478 VGQGGFGCVYKGEMLG---------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHPH 526
+G+G FG V E +G VA+KML S + L + E+ ++ + +H +
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 527 LVTLLGACPEAWSL--VYEYLPNGSLQDRL-----------FRKSNV--SPLLWKDRARI 571
++ LLGAC + L + EY G+L++ L + + V L +KD
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 572 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 631
A ++A G+ +L S +K +H DL +N+L+ + KI DFG+ R D ++ + +
Sbjct: 146 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKK 198
Query: 632 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 670
+T + + PE + T +SD +SFG+++ ++ T
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 24/205 (11%)
Query: 478 VGQGGFGCVYKGEML--GR---TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTLL 531
+G G FG V G + G+ VAIK L + + Q +F E ++ + HP+++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 532 GACPEAWS--LVYEYLPNGSLQDRLFRKSN----VSPLLWKDRARIAAEIASGLCFLHSS 585
G ++ +V EY+ NGSL D RK + V L+ R IASG+ +L
Sbjct: 72 GVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRG-----IASGMKYLSDM 125
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 645
VH DL +NIL++S L K+ DFG+ R++ +D + + + K + PE
Sbjct: 126 G---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP---EAAYTTRGGKIPIRWTAPE 179
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLT 670
T SD +S+G+++ ++++
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 37/221 (16%)
Query: 478 VGQGGFGCVYKGEMLG---------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHPH 526
+G+G FG V E +G TVA+KML L + E+ ++ + +H +
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 527 LVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSP---------------LLWKDRA 569
++ LLGAC + L + EY G+L R + ++ P L +KD
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNL--REYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 570 RIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 629
A ++A G+ +L S +K +H DL +N+L+ + KI DFG+ R D + +
Sbjct: 138 SCAYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLAR----DVHNIDYY 190
Query: 630 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 670
++T + + PE V T +SD +SFG+++ ++ T
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 478 VGQGGFGCVYKGEMLG---------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHPH 526
+G+G FG V + E G TVA+KML + L + E+ ++ + +H +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 527 LVTLLGACPEAWSL--VYEYLPNGSLQDRL-------------FRKSNVSPLLWKDRARI 571
++ LLG C + L + EY G+L++ L K L +KD
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 572 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 631
A ++A G+ +L S + +H DL +N+L+ + KI DFG+ R V + Y +
Sbjct: 140 AYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY----KK 192
Query: 632 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 670
++ + + PE V T +SD +SFG+++ ++ T
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 66/206 (32%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 478 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSK-LQHPHLVTLL 531
+G+G FG V K + G A+K+L + + Q E VL K L+HP LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 532 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPE 588
+ E V +Y+ G L L R+ + RAR AAE+AS + +LHS
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFL----EPRARFYAAEVASAIGYLHS---L 115
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 648
I++ DLKP+NILLDS+ + DFG+C+ E +F G+ Y PE R
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC------GTPEYLAPEVLR 169
Query: 649 TGVLTPKSDSYSFGLIILQLLTGRLP 674
D + G ++ ++L G P
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 24/207 (11%)
Query: 478 VGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQLEFQ---QEVRVLS-KLQHPHLVTLL 531
+G+G FG V + GR A+K+L + + + E R+LS HP L T L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL-TQL 61
Query: 532 GAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKP 587
C P+ V E++ G L + + + RAR AAEI S L FLH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD----EARARFYAAEITSALMFLHD--- 114
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 647
+ I++ DLK N+LLD E K+ DFG+C+ + +F G+ Y PE
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC------GTPDYIAPEIL 168
Query: 648 RTGVLTPKSDSYSFGLIILQLLTGRLP 674
+ + P D ++ G+++ ++L G P
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-11
Identities = 52/156 (33%), Positives = 83/156 (53%), Gaps = 17/156 (10%)
Query: 471 NFSESFKVGQGGFGCVYKGE--MLGRTVAIKML-YSHNMQGQLEFQ-QEVRVLSKLQHPH 526
NF + K+G+G +G VYK + G VA+K + +G +E+ +L +L HP+
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 527 LVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLCF 581
+V LL L V+E+L QD L + + SPL I + ++ GL F
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLH----QD-LKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 582 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
HS +++H DLKPQN+L+++E + K+ DFG+ R
Sbjct: 116 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 49/221 (22%)
Query: 479 GQGGFGCVYK--GEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-------HPHLVT 529
G+G +G V K G +A+K ++ + Q++ R+L L P+ VT
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVK-----RIRATVNSQEQKRLLMDLDISMRSVDCPYTVT 64
Query: 530 LLGA---------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDR--ARIAAEIASG 578
GA C E + + SL D+ ++K L + +IA I
Sbjct: 65 FYGALFREGDVWICME--------VMDTSL-DKFYKKVYDKGLTIPEDILGKIAVSIVKA 115
Query: 579 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS 638
L +LHS ++H D+KP N+L++ K+CDFGI + YL T G
Sbjct: 116 LEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGI-------SGYLVDSVAKTIDAGC 166
Query: 639 FPYA-----DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
PY +PE ++ G KSD +S G+ +++L TGR P
Sbjct: 167 KPYMAPERINPELNQKG-YDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 69/205 (33%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 478 VGQGGFGCVYKGEMLG--RTVAIKMLYSHN--MQGQLEFQQ-EVRVLS-KLQHPHLVTLL 531
+G+G FG V+ E+ G + AIK L M +E E RVLS +HP L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 532 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
E V EYL G L +F + AAEI GL FLHS +
Sbjct: 63 CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHS---KG 116
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
IV+ DLK NILLD++ KI DFG+C+ E+ L ++ G+ Y PE
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCK---ENML---GDAKTCTFCGTPDYIAPEILLG 170
Query: 650 GVLTPKSDSYSFGLIILQLLTGRLP 674
D +SFG+++ ++L G+ P
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 65/209 (31%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 478 VGQGGFGCVYKGEMLGRT--VAIKMLYSHN--MQGQLEFQQ-EVRVLS-KLQHPHLVTLL 531
+G+G FG V E+ G AIK L +E E RVL+ +HP L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 532 GACP----EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSK 586
C E V EYL G L + + RAR AAEI GL FLH
Sbjct: 63 --CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFD----EARARFYAAEIICGLQFLHK-- 114
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRL-VTEDTLYLPSFHRSTAPKGSFPYADPE 645
+ I++ DLK N+LLD + KI DFG+C+ + + +++ G+ Y PE
Sbjct: 115 -KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-------KASTFCGTPDYIAPE 166
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
+ D +SFG+++ ++L G+ P
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 71/271 (26%), Positives = 121/271 (44%), Gaps = 34/271 (12%)
Query: 477 KVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQ--LEFQQEVRVLSKLQHPHLVTLLG 532
K+G+G FG + K + G+ IK + M + E ++EV VLS ++HP++V
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 533 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIA--AEIASGLCFLHSSKPE 588
+ E +L V +Y G L ++ + V L+ + + +I L +H
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGV---LFPEDQILDWFVQICLALKHVHD---R 120
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 648
KI+H D+K QNI L + + K+ DFGI R V T+ L R+ G+ Y PE
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELA---RTCI--GTPYYLSPEICE 174
Query: 649 TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSS-ILDPLAGDWPTFVAR 707
KSD ++ G ++ ++ T ++ A G + + +L + G +P +
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCT----------LKHAFEAGNMKNLVLKIIRGSYPPVSSH 224
Query: 708 RLVDLGLQCCELYGR---ERPDITPSLVKEL 735
DL +L+ R +RP + L K
Sbjct: 225 YSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 16/195 (8%)
Query: 477 KVGQGGFGCVYKGEMLGRT--VAIKMLYSHNMQGQLE--FQQEVRVLSKLQHPHLVTLLG 532
++G+G FG V+ G + VA+K + L+ F QE R+L + HP++V L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 533 ACPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
C + +V E + G F ++ L K+ ++ A+G+ +L S +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLT--FLRTEGPRLKVKELIQMVENAAAGMEYLES---KHC 115
Query: 591 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 650
+H DL +N L+ + KI DFG+ R ED +Y + P + PE G
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIP---VKWTAPEALNYG 171
Query: 651 VLTPKSDSYSFGLII 665
+ +SD +SFG+++
Sbjct: 172 RYSSESDVWSFGILL 186
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 40/213 (18%)
Query: 479 GQGGFGCVYKGEMLGRT------------VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPH 526
GQG F +YKG + ++ V +K+L S + + L F + ++S+L H H
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS-DHRDSLAFFETASLMSQLSHKH 62
Query: 527 LVTLLGAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 585
LV L G C + +V EY+ G L L R+ N L WK +A ++AS L +L
Sbjct: 63 LVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED- 119
Query: 586 KPEKIVHGDLKPQNILLDSE-------LSSKICDFGICR-LVTEDTLYLPSFHRSTAPKG 637
+K+VHG++ +NIL+ K+ D GI +++ +
Sbjct: 120 --KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI--------- 168
Query: 638 SFPYADPEYHRTGV--LTPKSDSYSFGLIILQL 668
P+ PE R G LT +D +SFG +L++
Sbjct: 169 --PWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 20/154 (12%)
Query: 477 KVGQGGFGCVYK--GEMLGRTVAIKMLYSHNMQGQLE--FQQEVRVLSKLQHPHLVTLLG 532
K+G+G +G V+K G+ VAIK ++ +E+R+L +L+HP+LV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI- 66
Query: 533 ACPEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
E + LV+EY + L + V L K +I + + F H
Sbjct: 67 ---EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK---KIIWQTLQAVNFCHKHN 120
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 620
+H D+KP+NIL+ + K+CDFG R++T
Sbjct: 121 ---CIHRDVKPENILITKQGQIKLCDFGFARILT 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-11
Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 471 NFSESFKVGQGGFGCVYKGEMLG--RTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHP 525
+F+ +G+G FG V E G AIK+L + + + E RVL+ P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 526 HLVTLLGACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 582
+T L +C + +Y EY+ G L ++ V AAEI+ GL FL
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFL 117
Query: 583 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 642
H I++ DLK N++LDSE KI DFG+C+ D + +F G+ Y
Sbjct: 118 HR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC------GTPDYI 168
Query: 643 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
PE D +++G+++ ++L G+ P
Sbjct: 169 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 8e-11
Identities = 47/167 (28%), Positives = 74/167 (44%), Gaps = 35/167 (20%)
Query: 477 KVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHPHLVT 529
+G+G +G VYK + G+ AIK Q Q +E+ +L +L+H ++V+
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 530 LLGACPEAW----SLVYEYLPNGSLQ---------DRLFRKSNVSPLLWKDRARIAAEIA 576
L+ E L+++Y + Q S V LLW +I
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW--------QIL 118
Query: 577 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLV 619
+G+ +LHS+ ++H DLKP NIL+ E KI D G+ RL
Sbjct: 119 NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 79/298 (26%), Positives = 122/298 (40%), Gaps = 63/298 (21%)
Query: 477 KVGQGGFGCVYKGEML---GRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQ---HPHLV 528
++G+G +G V+K L GR VA+K + + + +EV VL L+ HP++V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 529 TLLGACPEA-------WSLVYEYLPNGSLQDRLFR--KSNVSPLLWKDRARIAAEIASGL 579
L C + +LV+E++ + L L + + V KD + ++ GL
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD---MMFQLLRGL 123
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 639
FLHS ++VH DLKPQNIL+ S K+ DFG+ R+ + T+ +
Sbjct: 124 DFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-------LTSVVVTL 173
Query: 640 PYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILD---- 695
Y PE D +S G I ++ R P+ R + +L ILD
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL-----FRGSSDVDQLGKILDVIGL 227
Query: 696 PLAGDWPTFVA--------------RRLV--------DLGLQCCELYGRERPDITPSL 731
P DWP VA + V DL L+C +R +L
Sbjct: 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 53/203 (26%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 477 KVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
K+G+G G C+ + + GR VA+KM+ Q + EV ++ QH ++V + +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 535 ---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591
E W L+ E+L G+L D + + + L + A + + LC+LHS + ++
Sbjct: 88 LVGEELWVLM-EFLQGGALTDIV----SQTRLNEEQIATVCESVLQALCYLHS---QGVI 139
Query: 592 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 651
H D+K +ILL + K+ DFG C +++D +P + + G+ + PE
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKD---VP---KRKSLVGTPYWMAPEVISRTP 193
Query: 652 LTPKSDSYSFGLIILQLLTGRLP 674
+ D +S G+++++++ G P
Sbjct: 194 YGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 72/226 (31%), Positives = 98/226 (43%), Gaps = 52/226 (23%)
Query: 472 FSESFKVGQGGFGCVY--KGEMLGRTVAIK-MLYSHNMQGQLEFQ---QEVRVLSKLQHP 525
F++ ++G G FG VY + VAIK M YS Q ++Q +EVR L +L+HP
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYS-GKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 526 HLVTLLGAC----PEAWSLVYEYLPNGSLQDRL--FRKSNVSPLLWKDRARIAAEIASGL 579
+ + G C AW LV EY GS D L +K PL + A I GL
Sbjct: 76 NTIEYKG-CYLREHTAW-LVMEYCL-GSASDILEVHKK----PLQEVEIAAICHGALQGL 128
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 639
+LHS + +H D+K NILL + K+ DFG LV +P SF
Sbjct: 129 AYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLV--------------SPANSF 171
Query: 640 ---PY--------ADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
PY A E G K D +S G+ ++L + P
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDG----KVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 66/243 (27%), Positives = 103/243 (42%), Gaps = 62/243 (25%)
Query: 460 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQ-GQLEFQQ 514
F+ DL+ + ++G+G FG V K ML G +A+K + S + Q
Sbjct: 1 FTAEDLK-------DLGEIGRGAFGTVNK--MLHKPSGTIMAVKRIRSTVDEKEQKRLLM 51
Query: 515 EVRVLSKLQH-PHLVTLLGA---------CPEA--------WSLVYEYLPNGSLQDRLFR 556
++ V+ + P++V GA C E + VYE L + + +
Sbjct: 52 DLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL-KSVIPEEILG 110
Query: 557 KSNVSPLLWKDRARIAAEIASGLCFLHSSKPE-KIVHGDLKPQNILLDSELSSKICDFGI 615
K V+ + +A L+ K E KI+H D+KP NILLD + K+CDFGI
Sbjct: 111 KIAVATV----KA------------LNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGI 154
Query: 616 C-RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTP---KSDSYSFGLIILQLLTG 671
+LV S + T G PY PE +SD +S G+ + ++ TG
Sbjct: 155 SGQLVD-------SIAK-TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
Query: 672 RLP 674
+ P
Sbjct: 207 KFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 24/205 (11%)
Query: 478 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQ---LEFQQEVRVL-SKLQHPHLVTLL 531
+ +G FG VY K G AIK+L +M + + E ++ + + P++ L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 532 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
+ + LV EYL G L + P W + AE+ G+ LH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWA--KQYIAEVVLGVEDLHQ---RG 117
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
I+H D+KP+N+L+D K+ DFG+ R E+ ++ G+ Y PE
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV----------GTPDYLAPETILG 167
Query: 650 GVLTPKSDSYSFGLIILQLLTGRLP 674
SD +S G +I + L G P
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 477 KVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
K+G+G G C+ + GR VA+K + Q + EV ++ QHP++V + +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 535 ---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591
E W +V E+L G+L D + + A + + L FLH+ + ++
Sbjct: 86 LVGDELW-VVMEFLEGGALTDIVTHTRMNEEQI----ATVCLAVLKALSFLHA---QGVI 137
Query: 592 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 651
H D+K +ILL S+ K+ DFG C V+++ +P R + G+ + PE
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKE---VP---RRKSLVGTPYWMAPEVISRLP 191
Query: 652 LTPKSDSYSFGLIILQLLTGRLP 674
+ D +S G+++++++ G P
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 55/213 (25%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 471 NFSESFKVGQGGFGCVYK------GEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH 524
+F + ++G G G V+K G ++ R + I + ++ Q+ +E++VL +
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKL-IHLEIKPAIRNQI--IRELQVLHECNS 62
Query: 525 PHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 582
P++V GA S+ E++ GSL D++ +K+ P + +++ + GL +L
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIP--EQILGKVSIAVIKGLTYL 119
Query: 583 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 642
+ KI+H D+KP NIL++S K+CDFG+ + + + + G+ Y
Sbjct: 120 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--------ANSFVGTRSYM 169
Query: 643 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 675
PE + + +SD +S GL ++++ GR P+
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 39/219 (17%)
Query: 469 TCNFSESFKVGQGGFG--CVYKGEMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQ 523
T + + VG G FG C + ++ G+ VAIK + +S + + + +E+++L L+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLR 67
Query: 524 HPHLVTL--LGACP-EAWSLVYEYLP---NGSLQDRLFRKSNVSPLLWKDRARIAAEIAS 577
H ++++L + P E V E L + L R K + L+ +I
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLY--------QILR 119
Query: 578 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG 637
GL ++HS+ +VH DLKP NIL++ KICDFG+ R + T
Sbjct: 120 GLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR---------IQDPQMTGYVS 167
Query: 638 SFPYADPE----YHRTGVLTPKSDSYSFGLIILQLLTGR 672
+ Y PE + + V + D +S G I ++L G+
Sbjct: 168 TRYYRAPEIMLTWQKYDV---EVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 78/254 (30%), Positives = 116/254 (45%), Gaps = 38/254 (14%)
Query: 471 NFSESFKV-GQGGFGCVY-----KGEMLGRTVAIKMLYSHNMQGQLEFQQEVR----VLS 520
NF E KV G G +G V+ G G+ A+K+L + + + + R VL
Sbjct: 1 NF-ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLE 59
Query: 521 KL-QHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIA 576
+ Q P LVTL A L+ +Y+ G + L+++ N S +D R + EI
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS----EDEVRFYSGEII 115
Query: 577 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR-LVTEDTLYLPSFHRSTAP 635
L LH IV+ D+K +NILLDSE + DFG+ + ++E+ R+ +
Sbjct: 116 LALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK------ERTYSF 166
Query: 636 KGSFPYADPEYHRTGVLTPKS-DSYSFGLIILQLLTGRLPVGLAGE-------VRRAVSC 687
G+ Y PE R K+ D +S G++I +LLTG P L GE RR + C
Sbjct: 167 CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC 226
Query: 688 G-KLSSILDPLAGD 700
S + P A D
Sbjct: 227 DPPFPSFIGPEAQD 240
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 478 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLG 532
+G+GGFG C + G+ A K L ++ G+ E ++L K+ +V+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 533 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 589
A +A LV + G L+ ++ N P ++RA AAEI GL LH E+
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHR---ER 122
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
IV+ DLKP+NILLD +I D G+ + +P G+ Y PE +
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGL-------AVEIPEGETIRGRVGTVGYMAPEVVKN 175
Query: 650 GVLTPKSDSYSFGLIILQLLTGRLP 674
T D + G +I +++ G+ P
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 30/210 (14%)
Query: 478 VGQGGFGCVYKGEMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSK-------LQHPHL 527
+G+G FG V +L R A + Y+ + + L+ ++E ++S+ ++HP L
Sbjct: 3 IGKGSFGKV----LLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58
Query: 528 VTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHS 584
V L + A L V +Y+ G L L R+ + RAR AAEIAS L +LHS
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHS 114
Query: 585 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 644
IV+ DLKP+NILLDS+ + DFG+C+ E +F G+ Y P
Sbjct: 115 LN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC------GTPEYLAP 165
Query: 645 EYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
E D + G ++ ++L G P
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-10
Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 42/231 (18%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
+G+GG G VY + R VA+K + S N + F +E ++ + L HP +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 532 GACPEAWSLVYEYLP----------------NGSLQDRLFRKSNVSPLLWKDRARIAAEI 575
C + VY +P SL L K++V L I +I
Sbjct: 69 SICSDG-DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL-----SIFHKI 122
Query: 576 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI---CRLVTEDTLYL------ 626
+ + ++HS + ++H DLKP NILL I D+G +L ED L +
Sbjct: 123 CATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 627 PSFHRSTAPK---GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
+ T P G+ Y PE + +D Y+ G+I+ Q+LT P
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 478 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLG 532
+G+GGFG C + G+ A K L ++ G+ E R+L K+ +V+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 533 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 589
A +A LV + G L+ ++ N P + RA AAE+ GL L E+
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQR---ER 122
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
IV+ DLKP+NILLD +I D G+ + +P G+ Y PE
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGL-------AVQIPEGETVRGRVGTVGYMAPEVINN 175
Query: 650 GVLTPKSDSYSFGLIILQLLTGRLP 674
T D + G +I +++ G+ P
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 49/201 (24%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 478 VGQGGFG--CVYKGEMLGRTVAIKM--LYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA 533
+G+G FG +Y+ V K L + + + + E+ +LS LQHP+++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 534 CPEAWSLV--YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA--EIASGLCFLHSSKPEK 589
+ +L+ EY G+L D++ R+ L+++ + +I S + ++H
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIHK---AG 121
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
I+H D+K NI L K+ DFGI +++ + + G+ Y PE +
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV------VGTPYYMSPELCQG 175
Query: 650 GVLTPKSDSYSFGLIILQLLT 670
KSD ++ G ++ +LLT
Sbjct: 176 VKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 66/249 (26%), Positives = 104/249 (41%), Gaps = 39/249 (15%)
Query: 443 NYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLY 502
N D F+ E E + L+ +F +G+G FG V L R + K +Y
Sbjct: 20 NIDNFLSRYEKAAEK----ITKLRMKAEDFDVIKVIGRGAFGEVQ----LVRHKSSKQVY 71
Query: 503 SHNMQGQLE---------FQQEVRVLSKLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQ 551
+ + + E F +E +++ +V L A + L V EY+P G L
Sbjct: 72 AMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLV 131
Query: 552 DRLFRKSNVS-PLLWKDRARI-AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSK 609
+ + SN P W AR AE+ L +HS +H D+KP N+LLD K
Sbjct: 132 NLM---SNYDIPEKW---ARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLK 182
Query: 610 ICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT----GVLTPKSDSYSFGLII 665
+ DFG C + + + TA G+ Y PE ++ G + D +S G+ +
Sbjct: 183 LADFGTCMKMDANGM----VRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237
Query: 666 LQLLTGRLP 674
++L G P
Sbjct: 238 YEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 6e-10
Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 36/214 (16%)
Query: 478 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM-QGQLE--FQQEVRVLSKLQHPHLVTLLG 532
+G GGFG V K + RT A+K + ++ + + E +L + HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 533 ACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPE 588
+ +Y EY G L L + L + AR A + +LH+
Sbjct: 61 TFKDKKY-IYMLMEYCLGGELWTILRDRG----LFDEYTARFYIACVVLAFEYLHN---R 112
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE--- 645
I++ DLKP+N+LLDS K+ DFG + L S ++ G+ Y PE
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAK-------KLKSGQKTWTFCGTPEYVAPEIIL 165
Query: 646 ---YHRTGVLTPKSDSYSFGLIILQLLTGRLPVG 676
Y + D +S G+++ +LLTGR P G
Sbjct: 166 NKGYDFS------VDYWSLGILLYELLTGRPPFG 193
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 9e-10
Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 478 VGQGGFGCVYKGEMLGRT--VAIKMLYSHN--MQGQLEFQQ-EVRVLS-KLQHPHLVTLL 531
+G+G FG V E+ G+ A+K L + +E E RVL+ ++P L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 532 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPE 588
E V E+L G L + K L+ RA AAEI GL FLHS +
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFD--LY--RATFYAAEIVCGLQFLHS---K 115
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 648
I++ DLK N++LD + KI DFG+C+ + ++ + R++ G+ Y PE +
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCK----ENVFGDN--RASTFCGTPDYIAPEILQ 169
Query: 649 TGVLTPKSDSYSFGLIILQLLTGRLP 674
T D +SFG+++ ++L G+ P
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 51/174 (29%), Positives = 81/174 (46%), Gaps = 22/174 (12%)
Query: 515 EVRVLSKLQH-PHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI 571
E +VL ++ P LVTL A L+ +Y+ G L L+++ + + + R+
Sbjct: 54 ERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT----ESEVRV 109
Query: 572 -AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 630
AEI L LH I++ D+K +NILLDSE + DFG+ + +
Sbjct: 110 YIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE----- 161
Query: 631 RSTAPKGSFPYADPEYHRTGVLTPKSDS----YSFGLIILQLLTGRLPVGLAGE 680
R+ + G+ Y PE R G + D +S G++ +LLTG P + GE
Sbjct: 162 RAYSFCGTIEYMAPEVIRGG--SGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 30/210 (14%)
Query: 478 VGQGGFGCVYKGEMLG--RTVAIKMLYSHNMQGQLEFQ---QEVRVLS-KLQHPHLVTLL 531
+G+G FG V E+ G AIK+L + + E R+L+ +HP L T L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFL-TAL 61
Query: 532 GAC---PEAWSLVYEYLPNGSL--QDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSS 585
C + V EY+ G L Q + RK + R+R AAE+ L FLH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP------RSRFYAAEVTLALMFLHR- 114
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRL-VTEDTLYLPSFHRSTAPKGSFPYADP 644
+++ DLK NILLD+E K+ DFG+C+ + +T G+ Y P
Sbjct: 115 --HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT-------TTTFCGTPDYIAP 165
Query: 645 EYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
E + P D ++ G+++ +++ G+ P
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 43/177 (24%), Positives = 81/177 (45%), Gaps = 36/177 (20%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQHPHLVTLLG 532
K+GQG FG V+K + VA+K + N + +E+++L L+H ++V L+
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 78
Query: 533 AC---PEAWS-------LVYEYLPN---GSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 579
C ++ LV+E+ + G L ++ + + + ++ + +GL
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLS------EIKKVMKMLLNGL 132
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 636
++H +K I+H D+K NIL+ + K+ DFG+ R +F S K
Sbjct: 133 YYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR----------AFSLSKNSK 176
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 41/221 (18%)
Query: 478 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKL-QHPHLVTLLG 532
VG G +G VYKG + G+ AIK++ ++ G + E +QE+ +L K H ++ T G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 533 AC---------PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 583
A + W LV E+ GS+ D L + + + L + A I EI GL LH
Sbjct: 71 AFIKKNPPGMDDQLW-LVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLH 128
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF---P 640
K++H D+K QN+LL K+ DFG+ R+ + +F P
Sbjct: 129 Q---HKVIHRDIKGQNVLLTENAEVKLVDFGVS----------AQLDRTVGRRNTFIGTP 175
Query: 641 Y-ADPEY-----HRTGVLTPKSDSYSFGLIILQLLTGRLPV 675
Y PE + KSD +S G+ +++ G P+
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 472 FSESFKVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPH 526
F + +G+GGFG C + G+ A K L ++ G+ E ++L K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 527 LVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLH 583
+V L A +A LV + G L+ ++ N P ++RA AAEI GL LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLH 119
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 643
E V+ DLKP+NILLD +I D G+ + +P G+ Y
Sbjct: 120 R---ENTVYRDLKPENILLDDYGHIRISDLGL-------AVKIPEGESIRGRVGTVGYMA 169
Query: 644 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
PE T D + G +I +++ G+ P
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 46/164 (28%), Positives = 84/164 (51%), Gaps = 15/164 (9%)
Query: 514 QEVRVLSKLQHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI 571
+E++VL + P++V GA S+ E++ GSL D++ +++ P + I
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGKVSI 110
Query: 572 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 631
A + GL +L + +I+H D+KP NIL++S K+CDFG+ + +
Sbjct: 111 A--VLRGLAYLR--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-------- 158
Query: 632 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 675
+ + G+ Y PE + + +SD +S GL +++L GR P+
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 50/150 (33%), Positives = 75/150 (50%), Gaps = 18/150 (12%)
Query: 478 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGA- 533
VG G +G VYKG + G+ AIK++ + + E + E+ +L K H ++ T GA
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE-EIKLEINMLKKYSHHRNIATYYGAF 82
Query: 534 ---CP-----EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 585
P + W LV E+ GS+ D L + + + L A I EI GL LH+
Sbjct: 83 IKKSPPGHDDQLW-LVMEFCGAGSVTD-LVKNTKGNALKEDWIAYICREILRGLAHLHA- 139
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGI 615
K++H D+K QN+LL K+ DFG+
Sbjct: 140 --HKVIHRDIKGQNVLLTENAEVKLVDFGV 167
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-09
Identities = 60/264 (22%), Positives = 108/264 (40%), Gaps = 60/264 (22%)
Query: 478 VGQGGFGCVYKGE--MLGRTVAIKML----YSHNMQGQLEF----------QQEVRVLSK 521
+G+G +G V K + G+ VAIK + S+++ + +E++++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 522 LQHPHLVTLLGA-CPEAW-SLVYEYLPNGSLQDRLFRK-----SNVSPLLWKDRARIAAE 574
++H +++ L+ + +LV + + L+ + RK S V +L +
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILL--------Q 127
Query: 575 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 634
I +GL LH +H DL P NI ++S+ KI DFG+ R T
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 635 PKG--------SFPYADPE-------YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG 679
+ + Y PE YH D +S G I +LLTG+
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFA------VDMWSVGCIFAELLTGKPLFPGEN 238
Query: 680 EVRRAVSCGKLSSIL-DPLAGDWP 702
E+ + G++ +L P +WP
Sbjct: 239 EIDQ---LGRIFELLGTPNEDNWP 259
|
Length = 335 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 46/147 (31%), Positives = 76/147 (51%), Gaps = 13/147 (8%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL--L 531
K+G+G + V+KG ++ VA+K + H +EV +L L+H ++VTL +
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 532 GACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA-EIASGLCFLHSSKPEKI 590
+LV+EYL + L+ L N L+ +I ++ GL + H KI
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKI 124
Query: 591 VHGDLKPQNILLDSELSSKICDFGICR 617
+H DLKPQN+L++ + K+ DFG+ R
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 478 VGQGGFGCVY--KGEMLGRTVAIKMLY----SHNMQGQLE-FQQEVRVLSKLQHPHLVTL 530
+GQG FG VY GR +A+K + S ++ + E+++L L H +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 531 LGACPE----AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
G + S+ E++P GS++D+L + L + +I G+ +LHS+
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQILEGVSYLHSNM 126
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 646
IVH D+K NIL DS + K+ DFG + + L T G+ + PE
Sbjct: 127 ---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT---GTPYWMSPEV 180
Query: 647 HRTGVLTPKSDSYSFGLIILQLLTGRLP 674
K+D +S G ++++LT + P
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 48/157 (30%), Positives = 72/157 (45%), Gaps = 10/157 (6%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA- 533
+VG G +G VYK L G A+K++ QQE+ ++ + +H ++V G+
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 534 -CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
E + EY GSLQD ++ + PL A + E GL +LHS +H
Sbjct: 76 LSREKLWICMEYCGGGSLQD-IYHVT--GPLSELQIAYVCRETLQGLAYLHSKGK---MH 129
Query: 593 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 629
D+K NILL K+ DFG+ +T SF
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 3e-09
Identities = 67/272 (24%), Positives = 114/272 (41%), Gaps = 26/272 (9%)
Query: 478 VGQGGFGCVY-------KGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTL 530
+GQG FG VY E+ + V + + E+++L LQH +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 531 LGACPE----AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
G + ++ EY+P GS++D+L ++ + + R +I G+ +LHS+
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR---QILEGMSYLHSNM 126
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 646
IVH D+K NIL DS + K+ DFG + + + T G+ + PE
Sbjct: 127 ---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT---GTPYWMSPEV 180
Query: 647 HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVA 706
K+D +S G ++++LT + P E + K+++ P P+ ++
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP---WAEYEAMAAIFKIAT--QPTNPQLPSHIS 235
Query: 707 RRLVDLGLQCCELYGRERPDITPSLVKELEQL 738
D L C + R RP L QL
Sbjct: 236 EHARDF-LGCIFVEARHRPSAEELLRHPFAQL 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 46/143 (32%), Positives = 71/143 (49%), Gaps = 13/143 (9%)
Query: 479 GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGAC- 534
G G FG VYK + G A K++ + +LE F E+ +LS+ +HP++V L A
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKII-QIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 535 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
+ W L+ E+ G+L D + + L + ++ L FLHS K++H
Sbjct: 73 YENKLWILI-EFCDGGAL-DSIMLELE-RGLTEPQIRYVCRQMLEALNFLHS---HKVIH 126
Query: 593 GDLKPQNILLDSELSSKICDFGI 615
DLK NILL + K+ DFG+
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGV 149
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 40/139 (28%), Positives = 66/139 (47%), Gaps = 16/139 (11%)
Query: 478 VGQGGFGCVYKG---------EMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLV 528
+GQG F ++KG E+ V +K+L + F + ++S+L H HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 529 TLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
G C + +V EY+ GSL L + N+ + WK +A ++A L FL
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLED-- 118
Query: 587 PEKIVHGDLKPQNILLDSE 605
+ + HG++ +N+LL E
Sbjct: 119 -KGLTHGNVCAKNVLLIRE 136
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 63/217 (29%), Positives = 93/217 (42%), Gaps = 46/217 (21%)
Query: 477 KVGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQ--------QEVRVLSKLQHPH 526
+VGQGG+G V+ K + G VA+K M+ L F+ E +L+ +
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKR-----MKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 527 LVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLH 583
LV LL A E L EY+P G + L N +L +D AR AE+ + LH
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL----NNLGVLSEDHARFYMAEMFEAVDALH 118
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 643
+H DLKP+N L+D+ K+ DFG+ + + + + GS Y
Sbjct: 119 ELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---------YANSVVGSPDYMA 166
Query: 644 PE------YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
PE Y T D +S G ++ + L G P
Sbjct: 167 PEVLRGKGYDFT------VDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 472 FSESFKVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPH 526
F + +G+GGFG C + G+ A K L ++ G+ E ++L K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 527 LVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLH 583
+V+L A +A LV + G L+ ++ + RA AAEI GL LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDLH 119
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 643
E+IV+ DLKP+NILLD +I D G+ +++P G+ Y
Sbjct: 120 Q---ERIVYRDLKPENILLDDHGHIRISDLGL-------AVHVPEGQTIKGRVGTVGYMA 169
Query: 644 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
PE + T D ++ G ++ +++ G+ P
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 43/150 (28%), Positives = 74/150 (49%), Gaps = 23/150 (15%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
++G G FG VYK + G A K++ + + + ++ E+ +L+ HP++V LLGA
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 535 ---PEAWSLVYEYLPNGSLQ------DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 585
+ W ++ E+ P G++ DR + + I ++ L +LHS
Sbjct: 79 YWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV--------ICRQMLEALQYLHS- 128
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGI 615
KI+H DLK N+LL + K+ DFG+
Sbjct: 129 --MKIIHRDLKAGNVLLTLDGDIKLADFGV 156
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 34/159 (21%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQ---------QEVRVLSKLQHP 525
K+G+G +G VYK + T+A+K + +LE + +E+ +L ++QH
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKI-------RLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 526 HLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAA---EIASGL 579
++V L + LV+EYL D +K + SP K+ I +I G+
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYL------DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGI 115
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSS-KICDFGICR 617
+ HS +++H DLKPQN+L+D ++ K+ DFG+ R
Sbjct: 116 AYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 4e-09
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 61/227 (26%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIKMLYS--HNMQ-GQLEFQQEVRVLSKL-QHPHLVTL 530
K+G+G +G V+K VA+K ++ N Q F+ E+ L +L HP++V L
Sbjct: 14 KLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKL 72
Query: 531 LGACPEA----WSLVYEYLPN--------GSLQDRLFRKSNVSPLLWKDRARIAAEIASG 578
L LV+EY+ L+D + ++ + LL +A
Sbjct: 73 LNVIKAENDKDIYLVFEYMETDLHAVIRANILED-VHKRYIMYQLL---KA--------- 119
Query: 579 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS---------- 628
L ++HS ++H DLKP NILL+S+ K+ DFG+ R ++E +
Sbjct: 120 LKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 629 FHRSTAPK---GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 672
++R AP+ GS Y GV D +S G I+ ++L G+
Sbjct: 177 WYR--APEILLGSTRYT------KGV-----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 5e-09
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 478 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLG 532
+G+GGFG C + + G+ A K L ++ G+ E +L K+ P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 533 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI---AAEIASGLCFLHSSKP 587
A LV + G L+ ++ + R+ +A+I G+ LHS
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERG----LEMERVIHYSAQITCGILHLHSMD- 115
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 647
IV+ D+KP+N+LLD + + ++ D G+ + L T G+ Y PE
Sbjct: 116 --IVYRDMKPENVLLDDQGNCRLSDLGL-------AVELKDGKTITQRAGTNGYMAPEIL 166
Query: 648 RTGVLTPKSDSYSFGLIILQLLTGRLP 674
+ + D ++ G I +++ GR P
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 478 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 532
+G+G FG V + R A+K + ++ + E E VL+++ P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 533 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
+ PE LV ++ G L L R+ D +R A LC L + +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRF------DLSRARFYTAELLCALENLHKFNV 114
Query: 591 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 650
++ DLKP+NILLD + +CDFG+C+L +D ++ G+ Y PE
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDD------DKTNTFCGTPEYLAPELLLGH 168
Query: 651 VLTPKSDSYSFGLIILQLLTGRLP 674
T D ++ G+++ ++LTG P
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 478 VGQGGFGCV--YKGEMLGRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLLG 532
+G+G FG V + + + A+K+L M + + F +E +++ P +V L
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 533 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 589
A + L V EY+P G L + L +V P W AR AE+ L +HS
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVN-LMSNYDV-PEKW---ARFYTAEVVLALDAIHSMG--- 162
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
+H D+KP N+LLD K+ DFG C + ++ + R G+ Y PE ++
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-----RCDTAVGTPDYISPEVLKS 217
Query: 650 ----GVLTPKSDSYSFGLIILQLLTGRLP 674
G + D +S G+ + ++L G P
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 478 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLLG 532
VG+G FG V + + G A+K++ + Q F++E +LS P + L
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 533 ACPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 589
A + + LV EY P G L L R + +D A+ AE+ + HS
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ---FDEDMAQFYLAELVLAI---HSVHQMG 122
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
VH D+KP+N+L+D K+ DFG +T + + P G+ Y PE T
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS-----KLPVGTPDYIAPEVLTT 177
Query: 650 ------GVLTPKSDSYSFGLIILQLLTGRLP 674
G + D +S G+I +++ GR P
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 49/203 (24%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 477 KVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
K+G+G G C+ + G+ VA+K + Q + EV ++ QH ++V + +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 535 ---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591
E W +V E+L G+L D + + + + A + + L LH+ + ++
Sbjct: 87 LVGDELW-VVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHA---QGVI 138
Query: 592 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 651
H D+K +ILL + K+ DFG C V+++ R + G+ + PE
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV------PRRKSLVGTPYWMAPELISRLP 192
Query: 652 LTPKSDSYSFGLIILQLLTGRLP 674
P+ D +S G+++++++ G P
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 66/269 (24%), Positives = 118/269 (43%), Gaps = 26/269 (9%)
Query: 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHP 525
NF K+G+G F VY+ L G VA+K + ++ + + + +E+ +L +L HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 526 HLVTLLGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRA--RIAAEIASGLCF 581
+++ + E ++V E G L R+ + L ++ + ++ S L
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLS-RMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 582 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 641
+HS +++H D+KP N+ + + K+ D G+ R + T S G+ Y
Sbjct: 122 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL------VGTPYY 172
Query: 642 ADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS-CGKLSSI-LDPLAG 699
PE KSD +S G ++ ++ + P G+ S C K+ PL
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLCKKIEQCDYPPLPS 230
Query: 700 DWPTFVARRLVDLGLQCCELYGRERPDIT 728
D + R+LV++ C +RPDIT
Sbjct: 231 DHYSEELRQLVNM---CINPDPEKRPDIT 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 59/221 (26%), Positives = 89/221 (40%), Gaps = 50/221 (22%)
Query: 478 VGQGGFGCVYKGEML--GRTVAIK-MLYSHNMQGQLEFQQEVRVLSKLQH--PHLVTLLG 532
+G G G VYK G +A+K M + N + ++ V+ K H P++V G
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK-SHDCPYIVKCYG 81
Query: 533 A---------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL- 582
C E S D+L ++ P+ ++ I L +L
Sbjct: 82 YFITDSDVFICMELMSTCL---------DKLLKRIQ-GPIPEDILGKMTVAIVKALHYLK 131
Query: 583 --HSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC-RLVTEDTLYLPSFHRSTAPKGSF 639
H ++H D+KP NILLD+ + K+CDFGI RLV T G
Sbjct: 132 EKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA--------KTRSAGCA 178
Query: 640 PYADPEYHRTGVLTPK------SDSYSFGLIILQLLTGRLP 674
Y PE R P +D +S G+ +++L TG+ P
Sbjct: 179 AYMAPE--RIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 36/110 (32%), Positives = 58/110 (52%), Gaps = 7/110 (6%)
Query: 561 SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 620
SPL +D + ++A G+ FL S K +H DL +NILL KICDFG+ R +
Sbjct: 169 SPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIY 225
Query: 621 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 670
+D P + R + + + PE V T +SD +SFG+++ ++ +
Sbjct: 226 KD----PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 66/277 (23%), Positives = 114/277 (41%), Gaps = 51/277 (18%)
Query: 478 VGQGGFGCVY---KGEMLGRTVAIKMLYSHNM---QGQLEFQQEVR--------VLSKLQ 523
+G G FGCVY K +A+K + HN + + E + + + +L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 524 HPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLF----RKSNVSP-LLWKDRARIAAEIA 576
HP++V E L V + + L + +K + +W I ++
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN----IFVQMV 123
Query: 577 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 636
L +LH K ++IVH DL P NI+L + I DFG+ + ++ + T+
Sbjct: 124 LALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES-------KLTSVV 174
Query: 637 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP------VGLAGEVRRAVSCGKL 690
G+ Y+ PE + K+D ++FG I+ Q+ T + P + LA ++ AV
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV----- 229
Query: 691 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDI 727
+PL + + D+ C RPDI
Sbjct: 230 ---YEPLPEG---MYSEDVTDVITSCLTPDAEARPDI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 21/151 (13%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL--L 531
K+G+G + V+KG ++ VA+K + H +EV +L L+H ++VTL +
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 532 GACPEAWSLVYEYLPNGSLQ-----DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
++ +LV+EYL Q + NV L+ +I GL + H
Sbjct: 73 VHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLY--------QILRGLAYCHR-- 122
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICR 617
K++H DLKPQN+L++ K+ DFG+ R
Sbjct: 123 -RKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 21/151 (13%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL--L 531
K+G+G + VYKG ++ VA+K + H +EV +L L+H ++VTL +
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 532 GACPEAWSLVYEYLPNGSLQ-----DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
++ +LV+EYL Q NV L+ ++ GL + H
Sbjct: 73 IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLF--------QLLRGLNYCHR-- 122
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICR 617
K++H DLKPQN+L++ K+ DFG+ R
Sbjct: 123 -RKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQHPH 526
F + ++G+G +G VY+ G VA+K + N + + +E+ +L L+HP+
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 527 LVTLL----GACPEAWSLVYEYLPN--GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLC 580
+V L G ++ LV EY SL D + +P + ++ GL
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLLD-----NMPTPFSESQVKCLMLQLLRGLQ 122
Query: 581 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK-GSF 639
+LH I+H DLK N+LL + KI DFG+ R T LP+ + PK +
Sbjct: 123 YLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLAR-----TYGLPAKPMT--PKVVTL 172
Query: 640 PYADPEY------HRTGVLTPKSDSYSFGLIILQLLTGR 672
Y PE + T + D ++ G I+ +LL +
Sbjct: 173 WYRAPELLLGCTTYTTAI-----DMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 69/282 (24%), Positives = 120/282 (42%), Gaps = 31/282 (10%)
Query: 472 FSESFKVGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHPH 526
F++ ++G G FG VY + VAIK + Q ++Q +EV+ L +++HP+
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 527 LVTLLGACPE---AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 583
+ G AW LV EY GS D L + + PL + A I GL +LH
Sbjct: 87 SIEYKGCYLREHTAW-LVMEYCL-GSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 643
S ++H D+K NILL K+ DFG + + ++ + + AP+ +
Sbjct: 143 S---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYW-MAPEVILAMDE 198
Query: 644 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPT 703
+Y K D +S G+ ++L + P+ + +S++ + PT
Sbjct: 199 GQY------DGKVDVWSLGITCIELAERKPPL---------FNMNAMSALYHIAQNESPT 243
Query: 704 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERP 745
+ D + ++ P P+ + L+ + V ERP
Sbjct: 244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 21/168 (12%)
Query: 474 ESFKV-GQGGFGCV--YKGEMLGRTVAIKMLYSHNM--QGQLE-FQQEVRVLSKLQHPHL 527
ES KV G+G FG V + + G A+K L M + Q+ + E +L++ +P +
Sbjct: 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWV 63
Query: 528 VTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 585
V L + L+ EYLP G + L +K + ++ R IA + + S
Sbjct: 64 VKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFT----EEETRFY--IAETILAIDSI 117
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 633
+H D+KP N+LLD++ K+ DFG+C L HR+
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT-------GLKKSHRTE 158
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 478 VGQGGFGCVY--KGEMLGRTVAIKML-YSHNMQGQLE----FQQEVRVLSKLQHPHLVTL 530
+G+G FG VY GR +A+K + + + Q + + E+++L L+H +V
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 531 LGAC--PE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
G PE S+ EY+P GS++D+L L R +I G+ +LHS+
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYTRQILQGVSYLHSNM 126
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 646
IVH D+K NIL DS + K+ DFG + + T+ + S + G+ + PE
Sbjct: 127 ---IVHRDIKGANILRDSAGNVKLGDFGASKRI--QTICM-SGTGIKSVTGTPYWMSPEV 180
Query: 647 HRTGVLTPKSDSYSFGLIILQLLTGRLP 674
K+D +S ++++LT + P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 70/236 (29%), Positives = 99/236 (41%), Gaps = 38/236 (16%)
Query: 455 PESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEF 512
P+ AE D FS+ ++G G FG VY + VAIK + Q ++
Sbjct: 2 PDVAELFFKDDPEKL--FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 513 Q---QEVRVLSKLQHPHLVTLLGACPE---AWSLVYEYLPNGSLQDRLFRKSNVSPLLWK 566
Q +EVR L KL+HP+ + G AW LV EY GS D L + + PL
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW-LVMEYCL-GSASDLL--EVHKKPLQEV 115
Query: 567 DRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626
+ A + GL +LHS ++H D+K NILL K+ DFG ++
Sbjct: 116 EIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------- 165
Query: 627 PSFHRSTAPKGSF---PY-ADPEY---HRTGVLTPKSDSYSFGLIILQLLTGRLPV 675
AP F PY PE G K D +S G+ ++L + P+
Sbjct: 166 -------APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 12/158 (7%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
++G G +G VYK + G AIK++ + QQE+ ++ +H ++V G+
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 535 ---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591
+ W + E+ GSLQD ++ + PL A ++ E GL +LHS +
Sbjct: 76 LRRDKLW-ICMEFCGGGSLQD-IYHVT--GPLSESQIAYVSRETLQGLYYLHSKGK---M 128
Query: 592 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 629
H D+K NILL K+ DFG+ +T SF
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 22/162 (13%)
Query: 524 HPHLVTLLGACPEAWS---LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGL 579
HP LV L +C + S V E++ G L + R+ L ++ AR +AEI+ L
Sbjct: 55 HPFLVGL-HSCFQTESRLFFVIEFVSGGDLMFHMQRQRK----LPEEHARFYSAEISLAL 109
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR--LVTEDTLYLPSFHRSTAPKG 637
FLH I++ DLK N+LLD+E K+ D+G+C+ + DT ++ G
Sbjct: 110 NFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--------TSTFCG 158
Query: 638 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG 679
+ Y PE R D ++ G+++ +++ GR P + G
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 64/243 (26%), Positives = 105/243 (43%), Gaps = 27/243 (11%)
Query: 443 NYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCV--YKGEMLGRTVAIKM 500
N D F+ E + + LQ ++ +G+G FG V + + + A+K+
Sbjct: 20 NIDNFLNRYEKIVRK----IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKL 75
Query: 501 LYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLF 555
L M + + F +E +++ P +V L A + L V EY+P G L + L
Sbjct: 76 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LM 134
Query: 556 RKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 615
+V P W AE+ L +HS ++H D+KP N+LLD K+ DFG
Sbjct: 135 SNYDV-PEKWAKF--YTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGT 188
Query: 616 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT----GVLTPKSDSYSFGLIILQLLTG 671
C + E + TA G+ Y PE ++ G + D +S G+ + ++L G
Sbjct: 189 CMKMDETGM----VRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
Query: 672 RLP 674
P
Sbjct: 244 DTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 35/110 (31%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 561 SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 620
PL +D + ++A G+ FL S K +H DL +NILL KICDFG+ R +
Sbjct: 168 EPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 621 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 670
+D P + R + + PE V T +SD +SFG+++ ++ +
Sbjct: 225 KD----PDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 22/209 (10%)
Query: 478 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLLG 532
+G+G FG V K + R A+K+L M + E F++E VL + TL
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68
Query: 533 ACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
A + LV +Y G L L + + P +D AR IA + +HS
Sbjct: 69 AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLP---EDMARFY--IAEMVLAIHSIHQLHY 123
Query: 591 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT- 649
VH D+KP N+LLD ++ DFG C + +D +S+ G+ Y PE +
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-----QSSVAVGTPDYISPEILQAM 178
Query: 650 ----GVLTPKSDSYSFGLIILQLLTGRLP 674
G P+ D +S G+ + ++L G P
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 5e-08
Identities = 67/230 (29%), Positives = 96/230 (41%), Gaps = 74/230 (32%)
Query: 478 VGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQLEFQ---------QEVRVLSKLQHPH 526
VG G +G V GR VAIK L FQ +E+R+L + H +
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSR-------PFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 527 LVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSN-VSPLLWKDRARIAA------------ 573
++ LL + P SL+D F+ V+ L+ D I
Sbjct: 76 VIGLLDV----------FTPASSLED--FQDVYLVTHLMGADLNNIVKCQKLSDDHIQFL 123
Query: 574 --EIASGLCFLHSSKPEKIVHGDLKPQNILL--DSELSSKICDFGICRLVTEDTLYLPSF 629
+I GL ++HS+ I+H DLKP NI + D EL KI DFG+ R T+D +
Sbjct: 124 VYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCEL--KILDFGLARH-TDDEM----- 172
Query: 630 HRSTAPKGSFPYADPE-------YHRTGVLTPKSDSYSFGLIILQLLTGR 672
T + Y PE Y++T D +S G I+ +LLTG+
Sbjct: 173 ---TGYVATRWYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 41/152 (26%), Positives = 74/152 (48%), Gaps = 9/152 (5%)
Query: 471 NFSESFKVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQ-QEVRVLSKLQHPHL 527
NF + K+G+G + VYKG G VA+K ++ +G +E+ ++ +L+H ++
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 528 VTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 585
V L LV+EY+ + L+ + L ++ G+ F H +
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
+ ++H DLKPQN+L++ K+ DFG+ R
Sbjct: 120 R---VLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 50/162 (30%), Positives = 79/162 (48%), Gaps = 22/162 (13%)
Query: 524 HPHLVTLLGACPEAWS---LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGL 579
HP LV L +C + S V EY+ G L + R+ L ++ AR +AEI+ L
Sbjct: 55 HPFLVGL-HSCFQTESRLFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLAL 109
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR--LVTEDTLYLPSFHRSTAPKG 637
+LH I++ DLK N+LLDSE K+ D+G+C+ L DT ++ G
Sbjct: 110 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--------TSTFCG 158
Query: 638 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG 679
+ Y PE R D ++ G+++ +++ GR P + G
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 6e-08
Identities = 48/154 (31%), Positives = 82/154 (53%), Gaps = 24/154 (15%)
Query: 477 KVGQGGFGCVYKG-EML-GRTVAIKML-YSHNMQG-QLEFQQEVRVLSKLQHPHLVTL-- 530
++ +G +G VY+ + G VA+K L +G + +E+ +L KLQHP++VT+
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKE 71
Query: 531 --LGACPEAWSLVYEYLPNG--SLQDRL---FRKSNVSPLLWKDRARIAAEIASGLCFLH 583
+G+ + +V EY+ + SL + + F +S V L+ ++ SG+ LH
Sbjct: 72 VVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLM--------LQLLSGVAHLH 123
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
+ I+H DLK N+LL++ KICDFG+ R
Sbjct: 124 DN---WILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 85/319 (26%), Positives = 125/319 (39%), Gaps = 62/319 (19%)
Query: 449 GLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVY--KGEMLGRTVAIKMLYSHNM 506
G+V+D PE A+ D F ++G G FG VY VA+K +
Sbjct: 3 GVVKD-PEIADLFYKDDPEEI--FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK 59
Query: 507 QGQLEFQ---QEVRVLSKLQHPHLVTLLGACPE---AWSLVYEYLPNGSLQDRLFRKSNV 560
Q ++Q +EV+ L +L+HP+ + G + AW LV EY GS D L + +
Sbjct: 60 QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAW-LVMEYCL-GSASDLL--EVHK 115
Query: 561 SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 620
PL + A I GL +LHS ++H D+K NILL K+ DFG +
Sbjct: 116 KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSS 172
Query: 621 EDTLYLPSFHRSTAPKGSF---PY-ADPEY---HRTGVLTPKSDSYSFGLIILQLLTGRL 673
P SF PY PE G K D +S G+ ++L +
Sbjct: 173 --------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 218
Query: 674 PVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVA-------RRLVDLGLQCCELYGRERPD 726
P+ + +S++ D PT + R VD LQ + P
Sbjct: 219 PL---------FNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQ-------KIPQ 262
Query: 727 ITPSLVKELEQLHVAEERP 745
P+ + L V +RP
Sbjct: 263 ERPASAELLRHDFVRRDRP 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 6e-08
Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 478 VGQGGFG--CVYKGEMLGRTVAIKMLYS--HNMQGQLEFQQEVRVLSKLQHPHLV----T 529
+G+G +G C G VAIK + ++ +E+++L L+HP +V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 530 LLGACPEAWS---LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
+L + +V+E L L + +++P + ++ L ++H++
Sbjct: 68 MLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTP---EHHQFFLYQLLRALKYIHTAN 123
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED-------TLYLPS-FHRSTAPKGS 638
+ H DLKP+NIL +++ KICDFG+ R+ D T Y+ + ++R+ GS
Sbjct: 124 ---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 639 FPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 672
F TP D +S G I ++LTG+
Sbjct: 181 F---------FSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 67/281 (23%), Positives = 124/281 (44%), Gaps = 38/281 (13%)
Query: 478 VGQGGFGCVYKGEMLGR----TVAIK-MLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLL 531
+G+G FG V +G++ VA+K M + + ++E F E + + HP+++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 532 GACPE--------AWSLVYEYLPNGSLQD-RLFRKSNVSPLLWKDR--ARIAAEIASGLC 580
G C + + ++ ++ +G L L+ + P + + +IASG+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 581 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP 640
+L S + +H DL +N +L+ ++ + DFG+ + + Y + K
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY----RQGRIAKMPVK 179
Query: 641 YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPV-GLA-GEVRRAVSCG-KLSSILDP 696
+ E V T KSD +SFG+ + ++ T G+ P G+ E+ + G +L D
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDC 239
Query: 697 LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 737
L G L L C L ++RP +L ELE+
Sbjct: 240 LDG---------LYSLMSSCWLLNPKDRPSFE-TLRCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 9e-08
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 26/209 (12%)
Query: 478 VGQGGFGCVY--KGEMLGRTVAIKMLYS--HNMQGQLEFQQEVRVLSKLQHPHLVTLLGA 533
+G G FG V+ G+ VA+K + + N+ +E+++L +H ++++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 534 CPEAWSLVYE--YLPNGSLQDRLFRKSNVSPL-LWKDRARI-AAEIASGLCFLHSSKPEK 589
+E Y+ +Q L K VSP L D ++ +I GL +LHS+
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDL-HKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--- 123
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY--- 646
I+H D+KP N+L++S KICDFG+ R+ D S H T + Y PE
Sbjct: 124 ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD----ESKHM-TQEVVTQYYRAPEILMG 178
Query: 647 --HRTGVLTPKSDSYSFGLIILQLLTGRL 673
H T + D +S G I +LL R+
Sbjct: 179 SRHYTSAV----DIWSVGCIFAELLGRRI 203
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 42/147 (28%), Positives = 74/147 (50%), Gaps = 13/147 (8%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQ-LEFQQEVRVLSKLQHPHLVTL--L 531
K+G+G + VYKG+ + G+ VA+K++ +G +E +L L+H ++V L +
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 532 GACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA-EIASGLCFLHSSKPEKI 590
E +LV+EY+ Q + P + ++ ++ GL ++H I
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYMDKHPGGLHP----ENVKLFLFQLLRGLSYIHQ---RYI 124
Query: 591 VHGDLKPQNILLDSELSSKICDFGICR 617
+H DLKPQN+L+ K+ DFG+ R
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 46/207 (22%), Positives = 80/207 (38%), Gaps = 19/207 (9%)
Query: 479 GQGGFGCVYKGEMLGRTVAIKM--LYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE 536
+ K + VA+K L S + + QQE+ +LQHP+++ + +
Sbjct: 11 EDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV 70
Query: 537 AWSL--VYEYLPNGSLQDRLFR--KSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
L V + GS +D L + L A I ++ + L ++HS + +H
Sbjct: 71 DSELYVVSPLMAYGSCEDLLKTHFPEGLPELAI---AFILKDVLNALDYIHS---KGFIH 124
Query: 593 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS---FPYADPEYHRT 649
+K +ILL + + + + H PK S P+ PE +
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF--PKSSVKNLPWLSPEVLQQ 182
Query: 650 GVL--TPKSDSYSFGLIILQLLTGRLP 674
+ KSD YS G+ +L G +P
Sbjct: 183 NLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 27/209 (12%)
Query: 478 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQH---PHLVT 529
+G+GGFG VY + G+ A+K L + QG+ E +LS + P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 530 LLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 587
+ A P+ + + + G L L + S K+ A EI GL +H+
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSE---KEMRFYATEIILGLEHMHN--- 115
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGI-CRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 646
+V+ DLKP NILLD +I D G+ C S + A G+ Y PE
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDF---------SKKKPHASVGTHGYMAPEV 166
Query: 647 HRTGVLTPKS-DSYSFGLIILQLLTGRLP 674
+ G S D +S G ++ +LL G P
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 474 ESFKV-GQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHL 527
E KV G+G FG V K + G+ A+K+L M + E F++E VL +
Sbjct: 4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWI 63
Query: 528 VTLLGACP--EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 585
L A LV +Y G L L + + P +D AR +A + + S
Sbjct: 64 TNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP---EDMARFY--LAEMVLAIDSV 118
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGIC-RLVTEDTLYLPSFHRSTAPKGSFPYADP 644
VH D+KP N+LLD ++ DFG C RL+ + T+ +S G+ Y P
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV------QSNVAVGTPDYISP 172
Query: 645 EYHR-----TGVLTPKSDSYSFGLIILQLLTGRLP 674
E + G P+ D +S G+ + ++L G P
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 18/153 (11%)
Query: 480 QGGFGCVYKGEMLG------RTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLG 532
+G FG ++ G ++ V +K + H + Q+ QE +L L H +++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 533 AC---PEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 584
C E ++Y Y+ G+L Q RL +N L + +A +IA G+ +LH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 585 SKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
++H D+ +N ++D EL KI D + R
Sbjct: 136 ---RGVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 45/209 (21%), Positives = 85/209 (40%), Gaps = 43/209 (20%)
Query: 486 VYKGEMLGRTVAIKML--YSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLG-------ACP 535
+YKG + V I+ + + ++ + E++ L ++ +++ + G P
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 536 EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS--SKPEKIVHG 593
SL+ EY G L++ L ++ + L +K + +A + GL L+ +KP +
Sbjct: 96 RL-SLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKP----YK 147
Query: 594 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP--------E 645
+L + L+ KI G+ E L P F Y E
Sbjct: 148 NLTSVSFLVTENYKLKIICHGL-----EKILSSPPFKNVNF----MVYFSYKMLNDIFSE 198
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
Y T K D YS G+++ ++ TG++P
Sbjct: 199 Y------TIKDDIYSLGVVLWEIFTGKIP 221
|
Length = 283 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 478 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQH---PHLVT 529
+G+GGFG VY + G+ A+K L + QG+ E +LS + P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 530 LLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 587
+ A P+ S + + + G L L + S + AAEI GL +H+
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE---AEMRFYAAEIILGLEHMHN--- 115
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGI-CRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 646
+V+ DLKP NILLD +I D G+ C S + A G+ Y PE
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDF---------SKKKPHASVGTHGYMAPEV 166
Query: 647 HRTGVLTPKS-DSYSFGLIILQLLTGRLP 674
+ GV S D +S G ++ +LL G P
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 22/209 (10%)
Query: 478 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLLG 532
+G+G FG V K + + A+K+L M + E F++E VL + + TL
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 533 ACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
A + LV +Y G L L + + P +D AR +A + + S
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP---EDMARFY--LAEMVIAIDSVHQLHY 123
Query: 591 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT- 649
VH D+KP NIL+D ++ DFG C + ED +S+ G+ Y PE +
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-----QSSVAVGTPDYISPEILQAM 178
Query: 650 ----GVLTPKSDSYSFGLIILQLLTGRLP 674
G P+ D +S G+ + ++L G P
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 44/146 (30%), Positives = 75/146 (51%), Gaps = 11/146 (7%)
Query: 478 VGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 532
+G+GGFG V +M G+ A K L ++ + ++ E R+L+K+ +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 533 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 589
A LV + G L+ ++ +P + RA A+I SGL LH +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RR 117
Query: 590 IVHGDLKPQNILLDSELSSKICDFGI 615
I++ DLKP+N+LLD++ + +I D G+
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGL 143
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 48/209 (22%), Positives = 95/209 (45%), Gaps = 29/209 (13%)
Query: 476 FKVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA 533
K+G+G G C+ + G+ VA+K + Q + EV ++ H ++V + +
Sbjct: 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 534 C---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
E W +V E+L G+L D + + + + A + + L +LH+ + +
Sbjct: 88 YLVGDELW-VVMEFLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHN---QGV 139
Query: 591 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 650
+H D+K +ILL S+ K+ DFG C V+++ PK P +
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-----------PKRKSLVGTPYWMAPE 188
Query: 651 VLT-----PKSDSYSFGLIILQLLTGRLP 674
V++ + D +S G+++++++ G P
Sbjct: 189 VISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 562 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621
L +D + ++A G+ FL S K +H DL +NILL KICDFG+ R + +
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 670
D P + R + + PE V T +SD +SFG+++ ++ +
Sbjct: 232 D----PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 47/167 (28%), Positives = 73/167 (43%), Gaps = 35/167 (20%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQE------VRVLSKLQ----H 524
K+G+G +G VYK G+ VA+K + +LE +E +R +S LQ
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALK-------KTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 525 PHLVTLL--------GACPEAWSLVYEYLPNG--SLQDRLFRKSNVSPLLWKDRARIAAE 574
++V LL P + LV+EYL + D + PL K +
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLY-LVFEYLDSDLKKFMDS-NGRGPGRPLPAKTIKSFMYQ 118
Query: 575 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS-KICDFGICRLVT 620
+ G+ H ++H DLKPQN+L+D + KI D G+ R +
Sbjct: 119 LLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS 162
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 55/225 (24%), Positives = 102/225 (45%), Gaps = 51/225 (22%)
Query: 478 VGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 535
+G G G V+ + VA+K + + Q +E++++ +L H ++V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK------ 66
Query: 536 EAWSLVYEYL-PNGS-LQDRLFRKSNVSPL-------------------LWKDRARI-AA 573
VYE L P+GS L + + + ++ + L ++ AR+
Sbjct: 67 -----VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMY 121
Query: 574 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDTLYLPSFHRS 632
++ GL ++HS+ ++H DLKP N+ +++E L KI DFG+ R+V D Y + S
Sbjct: 122 QLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIV--DPHYSHKGYLS 176
Query: 633 TAPKGSFPYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGR 672
+ Y P +L+P + D ++ G I ++LTG+
Sbjct: 177 EGLVTKW-YRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 35/158 (22%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQHPHLVTL-- 530
K+G+G + VYKG ++ G+ VA+K + + +G F +E +L L+H ++VTL
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHD 70
Query: 531 LGACPEAWSLVYEYL-----------PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 579
+ + +LV+EYL G NV L+ ++ GL
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGG------LSMHNVRLFLF--------QLLRGL 116
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
+ H +++H DLKPQN+L+ K+ DFG+ R
Sbjct: 117 AYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 32/147 (21%), Positives = 56/147 (38%), Gaps = 18/147 (12%)
Query: 477 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH-----PHLVTLL 531
+ G VY +K+ + + + + ++EV +L L P ++
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYVLKI--NPSREKGADREREVAILQLLARKGLPVPKVLASG 62
Query: 532 GACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591
+ ++ L+ E++ +L VS +D A AE+ L LH +
Sbjct: 63 ESDGWSY-LLMEWIEGETL-------DEVSEEEKEDIAEQLAEL---LAKLHQLPLLVLC 111
Query: 592 HGDLKPQNILLDSELSSKICDFGICRL 618
HGDL P NIL+D I D+
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 6e-07
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 27/205 (13%)
Query: 478 VGQGGFGCV--YKGEMLGRTVAIKMLYSHNMQGQLE--FQQEVRVLSKLQHPHLVTLLGA 533
VG+G +G V + G+ IK L N + +QE ++LS+L+HP++V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY--- 64
Query: 534 CPEAWS-------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRA-RIAAEIASGLCFLHSS 585
E+W +V + G L +L K LL +++ +IA L +LH
Sbjct: 65 -RESWEGEDGLLYIVMGFCEGGDLYHKL--KEQKGKLLPENQVVEWFVQIAMALQYLHE- 120
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 645
+ I+H DLK QN+ L K+ D GI R++ ++ G+ Y PE
Sbjct: 121 --KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN------QCDMASTLIGTPYYMSPE 172
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLT 670
KSD ++ G + ++ T
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 8e-07
Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 26/160 (16%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKML--YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 532
+G+G +G V G VAIK + + H Q + E+++L + +H +++ +L
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHENIIGILD 70
Query: 533 ACP----EAWSLVY---EYLPNGSLQD--RLFRKSNVSPLLWKDRAR-IAAEIASGLCFL 582
E+++ VY E + D +L + ++S D + +I GL ++
Sbjct: 71 IIRPPSFESFNDVYIVQELMET----DLYKLIKTQHLS----NDHIQYFLYQILRGLKYI 122
Query: 583 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622
HS+ ++H DLKP N+LL++ KICDFG+ R+ +
Sbjct: 123 HSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 8e-07
Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 477 KVGQGGFGCVY--KGEMLGRTVAIKMLYS-----HNMQGQLEFQQEVRVLSKLQHPHLVT 529
++G+G FG VY K + +K+L N ++ QE ++LSKL HP +V
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 530 LLGACPE--AWSLVYEYLPNGSLQDRLFR-KSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
+ E A+ ++ EY L +L K L ++ G+ ++H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-- 124
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 646
+I+H DLK +NI L + L KI DFG+ RL+ + S +T G+ Y PE
Sbjct: 125 -RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL------MGSCDLATTFTGTPYYMSPEA 176
Query: 647 HRTGVLTPKSDSYSFGLIILQL 668
+ KSD +S G I+ ++
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 32/271 (11%)
Query: 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHP 525
NF K+G+G F VY+ L + VA+K + M Q +E+ +L +L HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 526 HLVTLLGACPE--AWSLVYEYLPNGSLQDRLF---RKSNVSP--LLWKDRARIAAEIASG 578
+++ L + E ++V E G L + ++ + P +WK ++ S
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWK----YFVQLCSA 118
Query: 579 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS 638
+ +HS +++H D+KP N+ + + K+ D G+ R + T S G+
Sbjct: 119 VEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL------VGT 169
Query: 639 FPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS-CGKLSSI-LDP 696
Y PE KSD +S G ++ ++ + P G+ S C K+ P
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLFSLCQKIEQCDYPP 227
Query: 697 LAGDWPTFVARRLVDLGLQCCELYGRERPDI 727
L + + R LV + C +RPDI
Sbjct: 228 LPTEHYSEKLRELVSM---CIYPDPDQRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 21/168 (12%)
Query: 513 QQEVRVLSKLQHPHLVTLLGACPEAWS---LVYEYLPNGSLQDRLFRKSNVSPLLWKDRA 569
Q E V + + L +C + S LV EY+ G L + R+ L ++ A
Sbjct: 43 QTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK----LPEEHA 98
Query: 570 RI-AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR--LVTEDTLYL 626
R AAEI L FLH I++ DLK N+LLD++ K+ D+G+C+ L DT
Sbjct: 99 RFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--- 152
Query: 627 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
++ G+ Y PE R D ++ G+++ +++ GR P
Sbjct: 153 -----TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 16/133 (12%)
Query: 543 EYLPNGSLQDRLFRKSNVSPLL-WKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNIL 601
+YLP+ + R N SP L + D + ++A+G+ FL S + VH DL +N+L
Sbjct: 215 QYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVL 271
Query: 602 LDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS----FPYADPEYHRTGVLTPKSD 657
+ KICDFG+ R + D+ Y+ KGS + PE + T SD
Sbjct: 272 ICEGKLVKICDFGLARDIMRDSNYI--------SKGSTFLPLKWMAPESIFNNLYTTLSD 323
Query: 658 SYSFGLIILQLLT 670
+SFG+++ ++ T
Sbjct: 324 VWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 40/144 (27%), Positives = 68/144 (47%), Gaps = 11/144 (7%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
++G G FG VYK + G A K++ + + + ++ E+ +L+ HP++V LL A
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 535 ---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591
W L+ E+ G++ + PL + + L +LH +K I+
Sbjct: 72 YYENNLWILI-EFCAGGAVDAVMLELER--PLTEPQIRVVCKQTLEALNYLHENK---II 125
Query: 592 HGDLKPQNILLDSELSSKICDFGI 615
H DLK NIL + K+ DFG+
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGV 149
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 49/201 (24%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 478 VGQGGFGCVYKG--EMLGRT---VAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
+G G FG + +G ++ + VAI L + + + F E L + H ++V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 532 GACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
G ++ V EY+ NG+L D RK L+ + +ASG+ +L
Sbjct: 73 GVITRGNTMMIVTEYMSNGAL-DSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG--- 127
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
VH L +L++S+L KI F + + +Y +S +A PE +
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL-----WAAPEAIQY 182
Query: 650 GVLTPKSDSYSFGLIILQLLT 670
+ SD +SFG+++ ++++
Sbjct: 183 HHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 61/234 (26%), Positives = 99/234 (42%), Gaps = 50/234 (21%)
Query: 478 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM--QGQ-LEFQQEVRVLSKLQHPHLVTLLG 532
+G+G FG V+ + + G+ A+K+L +M + Q + E +L+ P +V L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY- 67
Query: 533 ACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLH 583
+S LV EY+P G L + L RK + AR AE+ L +H
Sbjct: 68 -----YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE----ETARFYIAELVLALDSVH 118
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGIC--------RLVTEDTLYLPSF------ 629
+H D+KP NIL+D++ K+ DFG+C R + + F
Sbjct: 119 K---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 630 ---------HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
R+ + G+ Y PE R + D +S G+I+ ++L G P
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 35/212 (16%)
Query: 478 VGQGGFG--CVYKGEMLGRTVAIKML----YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
VG+G FG + + + A+K + S ++ ++E +L+K++HP++V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS---RKEAVLLAKMKHPNIVAFK 64
Query: 532 GACPEAWSL--VYEYLPNGSL-------QDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 582
+ L V EY G L + +LF + + L W ++ G+ +
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI--LQW------FVQMCLGVQHI 116
Query: 583 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 642
H ++++H D+K +NI L K+ DFG RL+T Y ++ G+ Y
Sbjct: 117 HE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY------VGTPYYV 167
Query: 643 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
PE KSD +S G I+ +L T + P
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 42/147 (28%), Positives = 74/147 (50%), Gaps = 13/147 (8%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQHPHLVTL-- 530
K+G+G + VYKG + G+ VA+K++ +G + F +E +L L+H ++V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHD 70
Query: 531 LGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
+ E + V+EY+ Q + + P + ++ GL ++H + I
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPY---NVRLFMFQLLRGLAYIHG---QHI 124
Query: 591 VHGDLKPQNILLDSELSSKICDFGICR 617
+H DLKPQN+L+ K+ DFG+ R
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 3e-06
Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 20/157 (12%)
Query: 478 VGQGGFG--CVYKGEMLGRTVAIKMLYS--HNMQGQLEFQQEVRVLSKLQHPHLVTL--- 530
+G+G +G C K VAIK + + N +E+++L L H +++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 531 -LGACPEAWS---LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSS 585
EA++ +VYE L + L ++ R S L D + ++ GL ++HS+
Sbjct: 73 MPPPHREAFNDVYIVYE-LMDTDLH-QIIRSSQT---LSDDHCQYFLYQLLRGLKYIHSA 127
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622
++H DLKP N+LL++ KICDFG+ R +E
Sbjct: 128 N---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 27/225 (12%)
Query: 471 NFSESFKV-GQGGFGCVY-----KGEMLGRTVAIKMLYSHNMQGQLEFQQEVR----VLS 520
NF E KV G G +G V+ G G+ A+K+L + + + + R VL
Sbjct: 1 NF-ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59
Query: 521 KL-QHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIAS 577
+ Q P LVTL A L+ +Y+ G L L ++ ++ + EI
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE---QEVQIYSGEIVL 116
Query: 578 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG 637
L LH I++ D+K +NILLDS + DFG+ + ED + R+ + G
Sbjct: 117 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-----ERAYSFCG 168
Query: 638 SFPYADPEYHRTGVL--TPKSDSYSFGLIILQLLTGRLPVGLAGE 680
+ Y P+ R G D +S G+++ +LLTG P + GE
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE 213
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 32/215 (14%)
Query: 472 FSESFKVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQL---EFQQEVRVLSKLQHPH 526
+ + +VG G +G C G VAIK LY Q +L +E+R+L ++H +
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKHMKHEN 75
Query: 527 LVTLLGACPEAWSL-----VYEYLP-NGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGL 579
++ LL SL Y +P G+ +L + +S +DR + + ++ GL
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS----EDRIQFLVYQMLKGL 131
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV-TEDTLYLPS-FHRSTAPKG 637
++H++ I+H DLKP N+ ++ + KI DFG+ R +E T Y+ + ++R AP+
Sbjct: 132 KYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYR--APEV 186
Query: 638 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 672
+ Y +T D +S G I+ ++LTG+
Sbjct: 187 ILNWM--HYTQT------VDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 45/214 (21%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSH-NMQGQLEFQQEVRVLSKLQ-HPHLVTL-- 530
K+G+G F V K + G+ AIK + H Q+ +E++ L +L HP+++ L
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 531 --LGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 588
+LV+E L + +L + K PL K ++ L +H +
Sbjct: 66 VLFDRKTGRLALVFE-LMDMNLYE--LIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG-- 120
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 648
I H D+KP+NIL+ ++ K+ DFG C R K PY EY
Sbjct: 121 -IFHRDIKPENILIKDDI-LKLADFGSC--------------RGIYSKP--PYT--EYIS 160
Query: 649 T------------GVLTPKSDSYSFGLIILQLLT 670
T G PK D ++ G + ++L+
Sbjct: 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 49/216 (22%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 478 VGQGGFGCVYKGEM-----LGRTVAIKMLYSH-NMQGQLE-FQQEVRVLSKLQHPHLVTL 530
+G+G FG V + ++ + VA+KML + +E F +E + + HP+++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 531 LGACPEAWS--------LVYEYLPNGSLQDRLFRK---SNVSPLLWKDRARIAAEIASGL 579
+G + + ++ ++ +G L L L + R +IASG+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 639
+L S + +H DL +N +L+ ++ + DFG+ + + Y + A K
Sbjct: 127 EYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYY----RQGCASKLPV 179
Query: 640 PYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 674
+ E V T SD ++FG+ + +++T G+ P
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 5e-06
Identities = 49/144 (34%), Positives = 67/144 (46%), Gaps = 25/144 (17%)
Query: 475 SFKV----GQGGFGCVY----KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQ 523
FK G+G G V+ KG G+ A+K+L M + + ++ E +L+ L
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGT--GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD 59
Query: 524 HPHLVTLLG--ACPEAWSLVYEYLPNGSLQDRLFRKSNVSP--LLWKDRARI-AAEIASG 578
HP L TL LV +Y P G L FR P L ++ AR AAE+
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGEL----FRLLQRQPGKCLSEEVARFYAAEVLLA 115
Query: 579 LCFLHSSKPEKIVHGDLKPQNILL 602
L +LH IV+ DLKP+NILL
Sbjct: 116 LEYLHL---LGIVYRDLKPENILL 136
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 34/114 (29%), Positives = 61/114 (53%), Gaps = 8/114 (7%)
Query: 562 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621
PL D R ++++A G+ FL S + +H D+ +N+LL +KICDFG+ R +
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 674
D+ Y+ + K + PE V T +SD +S+G+++ ++ + G+ P
Sbjct: 265 DSNYVVKGNARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-06
Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 22/152 (14%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIKML-YSHNMQGQLEFQ-QEVRVLSKLQHPHLVTLLG 532
K+G+G +G V+K VA+K + + +G +E+ +L +L+H ++V L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 533 A--CPEAWSLVYEYLPNGSLQD--RLFRKSNVSPLLWKDRARIAA---EIASGLCFLHSS 585
+ +LV+EY QD + F N D + + ++ GL F HS
Sbjct: 67 VLHSDKKLTLVFEYCD----QDLKKYFDSCNGDI----DPEIVKSFMFQLLKGLAFCHS- 117
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
++H DLKPQN+L++ K+ DFG+ R
Sbjct: 118 --HNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 478 VGQGGFGCVYK--GEMLGRTVAIKMLYS-HNMQGQLEFQQEVRVLSKLQ-HPHLVTLLG- 532
+G+G +G V+K + G A+K+L H++ ++E E +L L HP++V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIE--AEYNILKALSDHPNVVKFYGM 83
Query: 533 -------ACPEAWSLVYEYLPNGSLQDR----LFRKSNVSPLLWKDRARIAAEIASGLCF 581
+ W LV E GS+ D L R + + A I E GL
Sbjct: 84 YYKKDVKNGDQLW-LVLELCNGGSVTDLVKGFLKRGERMEEPII---AYILHEALMGLQH 139
Query: 582 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 641
LH +K +H D+K NILL +E K+ DFG+ +T + R G+ +
Sbjct: 140 LHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS------TRLRRNTSVGTPFW 190
Query: 642 ADPEY-----HRTGVLTPKSDSYSFGLIILQLLTGRLPVG 676
PE + D +S G+ ++L G P+
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 6e-06
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 36/211 (17%)
Query: 478 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 532
VG G +G C G VA+K L S Q + ++ E+R+L ++H +++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83
Query: 533 ACPEAWSL-----VY--EYLPNGSLQD----RLFRKSNVSPLLWKDRARIAAEIASGLCF 581
A SL VY +L L + + +V L++ +I GL +
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY--------QILRGLKY 135
Query: 582 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 641
+HS+ I+H DLKP N+ ++ + KI DFG+ R ++ + AP+ +
Sbjct: 136 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNW 192
Query: 642 ADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 672
Y++T D +S G I+ +LLTGR
Sbjct: 193 M--HYNQT------VDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 574 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 633
++A G+ FL S + +H DL +NILL +KICDFG+ R + D+ Y+ +
Sbjct: 222 QVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278
Query: 634 APKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 670
K + PE V T +SD +S+G+++ ++ +
Sbjct: 279 PVK----WMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 8e-06
Identities = 42/166 (25%), Positives = 77/166 (46%), Gaps = 32/166 (19%)
Query: 478 VGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQHPHLVTLLGA 533
+G+G +G VYK + G VA+K + N + +E+++L +L H ++V L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74
Query: 534 C------------PEAWSLVYEYLPN---GSLQDRL--FRKSNVSPLLWKDRARIAAEIA 576
A+ LV+EY+ + G L+ L F + ++ + ++
Sbjct: 75 VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM--------KQLL 126
Query: 577 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622
GL + H + +H D+K NILL+++ K+ DFG+ RL +
Sbjct: 127 EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 47/166 (28%), Positives = 73/166 (43%), Gaps = 33/166 (19%)
Query: 479 GQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVR--VLSKL-QHPHLVTLLGACP 535
G G C + G+ VAIK L S Q ++ R VL KL H +++ LL
Sbjct: 27 GAQGIVCAAYDTVTGQNVAIKKL-SRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV-- 83
Query: 536 EAWSLVYEYLPNGSLQDRLFRK---------SNVSPLLWK--DRARIAAEIASGLC---F 581
+ P SL++ F+ +N+ ++ D R++ + LC
Sbjct: 84 --------FTPQKSLEE--FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKH 133
Query: 582 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627
LHS+ I+H DLKP NI++ S+ + KI DFG+ R + P
Sbjct: 134 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 176
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 34/112 (30%), Positives = 58/112 (51%), Gaps = 7/112 (6%)
Query: 496 VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWS--LVYEYLPNGSLQDR 553
V +K+L + L F + ++ ++ H H+V L G C +V E++ G L
Sbjct: 35 VILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLF 94
Query: 554 LFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE 605
+ RKS+V WK ++A ++AS L +L + +VHG++ +NILL E
Sbjct: 95 MHRKSDVLTTPWK--FKVAKQLASALSYLED---KDLVHGNVCTKNILLARE 141
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 19/151 (12%)
Query: 478 VGQGGFGCVYKGE--MLGRTVAIKM-----LYSHNMQGQLEFQQEVRVLSKLQHPHLVTL 530
+ +G FG VY G + A+K+ + + NM Q++ +++ LSK P +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK--SPFIVHL 69
Query: 531 LGACPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKP 587
+ A + LV EYL G ++ L ++ ++ A +E+A L +LH
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDVKSLL----HIYGYFDEEMAVKYISEVALALDYLHR--- 122
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGICRL 618
I+H DLKP N+L+ +E K+ DFG+ ++
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 66/247 (26%), Positives = 107/247 (43%), Gaps = 37/247 (14%)
Query: 478 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVL---SKLQHPHLVT 529
+G+G FG VY + + R A+K+L + + E E +L + P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 530 LLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSK 586
L + LV +Y+ G L L ++ S +DRA+ AE+ L LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS----EDRAKFYIAELVLALEHLHKYD 116
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 646
IV+ DLKP+NILLD+ +CDFG+ + D +F G+ Y PE
Sbjct: 117 ---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC------GTTEYLAPE- 166
Query: 647 HRTGVL------TPKSDSYSFGLIILQLLTGRLP--VGLAGEVRRAVSCGKLSSILDPLA 698
VL T D +S G+++ ++ G P ++ R ++ GK+ + L+
Sbjct: 167 ----VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLS 222
Query: 699 GDWPTFV 705
+ FV
Sbjct: 223 DEGRQFV 229
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 25/196 (12%)
Query: 470 CNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHN--------MQGQL-EFQQEVRVLS 520
F + +G G FG V L R V K LY+ ++ Q+ + E +L+
Sbjct: 1 SMFVKIKTLGIGAFGEV----CLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILA 56
Query: 521 KLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASG 578
+ + +V L + + +L V +Y+P G + L R + +D AR IA
Sbjct: 57 EADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG----IFPEDLARFY--IAEL 110
Query: 579 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC---RLVTEDTLYLPSFH-RSTA 634
C + S +H D+KP NIL+D + K+ DFG+C R + Y H R +
Sbjct: 111 TCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDS 170
Query: 635 PKGSFPYADPEYHRTG 650
S + DP R G
Sbjct: 171 MDFSNEWGDPANCRCG 186
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 27/207 (13%)
Query: 478 VGQGGFGCV----YKGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTL 530
+G G FG V YK E VAIK + Q + E ++L+ + HP V L
Sbjct: 38 LGTGSFGRVILATYKNEDF-PPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNL 96
Query: 531 LGACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKP 587
G+ + LV E++ G L R++ P D AA+I +L S
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFP---NDVGCFYAAQIVLIFEYLQSLN- 151
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 647
IV+ DLKP+N+LLD + K+ DFG ++V T L G+ Y PE
Sbjct: 152 --IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC---------GTPEYIAPEIL 200
Query: 648 RTGVLTPKSDSYSFGLIILQLLTGRLP 674
+D ++ G+ I ++L G P
Sbjct: 201 LNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 20/49 (40%), Positives = 34/49 (69%), Gaps = 3/49 (6%)
Query: 574 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622
+I GL ++HS+ ++H DLKP N+L++++ KICDFG+ R +E+
Sbjct: 113 QILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 5e-05
Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 524 HPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCF 581
+P+ + L + + L+ +Y+ +G L D L ++ +S K +I ++ L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVK---KIIRQLVEALND 124
Query: 582 LHSSKPEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFP 640
LH I+H D+K +N+L D +CD+G+C+ T PS + G+
Sbjct: 125 LHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIGT---PSCYD-----GTLD 171
Query: 641 YADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
Y PE + D ++ G++ +LLTG+ P
Sbjct: 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 35/133 (26%), Positives = 58/133 (43%), Gaps = 16/133 (12%)
Query: 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNIL 601
Y+ + + L L D ++A G+ FL S + VH DL +N+L
Sbjct: 214 YKGSNDSEV-KNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVL 269
Query: 602 LDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS----FPYADPEYHRTGVLTPKSD 657
L KICDFG+ R + D+ Y+ KGS + PE + T SD
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYV--------SKGSTFLPVKWMAPESIFDNLYTTLSD 321
Query: 658 SYSFGLIILQLLT 670
+S+G+++ ++ +
Sbjct: 322 VWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 20/154 (12%)
Query: 474 ESFKV-GQGGFGCV--YKGEMLGRTVAIKMLYSHNMQGQLEFQQ------EVRVLSKLQH 524
ES KV G+G FG V + + G A+K+L +M LE +Q E +L +
Sbjct: 4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM---LEKEQVGHIRAERDILVEADS 60
Query: 525 PHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 582
+V + + + +L + E+LP G + L +K ++ IA + +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT------EEETQFYIAETVLAI 114
Query: 583 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 616
S +H D+KP N+LLDS+ K+ DFG+C
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLC 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 9e-05
Identities = 44/161 (27%), Positives = 70/161 (43%), Gaps = 23/161 (14%)
Query: 479 GQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVR--VLSK-LQHPHLVTLLGACP 535
G G C +L R VAIK L S Q Q ++ R VL K + H ++++LL
Sbjct: 28 GAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV-- 84
Query: 536 EAWSLVYEYLPNGSLQD-------RLFRKSNVSPLLWK--DRARIAAEIASGLCFLHSSK 586
+ P SL++ +N+ ++ D R++ + LC +
Sbjct: 85 --------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627
I+H DLKP NI++ S+ + KI DFG+ R + P
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 177
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-05
Identities = 44/169 (26%), Positives = 74/169 (43%), Gaps = 46/169 (27%)
Query: 478 VGQGGFGCVYK--GEMLGRTVAIKMLYSHNMQGQLEFQQ----EVRVLSKLQHPHLVTLL 531
VG+G +G V K + VAIK + + E ++ E+++L L+ ++V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLKQENIVEL- 65
Query: 532 GACPEAWS------LVYEY-----------LPNGSLQDRLFRKSNVSPLLWKDRARIAAE 574
EA+ LV+EY +PNG +++ R+ I
Sbjct: 66 ---KEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKV-------------RSYIYQL 109
Query: 575 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623
I + +H IVH D+KP+N+L+ K+CDFG R ++E +
Sbjct: 110 IKA----IHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 36/219 (16%)
Query: 473 SESFK----VGQGGFGCVYKGEMLGRT--VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPH 526
++S+K +G G FG VY+ + + VAIK + +Q +E+ ++ L H +
Sbjct: 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHIN 120
Query: 527 LVTL----LGACPEA------WSLVYEYLPNG--SLQDRLFRKSNVSPLLWKDRARIAAE 574
++ L C + ++V E++P R ++ PL + +
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL--YSYQ 178
Query: 575 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRST 633
+ L ++HS + I H DLKPQN+L+D + K+CDFG + L + RS
Sbjct: 179 LCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAK-------NLLAGQRSV 228
Query: 634 APKGSFPYADPEYHRTGV-LTPKSDSYSFGLIILQLLTG 671
+ S Y PE T D +S G II +++ G
Sbjct: 229 SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 42/145 (28%), Positives = 64/145 (44%), Gaps = 23/145 (15%)
Query: 566 KDRARIA---AEIASGLCFL------HSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 616
K RA+ E +GL F+ H + ++H D+K NILL S K+ DFG
Sbjct: 131 KSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190
Query: 617 RL----VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 672
++ V++D G+ Y PE R + K+D +S G+++ +LLT +
Sbjct: 191 KMYAATVSDDV--------GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242
Query: 673 LPVGLAGEVRRAVSCGKLSSILDPL 697
P GE V L+ DPL
Sbjct: 243 RP--FDGENMEEVMHKTLAGRYDPL 265
|
Length = 496 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 26/76 (34%), Positives = 38/76 (50%), Gaps = 6/76 (7%)
Query: 541 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNI 600
V +Y+P G + L R + +D AR IA C + S +H D+KP NI
Sbjct: 79 VMDYIPGGDMMSLLIRLG----IFEEDLARFY--IAELTCAIESVHKMGFIHRDIKPDNI 132
Query: 601 LLDSELSSKICDFGIC 616
L+D + K+ DFG+C
Sbjct: 133 LIDRDGHIKLTDFGLC 148
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 20/154 (12%)
Query: 474 ESFKV-GQGGFGCV--YKGEMLGRTVAIKMLYSHNMQGQLEFQQ------EVRVLSKLQH 524
ES KV G+G FG V + + G A+K+L +M LE +Q E +L +
Sbjct: 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM---LEKEQVAHIRAERDILVEADG 60
Query: 525 PHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 582
+V + + + +L + E+LP G + L +K +S IA + +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLS------EEATQFYIAETVLAI 114
Query: 583 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 616
+ +H D+KP N+LLD++ K+ DFG+C
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLC 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 28/216 (12%)
Query: 478 VGQGGFGCVY---KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLL 531
+ G +G VY E R A+K + N+ + + QQ E +L+ ++P +V++
Sbjct: 9 ISNGAYGAVYLVRHKETRQR-FAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMF 67
Query: 532 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIA-AEIASGLCFLHSSKPE 588
+ +V EY+ G L N+ L D AR+ AE L +LH+
Sbjct: 68 CSFETKRHLCMVMEYVEGGDCATLL---KNIGALP-VDMARMYFAETVLALEYLHNYG-- 121
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICR--LVTEDT-LYLPSFHRSTAP------KGSF 639
IVH DLKP N+L+ S K+ DFG+ + L++ T LY + T G+
Sbjct: 122 -IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180
Query: 640 PYADPEY-HRTGVLTPKSDSYSFGLIILQLLTGRLP 674
Y PE R G P D ++ G+I+ + L G +P
Sbjct: 181 EYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 44/202 (21%)
Query: 496 VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC---PEAWSLVYEYLPNGSLQD 552
V +K+L + L F + ++S++ H HL + G C E +V E++ +G L
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSEN-IMVEEFVEHGPLDV 105
Query: 553 RLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICD 612
L ++ P+ WK +A ++AS L +L + +VHG++ +NILL
Sbjct: 106 CLRKEKGRVPVAWK--ITVAQQLASALSYLED---KNLVHGNVCAKNILLARL------- 153
Query: 613 FGICRLVTEDTLYLPSFHRSTAPKGSF------------PYADPEYHRTGV-LTPKSDSY 659
G+ E T F + + P SF P+ PE G L+ +D +
Sbjct: 154 -GLA----EGTS---PFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKW 205
Query: 660 SFGLIILQL-------LTGRLP 674
SFG +L++ L R P
Sbjct: 206 SFGTTLLEICFDGEVPLKERTP 227
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 3e-04
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 45/215 (20%)
Query: 478 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQL---EFQQEVRVLSKLQHPHLVTLLG 532
VG G +G C + G VAIK L S Q ++ +E+ +L +QH +++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 533 ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA-------------EIASGL 579
A S QD V P + D +I ++ GL
Sbjct: 82 VFTSAVSG-------DEFQDFYL----VMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGL 130
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV-TEDTLYLPS-FHRSTAPKG 637
++HS+ I+H DLKP N+ ++ + KI DFG+ R E T Y+ + ++R AP+
Sbjct: 131 KYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYR--APEV 185
Query: 638 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 672
+ Y++T D +S G I+ ++LTG+
Sbjct: 186 ILNWM--HYNQT------VDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 43/151 (28%), Positives = 67/151 (44%), Gaps = 23/151 (15%)
Query: 479 GQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVR--VLSK-LQHPHLVTLLGACP 535
G G C +L R VAIK L S Q Q ++ R VL K + H +++ LL
Sbjct: 35 GAQGIVCAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV-- 91
Query: 536 EAWSLVYEYLPNGSLQD-------RLFRKSNVSPLLWK--DRARIAAEIASGLCFLHSSK 586
+ P SL++ +N+ ++ D R++ + LC +
Sbjct: 92 --------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICR 617
I+H DLKP NI++ S+ + KI DFG+ R
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 32/217 (14%)
Query: 478 VGQGGFGCVYK--GEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGAC 534
+G+G +G VYK + G A+K+L + + E + E +L L HP++V G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 535 PEA--------WSLVYEYLPNGSLQDRLFRKSNVSPLLWK----DRARIAAEIASGLCFL 582
+A W LV E GS+ + V LL D A I+ + L L
Sbjct: 89 YKADKLVGGQLW-LVLELCNGGSVTEL------VKGLLICGQRLDEAMISYILYGALLGL 141
Query: 583 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 642
+I+H D+K NILL +E K+ DFG+ +T L R+T+ F A
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-----RRNTSVGTPFWMA 196
Query: 643 DP----EYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 675
E + D +S G+ ++L G P+
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 4e-04
Identities = 28/135 (20%), Positives = 56/135 (41%), Gaps = 2/135 (1%)
Query: 303 KAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRK-EAEDALQTTIQDQE 361
+ EEL+ ++L +E E K++ E+ E + L +
Sbjct: 240 ELEELQEELKEAEEELEELTAELQELEEKLEELRLEV-SELEEEIEELQKELYALANEIS 298
Query: 362 KLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRR 421
+L+Q+K + + L R + L ++ +E + DE EL ++ + L++E + +
Sbjct: 299 RLEQQKQILRERLANLERQLEELEAQLEELESKLDELAEELAELEEKLEELKEELESLEA 358
Query: 422 QKVEAVRWLERWRSR 436
+ E LE SR
Sbjct: 359 ELEELEAELEELESR 373
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 23/161 (14%)
Query: 479 GQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ---HPHLVTLLGACP 535
G G C +LG VA+K L S Q Q ++ R L L+ H ++++LL
Sbjct: 32 GAQGIVCAAFDTVLGINVAVKKL-SRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV-- 88
Query: 536 EAWSLVYEYLPNGSLQD-------RLFRKSNVSPLLWK--DRARIAAEIASGLCFLHSSK 586
+ P SL++ +N+ ++ D R++ + LC +
Sbjct: 89 --------FTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 140
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627
I+H DLKP NI++ S+ + KI DFG+ R + + P
Sbjct: 141 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTP 181
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 4e-04
Identities = 16/46 (34%), Positives = 30/46 (65%), Gaps = 3/46 (6%)
Query: 574 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 619
++ GL ++HS+ ++H DLKP N+L++ + +I DFG+ R +
Sbjct: 115 QLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (102), Expect = 5e-04
Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 45/205 (21%)
Query: 515 EVRVLSKLQHPHLVT----LLGACPEAWSLVYEYLPNGSLQD------RLFRKSNVSPLL 564
EV V+ +L+H ++V L + ++ E+ G L ++F K ++
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 565 WKDRARIAAEIASGLCFLHSSKP----EKIVHGDLKPQNILLDSELS------------- 607
I ++ L + H+ K E+++H DLKPQNI L + +
Sbjct: 122 -----DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176
Query: 608 ----SKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE--YHRTGVLTPKSDSYSF 661
+KI DFG+ + + +++ + + G+ Y PE H T KSD ++
Sbjct: 177 GRPIAKIGDFGLSKNIGIESM-------AHSCVGTPYYWSPELLLHETKSYDDKSDMWAL 229
Query: 662 GLIILQLLTGRLPVGLAGEVRRAVS 686
G II +L +G+ P A + +S
Sbjct: 230 GCIIYELCSGKTPFHKANNFSQLIS 254
|
Length = 1021 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 45/153 (29%), Positives = 70/153 (45%), Gaps = 15/153 (9%)
Query: 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQL-EFQQEVRVLSKLQHP 525
+F +G+G FG V + G+ A+K L M + QL + E VL++ P
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61
Query: 526 HLVTLLGACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFL 582
+V+L + +A L+ E+LP G L L + S +D R AE + +
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFS----EDVTRFYMAECVLAIEAV 117
Query: 583 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 615
H +H D+KP NIL+D K+ DFG+
Sbjct: 118 HKLG---FIHRDIKPDNILIDRGGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 46/221 (20%), Positives = 89/221 (40%), Gaps = 32/221 (14%)
Query: 478 VGQGGFGCVYK-----GEMLGRTVAIKMLYSHNMQGQLEF-----QQEVRVLSKLQHPHL 527
+G GGFGCVY+ + K+ N +E ++ ++ ++ H
Sbjct: 20 IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHN 79
Query: 528 VTLLGACPEAW--------SLVYEYLPNGSLQDRLFRKSN--VSPLLWKDR---ARIAAE 574
+ LG P+ + + Y ++ L ++L + + K++ I +
Sbjct: 80 IDHLG-IPKYYGCGSFKRCRMYYRFI----LLEKLVENTKEIFKRIKCKNKKLIKNIMKD 134
Query: 575 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 634
+ + L ++H I HGD+KP+NI++D I D+GI ++
Sbjct: 135 MLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKD 191
Query: 635 -PKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
+G+ YA + H +T + D S G +L+ +LP
Sbjct: 192 LHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232
|
Length = 294 |
| >gnl|CDD|238182 cd00293, USP_Like, Usp: Universal stress protein family | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 6e-04
Identities = 24/106 (22%), Positives = 38/106 (35%), Gaps = 22/106 (20%)
Query: 39 LLHWTL---QRFGSSREICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQKMKK 95
L W +R G+ E+ +LHV P P ++ +
Sbjct: 15 ALRWAARLARRLGA--ELVLLHVVDPPPSSAA----------------ELAELLEEEARA 56
Query: 96 LLDNYLRICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGA 141
LL+ EA VK + E D +AI++ G +VMG+
Sbjct: 57 LLEALREALAEAGVKVETVVLEGD-PAEAILEAAEELGADLIVMGS 101
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. Length = 130 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 38/221 (17%)
Query: 474 ESFKVGQGGFGCVYKGEMLG----RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 529
E KVG+G +G VYK + R A+K + + + +E+ +L +L+HP++++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--MSACREIALLRELKHPNVIS 62
Query: 530 LLG-----ACPEAWSLVYEYLPNGSLQDRLFR---KSNVSPLLWKDRARIAA---EIASG 578
L A + W L+++Y + F K+N P+ R + + +I G
Sbjct: 63 LQKVFLSHADRKVW-LLFDYAEHDLWHIIKFHRASKANKKPVQLP-RGMVKSLLYQILDG 120
Query: 579 LCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLVTEDTLYLPSFHRSTA 634
+ +LH++ ++H DLKP NIL+ E KI D G RL L
Sbjct: 121 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 635 PKGSFPYADPEY-----HRTGVLTPKSDSYSFGLIILQLLT 670
+F Y PE H T + D ++ G I +LLT
Sbjct: 178 ---TFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 34/157 (21%), Positives = 62/157 (39%), Gaps = 15/157 (9%)
Query: 515 EVRVLSKLQHPHLVTLLG--ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIA 572
E +L + HP ++ + +V LP+ S + PL I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 573 AEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRS 632
+I GL +LH+ ++I+H D+K +NI ++ I D G + +L
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL------ 214
Query: 633 TAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLL 669
G+ PE K+D +S G+++ ++L
Sbjct: 215 -GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 43/150 (28%), Positives = 61/150 (40%), Gaps = 17/150 (11%)
Query: 525 PHLVTLLG--ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 582
P++V L ++ LV ++ G L + + N+ K R AAE+ L L
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK---RWAAEMVVALDAL 101
Query: 583 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 642
H E IV DL P NILLD ++ F V ED+ + Y
Sbjct: 102 HR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEV-EDSCDGEAVENM--------YC 149
Query: 643 DPEYHRTGVLTPKSDSYSFGLIILQLLTGR 672
PE T D +S G I+ +LLTG+
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.002
Identities = 64/247 (25%), Positives = 87/247 (35%), Gaps = 68/247 (27%)
Query: 477 KVGQGGFGCVYKGEMLGRTVAIK---MLYSHNMQGQLEFQQEVRV-------LSKLQHPH 526
K+G+G FG VYK ++ + + +L G +E RV + +
Sbjct: 139 KLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGF 198
Query: 527 LVTLLG-ACPEAWSLVYEYLPNGSLQDRLFRKS---NVSPLLWKDR-------------- 568
L + E W LV+ Y +L D + K NV P L
Sbjct: 199 LEPVSSKKEDEYW-LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKII 257
Query: 569 ARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLP 627
I +I L LHS+ IVH D+KPQNI+ S KI D G + Y+P
Sbjct: 258 QTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIP 314
Query: 628 SFHRSTAPKGSF---P-YADPEYHRTGVLTPKS----------------------DSYSF 661
F P YA PE + TP + D YS
Sbjct: 315 K---------EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365
Query: 662 GLIILQL 668
GLI LQ+
Sbjct: 366 GLIFLQM 372
|
Length = 566 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 44/215 (20%)
Query: 478 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 532
VG G +G C L + VA+K L S Q + ++ E+R+L ++H +++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKL-SRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 533 ACPEAWSLVYEYLPNGSLQDRLFRKSN-VSPLLWKDRARIAA--------------EIAS 577
+ P S+++ F + V+ L+ D I ++
Sbjct: 82 V----------FTPATSIEN--FNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR 129
Query: 578 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG 637
GL ++HS+ I+H DLKP N+ ++ + +I DFG+ R ++ + AP+
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPEI 186
Query: 638 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 672
+ Y++T D +S G I+ +LL G+
Sbjct: 187 MLNWM--HYNQT------VDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.002
Identities = 35/173 (20%), Positives = 73/173 (42%), Gaps = 16/173 (9%)
Query: 276 SEKRESTDSDSKVEEDPLYVQHREVSIKA--EELRNSAFAEFLRRKKLESEAMEAIGKVK 333
E E + ++EE+ ++ +K EEL A ++LE E EA ++
Sbjct: 751 EELEELQERLEELEEELESLEEALAKLKEEIEELEEKRQALQEELEELEEELEEAERRLD 810
Query: 334 AFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALLNSRAQEANR 393
A E R+ E ++ ++ E+L+++ + +EL + + L +E
Sbjct: 811 ALERELESLEQRRERLEQEIEELEEEIEELEEKLDELEEELEELEKELEELKEELEELEA 870
Query: 394 R--------------RDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLER 432
++E EL+ +++ +A L++E +++R + E LER
Sbjct: 871 EKEELEDELKELEEEKEELEEELRELESELAELKEEIEKLRERLEELEAKLER 923
|
Length = 1163 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 36/220 (16%)
Query: 474 ESFKVGQGGFGCVYKGEMLG----RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 529
E KVG+G +G VYK + + A+K + + + +E+ +L +L+HP+++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIA 62
Query: 530 L----LGACPEAWSLVYEYLPNGSLQDRLFR---KSNVSPLLWKDRARIAA---EIASGL 579
L L L+++Y + F K+N P+ R+ + + +I G+
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLP-RSMVKSLLYQILDGI 121
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLVTEDTLYLPSFHRSTAP 635
+LH++ ++H DLKP NIL+ E KI D G RL L
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV- 177
Query: 636 KGSFPYADPEY-----HRTGVLTPKSDSYSFGLIILQLLT 670
+F Y PE H T + D ++ G I +LLT
Sbjct: 178 --TFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|222135 pfam13445, zf-RING_LisH, RING-type zinc-finger, LisH dimerisation motif | Back alignment and domain information |
|---|
Score = 36.5 bits (85), Expect = 0.002
Identities = 15/50 (30%), Positives = 23/50 (46%), Gaps = 4/50 (8%)
Query: 740 VAEERPVPSFFLCPILQEIMHD----PQVAADGFTYEGKAIRDWLENGRE 785
+ S F+CPI +E+M D P + G Y KA+ +NG +
Sbjct: 1 LPYAHHFHSIFVCPISKEVMTDEENPPVMLPCGHVYSRKALEKLAKNGGK 50
|
This zinc-finger is the dimerisation motif for LisH proteins, and is also a typical RING-type of plant ubiquitin ligases. Length = 55 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.003
Identities = 20/86 (23%), Positives = 38/86 (44%)
Query: 347 KEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQ 406
+E + L+ ++ ++ ++E +T EL + L E +E EL +
Sbjct: 235 EELREELEELQEELKEAEEELEELTAELQELEEKLEELRLEVSELEEEIEELQKELYALA 294
Query: 407 ASIATLQQEKQRIRRQKVEAVRWLER 432
I+ L+Q+KQ +R + R LE
Sbjct: 295 NEISRLEQQKQILRERLANLERQLEE 320
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.003
Identities = 30/137 (21%), Positives = 57/137 (41%), Gaps = 16/137 (11%)
Query: 541 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNI 600
+Y ++ + + + PLL + R I ++ + ++H +K++H D+K +NI
Sbjct: 249 LYSFMYDEAFDWK------DRPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENI 298
Query: 601 LLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYS 660
L+ + + DFG T G+ PE +D +S
Sbjct: 299 FLNCDGKIVLGDFG-----TAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWS 353
Query: 661 FGLIILQLLTGRL-PVG 676
GLI+L +L+ P+G
Sbjct: 354 CGLILLDMLSHDFCPIG 370
|
Length = 501 |
| >gnl|CDD|100796 PRK01156, PRK01156, chromosome segregation protein; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.003
Identities = 16/119 (13%), Positives = 48/119 (40%), Gaps = 4/119 (3%)
Query: 303 KAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEK 362
K L+ + +++++K + I +++ +E Y K E + + +
Sbjct: 330 KLSVLQ-KDYNDYIKKKSRYDDLNNQILELEGYEMDY---NSYLKSIESLKKKIEEYSKN 385
Query: 363 LKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRR 421
+++ AF+++ L + + E N + + + ++ + I L++ + R
Sbjct: 386 IERMSAFISEILKIQEIDPDAIKKELNEINVKLQDISSKVSSLNQRIRALRENLDELSR 444
|
Length = 895 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 33/128 (25%), Positives = 51/128 (39%), Gaps = 27/128 (21%)
Query: 562 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS------------- 608
P + A+I + L + H+ ++H DLKP+NIL+++ +
Sbjct: 227 PFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284
Query: 609 ---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLII 665
+ICD G C H TA + Y PE +D +S G II
Sbjct: 285 CRVRICDLGGC---------CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCII 335
Query: 666 LQLLTGRL 673
+L TG+L
Sbjct: 336 YELYTGKL 343
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 816 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| cd01989 | 146 | STK_N The N-terminal domain of Eukaryotic Serine T | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| PRK15456 | 142 | universal stress protein UspG; Provisional | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| PRK15005 | 144 | universal stress protein F; Provisional | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.76 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| cd01987 | 124 | USP_OKCHK USP domain is located between the N-term | 99.74 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| PRK15118 | 144 | universal stress global response regulator UspA; P | 99.73 | |
| PRK09982 | 142 | universal stress protein UspD; Provisional | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.72 | |
| cd01988 | 132 | Na_H_Antiporter_C The C-terminal domain of a subfa | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.68 | |
| PF00582 | 140 | Usp: Universal stress protein family; InterPro: IP | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.65 | |
| PRK10116 | 142 | universal stress protein UspC; Provisional | 99.65 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.65 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| cd00293 | 130 | USP_Like Usp: Universal stress protein family. The | 99.53 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.52 | |
| PRK11175 | 305 | universal stress protein UspE; Provisional | 99.52 | |
| COG0589 | 154 | UspA Universal stress protein UspA and related nuc | 99.48 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.47 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.34 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.24 | |
| PF04564 | 73 | U-box: U-box domain; InterPro: IPR003613 Quality c | 99.21 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.11 | |
| PRK12652 | 357 | putative monovalent cation/H+ antiporter subunit E | 99.11 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.09 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.09 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.08 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.05 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.05 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.98 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.85 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.74 | |
| PRK10490 | 895 | sensor protein KdpD; Provisional | 98.69 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.69 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.56 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.55 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.46 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.45 | |
| COG2205 | 890 | KdpD Osmosensitive K+ channel histidine kinase [Si | 98.39 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.23 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.22 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.22 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.19 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.19 | |
| smart00504 | 63 | Ubox Modified RING finger domain. Modified RING fi | 98.14 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.05 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.99 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.94 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.87 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.84 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.82 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.77 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.72 | |
| cd01984 | 86 | AANH_like Adenine nucleotide alpha hydrolases supe | 97.68 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.6 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.53 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.53 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.53 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.51 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.46 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.43 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.37 | |
| KOG4642 | 284 | consensus Chaperone-dependent E3 ubiquitin protein | 97.35 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.31 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.3 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.22 | |
| PLN02236 | 344 | choline kinase | 96.98 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.89 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-51 Score=447.55 Aligned_cols=275 Identities=47% Similarity=0.776 Sum_probs=240.4
Q ss_pred cCcccCHHHHHHHhcCCCccceeeeecceEEEEEEEcC-eEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccc
Q 003481 456 ESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLG-RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534 (816)
Q Consensus 456 ~~~~~~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~g-~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~ 534 (816)
....|++.+|..||++|+..+.||+||||.||+|.+.+ ..||||++.........+|.+|+.+|++++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46779999999999999999999999999999999984 89999988766544144599999999999999999999999
Q ss_pred cC---CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEe
Q 003481 535 PE---AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKIC 611 (816)
Q Consensus 535 ~~---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~ 611 (816)
.+ ..+||||||++|+|.++|+..... +++|..|++|+.++|.||+|||...+++||||||||+|||||.++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 53 279999999999999999887644 89999999999999999999999987789999999999999999999999
Q ss_pred ecccceeccC-CCCcCCCccccCCC-CCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCC---------ChHH
Q 003481 612 DFGICRLVTE-DTLYLPSFHRSTAP-KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVG---------LAGE 680 (816)
Q Consensus 612 DFGla~~~~~-~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~---------~~~~ 680 (816)
|||+|+..+. ... .... .||.+|+||||+..+.++.|+|||||||+|+||+||+.|.. ...|
T Consensus 220 DFGLa~~~~~~~~~-------~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w 292 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTS-------VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW 292 (361)
T ss_pred CccCcccCCccccc-------eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence 9999976654 221 1111 79999999999999999999999999999999999998875 2455
Q ss_pred HHHHhhcCccccccCCCC--CCCCH-HHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhh
Q 003481 681 VRRAVSCGKLSSILDPLA--GDWPT-FVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 681 ~~~~~~~~~~~~~~d~~~--~~~~~-~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~ 739 (816)
....+..+.+.+++|+.. ..++. .....+..++.+|++.+|.+||+|. ++++.|+.+.
T Consensus 293 ~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~-~Vv~~L~~~~ 353 (361)
T KOG1187|consen 293 AKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMS-QVVKELEGIL 353 (361)
T ss_pred HHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHH-HHHHHHHhhc
Confidence 667788889999999986 45664 5778899999999999999999999 5677776543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=397.21 Aligned_cols=249 Identities=37% Similarity=0.598 Sum_probs=209.7
Q ss_pred cceeeeecceEEEEEEEcCeE-EEEEEeccCCccc--HHHHHHHHHHHhcCCCCceeeEeccccCC---ccceeeccCCC
Q 003481 475 SFKVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLGACPEA---WSLVYEYLPNG 548 (816)
Q Consensus 475 ~~~LG~G~~g~Vy~~~~~g~~-vAiK~l~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~g~~~~~---~~lV~E~~~~g 548 (816)
...||.|+||+||+|.+.|.. ||||++....... ...|.+|+.+|.+++|||||+|+|+|.+. .+|||||+++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 345999999999999999988 9999997654333 45899999999999999999999999654 68999999999
Q ss_pred chhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCC-CeeEeecccceeccCCCCcCC
Q 003481 549 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 549 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~~~~~~~~ 627 (816)
+|.++|... ....+++..+++|+.|||.||.|||+.++ ||||||||+||||+.++ ++||+|||+++......
T Consensus 126 sL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~---- 198 (362)
T KOG0192|consen 126 SLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK---- 198 (362)
T ss_pred cHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc----
Confidence 999999885 23579999999999999999999999884 99999999999999998 99999999998876432
Q ss_pred CccccCCCCCCCCCCCccccc--cCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCccccccCCCCCCCCH
Q 003481 628 SFHRSTAPKGSFPYADPEYHR--TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPT 703 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~--~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~~~~~ 703 (816)
...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||...... ...+..+. .....|.
T Consensus 199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~-------~Rp~~p~ 269 (362)
T KOG0192|consen 199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGG-------LRPPIPK 269 (362)
T ss_pred --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcC-------CCCCCCc
Confidence 1234578999999999999 569999999999999999999999999865542 22221111 1223344
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhhh
Q 003481 704 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740 (816)
Q Consensus 704 ~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~~ 740 (816)
..+..+..|+.+||+.||..||++. +++..|+.+..
T Consensus 270 ~~~~~l~~l~~~CW~~dp~~RP~f~-ei~~~l~~~~~ 305 (362)
T KOG0192|consen 270 ECPPHLSSLMERCWLVDPSRRPSFL-EIVSRLESIMS 305 (362)
T ss_pred cCCHHHHHHHHHhCCCCCCcCCCHH-HHHHHHHHHHH
Confidence 4677899999999999999999999 78888887754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=379.18 Aligned_cols=250 Identities=30% Similarity=0.430 Sum_probs=210.3
Q ss_pred cCHHHHHHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCceeeEecccc-
Q 003481 460 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACP- 535 (816)
Q Consensus 460 ~~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~- 535 (816)
++..||+.. ..||+|..|+||++++. ++.+|+|++.... ...++++.+|++++...+|||||.+||+|.
T Consensus 76 i~~~dle~~-------~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLERL-------GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhhh-------hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 455566544 56999999999999987 8899999995443 345668999999999999999999999983
Q ss_pred -C-CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceeeCCCCCCceEecCCCCeeEee
Q 003481 536 -E-AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS-SKPEKIVHGDLKPQNILLDSELSSKICD 612 (816)
Q Consensus 536 -~-~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkL~D 612 (816)
. ..+|+||||++|||++++...+ .+++...-+|+.+|++||.|||. .+ ||||||||+|||++..|.|||||
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicD 222 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICD 222 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEecc
Confidence 3 3789999999999999997653 58899999999999999999996 66 99999999999999999999999
Q ss_pred cccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCCh-----HHHHHHhhc
Q 003481 613 FGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLA-----GEVRRAVSC 687 (816)
Q Consensus 613 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~-----~~~~~~~~~ 687 (816)
||.++.+.... ....+||..|||||.+.+..|+.++||||||++++|+.+|+.||... +++ .
T Consensus 223 FGVS~~lvnS~--------a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~-~---- 289 (364)
T KOG0581|consen 223 FGVSGILVNSI--------ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIF-E---- 289 (364)
T ss_pred ccccHHhhhhh--------cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHH-H----
Confidence 99999876542 35678999999999999999999999999999999999999999653 221 1
Q ss_pred CccccccCCCCCCCCHH-HHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 688 GKLSSILDPLAGDWPTF-VARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 688 ~~~~~~~d~~~~~~~~~-~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
-+..+++...+..|.. .++++..++..||++||.+||++.+.+.|.+-
T Consensus 290 -Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi 338 (364)
T KOG0581|consen 290 -LLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFI 338 (364)
T ss_pred -HHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHH
Confidence 1223344334455664 88899999999999999999999987766654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=364.88 Aligned_cols=253 Identities=25% Similarity=0.375 Sum_probs=210.6
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCCceeeEecc-ccC--C-cccee
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGA-CPE--A-WSLVY 542 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~-~~~--~-~~lV~ 542 (816)
+|.+.++||.|.||+||++... |..||.|.+...... .......|+.+|++|+|||||+++++ |.+ . .+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 4666778999999999999774 899999999866543 34468899999999999999999984 432 2 78999
Q ss_pred eccCCCchhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCC-ceeeCCCCCCceEecCCCCeeEeecccceecc
Q 003481 543 EYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPE-KIVHGDLKPQNILLDSELSSKICDFGICRLVT 620 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 620 (816)
|||..|+|..++.... ....++++.+|+++.|++.||..+|+.-+. -|+||||||.||+|+.+|.+||+|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 9999999999987543 345689999999999999999999994422 39999999999999999999999999999987
Q ss_pred CCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChH--HHHHHhhcCccccccCCCC
Q 003481 621 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLA 698 (816)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~--~~~~~~~~~~~~~~~d~~~ 698 (816)
.... .....+|||.||+||.+...+|++||||||+||++|||+.-++||...+ .....+..|.+..
T Consensus 180 s~~t------fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~------ 247 (375)
T KOG0591|consen 180 SKTT------FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP------ 247 (375)
T ss_pred chhH------HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC------
Confidence 6553 3467799999999999999999999999999999999999999997553 2344455554432
Q ss_pred CCCC-HHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHH
Q 003481 699 GDWP-TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 737 (816)
Q Consensus 699 ~~~~-~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~ 737 (816)
.| ..++..+..||..|+..||..||+....+.+.-..
T Consensus 248 --~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 248 --LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred --CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 24 67899999999999999999999966455444443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=392.93 Aligned_cols=246 Identities=26% Similarity=0.399 Sum_probs=214.1
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
..|...+.||+|||+.||.+++. |..||+|++.+... ...+.+.+|++|.+.|+|||||+++++|++ +.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 46899999999999999999983 99999999987543 334568899999999999999999999976 489999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
|+|++++|..++.+. .++++.++..++.||+.||.|||+.+ |+|||||..||||+++.++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999999754 47999999999999999999999988 999999999999999999999999999998754
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCCh--HHHHHHhhcCccccccCCCCCC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLA--GEVRRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~--~~~~~~~~~~~~~~~~d~~~~~ 700 (816)
. .+..+.+|||.|+|||++....++..+||||+|||||-||+|++||... .+....+..... .
T Consensus 172 ~------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y---------~ 236 (592)
T KOG0575|consen 172 G------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY---------S 236 (592)
T ss_pred c------cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc---------c
Confidence 3 2457789999999999999999999999999999999999999999743 334444433322 2
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
.|...+....+||.++|+.||.+|||+.++|.+.+=
T Consensus 237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 455677889999999999999999999988777664
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=372.25 Aligned_cols=248 Identities=30% Similarity=0.428 Sum_probs=206.8
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccC--CcccHHHHHHHHHHHhcCCCCceeeEeccc--cCCccceee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSH--NMQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYE 543 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~E 543 (816)
++|.....||.|+||+||+|++. +..||||.+.+. .....+-+..|+.+|+.++|||||.|++++ .+..|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 57888889999999999999986 889999999877 344556678999999999999999999998 456899999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCC------CCeeEeecccce
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE------LSSKICDFGICR 617 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~------~~vkL~DFGla~ 617 (816)
||+||+|.++|...+ .+++..+..++.|||.||++||+++ ||||||||.||||+.+ -.+||+|||+|+
T Consensus 90 yC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred eCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999998876 5888999999999999999999988 9999999999999765 458999999999
Q ss_pred eccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChH--HHHHHhhcCccccccC
Q 003481 618 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILD 695 (816)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~--~~~~~~~~~~~~~~~d 695 (816)
.+.++. ...+.+|++.|||||++..++|+.|+|+||+|+|||+|++|++||.... +....+..++-.
T Consensus 164 ~L~~~~-------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~---- 232 (429)
T KOG0595|consen 164 FLQPGS-------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI---- 232 (429)
T ss_pred hCCchh-------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc----
Confidence 988655 2456789999999999999999999999999999999999999997433 333333333211
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 696 PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 696 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
....+...+..+.+|+...++.+|.+|-+..+-+.+.+-
T Consensus 233 --~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l 271 (429)
T KOG0595|consen 233 --VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFL 271 (429)
T ss_pred --cCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhc
Confidence 123344455567788888888888888888765555553
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=376.09 Aligned_cols=248 Identities=25% Similarity=0.354 Sum_probs=205.9
Q ss_pred HhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCccc-------HHHHHHHHHHHhcCCCCceeeEecccc--C
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG-------QLEFQQEVRVLSKLQHPHLVTLLGACP--E 536 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~-------~~~~~~E~~il~~l~HpnIv~l~g~~~--~ 536 (816)
..+.|...+.||+|+||.|-+|... |+.||||++++..... ...+.+|+++|++|+|||||+++++|. +
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4456788899999999999999775 8999999997754322 223579999999999999999999994 4
Q ss_pred CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCC---CCeeEeec
Q 003481 537 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE---LSSKICDF 613 (816)
Q Consensus 537 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~---~~vkL~DF 613 (816)
..|+||||+.||.|.+.+...+ .+.+..-..++.|++.|+.|||+.| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 5799999999999999998765 3666777889999999999999998 9999999999999766 78999999
Q ss_pred ccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCC---CcchhHhHHHHHHHHHHhCCCCCCChH---HHHHHhhc
Q 003481 614 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL---TPKSDSYSFGLIILQLLTGRLPVGLAG---EVRRAVSC 687 (816)
Q Consensus 614 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~---s~ksDVwSlGviL~elltG~~Pf~~~~---~~~~~~~~ 687 (816)
|+|+...... .+.+.+|||.|.|||++.+..+ ..++|+||+||+||-+++|.+||.... ...+.+..
T Consensus 324 GlAK~~g~~s-------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~ 396 (475)
T KOG0615|consen 324 GLAKVSGEGS-------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK 396 (475)
T ss_pred chhhccccce-------ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc
Confidence 9999887544 4578899999999999977643 348899999999999999999996322 25566666
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 688 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 688 ~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
|.+... +..-..++++..+||.+||..||++||++.++|.+
T Consensus 397 G~y~f~-----p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 397 GRYAFG-----PLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred Cccccc-----ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 765432 12234578899999999999999999999976643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=362.45 Aligned_cols=238 Identities=29% Similarity=0.393 Sum_probs=203.6
Q ss_pred hcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc---cHHHHHHHHHHHhcCCCCceeeEeccccC--Cccce
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 541 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 541 (816)
.++|.+.+.||+|+||.||.++.. ++.+|+|++++.... ......+|..||..++||+||+++..|++ .+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 356899999999999999999764 889999999887543 34568899999999999999999999954 59999
Q ss_pred eeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
++|+.||.|..+|.+.. .+++..+.-++.+|+.||.|||+.+ ||||||||+|||||.+|+++|+|||+|+..-.
T Consensus 104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999998765 4777888899999999999999988 99999999999999999999999999996554
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChH--HHHHHhhcCccccccCCCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAG 699 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~--~~~~~~~~~~~~~~~d~~~~ 699 (816)
... .+...+||+.|||||++.+.+|+..+|+|||||++|||++|.+||...+ .....+..+++.
T Consensus 178 ~~~------~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~-------- 243 (357)
T KOG0598|consen 178 DGD------ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLP-------- 243 (357)
T ss_pred CCC------ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC--------
Confidence 432 2355799999999999999999999999999999999999999997544 344455555422
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCC
Q 003481 700 DWPTFVARRLVDLGLQCCELYGRERPD 726 (816)
Q Consensus 700 ~~~~~~~~~l~~Li~~cl~~dP~~RPs 726 (816)
..|...+....+|+.+.|..||.+|-.
T Consensus 244 ~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 244 LPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred CCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 234446678999999999999999963
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=376.93 Aligned_cols=249 Identities=33% Similarity=0.512 Sum_probs=210.3
Q ss_pred CccceeeeecceEEEEEEEcCe-EEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccCCCc
Q 003481 473 SESFKVGQGGFGCVYKGEMLGR-TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGS 549 (816)
Q Consensus 473 ~~~~~LG~G~~g~Vy~~~~~g~-~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gs 549 (816)
...+.||+|-||.||.|.+++. .||+|.++.... ....|.+|+.+|.+|+|+|||+|+|+|.. ..+||||||+.|+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 3456799999999999999976 899999987643 34578899999999999999999999954 3799999999999
Q ss_pred hhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCc
Q 003481 550 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 629 (816)
Q Consensus 550 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 629 (816)
|.++|.... ...+...+.+.++.|||.|++||++++ +|||||...||||++++.+||+|||+|+...++...
T Consensus 288 Ll~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~---- 359 (468)
T KOG0197|consen 288 LLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT---- 359 (468)
T ss_pred HHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee----
Confidence 999998733 356888999999999999999999988 999999999999999999999999999955544321
Q ss_pred cccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCCh--HHHHHHhhcCccccccCCCCCCCCHHHH
Q 003481 630 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLA--GEVRRAVSCGKLSSILDPLAGDWPTFVA 706 (816)
Q Consensus 630 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~--~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 706 (816)
......-..-|.|||.+..+.++.|||||||||+||||+| |+.||... .++...+..|... ..|..++
T Consensus 360 -~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRl--------p~P~~CP 430 (468)
T KOG0197|consen 360 -ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRL--------PRPEGCP 430 (468)
T ss_pred -ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcC--------CCCCCCC
Confidence 2233345567999999999999999999999999999999 99998644 3455666666432 3356677
Q ss_pred HHHHHHHHHhhccCCCCCCCChHHHHHHHHHhhh
Q 003481 707 RRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740 (816)
Q Consensus 707 ~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~~ 740 (816)
..+.+|+..||+.+|++|||+. .|...|+.+..
T Consensus 431 ~~vY~lM~~CW~~~P~~RPtF~-~L~~~l~~~~~ 463 (468)
T KOG0197|consen 431 DEVYELMKSCWHEDPEDRPTFE-TLREVLEDFFT 463 (468)
T ss_pred HHHHHHHHHHhhCCcccCCCHH-HHHHHHHHhhh
Confidence 8999999999999999999999 78888877643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=359.67 Aligned_cols=246 Identities=24% Similarity=0.290 Sum_probs=197.9
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCccc---HHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++|..+..||+|+||.||+++-. |..+|+|++++..+.. ...+..|-++|....+|+||+||..|.+ .+||||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 46788889999999999999764 9999999999876643 3457889999999999999999999955 589999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||++||++..+|.+.+ .|+...+..++.+++.|+..||+.| +|||||||+|+|||..|++||+|||||.-+...
T Consensus 221 EylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999998765 6888999999999999999999998 999999999999999999999999999643210
Q ss_pred CC-----------------cCCCcc------------------------ccCCCCCCCCCCCccccccCCCCcchhHhHH
Q 003481 623 TL-----------------YLPSFH------------------------RSTAPKGSFPYADPEYHRTGVLTPKSDSYSF 661 (816)
Q Consensus 623 ~~-----------------~~~~~~------------------------~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSl 661 (816)
.. ....+. .....+|||.|||||++.+..|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 00 000000 0114689999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCChH--HHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCC
Q 003481 662 GLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDI 727 (816)
Q Consensus 662 GviL~elltG~~Pf~~~~--~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~ 727 (816)
|||+||||.|.+||.... ..+..+...+.. +.-|. ....+.+..+||.+||. ||.+|-..
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~-l~fP~----~~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRET-LKFPE----EVDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh-ccCCC----cCcccHHHHHHHHHHhc-CHHHhcCc
Confidence 999999999999996433 344433332211 10111 11244789999999999 99999883
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=366.33 Aligned_cols=251 Identities=28% Similarity=0.365 Sum_probs=208.6
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc---cHHHHHHHHHHHhcC-CCCceeeEeccccC--Cccce
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLV 541 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~---~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV 541 (816)
++|.+++.||.|+|++||+|+.. ++.||||++.+.... ..+.+..|-.+|.+| .||.|++||..|.+ .+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 56888889999999999999875 899999999776432 234577899999999 89999999999965 49999
Q ss_pred eeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
+||+++|+|.++|.+.+ .|++.....++.+|+.||+|||++| ||||||||+|||||.|+++||+|||.|+.+++
T Consensus 153 Le~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 99999999999998775 5788888999999999999999998 99999999999999999999999999999875
Q ss_pred CCCc-----CCC--ccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCcccccc
Q 003481 622 DTLY-----LPS--FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSIL 694 (816)
Q Consensus 622 ~~~~-----~~~--~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 694 (816)
.... ... .......+||..|.+||++..+..++.+|+|+||||||+|+.|++||...++..-.- ++.
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq---kI~--- 300 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ---KIQ--- 300 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH---HHH---
Confidence 4332 111 111256899999999999999999999999999999999999999998766532211 111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 695 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 695 d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
...-.||...++...+|+.+.|..||.+|++..++-.|
T Consensus 301 -~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 301 -ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred -HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11234566666889999999999999999999754443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=354.46 Aligned_cols=257 Identities=29% Similarity=0.457 Sum_probs=209.5
Q ss_pred hcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccc--cC--Ccccee
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PE--AWSLVY 542 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~--~~~lV~ 542 (816)
..+|...+.||+|+||.||++... |...|||.+...+....+.+.+|+.+|++++|||||+++|.. .+ .++++|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 346778889999999999999886 799999998766433356688999999999999999999963 34 488999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecC-CCCeeEeecccceeccC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-ELSSKICDFGICRLVTE 621 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~~~~ 621 (816)
||+++|+|.+++.+.+. .|++..+..+..||+.||.|||+++ ||||||||+||||+. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999987764 6999999999999999999999987 999999999999999 79999999999987764
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCC-CCcchhHhHHHHHHHHHHhCCCCCCCh-HHHHHHhhcCccccccCCCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGV-LTPKSDSYSFGLIILQLLTGRLPVGLA-GEVRRAVSCGKLSSILDPLAG 699 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~-~~~~~~~~~~~~~~~~d~~~~ 699 (816)
... .........||+.|||||++..+. ..+++|||||||+++||+||++||... ......+..+.-. ..+
T Consensus 171 ~~~---~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-----~~P 242 (313)
T KOG0198|consen 171 KGT---KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-----SLP 242 (313)
T ss_pred ccc---cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-----CCC
Confidence 111 112345678999999999998643 345999999999999999999999752 2222222222111 223
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 700 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 700 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
.+|...+....+++.+|+..+|.+|||+.+.|.+.+...
T Consensus 243 ~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 243 EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 667778889999999999999999999998777776543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=335.42 Aligned_cols=230 Identities=29% Similarity=0.407 Sum_probs=202.8
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCccc---HHHHHHHHHHHhcCCCCceeeEeccccC--Cccceee
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 543 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 543 (816)
+|.....||.|+||.|.+++.. |..+|+|++.+...-. .+...+|..+|+.+.||++++|++.|.+ ..++|||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 4667788999999999999886 8899999998775543 3457799999999999999999998855 4899999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
|++||.|..+|.+.+ +++.+.+.-++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+.+...
T Consensus 125 yv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 125 YVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred ccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 999999999998765 5888999999999999999999988 999999999999999999999999999998653
Q ss_pred CcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCCCC
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDW 701 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~ 701 (816)
+.+.+|||.|+|||++...+|+.++|+|||||++|||+.|.+||..... +...+..|++ .+
T Consensus 198 --------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v---------~f 260 (355)
T KOG0616|consen 198 --------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV---------KF 260 (355)
T ss_pred --------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc---------cC
Confidence 3567899999999999999999999999999999999999999975543 4455555544 46
Q ss_pred CHHHHHHHHHHHHHhhccCCCCC
Q 003481 702 PTFVARRLVDLGLQCCELYGRER 724 (816)
Q Consensus 702 ~~~~~~~l~~Li~~cl~~dP~~R 724 (816)
|...+..+.+|+...|+.|-.+|
T Consensus 261 P~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 261 PSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CcccCHHHHHHHHHHHhhhhHhh
Confidence 77788899999999999999999
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=336.60 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=200.0
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYE 543 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E 543 (816)
+.|+...++|+|+||.||++++. |+.||||++..... .-.+-..+|+++|++|+|+|+|.|+.+|. ..++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35777889999999999999885 99999999865433 22344679999999999999999999994 45899999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceecc-CC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT-ED 622 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~-~~ 622 (816)
||+..-|.+ |.... ..++...+.+++.|++.|+.|+|+++ +|||||||+||||+.+|.+||||||+|+.+. ++
T Consensus 82 ~~dhTvL~e-Le~~p--~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 82 YCDHTVLHE-LERYP--NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred ecchHHHHH-HHhcc--CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 997755544 44433 35788999999999999999999998 9999999999999999999999999999987 43
Q ss_pred CCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhc----Cc--------
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----GK-------- 689 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~----~~-------- 689 (816)
. ..+..+.|.+|.|||.+.+ -+|+..+||||+||++.||++|.+.|.+..++.+.... |.
T Consensus 156 d-------~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 156 D-------NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred c-------hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHH
Confidence 3 2467789999999998877 68999999999999999999999999776665543211 11
Q ss_pred ------cccccCCCC-------CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 690 ------LSSILDPLA-------GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 690 ------~~~~~d~~~-------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
+..+.-|.. ..+| ..+.-+.+|+..||+.||.+|++..+.+.+
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 111111111 1122 345578999999999999999999876544
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=362.36 Aligned_cols=249 Identities=27% Similarity=0.418 Sum_probs=213.2
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccc--cCCccceeeccC
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLP 546 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~E~~~ 546 (816)
.|....+||+|..|.||.+... +..||||++........+-+.+|+.+|+..+|+|||.++..| .+.+++|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 3555568999999999999775 788999999888777777789999999999999999999887 567999999999
Q ss_pred CCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcC
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626 (816)
Q Consensus 547 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 626 (816)
||+|.|.+... .+++.++..|+.+++.||+|||..+ |+|||||.+||||+.+|.+||+|||+|..+.....
T Consensus 354 ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 354 GGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred CCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 99999988553 4899999999999999999999988 99999999999999999999999999998876542
Q ss_pred CCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH--hhcCccccccCCCCCCCCHH
Q 003481 627 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCGKLSSILDPLAGDWPTF 704 (816)
Q Consensus 627 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~--~~~~~~~~~~d~~~~~~~~~ 704 (816)
.....+|||+|||||+.....|++|.||||||++++||+-|.+||-..+.++.. +...... .-..+..
T Consensus 425 ----KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P------~lk~~~k 494 (550)
T KOG0578|consen 425 ----KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP------KLKNPEK 494 (550)
T ss_pred ----ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCC------CcCCccc
Confidence 457789999999999999999999999999999999999999999644443322 2211111 1234667
Q ss_pred HHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 705 VARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 705 ~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
++..|.+++.+||+.|+.+||++.++|.+.+-.+
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence 8899999999999999999999998887776544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=355.77 Aligned_cols=247 Identities=29% Similarity=0.385 Sum_probs=211.7
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 543 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 543 (816)
++|.+.+.||+|+||.||+|+.. .+.||||.+.+.... ....+.+|++|++.++|||||.++.+|+. +.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46888889999999999999875 688999999765433 34568899999999999999999999965 5899999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
|+.| +|..+|.... .++++.+..|+.+++.||.|||+++ |+|||+||.||||+.+|++|+||||+|+......
T Consensus 82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9976 9999997765 4889999999999999999999988 9999999999999999999999999999887644
Q ss_pred CcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCH
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPT 703 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 703 (816)
. ..+...|||.|||||...+++|+..+|.||+|||||||++|++||.. ..+...+.. +-.....||.
T Consensus 155 ~------vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~------I~~d~v~~p~ 221 (808)
T KOG0597|consen 155 S------VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKS------ILKDPVKPPS 221 (808)
T ss_pred e------eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHH------HhcCCCCCcc
Confidence 2 45778899999999999999999999999999999999999999953 223222211 1112235777
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 704 FVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 704 ~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
..+..+.+++...|.+||..|.+..+.+-|.+-
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~ 254 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFW 254 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHhcChHH
Confidence 899999999999999999999999987777663
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=357.63 Aligned_cols=255 Identities=29% Similarity=0.455 Sum_probs=203.7
Q ss_pred hcCCCccceeeeecceEEEEEEEc-------CeEEEEEEeccCCc-ccHHHHHHHHHHHhcC-CCCceeeEeccccC---
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--- 536 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~-------g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--- 536 (816)
.++|.+.+.||+|+||.||+|.+. +..||+|++..... .....+.+|+.+|.++ +||||++++|+|..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 467889999999999999999752 46799999875432 2345688999999999 89999999998843
Q ss_pred CccceeeccCCCchhhhhhhcCC---------------------------------------------------------
Q 003481 537 AWSLVYEYLPNGSLQDRLFRKSN--------------------------------------------------------- 559 (816)
Q Consensus 537 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 559 (816)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 36899999999999999875321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCccccCCCCC
Q 003481 560 --VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG 637 (816)
Q Consensus 560 --~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~g 637 (816)
..++++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........ .......+
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~----~~~~~~~~ 238 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----VRKGSARL 238 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcch----hcccCCCC
Confidence 135889999999999999999999987 999999999999999999999999999876433211 12234456
Q ss_pred CCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChH---HHHHHhhcCccccccCCCCCCCCHHHHHHHHHHH
Q 003481 638 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG---EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLG 713 (816)
Q Consensus 638 t~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~---~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li 713 (816)
++.|+|||++.+..++.++|||||||+||||++ |..||.... .....+..+... ..+...+..+.+|+
T Consensus 239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li 310 (338)
T cd05102 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM--------RAPENATPEIYRIM 310 (338)
T ss_pred CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC--------CCCCCCCHHHHHHH
Confidence 788999999998999999999999999999997 999996432 222222222211 12334556899999
Q ss_pred HHhhccCCCCCCCChHHHHHHHHHhh
Q 003481 714 LQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 714 ~~cl~~dP~~RPs~~e~l~~~Le~l~ 739 (816)
.+||+.||.+||++. ++++.|+.+.
T Consensus 311 ~~cl~~dp~~RPs~~-el~~~l~~~~ 335 (338)
T cd05102 311 LACWQGDPKERPTFS-ALVEILGDLL 335 (338)
T ss_pred HHHccCChhhCcCHH-HHHHHHHHHH
Confidence 999999999999999 7888888653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=345.16 Aligned_cols=256 Identities=18% Similarity=0.259 Sum_probs=207.2
Q ss_pred cCcccCHHHHHHHhcCCCccceeeeecceEEEEEEEcCeEEEEEEeccCCccc---HHHHHHHHHHHhcCCCCceeeEec
Q 003481 456 ESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQHPHLVTLLG 532 (816)
Q Consensus 456 ~~~~~~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~g 532 (816)
..+.++..+| +......||+|++|.||+|.+.|+.||||++....... ...|.+|+.+|.+++||||++++|
T Consensus 11 ~~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 11 DIKCIESDDI-----DKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred cceecCHHHc-----CCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 3445666666 33333679999999999999999999999997654433 356889999999999999999999
Q ss_pred cccC------CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCceeeCCCCCCceEecCC
Q 003481 533 ACPE------AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS-KPEKIVHGDLKPQNILLDSE 605 (816)
Q Consensus 533 ~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~ivHrDIkp~NILl~~~ 605 (816)
+|.+ ..++||||+++|+|.+++.... .++|...+.++.+++.||.|||+. + ++||||||+|||++.+
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~ 159 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTEN 159 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCC
Confidence 8844 3679999999999999997643 588999999999999999999985 5 8899999999999999
Q ss_pred CCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCcccccc--CCCCcchhHhHHHHHHHHHHhCCCCCCChH--HH
Q 003481 606 LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT--GVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EV 681 (816)
Q Consensus 606 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVwSlGviL~elltG~~Pf~~~~--~~ 681 (816)
+.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.... .+
T Consensus 160 ~~~kl~dfg~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~ 230 (283)
T PHA02988 160 YKLKIICHGLEKILSSPP---------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI 230 (283)
T ss_pred CcEEEcccchHhhhcccc---------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 999999999988654321 23468899999999876 689999999999999999999999997543 22
Q ss_pred HHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhh
Q 003481 682 RRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 682 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~ 739 (816)
...+..+... ...+...+..+.+|+.+||+.||.+||++. ++++.|+.+.
T Consensus 231 ~~~i~~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~-ell~~l~~~~ 280 (283)
T PHA02988 231 YDLIINKNNS-------LKLPLDCPLEIKCIVEACTSHDSIKRPNIK-EILYNLSLYK 280 (283)
T ss_pred HHHHHhcCCC-------CCCCCcCcHHHHHHHHHHhcCCcccCcCHH-HHHHHHHHHH
Confidence 2222222111 112334567899999999999999999999 7888888764
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=357.64 Aligned_cols=262 Identities=29% Similarity=0.481 Sum_probs=207.2
Q ss_pred HHHHHHhcCCCccceeeeecceEEEEEEEcCeEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCCceeeEeccccC-Ccc
Q 003481 463 ADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWS 539 (816)
Q Consensus 463 ~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~ 539 (816)
.+.....+.+.+...||+|.||+||+|.|.| .||||+++..... ..+.|++|+.+|++-+|-||+-++|||-+ ...
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~A 463 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLA 463 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCcee
Confidence 3334444555667889999999999999987 6999999877654 34579999999999999999999999944 468
Q ss_pred ceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceec
Q 003481 540 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 619 (816)
Q Consensus 540 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 619 (816)
||..+|.|.+|+.+|+-.. ..|.....+.|+.|||+|+.|||..+ |||||||..||||.++++|||+|||++...
T Consensus 464 IiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred eeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeee
Confidence 9999999999999998765 46888999999999999999999987 999999999999999999999999999765
Q ss_pred cCCCCcCCCccccCCCCCCCCCCCcccccc---CCCCcchhHhHHHHHHHHHHhCCCCCCChH--HHHHHhhcCcccccc
Q 003481 620 TEDTLYLPSFHRSTAPKGSFPYADPEYHRT---GVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSIL 694 (816)
Q Consensus 620 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVwSlGviL~elltG~~Pf~~~~--~~~~~~~~~~~~~~~ 694 (816)
.... .........|...|||||+++. .+|++.+|||||||++|||+||..||.... .+..++-.|.+.
T Consensus 539 ~~w~----g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~--- 611 (678)
T KOG0193|consen 539 TRWS----GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLM--- 611 (678)
T ss_pred eeec----cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccC---
Confidence 4331 1123355668899999998864 479999999999999999999999997222 222222223221
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 695 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 695 d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
+.........+.++.+|+..||..++++||.+.+++...++.+
T Consensus 612 -pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~ 654 (678)
T KOG0193|consen 612 -PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELL 654 (678)
T ss_pred -ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhh
Confidence 1111223346678999999999999999999995444444433
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=342.34 Aligned_cols=261 Identities=22% Similarity=0.293 Sum_probs=211.5
Q ss_pred hcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccH-HHHHHHHHHHhcCCCCceeeEeccc--cCCccceee
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ-LEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYE 543 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~-~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~E 543 (816)
.+.|.....||.|..++||+|+.. +..||||++........ ..+.+|+..|+.++||||++++..| .+.+++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 457899999999999999999885 89999999987765544 7789999999999999999999988 456899999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
||.+||+.+++...-. ..+++..+..|+.+++.||.|||.+| .||||||+.||||+.+|.|||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999999999976543 34889999999999999999999998 9999999999999999999999999887765543
Q ss_pred CcCCCccccCCCCCCCCCCCccccc--cCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH--hhcCccccccCC-CC
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHR--TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCGKLSSILDP-LA 698 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~--~~~~~~~~~~d~-~~ 698 (816)
.... ......+||++|||||++. ...|+.|+||||||++.+||.+|..||......... ...+........ ..
T Consensus 181 -~R~~-~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~ 258 (516)
T KOG0582|consen 181 -DRQV-TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD 258 (516)
T ss_pred -ceee-EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC
Confidence 1111 1226779999999999853 347999999999999999999999999855543322 223332222110 11
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 699 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 699 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
.+.....+..+.+++..||+.||.+|||+.+.+.+.+
T Consensus 259 ~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~F 295 (516)
T KOG0582|consen 259 KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAF 295 (516)
T ss_pred hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHH
Confidence 1222345668999999999999999999998776665
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=355.56 Aligned_cols=247 Identities=28% Similarity=0.416 Sum_probs=206.0
Q ss_pred HHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccC----Cc-ccHHHHHHHHHHHhcCC-CCceeeEeccc--c
Q 003481 466 QTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSH----NM-QGQLEFQQEVRVLSKLQ-HPHLVTLLGAC--P 535 (816)
Q Consensus 466 ~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~----~~-~~~~~~~~E~~il~~l~-HpnIv~l~g~~--~ 535 (816)
....++|...+.||+|+||.|+.|... +..||+|++... .. .....+.+|+.++++++ ||||++++.++ .
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 345678999999999999999999875 899999977664 11 23445678999999998 99999999998 4
Q ss_pred CCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCC-CCeeEeecc
Q 003481 536 EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFG 614 (816)
Q Consensus 536 ~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DFG 614 (816)
...++||||+.||+|.+++...+ ++.+.....++.|++.|+.|||+.+ |+||||||+||||+.+ +++||+|||
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccc
Confidence 46999999999999999998743 5888999999999999999999988 9999999999999999 999999999
Q ss_pred cceecc-CCCCcCCCccccCCCCCCCCCCCccccccCC-CC-cchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCc
Q 003481 615 ICRLVT-EDTLYLPSFHRSTAPKGSFPYADPEYHRTGV-LT-PKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGK 689 (816)
Q Consensus 615 la~~~~-~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s-~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~ 689 (816)
++.... .+. .....+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||...+.. ...+..+.
T Consensus 167 ~s~~~~~~~~-------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~ 239 (370)
T KOG0583|consen 167 LSAISPGEDG-------LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGE 239 (370)
T ss_pred cccccCCCCC-------cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCC
Confidence 999873 322 346778999999999999877 75 7999999999999999999999864432 22222222
Q ss_pred cccccCCCCCCCCHHH-HHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 690 LSSILDPLAGDWPTFV-ARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 690 ~~~~~d~~~~~~~~~~-~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
+ .+|... +..+..|+.+||..||..|+++.+.+.+.
T Consensus 240 ~---------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~ 276 (370)
T KOG0583|consen 240 F---------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHP 276 (370)
T ss_pred c---------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhCh
Confidence 2 344445 88999999999999999999999655433
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=355.15 Aligned_cols=233 Identities=28% Similarity=0.470 Sum_probs=197.5
Q ss_pred ceeeeecceEEEEEEEcCeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccCC--ccceeeccCCCchhhh
Q 003481 476 FKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEA--WSLVYEYLPNGSLQDR 553 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV~E~~~~gsL~~~ 553 (816)
..||.|+.|.||+|++.+..||||+++.-. ..+++-|++|+||||+.|.|+|... +|||||||..|-|..+
T Consensus 130 eWlGSGaQGAVF~Grl~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V 202 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLHNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV 202 (904)
T ss_pred hhhccCcccceeeeeccCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence 579999999999999999999999875322 2478889999999999999999664 7899999999999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCccccC
Q 003481 554 LFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 633 (816)
Q Consensus 554 l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 633 (816)
|.... +++-.....|..+||.|+.|||.++ |||||||.-||||..+..|||+|||.++...... ...
T Consensus 203 Lka~~---~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S-------TkM 269 (904)
T KOG4721|consen 203 LKAGR---PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS-------TKM 269 (904)
T ss_pred HhccC---ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh-------hhh
Confidence 97654 5677888999999999999999998 9999999999999999999999999998876543 245
Q ss_pred CCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHH
Q 003481 634 APKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLG 713 (816)
Q Consensus 634 ~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li 713 (816)
.++||..|||||++.+.+.+.|+|||||||||||||||..||...+.. ++.-|.-...+ ....|..+++.|.-|+
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss--AIIwGVGsNsL---~LpvPstcP~GfklL~ 344 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS--AIIWGVGSNSL---HLPVPSTCPDGFKLLL 344 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh--eeEEeccCCcc---cccCcccCchHHHHHH
Confidence 678999999999999999999999999999999999999999766552 22222111111 2234667778999999
Q ss_pred HHhhccCCCCCCCChHHHHH
Q 003481 714 LQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 714 ~~cl~~dP~~RPs~~e~l~~ 733 (816)
++||+..|..||++++++.+
T Consensus 345 Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 345 KQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred HHHHhcCCCCCccHHHHHHH
Confidence 99999999999999965544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=349.83 Aligned_cols=256 Identities=26% Similarity=0.341 Sum_probs=208.2
Q ss_pred HhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHH-HHHHHHHHHhcCC-CCceeeEeccccC---Cccc
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL-EFQQEVRVLSKLQ-HPHLVTLLGACPE---AWSL 540 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~-~~~~E~~il~~l~-HpnIv~l~g~~~~---~~~l 540 (816)
.-++|...++||.|.||.||+|+.. |..||||.++..-....+ --.+|+..|++|+ |||||+|..++.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 3467888999999999999999875 889999999765433222 2358999999998 9999999999843 4799
Q ss_pred eeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceecc
Q 003481 541 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 620 (816)
Q Consensus 541 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 620 (816)
|||||+ .+|.+++..+. ..+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+.+.
T Consensus 88 VfE~Md-~NLYqLmK~R~--r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDRN--RLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhcC--CcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999995 59999998774 68999999999999999999999998 9999999999999999999999999999887
Q ss_pred CCCCcCCCccccCCCCCCCCCCCcccc-ccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhc----C-------
Q 003481 621 EDTLYLPSFHRSTAPKGSFPYADPEYH-RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----G------- 688 (816)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~----~------- 688 (816)
... ..+..+.|.+|.|||++ +.+.|+.+.|+||+|||++|+.+-++.|.+.+++++.+.. |
T Consensus 162 Skp-------PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 162 SKP-------PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred cCC-------CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence 654 34677899999999965 6678999999999999999999999999877766554321 1
Q ss_pred ----ccccccC---CC-----CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 689 ----KLSSILD---PL-----AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 689 ----~~~~~~d---~~-----~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
.+...+. |. ....-...+.++.+|+.+||.+||.+|||+.+.+.+.+=
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pff 294 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFF 294 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccc
Confidence 0111111 10 111112367789999999999999999999977766553
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=347.16 Aligned_cols=254 Identities=26% Similarity=0.378 Sum_probs=203.9
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCCceeeEecccc----CCccce
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACP----EAWSLV 541 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~----~~~~lV 541 (816)
+.|..+.+||+|.||.||++++. |+.||+|++..+... ......+||.||++|+||||++|.+... ...|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 45677788999999999999985 889999999887643 3345679999999999999999999863 358999
Q ss_pred eeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
+|||+. +|.-++.... -.|+..++..++.||+.||.|||..+ |+|||||.+|||||.+|.+||+|||+|+.+..
T Consensus 197 FeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999965 8888775543 35899999999999999999999988 99999999999999999999999999998765
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhh----cCc-------
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGK------- 689 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~----~~~------- 689 (816)
.... ..+..+-|+.|.|||++.+. .|++++|+||.||||.||++|++.|....++.+.-. +|.
T Consensus 271 ~~~~-----~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 271 SGSA-----PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred CCCc-----ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence 5421 35778899999999987664 799999999999999999999999987776654321 121
Q ss_pred ---cc--cccCCCCCCCCH-------HHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 690 ---LS--SILDPLAGDWPT-------FVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 690 ---~~--~~~d~~~~~~~~-------~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
+. ..+.+. ..+.. ..+....+|+..+|..||.+|.|+.+.|...+
T Consensus 346 ~~kLP~~~~~kp~-~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~sey 402 (560)
T KOG0600|consen 346 VSKLPHATIFKPQ-QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEY 402 (560)
T ss_pred cccCCcccccCCC-CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcc
Confidence 11 011110 11111 23456789999999999999999997665543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=353.12 Aligned_cols=245 Identities=29% Similarity=0.444 Sum_probs=211.6
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
+-|..++.||.|+.|.|-+|++. |+.+|||++.+... .....+.+|+-+|+.+.|||+++||+++.+ ++|||+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 34778889999999999999885 99999999977632 223457899999999999999999999855 589999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++|-|.++|..++ ++++.+..+++.||+.|+.|+|..+ |+||||||+|+|||.++++||+|||+|..-.++
T Consensus 92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999998876 5888999999999999999999998 999999999999999999999999999887666
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccCCC-CcchhHhHHHHHHHHHHhCCCCCCChH--HHHHHhhcCccccccCCCCC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVL-TPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAG 699 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGviL~elltG~~Pf~~~~--~~~~~~~~~~~~~~~d~~~~ 699 (816)
.. -.+.+|.|.|.+||++.+.+| +.++||||+|||||.||||+.||+..+ .+...+..|.+
T Consensus 166 kl-------LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f--------- 229 (786)
T KOG0588|consen 166 KL-------LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF--------- 229 (786)
T ss_pred cc-------ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc---------
Confidence 53 356689999999999999988 479999999999999999999997332 23334455554
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 700 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 700 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
+.|.+++.+..+|+.+|+..||..|.|+.+++.|.+-
T Consensus 230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l 266 (786)
T KOG0588|consen 230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFL 266 (786)
T ss_pred cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchh
Confidence 3466788899999999999999999999988877764
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.22 Aligned_cols=241 Identities=25% Similarity=0.343 Sum_probs=195.3
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceee
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYE 543 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E 543 (816)
.|...+.||+|+||.||++.+. |..||+|.+..... .....+.+|+.++.+++|+||++++++|. +..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3777889999999999999874 88999999865432 22345789999999999999999999874 35889999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999999988865432 35899999999999999999999987 9999999999999999999999999998764332
Q ss_pred CcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCccccccCCCCCCC
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDW 701 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~~~ 701 (816)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+... +......+
T Consensus 157 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-----~~~~~~~~ 224 (285)
T cd05631 157 -------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR-----VKEDQEEY 224 (285)
T ss_pred -------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH-----hhcccccC
Confidence 123456999999999999999999999999999999999999999743321 0111100 01111234
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCC
Q 003481 702 PTFVARRLVDLGLQCCELYGRERPDI 727 (816)
Q Consensus 702 ~~~~~~~l~~Li~~cl~~dP~~RPs~ 727 (816)
+...+..+.+|+.+||+.||.+||+.
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~ 250 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGC 250 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCC
Confidence 44566789999999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=340.98 Aligned_cols=247 Identities=26% Similarity=0.344 Sum_probs=207.2
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCceeeEeccc--cCCccceeecc
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYL 545 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~E~~ 545 (816)
.|+....||+|.||.||+|.+. ++.||||++...... ..+.+++|+.+|.+++++||.++||.+ ...++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 4666678999999999999986 889999999876544 456789999999999999999999987 44588999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
.||++.+.|.... .+.+..+.-|+.+++.||.|||..+ .+|||||+.||||..+|.+||+|||.+..+.....
T Consensus 94 ~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~- 166 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK- 166 (467)
T ss_pred cCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh-
Confidence 9999999986543 3467778889999999999999988 99999999999999999999999999988876542
Q ss_pred CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHH
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 705 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 705 (816)
+....+||+.|||||++....|+.|+||||||++.+||.+|.+|+......+ .+.-+.....+.+....
T Consensus 167 -----rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr------vlflIpk~~PP~L~~~~ 235 (467)
T KOG0201|consen 167 -----RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR------VLFLIPKSAPPRLDGDF 235 (467)
T ss_pred -----ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce------EEEeccCCCCCcccccc
Confidence 3477899999999999998899999999999999999999999997554421 11111112233344467
Q ss_pred HHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 706 ARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 706 ~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
++.+.+++..||+.||+.||++.+.|.+.+
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~LLKh~F 265 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKELLKHKF 265 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhhHH
Confidence 788999999999999999999998776655
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=366.38 Aligned_cols=254 Identities=30% Similarity=0.503 Sum_probs=215.9
Q ss_pred CCCccceeeeecceEEEEEEEc-------CeEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCceeeEeccccC--Cccc
Q 003481 471 NFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 540 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~-------g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 540 (816)
+....+.||+|.||.||+|+.. ...||||.++..... .+.+|++|+++|..|+|||||+|+|+|.+ ..++
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 3455567999999999999875 356999999887665 77899999999999999999999999954 4899
Q ss_pred eeeccCCCchhhhhhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCee
Q 003481 541 VYEYLPNGSLQDRLFRKSN-----------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSK 609 (816)
Q Consensus 541 V~E~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 609 (816)
|+|||..|+|.++|..... .++|+..+.+.|+.|||.|+.||-++. +|||||-..|+||.++..||
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEE
Confidence 9999999999999975431 234899999999999999999999998 99999999999999999999
Q ss_pred EeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCC--hHHHHHHhh
Q 003481 610 ICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGL--AGEVRRAVS 686 (816)
Q Consensus 610 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~--~~~~~~~~~ 686 (816)
|+|||+++.+-..+.+. ......-...|||||.+..++||++||||||||+|||+++ |+.||.. ..++...+.
T Consensus 644 IsDfGLsRdiYssDYYk----~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~ 719 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYK----VRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR 719 (774)
T ss_pred ecccccchhhhhhhhhc----ccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence 99999999775544331 1224445678999999999999999999999999999999 9999863 446777788
Q ss_pred cCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhhh
Q 003481 687 CGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740 (816)
Q Consensus 687 ~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~~ 740 (816)
.|++. ..|...+..+..|+..||+.+|.+||++. ++-..|+....
T Consensus 720 ~g~lL--------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~-eI~~~L~~~~~ 764 (774)
T KOG1026|consen 720 AGQLL--------SCPENCPTEVYSLMLECWNENPKRRPSFK-EIHSRLQAWAQ 764 (774)
T ss_pred cCCcc--------cCCCCCCHHHHHHHHHHhhcCcccCCCHH-HHHHHHHHHHh
Confidence 88763 34666778999999999999999999999 78888887643
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=352.95 Aligned_cols=238 Identities=26% Similarity=0.383 Sum_probs=203.0
Q ss_pred HhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcC-CCCceeeEeccc--cCCcc
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGAC--PEAWS 539 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~g~~--~~~~~ 539 (816)
.-++|.....||+|.||+|+++.+. ++.+|||++++... .+.+....|.+|+... +||.++.|+.+| .++.|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3467999999999999999999886 67899999998865 3455677898888887 599999999999 45799
Q ss_pred ceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceec
Q 003481 540 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 619 (816)
Q Consensus 540 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 619 (816)
+||||+.||++..+... ..+++..+.-++..|+.||.|||+++ |||||||.+|||||.+|++||+|||+++..
T Consensus 446 fvmey~~Ggdm~~~~~~----~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHT----DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEecCCCcEEEEEec----ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 99999999996554432 35888999999999999999999998 999999999999999999999999999976
Q ss_pred cCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCC
Q 003481 620 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPL 697 (816)
Q Consensus 620 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~ 697 (816)
.... ..+.+.+|||.|||||++.+..|+.++|+|||||+|||||+|..||...++ +...+...
T Consensus 519 m~~g------~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d--------- 583 (694)
T KOG0694|consen 519 MGQG------DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND--------- 583 (694)
T ss_pred CCCC------CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------
Confidence 5322 145778999999999999999999999999999999999999999975554 32332221
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCC
Q 003481 698 AGDWPTFVARRLVDLGLQCCELYGRERPDI 727 (816)
Q Consensus 698 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~ 727 (816)
..-||..++.+...++.++|..||++|-.+
T Consensus 584 ~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 124677889999999999999999999987
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=341.18 Aligned_cols=258 Identities=28% Similarity=0.411 Sum_probs=197.6
Q ss_pred cCCCccceeeeecceEEEEEEEc------------------CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeE
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML------------------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTL 530 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~------------------g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l 530 (816)
++|...++||+|+||.||++.+. +..||+|.+..... .....|.+|+.+|.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 56888899999999999999752 34699999876533 234578999999999999999999
Q ss_pred ecccc--CCccceeeccCCCchhhhhhhcC----------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceee
Q 003481 531 LGACP--EAWSLVYEYLPNGSLQDRLFRKS----------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592 (816)
Q Consensus 531 ~g~~~--~~~~lV~E~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivH 592 (816)
+++|. +..++||||+++|+|.+++.... ....++|..++.|+.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 99984 35899999999999999886432 1235789999999999999999999988 999
Q ss_pred CCCCCCceEecCCCCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh--
Q 003481 593 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-- 670 (816)
Q Consensus 593 rDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-- 670 (816)
|||||+|||++.++.+||+|||+++........ .......++..|+|||++..+.++.++|||||||++|+|++
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYY----RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCcee----EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 999999999999999999999999876443211 12234456889999999988899999999999999999987
Q ss_pred CCCCCCChHH--HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 671 GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 671 G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
|..||..... ....... .+...........+...+..+.+|+.+||+.+|.+||++. ++...|+
T Consensus 238 ~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~-~i~~~l~ 303 (304)
T cd05096 238 KEQPYGELTDEQVIENAGE-FFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFS-DIHAFLT 303 (304)
T ss_pred CCCCCCcCCHHHHHHHHHH-HhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHH-HHHHHHh
Confidence 5677764322 1111100 0000000000111223456899999999999999999998 5666654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=314.18 Aligned_cols=253 Identities=26% Similarity=0.360 Sum_probs=202.6
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCccc--HHHHHHHHHHHhcCCCCceeeEeccccC--Cccceee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 543 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 543 (816)
.+|...++||+|.||.||+|++. |+.||||+++.....+ .....+|++.|+.++|+||+.|+++|.. ...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 35777889999999999999986 8999999997764432 2356799999999999999999999954 5789999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
||+ .+|+..+.... ..++-.++..++.++++||+|||.+. |+||||||.|+|++.+|.+||+|||+|+.+....
T Consensus 82 fm~-tdLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 995 59999997665 46888999999999999999999988 9999999999999999999999999999987544
Q ss_pred CcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhc----C--------cc
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----G--------KL 690 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~----~--------~~ 690 (816)
. ..+..+-|..|.|||.+.+ ..|+..+|+||.|||+.||+-|.+-|.+..++.+.... | .+
T Consensus 156 ~------~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~ 229 (318)
T KOG0659|consen 156 R------IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEM 229 (318)
T ss_pred c------ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccc
Confidence 2 2233478999999997655 57999999999999999999999988766665443211 1 01
Q ss_pred ccccC---------CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 691 SSILD---------PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 691 ~~~~d---------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
..+.| +.....-...+....+|+..|+.+||.+|+++.|.+.+.
T Consensus 230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~ 282 (318)
T KOG0659|consen 230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP 282 (318)
T ss_pred cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence 11111 111111223556779999999999999999999766443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=339.88 Aligned_cols=233 Identities=26% Similarity=0.349 Sum_probs=195.6
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++|...+.||+|+||.||+|... ++.||+|++..... .....+.+|+.++.+++||||+++++++.+ ..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999886 88999999865432 234468899999999999999999998854 478999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999987643 5888999999999999999999988 999999999999999999999999998865432
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCCC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~ 700 (816)
. ....||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+. ..
T Consensus 155 ~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~---------~~ 216 (291)
T cd05612 155 T---------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK---------LE 216 (291)
T ss_pred c---------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------cC
Confidence 1 234699999999999988999999999999999999999999975432 222222222 12
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCC
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPD 726 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~cl~~dP~~RPs 726 (816)
++...+..+.+|+.+||+.||.+||+
T Consensus 217 ~~~~~~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 217 FPRHLDLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred CCccCCHHHHHHHHHHcCCCHHHccC
Confidence 34445678999999999999999996
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=347.82 Aligned_cols=234 Identities=24% Similarity=0.367 Sum_probs=196.2
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEecccc--CCcccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~ 542 (816)
++|.+.+.||+|+||.||+|++. ++.||+|++..... .....+.+|+.++.+++||||+++++++. +..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888899999999999999885 78999999875432 23456889999999999999999999884 4588999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999987643 5788999999999999999999988 999999999999999999999999999876432
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCCC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~ 700 (816)
. ....||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....+..+.+ .
T Consensus 172 ~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~---------~ 233 (329)
T PTZ00263 172 T---------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL---------K 233 (329)
T ss_pred c---------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc---------C
Confidence 2 234699999999999999999999999999999999999999965433 2222333221 2
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCC
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDI 727 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~cl~~dP~~RPs~ 727 (816)
+|...+..+.+|+.+||+.||.+||+.
T Consensus 234 ~p~~~~~~~~~li~~~L~~dP~~R~~~ 260 (329)
T PTZ00263 234 FPNWFDGRARDLVKGLLQTDHTKRLGT 260 (329)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 233355678999999999999999984
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=332.46 Aligned_cols=255 Identities=24% Similarity=0.309 Sum_probs=199.4
Q ss_pred HHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--------------ccHHHHHHHHHHHhcCCCCceeeE
Q 003481 467 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--------------QGQLEFQQEVRVLSKLQHPHLVTL 530 (816)
Q Consensus 467 ~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--------------~~~~~~~~E~~il~~l~HpnIv~l 530 (816)
..-|.|.+...||+|.||.|-+|+.. ++.||||++.+... ...+.+.+|+.+|++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34478999999999999999999886 88999999965422 123468899999999999999999
Q ss_pred ecccc----CCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCC
Q 003481 531 LGACP----EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL 606 (816)
Q Consensus 531 ~g~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~ 606 (816)
+.+.. +..|||+|||..|.+...- .....+++.++++++.++..||.|||.++ ||||||||+|+||+.+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 99874 4589999999988775532 22223899999999999999999999988 99999999999999999
Q ss_pred CeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCC----CCcchhHhHHHHHHHHHHhCCCCCCChHHHH
Q 003481 607 SSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV----LTPKSDSYSFGLIILQLLTGRLPVGLAGEVR 682 (816)
Q Consensus 607 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDVwSlGviL~elltG~~Pf~~~~~~~ 682 (816)
++||+|||.+...+.+..... .......+|||.|+|||...++. .+.+.||||+||+||.|+.|+.||.......
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~-d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGS-DDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred cEEeeccceeeecccCCcccc-HHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 999999999988754422111 11223478999999999887632 3578999999999999999999996544332
Q ss_pred H--HhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 683 R--AVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 683 ~--~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
. .+.. +|..-.-.+++.+.+.+||+++|.+||..|.++.++.++..
T Consensus 327 l~~KIvn-------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 327 LFDKIVN-------DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HHHHHhc-------CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 1 1211 12211112246789999999999999999999985544443
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=346.24 Aligned_cols=230 Identities=26% Similarity=0.319 Sum_probs=189.6
Q ss_pred ceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccCCC
Q 003481 476 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNG 548 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~g 548 (816)
+.||+|+||.||++... |+.||||++..... .....+.+|+.++.+++||||++++++|.. ..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999875 88999999975432 233467889999999999999999998843 488999999999
Q ss_pred chhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCC
Q 003481 549 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 628 (816)
Q Consensus 549 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 628 (816)
+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~----- 149 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG----- 149 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-----
Confidence 9999887543 5889999999999999999999988 9999999999999999999999999987543221
Q ss_pred ccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCccccccCCCCCCCCHHHH
Q 003481 629 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPTFVA 706 (816)
Q Consensus 629 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~~~~~~~~ 706 (816)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.. ...+..+. ..+|...+
T Consensus 150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~---------~~~p~~~~ 219 (323)
T cd05571 150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---------IRFPRTLS 219 (323)
T ss_pred -CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC---------CCCCCCCC
Confidence 1123456999999999999999999999999999999999999999654321 12222111 13344567
Q ss_pred HHHHHHHHHhhccCCCCCCC
Q 003481 707 RRLVDLGLQCCELYGRERPD 726 (816)
Q Consensus 707 ~~l~~Li~~cl~~dP~~RPs 726 (816)
..+.+|+.+||+.||.+||+
T Consensus 220 ~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 220 PEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred HHHHHHHHHHccCCHHHcCC
Confidence 78999999999999999994
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=340.71 Aligned_cols=254 Identities=23% Similarity=0.340 Sum_probs=200.6
Q ss_pred hcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceee
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYE 543 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E 543 (816)
.++|...+.||+|+||.||++++. +..||+|.+..... .....+.+|+.+|.+++||||+++++++. +..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367899999999999999999986 78899999876432 23456899999999999999999999884 35899999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
|+++|+|.+++.... .+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 999999999986643 5888999999999999999999853 39999999999999999999999999987664322
Q ss_pred CcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCcc-------cc--
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKL-------SS-- 692 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~-------~~-- 692 (816)
.....||+.|+|||++.+..++.++|||||||++|+|+||+.||..... ....+..... ..
T Consensus 159 --------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 159 --------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred --------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccC
Confidence 2345699999999999998999999999999999999999999964332 1111110000 00
Q ss_pred -----------------------------ccCCCCCCC-CHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 693 -----------------------------ILDPLAGDW-PTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 693 -----------------------------~~d~~~~~~-~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
+........ ...++..+.+|+.+||+.||++||++.+.+.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 000000000 1135678999999999999999999997665544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=327.41 Aligned_cols=244 Identities=25% Similarity=0.393 Sum_probs=210.3
Q ss_pred hcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHH---HHHHHHHHHhcCCCCceeeEeccccC--Cccce
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL---EFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 541 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~---~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 541 (816)
..+|.+.+.||+|.||.|-++... |+.||||.++++...+.. .+.+|++||+.|+||||+.+|.+|++ ...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 457888899999999999999774 999999999888665544 57899999999999999999999965 58899
Q ss_pred eeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
|||..+|.|+|++.... .|++.+...++.||.+|+.|+|.++ ++|||||.+|||||.|+++||+|||++..+..
T Consensus 132 MEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999998775 5899999999999999999999988 99999999999999999999999999998876
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCCC-CcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVL-TPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLA 698 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~ 698 (816)
+.. ....+|+|.|.+||++.+.+| ++.+|-|||||+||.|+.|..||++.+. ....+..|.+.+.-
T Consensus 206 ~kf-------LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~---- 274 (668)
T KOG0611|consen 206 KKF-------LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE---- 274 (668)
T ss_pred ccH-------HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC----
Confidence 553 367789999999999999988 5899999999999999999999986553 44556666655432
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 699 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 699 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
.+....-||.+||-.||.+|-|+.++.-+..
T Consensus 275 ------~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 275 ------TPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred ------CCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 2235677999999999999999986554443
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=344.61 Aligned_cols=247 Identities=24% Similarity=0.283 Sum_probs=200.3
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++|.+.+.||+|+||.||+|++. +..||||++..... .....+.+|+.++..++||||+++++++.+ ..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999985 78999999975432 234568899999999999999999998844 488999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999996543 5888999999999999999999988 99999999999999999999999999976543
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCcccccc-CCCCC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSIL-DPLAG 699 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~-d~~~~ 699 (816)
......||+.|+|||++.+..++.++|||||||++|||++|..||...... ...+... ...+ .+...
T Consensus 154 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~ 223 (333)
T cd05600 154 --------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW--KETLQRPVYD 223 (333)
T ss_pred --------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc--cccccCCCCC
Confidence 124457999999999999989999999999999999999999999754332 1222111 1111 11111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 700 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 700 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
+.....+..+.+|+.+||..+|.+||++.+.+.+
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1112356789999999999999999999865544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=346.76 Aligned_cols=253 Identities=29% Similarity=0.420 Sum_probs=200.3
Q ss_pred hcCCCccceeeeecceEEEEEEEc-------CeEEEEEEeccCCc-ccHHHHHHHHHHHhcC-CCCceeeEeccccC--C
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--A 537 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~-------g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~ 537 (816)
.++|.+.+.||+|+||.||+|++. +..||||++..... .....+.+|+.+|..+ +||||++++|+|.+ .
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 457888999999999999999742 45899999875432 3345688999999999 89999999999844 5
Q ss_pred ccceeeccCCCchhhhhhhcCC----------------------------------------------------------
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSN---------------------------------------------------------- 559 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 559 (816)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 8899999999999998864321
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 560 --------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 560 --------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
...++|..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 125789999999999999999999987 999999999999999999999999999876543211
Q ss_pred CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChH---HHHHHhhcCccccccCCCCCCC
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG---EVRRAVSCGKLSSILDPLAGDW 701 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~---~~~~~~~~~~~~~~~d~~~~~~ 701 (816)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.... .....+..+... ..
T Consensus 271 ----~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--------~~ 338 (375)
T cd05104 271 ----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM--------LS 338 (375)
T ss_pred ----cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC--------CC
Confidence 11223445678999999999999999999999999999998 899986432 222333322211 11
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHH
Q 003481 702 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 737 (816)
Q Consensus 702 ~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~ 737 (816)
+...+..+.+|+.+||+.||.+||++. .+++.|+.
T Consensus 339 ~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~~l~~ 373 (375)
T cd05104 339 PECAPSEMYDIMKSCWDADPLKRPTFK-QIVQLIEQ 373 (375)
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHH-HHHHHHHh
Confidence 222356899999999999999999999 66666764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=357.99 Aligned_cols=261 Identities=23% Similarity=0.328 Sum_probs=209.5
Q ss_pred HHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCC-CCceeeEeccc------cC-
Q 003481 467 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGAC------PE- 536 (816)
Q Consensus 467 ~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~------~~- 536 (816)
....++++.+.|.+|||+.||++.+. |..||+|++...+......+.+|+++|++|+ |||||.+++.. ..
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 34567888899999999999999986 4899999998887778888999999999996 99999999943 11
Q ss_pred --CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecc
Q 003481 537 --AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 614 (816)
Q Consensus 537 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 614 (816)
+.+|.||||.||.|-|+|..+.... |++.++++|+.++|+|+.+||... .||||||||-+||||+.+|+.||||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence 2679999999999999998765544 999999999999999999999998 689999999999999999999999999
Q ss_pred cceeccCCCCc---CCCccccCCCCCCCCCCCcccc---ccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcC
Q 003481 615 ICRLVTEDTLY---LPSFHRSTAPKGSFPYADPEYH---RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCG 688 (816)
Q Consensus 615 la~~~~~~~~~---~~~~~~~~~~~gt~~Y~aPE~~---~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~ 688 (816)
.|......... .......-...-|+.|.|||.+ .+.+.+.|+|||+|||+||-|+....||+..+. .+|..|
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--laIlng 269 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--LAILNG 269 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--eeEEec
Confidence 98754322200 0000011123478999999965 677899999999999999999999999975543 233333
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 689 KLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 689 ~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
++.- +.+ +.++..|.+||..||+.||.+||++.+.+...++-.
T Consensus 270 ~Y~~------P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 270 NYSF------PPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred cccC------CCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 3321 122 358899999999999999999999996555555433
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=311.91 Aligned_cols=244 Identities=24% Similarity=0.359 Sum_probs=206.2
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++|.+++.||+|-||.||.|+.. +..||+|++.+... ....++.+|++|-+.|+||||+++||+|.+ ..||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 45788899999999999999886 67899999977643 334578999999999999999999999965 489999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||.++|+|...|..... ..++......++.|+|.||.|+|..+ ||||||||+|+|++..+.+||+|||.+...+.+
T Consensus 102 Eya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~ 177 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSN 177 (281)
T ss_pred EecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence 99999999999975432 45778888999999999999999987 999999999999999999999999998765422
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCCC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~ 700 (816)
.....+||..|.+||...+..++.++|+|++|++.||++.|.+||..... ....+..- ...
T Consensus 178 --------kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~---------~~~ 240 (281)
T KOG0580|consen 178 --------KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV---------DLK 240 (281)
T ss_pred --------CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc---------ccc
Confidence 45677899999999999999999999999999999999999999974432 22222221 123
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
+|..++....+||.+|+..+|.+|....+.+.+.
T Consensus 241 ~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 241 FPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred CCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 4567888999999999999999999998665443
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=333.26 Aligned_cols=251 Identities=23% Similarity=0.278 Sum_probs=195.9
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 543 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 543 (816)
++|.+.+.||+|+||.||++++. +..||+|++..... .....+.+|+.++..++||||++++++|.+ ..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47889999999999999999986 78899999875432 234568899999999999999999999843 5889999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
|+++++|..+.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99988776554322 35889999999999999999999987 9999999999999999999999999998764332
Q ss_pred CcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhh----cCc----------
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGK---------- 689 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~----~~~---------- 689 (816)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|++||........... .+.
T Consensus 155 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 155 NA-----NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred cc-----cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 11 12345689999999999888899999999999999999999999975432211110 000
Q ss_pred ----cccccCCCC-------CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 690 ----LSSILDPLA-------GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 690 ----~~~~~d~~~-------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
......+.. ..+....+..+.+|+.+||+.||.+||++.+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l 282 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCL 282 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000000000 011123566799999999999999999998544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=327.76 Aligned_cols=250 Identities=25% Similarity=0.363 Sum_probs=200.5
Q ss_pred cCCCccceeeeecceEEEEEEEc-----CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccce
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLV 541 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~-----g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV 541 (816)
++|.+.+.||+|+||.||+|.+. +..||+|.+..... .....|.+|+.++.+++||||++++|++. +..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46888899999999999999763 56899999876533 23456889999999999999999999984 458999
Q ss_pred eeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
|||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999987643 36899999999999999999999987 99999999999999999999999998765432
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLA 698 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~ 698 (816)
.... ......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ....+..+..
T Consensus 160 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-------- 226 (266)
T cd05064 160 EAIY-----TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR-------- 226 (266)
T ss_pred cchh-----cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC--------
Confidence 2111 1123345678999999999999999999999999999775 9999964332 2222322211
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 699 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 699 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
...+...+..+.+++.+||+.+|.+||++. .+.+.|..+
T Consensus 227 ~~~~~~~~~~~~~li~~c~~~~p~~RP~~~-~i~~~l~~~ 265 (266)
T cd05064 227 LPAPRNCPNLLHQLMLDCWQKERGERPRFS-QIHSILSKM 265 (266)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCCCHH-HHHHHHHhh
Confidence 112334556899999999999999999998 677777653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=357.11 Aligned_cols=249 Identities=21% Similarity=0.255 Sum_probs=203.0
Q ss_pred CCCccceeeeecceEEEEEEEc---CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeecc
Q 003481 471 NFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 545 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~---g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 545 (816)
.|...+.||+|+||.||++... +..||+|.+..........+.+|+.+|..++|||||+++++|. +..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888999999999999999764 5679999876555444556888999999999999999999984 4589999999
Q ss_pred CCCchhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 546 PNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 546 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
++|+|.++|... ....++++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988643 22346889999999999999999999987 99999999999999999999999999987654321
Q ss_pred cCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCCCCC
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWP 702 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~ 702 (816)
. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... +...+..+... .++
T Consensus 225 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~--------~~~ 292 (478)
T PTZ00267 225 L----DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD--------PFP 292 (478)
T ss_pred c----ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------CCC
Confidence 1 123455799999999999999999999999999999999999999975433 22222222221 223
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 703 TFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 703 ~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
..++..+.+|+.+||..+|.+||++.+.+.+.
T Consensus 293 ~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~ 324 (478)
T PTZ00267 293 CPVSSGMKALLDPLLSKNPALRPTTQQLLHTE 324 (478)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHhCH
Confidence 34567899999999999999999999766543
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=342.03 Aligned_cols=230 Identities=26% Similarity=0.326 Sum_probs=188.6
Q ss_pred ceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeeccCCC
Q 003481 476 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPNG 548 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~~g 548 (816)
+.||+|+||.||++... |..||+|++..... .....+.+|+.++..++||||++++++|. +..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999875 88999999975422 23345778999999999999999999884 3588999999999
Q ss_pred chhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCC
Q 003481 549 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 628 (816)
Q Consensus 549 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 628 (816)
+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---- 150 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---- 150 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC----
Confidence 9998886543 5889999999999999999999988 99999999999999999999999999875432211
Q ss_pred ccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCccccccCCCCCCCCHHHH
Q 003481 629 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPTFVA 706 (816)
Q Consensus 629 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~~~~~~~~ 706 (816)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.. ...+..+. ..+|...+
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~---------~~~p~~~~ 219 (323)
T cd05595 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE---------IRFPRTLS 219 (323)
T ss_pred --ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---------CCCCCCCC
Confidence 123456999999999999999999999999999999999999999644322 12221111 12344566
Q ss_pred HHHHHHHHHhhccCCCCCCC
Q 003481 707 RRLVDLGLQCCELYGRERPD 726 (816)
Q Consensus 707 ~~l~~Li~~cl~~dP~~RPs 726 (816)
..+.+|+.+||+.||.+||+
T Consensus 220 ~~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05595 220 PEAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred HHHHHHHHHHccCCHHHhCC
Confidence 78999999999999999983
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=338.26 Aligned_cols=230 Identities=25% Similarity=0.330 Sum_probs=189.9
Q ss_pred eeeecceEEEEEEEc--CeEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccCCCch
Q 003481 478 VGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSL 550 (816)
Q Consensus 478 LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL 550 (816)
||+|+||.||++.+. +..||+|++.... ......+.+|+.++.+++||||++++++|.+ ..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999885 7889999986532 2334567889999999999999999998843 58999999999999
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCcc
Q 003481 551 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 630 (816)
Q Consensus 551 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 630 (816)
.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~------ 148 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD------ 148 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC------
Confidence 99987643 5889999999999999999999988 99999999999999999999999999876432221
Q ss_pred ccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCCCCCHHHHHH
Q 003481 631 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARR 708 (816)
Q Consensus 631 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 708 (816)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+ ...++...+..
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~---------~~~~~~~~~~~ 219 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE---------PLRFPDGFDRD 219 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC---------CCCCCCcCCHH
Confidence 22445799999999999999999999999999999999999999964332 11222111 11234456678
Q ss_pred HHHHHHHhhccCCCCCCCCh
Q 003481 709 LVDLGLQCCELYGRERPDIT 728 (816)
Q Consensus 709 l~~Li~~cl~~dP~~RPs~~ 728 (816)
+.+|+.+||..||.+||++.
T Consensus 220 ~~~li~~~L~~dp~~R~~~~ 239 (312)
T cd05585 220 AKDLLIGLLSRDPTRRLGYN 239 (312)
T ss_pred HHHHHHHHcCCCHHHcCCCC
Confidence 99999999999999999764
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=335.21 Aligned_cols=252 Identities=25% Similarity=0.430 Sum_probs=200.9
Q ss_pred cCCCccceeeeecceEEEEEEEc--Ce----EEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEecccc-CCccce
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GR----TVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP-EAWSLV 541 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~----~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~lV 541 (816)
.+|+..+.||+|+||.||+|.+. +. .||+|++..... .....|.+|+.+++.++||||++++|+|. +..++|
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 46888999999999999999873 33 489999875432 34567889999999999999999999984 457899
Q ss_pred eeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
++|+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 87 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence 99999999999987643 35889999999999999999999987 99999999999999999999999999987654
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLA 698 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~ 698 (816)
.... .......++..|+|||++.+..++.++|||||||++|||++ |..||..... .......+...
T Consensus 162 ~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------- 230 (316)
T cd05108 162 DEKE----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL------- 230 (316)
T ss_pred CCcc----eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCC-------
Confidence 3321 11122345678999999999999999999999999999998 9999965332 22222222111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhh
Q 003481 699 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 699 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~ 739 (816)
..+...+..+.+++.+||..+|.+||++. .++..|..+.
T Consensus 231 -~~~~~~~~~~~~li~~cl~~~p~~Rps~~-~l~~~l~~~~ 269 (316)
T cd05108 231 -PQPPICTIDVYMIMVKCWMIDADSRPKFR-ELIIEFSKMA 269 (316)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCcCHH-HHHHHHHHHH
Confidence 11223445789999999999999999999 5556666654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=341.83 Aligned_cols=229 Identities=27% Similarity=0.323 Sum_probs=188.7
Q ss_pred ceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeeccCCC
Q 003481 476 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPNG 548 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~~g 548 (816)
+.||+|+||.||++... +..||+|++..... .....+.+|+.++..++||||+++++++. +..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999875 78999999975432 23456789999999999999999999884 3588999999999
Q ss_pred chhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCC
Q 003481 549 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 628 (816)
Q Consensus 549 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 628 (816)
+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~---- 150 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---- 150 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc----
Confidence 9998886543 5889999999999999999999988 99999999999999999999999999875432211
Q ss_pred ccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCccccccCCCCCCCCHHHH
Q 003481 629 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPTFVA 706 (816)
Q Consensus 629 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~~~~~~~~ 706 (816)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.. ...+..+ ...+|...+
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~---------~~~~p~~~~ 219 (328)
T cd05593 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME---------DIKFPRTLS 219 (328)
T ss_pred --ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC---------CccCCCCCC
Confidence 123457999999999999889999999999999999999999999654332 1111111 112344566
Q ss_pred HHHHHHHHHhhccCCCCCC
Q 003481 707 RRLVDLGLQCCELYGRERP 725 (816)
Q Consensus 707 ~~l~~Li~~cl~~dP~~RP 725 (816)
..+.+|+.+||..||.+||
T Consensus 220 ~~~~~li~~~L~~dP~~R~ 238 (328)
T cd05593 220 ADAKSLLSGLLIKDPNKRL 238 (328)
T ss_pred HHHHHHHHHHcCCCHHHcC
Confidence 7899999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=345.20 Aligned_cols=254 Identities=28% Similarity=0.451 Sum_probs=201.2
Q ss_pred hcCCCccceeeeecceEEEEEEEc-------CeEEEEEEeccCCc-ccHHHHHHHHHHHhcC-CCCceeeEeccccC--C
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--A 537 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~-------g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~ 537 (816)
.++|...+.||+|+||.||+|++. +..||+|++..... .....+.+|+.+++.+ +||||++++|+|.+ .
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 357888999999999999999753 24799999975433 2345688999999999 89999999999854 4
Q ss_pred ccceeeccCCCchhhhhhhcCC----------------------------------------------------------
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSN---------------------------------------------------------- 559 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 559 (816)
.++||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 8899999999999998854210
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCcc
Q 003481 560 ---------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 630 (816)
Q Consensus 560 ---------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 630 (816)
..++++..+++|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........ .
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~----~ 269 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY----V 269 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcce----e
Confidence 125788999999999999999999987 999999999999999999999999999876443211 1
Q ss_pred ccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH---HHHHhhcCccccccCCCCCCCCHHHH
Q 003481 631 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE---VRRAVSCGKLSSILDPLAGDWPTFVA 706 (816)
Q Consensus 631 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~---~~~~~~~~~~~~~~d~~~~~~~~~~~ 706 (816)
......+++.|+|||++....++.++|||||||++|+|++ |+.||..... ....+..+. . ...+...+
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~-----~---~~~~~~~~ 341 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY-----Q---MSRPDFAP 341 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc-----C---ccCCCCCC
Confidence 1223346678999999988899999999999999999997 9999964332 112221111 1 11222345
Q ss_pred HHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 707 RRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 707 ~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
..+.+++.+||+.||.+||++. .+++.|+.+
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~-~l~~~l~~~ 372 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFS-QISQLIQRQ 372 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHH-HHHHHHHHH
Confidence 7899999999999999999999 788888765
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=308.07 Aligned_cols=265 Identities=22% Similarity=0.292 Sum_probs=208.8
Q ss_pred HHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc-------CC
Q 003481 467 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP-------EA 537 (816)
Q Consensus 467 ~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-------~~ 537 (816)
...++|++.+.||+|||+-||+++.. +..+|+|++......+.+...+|++..++++|||++++++++- +.
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 34578999999999999999999864 7889999998888788888999999999999999999999871 23
Q ss_pred ccceeeccCCCchhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccc
Q 003481 538 WSLVYEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 616 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 616 (816)
.||+++|...|+|.+.+.... ....+++.+++.|+.+|++||.+||... .|++||||||.|||+.+.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 799999999999999987654 3347999999999999999999999988 48999999999999999999999999998
Q ss_pred eeccCCCC---cCCCccccCCCCCCCCCCCccccc---cCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCcc
Q 003481 617 RLVTEDTL---YLPSFHRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKL 690 (816)
Q Consensus 617 ~~~~~~~~---~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~ 690 (816)
....-... ..........-..|..|.|||.+. +...+.++|||||||+||.|+.|..||...-. ..|.+
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-----~GgSl 251 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-----QGGSL 251 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----cCCeE
Confidence 76542111 001112233456889999999885 44678899999999999999999999962211 22222
Q ss_pred ccccCCCCCCCC--HHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 691 SSILDPLAGDWP--TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 691 ~~~~d~~~~~~~--~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
.-.+....-.+| ..+++.+.+||.+|++.||.+||++. +|+..++.+
T Consensus 252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~-~ll~~~d~L 300 (302)
T KOG2345|consen 252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIP-ELLSKLDDL 300 (302)
T ss_pred EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHH-HHHHHHHhh
Confidence 211111111111 22788999999999999999999999 555555543
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=340.95 Aligned_cols=248 Identities=21% Similarity=0.286 Sum_probs=210.8
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCccc--HHHHHHHHHHHhcCCCCceeeEeccccC--C-cccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLGACPE--A-WSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~g~~~~--~-~~lV~ 542 (816)
++|...+++|+|+||.++..+.. ++.|++|.+....... .....+|+.++++++|||||.+++.|.+ . .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 47888899999999999988775 7889999997765433 3357899999999999999999999844 3 78999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
+||+||+|.+.|.+.. ...++++.++.|+.|++.|+.|||+.. |+|||||+.|||++.++.|||+|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998776 356899999999999999999999877 999999999999999999999999999998876
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCccccccCCCCCC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~~ 700 (816)
.. .....+||+.||.||.+.+.+|+.|+|||||||++|||++-+++|...+.. ...+..+. +. .
T Consensus 160 ~~------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~----~~----P 225 (426)
T KOG0589|consen 160 DS------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL----YS----P 225 (426)
T ss_pred hh------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc----CC----C
Confidence 52 245678999999999999999999999999999999999999999755432 22222222 22 3
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
.|..++..+..|+..|+..+|..||++.+.|.+.+
T Consensus 226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~ 260 (426)
T KOG0589|consen 226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPH 260 (426)
T ss_pred CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChh
Confidence 45667789999999999999999999997776644
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=342.03 Aligned_cols=232 Identities=25% Similarity=0.299 Sum_probs=193.5
Q ss_pred cCCCccceeeeecceEEEEEEEc---CeEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccce
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 541 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~---g~~vAiK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 541 (816)
++|...+.||+|+||.||+|.+. +..||+|++.... ......+.+|+.++..++||||+++++++.+ ..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 46888899999999999999864 3579999986542 2234568899999999999999999999854 47899
Q ss_pred eeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 110 ~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999987653 5889999999999999999999988 99999999999999999999999999987643
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCccccccCCCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAG 699 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~ 699 (816)
. .....||+.|+|||++.+..++.++|||||||++|||++|..||...... ...+..+..
T Consensus 184 ~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~--------- 245 (340)
T PTZ00426 184 R---------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII--------- 245 (340)
T ss_pred C---------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---------
Confidence 2 13456999999999999888999999999999999999999999755432 222222221
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCC
Q 003481 700 DWPTFVARRLVDLGLQCCELYGRERP 725 (816)
Q Consensus 700 ~~~~~~~~~l~~Li~~cl~~dP~~RP 725 (816)
.+|...+..+.+++.+||+.||.+|+
T Consensus 246 ~~p~~~~~~~~~li~~~l~~dp~~R~ 271 (340)
T PTZ00426 246 YFPKFLDNNCKHLMKKLLSHDLTKRY 271 (340)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHcC
Confidence 23444566789999999999999996
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=327.74 Aligned_cols=251 Identities=33% Similarity=0.520 Sum_probs=202.3
Q ss_pred CCCccceeeeecceEEEEEEEcC-------eEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccc
Q 003481 471 NFSESFKVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 540 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~g-------~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 540 (816)
+|.+.+.||+|+||.||+|...+ ..||+|.+..... .....|.+|+.++.+++||||+++++++.+ ..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 57778899999999999998752 5699999875433 234568999999999999999999999854 4789
Q ss_pred eeeccCCCchhhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCC
Q 003481 541 VYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS 607 (816)
Q Consensus 541 V~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 607 (816)
+|||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCc
Confidence 9999999999999976422 145889999999999999999999988 999999999999999999
Q ss_pred eeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChH--HHHHH
Q 003481 608 SKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRA 684 (816)
Q Consensus 608 vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~--~~~~~ 684 (816)
+||+|||++......... .......+++.|+|||++.++.++.++|||||||++|||++ |..||.... .+...
T Consensus 163 ~~L~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 163 VKISDFGLSRDIYSADYY----RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred EEECCCcceeeccccccc----cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999865433211 12234457889999999988899999999999999999998 999986432 23333
Q ss_pred hhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHH
Q 003481 685 VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 737 (816)
Q Consensus 685 ~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~ 737 (816)
+..+... ..+..++..+.+|+.+||+.||.+||++. ++...|+.
T Consensus 239 i~~~~~~--------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~-~i~~~l~~ 282 (283)
T cd05048 239 IRSRQLL--------PCPEDCPARVYALMIECWNEIPARRPRFK-DIHTRLRS 282 (283)
T ss_pred HHcCCcC--------CCcccCCHHHHHHHHHHccCChhhCcCHH-HHHHHHhc
Confidence 3333221 23445667899999999999999999999 66666653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=330.23 Aligned_cols=250 Identities=26% Similarity=0.370 Sum_probs=192.1
Q ss_pred cCCCccceeeeecceEEEEEEEc---CeEEEEEEeccCCcc--cHHHHHHHHHHHhcC---CCCceeeEecccc------
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKL---QHPHLVTLLGACP------ 535 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~---g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l---~HpnIv~l~g~~~------ 535 (816)
++|.+.+.||+|+||.||+|++. +..||+|++...... ....+.+|+.++..+ +||||++++++|.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999873 678999998654322 233566777777665 6999999999873
Q ss_pred -CCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecc
Q 003481 536 -EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 614 (816)
Q Consensus 536 -~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 614 (816)
...++||||++ ++|.+++..... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 23789999996 689888865432 35899999999999999999999988 9999999999999999999999999
Q ss_pred cceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH--hhcC----
Q 003481 615 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCG---- 688 (816)
Q Consensus 615 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~--~~~~---- 688 (816)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|++||......... +...
T Consensus 156 ~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~ 228 (290)
T cd07862 156 LARIYSFQM-------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 228 (290)
T ss_pred ceEeccCCc-------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 998764332 234556899999999998889999999999999999999999999754332111 1100
Q ss_pred ---ccc-------cccCCCCC----CCCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 689 ---KLS-------SILDPLAG----DWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 689 ---~~~-------~~~d~~~~----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
.+. ..+.+... .+....+..+.+|+.+||+.||++||++.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 285 (290)
T cd07862 229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285 (290)
T ss_pred ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHh
Confidence 000 00000000 01123456788999999999999999999655
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=336.61 Aligned_cols=254 Identities=23% Similarity=0.318 Sum_probs=193.6
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCceeeEeccccC-------Ccc
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------AWS 539 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------~~~ 539 (816)
+|.+.+.||+|+||.||+|++. +..||||++.... ......+.+|+.++++++||||+++++++.. ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999875 7899999986432 2334568899999999999999999998721 368
Q ss_pred ceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceec
Q 003481 540 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 619 (816)
Q Consensus 540 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 619 (816)
+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68988886543 5899999999999999999999988 999999999999999999999999999865
Q ss_pred cCCCCcCCCccccCCCCCCCCCCCcccccc--CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHH--------------
Q 003481 620 TEDTLYLPSFHRSTAPKGSFPYADPEYHRT--GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR-------------- 683 (816)
Q Consensus 620 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~-------------- 683 (816)
...... ........||+.|+|||++.+ ..++.++|||||||++|+|+||++||........
T Consensus 154 ~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 154 FNDTPT---AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred ccccCc---cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 432211 011244579999999999865 6789999999999999999999999964332111
Q ss_pred ---HhhcCcccccc----CCCCCCC---CHHHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 684 ---AVSCGKLSSIL----DPLAGDW---PTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 684 ---~~~~~~~~~~~----d~~~~~~---~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
.+........+ ......+ ....+..+.+|+.+||+.||.+||++.+.+.+.
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp 291 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADP 291 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCc
Confidence 00000000000 0000000 012345788999999999999999999766544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.30 Aligned_cols=249 Identities=29% Similarity=0.453 Sum_probs=201.8
Q ss_pred cCCCccceeeeecceEEEEEEEc-CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeeccC
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLP 546 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~ 546 (816)
++|...++||+|+||.||+|... +..||+|.+..... ....+.+|+.++..++||||+++++++. +..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 46888899999999999999876 67799998865432 3567899999999999999999998874 34789999999
Q ss_pred CCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcC
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626 (816)
Q Consensus 547 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 626 (816)
+|+|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 85 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05072 85 KGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT- 159 (261)
T ss_pred CCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence 999999987543 245889999999999999999999987 999999999999999999999999999876543211
Q ss_pred CCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChH--HHHHHhhcCccccccCCCCCCCCH
Q 003481 627 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPT 703 (816)
Q Consensus 627 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~--~~~~~~~~~~~~~~~d~~~~~~~~ 703 (816)
......++..|+|||++..+.++.++|||||||++|+|+| |..||.... .....+..+.. .+. +.
T Consensus 160 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~----~~~----~~ 227 (261)
T cd05072 160 ----AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR----MPR----ME 227 (261)
T ss_pred ----ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC----CCC----CC
Confidence 1223446778999999988899999999999999999998 999996432 22222222211 111 12
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHH
Q 003481 704 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 737 (816)
Q Consensus 704 ~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~ 737 (816)
..+..+.+++.+||..+|++||++. ++...|+.
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~ 260 (261)
T cd05072 228 NCPDELYDIMKTCWKEKAEERPTFD-YLQSVLDD 260 (261)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHH-HHHHHHhc
Confidence 2456789999999999999999998 78888875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=330.82 Aligned_cols=253 Identities=21% Similarity=0.339 Sum_probs=193.3
Q ss_pred hcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCceeeEecccc--CCccceee
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYE 543 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E 543 (816)
.++|.+.+.||.|+||.||+|... +..||||++...... ....+.+|+.+++.++||||+++++++. +..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999885 789999998754332 2345778999999999999999999984 35889999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
|+. ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 57777776543 35888999999999999999999988 9999999999999999999999999987653222
Q ss_pred CcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhh-----cCcc-----cc
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS-----CGKL-----SS 692 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~-----~~~~-----~~ 692 (816)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........+. .+.. ..
T Consensus 158 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 158 H------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred c------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccc
Confidence 1 1234568999999998765 4588999999999999999999999975433211110 0000 00
Q ss_pred -----ccCCC-CC-CCCH---------HHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 693 -----ILDPL-AG-DWPT---------FVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 693 -----~~d~~-~~-~~~~---------~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
...+. .. ..+. ..+..+.+|+.+||+.||.+|||+.+.+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00000 00 0000 123568899999999999999999865543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=329.13 Aligned_cols=250 Identities=24% Similarity=0.313 Sum_probs=193.1
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeec
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 544 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 544 (816)
++|...+.||.|+||.||+|... +..||+|++..... .....+.+|+.++++++||||+++++++.. ..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999875 78999999865432 234467899999999999999999998844 47899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+++ +|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 975 8988886543 35788999999999999999999987 99999999999999999999999999976543221
Q ss_pred cCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH--h-h-cC-----------
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--V-S-CG----------- 688 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~--~-~-~~----------- 688 (816)
......|++.|+|||++.+ ..++.++|||||||++|+|+||++||......... + . .+
T Consensus 159 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred ------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence 1234568999999998865 56899999999999999999999999643321110 0 0 00
Q ss_pred ---ccccccCCCCC-----CCCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 689 ---KLSSILDPLAG-----DWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 689 ---~~~~~~d~~~~-----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
.+.....+... ......+..+.+|+.+||+.||.+|||+.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l 283 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 00001101000 00112356789999999999999999998655
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=334.26 Aligned_cols=255 Identities=24% Similarity=0.370 Sum_probs=199.9
Q ss_pred hcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceee
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYE 543 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E 543 (816)
.++|...++||.|+||.||++.+. +..||+|.+..... .....+.+|+.++.+++||||++++++|. +..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 368999999999999999999886 77899998875432 23456889999999999999999999984 35899999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
|+++|+|.+++.... .+++..+..++.+++.||.|||+.+ +|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 999999999986543 5788999999999999999999853 39999999999999999999999999987654321
Q ss_pred CcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhh---cCccccc-----
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVS---CGKLSSI----- 693 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~---~~~~~~~----- 693 (816)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||..... ....+. .+.....
T Consensus 159 --------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 159 --------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred --------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 2344689999999999988899999999999999999999999964332 111110 0000000
Q ss_pred ----------------------------cCCCCCCCC-HHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 694 ----------------------------LDPLAGDWP-TFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 694 ----------------------------~d~~~~~~~-~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
........+ ...+..+.+|+.+||+.||.+||++.+.+.+.+-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~ 302 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI 302 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHH
Confidence 000000000 1134678999999999999999999977766654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=351.38 Aligned_cols=257 Identities=21% Similarity=0.277 Sum_probs=207.0
Q ss_pred HHHHHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEeccccC--
Q 003481 463 ADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-- 536 (816)
Q Consensus 463 ~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-- 536 (816)
..+....++|.+.+.||+|+||.||++++. |..||||++..... .....+.+|+.++..++|+||+++++.+..
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 445556689999999999999999999874 88999999876533 334568899999999999999999876521
Q ss_pred --------CccceeeccCCCchhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCC
Q 003481 537 --------AWSLVYEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS 607 (816)
Q Consensus 537 --------~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 607 (816)
..++||||+++|+|.++|.... ....+++..+..|+.|++.||.|||+.+ |+||||||+||||+.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 1579999999999999987542 2356899999999999999999999987 999999999999999999
Q ss_pred eeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHh
Q 003481 608 SKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAV 685 (816)
Q Consensus 608 vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~ 685 (816)
+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++|+.||..... +...+
T Consensus 182 vkL~DFGls~~~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~ 257 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSD----DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT 257 (496)
T ss_pred EEEEecccCeeccccccc----cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 999999999876532211 123456799999999999999999999999999999999999999975432 22222
Q ss_pred hcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 686 SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 686 ~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
..+.. ...+...+..+.+|+.+||+.||.+||++.+.+.+.
T Consensus 258 ~~~~~--------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p 298 (496)
T PTZ00283 258 LAGRY--------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298 (496)
T ss_pred hcCCC--------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCH
Confidence 22221 123344567899999999999999999999766543
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=333.54 Aligned_cols=235 Identities=27% Similarity=0.355 Sum_probs=189.4
Q ss_pred ceeeeecceEEEEEEEc--CeEEEEEEeccCC---cccHHHHHHHHHHHhcC-CCCceeeEecccc--CCccceeeccCC
Q 003481 476 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKL-QHPHLVTLLGACP--EAWSLVYEYLPN 547 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~--~~~~lV~E~~~~ 547 (816)
+.||+|+||.||+|.+. +..||||++.... ......+..|..++..+ +||||+++++++. +..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999885 6789999997542 22334456677777654 8999999999874 358899999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~---- 150 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---- 150 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC----
Confidence 99999886543 5888999999999999999999987 9999999999999999999999999998653322
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCccccccCCCCCCCCHHH
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPTFV 705 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~~~~~~~ 705 (816)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.. ...+... ...+|...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~---------~~~~~~~~ 219 (316)
T cd05592 151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND---------RPHFPRWI 219 (316)
T ss_pred --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------CCCCCCCC
Confidence 1234557999999999999889999999999999999999999999754432 1111111 12234445
Q ss_pred HHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 706 ARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 706 ~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
+..+.+|+.+||+.||.+||++.+.+
T Consensus 220 ~~~~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 220 SKEAKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHH
Confidence 67889999999999999999986444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=326.38 Aligned_cols=245 Identities=36% Similarity=0.622 Sum_probs=191.8
Q ss_pred ccceeeeecceEEEEEEEc------CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeec
Q 003481 474 ESFKVGQGGFGCVYKGEML------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 544 (816)
Q Consensus 474 ~~~~LG~G~~g~Vy~~~~~------g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 544 (816)
..+.||.|.||.||+|.+. +..|+||.+..... .....|.+|++.+.+++||||++++|+|. +..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3467999999999999987 67899999965433 34678999999999999999999999995 347899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+++|+|.++|.... ...+++..++.|+.||+.||.|||+.+ |+|+||+|+|||++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccc-ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999998762 246899999999999999999999987 99999999999999999999999999988733221
Q ss_pred cCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCCCCC
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDW 701 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~ 701 (816)
. .......+...|+|||.+....++.++||||||+++|||++ |+.||..... +...+..+... ..
T Consensus 159 ~----~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~--------~~ 226 (259)
T PF07714_consen 159 Y----KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRL--------PI 226 (259)
T ss_dssp E----EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEET--------TS
T ss_pred c----ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------ee
Confidence 1 12334457788999999999999999999999999999999 7899864332 22333333221 12
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 702 PTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 702 ~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
+...+..+.+++..||..+|.+||++. .+.+.|
T Consensus 227 ~~~~~~~~~~li~~C~~~~p~~RPs~~-~i~~~L 259 (259)
T PF07714_consen 227 PDNCPKDIYSLIQQCWSHDPEKRPSFQ-EILQEL 259 (259)
T ss_dssp BTTSBHHHHHHHHHHT-SSGGGS--HH-HHHHHH
T ss_pred ccchhHHHHHHHHHHcCCChhhCcCHH-HHHhcC
Confidence 333556889999999999999999999 555443
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=321.87 Aligned_cols=249 Identities=27% Similarity=0.434 Sum_probs=201.8
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeeccC
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLP 546 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~ 546 (816)
+|...+.||.|+||.||+|.+. +..||+|.+... ......+.+|+.++.+++||||++++++|. +..++||||++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMT 85 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCC
Confidence 4777889999999999999875 788999998654 334567899999999999999999999984 34789999999
Q ss_pred CCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcC
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626 (816)
Q Consensus 547 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 626 (816)
+++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 86 ~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~- 160 (263)
T cd05052 86 YGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT- 160 (263)
T ss_pred CCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee-
Confidence 9999999865432 45899999999999999999999987 999999999999999999999999999876543211
Q ss_pred CCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCCCCCCH
Q 003481 627 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPT 703 (816)
Q Consensus 627 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~ 703 (816)
......++..|+|||++.+..++.++|||||||++|+|++ |..||..... ....+..+. ....+.
T Consensus 161 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 228 (263)
T cd05052 161 ----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY--------RMERPE 228 (263)
T ss_pred ----ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC--------CCCCCC
Confidence 1122334678999999998999999999999999999998 9999864332 222222211 112333
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 704 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 704 ~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
..+..+.+++.+||+.+|.+||++. .+.+.|+.+
T Consensus 229 ~~~~~~~~li~~cl~~~p~~Rp~~~-~l~~~l~~~ 262 (263)
T cd05052 229 GCPPKVYELMRACWQWNPSDRPSFA-EIHQAFETM 262 (263)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHH-HHHHHHHhh
Confidence 4567899999999999999999999 677777754
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=326.12 Aligned_cols=255 Identities=28% Similarity=0.449 Sum_probs=206.1
Q ss_pred cCCCccceeeeecceEEEEEEEc-------CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc--CCccc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSL 540 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~-------g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~l 540 (816)
++|.+.+.||.|+||.||++... +..||+|.+..........+.+|+.++.+++||||++++++|. +..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46888899999999999999752 4568999987665555667999999999999999999999984 45889
Q ss_pred eeeccCCCchhhhhhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeE
Q 003481 541 VYEYLPNGSLQDRLFRKS----------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI 610 (816)
Q Consensus 541 V~E~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL 610 (816)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986542 1235899999999999999999999987 999999999999999999999
Q ss_pred eecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChH--HHHHHhhc
Q 003481 611 CDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSC 687 (816)
Q Consensus 611 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~--~~~~~~~~ 687 (816)
+|||+++........ .......+++.|+|||++.+..++.++|||||||++|+|+| |.+||.... .....+..
T Consensus 162 ~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 162 GDFGMSRDVYSTDYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred ccCCccccccCCcee----ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999865432211 11233456788999999998899999999999999999998 999986433 23333333
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhhh
Q 003481 688 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740 (816)
Q Consensus 688 ~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~~ 740 (816)
+.... .+...+..+.+|+.+||+.||.+||++. ++...|+.+..
T Consensus 238 ~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~-~v~~~l~~~~~ 281 (288)
T cd05093 238 GRVLQ--------RPRTCPKEVYDLMLGCWQREPHMRLNIK-EIHSLLQNLAK 281 (288)
T ss_pred CCcCC--------CCCCCCHHHHHHHHHHccCChhhCCCHH-HHHHHHHHHHH
Confidence 33221 1222445799999999999999999999 77888887753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=337.60 Aligned_cols=237 Identities=27% Similarity=0.362 Sum_probs=190.7
Q ss_pred CCccceeeeecceEEEEEEEc--CeEEEEEEeccCC---cccHHHHHHHHHHH---hcCCCCceeeEecccc--CCccce
Q 003481 472 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVL---SKLQHPHLVTLLGACP--EAWSLV 541 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~---~~~~~~~~~E~~il---~~l~HpnIv~l~g~~~--~~~~lV 541 (816)
|.+.+.||+|+||.||+|.+. +..||||++.... ......+..|+.++ ..++||||+++++++. +..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999885 7899999997542 12234566676655 5678999999999984 458999
Q ss_pred eeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
|||+++|+|..++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999888753 35899999999999999999999988 99999999999999999999999999875432
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAG 699 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~ 699 (816)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+. .
T Consensus 154 ~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~---------~ 218 (324)
T cd05589 154 FG------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE---------V 218 (324)
T ss_pred CC------CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------C
Confidence 21 122456799999999999999999999999999999999999999975432 222222221 1
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCChHH
Q 003481 700 DWPTFVARRLVDLGLQCCELYGRERPDITPS 730 (816)
Q Consensus 700 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~ 730 (816)
.+|...+..+.+|+.+||+.||.+||+..+.
T Consensus 219 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~ 249 (324)
T cd05589 219 RYPRFLSREAISIMRRLLRRNPERRLGSGEK 249 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCC
Confidence 2334456788999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=320.38 Aligned_cols=246 Identities=26% Similarity=0.458 Sum_probs=197.5
Q ss_pred cCCCccceeeeecceEEEEEEEc-CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccC
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLP 546 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~ 546 (816)
++|...+.||+|+||.||++.+. +..+|+|.+.... .....|.+|+.+|++++||||++++++|.+ ..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 35777889999999999999886 5689999876443 334678899999999999999999999854 4889999999
Q ss_pred CCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcC
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626 (816)
Q Consensus 547 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 626 (816)
+|+|.+++.... ..++|..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 999999886543 35899999999999999999999987 999999999999999999999999998865432211
Q ss_pred CCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCCCCCCH
Q 003481 627 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPT 703 (816)
Q Consensus 627 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~ 703 (816)
......++..|+|||++.+..++.++||||||+++|+|++ |+.||..... ....+..+... ..+.
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~--------~~~~ 224 (256)
T cd05114 157 ----SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL--------YRPK 224 (256)
T ss_pred ----ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC--------CCCC
Confidence 1223345678999999988889999999999999999999 9999965432 22233322211 1122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 704 FVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 704 ~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
..+..+.+|+.+||+.+|.+||++. +++..|
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~-~l~~~l 255 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFA-ELLRAI 255 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHH-HHHHhh
Confidence 2446789999999999999999999 454443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=341.78 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=203.4
Q ss_pred hcCCCccceeeeecceEEEEEEEc-------CeEEEEEEeccCCcc-cHHHHHHHHHHHhcCC-CCceeeEeccccC--C
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQ-HPHLVTLLGACPE--A 537 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~-------g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~-HpnIv~l~g~~~~--~ 537 (816)
.++|.+.+.||+|+||.||+|++. +..||||++...... ....|.+|+.+|.++. ||||++++|+|.+ .
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 568889999999999999999863 246999999754332 3456899999999996 9999999999954 4
Q ss_pred ccceeeccCCCchhhhhhhcCC----------------------------------------------------------
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSN---------------------------------------------------------- 559 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 559 (816)
.+|||||+++|+|.++|.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 8999999999999998865310
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecC
Q 003481 560 -----------------------------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS 604 (816)
Q Consensus 560 -----------------------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~ 604 (816)
...+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124888999999999999999999987 999999999999999
Q ss_pred CCCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChH---H
Q 003481 605 ELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG---E 680 (816)
Q Consensus 605 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~---~ 680 (816)
++.+||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.... .
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNY----VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred CCEEEEEeCCcceeccccccc----cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 999999999999876443211 11233457788999999988899999999999999999997 999986432 1
Q ss_pred HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 681 VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 681 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
....+..+.. ...+...+..+.+|+.+||+.+|++||++. .|.+.|+.+
T Consensus 349 ~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-~l~~~l~~l 397 (400)
T cd05105 349 FYNKIKSGYR--------MAKPDHATQEVYDIMVKCWNSEPEKRPSFL-HLSDIVESL 397 (400)
T ss_pred HHHHHhcCCC--------CCCCccCCHHHHHHHHHHCccCHhHCcCHH-HHHHHHHHH
Confidence 2222222211 112334567899999999999999999999 788888875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=329.49 Aligned_cols=244 Identities=25% Similarity=0.321 Sum_probs=196.0
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc---cHHHHHHHHHHHhcCCCCceeeEecccc--CCccceee
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYE 543 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E 543 (816)
+|+..+.||+|+||.||++.+. +..||+|++...... ....+.+|+.++..++||||+++++++. +..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999875 789999998654322 2345778999999999999999999884 45899999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 9999999988865432 46899999999999999999999987 9999999999999999999999999998764322
Q ss_pred CcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCH
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPT 703 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 703 (816)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||.......... .+...+......++.
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~ 226 (285)
T cd05605 157 -------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE---EVERRVKEDQEEYSE 226 (285)
T ss_pred -------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH---HHHHHhhhcccccCc
Confidence 1233468999999999998899999999999999999999999997533211000 000011111223445
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCCh
Q 003481 704 FVARRLVDLGLQCCELYGRERPDIT 728 (816)
Q Consensus 704 ~~~~~l~~Li~~cl~~dP~~RPs~~ 728 (816)
..+..+.+|+.+||..||.+||+..
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGCR 251 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCCC
Confidence 5677899999999999999999543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=319.50 Aligned_cols=250 Identities=28% Similarity=0.448 Sum_probs=202.1
Q ss_pred hcCCCccceeeeecceEEEEEEEc-CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeecc
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 545 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 545 (816)
.++|...+.||+|+||.||+|.+. +..||+|.+.... .....|.+|+.++.+++||||+++++++.. ..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 456888899999999999999875 6789999987544 345678999999999999999999998844 478999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999986644 246899999999999999999999987 999999999999999999999999999877532211
Q ss_pred CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCCCCCC
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWP 702 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~ 702 (816)
......++..|+|||++.+..++.++||||||+++|+|+| |+.||..... ....+..+.. ...+
T Consensus 160 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------~~~~ 226 (261)
T cd05068 160 -----AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR--------MPCP 226 (261)
T ss_pred -----ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------CCCC
Confidence 1122233468999999998899999999999999999999 9999965432 2222221110 1122
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHH
Q 003481 703 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 737 (816)
Q Consensus 703 ~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~ 737 (816)
...+..+.+++.+||+.+|.+||++. .+...|+.
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~-~l~~~l~~ 260 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFE-TLQWKLED 260 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHH-HHHHHHhc
Confidence 33457899999999999999999999 67777764
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=324.03 Aligned_cols=253 Identities=29% Similarity=0.463 Sum_probs=200.1
Q ss_pred HhcCCCccceeeeecceEEEEEEEc-------CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEeccccC--C
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--A 537 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~-------g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~ 537 (816)
.+++|+..+.||+|+||.||+|.+. +..||||++..... .....|.+|+.++..++||||+++++++.+ .
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 5678999999999999999999764 35799999864332 234568899999999999999999999854 4
Q ss_pred ccceeeccCCCchhhhhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeE
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSN-------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI 610 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL 610 (816)
.++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 7899999999999999865321 234688999999999999999999987 999999999999999999999
Q ss_pred eecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhc
Q 003481 611 CDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSC 687 (816)
Q Consensus 611 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~ 687 (816)
+|||+++........ .......+++.|+|||++.++.++.++|||||||++|||++ |..||..... ....+..
T Consensus 161 ~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 161 GDFGMTRDIYETDYY----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred CCCCCccccCCccee----ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999998865443221 11223456788999999998899999999999999999999 7889864332 2222222
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 688 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 688 ~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
+... ..+...+..+.+++.+||+.+|.+||++. +++..|+
T Consensus 237 ~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~-e~l~~l~ 276 (277)
T cd05062 237 GGLL--------DKPDNCPDMLFELMRMCWQYNPKMRPSFL-EIISSIK 276 (277)
T ss_pred CCcC--------CCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHhh
Confidence 2211 12333456899999999999999999999 5555543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=325.58 Aligned_cols=255 Identities=29% Similarity=0.467 Sum_probs=206.4
Q ss_pred cCCCccceeeeecceEEEEEEEc-------CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 540 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~-------g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 540 (816)
.+|.....||+|+||.||+|... +..|++|.+..........+.+|+.++++++||||+++++++.+ ..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777789999999999999753 35689999876665556679999999999999999999999854 4789
Q ss_pred eeeccCCCchhhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCC
Q 003481 541 VYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS 607 (816)
Q Consensus 541 V~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 607 (816)
||||+++++|.+++..... ...++|..++.|+.||+.||.|||+.+ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999975431 234899999999999999999999988 999999999999999999
Q ss_pred eeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHH
Q 003481 608 SKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRA 684 (816)
Q Consensus 608 vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~ 684 (816)
++|+|||++........ ........++..|+|||++.+..++.++|||||||++|+|+| |..||..... ....
T Consensus 162 ~~l~dfg~a~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDY----YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred EEECCCCcccccCCCce----eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999976543321 112234557889999999998999999999999999999999 9999854332 2233
Q ss_pred hhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhhh
Q 003481 685 VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740 (816)
Q Consensus 685 ~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~~ 740 (816)
+..+... ..+...+..+.+|+.+||+.+|.+||++. .+.+.|+.+..
T Consensus 238 ~~~~~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~-~v~~~l~~~~~ 284 (291)
T cd05094 238 ITQGRVL--------ERPRVCPKEVYDIMLGCWQREPQQRLNIK-EIYKILHALGK 284 (291)
T ss_pred HhCCCCC--------CCCccCCHHHHHHHHHHcccChhhCcCHH-HHHHHHHHHHh
Confidence 3333222 12223456799999999999999999999 78889888754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=322.25 Aligned_cols=251 Identities=26% Similarity=0.399 Sum_probs=199.3
Q ss_pred CCCccceeeeecceEEEEEEEc--Ce----EEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEeccccC-Ccccee
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GR----TVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVY 542 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~----~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~ 542 (816)
+|...+.||.|+||.||+|.+. +. .|++|.+..... ....++..|+.++.+++||||++++|++.+ ..++++
T Consensus 8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i~ 87 (279)
T cd05111 8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVT 87 (279)
T ss_pred hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEEE
Confidence 5677789999999999999884 43 478888754332 223467788889999999999999999854 467999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++|+|.+++.... ..++|..++.|+.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 88 e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 88 QLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 9999999999997644 36899999999999999999999987 999999999999999999999999999876543
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCCC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAG 699 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~ 699 (816)
... .......++..|+|||++.++.++.++|||||||++|||++ |..||..... ....+..+....
T Consensus 163 ~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------- 231 (279)
T cd05111 163 DKK----YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLA------- 231 (279)
T ss_pred Ccc----cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCC-------
Confidence 211 11234557789999999998899999999999999999998 9999965332 233333332211
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhh
Q 003481 700 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 700 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~ 739 (816)
.+...+..+.+++.+||..+|.+||++. ++.+.|..+.
T Consensus 232 -~~~~~~~~~~~li~~c~~~~p~~Rps~~-el~~~l~~~~ 269 (279)
T cd05111 232 -QPQICTIDVYMVMVKCWMIDENVRPTFK-ELANEFTRMA 269 (279)
T ss_pred -CCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHHHH
Confidence 1112345678899999999999999998 6777777654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=341.44 Aligned_cols=251 Identities=23% Similarity=0.305 Sum_probs=195.5
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++|...+.||+|+||.||+++.. ++.||||++..... .....+.+|+.+|..++||||++++++|.+ ..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999885 78999999975422 223457889999999999999999999844 488999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999987643 5889999999999999999999988 999999999999999999999999999765322
Q ss_pred CCcCC--------------------------------CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh
Q 003481 623 TLYLP--------------------------------SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 670 (816)
Q Consensus 623 ~~~~~--------------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt 670 (816)
..... .........||+.|+|||++....++.++|||||||++|+|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 11000 0001123469999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHH--HhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCC---ChHHHH
Q 003481 671 GRLPVGLAGEVRR--AVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPD---ITPSLV 732 (816)
Q Consensus 671 G~~Pf~~~~~~~~--~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs---~~e~l~ 732 (816)
|..||........ .+..... ...-+. ....+..+.+|+.+|+. +|.+|++ +.+.+.
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNPQETYRKIINWKE-TLQFPD----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCHHHHHHHHHcCCC-ccCCCC----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999975443221 1111110 000011 11245678899999996 9999998 654443
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=336.02 Aligned_cols=237 Identities=26% Similarity=0.322 Sum_probs=192.8
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC---cccHHHHHHHHHHHhcCCCC-ceeeEecccc--CCcccee
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKLQHP-HLVTLLGACP--EAWSLVY 542 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~---~~~~~~~~~E~~il~~l~Hp-nIv~l~g~~~--~~~~lV~ 542 (816)
+|.+.+.||+|+||.||+|... ++.||||++.... ......+..|..++..+.|+ +|+++++++. +..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999886 6789999987542 23345678899999999765 5788888774 4589999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999886543 5889999999999999999999987 999999999999999999999999998753221
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCccccccCCCCCC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~~ 700 (816)
. .......||+.|+|||++.+..++.++|||||||++|+|+||+.||...... ...+..+ ...
T Consensus 155 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~---------~~~ 219 (324)
T cd05587 155 G------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH---------NVS 219 (324)
T ss_pred C------CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------CCC
Confidence 1 1123456999999999999999999999999999999999999999754432 2222211 122
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCCh
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDIT 728 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~ 728 (816)
+|...+..+.+|+.+||..||.+||+..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~ 247 (324)
T cd05587 220 YPKSLSKEAVSICKGLLTKHPAKRLGCG 247 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCC
Confidence 3444567899999999999999999874
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=328.31 Aligned_cols=238 Identities=23% Similarity=0.347 Sum_probs=190.9
Q ss_pred eeeecceEEEEEEEc--CeEEEEEEeccCCcc---cHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccCCCch
Q 003481 478 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSL 550 (816)
Q Consensus 478 LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL 550 (816)
||+|+||.||++.+. ++.||+|.+...... ....+..|+.++..++||||+++++++.. ..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999875 789999998754332 23457789999999999999999998743 48899999999999
Q ss_pred hhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCc
Q 003481 551 QDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 629 (816)
Q Consensus 551 ~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 629 (816)
.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~----- 152 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS----- 152 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-----
Confidence 98875432 2346899999999999999999999987 99999999999999999999999999987654321
Q ss_pred cccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCccccccCCCCCCCCHHHHH
Q 003481 630 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPTFVAR 707 (816)
Q Consensus 630 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~~~~~~~~~ 707 (816)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+... ++.. ...++...+.
T Consensus 153 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~ 226 (280)
T cd05608 153 -KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR----ILND-SVTYPDKFSP 226 (280)
T ss_pred -cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHh----hccc-CCCCcccCCH
Confidence 123457899999999999999999999999999999999999999643211 1111111 1111 1133445677
Q ss_pred HHHHHHHHhhccCCCCCCCChH
Q 003481 708 RLVDLGLQCCELYGRERPDITP 729 (816)
Q Consensus 708 ~l~~Li~~cl~~dP~~RPs~~e 729 (816)
.+.+|+.+||+.||.+||++.+
T Consensus 227 ~~~~li~~~l~~~P~~R~~~~~ 248 (280)
T cd05608 227 ASKSFCEALLAKDPEKRLGFRD 248 (280)
T ss_pred HHHHHHHHHhcCCHHHhcCCCC
Confidence 8999999999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=325.48 Aligned_cols=251 Identities=30% Similarity=0.524 Sum_probs=207.0
Q ss_pred HhcCCCccceeeeecceEEEEEEEc-CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeec
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 544 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 544 (816)
...+|...++||.|+||.||+|.+. +..|++|++..........+.+|+.++..++||||+++++++.+ ..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 3457888899999999999999886 68899999987766566789999999999999999999998843 47899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+++++|.+++..... ..+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999999999976432 46899999999999999999999987 99999999999999999999999999987654321
Q ss_pred cCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCCCCC
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDW 701 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~ 701 (816)
......++..|+|||++....++.++||||||+++|+|++ |+.||..... ....+..+. ....
T Consensus 160 ------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~ 225 (261)
T cd05148 160 ------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGY--------RMPC 225 (261)
T ss_pred ------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCC--------cCCC
Confidence 1223446778999999988899999999999999999998 8999964332 222222111 1122
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHH
Q 003481 702 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 737 (816)
Q Consensus 702 ~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~ 737 (816)
+...+..+.+++.+||+.+|.+||++. ++.+.|+.
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~-~l~~~L~~ 260 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFK-ALREELDN 260 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHH-HHHHHHhc
Confidence 334557899999999999999999999 78788764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=339.64 Aligned_cols=252 Identities=25% Similarity=0.318 Sum_probs=199.9
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++|.+.+.||+|+||.||+|.+. +..||||++..... .....+..|+.++..++||||+++++++.+ ..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47889999999999999999986 89999999975432 334568899999999999999999998844 588999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++|+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999765 35889999999999999999999987 999999999999999999999999999876543
Q ss_pred CCc-----------------------CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChH
Q 003481 623 TLY-----------------------LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG 679 (816)
Q Consensus 623 ~~~-----------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~ 679 (816)
... ...........||+.|+|||++.+..++.++|||||||+||+|++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 200 000012234579999999999999999999999999999999999999997544
Q ss_pred HHHH--HhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCC-ChHHHHH
Q 003481 680 EVRR--AVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPD-ITPSLVK 733 (816)
Q Consensus 680 ~~~~--~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs-~~e~l~~ 733 (816)
.... .+... .....-+... ..+..+.+|+.+|+. +|.+||+ +.+.+.+
T Consensus 235 ~~~~~~~i~~~-~~~~~~p~~~----~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQETYNKIINW-KESLRFPPDP----PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHHHHHHhcc-CCcccCCCCC----CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 3221 11110 0001011111 146789999999998 9999999 7755543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=341.58 Aligned_cols=241 Identities=25% Similarity=0.396 Sum_probs=188.3
Q ss_pred CCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccC
Q 003481 472 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLP 546 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~ 546 (816)
|...++||+|+||.||+|++. ++.||||++..... .....+.+|+.++..++|+||+++++++.+ ..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 445678999999999999885 78999999865433 234568899999999999999999999854 5889999999
Q ss_pred CCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcC
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626 (816)
Q Consensus 547 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 626 (816)
+|+|.+.. .+.+..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 156 ~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 223 (353)
T PLN00034 156 GGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-- 223 (353)
T ss_pred CCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence 99986532 3456778899999999999999988 99999999999999999999999999987653221
Q ss_pred CCccccCCCCCCCCCCCcccccc-----CCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCC
Q 003481 627 PSFHRSTAPKGSFPYADPEYHRT-----GVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAG 699 (816)
Q Consensus 627 ~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~ 699 (816)
......||..|+|||++.. ...+.++|||||||++|||++|+.||..... ......... .....
T Consensus 224 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~ 294 (353)
T PLN00034 224 ----PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-----MSQPP 294 (353)
T ss_pred ----cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-----ccCCC
Confidence 1234579999999998743 2345699999999999999999999963211 111111000 00111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 700 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 700 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
..+...+..+.+|+.+||+.||.+||++.+.+.+
T Consensus 295 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 2233456789999999999999999999965544
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=335.82 Aligned_cols=230 Identities=27% Similarity=0.397 Sum_probs=188.3
Q ss_pred ceeeeecceEEEEEEE-----cCeEEEEEEeccCCc----ccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeec
Q 003481 476 FKVGQGGFGCVYKGEM-----LGRTVAIKMLYSHNM----QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 544 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~-----~g~~vAiK~l~~~~~----~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 544 (816)
+.||+|+||.||+++. .++.||+|++..... .....+.+|+.+|..++||||++++++|.. ..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 378899999875322 223457789999999999999999998843 47899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999986643 5788889999999999999999988 99999999999999999999999999875432221
Q ss_pred cCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCccccccCCCCCCCC
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWP 702 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~~~~ 702 (816)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+..+. ..+|
T Consensus 156 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~---------~~~~ 220 (323)
T cd05584 156 ------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK---------LNLP 220 (323)
T ss_pred ------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC---------CCCC
Confidence 123457999999999999888999999999999999999999999754432 12222221 1234
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCC
Q 003481 703 TFVARRLVDLGLQCCELYGRERPD 726 (816)
Q Consensus 703 ~~~~~~l~~Li~~cl~~dP~~RPs 726 (816)
...+..+.+|+.+||+.+|.+||+
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~~ 244 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRLG 244 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcCC
Confidence 445678999999999999999994
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=339.50 Aligned_cols=229 Identities=26% Similarity=0.325 Sum_probs=187.1
Q ss_pred ceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccCCC
Q 003481 476 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNG 548 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~g 548 (816)
+.||+|+||.||++... |..||+|++..... .....+.+|+.++..++||||+++++++.. ..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999874 88999999975432 233467789999999999999999998843 588999999999
Q ss_pred chhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 549 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS-SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 549 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
+|..++.... .+++..+..|+.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--- 151 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--- 151 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---
Confidence 9998886543 58999999999999999999997 56 99999999999999999999999999876432221
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCCCCCHHH
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFV 705 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~~ 705 (816)
......||+.|+|||++.+..++.++|||||||+||+|+||..||..... ....+..+. ..+|...
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~---------~~~p~~~ 219 (325)
T cd05594 152 ---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---------IRFPRTL 219 (325)
T ss_pred ---ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC---------CCCCCCC
Confidence 12345699999999999999999999999999999999999999964432 112221111 1234445
Q ss_pred HHHHHHHHHHhhccCCCCCC
Q 003481 706 ARRLVDLGLQCCELYGRERP 725 (816)
Q Consensus 706 ~~~l~~Li~~cl~~dP~~RP 725 (816)
+..+.+|+.+||+.||.+|+
T Consensus 220 ~~~~~~li~~~L~~dP~~R~ 239 (325)
T cd05594 220 SPEAKSLLSGLLKKDPKQRL 239 (325)
T ss_pred CHHHHHHHHHHhhcCHHHhC
Confidence 67899999999999999997
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=335.85 Aligned_cols=237 Identities=27% Similarity=0.346 Sum_probs=193.8
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcC-CCCceeeEecccc--CCcccee
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACP--EAWSLVY 542 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~g~~~--~~~~lV~ 542 (816)
+|...+.||+|+||.||+|... +..||||++..... .....+..|..++..+ +||+|+++++++. +..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5788899999999999999886 67899999876432 2234566788888877 5899999998874 3588999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999886543 5888999999999999999999987 999999999999999999999999999764322
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCCC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~ 700 (816)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ....+..+. ..
T Consensus 155 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---------~~ 219 (323)
T cd05616 155 GV------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---------VA 219 (323)
T ss_pred CC------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------CC
Confidence 21 22455799999999999999999999999999999999999999975443 222222221 12
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCCh
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDIT 728 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~ 728 (816)
+|...+..+.+|+.+||+.+|.+|++..
T Consensus 220 ~p~~~s~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05616 220 YPKSMSKEAVAICKGLMTKHPGKRLGCG 247 (323)
T ss_pred CCCcCCHHHHHHHHHHcccCHHhcCCCC
Confidence 3445667899999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=361.44 Aligned_cols=251 Identities=31% Similarity=0.536 Sum_probs=207.2
Q ss_pred CCCccceeeeecceEEEEEEEc---Ce----EEEEEEeccCC-cccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccc
Q 003481 471 NFSESFKVGQGGFGCVYKGEML---GR----TVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 540 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~---g~----~vAiK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 540 (816)
+......||+|.||.||.|... |. .||||.+.... .+...+|.+|..+|+.++|||||+++|+|.+ ..+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 3455678999999999999885 33 49999997764 4566789999999999999999999999944 5889
Q ss_pred eeeccCCCchhhhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccc
Q 003481 541 VYEYLPNGSLQDRLFRKS----NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 616 (816)
Q Consensus 541 V~E~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 616 (816)
++|||.+|+|..+|.... ....|+..+.+.|+.|||.|+.||++.+ +|||||...|+||+....|||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchh
Confidence 999999999999998752 1356899999999999999999999988 999999999999999999999999999
Q ss_pred eeccCCCCcCCCccccCCC-CCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHH-HhhcCccc
Q 003481 617 RLVTEDTLYLPSFHRSTAP-KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRR-AVSCGKLS 691 (816)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~-~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~-~~~~~~~~ 691 (816)
+.+-....+ +.... .-...|||||.+..+.+|.|+|||||||+|||++| |..||...+. +.. ....|++
T Consensus 850 rDiy~~~yy-----r~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL- 923 (1025)
T KOG1095|consen 850 RDIYDKDYY-----RKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL- 923 (1025)
T ss_pred Hhhhhchhe-----eccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc-
Confidence 965544432 22222 33457999999999999999999999999999999 9999976554 223 2333322
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhh
Q 003481 692 SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 692 ~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~ 739 (816)
+.|..++..+.+|+.+||+.+|++||++. .|++.+..+.
T Consensus 924 --------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~-~i~~q~~~i~ 962 (1025)
T KOG1095|consen 924 --------DPPSYCPEKLYQLMLQCWKHDPEDRPSFR-TIVEQDPAIS 962 (1025)
T ss_pred --------CCCCCCChHHHHHHHHHccCChhhCccHH-HHHhhhhhhh
Confidence 33666778999999999999999999999 6767666653
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=334.05 Aligned_cols=253 Identities=30% Similarity=0.480 Sum_probs=200.7
Q ss_pred cCCCccceeeeecceEEEEEEEc-------CeEEEEEEeccCCcc-cHHHHHHHHHHHhcC-CCCceeeEecccc---CC
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKL-QHPHLVTLLGACP---EA 537 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~-------g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l-~HpnIv~l~g~~~---~~ 537 (816)
++|.+.+.||.|+||.||+|... ++.||+|++...... ....+..|+.++.++ +||||++++++|. ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46888899999999999999653 367999998754322 334677899999999 8999999999874 24
Q ss_pred ccceeeccCCCchhhhhhhcCC----------------------------------------------------------
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSN---------------------------------------------------------- 559 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 559 (816)
.+++|||+++|+|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 7899999999999998864321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCccccCCCCCCC
Q 003481 560 VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 639 (816)
Q Consensus 560 ~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~ 639 (816)
..+++|..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...... .......++.
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~----~~~~~~~~~~ 239 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----VRKGDARLPL 239 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcch----hhccCCCCCc
Confidence 136899999999999999999999987 999999999999999999999999999876433211 1223445678
Q ss_pred CCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChH---HHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHH
Q 003481 640 PYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG---EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQ 715 (816)
Q Consensus 640 ~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~---~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~ 715 (816)
.|+|||++.+..++.++|||||||+||||++ |..||.... .....+..+... ..+...+..+.+++.+
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~~ 311 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM--------RAPEYATPEIYSIMLD 311 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC--------CCCccCCHHHHHHHHH
Confidence 8999999999999999999999999999998 999996422 222222222111 1123345689999999
Q ss_pred hhccCCCCCCCChHHHHHHHHHh
Q 003481 716 CCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 716 cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
||+.+|.+||++. ++++.|+.+
T Consensus 312 cl~~~p~~RPs~~-ell~~l~~~ 333 (337)
T cd05054 312 CWHNNPEDRPTFS-ELVEILGDL 333 (337)
T ss_pred HccCChhhCcCHH-HHHHHHHHH
Confidence 9999999999999 677777765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=317.82 Aligned_cols=243 Identities=28% Similarity=0.469 Sum_probs=196.3
Q ss_pred eeeeecceEEEEEEEc----CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEecccc-CCccceeeccCCCc
Q 003481 477 KVGQGGFGCVYKGEML----GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP-EAWSLVYEYLPNGS 549 (816)
Q Consensus 477 ~LG~G~~g~Vy~~~~~----g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~lV~E~~~~gs 549 (816)
.||+|+||.||+|.+. +..||+|++..... .....|.+|+.++..+.||||++++|++. +..++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 5899999999999753 67899999865433 23457899999999999999999999985 45789999999999
Q ss_pred hhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCc
Q 003481 550 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 629 (816)
Q Consensus 550 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 629 (816)
|.+++.... .+++..++.|+.|++.||.|||+.+ |+||||||.|||++.++.+||+|||++..........
T Consensus 82 L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~--- 152 (257)
T cd05116 82 LNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY--- 152 (257)
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCee---
Confidence 999986543 5889999999999999999999987 9999999999999999999999999998765432110
Q ss_pred cccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChH--HHHHHhhcCccccccCCCCCCCCHHHH
Q 003481 630 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPTFVA 706 (816)
Q Consensus 630 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~--~~~~~~~~~~~~~~~d~~~~~~~~~~~ 706 (816)
.......++..|+|||.+....++.++|||||||++|||++ |..||.... .....+..+.. ...|...+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~--------~~~~~~~~ 224 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER--------MECPQRCP 224 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCC--------CCCCCCCC
Confidence 11122345678999999988889999999999999999998 999996433 23333333221 12334456
Q ss_pred HHHHHHHHHhhccCCCCCCCChHHHHHHHHH
Q 003481 707 RRLVDLGLQCCELYGRERPDITPSLVKELEQ 737 (816)
Q Consensus 707 ~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~ 737 (816)
..+.+||.+||+.||.+||++. .|.+.|+.
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~-~i~~~l~~ 254 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFA-VVELRLRN 254 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHH-HHHHHHhc
Confidence 7899999999999999999998 77777764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=323.13 Aligned_cols=251 Identities=28% Similarity=0.466 Sum_probs=201.7
Q ss_pred cCCCccceeeeecceEEEEEEEc-------CeEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCceeeEeccccC--Ccc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWS 539 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~-------g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~ 539 (816)
.+|.+.+.||+|+||.||+|... +..||||.+...... ....|.+|+.+|..++||||+++++++.. ..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45777889999999999999763 367999998765444 45679999999999999999999999843 589
Q ss_pred ceeeccCCCchhhhhhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCe
Q 003481 540 LVYEYLPNGSLQDRLFRKS-----------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 608 (816)
Q Consensus 540 lV~E~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 608 (816)
+||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999997542 1245889999999999999999999987 9999999999999999999
Q ss_pred eEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHh
Q 003481 609 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAV 685 (816)
Q Consensus 609 kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~ 685 (816)
||+|||++......... .......+++.|+|||++.+..+++++|||||||++|+|++ |..||..... ....+
T Consensus 162 kl~d~g~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred EECCcccceecccCcce----ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 99999999765432211 11234456788999999999999999999999999999998 9999854332 22223
Q ss_pred hcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 686 SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 686 ~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
..+... ..+...+..+.+++.+||+.||.+||++. ++++.|+
T Consensus 238 ~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-eil~~l~ 279 (280)
T cd05049 238 TQGRLL--------QRPRTCPSEVYDIMLGCWKRDPQQRINIK-DIHERLQ 279 (280)
T ss_pred HcCCcC--------CCCCCCCHHHHHHHHHHcCCCcccCCCHH-HHHHHhh
Confidence 333221 12233556899999999999999999998 5666554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=317.77 Aligned_cols=249 Identities=32% Similarity=0.466 Sum_probs=201.3
Q ss_pred cCCCccceeeeecceEEEEEEEc-CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC-CccceeeccCC
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPN 547 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~~~ 547 (816)
++|.+.+.||+|+||.||+|... +..||+|.+..... ....|.+|+.++++++||||+++++++.+ ..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCC
Confidence 46788899999999999999876 67899999876443 34578999999999999999999998743 57899999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
++|.+++.... ...+++..++.++.+++.||.|||+.+ |+||||||+||+++.++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-- 158 (260)
T cd05070 85 GSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-- 158 (260)
T ss_pred CcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc--
Confidence 99999986543 245899999999999999999999988 999999999999999999999999999876543211
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCCCCCCHH
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTF 704 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~ 704 (816)
......++..|+|||++.+..++.++||||||+++|+|++ |..||..... ....+..+. ....+..
T Consensus 159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 227 (260)
T cd05070 159 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY--------RMPCPQD 227 (260)
T ss_pred ---cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------CCCCCCc
Confidence 1122345678999999988899999999999999999999 8999964332 222222111 1122344
Q ss_pred HHHHHHHHHHHhhccCCCCCCCChHHHHHHHHH
Q 003481 705 VARRLVDLGLQCCELYGRERPDITPSLVKELEQ 737 (816)
Q Consensus 705 ~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~ 737 (816)
.+..+.+|+.+||..+|.+||++. .+...|+.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rpt~~-~l~~~l~~ 259 (260)
T cd05070 228 CPISLHELMLQCWKKDPEERPTFE-YLQSFLED 259 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHH-HHHHHHhc
Confidence 566899999999999999999999 67677653
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=317.34 Aligned_cols=244 Identities=28% Similarity=0.439 Sum_probs=199.8
Q ss_pred cCCCccceeeeecceEEEEEEEcCeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc---CCccceeeccC
Q 003481 470 CNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP---EAWSLVYEYLP 546 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~---~~~~lV~E~~~ 546 (816)
.+|...+.||+|+||.||++...|..||+|.+.... ....|.+|+.++++++|+|++++++++. +..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 367888899999999999999999999999986433 3457889999999999999999999752 34789999999
Q ss_pred CCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcC
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626 (816)
Q Consensus 547 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 626 (816)
+++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 84 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999876442 45889999999999999999999987 9999999999999999999999999987654321
Q ss_pred CCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChH--HHHHHhhcCccccccCCCCCCCCH
Q 003481 627 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPT 703 (816)
Q Consensus 627 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~--~~~~~~~~~~~~~~~d~~~~~~~~ 703 (816)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||.... .....+..+.. ...+.
T Consensus 157 ------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~ 222 (256)
T cd05082 157 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------MDAPD 222 (256)
T ss_pred ------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------CCCCC
Confidence 22345678999999998899999999999999999998 999986432 22222222211 12233
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHH
Q 003481 704 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 737 (816)
Q Consensus 704 ~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~ 737 (816)
..+..+.+++.+||+.+|.+||++. .+...|+.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~-~l~~~l~~ 255 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFL-QLREQLEH 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHH-HHHHHHhc
Confidence 4567899999999999999999999 66677664
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=312.43 Aligned_cols=252 Identities=24% Similarity=0.315 Sum_probs=200.1
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCccc--HHHHHHHHHHHhcCCCCceeeEeccc----cCCcccee
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLGAC----PEAWSLVY 542 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~g~~----~~~~~lV~ 542 (816)
+|...+.|++|.||.||+|++. +..||+|+++...... .-.-.+|+.+|.+++|||||.+-.+. -+..|+||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 4666788999999999999986 7899999997764321 12357999999999999999986554 45699999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
|||+. +|..+|.... .++...++.-+..|++.||+|||.+. |+||||||+|+|+...|.+||+|||+|+.+...
T Consensus 157 e~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 99965 8988887665 57888999999999999999999998 999999999999999999999999999988764
Q ss_pred CCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhh----cCccccccCC-
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGKLSSILDP- 696 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~----~~~~~~~~d~- 696 (816)
. ...+..+-|..|.|||.+.+ ..|+++.|+||+|||+.||+++++.|.+..++.+... -|.-.+.+-|
T Consensus 231 ~------k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 231 L------KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred c------ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence 3 24577789999999998765 4799999999999999999999999976655433211 1111111000
Q ss_pred -------------------CCCCCCHH-HHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 697 -------------------LAGDWPTF-VARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 697 -------------------~~~~~~~~-~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
....++.. .++.-.+|+..+|.+||.+|.|+.+.|.+.
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~ 362 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE 362 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence 01112222 456788999999999999999999765443
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=334.37 Aligned_cols=232 Identities=27% Similarity=0.364 Sum_probs=189.8
Q ss_pred ceeeeecceEEEEEEEc--CeEEEEEEeccCC---cccHHHHHHHHHHHhcC-CCCceeeEeccccC--CccceeeccCC
Q 003481 476 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVYEYLPN 547 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV~E~~~~ 547 (816)
+.||+|+||.||+|++. ++.||||++.... ......+..|..++..+ +||||+++++++.+ ..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999885 7899999987542 23345677888888876 79999999998844 58899999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--- 151 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--- 151 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC---
Confidence 99999886543 5889999999999999999999988 99999999999999999999999999876432211
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCCCCCHHH
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFV 705 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~~ 705 (816)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+.. .++...
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~---------~~~~~~ 219 (320)
T cd05590 152 ---TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV---------VYPTWL 219 (320)
T ss_pred ---cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC---------CCCCCC
Confidence 22345799999999999999999999999999999999999999975443 2222222211 223345
Q ss_pred HHHHHHHHHHhhccCCCCCCCCh
Q 003481 706 ARRLVDLGLQCCELYGRERPDIT 728 (816)
Q Consensus 706 ~~~l~~Li~~cl~~dP~~RPs~~ 728 (816)
+..+.+|+.+||+.||.+||+..
T Consensus 220 ~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 220 SQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred CHHHHHHHHHHcccCHHHCCCCC
Confidence 67889999999999999999984
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=356.65 Aligned_cols=264 Identities=22% Similarity=0.254 Sum_probs=205.7
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc---cHHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++|.+.++||+|+||.||+|.+. |+.||||++...... ....|.+|+.++++++||||+++++++.+ ..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57889999999999999999885 789999998754322 24568999999999999999999999854 478999
Q ss_pred eccCCCchhhhhhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecc
Q 003481 543 EYLPNGSLQDRLFRKS--------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 614 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 614 (816)
||++||+|.+++.... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 1234677888999999999999999987 9999999999999999999999999
Q ss_pred cceeccCCCCc------------CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHH
Q 003481 615 ICRLVTEDTLY------------LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR 682 (816)
Q Consensus 615 la~~~~~~~~~------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~ 682 (816)
+++........ ...........||+.|+|||++.+..++.++|||||||++|||+||..||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99876221100 000111234579999999999999999999999999999999999999996433211
Q ss_pred HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhhh
Q 003481 683 RAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740 (816)
Q Consensus 683 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~~ 740 (816)
... ...+ .++.........+..+.+++.+||..||.+||+..+++.+.|+....
T Consensus 239 i~~-~~~i---~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISY-RDVI---LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhh-hhhc---cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111 1111 11111001123456789999999999999999988899998887643
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=323.55 Aligned_cols=243 Identities=23% Similarity=0.315 Sum_probs=191.1
Q ss_pred eeeecceEEEEEEEc--CeEEEEEEeccCCcc---cHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccCCCch
Q 003481 478 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSL 550 (816)
Q Consensus 478 LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL 550 (816)
||+|+||.||++... |..||+|.+...... ....+..|+.++.+++||||+++++++.+ ..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 889999998653321 23345679999999999999999998843 48899999999999
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCcc
Q 003481 551 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 630 (816)
Q Consensus 551 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 630 (816)
.+++..... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~------- 149 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK------- 149 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-------
Confidence 988865432 35889999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCCCCCHHHHHH
Q 003481 631 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARR 708 (816)
Q Consensus 631 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 708 (816)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+....+...+.. .....+..
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 225 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF----EHQNFTEE 225 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc----ccccCCHH
Confidence 12345689999999999988899999999999999999999999964321 1111111111111110 11234567
Q ss_pred HHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 709 LVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 709 l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
+.+|+.+||+.||.+||++.+.+.+.+
T Consensus 226 ~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 226 SKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred HHHHHHHHhccCHhhCCCCccchhhhh
Confidence 899999999999999999985554443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=318.52 Aligned_cols=251 Identities=28% Similarity=0.445 Sum_probs=201.6
Q ss_pred cCCCccceeeeecceEEEEEEEc-----CeEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCceeeEeccccC--Cccce
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 541 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~-----g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 541 (816)
++|...+.||+|+||.||+|.+. ...||||.+...... ....|.+|+.++.+++||||+++++++.+ ..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 56888999999999999999874 347999998755432 34578899999999999999999998843 47899
Q ss_pred eeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999987644 36899999999999999999999987 99999999999999999999999999988752
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLA 698 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~ 698 (816)
.... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ....+..+.. .+
T Consensus 159 ~~~~----~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~----~~-- 228 (266)
T cd05033 159 SEAT----YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR----LP-- 228 (266)
T ss_pred cccc----eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC----CC--
Confidence 2211 11223345678999999998899999999999999999998 9999854332 2222222211 11
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 699 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 699 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
.+...+..+.+|+.+||+.+|.+||++. ++...|+.+
T Consensus 229 --~~~~~~~~l~~li~~cl~~~p~~Rp~~~-ei~~~l~~~ 265 (266)
T cd05033 229 --PPMDCPSALYQLMLDCWQKDRNERPTFS-QIVSTLDKM 265 (266)
T ss_pred --CCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHhh
Confidence 1223456789999999999999999999 677777654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=331.67 Aligned_cols=235 Identities=29% Similarity=0.368 Sum_probs=189.4
Q ss_pred ceeeeecceEEEEEEEc--CeEEEEEEeccCC---cccHHHHHHHHHHHhcC-CCCceeeEeccccC--CccceeeccCC
Q 003481 476 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVYEYLPN 547 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV~E~~~~ 547 (816)
+.||+|+||.||+|.+. +..||||++.... ......+..|..++..+ +||||+++++++.+ ..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999886 6789999987642 22334566788888764 99999999999843 58899999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 151 (316)
T cd05619 81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--- 151 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---
Confidence 9999998654 35889999999999999999999987 99999999999999999999999999875432211
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCCCCCHHH
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFV 705 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~~ 705 (816)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+. ..++...
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~---------~~~~~~~ 219 (316)
T cd05619 152 ---KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN---------PCYPRWL 219 (316)
T ss_pred ---ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------CCCCccC
Confidence 12345699999999999988999999999999999999999999965432 222222111 1123345
Q ss_pred HHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 706 ARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 706 ~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
+..+.+|+.+||+.||.+||++.+.+
T Consensus 220 ~~~~~~li~~~l~~~P~~R~~~~~~l 245 (316)
T cd05619 220 TREAKDILVKLFVREPERRLGVKGDI 245 (316)
T ss_pred CHHHHHHHHHHhccCHhhcCCChHHH
Confidence 66889999999999999999997433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=322.76 Aligned_cols=260 Identities=27% Similarity=0.401 Sum_probs=200.5
Q ss_pred cCCCccceeeeecceEEEEEEE------cCeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc----CCcc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEM------LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP----EAWS 539 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~------~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~----~~~~ 539 (816)
.+|.+.+.||+|+||.||++.. .+..||+|.+..........|.+|+.++.+++||||+++++++. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678889999999999999974 26789999987766555667899999999999999999999762 2478
Q ss_pred ceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceec
Q 003481 540 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 619 (816)
Q Consensus 540 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 619 (816)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 9999999999999986543 35899999999999999999999987 999999999999999999999999999876
Q ss_pred cCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH-HHHhhcCcc--------
Q 003481 620 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV-RRAVSCGKL-------- 690 (816)
Q Consensus 620 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~-~~~~~~~~~-------- 690 (816)
....... .......++..|+|||++.+..++.++|||||||++|||++|..|+...... ...+.....
T Consensus 159 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 159 PQDKEYY---KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred cCCCcce---eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 5433110 0112223455699999998889999999999999999999998776433221 111111000
Q ss_pred ccccC-CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 691 SSILD-PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 691 ~~~~d-~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
...+. ......+...+..+.+|+.+||..+|.+|||+. ++...|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~-ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFS-ELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHH-HHHHHHHhc
Confidence 00000 001112233456899999999999999999999 677777754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=336.58 Aligned_cols=231 Identities=24% Similarity=0.318 Sum_probs=188.1
Q ss_pred ceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcC-CCCceeeEeccccC--CccceeeccCC
Q 003481 476 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVYEYLPN 547 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV~E~~~~ 547 (816)
+.||+|+||.||++.+. +..||+|++..... .....+..|..++..+ +||||++++++|.+ ..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999885 78999999976432 2334578899999998 79999999999844 48999999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~---- 150 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG---- 150 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC----
Confidence 99998886543 5899999999999999999999988 9999999999999999999999999987532211
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChH-----------HHHHHhhcCccccccCC
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG-----------EVRRAVSCGKLSSILDP 696 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~-----------~~~~~~~~~~~~~~~d~ 696 (816)
.......||+.|+|||++.+..++.++|||||||++|+|+||+.||.... .....+..+
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-------- 220 (329)
T cd05588 151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK-------- 220 (329)
T ss_pred --CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--------
Confidence 12234579999999999999999999999999999999999999995321 111111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCC
Q 003481 697 LAGDWPTFVARRLVDLGLQCCELYGRERPDI 727 (816)
Q Consensus 697 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~ 727 (816)
....|...+..+.+|+.+||+.||.+||+.
T Consensus 221 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 221 -QIRIPRSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred -CCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 112344456789999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=332.50 Aligned_cols=235 Identities=27% Similarity=0.365 Sum_probs=189.5
Q ss_pred ceeeeecceEEEEEEEc--CeEEEEEEeccCC---cccHHHHHHHHHHHhcC-CCCceeeEeccccC--CccceeeccCC
Q 003481 476 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVYEYLPN 547 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV~E~~~~ 547 (816)
+.||+|+||.||+|.+. |..||+|++.... ......+..|..++..+ +||||+++++++.+ ..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999885 7899999997542 12334567788888754 89999999998844 57899999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
|+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 150 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---- 150 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC----
Confidence 99999886543 5888999999999999999999988 9999999999999999999999999987532211
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCCCCCHHH
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFV 705 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~~ 705 (816)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+. ....+..+ ...++...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~---------~~~~~~~~ 219 (316)
T cd05620 151 --NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD---------TPHYPRWI 219 (316)
T ss_pred --CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC---------CCCCCCCC
Confidence 122445799999999999999999999999999999999999999964433 12222111 11223345
Q ss_pred HHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 706 ARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 706 ~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
+..+.+|+.+||+.||.+||++.+++
T Consensus 220 ~~~~~~li~~~l~~dP~~R~~~~~~~ 245 (316)
T cd05620 220 TKESKDILEKLFERDPTRRLGVVGNI 245 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHH
Confidence 67889999999999999999986444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=317.17 Aligned_cols=250 Identities=34% Similarity=0.457 Sum_probs=202.2
Q ss_pred cCCCccceeeeecceEEEEEEEc-CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc-CCccceeeccCC
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP-EAWSLVYEYLPN 547 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~lV~E~~~~ 547 (816)
++|.+.++||+|+||.||+|.+. +..||+|.+..... ....|.+|+.++.+++||||+++++++. +..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCC
Confidence 56889999999999999999886 45799999875432 3457899999999999999999999874 457899999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.........
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-- 158 (262)
T cd05071 85 GSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-- 158 (262)
T ss_pred CcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc--
Confidence 99999997543 235799999999999999999999987 999999999999999999999999999876543211
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCCCCCCHH
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTF 704 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~ 704 (816)
......++..|+|||+..+..++.++|||||||++|+|+| |..||..... ....+..+. ....+..
T Consensus 159 ---~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 227 (262)
T cd05071 159 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--------RMPCPPE 227 (262)
T ss_pred ---cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCC--------CCCCccc
Confidence 1123446778999999988899999999999999999999 8889864322 222221111 0112334
Q ss_pred HHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 705 VARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 705 ~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
.+..+.+|+.+||+.+|.+||++. .+...|+.+
T Consensus 228 ~~~~l~~li~~~l~~~p~~Rp~~~-~~~~~l~~~ 260 (262)
T cd05071 228 CPESLHDLMCQCWRKEPEERPTFE-YLQAFLEDY 260 (262)
T ss_pred cCHHHHHHHHHHccCCcccCCCHH-HHHHHHHHh
Confidence 567899999999999999999999 677777754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=335.76 Aligned_cols=237 Identities=28% Similarity=0.383 Sum_probs=193.2
Q ss_pred ceeeeecceEEEEEEE-----cCeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccC
Q 003481 476 FKVGQGGFGCVYKGEM-----LGRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLP 546 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~-----~g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~ 546 (816)
+.||+|+||.||+++. .|..||+|++..... .....+.+|+.+|.+++||||+++++++.+ ..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 378999999975432 233457789999999999999999999843 4889999999
Q ss_pred CCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcC
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626 (816)
Q Consensus 547 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 626 (816)
+|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 999999986543 5899999999999999999999988 99999999999999999999999999886543321
Q ss_pred CCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCccccccCCCCCCCCHH
Q 003481 627 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPTF 704 (816)
Q Consensus 627 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~~~~~~ 704 (816)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+..+. ..+|..
T Consensus 154 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~---------~~~p~~ 220 (318)
T cd05582 154 ----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK---------LGMPQF 220 (318)
T ss_pred ----ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC---------CCCCCC
Confidence 123457999999999999888999999999999999999999999754432 12221111 123444
Q ss_pred HHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 705 VARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 705 ~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
.+..+.+|+.+||+.||.+||++.++++.
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~~~~~ 249 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGPDGVE 249 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCCCCHH
Confidence 56789999999999999999998754333
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=323.01 Aligned_cols=257 Identities=28% Similarity=0.422 Sum_probs=199.0
Q ss_pred CC-CccceeeeecceEEEEEEE------cCeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEeccccC----Cc
Q 003481 471 NF-SESFKVGQGGFGCVYKGEM------LGRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AW 538 (816)
Q Consensus 471 ~f-~~~~~LG~G~~g~Vy~~~~------~g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~ 538 (816)
+| ...+.||+|+||.||++.. .+..||+|.+..... .....|.+|+.+|++++||||++++++|.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 44 7888999999999988753 267899999876533 345578899999999999999999998742 36
Q ss_pred cceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccccee
Q 003481 539 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 539 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 618 (816)
++||||+++++|.+++... .+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccc
Confidence 8999999999999998653 4899999999999999999999987 99999999999999999999999999987
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH-HHHHhh--cC-----cc
Q 003481 619 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE-VRRAVS--CG-----KL 690 (816)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~-~~~~~~--~~-----~~ 690 (816)
....... ........++..|+|||++....++.++||||||+++|+|+||..||..... ...... .+ .+
T Consensus 157 ~~~~~~~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05080 157 VPEGHEY---YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL 233 (283)
T ss_pred cCCcchh---hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhh
Confidence 6543211 0111233456779999999888899999999999999999999999864322 111110 00 01
Q ss_pred ccccCCC-CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 691 SSILDPL-AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 691 ~~~~d~~-~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
...++.. ....+...+..+.+++.+||+.+|.+||++. .++..|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~-~i~~~l~~~ 281 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFR-SLIPILKEM 281 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHH-HHHHHHHHh
Confidence 1111111 1112334567899999999999999999999 677787765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=337.36 Aligned_cols=255 Identities=29% Similarity=0.464 Sum_probs=205.5
Q ss_pred cCCCccceeeeecceEEEEEEEc---C--eE-EEEEEeccCC---cccHHHHHHHHHHHhcCCCCceeeEecccc--CCc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML---G--RT-VAIKMLYSHN---MQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAW 538 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~---g--~~-vAiK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~ 538 (816)
++....++||+|.||.||+|++. + .. ||||...... .....+|.+|.+++++++|||||++||++. +..
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 34455589999999999999885 2 23 8999987532 345668999999999999999999999984 458
Q ss_pred cceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccccee
Q 003481 539 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 539 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 618 (816)
+||||+|+||+|.++|.+... .++..+++.++.+.|.||+|||+.+ +|||||-..|+|++.++.+||+|||+++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence 999999999999999987653 6899999999999999999999988 99999999999999999999999999876
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccC
Q 003481 619 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILD 695 (816)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d 695 (816)
...-.. ......-...|+|||.+..+.|++++|||||||++||+++ |..||..... +...+....+
T Consensus 312 ~~~~~~------~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~----- 380 (474)
T KOG0194|consen 312 GSQYVM------KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGY----- 380 (474)
T ss_pred Ccceee------ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCc-----
Confidence 541110 0112235578999999999999999999999999999999 8889975443 3344422111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhhhccc
Q 003481 696 PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE 743 (816)
Q Consensus 696 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~~~~~ 743 (816)
....|...+..+..++.+||..+|++||+|. .+.+.|+.+.....
T Consensus 381 --r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~-~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 381 --RMPIPSKTPKELAKVMKQCWKKDPEDRPTMS-TIKKKLEALEKKKE 425 (474)
T ss_pred --cCCCCCCCHHHHHHHHHHhccCChhhccCHH-HHHHHHHHHHhccc
Confidence 1123345667888999999999999999999 78888887755433
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=339.99 Aligned_cols=256 Identities=21% Similarity=0.249 Sum_probs=194.9
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceee
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 543 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 543 (816)
.|...+.||+|+||.||+|++. +..||||++..... .....+.+|+.++.+++||||+++++++.+ ..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888899999999999999885 78999999976432 233468899999999999999999999853 5889999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
|+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999987643 5888999999999999999999987 9999999999999999999999999986432100
Q ss_pred Cc-----------------------------------------CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHH
Q 003481 624 LY-----------------------------------------LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFG 662 (816)
Q Consensus 624 ~~-----------------------------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlG 662 (816)
.. ...........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 00 0000011245799999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHH--hhccCCCCCCCChHHHHHHH
Q 003481 663 LIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQ--CCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 663 viL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~--cl~~dP~~RPs~~e~l~~~L 735 (816)
|++|||+||..||..................+ .. ......+..+.+|+.+ |+..+|..||++.+.+.+.+
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~~-~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~ 307 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTL--HI-PPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHcccccc--CC-CCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcc
Confidence 99999999999997544322111110000000 00 0111245678888887 55666677999997665543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=337.65 Aligned_cols=246 Identities=19% Similarity=0.226 Sum_probs=190.2
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeecc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 545 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 545 (816)
++|.+.+.||+|+||.||++.+. ++.||||.... ..+.+|+.+|++++||||++++++|. ...++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 57999999999999999999885 78999997532 34678999999999999999999884 4578999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
. ++|..++.... .+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 166 ~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 166 K-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred C-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 5 68888876543 5889999999999999999999987 99999999999999999999999999975432111
Q ss_pred CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChH----------HHHHHhh-cCcc----
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG----------EVRRAVS-CGKL---- 690 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~----------~~~~~~~-~~~~---- 690 (816)
.......||+.|+|||++.+..++.++|||||||+||||+||+.||.... .+...+. .|..
T Consensus 238 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 238 ----NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred ----cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 12234579999999999999999999999999999999999998863211 0100000 0000
Q ss_pred --------ccc---------cCCC-CCCCC--HHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 691 --------SSI---------LDPL-AGDWP--TFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 691 --------~~~---------~d~~-~~~~~--~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
... ..+. ...|. ...+..+.+|+.+||+.||.+|||+.+.+.+
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000 0000 00111 1245689999999999999999999965543
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=319.35 Aligned_cols=253 Identities=27% Similarity=0.424 Sum_probs=201.9
Q ss_pred cCCCccceeeeecceEEEEEEEc--Ce----EEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEeccccC-Cccce
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GR----TVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLV 541 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~----~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV 541 (816)
++|...+.||.|+||.||+|.+. +. .||+|++..... .....+.+|+.++..++||||++++++|.. ..+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~ 86 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLV 86 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEE
Confidence 46788899999999999999864 33 589999875433 334578899999999999999999999844 57899
Q ss_pred eeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
++|+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 87 TQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 99999999999986543 36899999999999999999999987 99999999999999999999999999987754
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChH--HHHHHhhcCccccccCCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLA 698 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~--~~~~~~~~~~~~~~~d~~~ 698 (816)
.... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.... .....+..+...
T Consensus 162 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------- 230 (279)
T cd05109 162 DETE----YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL------- 230 (279)
T ss_pred ccce----eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC-------
Confidence 3211 11223345778999999988899999999999999999998 999986432 222333322211
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhhh
Q 003481 699 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740 (816)
Q Consensus 699 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~~ 740 (816)
..+...+..+.+++.+||..||..||++. .+.+.|+.+..
T Consensus 231 -~~~~~~~~~~~~li~~~l~~dp~~Rp~~~-~l~~~l~~~~~ 270 (279)
T cd05109 231 -PQPPICTIDVYMIMVKCWMIDSECRPRFR-ELVDEFSRMAR 270 (279)
T ss_pred -CCCccCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHhhc
Confidence 11223456889999999999999999999 56677776643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=317.73 Aligned_cols=255 Identities=25% Similarity=0.353 Sum_probs=196.8
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc----C---Cccc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP----E---AWSL 540 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~----~---~~~l 540 (816)
-.|...+++|.|+||.||+|... +..||||+.-.+..- -.+|+.+|+.+.|||||+|+.+|. . ...|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 35667789999999999999986 689999987654432 236999999999999999998872 2 2458
Q ss_pred eeeccCCCchhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCC-CCeeEeeccccee
Q 003481 541 VYEYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRL 618 (816)
Q Consensus 541 V~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DFGla~~ 618 (816)
|||||+. +|.+.+... .....++.-.+.-+..||++||.|||+.+ |+||||||.|||+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999976 888888742 11245777778889999999999999987 9999999999999976 8999999999999
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhh-----------
Q 003481 619 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----------- 686 (816)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~----------- 686 (816)
+..+.. ......|..|.|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.+.+.++..
T Consensus 176 L~~~ep-------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e 248 (364)
T KOG0658|consen 176 LVKGEP-------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE 248 (364)
T ss_pred eccCCC-------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH
Confidence 876653 244567889999997765 5799999999999999999999999975444332211
Q ss_pred ---cC-------ccccccCCCCCC-CCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH-HHhh
Q 003481 687 ---CG-------KLSSILDPLAGD-WPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL-EQLH 739 (816)
Q Consensus 687 ---~~-------~~~~~~d~~~~~-~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L-e~l~ 739 (816)
.. ++..+....... +....++++.+|+.++|.++|.+|.+..+.+.+.+ +.+.
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 00 111111111111 33456778999999999999999999998887765 4443
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=334.20 Aligned_cols=240 Identities=26% Similarity=0.336 Sum_probs=190.6
Q ss_pred ceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHH-HHhcCCCCceeeEecccc--CCccceeeccCC
Q 003481 476 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVR-VLSKLQHPHLVTLLGACP--EAWSLVYEYLPN 547 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~-il~~l~HpnIv~l~g~~~--~~~~lV~E~~~~ 547 (816)
+.||+|+||.||+|.+. |+.||||++..... .....+..|.. +++.++||||+++++++. +..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999985 88999999865422 22234555554 567899999999999884 358899999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
|+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~---- 150 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS---- 150 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC----
Confidence 99999886543 5888999999999999999999988 9999999999999999999999999987543221
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCCCCCHHH
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFV 705 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~~ 705 (816)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...+. ....+..+.. ..+...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---------~~~~~~ 219 (323)
T cd05575 151 --KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL---------RLKPNI 219 (323)
T ss_pred --CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC---------CCCCCC
Confidence 122445699999999999999999999999999999999999999965432 2222222211 122234
Q ss_pred HHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 706 ARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 706 ~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
+..+.+|+.+||+.||.+||++.+.+.+.++
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~il~ 250 (323)
T cd05575 220 SVSARHLLEGLLQKDRTKRLGAKDDFLEIKN 250 (323)
T ss_pred CHHHHHHHHHHhhcCHHhCCCCCCCHHHHHc
Confidence 6789999999999999999999755545444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=317.92 Aligned_cols=251 Identities=24% Similarity=0.401 Sum_probs=197.0
Q ss_pred CCccceeeeecceEEEEEEEc--C--eEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCceeeEeccccC--------C
Q 003481 472 FSESFKVGQGGFGCVYKGEML--G--RTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--------A 537 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~--g--~~vAiK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--------~ 537 (816)
|.+.+.||+|+||.||+|.+. + ..||+|.+.... ......|..|+.++..++||||++++++|.. .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 345678999999999999885 3 269999886543 2334578899999999999999999997621 2
Q ss_pred ccceeeccCCCchhhhhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecc
Q 003481 538 WSLVYEYLPNGSLQDRLFRK---SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 614 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 614 (816)
.++||||+++|+|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 57999999999999887432 12345899999999999999999999977 9999999999999999999999999
Q ss_pred cceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccc
Q 003481 615 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLS 691 (816)
Q Consensus 615 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~ 691 (816)
+++........ .......+++.|++||++....++.++|||||||++|+|++ |+.||..... ....+..+...
T Consensus 158 ~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 233 (272)
T cd05075 158 LSKKIYNGDYY----RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRL 233 (272)
T ss_pred cccccCcccce----ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99876543211 11223346778999999998899999999999999999999 8899964332 22333333221
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 692 SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 692 ~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
..+...+..+.+++.+||+.+|.+||++. .|...|+.+
T Consensus 234 --------~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~l~~~l~~~ 271 (272)
T cd05075 234 --------KQPPDCLDGLYSLMSSCWLLNPKDRPSFE-TLRCELEKA 271 (272)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHhh
Confidence 11223456789999999999999999999 676777653
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=321.46 Aligned_cols=251 Identities=30% Similarity=0.444 Sum_probs=198.7
Q ss_pred cCCCccceeeeecceEEEEEEE------cCeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEM------LGRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSL 540 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~------~g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~l 540 (816)
.+|+..+.||+|+||.||+|.+ .+..|++|.+..... .....|.+|+.+++.++||||+++++++. +..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3567778999999999999985 257899999875433 33457889999999999999999999874 45789
Q ss_pred eeeccCCCchhhhhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCC
Q 003481 541 VYEYLPNGSLQDRLFRKSN--------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL 606 (816)
Q Consensus 541 V~E~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~ 606 (816)
||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999854321 235789999999999999999999987 99999999999999999
Q ss_pred CeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChH--HHHH
Q 003481 607 SSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRR 683 (816)
Q Consensus 607 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~--~~~~ 683 (816)
.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.... .+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYY----RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237 (283)
T ss_pred cEEeccccccccccCCcce----ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999876433211 11233446778999999988889999999999999999998 999986433 2223
Q ss_pred HhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 684 AVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 684 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
.+..+... ..+...+..+.+++.+||+.+|.+||++. .+.+.|.
T Consensus 238 ~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~-~i~~~l~ 281 (283)
T cd05090 238 MVRKRQLL--------PCSEDCPPRMYSLMTECWQEGPSRRPRFK-DIHTRLR 281 (283)
T ss_pred HHHcCCcC--------CCCCCCCHHHHHHHHHHcccCcccCcCHH-HHHHHhh
Confidence 33222211 12333456899999999999999999999 5665554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=321.55 Aligned_cols=251 Identities=26% Similarity=0.358 Sum_probs=199.0
Q ss_pred HHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCceeeEeccccC------
Q 003481 466 QTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE------ 536 (816)
Q Consensus 466 ~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~------ 536 (816)
+.+++.|...+.||+|+||.||+|... +..||+|++.... .....+.+|+.++.++ +||||++++++|..
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 356778999999999999999999885 7889999986543 3455788999999998 79999999998742
Q ss_pred --CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecc
Q 003481 537 --AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 614 (816)
Q Consensus 537 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 614 (816)
..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence 3689999999999999987643 246899999999999999999999987 9999999999999999999999999
Q ss_pred cceeccCCCCcCCCccccCCCCCCCCCCCccccc-----cCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCc
Q 003481 615 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGK 689 (816)
Q Consensus 615 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~ 689 (816)
++....... .......|++.|+|||++. ...++.++|||||||++|+|++|+.||..............
T Consensus 157 ~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~ 230 (272)
T cd06637 157 VSAQLDRTV------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 230 (272)
T ss_pred Cceeccccc------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc
Confidence 998654322 1234557899999999885 34688899999999999999999999964433222211110
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 690 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 690 ~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
.+.....+...+..+.+|+.+||..+|.+||++.+.+.
T Consensus 231 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 -----NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -----CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00000111224567899999999999999999985543
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=319.49 Aligned_cols=248 Identities=25% Similarity=0.309 Sum_probs=196.6
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeecc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 545 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 545 (816)
++|.+.+.||+|+||.||+|+.. +..||+|++..........+.+|+.++.+++||||+++++++. +..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 47889999999999999999874 7889999997665555567889999999999999999999884 4578999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 89 GGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 999999988654 35889999999999999999999987 99999999999999999999999999987643221
Q ss_pred CCCccccCCCCCCCCCCCccccc---cCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCC
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 702 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~ 702 (816)
......|++.|+|||.+. ...++.++|||||||++|+|++|+.||............. ...+.+.....+
T Consensus 162 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~ 234 (267)
T cd06646 162 -----KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMS--KSNFQPPKLKDK 234 (267)
T ss_pred -----ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeee--cCCCCCCCCccc
Confidence 123456889999999874 4457889999999999999999999985433221111100 000111111112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 703 TFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 703 ~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
...+..+.+|+.+||..+|.+||++.+.+
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il 263 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAERLL 263 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence 23456899999999999999999998544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=333.05 Aligned_cols=241 Identities=26% Similarity=0.342 Sum_probs=194.2
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCC-CCceeeEecccc--CCcccee
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQ-HPHLVTLLGACP--EAWSLVY 542 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~-HpnIv~l~g~~~--~~~~lV~ 542 (816)
+|...+.||+|+||.||++... |..||+|++..... .....+..|..++..+. |++|+++++++. +..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4777889999999999999875 78999999875422 23345778999998885 577888888774 3588999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999886543 5899999999999999999999987 999999999999999999999999998764322
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCCC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~ 700 (816)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+. ..
T Consensus 155 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~---------~~ 219 (323)
T cd05615 155 GV------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN---------VS 219 (323)
T ss_pred Cc------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------CC
Confidence 21 12345699999999999988999999999999999999999999975432 222222211 12
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
+|...+..+.+|+.+||+.+|.+|++..+...
T Consensus 220 ~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 251 (323)
T cd05615 220 YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGE 251 (323)
T ss_pred CCccCCHHHHHHHHHHcccCHhhCCCCCCCCH
Confidence 34445678899999999999999999764333
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=335.93 Aligned_cols=238 Identities=29% Similarity=0.388 Sum_probs=190.9
Q ss_pred CCCccceeeeecceEEEEEEE-----cCeEEEEEEeccCCc----ccHHHHHHHHHHHhcC-CCCceeeEeccccC--Cc
Q 003481 471 NFSESFKVGQGGFGCVYKGEM-----LGRTVAIKMLYSHNM----QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AW 538 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~-----~g~~vAiK~l~~~~~----~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~ 538 (816)
+|.+.+.||+|+||.||+++. .+..||+|++..... .....+..|+.++..+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 578889999999999999876 378899999865322 2334678899999999 59999999988844 47
Q ss_pred cceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccccee
Q 003481 539 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 539 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 618 (816)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 89999999999999987643 5889999999999999999999988 99999999999999999999999999986
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHhCCCCCCChH------HHHHHhhcCccc
Q 003481 619 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAG------EVRRAVSCGKLS 691 (816)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~------~~~~~~~~~~~~ 691 (816)
....... ......||+.|+|||++.+. .++.++|||||||++|+|+||+.||.... .+...+..
T Consensus 155 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~---- 225 (332)
T cd05614 155 FLSEEKE-----RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK---- 225 (332)
T ss_pred ccccCCC-----ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc----
Confidence 5432211 12345799999999998765 47899999999999999999999995321 11111111
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCCh
Q 003481 692 SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 728 (816)
Q Consensus 692 ~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~ 728 (816)
....++...+..+.+|+.+||+.||.+||+..
T Consensus 226 -----~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 257 (332)
T cd05614 226 -----CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAG 257 (332)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCC
Confidence 11123444567889999999999999999543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=318.98 Aligned_cols=261 Identities=24% Similarity=0.326 Sum_probs=207.9
Q ss_pred HHHHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEec--cCCcccHHHHHHHHHHHhcCCCCceeeEecccc----
Q 003481 464 DLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLY--SHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP---- 535 (816)
Q Consensus 464 el~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~--~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~---- 535 (816)
+...+...|...+.||.|+||.|..+.+. |..||||++. .......++..+|+.+|+.++|+||+.+++.+.
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 33445566777889999999999999885 8999999997 445556677889999999999999999999872
Q ss_pred ---CCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEee
Q 003481 536 ---EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICD 612 (816)
Q Consensus 536 ---~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~D 612 (816)
.+.|+|+|+| +.+|...|.... .|+...+..++.||++||.|+|+.+ |+||||||+|+|++.+..+||+|
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~D 168 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICD 168 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecc
Confidence 2489999999 668999886543 4888999999999999999999998 99999999999999999999999
Q ss_pred cccceeccCCCCcCCCccccCCCCCCCCCCCcccc-ccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH-------
Q 003481 613 FGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH-RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA------- 684 (816)
Q Consensus 613 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~------- 684 (816)
||+|+..... +.....+..+.|..|.|||++ ....||.+.||||.||||.||++|++-|.+.+.+.+.
T Consensus 169 FGLAR~~~~~----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~l 244 (359)
T KOG0660|consen 169 FGLARYLDKF----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELL 244 (359)
T ss_pred ccceeecccc----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhc
Confidence 9999988643 122345778899999999976 4568999999999999999999999999654443221
Q ss_pred ----------hhcCccccccCCC--C------CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 685 ----------VSCGKLSSILDPL--A------GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 685 ----------~~~~~~~~~~d~~--~------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
+...+....+... . .-+| ...+...+|+.+||..||.+|+|+.++|.+..-
T Consensus 245 GtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl 313 (359)
T KOG0660|consen 245 GTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYL 313 (359)
T ss_pred CCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhh
Confidence 1111111111110 0 1122 456688999999999999999999988877653
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=314.86 Aligned_cols=245 Identities=28% Similarity=0.469 Sum_probs=202.9
Q ss_pred cCCCccceeeeecceEEEEEEEcCeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeeccCC
Q 003481 470 CNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPN 547 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~~ 547 (816)
++|...+.||.|+||.||+|...|+.||+|.+..... ....+.+|+.++..++|+||+++++++. +..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 4678889999999999999999999999999976544 4567899999999999999999999884 458899999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
++|.+++..... ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++......
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---- 156 (256)
T cd05039 85 GSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---- 156 (256)
T ss_pred CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc----
Confidence 999999876542 35899999999999999999999988 9999999999999999999999999998764322
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCCCCCCHH
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTF 704 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~ 704 (816)
....++..|+|||++..+.++.++||||||+++|+|++ |..||..... ....+..+.. ...+..
T Consensus 157 -----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~ 223 (256)
T cd05039 157 -----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR--------MEAPEG 223 (256)
T ss_pred -----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC--------CCCccC
Confidence 12335678999999988899999999999999999997 9999864432 2222222211 112333
Q ss_pred HHHHHHHHHHHhhccCCCCCCCChHHHHHHHHH
Q 003481 705 VARRLVDLGLQCCELYGRERPDITPSLVKELEQ 737 (816)
Q Consensus 705 ~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~ 737 (816)
.+..+.+++.+||..+|.+||++. ++...|+.
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rp~~~-~l~~~l~~ 255 (256)
T cd05039 224 CPPEVYKVMKDCWELDPAKRPTFK-QLREQLAL 255 (256)
T ss_pred CCHHHHHHHHHHhccChhhCcCHH-HHHHHHhc
Confidence 457899999999999999999998 67777654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=315.13 Aligned_cols=242 Identities=26% Similarity=0.452 Sum_probs=192.4
Q ss_pred eeeeecceEEEEEEEc--CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccCCCchh
Q 003481 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSLQ 551 (816)
Q Consensus 477 ~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL~ 551 (816)
.||+|+||.||+|++. ++.||+|.+..... .....|.+|+.++++++||||++++++|.. ..++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 5999999999999884 88999998765432 334568999999999999999999999843 578999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCccc
Q 003481 552 DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 631 (816)
Q Consensus 552 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 631 (816)
+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......... ..
T Consensus 82 ~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~----~~ 152 (252)
T cd05084 82 TFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA----ST 152 (252)
T ss_pred HHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccc----cc
Confidence 9986543 45899999999999999999999987 999999999999999999999999998765432211 01
Q ss_pred cCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCCCCCCHHHHHH
Q 003481 632 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARR 708 (816)
Q Consensus 632 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 708 (816)
.....++..|+|||.+.++.++.++|||||||++|+|++ |..||..... ....+..+. ....+...+..
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 224 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV--------RLPCPELCPDA 224 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC--------CCCCcccCCHH
Confidence 112233567999999999999999999999999999998 8899864332 222222111 11233345678
Q ss_pred HHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 709 LVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 709 l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
+.+|+.+||+.+|.+||++. ++.+.|+
T Consensus 225 ~~~li~~~l~~~p~~Rps~~-~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFS-TVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHH-HHHHHHh
Confidence 99999999999999999999 5666554
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=335.93 Aligned_cols=248 Identities=25% Similarity=0.296 Sum_probs=197.9
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++|.+...||+|+||.||++... +..||+|++..... .....+.+|+.++..++||||+++++++.+ ..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999875 88999999976432 234468899999999999999999998844 488999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999997653 36899999999999999999999988 999999999999999999999999999876543
Q ss_pred CCcCCCccccCCCCCCCCCCCccccc------cCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHH--HHhhcCcccccc
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHR------TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSIL 694 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~--~~~~~~~~~~~~ 694 (816)
... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||....... ..+... ...+
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~ 228 (330)
T cd05601 156 KMV-----NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--QRFL 228 (330)
T ss_pred Cce-----eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC--CCcc
Confidence 311 123457999999999886 4567899999999999999999999996443321 111111 1111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 695 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 695 d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
. .. .....+..+.+|+..||. +|.+||++.+.+.+
T Consensus 229 ~--~~-~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 229 K--FP-EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred C--CC-CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 00 111245678999999998 99999999865544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=318.09 Aligned_cols=251 Identities=24% Similarity=0.398 Sum_probs=199.6
Q ss_pred CCccceeeeecceEEEEEEEc-----CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEeccccC--------
Q 003481 472 FSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------- 536 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~-----g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------- 536 (816)
|.+.+.||+|+||.||+|.+. +..||+|.+..... .....+.+|+..++.++||||+++++++..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 566788999999999999874 36799999875432 234578999999999999999999998732
Q ss_pred CccceeeccCCCchhhhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeec
Q 003481 537 AWSLVYEYLPNGSLQDRLFRKS---NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 613 (816)
Q Consensus 537 ~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 613 (816)
..++|+||+++|+|..++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 2689999999999999886532 2246899999999999999999999987 999999999999999999999999
Q ss_pred ccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCcc
Q 003481 614 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKL 690 (816)
Q Consensus 614 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~ 690 (816)
|+++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||..... ....+..+..
T Consensus 158 g~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 233 (273)
T cd05035 158 GLSKKIYSGDYYR----QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR 233 (273)
T ss_pred cceeecccccccc----ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 9998765433211 1222345678999999988899999999999999999999 8899864432 2222222221
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 691 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 691 ~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
...+...+..+.+++.+||+.||.+||++. ++.+.|+.+
T Consensus 234 --------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-e~~~~l~~~ 272 (273)
T cd05035 234 --------LKQPEDCLDELYDLMYSCWRADPKDRPTFT-KLREVLENI 272 (273)
T ss_pred --------CCCCcCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHhh
Confidence 122334567899999999999999999999 677777654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=316.74 Aligned_cols=244 Identities=27% Similarity=0.475 Sum_probs=196.8
Q ss_pred CCCccceeeeecceEEEEEEEcC-eEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccCC
Q 003481 471 NFSESFKVGQGGFGCVYKGEMLG-RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPN 547 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~g-~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~ 547 (816)
+|.....||+|+||.||+|.+.+ ..||+|.+.... .....|.+|+.++.+++||||++++++|.+ ..++||||+.+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 57778899999999999998874 469999987543 334678999999999999999999999854 47899999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
|+|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--- 155 (256)
T cd05113 84 GCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY--- 155 (256)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce---
Confidence 99999986543 26899999999999999999999987 99999999999999999999999999887643321
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCCCCCCHH
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTF 704 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~ 704 (816)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||..... ....+..+... ..+..
T Consensus 156 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~ 225 (256)
T cd05113 156 --TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL--------YRPHL 225 (256)
T ss_pred --eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC--------CCCCC
Confidence 11223346678999999988889999999999999999999 9999964332 22223222111 11222
Q ss_pred HHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 705 VARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 705 ~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
.+..+.+++.+||+.+|.+||++. .++..
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rp~~~-~ll~~ 254 (256)
T cd05113 226 ASEKVYAIMYSCWHEKAEERPTFQ-QLLSS 254 (256)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHH-HHHHh
Confidence 457899999999999999999998 45443
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.40 Aligned_cols=230 Identities=25% Similarity=0.369 Sum_probs=187.8
Q ss_pred eeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcC-CCCceeeEeccccC--CccceeeccCCC
Q 003481 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVYEYLPNG 548 (816)
Q Consensus 477 ~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV~E~~~~g 548 (816)
.||+|+||.||+|++. +..||||++..... .....+..|..++..+ +||||+++++++.+ ..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 5999999999999886 67899999875422 2334577899998876 89999999999843 589999999999
Q ss_pred chhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCC
Q 003481 549 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 628 (816)
Q Consensus 549 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 628 (816)
+|...+.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---- 151 (321)
T cd05591 82 DLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---- 151 (321)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc----
Confidence 9999886543 5889999999999999999999988 99999999999999999999999999876432221
Q ss_pred ccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCCCCCHHHH
Q 003481 629 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVA 706 (816)
Q Consensus 629 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~~~ 706 (816)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+.. .+|...+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~---------~~p~~~~ 220 (321)
T cd05591 152 --TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV---------LYPVWLS 220 (321)
T ss_pred --cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------CCCCCCC
Confidence 12345699999999999988999999999999999999999999975443 2222222211 1233356
Q ss_pred HHHHHHHHHhhccCCCCCCCC
Q 003481 707 RRLVDLGLQCCELYGRERPDI 727 (816)
Q Consensus 707 ~~l~~Li~~cl~~dP~~RPs~ 727 (816)
..+.+|+.+||+.||.+||+.
T Consensus 221 ~~~~~ll~~~L~~dp~~R~~~ 241 (321)
T cd05591 221 KEAVSILKAFMTKNPNKRLGC 241 (321)
T ss_pred HHHHHHHHHHhccCHHHcCCC
Confidence 789999999999999999944
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=315.81 Aligned_cols=250 Identities=32% Similarity=0.468 Sum_probs=202.9
Q ss_pred hcCCCccceeeeecceEEEEEEEc-CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc-CCccceeeccC
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP-EAWSLVYEYLP 546 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~lV~E~~~ 546 (816)
.++|.+.++||+|+||.||+|... +..||+|.+..... ....|.+|+.++++++||||+++++++. +..++||||+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCC
Confidence 357888899999999999999875 78899999875443 3567899999999999999999999874 45899999999
Q ss_pred CCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcC
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626 (816)
Q Consensus 547 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 626 (816)
+++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 158 (260)
T cd05067 84 NGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT- 158 (260)
T ss_pred CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-
Confidence 9999999865443 46899999999999999999999987 999999999999999999999999999876532211
Q ss_pred CCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCCCCCCH
Q 003481 627 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPT 703 (816)
Q Consensus 627 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~ 703 (816)
......++..|+|||++....++.++||||||+++|+|++ |+.||..... ....+..+... ..+.
T Consensus 159 ----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~ 226 (260)
T cd05067 159 ----AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM--------PRPD 226 (260)
T ss_pred ----cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--------CCCC
Confidence 1223446788999999998899999999999999999999 9999964332 22222222111 1222
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHH
Q 003481 704 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 737 (816)
Q Consensus 704 ~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~ 737 (816)
..+..+.+++.+||..+|++||++. .+...|+.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~-~l~~~l~~ 259 (260)
T cd05067 227 NCPEELYELMRLCWKEKPEERPTFE-YLRSVLED 259 (260)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHH-HHHHHhhc
Confidence 3456899999999999999999998 67777654
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=332.62 Aligned_cols=253 Identities=21% Similarity=0.244 Sum_probs=195.2
Q ss_pred HhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCceeeEeccccC-------
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE------- 536 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------- 536 (816)
..++|...+.||+|+||.||++.+. |..||+|++.... ......+.+|+.++..++||||+++++++..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4578999999999999999999875 7899999986542 2334568899999999999999999998732
Q ss_pred -CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccc
Q 003481 537 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 615 (816)
Q Consensus 537 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 615 (816)
..++||||+.+ +|.+.+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 36899999975 5655553 24788899999999999999999988 99999999999999999999999999
Q ss_pred ceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH---hh------
Q 003481 616 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VS------ 686 (816)
Q Consensus 616 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~---~~------ 686 (816)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..... +.
T Consensus 170 a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 242 (359)
T cd07876 170 ARTACTNF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242 (359)
T ss_pred ccccccCc-------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 97653322 124457899999999999999999999999999999999999999644321110 00
Q ss_pred ----------------c-Cccc-----cc----cCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 687 ----------------C-GKLS-----SI----LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 687 ----------------~-~~~~-----~~----~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
. .... +. ..+.........+..+.+|+.+||..||.+|||+.+.+.+.+-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 318 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 0 0000 00 0000001111234678999999999999999999977766543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=316.50 Aligned_cols=243 Identities=28% Similarity=0.393 Sum_probs=200.6
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeec
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 544 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 544 (816)
+|...+.||+|+||.||+|... +..|++|.+.... ......+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999885 7899999986543 2345578899999999999999999999854 48999999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+++++|.+++.... ...+++..++.++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999987652 246899999999999999999999987 99999999999999999999999999987654331
Q ss_pred cCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHH--HHhhcCccccccCCCCCCCC
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDWP 702 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~--~~~~~~~~~~~~d~~~~~~~ 702 (816)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+..+.. ...+
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~ 222 (256)
T cd08529 157 ------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF--------PPVS 222 (256)
T ss_pred ------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC--------CCCc
Confidence 1234468899999999999999999999999999999999999997554321 11222211 1223
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 703 TFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 703 ~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
..++..+.+++.+||+.+|++||++.+.+
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll 251 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLL 251 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHh
Confidence 34567899999999999999999999544
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=360.03 Aligned_cols=258 Identities=22% Similarity=0.300 Sum_probs=200.5
Q ss_pred HHHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEecccc----C
Q 003481 465 LQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP----E 536 (816)
Q Consensus 465 l~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~----~ 536 (816)
.....++|.+...||.|+||.||++.+. +..||+|++..... .....|..|+.+|.+|+|||||+++++|. .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 3445578999999999999999999886 77899999875433 23456889999999999999999999873 2
Q ss_pred CccceeeccCCCchhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCC----CceeeCCCCCCceEecC-------
Q 003481 537 AWSLVYEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKP----EKIVHGDLKPQNILLDS------- 604 (816)
Q Consensus 537 ~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~----~~ivHrDIkp~NILl~~------- 604 (816)
.+||||||+++|+|.++|.... ....+++..++.|+.||+.||.|||+.++ ++||||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 3789999999999999987532 23469999999999999999999998642 35999999999999964
Q ss_pred ----------CCCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCcccccc--CCCCcchhHhHHHHHHHHHHhCC
Q 003481 605 ----------ELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT--GVLTPKSDSYSFGLIILQLLTGR 672 (816)
Q Consensus 605 ----------~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVwSlGviL~elltG~ 672 (816)
.+.+||+|||++..+.... ......||+.|+|||++.. ..+++++||||||||||+|+||.
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIES-------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccc-------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 2358999999998764332 1234579999999998854 45899999999999999999999
Q ss_pred CCCCChHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 673 LPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 673 ~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
.||.........+..- ....... ....+..+.+||..||..+|.+||++.+.|.+.+
T Consensus 241 ~PF~~~~~~~qli~~l--k~~p~lp----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ 297 (1021)
T PTZ00266 241 TPFHKANNFSQLISEL--KRGPDLP----IKGKSKELNILIKNLLNLSAKERPSALQCLGYQI 297 (1021)
T ss_pred CCCCcCCcHHHHHHHH--hcCCCCC----cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence 9997544322222110 0000000 1123568999999999999999999997665443
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=321.60 Aligned_cols=253 Identities=28% Similarity=0.442 Sum_probs=201.1
Q ss_pred CCCccceeeeecceEEEEEEEc-------CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccc
Q 003481 471 NFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSL 540 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~-------g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~l 540 (816)
+|...+.||+|+||.||+|... ...|++|.+..... .....+.+|+.++..++||||++++++|. +..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4777889999999999999864 25689998865443 23456889999999999999999999884 35889
Q ss_pred eeeccCCCchhhhhhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCc
Q 003481 541 VYEYLPNGSLQDRLFRKS---------------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQN 599 (816)
Q Consensus 541 V~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~N 599 (816)
|+||+.+|+|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999886421 1235889999999999999999999987 9999999999
Q ss_pred eEecCCCCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCCh
Q 003481 600 ILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLA 678 (816)
Q Consensus 600 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~ 678 (816)
||++.++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|+|+| |..||...
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSY----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred EEEcCCCcEEeccccccccccCccch----hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999865433211 11233456778999999988889999999999999999999 99999643
Q ss_pred H--HHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhh
Q 003481 679 G--EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 679 ~--~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~ 739 (816)
. .+...+..+. ....+...+..+.+++.+||+.+|.+||++. ++...|+.+.
T Consensus 234 ~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~-~i~~~l~~~~ 287 (290)
T cd05045 234 APERLFNLLKTGY--------RMERPENCSEEMYNLMLTCWKQEPDKRPTFA-DISKELEKMM 287 (290)
T ss_pred CHHHHHHHHhCCC--------CCCCCCCCCHHHHHHHHHHccCCcccCCCHH-HHHHHHHHHH
Confidence 3 2222222221 1112334556899999999999999999999 7888887764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.90 Aligned_cols=245 Identities=27% Similarity=0.453 Sum_probs=196.0
Q ss_pred eeeeecceEEEEEEEc----CeEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCceeeEeccccC-CccceeeccCCCch
Q 003481 477 KVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPNGSL 550 (816)
Q Consensus 477 ~LG~G~~g~Vy~~~~~----g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~~~gsL 550 (816)
.||+|+||.||+|.+. +..||+|++...... ....|.+|+.++.+++||||++++++|.. ..++||||+++|+|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L 81 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL 81 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence 3899999999999764 456999998765432 34568999999999999999999999854 57899999999999
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCcc
Q 003481 551 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 630 (816)
Q Consensus 551 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 630 (816)
.+++.... ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......... .
T Consensus 82 ~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~---~ 153 (257)
T cd05115 82 NKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY---K 153 (257)
T ss_pred HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccce---e
Confidence 99986543 46899999999999999999999987 9999999999999999999999999998654332111 1
Q ss_pred ccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChH--HHHHHhhcCccccccCCCCCCCCHHHHH
Q 003481 631 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPTFVAR 707 (816)
Q Consensus 631 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~--~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 707 (816)
......+++.|+|||++.+..++.++|||||||++|+|++ |..||.... .+...+..+.. ...+...+.
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~ 225 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR--------LDCPAECPP 225 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC--------CCCCCCCCH
Confidence 1122334678999999988889999999999999999996 999996433 22233333321 123344567
Q ss_pred HHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 708 RLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 708 ~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
.+.+++.+||..+|++||++. .+.+.|+.+
T Consensus 226 ~l~~li~~c~~~~~~~Rp~~~-~i~~~l~~~ 255 (257)
T cd05115 226 EMYALMKDCWIYKWEDRPNFA-KVEERMRTY 255 (257)
T ss_pred HHHHHHHHHcCCChhhCcCHH-HHHHHHhhh
Confidence 899999999999999999999 677777653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=345.80 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=192.1
Q ss_pred HhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC---------
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--------- 536 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--------- 536 (816)
.+.+|...+.||+|+||.||+|... +..||||++.... ....+|+.+|+.++||||+++++++..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999884 7899999885432 234579999999999999999887521
Q ss_pred -CccceeeccCCCchhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCC-CeeEeec
Q 003481 537 -AWSLVYEYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICDF 613 (816)
Q Consensus 537 -~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~DF 613 (816)
..++||||+++ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 14589999975 676666432 22346899999999999999999999988 99999999999998664 6999999
Q ss_pred ccceeccCCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHH---Hhh-cC
Q 003481 614 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVS-CG 688 (816)
Q Consensus 614 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~---~~~-~~ 688 (816)
|+|+.+.... ......||+.|+|||++.+ ..++.++|||||||+||||+||.+||........ .+. .+
T Consensus 216 Gla~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 288 (440)
T PTZ00036 216 GSAKNLLAGQ-------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG 288 (440)
T ss_pred ccchhccCCC-------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9998765432 1234568999999998765 4689999999999999999999999975432211 110 00
Q ss_pred c------------cccccCCC------CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 689 K------------LSSILDPL------AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 689 ~------------~~~~~d~~------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
. +..+.-+. ...+|...+..+.+|+.+||..||.+||++.+.+.+.+
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 0 00000000 01123334568999999999999999999998777655
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=315.40 Aligned_cols=253 Identities=22% Similarity=0.340 Sum_probs=203.4
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEecccc--CCcccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~ 542 (816)
++|.+.+.||.|+||.||+|+.. +..||||.+..... .....|.+|+.+++.++||||+++++++. +..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47889999999999999999874 88999998865332 23346889999999999999999999874 4588999
Q ss_pred eccCCCchhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 543 EYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999886432 2245788999999999999999999987 99999999999999999999999999987654
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChH----HHHHHhhcCccccccCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG----EVRRAVSCGKLSSILDPL 697 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~----~~~~~~~~~~~~~~~d~~ 697 (816)
... ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.... .....+..... +
T Consensus 159 ~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----~- 226 (267)
T cd08228 159 KTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY-----P- 226 (267)
T ss_pred hhH------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCC-----C-
Confidence 321 1234468899999999988889999999999999999999999985332 11111111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhh
Q 003481 698 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 698 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~ 739 (816)
...+...+..+.+++.+||..+|.+||++. +++..|+++.
T Consensus 227 -~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~-~vl~~~~~~~ 266 (267)
T cd08228 227 -PLPTEHYSEKLRELVSMCIYPDPDQRPDIG-YVHQIAKQMH 266 (267)
T ss_pred -CCChhhcCHHHHHHHHHHCCCCcccCcCHH-HHHHHHHHhc
Confidence 111234567899999999999999999999 7888887764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=334.48 Aligned_cols=231 Identities=24% Similarity=0.312 Sum_probs=187.5
Q ss_pred ceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcC-CCCceeeEecccc--CCccceeeccCC
Q 003481 476 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACP--EAWSLVYEYLPN 547 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~g~~~--~~~~lV~E~~~~ 547 (816)
+.||+|+||.||++.+. +..||+|++..... .....+..|+.++.++ +||||+++++++. +..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999885 78899999976432 2334577899988877 8999999999884 458899999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
|+|..++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--- 151 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--- 151 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---
Confidence 99998886543 5889999999999999999999988 99999999999999999999999999875432211
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChH-----------HHHHHhhcCccccccCC
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG-----------EVRRAVSCGKLSSILDP 696 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~-----------~~~~~~~~~~~~~~~d~ 696 (816)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .....+..+
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-------- 220 (329)
T cd05618 152 ---TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-------- 220 (329)
T ss_pred ---ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--------
Confidence 1234579999999999999999999999999999999999999995211 111111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCC
Q 003481 697 LAGDWPTFVARRLVDLGLQCCELYGRERPDI 727 (816)
Q Consensus 697 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~ 727 (816)
...+|...+..+.+|+.+||+.||.+||+.
T Consensus 221 -~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 221 -QIRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -CCCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 112344566788999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=331.05 Aligned_cols=231 Identities=26% Similarity=0.350 Sum_probs=189.3
Q ss_pred ceeeeecceEEEEEEEc--CeEEEEEEeccCC---cccHHHHHHHHHHHhcC-CCCceeeEecccc--CCccceeeccCC
Q 003481 476 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKL-QHPHLVTLLGACP--EAWSLVYEYLPN 547 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~---~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~--~~~~lV~E~~~~ 547 (816)
+.||+|+||.||+|.+. +..||||++.... ......+..|..++..+ +||||+++++++. +..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999885 6789999997643 22344577899999888 7999999999884 458999999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
|+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 151 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--- 151 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---
Confidence 99999886543 5899999999999999999999987 99999999999999999999999999875332221
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCCCCCHHH
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFV 705 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~~ 705 (816)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+. ..++...
T Consensus 152 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~---------~~~~~~~ 219 (318)
T cd05570 152 ---TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE---------VRYPRWL 219 (318)
T ss_pred ---cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC---------CCCCCcC
Confidence 12344689999999999999999999999999999999999999974432 222222211 1233445
Q ss_pred HHHHHHHHHHhhccCCCCCCCC
Q 003481 706 ARRLVDLGLQCCELYGRERPDI 727 (816)
Q Consensus 706 ~~~l~~Li~~cl~~dP~~RPs~ 727 (816)
+..+.+|+.+||+.||.+||++
T Consensus 220 ~~~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 220 SKEAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred CHHHHHHHHHHccCCHHHcCCC
Confidence 6789999999999999999999
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=340.52 Aligned_cols=254 Identities=21% Similarity=0.270 Sum_probs=193.4
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEecccc--CCcccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~ 542 (816)
++|.+.+.||+|+||.||+++.. ++.||||++..... .....+.+|+.+|.+++||||+++++.|. +..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999875 78999999865322 23346789999999999999999999884 3588999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999997643 5788889999999999999999988 999999999999999999999999998533210
Q ss_pred CCc-------------------------------------CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHH
Q 003481 623 TLY-------------------------------------LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLII 665 (816)
Q Consensus 623 ~~~-------------------------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL 665 (816)
... ...........||+.|+|||++.+..++.++|||||||+|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 000 0000011235799999999999999999999999999999
Q ss_pred HHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCC---CChHHHHH
Q 003481 666 LQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERP---DITPSLVK 733 (816)
Q Consensus 666 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RP---s~~e~l~~ 733 (816)
|+|++|+.||.................... .......+..+.+|+.+|+ .+|.+|+ ++.+.+.+
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVINWETTLH---IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhccCcccc---CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999999975543222111111100000 0111234567888888876 4999999 66654433
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=318.04 Aligned_cols=254 Identities=26% Similarity=0.361 Sum_probs=201.8
Q ss_pred HHHHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC--Ccc
Q 003481 464 DLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWS 539 (816)
Q Consensus 464 el~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~ 539 (816)
|++.+++++.....||+|+||.||+|.+. +..|++|.+..........+.+|+.++++++|+||+++++++.. ..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34567778888889999999999999875 67899999877666666789999999999999999999999843 578
Q ss_pred ceeeccCCCchhhhhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecC-CCCeeEeecccc
Q 003481 540 LVYEYLPNGSLQDRLFRKSNVSPL--LWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-ELSSKICDFGIC 616 (816)
Q Consensus 540 lV~E~~~~gsL~~~l~~~~~~~~l--~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkL~DFGla 616 (816)
+|+||+++++|.+++.... ..+ ++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.++|+|||++
T Consensus 82 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW--GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEEecCCCCCHHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 9999999999999987643 234 78889999999999999999987 999999999999976 679999999998
Q ss_pred eeccCCCCcCCCccccCCCCCCCCCCCccccccCC--CCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCcccccc
Q 003481 617 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV--LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSIL 694 (816)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~ 694 (816)
........ ......|++.|+|||++.... ++.++||||||+++|+|++|+.||.............. .
T Consensus 157 ~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~----~ 226 (268)
T cd06624 157 KRLAGINP------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG----M 226 (268)
T ss_pred eecccCCC------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhh----h
Confidence 76643221 122345889999999986643 78999999999999999999999964322111110000 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 695 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 695 d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
......++......+.+++.+||+.+|.+||++.+.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 227 FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 11122345556678999999999999999999996554
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=321.48 Aligned_cols=258 Identities=27% Similarity=0.397 Sum_probs=200.5
Q ss_pred cCCCccceeeeecceEEEEEEEcC------------------eEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeE
Q 003481 470 CNFSESFKVGQGGFGCVYKGEMLG------------------RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTL 530 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~g------------------~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l 530 (816)
.+|.+.+.||+|+||.||++.+.+ ..||+|.+..... .....|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 578888999999999999987642 4589999876543 345578899999999999999999
Q ss_pred eccccC--CccceeeccCCCchhhhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCce
Q 003481 531 LGACPE--AWSLVYEYLPNGSLQDRLFRKSN--------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNI 600 (816)
Q Consensus 531 ~g~~~~--~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NI 600 (816)
+++|.. ..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence 999854 58899999999999999876431 236899999999999999999999987 99999999999
Q ss_pred EecCCCCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh--CCCCCCCh
Q 003481 601 LLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT--GRLPVGLA 678 (816)
Q Consensus 601 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt--G~~Pf~~~ 678 (816)
+++.++.++|+|||+++........ .......+++.|+|||++..+.++.++|||||||++|+|++ |..||...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYY----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eecCCCceEEccccceeecccCcce----eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999999865433211 12334557789999999988889999999999999999998 77888643
Q ss_pred HH--HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 679 GE--VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 679 ~~--~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
.. ........ +...-.......+...+..+.+|+.+||+.||.+||++. +|...|+
T Consensus 238 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~-el~~~L~ 295 (296)
T cd05051 238 TDQQVIENAGHF-FRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFR-EIHLFLQ 295 (296)
T ss_pred ChHHHHHHHHhc-cccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHH-HHHHHhc
Confidence 22 21111111 000000011112333457899999999999999999999 5665553
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=332.97 Aligned_cols=253 Identities=23% Similarity=0.334 Sum_probs=192.2
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++|...+.||+|+||+||++... ++.||||++..... .....+.+|+.++.+++||||+++++.+.+ ..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47888999999999999999875 78999999975432 223467889999999999999999999854 478999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999997643 5889999999999999999999988 999999999999999999999999999765321
Q ss_pred CCcC---------C--------------------CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCC
Q 003481 623 TLYL---------P--------------------SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRL 673 (816)
Q Consensus 623 ~~~~---------~--------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~ 673 (816)
.... + .........||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 1000 0 0001124579999999999999999999999999999999999999
Q ss_pred CCCChHH--HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhc--cCCCCCCCChHHHHH
Q 003481 674 PVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCE--LYGRERPDITPSLVK 733 (816)
Q Consensus 674 Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~--~dP~~RPs~~e~l~~ 733 (816)
||..... ....+...... +..+.. ...+..+.+|+.+++. .++..||++.+.+.+
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~-~~~p~~----~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSETPQETYKKVMNWKET-LIFPPE----VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCHHHHHHHHHcCcCc-ccCCCc----CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9975432 22222221111 111111 1134577788887554 233356888755443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=302.18 Aligned_cols=253 Identities=25% Similarity=0.373 Sum_probs=211.3
Q ss_pred HHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc----c----HHHHHHHHHHHhcC-CCCceeeEeccc
Q 003481 466 QTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ----G----QLEFQQEVRVLSKL-QHPHLVTLLGAC 534 (816)
Q Consensus 466 ~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~----~----~~~~~~E~~il~~l-~HpnIv~l~g~~ 534 (816)
...-++|...+.||.|+.+.|-++... |..+|+|++...... . .+.-..|+.||+++ .||||+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 344567888889999999999998775 888999988543221 1 23456899999998 699999999999
Q ss_pred cCC--ccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEee
Q 003481 535 PEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICD 612 (816)
Q Consensus 535 ~~~--~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~D 612 (816)
+.. .++|+|.|+.|.|.|+|...- .++++...+|+.|+..|+.|||..+ ||||||||+|||+|+|.++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 654 678999999999999997654 5889999999999999999999988 99999999999999999999999
Q ss_pred cccceeccCCCCcCCCccccCCCCCCCCCCCcccccc------CCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHH
Q 003481 613 FGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT------GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRA 684 (816)
Q Consensus 613 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~ 684 (816)
||+++.+.++. .-...+|||+|+|||.+.. ..|+..+|+|++|||+|.|+.|.+||-...++ ...
T Consensus 167 FGFa~~l~~Ge-------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ 239 (411)
T KOG0599|consen 167 FGFACQLEPGE-------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRM 239 (411)
T ss_pred cceeeccCCch-------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHH
Confidence 99999988766 3467889999999997743 46888999999999999999999999766553 345
Q ss_pred hhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 685 VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 685 ~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
+..|++.- ..++|. +.+....+||.+||+.||.+|.|..+.|.+.+=
T Consensus 240 ImeGkyqF----~speWa-dis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 240 IMEGKYQF----RSPEWA-DISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred HHhccccc----CCcchh-hccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 66666542 233443 467789999999999999999999998887763
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=314.56 Aligned_cols=244 Identities=28% Similarity=0.468 Sum_probs=195.2
Q ss_pred CCCccceeeeecceEEEEEEEc-CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccCC
Q 003481 471 NFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPN 547 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~ 547 (816)
+|.+.+.||+|+||.||+|.+. +..+|+|.+..... ....|.+|+.++.+++||||+++++++.+ ..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4677788999999999999886 55799999864432 34568899999999999999999998844 47899999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
++|.+++.... ..+++..++.|+.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-- 156 (256)
T cd05059 84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-- 156 (256)
T ss_pred CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc--
Confidence 99999987544 36899999999999999999999988 999999999999999999999999999866432211
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCCCCCCHH
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTF 704 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~ 704 (816)
......++..|+|||++.+..++.++||||||+++|+|++ |..||..... ....+..+. . ...+..
T Consensus 157 ---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-----~---~~~~~~ 225 (256)
T cd05059 157 ---SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY-----R---LYRPKL 225 (256)
T ss_pred ---ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC-----c---CCCCCC
Confidence 1122234568999999998899999999999999999999 8999964332 222222211 1 112233
Q ss_pred HHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 705 VARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 705 ~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
.+..+.+|+.+||..+|.+||++.+ ++..
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~~-~l~~ 254 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFKK-LLSQ 254 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHH-HHHH
Confidence 5678999999999999999999994 4443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=313.55 Aligned_cols=249 Identities=31% Similarity=0.436 Sum_probs=200.7
Q ss_pred cCCCccceeeeecceEEEEEEEc-CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC-CccceeeccCC
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPN 547 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~~~ 547 (816)
++|.+...||.|+||.||+|.+. +..||+|.+.... .....|.+|+.++++++|||++++++++.. ..++||||+.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCC
Confidence 45788889999999999999886 4579999886543 234578899999999999999999998844 47899999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-- 158 (260)
T cd05069 85 GSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-- 158 (260)
T ss_pred CCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc--
Confidence 99999997643 245899999999999999999999987 999999999999999999999999999876433211
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCCCCCCHH
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTF 704 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~ 704 (816)
......++..|+|||+..+..++.++|||||||++|+|+| |..||..... ....+..+. ....+..
T Consensus 159 ---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 227 (260)
T cd05069 159 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGY--------RMPCPQG 227 (260)
T ss_pred ---ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------CCCCCcc
Confidence 1123346778999999988899999999999999999999 8999964332 112221111 1112334
Q ss_pred HHHHHHHHHHHhhccCCCCCCCChHHHHHHHHH
Q 003481 705 VARRLVDLGLQCCELYGRERPDITPSLVKELEQ 737 (816)
Q Consensus 705 ~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~ 737 (816)
.+..+.+++.+||..+|.+||++. .+.+.|+.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~ 259 (260)
T cd05069 228 CPESLHELMKLCWKKDPDERPTFE-YIQSFLED 259 (260)
T ss_pred cCHHHHHHHHHHccCCcccCcCHH-HHHHHHhc
Confidence 567899999999999999999998 67777763
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=322.89 Aligned_cols=258 Identities=25% Similarity=0.405 Sum_probs=196.8
Q ss_pred cCCCccceeeeecceEEEEEEEcC----------------eEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEec
Q 003481 470 CNFSESFKVGQGGFGCVYKGEMLG----------------RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLG 532 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~g----------------~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g 532 (816)
++|.+.+.||+|+||.||++...+ ..||+|.+..... .....|.+|++++.+++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 478888999999999999987632 3589999876532 23456899999999999999999999
Q ss_pred ccc--CCccceeeccCCCchhhhhhhcC---------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceE
Q 003481 533 ACP--EAWSLVYEYLPNGSLQDRLFRKS---------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNIL 601 (816)
Q Consensus 533 ~~~--~~~~lV~E~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NIL 601 (816)
++. +..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 984 45889999999999999986532 1134789999999999999999999987 999999999999
Q ss_pred ecCCCCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh--CCCCCCChH
Q 003481 602 LDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT--GRLPVGLAG 679 (816)
Q Consensus 602 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt--G~~Pf~~~~ 679 (816)
++.++.+||+|||++......... .......++..|+|||++..+.++.++|||||||++|+|++ |..||....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYY----RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EcCCCcEEecccccccccccCcce----eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 999999999999999865433211 12233456788999999988899999999999999999998 667886432
Q ss_pred H--HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 680 E--VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 680 ~--~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
. ....... .............+...+..+.+|+.+||+.+|.+||++. .+.+.|+
T Consensus 238 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~-~i~~~l~ 294 (295)
T cd05097 238 DEQVIENTGE-FFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFN-KIHHFLR 294 (295)
T ss_pred hHHHHHHHHH-hhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHH-HHHHHHh
Confidence 2 1111100 0000000000111223456899999999999999999998 6666654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=337.90 Aligned_cols=247 Identities=23% Similarity=0.306 Sum_probs=196.6
Q ss_pred HhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccc
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 540 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 540 (816)
..++|...+.||+|+||.||+++.. +..||+|++..... .....+.+|+.++..++||||+++++++.+ ..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3467889999999999999999885 78999999865322 233457789999999999999999998854 4789
Q ss_pred eeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceecc
Q 003481 541 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 620 (816)
Q Consensus 541 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 620 (816)
||||+++|+|.+++... .++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999988543 4778889999999999999999987 9999999999999999999999999998764
Q ss_pred CCCCcCCCccccCCCCCCCCCCCccccccC----CCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCcccccc
Q 003481 621 EDTLYLPSFHRSTAPKGSFPYADPEYHRTG----VLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSIL 694 (816)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~ 694 (816)
.... .......||+.|+|||++.+. .++.++|||||||+||||++|+.||...... ...+..+.. .
T Consensus 194 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~-- 265 (370)
T cd05596 194 ANGM-----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN-S-- 265 (370)
T ss_pred CCCc-----ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC-c--
Confidence 3321 122345799999999988643 4789999999999999999999999754432 122211110 0
Q ss_pred CCCCCCCCH--HHHHHHHHHHHHhhccCCCC--CCCChHHHHH
Q 003481 695 DPLAGDWPT--FVARRLVDLGLQCCELYGRE--RPDITPSLVK 733 (816)
Q Consensus 695 d~~~~~~~~--~~~~~l~~Li~~cl~~dP~~--RPs~~e~l~~ 733 (816)
..+|. ..+..+.+|+.+||+.+|.+ ||++.+.+.+
T Consensus 266 ----~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 ----LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ----CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11121 35678999999999999988 9999865544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=337.92 Aligned_cols=252 Identities=22% Similarity=0.276 Sum_probs=192.8
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++|.+.+.||.|+||.||++... ++.||||++..... .....+.+|+.++.+++||||++++++|.+ ..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47888999999999999999875 88999999865422 233468899999999999999999999854 489999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999986543 5888999999999999999999988 999999999999999999999999999643211
Q ss_pred CCc------------CCC-----------------------------ccccCCCCCCCCCCCccccccCCCCcchhHhHH
Q 003481 623 TLY------------LPS-----------------------------FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSF 661 (816)
Q Consensus 623 ~~~------------~~~-----------------------------~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSl 661 (816)
... ... ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 000 000012469999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCChHHHH--HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCC---CCChHHHHH
Q 003481 662 GLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRER---PDITPSLVK 733 (816)
Q Consensus 662 GviL~elltG~~Pf~~~~~~~--~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~R---Ps~~e~l~~ 733 (816)
||+||||+||.+||....... ..+.... ..+.-+ + ....+..+.+|+.+||. +|.+| |++.+.+.+
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p---~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHETYRKIINWR-ETLYFP---D-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHHHHHHHccC-CccCCC---C-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 999999999999996543321 1111110 000001 1 11245678999999997 77776 477755544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=333.30 Aligned_cols=232 Identities=23% Similarity=0.301 Sum_probs=188.6
Q ss_pred ceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcC-CCCceeeEecccc--CCccceeeccCC
Q 003481 476 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACP--EAWSLVYEYLPN 547 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~g~~~--~~~~lV~E~~~~ 547 (816)
+.||+|+||.||+|... +..||+|++..... .....+.+|+.++.++ +||||+++++++. +..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999885 78899999976432 2334578899999888 6999999999884 358899999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
|+|..++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--- 151 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--- 151 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC---
Confidence 99998886543 5899999999999999999999987 99999999999999999999999999875322111
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChH---------HHHHHhhcCccccccCCCC
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG---------EVRRAVSCGKLSSILDPLA 698 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~---------~~~~~~~~~~~~~~~d~~~ 698 (816)
......||+.|+|||++.+..++.++|||||||+||+|++|..||.... .....+.. ..
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---------~~ 219 (327)
T cd05617 152 ---TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE---------KP 219 (327)
T ss_pred ---ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh---------CC
Confidence 1234579999999999999999999999999999999999999995211 11111111 11
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCCh
Q 003481 699 GDWPTFVARRLVDLGLQCCELYGRERPDIT 728 (816)
Q Consensus 699 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~ 728 (816)
..+|...+..+.+++.+||+.||.+||++.
T Consensus 220 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 220 IRIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 123444567889999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=339.05 Aligned_cols=246 Identities=21% Similarity=0.270 Sum_probs=189.3
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceee
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 543 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 543 (816)
+|...+.||+|+||.||+|+.. +..||+|++..... .....+.+|+.++.+++||||++++++|.+ ..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999885 78899999875432 223468899999999999999999999854 4899999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
|+++|+|.+++.+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999986643 5788899999999999999999988 9999999999999999999999999986432100
Q ss_pred Cc-----------------------------------------CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHH
Q 003481 624 LY-----------------------------------------LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFG 662 (816)
Q Consensus 624 ~~-----------------------------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlG 662 (816)
.. ...........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00 0000011235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCC
Q 003481 663 LIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPD 726 (816)
Q Consensus 663 viL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs 726 (816)
|+||||++|++||..................+ ........+..+.+++.+|+ .+|.+|++
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---~~p~~~~~s~~~~~li~~l~-~~p~~R~~ 295 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSL---HIPPQAKLSPEASDLIIKLC-RGPEDRLG 295 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc---CCCCcccCCHHHHHHHHHHc-cCHhHcCC
Confidence 99999999999997544322211111110000 00111234567888888876 49999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.83 Aligned_cols=252 Identities=25% Similarity=0.401 Sum_probs=202.9
Q ss_pred cCCCccceeeeecceEEEEEEEcC-----eEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCceeeEeccccC-Ccccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEMLG-----RTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~g-----~~vAiK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~ 542 (816)
++|...+.||+|+||.||+|.+.+ ..|+||...... ......|.+|+.++.+++||||++++++|.+ ..++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 457788899999999999998742 368999886654 3345578999999999999999999998854 578999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++|+|.+++.... ..+++..++.++.+++.||.|||+.+ ++|+||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 86 ELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence 9999999999996543 35899999999999999999999987 999999999999999999999999999876543
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHHHH--HHhhcCccccccCCCCC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVR--RAVSCGKLSSILDPLAG 699 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~~d~~~~ 699 (816)
... ......+++.|+|||.+....++.++||||||+++|+|++ |..||....... ..+..+...
T Consensus 161 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-------- 227 (270)
T cd05056 161 SYY-----KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL-------- 227 (270)
T ss_pred cce-----ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC--------
Confidence 211 1223345678999999988889999999999999999996 999996544321 222222111
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhhh
Q 003481 700 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740 (816)
Q Consensus 700 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~~ 740 (816)
..+...+..+.+++.+||..+|.+||++. .+...|+.+..
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~-~~~~~l~~~~~ 267 (270)
T cd05056 228 PMPPNCPPTLYSLMTKCWAYDPSKRPRFT-ELKAQLSDILQ 267 (270)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHHh
Confidence 12234456899999999999999999998 67778777643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=319.13 Aligned_cols=251 Identities=27% Similarity=0.431 Sum_probs=200.1
Q ss_pred cCCCccceeeeecceEEEEEEEc-------CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 540 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~-------g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 540 (816)
.+|....+||+|+||.||++... +..+|+|.+..........|.+|+.++..++||||+++++++.+ ..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35677789999999999999642 56799999876665566789999999999999999999998853 4789
Q ss_pred eeeccCCCchhhhhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCe
Q 003481 541 VYEYLPNGSLQDRLFRKSN------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 608 (816)
Q Consensus 541 V~E~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 608 (816)
||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999875431 135889999999999999999999987 9999999999999999999
Q ss_pred eEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHHH--HHHh
Q 003481 609 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEV--RRAV 685 (816)
Q Consensus 609 kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~--~~~~ 685 (816)
||+|||++......... .......+++.|+|||++.+..++.++|||||||++|+|++ |.+||...... ....
T Consensus 162 kL~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDYY----RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred EECCCCceeEcCCCcee----ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 99999999866432211 11233446788999999998999999999999999999998 99998543322 2222
Q ss_pred hcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 686 SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 686 ~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
..+.. ...+...+..+.+|+.+||+.||.+||++. +|.+.|+
T Consensus 238 ~~~~~--------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~-~l~~~l~ 279 (280)
T cd05092 238 TQGRE--------LERPRTCPPEVYAIMQGCWQREPQQRMVIK-DIHSRLQ 279 (280)
T ss_pred HcCcc--------CCCCCCCCHHHHHHHHHHccCChhhCCCHH-HHHHHHh
Confidence 22211 111223456789999999999999999999 5666554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=315.37 Aligned_cols=249 Identities=26% Similarity=0.428 Sum_probs=198.6
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCccc---------HHHHHHHHHHHhcCCCCceeeEecccc--CC
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---------QLEFQQEVRVLSKLQHPHLVTLLGACP--EA 537 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~---------~~~~~~E~~il~~l~HpnIv~l~g~~~--~~ 537 (816)
+|.....||.|+||.||+|.+. +..||+|.+....... ...+.+|+.++++++||||+++++++. +.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4677789999999999999874 7889999886543322 245789999999999999999999984 45
Q ss_pred ccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccce
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 617 (816)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 789999999999999996543 5888999999999999999999987 9999999999999999999999999998
Q ss_pred eccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCC
Q 003481 618 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPL 697 (816)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~ 697 (816)
...................|+..|+|||++.+..++.++|||||||++|+|++|+.||.............. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------~~ 228 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE------NA 228 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc------cC
Confidence 775322111111112234588999999999888899999999999999999999999975544322221111 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 698 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 698 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
....+...+..+.+++.+||+.+|.+||++.+.+
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 262 (267)
T cd06628 229 SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELL 262 (267)
T ss_pred CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHh
Confidence 1223344567899999999999999999998544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=322.97 Aligned_cols=250 Identities=28% Similarity=0.430 Sum_probs=198.0
Q ss_pred CCCccceeeeecceEEEEEEEc-------CeEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCceeeEecccc--CCccc
Q 003481 471 NFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSL 540 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~-------g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~l 540 (816)
+|.+.+.||.|+||.||+|.+. +..||||++...... ....|.+|+.++..++||||+++++++. +..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3566678999999999999864 367999999755432 2356889999999999999999999984 35789
Q ss_pred eeeccCCCchhhhhhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCC
Q 003481 541 VYEYLPNGSLQDRLFRKS-------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS 607 (816)
Q Consensus 541 V~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 607 (816)
++||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985321 1235889999999999999999999987 999999999999999999
Q ss_pred eeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHH
Q 003481 608 SKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRA 684 (816)
Q Consensus 608 vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~ 684 (816)
+||+|||+++........ .......+++.|+|||++.++.++.++|||||||++|||++ |..||..... ....
T Consensus 163 ~kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05091 163 VKISDLGLFREVYAADYY----KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM 238 (283)
T ss_pred eEecccccccccccchhe----eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999998866433211 11234456789999999988889999999999999999998 8888864322 2233
Q ss_pred hhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 685 VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 685 ~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
+..+.. ...+...+..+.+|+.+||+.+|.+||++. ++...|+
T Consensus 239 i~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~-~i~~~l~ 281 (283)
T cd05091 239 IRNRQV--------LPCPDDCPAWVYTLMLECWNEFPSRRPRFK-DIHSRLR 281 (283)
T ss_pred HHcCCc--------CCCCCCCCHHHHHHHHHHhCCCcccCCCHH-HHHHHhh
Confidence 333222 123344566789999999999999999999 5666654
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=320.76 Aligned_cols=243 Identities=24% Similarity=0.317 Sum_probs=195.0
Q ss_pred CCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc---cHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeec
Q 003481 472 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 544 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 544 (816)
|+..+.||.|+||+||+|.+. ++.||+|.+...... ....+.+|+.+|..++|+||+++++++. +..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667788999999999999885 789999998654332 2345778999999999999999998874 357899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 999999988865432 46999999999999999999999987 9999999999999999999999999987654322
Q ss_pred cCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHH--HHhhcCccccccCCCCCCCC
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDWP 702 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~--~~~~~~~~~~~~d~~~~~~~ 702 (816)
......|++.|+|||++.+..++.++|||||||++|+|++|..||....... ..+. ..+... ...++
T Consensus 157 ------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~-~~~~~~----~~~~~ 225 (285)
T cd05632 157 ------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD-RRVLET----EEVYS 225 (285)
T ss_pred ------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-Hhhhcc----ccccC
Confidence 1234468999999999988899999999999999999999999997543211 1111 111111 11233
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCChHH
Q 003481 703 TFVARRLVDLGLQCCELYGRERPDITPS 730 (816)
Q Consensus 703 ~~~~~~l~~Li~~cl~~dP~~RPs~~e~ 730 (816)
...+..+.+|+..||+.||.+||++.+.
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~ 253 (285)
T cd05632 226 AKFSEEAKSICKMLLTKDPKQRLGCQEE 253 (285)
T ss_pred ccCCHHHHHHHHHHccCCHhHcCCCccc
Confidence 4456678999999999999999996533
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=331.47 Aligned_cols=240 Identities=27% Similarity=0.341 Sum_probs=189.9
Q ss_pred ceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHH-HHhcCCCCceeeEecccc--CCccceeeccCC
Q 003481 476 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVR-VLSKLQHPHLVTLLGACP--EAWSLVYEYLPN 547 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~-il~~l~HpnIv~l~g~~~--~~~~lV~E~~~~ 547 (816)
+.||+|+||.||+|++. +..||+|++..... .....+..|.. ++..++||||+++++++. +..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999885 78999999865432 22334555554 578899999999999884 358899999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
|+|...+.... .+++..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---- 150 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE---- 150 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC----
Confidence 99998886543 5788889999999999999999987 9999999999999999999999999987532221
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCCCCCHHH
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFV 705 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~~ 705 (816)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...+. ....+..+. ..++...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---------~~~~~~~ 219 (321)
T cd05603 151 --ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP---------LQLPGGK 219 (321)
T ss_pred --CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC---------CCCCCCC
Confidence 122345689999999999988999999999999999999999999965432 222221111 1233345
Q ss_pred HHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 706 ARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 706 ~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
+..+.+++.+||+.+|.+||+....+.+.++
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~ 250 (321)
T cd05603 220 TVAACDLLVGLLHKDQRRRLGAKADFLEIKN 250 (321)
T ss_pred CHHHHHHHHHHccCCHhhcCCCCCCHHHHhC
Confidence 6689999999999999999998655554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.26 Aligned_cols=245 Identities=30% Similarity=0.512 Sum_probs=197.7
Q ss_pred ceeeeecceEEEEEEEc--C---eEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCceeeEecccc-CCccceeeccCCC
Q 003481 476 FKVGQGGFGCVYKGEML--G---RTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACP-EAWSLVYEYLPNG 548 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~--g---~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~lV~E~~~~g 548 (816)
++||+|+||.||+|.+. + ..||+|.+...... ....+.+|+.+++.+.||||+++++++. +..++||||+++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~ 80 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG 80 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence 36999999999999874 2 67999998766543 4457899999999999999999999885 4578999999999
Q ss_pred chhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCC
Q 003481 549 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 628 (816)
Q Consensus 549 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 628 (816)
+|.+++.... .+++..++.++.|++.||.|||..+ ++|+||||+|||++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~-- 152 (257)
T cd05060 81 PLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY-- 152 (257)
T ss_pred cHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc--
Confidence 9999997654 5899999999999999999999987 9999999999999999999999999998765433211
Q ss_pred ccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCCCCCCHHH
Q 003481 629 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFV 705 (816)
Q Consensus 629 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~~ 705 (816)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+. +...+..+.. ...+...
T Consensus 153 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~ 223 (257)
T cd05060 153 -RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGER--------LPRPEEC 223 (257)
T ss_pred -ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc--------CCCCCCC
Confidence 11122234568999999998899999999999999999998 9999964332 2222322211 1123345
Q ss_pred HHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 706 ARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 706 ~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
+..+.+++.+||..+|.+||++. .|...|+.+
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~~-~l~~~l~~~ 255 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTFS-ELESTFRRD 255 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCHH-HHHHHHHhc
Confidence 56899999999999999999999 777777754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=313.19 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=199.4
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc-----cHHHHHHHHHHHhcCCCCceeeEeccccC--Cccc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-----GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 540 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 540 (816)
++|...+.||.|++|.||++... +..||+|.+...... ....+.+|+.++.+++||||+++++++.+ ..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999874 789999998654321 23468899999999999999999999844 5889
Q ss_pred eeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceecc
Q 003481 541 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 620 (816)
Q Consensus 541 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 620 (816)
|+||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999886543 5888999999999999999999988 9999999999999999999999999998654
Q ss_pred CCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCC
Q 003481 621 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 700 (816)
...... .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.............. ......
T Consensus 156 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-----~~~~~~ 227 (263)
T cd06625 156 TICSSG---TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT-----QPTNPQ 227 (263)
T ss_pred cccccc---ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc-----cCCCCC
Confidence 322110 011345688899999999998899999999999999999999999965433222111110 111123
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
.+...+..+.+++.+||..+|.+||++.+.+
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 258 (263)
T cd06625 228 LPSHVSPDARNFLRRTFVENAKKRPSAEELL 258 (263)
T ss_pred CCccCCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 4445667899999999999999999998544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.81 Aligned_cols=249 Identities=25% Similarity=0.385 Sum_probs=202.4
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeecc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 545 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 545 (816)
.+|...+.||.|+||.||+|... +..|++|.+..........+.+|+.++..++||||+++++.|. ...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 47888899999999999999874 7899999998766666677899999999999999999999874 4589999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
++++|.+++.. ..+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 99999998854 24789999999999999999999987 99999999999999999999999999876543221
Q ss_pred CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHH
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 705 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 705 (816)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||................ .+ ....+...
T Consensus 172 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~---~~-~~~~~~~~ 242 (296)
T cd06654 172 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG---TP-ELQNPEKL 242 (296)
T ss_pred -----ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC---CC-CCCCcccc
Confidence 1234468899999999988889999999999999999999999996544322211110000 00 11223446
Q ss_pred HHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 706 ARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 706 ~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
+..+.+|+.+||..+|.+||++.+.+.+.+
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~eil~~~~ 272 (296)
T cd06654 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (296)
T ss_pred CHHHHHHHHHHCcCCcccCcCHHHHhhChh
Confidence 678999999999999999999996665443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=321.63 Aligned_cols=256 Identities=28% Similarity=0.449 Sum_probs=203.2
Q ss_pred HHhcCCCccceeeeecceEEEEEEEc-------CeEEEEEEeccCCc-ccHHHHHHHHHHHhcC-CCCceeeEeccccC-
Q 003481 467 TATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE- 536 (816)
Q Consensus 467 ~~t~~f~~~~~LG~G~~g~Vy~~~~~-------g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~- 536 (816)
...++|...+.||+|+||.||++... ...||+|.+..... .....+.+|+.++.++ +||||++++++|..
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34457888899999999999999864 25799999875432 3345688999999999 89999999999844
Q ss_pred -CccceeeccCCCchhhhhhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEe
Q 003481 537 -AWSLVYEYLPNGSLQDRLFRK-------------SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 602 (816)
Q Consensus 537 -~~~lV~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl 602 (816)
..++||||+++|+|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 478999999999999998643 12346899999999999999999999987 9999999999999
Q ss_pred cCCCCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH-
Q 003481 603 DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE- 680 (816)
Q Consensus 603 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~- 680 (816)
+.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYY----RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred cCCCeEEeCccccccccccccce----eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 99999999999999876543211 11223345678999999988899999999999999999998 9999864332
Q ss_pred -HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 681 -VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 681 -~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
....+..+.. ...+...+..+.+|+.+||..+|.+|||+. +++..|+.+
T Consensus 242 ~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-eil~~l~~~ 291 (293)
T cd05053 242 ELFKLLKEGYR--------MEKPQNCTQELYHLMRDCWHEVPSQRPTFK-QLVEDLDRM 291 (293)
T ss_pred HHHHHHHcCCc--------CCCCCCCCHHHHHHHHHHcccCcccCcCHH-HHHHHHHHh
Confidence 2232222211 122334556899999999999999999999 677777654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.82 Aligned_cols=252 Identities=28% Similarity=0.440 Sum_probs=197.3
Q ss_pred cCCCccceeeeecceEEEEEEEc--C--eEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCCceeeEeccccC--Cccce
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--G--RTVAIKMLYSHN-MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLV 541 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g--~~vAiK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV 541 (816)
++|.+...||+|+||.||+|.+. + ..+++|.++... ......|.+|+.++.++ +||||+++++++.+ ..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46888899999999999999875 3 347888876432 23345688999999999 79999999999854 47899
Q ss_pred eeccCCCchhhhhhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCe
Q 003481 542 YEYLPNGSLQDRLFRKS-------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 608 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 608 (816)
+||+++|+|.+++.... ....+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999986532 1235889999999999999999999987 9999999999999999999
Q ss_pred eEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHh
Q 003481 609 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAV 685 (816)
Q Consensus 609 kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~ 685 (816)
||+|||++....... .......+..|+|||++....++.++|||||||++|+|++ |..||..... ....+
T Consensus 159 kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~ 231 (297)
T cd05089 159 KIADFGLSRGEEVYV-------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231 (297)
T ss_pred EECCcCCCcccccee-------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999986432111 1122233567999999988889999999999999999998 9999964332 22222
Q ss_pred hcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhhh
Q 003481 686 SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740 (816)
Q Consensus 686 ~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~~ 740 (816)
..+. ....+..++..+.+|+.+||+.+|.+||++. .++..|+.+..
T Consensus 232 ~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~~~~ 277 (297)
T cd05089 232 PQGY--------RMEKPRNCDDEVYELMRQCWRDRPYERPPFA-QISVQLSRMLE 277 (297)
T ss_pred hcCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHHH
Confidence 2111 1112334556899999999999999999999 56666766654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=319.49 Aligned_cols=249 Identities=25% Similarity=0.356 Sum_probs=190.5
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc--cHHHHHHHHHHHhcC---CCCceeeEeccccC-------
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKL---QHPHLVTLLGACPE------- 536 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l---~HpnIv~l~g~~~~------- 536 (816)
+|...+.||+|+||.||+|.+. ++.||+|.+...... ....+.+|+.++..+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999885 789999998754322 223456777777665 79999999998732
Q ss_pred CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccc
Q 003481 537 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 616 (816)
Q Consensus 537 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 616 (816)
..++||||+.+ +|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 26899999974 88888765432 45899999999999999999999988 999999999999999999999999999
Q ss_pred eeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHH---Hhhc-C----
Q 003481 617 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVSC-G---- 688 (816)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~---~~~~-~---- 688 (816)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|++||........ .... +
T Consensus 156 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07863 156 RIYSCQM-------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 228 (288)
T ss_pred ccccCcc-------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence 8764322 12345689999999999888999999999999999999999999964332211 1100 0
Q ss_pred -cccc-------ccCCCC----CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 689 -KLSS-------ILDPLA----GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 689 -~~~~-------~~d~~~----~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
.+.. .+.+.. .......+..+.+|+.+||+.||.+||++.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l 283 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHh
Confidence 0000 000000 011123456789999999999999999998655
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=312.92 Aligned_cols=251 Identities=24% Similarity=0.381 Sum_probs=204.1
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++|...+.||.|+||.||+|... |..||+|.++.... .....+.+|+.++++++|+||+++++++.+ ..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 67899999999999999999885 88999998864322 234578899999999999999999998843 478999
Q ss_pred eccCCCchhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 543 EYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
||+++|+|.+++.... ....+++..++.++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999886532 2345899999999999999999999988 99999999999999999999999999887643
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH----HHHHhhcCccccccCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE----VRRAVSCGKLSSILDPL 697 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~----~~~~~~~~~~~~~~d~~ 697 (816)
... ......+++.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+..
T Consensus 159 ~~~------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------- 225 (267)
T cd08224 159 KTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY------- 225 (267)
T ss_pred CCc------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC-------
Confidence 321 12334688999999999888899999999999999999999999953321 1111111211
Q ss_pred CCCCCH-HHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 698 AGDWPT-FVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 698 ~~~~~~-~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
...+. ..+..+.+++.+||..+|.+||++. .+...|..+
T Consensus 226 -~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~-~il~~~~~~ 265 (267)
T cd08224 226 -PPLPADHYSEELRDLVSRCINPDPEKRPDIS-YVLQVAKEM 265 (267)
T ss_pred -CCCChhhcCHHHHHHHHHHcCCCcccCCCHH-HHHHHHHHh
Confidence 11222 4566899999999999999999999 677777765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=306.34 Aligned_cols=247 Identities=24% Similarity=0.371 Sum_probs=203.6
Q ss_pred hcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++.|++...||+|.|+.||++... |+.+|+|+++... ..+.+.+.+|+.|...|+||||++|.....+ ..|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 456777788999999999998774 8889999875442 3356678899999999999999999998744 378999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecC---CCCeeEeecccceec
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS---ELSSKICDFGICRLV 619 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkL~DFGla~~~ 619 (816)
|+|.|++|..-|..+. .+++..+-.++.||+.||.|+|.++ |||||+||.|+||.. ..-+||+|||+|..+
T Consensus 90 e~m~G~dl~~eIV~R~---~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVARE---FYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999976665542 4677788899999999999999998 999999999999954 345999999999998
Q ss_pred cCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCCh--HHHHHHhhcCccccccCCC
Q 003481 620 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLA--GEVRRAVSCGKLSSILDPL 697 (816)
Q Consensus 620 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~--~~~~~~~~~~~~~~~~d~~ 697 (816)
..+. .....+|||+|||||++...+|+..+|||+.|||||-|+.|.+||... ..+.+.+..|.+. -.
T Consensus 164 ~~g~-------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd----~~ 232 (355)
T KOG0033|consen 164 NDGE-------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYD----YP 232 (355)
T ss_pred CCcc-------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccC----CC
Confidence 8433 346778999999999999999999999999999999999999999753 3455556555442 22
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 698 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 698 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
...|+ .+++...+|+.+||..||.+|.|+.+.|.+
T Consensus 233 ~~~w~-~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 233 SPEWD-TVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CcccC-cCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 23444 467789999999999999999999876644
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=317.37 Aligned_cols=252 Identities=30% Similarity=0.472 Sum_probs=201.2
Q ss_pred hcCCCccceeeeecceEEEEEEEc-------CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEeccccC--Cc
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AW 538 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~-------g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~ 538 (816)
.++|.+...||+|+||.||+|.+. +..||+|.+..... .....+.+|+.++..++||||+++++++.. ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 357888899999999999999875 26799999865432 334568899999999999999999999843 58
Q ss_pred cceeeccCCCchhhhhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEe
Q 003481 539 SLVYEYLPNGSLQDRLFRKSN-------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKIC 611 (816)
Q Consensus 539 ~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~ 611 (816)
++||||+++|+|.+++..... ...++|..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 899999999999999875432 234789999999999999999999987 9999999999999999999999
Q ss_pred ecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChH--HHHHHhhcC
Q 003481 612 DFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCG 688 (816)
Q Consensus 612 DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~--~~~~~~~~~ 688 (816)
|||+++........ .......++..|+|||.+.++.++.++|||||||++|||+| |..||.... .....+..+
T Consensus 162 dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05032 162 DFGMTRDIYETDYY----RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG 237 (277)
T ss_pred CcccchhhccCccc----ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC
Confidence 99999876543321 12234457889999999988889999999999999999998 999986433 222323222
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 689 KLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 689 ~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
.. ...|...+..+.+++.+||+.+|.+|||+. .+...|+
T Consensus 238 ~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~l~~~l~ 276 (277)
T cd05032 238 GH--------LDLPENCPDKLLELMRMCWQYNPKMRPTFL-EIVSSLK 276 (277)
T ss_pred CC--------CCCCCCCCHHHHHHHHHHcCCChhhCCCHH-HHHHHhc
Confidence 21 122333467899999999999999999999 5555553
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=331.66 Aligned_cols=242 Identities=25% Similarity=0.313 Sum_probs=190.9
Q ss_pred ceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHH-HHhcCCCCceeeEecccc--CCccceeeccCC
Q 003481 476 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVR-VLSKLQHPHLVTLLGACP--EAWSLVYEYLPN 547 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~-il~~l~HpnIv~l~g~~~--~~~~lV~E~~~~ 547 (816)
+.||+|+||.||++++. +..||+|++..... .....+..|.. ++..++||||+++++++. +..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999885 67899999865422 22233444444 567889999999999884 458999999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--- 151 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--- 151 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---
Confidence 99999886543 4778888999999999999999988 99999999999999999999999999875432221
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHH--HHhhcCccccccCCCCCCCCHHH
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDWPTFV 705 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~--~~~~~~~~~~~~d~~~~~~~~~~ 705 (816)
......||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..+.... ...+...
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---------~~~~~~~ 219 (325)
T cd05602 152 ---TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP---------LQLKPNI 219 (325)
T ss_pred ---CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC---------cCCCCCC
Confidence 2245579999999999999999999999999999999999999996543321 2221111 1122345
Q ss_pred HHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 706 ARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 706 ~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
+..+.+|+.+||+.||.+||++.+.+.+.++..
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~ 252 (325)
T cd05602 220 TNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHI 252 (325)
T ss_pred CHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCc
Confidence 668999999999999999999986665555543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=333.58 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=193.5
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCceeeEeccccC-------Ccc
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------AWS 539 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------~~~ 539 (816)
+|+..+.||+|+||.||++.+. ++.||||.+.... ......+.+|+.++..++||||+++++++.. ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999999874 8999999986532 2334568899999999999999999998842 468
Q ss_pred ceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceec
Q 003481 540 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 619 (816)
Q Consensus 540 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 619 (816)
+|+||+. ++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 5777777543 35899999999999999999999988 999999999999999999999999999875
Q ss_pred cCCCCcCCCccccCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH--hhc--C--c---
Q 003481 620 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSC--G--K--- 689 (816)
Q Consensus 620 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~--~~~--~--~--- 689 (816)
..... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||...+..... +.. | .
T Consensus 154 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 154 EPDES-----KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228 (372)
T ss_pred ccCcc-----ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 43321 122345689999999988764 5799999999999999999999999644322110 000 0 0
Q ss_pred -----------c-ccccCCC----CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 690 -----------L-SSILDPL----AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 690 -----------~-~~~~d~~----~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
+ .....+. ........+..+.+|+.+||+.||.+||++.+.+.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 0 0000000 0011122356789999999999999999999766554
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=332.40 Aligned_cols=240 Identities=27% Similarity=0.325 Sum_probs=190.3
Q ss_pred ceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHH-HHhcCCCCceeeEecccc--CCccceeeccCC
Q 003481 476 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVR-VLSKLQHPHLVTLLGACP--EAWSLVYEYLPN 547 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~-il~~l~HpnIv~l~g~~~--~~~~lV~E~~~~ 547 (816)
+.||+|+||.||+++.. |..||+|++..... .....+..|.. +++.++||||+++++++. +..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999875 88999999865422 22344556655 467789999999999884 458999999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
|+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~---- 150 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS---- 150 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC----
Confidence 99998886543 5889999999999999999999988 9999999999999999999999999987543221
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCCCCCHHH
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFV 705 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~~ 705 (816)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||...+. ....+..+.+ ..+...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~---------~~~~~~ 219 (325)
T cd05604 151 --DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL---------VLRPGA 219 (325)
T ss_pred --CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc---------cCCCCC
Confidence 122455799999999999999999999999999999999999999975432 2222222211 112234
Q ss_pred HHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 706 ARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 706 ~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
+..+.+++.+||+.+|.+||++.+.+.+.++
T Consensus 220 ~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05604 220 SLTAWSILEELLEKDRQRRLGAKEDFLEIQE 250 (325)
T ss_pred CHHHHHHHHHHhccCHHhcCCCCCCHHHHhc
Confidence 5678899999999999999999755544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=345.50 Aligned_cols=255 Identities=22% Similarity=0.300 Sum_probs=190.5
Q ss_pred HHHHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCC------CCceeeEecccc
Q 003481 464 DLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ------HPHLVTLLGACP 535 (816)
Q Consensus 464 el~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~------HpnIv~l~g~~~ 535 (816)
++...+++|.+.++||+|+||.||+|.+. +..||||++.... .....+..|+.++..++ |+++++++++|.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 44456789999999999999999999875 7889999986432 22334556777776665 456888888874
Q ss_pred C---CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCceeeCCCCCCceEecCCC-----
Q 003481 536 E---AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS-KPEKIVHGDLKPQNILLDSEL----- 606 (816)
Q Consensus 536 ~---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~ivHrDIkp~NILl~~~~----- 606 (816)
. ..++||+++ +++|.+++.... .+++..+..|+.||+.||.|||+. + ||||||||+||||+.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 3 478999988 778888886543 589999999999999999999984 6 99999999999998765
Q ss_pred -----------CeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCC
Q 003481 607 -----------SSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 675 (816)
Q Consensus 607 -----------~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf 675 (816)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||+||||++|++||
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~---------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH---------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc---------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 499999998754322 224567999999999999999999999999999999999999999
Q ss_pred CChHHHHHH--hh--cCccc-------------cccC------CCC-----------CCC-CHHHHHHHHHHHHHhhccC
Q 003481 676 GLAGEVRRA--VS--CGKLS-------------SILD------PLA-----------GDW-PTFVARRLVDLGLQCCELY 720 (816)
Q Consensus 676 ~~~~~~~~~--~~--~~~~~-------------~~~d------~~~-----------~~~-~~~~~~~l~~Li~~cl~~d 720 (816)
...+..... +. .|.+. .+++ +.. ..+ .......+.+||.+||++|
T Consensus 346 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 425 (467)
T PTZ00284 346 DTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD 425 (467)
T ss_pred CCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence 654322111 00 01000 0000 000 000 0012356789999999999
Q ss_pred CCCCCCChHHHHHHH
Q 003481 721 GRERPDITPSLVKEL 735 (816)
Q Consensus 721 P~~RPs~~e~l~~~L 735 (816)
|.+||++.+.|.|.+
T Consensus 426 P~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 426 RQKRLNARQMTTHPY 440 (467)
T ss_pred hhhCCCHHHHhcCcc
Confidence 999999997775554
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=324.18 Aligned_cols=254 Identities=21% Similarity=0.314 Sum_probs=194.5
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeec
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 544 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 544 (816)
++|...+.||+|+||.||+|++. +..||+|.+...... ....+.+|+.++.+++||||+++++++. +..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888999999999999999875 788999998755432 2345778999999999999999999984 458899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+++ +|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 7888776543 35788999999999999999999987 99999999999999999999999999976543221
Q ss_pred cCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHH--Hhhc--Cc-----cccc-
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVSC--GK-----LSSI- 693 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~--~~~~--~~-----~~~~- 693 (816)
......+|+.|+|||++.+ ..++.++|||||||++|+|+||++||...+.... .+.. +. +..+
T Consensus 160 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 160 ------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred ------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 1234467899999998764 4689999999999999999999999964332111 0000 00 0000
Q ss_pred -------cC-CCC-----CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 694 -------LD-PLA-----GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 694 -------~d-~~~-----~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
.+ +.. .......+..+.+|+.+||+.||.+|||+.+.+.+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 00 000 0011134567899999999999999999997665444
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=318.63 Aligned_cols=260 Identities=24% Similarity=0.322 Sum_probs=204.8
Q ss_pred cCHHHHHHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCceeeEecccc-
Q 003481 460 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACP- 535 (816)
Q Consensus 460 ~~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~- 535 (816)
+.++.+..++++|.+...||+|+||.||++.+. ++.||+|++.... .....+.+|+.++..+ +||||++++++|.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 556778888999999999999999999999885 7899999886532 2235688899999999 6999999999872
Q ss_pred ------CCccceeeccCCCchhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCe
Q 003481 536 ------EAWSLVYEYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 608 (816)
Q Consensus 536 ------~~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 608 (816)
+..++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 2378999999999999987643 22346889999999999999999999987 9999999999999999999
Q ss_pred eEeecccceeccCCCCcCCCccccCCCCCCCCCCCcccccc-----CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHH
Q 003481 609 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-----GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR 683 (816)
Q Consensus 609 kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~ 683 (816)
||+|||++........ ......|++.|+|||++.. ..++.++|||||||++|+|++|+.||........
T Consensus 164 kl~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~ 237 (286)
T cd06638 164 KLVDFGVSAQLTSTRL------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA 237 (286)
T ss_pred EEccCCceeecccCCC------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence 9999999987643221 2234569999999998753 4578999999999999999999999975543322
Q ss_pred HhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 684 AVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 684 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
....... ..+. ...+...+..+.+|+.+||+.+|.+||++.+.+.+
T Consensus 238 ~~~~~~~---~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 LFKIPRN---PPPT-LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred Hhhcccc---CCCc-ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 2211111 0010 01122345679999999999999999999965543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=318.25 Aligned_cols=244 Identities=23% Similarity=0.335 Sum_probs=196.2
Q ss_pred CCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeeccCC
Q 003481 472 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPN 547 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~~ 547 (816)
|++.+.||.|+||.||+|.+. +..+++|.+..........+.+|+.+++.++||||++++++|. +..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 566778999999999999986 6788999987665555667899999999999999999999874 457899999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
++|..++.... .++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~---- 157 (282)
T cd06643 87 GAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 157 (282)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc----
Confidence 99998876533 46899999999999999999999987 9999999999999999999999999987654322
Q ss_pred CccccCCCCCCCCCCCccccc-----cCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhh--cCccccccCCCCCC
Q 003481 628 SFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS--CGKLSSILDPLAGD 700 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~--~~~~~~~~d~~~~~ 700 (816)
.......|++.|+|||++. +..++.++|||||||++|+|++|++||........... .+..... .
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------~ 229 (282)
T cd06643 158 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL------A 229 (282)
T ss_pred --cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC------C
Confidence 1223456899999999874 44578899999999999999999999975443222211 1111111 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
.+..++..+.+|+.+||+.+|.+||++.+.+.
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 23335568999999999999999999985543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=314.11 Aligned_cols=253 Identities=26% Similarity=0.429 Sum_probs=200.3
Q ss_pred hcCCCccceeeeecceEEEEEEEc--C---eEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccc
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--G---RTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 540 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~--g---~~vAiK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 540 (816)
+++|+..+.||+|+||.||+|.+. + ..||+|.+.... ......+.+|+.++.+++||||+++++++.+ ..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888899999999999999874 3 369999986553 2334578899999999999999999999843 5789
Q ss_pred eeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceecc
Q 003481 541 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 620 (816)
Q Consensus 541 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 620 (816)
||||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999986543 46899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCC
Q 003481 621 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPL 697 (816)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~ 697 (816)
...... ........++.|+|||++....++.++|||||||++|+|++ |..||..... ....+..+.
T Consensus 159 ~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~-------- 227 (268)
T cd05063 159 DDPEGT---YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF-------- 227 (268)
T ss_pred cccccc---eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCC--------
Confidence 332110 11122234567999999988889999999999999999998 9999954322 222222221
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 698 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 698 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
....+...+..+.+++.+||..+|.+||++. .+...|+.+
T Consensus 228 ~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~-~i~~~l~~~ 267 (268)
T cd05063 228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFV-DIVNLLDKL 267 (268)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHhh
Confidence 1111223456789999999999999999999 677777654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=312.81 Aligned_cols=251 Identities=25% Similarity=0.390 Sum_probs=198.4
Q ss_pred CCCccceeeeecceEEEEEEEc-CeEEEEEEeccCCc------ccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccce
Q 003481 471 NFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNM------QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 541 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 541 (816)
+|...+.||.|+||.||+|... +..+|+|.+..... .....+.+|+.++++++|+||++++++|.+ ..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4777889999999999999874 78899998865432 122458899999999999999999999854 47899
Q ss_pred eeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999996543 5788999999999999999999988 99999999999999999999999999886542
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 701 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~ 701 (816)
...............|+..|+|||++.+..++.++|||||||++|+|++|..||...+.............. ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~ 230 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL----MPRL 230 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC----CCCC
Confidence 211111111223456899999999999888999999999999999999999999754433222211111111 1122
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 702 PTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 702 ~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
+..++..+.+++.+||+.+|.+||++.+.+
T Consensus 231 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l 260 (265)
T cd06631 231 PDSFSAAAIDFVTSCLTRDQHERPSALQLL 260 (265)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence 334567889999999999999999998554
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=334.41 Aligned_cols=247 Identities=23% Similarity=0.322 Sum_probs=194.0
Q ss_pred HhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccc
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 540 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 540 (816)
..++|...+.||+|+||.||+++.. +..||+|++..... .....+.+|+.+++.++||||+++++++.+ ..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3467999999999999999999885 78899999865322 233457899999999999999999999854 4899
Q ss_pred eeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceecc
Q 003481 541 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 620 (816)
Q Consensus 541 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 620 (816)
||||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 99999999999988543 4788899999999999999999988 9999999999999999999999999998764
Q ss_pred CCCCcCCCccccCCCCCCCCCCCccccccC----CCCcchhHhHHHHHHHHHHhCCCCCCChHHHH--HHhhcCcccccc
Q 003481 621 EDTLYLPSFHRSTAPKGSFPYADPEYHRTG----VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSIL 694 (816)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~--~~~~~~~~~~~~ 694 (816)
.... .......||+.|+|||++... .++.++|||||||+||+|++|+.||....... ..+.....
T Consensus 194 ~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~---- 264 (370)
T cd05621 194 ETGM-----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN---- 264 (370)
T ss_pred cCCc-----eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc----
Confidence 3221 122456799999999988653 37899999999999999999999997544321 11111110
Q ss_pred CCCCCCCCH--HHHHHHHHHHHHhhccCCCC--CCCChHHHHH
Q 003481 695 DPLAGDWPT--FVARRLVDLGLQCCELYGRE--RPDITPSLVK 733 (816)
Q Consensus 695 d~~~~~~~~--~~~~~l~~Li~~cl~~dP~~--RPs~~e~l~~ 733 (816)
...+|. ..+..+.+++..||..++.+ ||++.+.+.+
T Consensus 265 ---~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 ---SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ---ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 011222 34678889999999855543 7888765544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=322.06 Aligned_cols=256 Identities=26% Similarity=0.434 Sum_probs=203.0
Q ss_pred hcCCCccceeeeecceEEEEEEEc---------CeEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCCceeeEeccccC-
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML---------GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE- 536 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~---------g~~vAiK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~- 536 (816)
.++|.+.+.||+|+||.||++... +..||+|.+.... ......+.+|+.++..+ +||||++++++|.+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357899999999999999999763 2469999987543 23345688899999999 79999999999843
Q ss_pred -CccceeeccCCCchhhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEe
Q 003481 537 -AWSLVYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 602 (816)
Q Consensus 537 -~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl 602 (816)
..++||||+++|+|.+++..... ...++|..++.|+.|++.||.|||+.+ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 58899999999999999976431 135899999999999999999999987 9999999999999
Q ss_pred cCCCCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH-
Q 003481 603 DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE- 680 (816)
Q Consensus 603 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~- 680 (816)
+.++.+||+|||++......... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYY----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred cCCCcEEECCCcccccccccchh----hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 99999999999998766432211 11122335578999999988889999999999999999998 8889864332
Q ss_pred -HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhhh
Q 003481 681 -VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740 (816)
Q Consensus 681 -~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~~ 740 (816)
+...+..+.. ...+...+..+.+|+.+||..+|.+||++. +++..|+.+..
T Consensus 250 ~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-evl~~l~~~~~ 301 (307)
T cd05098 250 ELFKLLKEGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRILA 301 (307)
T ss_pred HHHHHHHcCCC--------CCCCCcCCHHHHHHHHHHcccChhhCcCHH-HHHHHHHHHHH
Confidence 2222222211 122334567899999999999999999999 77788877643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=330.91 Aligned_cols=252 Identities=21% Similarity=0.235 Sum_probs=195.1
Q ss_pred HHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEeccccC------
Q 003481 467 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE------ 536 (816)
Q Consensus 467 ~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------ 536 (816)
...++|...+.||+|+||.||++.+. +..||||++..... .....+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34578999999999999999999875 88999999875432 234567889999999999999999998732
Q ss_pred --CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecc
Q 003481 537 --AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 614 (816)
Q Consensus 537 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 614 (816)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 35899999965 56665532 4788999999999999999999988 9999999999999999999999999
Q ss_pred cceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH---hh-----
Q 003481 615 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VS----- 686 (816)
Q Consensus 615 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~---~~----- 686 (816)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..... +.
T Consensus 165 ~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (355)
T cd07874 165 LARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237 (355)
T ss_pred ccccCCCcc-------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 998654322 123457899999999999889999999999999999999999999644321110 00
Q ss_pred -----------------c-Ccccccc---------CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 687 -----------------C-GKLSSIL---------DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 687 -----------------~-~~~~~~~---------d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
. .....+. -+.....+...+..+.+|+.+||+.||.+|||+.+.+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 0 0000000 0000111222456789999999999999999999766554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=333.15 Aligned_cols=256 Identities=29% Similarity=0.435 Sum_probs=202.7
Q ss_pred HHhcCCCccceeeeecceEEEEEEEc-------CeEEEEEEeccCCccc-HHHHHHHHHHHhcCC-CCceeeEeccccC-
Q 003481 467 TATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQG-QLEFQQEVRVLSKLQ-HPHLVTLLGACPE- 536 (816)
Q Consensus 467 ~~t~~f~~~~~LG~G~~g~Vy~~~~~-------g~~vAiK~l~~~~~~~-~~~~~~E~~il~~l~-HpnIv~l~g~~~~- 536 (816)
...++|.+.++||+|+||.||+|++. +..||+|++....... ...+.+|+.+|.++. ||||++++|+|..
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34456788899999999999999864 3579999997653332 346889999999997 9999999999854
Q ss_pred -CccceeeccCCCchhhhhhhcCC--------------------------------------------------------
Q 003481 537 -AWSLVYEYLPNGSLQDRLFRKSN-------------------------------------------------------- 559 (816)
Q Consensus 537 -~~~lV~E~~~~gsL~~~l~~~~~-------------------------------------------------------- 559 (816)
..++||||+++|+|.+++.....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 57899999999999999865321
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCce
Q 003481 560 ---------------------------------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNI 600 (816)
Q Consensus 560 ---------------------------------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NI 600 (816)
...++|..++.|+.||+.||.|||+.+ |+||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceE
Confidence 134788889999999999999999977 99999999999
Q ss_pred EecCCCCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChH
Q 003481 601 LLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG 679 (816)
Q Consensus 601 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~ 679 (816)
|++.++.+||+|||+++........ .......++..|+|||++....++.++|||||||++|||++ |..||....
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~ 346 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNY----ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346 (401)
T ss_pred EEeCCCEEEEEecCcceeccccccc----ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999875432211 11233457889999999988889999999999999999998 899986432
Q ss_pred H---HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 680 E---VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 680 ~---~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
. ....+..+.. ...|...+..+.+|+.+||..+|.+||++. .|++.|+.+
T Consensus 347 ~~~~~~~~~~~~~~--------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~-ell~~L~~~ 399 (401)
T cd05107 347 MNEQFYNAIKRGYR--------MAKPAHASDEIYEIMQKCWEEKFEIRPDFS-QLVHLVGDL 399 (401)
T ss_pred chHHHHHHHHcCCC--------CCCCCCCCHHHHHHHHHHcCCChhHCcCHH-HHHHHHHHH
Confidence 2 1122222211 112333567899999999999999999999 677778765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=317.25 Aligned_cols=255 Identities=24% Similarity=0.321 Sum_probs=203.7
Q ss_pred hcCCCccceeeeecceEEEEEEEc------CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEecccc---CCc
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP---EAW 538 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~------g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~---~~~ 538 (816)
.++|...+.||+|+||.||+|.+. +..|++|.+..... .....+.+|+.++.+++||||+++++++. ...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 467888899999999999999875 37799998865432 33456889999999999999999999873 347
Q ss_pred cceeeccCCCchhhhhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeec
Q 003481 539 SLVYEYLPNGSLQDRLFRKSNV-----SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 613 (816)
Q Consensus 539 ~lV~E~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 613 (816)
+++++|+++|+|.+++...... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 8999999999999998764322 46899999999999999999999987 999999999999999999999999
Q ss_pred ccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCcc
Q 003481 614 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKL 690 (816)
Q Consensus 614 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~ 690 (816)
|+++.+...... .......++..|+|||++.+..++.++|||||||++|++++ |+.||..... ....+..+..
T Consensus 162 g~~~~~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 237 (280)
T cd05043 162 ALSRDLFPMDYH----CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR 237 (280)
T ss_pred CCcccccCCceE----EeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC
Confidence 999866433211 01123346778999999988889999999999999999999 9999964432 2222222211
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhh
Q 003481 691 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 691 ~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~ 739 (816)
...+...+..+.+++.+||..+|++||++. +++..|+.+.
T Consensus 238 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~~~~~l~~~~ 277 (280)
T cd05043 238 --------LAQPINCPDELFAVMACCWALDPEERPSFS-QLVQCLTDFH 277 (280)
T ss_pred --------CCCCCcCCHHHHHHHHHHcCCChhhCCCHH-HHHHHHHHHH
Confidence 111223456789999999999999999999 7778887664
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.15 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=198.0
Q ss_pred HhcCCCccceeeeecceEEEEEEEc-------CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEecccc--CC
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EA 537 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~-------g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~ 537 (816)
.+++|.+.+.||+|+||.||+|.+. +..||+|.+..... .....|.+|+.+++.++||||+++++++. +.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3567899999999999999999884 36789998865432 23456899999999999999999999874 35
Q ss_pred ccceeeccCCCchhhhhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCC---CeeE
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSN----VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL---SSKI 610 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkL 610 (816)
.++||||+++++|.+++..... ...++|..++.++.||+.||.|||+.+ ++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 7899999999999999876532 235899999999999999999999988 99999999999998754 5999
Q ss_pred eecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChH--HHHHHhhc
Q 003481 611 CDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSC 687 (816)
Q Consensus 611 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~--~~~~~~~~ 687 (816)
+|||+++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.... .....+..
T Consensus 161 ~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~ 236 (277)
T cd05036 161 ADFGMARDIYRASYY----RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236 (277)
T ss_pred ccCccccccCCccce----ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999876432211 11123334578999999998999999999999999999997 999996433 22222221
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 688 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 688 ~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
+. ...++...+..+.+++.+||+.+|++||++.+ |++.|
T Consensus 237 ~~--------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~-vl~~l 275 (277)
T cd05036 237 GG--------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFAT-ILERI 275 (277)
T ss_pred CC--------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHH-HHHHh
Confidence 11 11233445678999999999999999999994 55444
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=317.61 Aligned_cols=248 Identities=23% Similarity=0.325 Sum_probs=198.2
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccc--cCCccceeecc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYL 545 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~E~~ 545 (816)
++|++.++||.|+||.||+|.+. +..|++|.+..........+.+|+.+++.++||||++++++| ....++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 46888899999999999999885 789999999876666667789999999999999999999987 34589999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
++++|..++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 92 PGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred CCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 9999988876543 35899999999999999999999987 9999999999999999999999999987643321
Q ss_pred CCCccccCCCCCCCCCCCccccc-----cCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCC
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 700 (816)
.......+++.|+|||++. ...++.++|||||||++|+|++|..||.............. ...+ ...
T Consensus 165 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~-~~~ 236 (292)
T cd06644 165 ----QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPP-TLS 236 (292)
T ss_pred ----cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc---CCCc-cCC
Confidence 1223456889999999884 34578899999999999999999999965433221111100 0011 111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
.+...+..+.+++.+||..+|.+||++.+.+.
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 23345567899999999999999999985543
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.12 Aligned_cols=256 Identities=22% Similarity=0.325 Sum_probs=202.3
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEecccc--CCcccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~ 542 (816)
++|...+.||.|+||.||++... +..||||.+..... .....|.+|+.++..++||||++++++|. +..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 36778889999999999999874 88999998865432 23357889999999999999999999884 3578999
Q ss_pred eccCCCchhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 543 EYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
||+++++|.+++.... ....+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999886432 2346899999999999999999999988 99999999999999999999999999887654
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 701 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~ 701 (816)
... ......|+..|+|||++.+..++.++||||||+++|+|++|..||........... ..+.....+ ...
T Consensus 159 ~~~------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~--~~~ 229 (267)
T cd08229 159 KTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC-KKIEQCDYP--PLP 229 (267)
T ss_pred CCc------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHh-hhhhcCCCC--CCC
Confidence 321 12334688999999999888899999999999999999999999953321111100 011111111 011
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 702 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 702 ~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
+...+..+.+++.+||..+|.+|||+. .+.+.+..+
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~Rpt~~-~i~~~~~~~ 265 (267)
T cd08229 230 SDHYSEELRQLVNMCINPDPEKRPDIT-YVYDVAKRM 265 (267)
T ss_pred cccccHHHHHHHHHhcCCCcccCCCHH-HHHHHHhhh
Confidence 234667899999999999999999999 677777654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=317.93 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=205.7
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeecc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 545 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 545 (816)
.+|...+.||.|+||.||+|... ++.|++|.+..........+.+|+.+++.++||||++++++|. +..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46888899999999999999864 8899999997665555667899999999999999999999984 4589999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
++++|..++.. ..+++.++..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 99999998854 24899999999999999999999988 99999999999999999999999999886654321
Q ss_pred CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhh--cCccccccCCCCCCCCH
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS--CGKLSSILDPLAGDWPT 703 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~--~~~~~~~~d~~~~~~~~ 703 (816)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||........... ..... ....+.
T Consensus 171 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~------~~~~~~ 239 (296)
T cd06655 171 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP------ELQNPE 239 (296)
T ss_pred -----cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCc------ccCCcc
Confidence 12344688999999999988899999999999999999999999976544322211 11111 111233
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 704 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 704 ~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
..+..+.+||.+||..+|.+||++.+.+.+.+-..
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 45568999999999999999999998777666543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=320.43 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=203.4
Q ss_pred hcCCCccceeeeecceEEEEEEEc---------CeEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCCceeeEeccccC-
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML---------GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE- 536 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~---------g~~vAiK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~- 536 (816)
.++|.+...||+|+||.||+++.. +..||+|.+.... ......+.+|+.++..+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 457888899999999999999752 3479999986543 23345788999999999 89999999999854
Q ss_pred -CccceeeccCCCchhhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEe
Q 003481 537 -AWSLVYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 602 (816)
Q Consensus 537 -~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl 602 (816)
..++||||+++|+|.+++..... ...++|..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 47899999999999999976421 135889999999999999999999987 9999999999999
Q ss_pred cCCCCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChH--
Q 003481 603 DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG-- 679 (816)
Q Consensus 603 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~-- 679 (816)
+.++.+||+|||+++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred cCCCcEEECCCccceeccccccc----ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 99999999999999877543311 11233456778999999988889999999999999999998 788886432
Q ss_pred HHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhhh
Q 003481 680 EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740 (816)
Q Consensus 680 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~~ 740 (816)
.....+..+.. ...+...+..+.+|+.+||+.+|.+||++. ++++.|+.+..
T Consensus 247 ~~~~~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~-e~l~~l~~~~~ 298 (304)
T cd05101 247 ELFKLLKEGHR--------MDKPANCTNELYMMMRDCWHAIPSHRPTFK-QLVEDLDRILT 298 (304)
T ss_pred HHHHHHHcCCc--------CCCCCCCCHHHHHHHHHHcccChhhCCCHH-HHHHHHHHHHH
Confidence 22222322211 112234557899999999999999999998 67778877643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=313.13 Aligned_cols=247 Identities=26% Similarity=0.318 Sum_probs=199.5
Q ss_pred CCCccceeeeecceEEEEEEEcC--eEEEEEEeccCCcccH---HHHHHHHHHHhcCCCCceeeEeccccC--Cccceee
Q 003481 471 NFSESFKVGQGGFGCVYKGEMLG--RTVAIKMLYSHNMQGQ---LEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 543 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~g--~~vAiK~l~~~~~~~~---~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 543 (816)
+|+..+.||.|.-|+||++.+.+ ..+|+|++.+...... .+.+.|-+||+.++||.++.||..|+. ..|||||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 45556789999999999999985 7899999987755433 356789999999999999999999954 4789999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
||+||+|..+++++.. ..++...+.-++.+++.||+|||-.| ||+|||||+||||.++|++.|+||.++.......
T Consensus 158 yCpGGdL~~LrqkQp~-~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPG-KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred cCCCccHHHHHhhCCC-CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 9999999998876654 57999999999999999999999998 9999999999999999999999999986542100
Q ss_pred Cc--------------------------------------------------CCCccccCCCCCCCCCCCccccccCCCC
Q 003481 624 LY--------------------------------------------------LPSFHRSTAPKGSFPYADPEYHRTGVLT 653 (816)
Q Consensus 624 ~~--------------------------------------------------~~~~~~~~~~~gt~~Y~aPE~~~~~~~s 653 (816)
.. .+...+....+||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 00 1111233456899999999999999999
Q ss_pred cchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCC--CCCCCCHHHHHHHHHHHHHhhccCCCCCCCCh
Q 003481 654 PKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDP--LAGDWPTFVARRLVDLGLQCCELYGRERPDIT 728 (816)
Q Consensus 654 ~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~--~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~ 728 (816)
.++|+|+|||+||||+.|..||.+.+.-.. +..++.. .....+ .++..+.+||.+.|.+||.+|....
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~T------l~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~ 383 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKET------LRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSK 383 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhh------HHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccc
Confidence 999999999999999999999975543211 1112211 112223 5778999999999999999999844
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=321.53 Aligned_cols=243 Identities=24% Similarity=0.343 Sum_probs=192.9
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc---cHHHHHHHHHHHhcCCCCceeeEecccc--CCccceee
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYE 543 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E 543 (816)
.|+..+.||+|+||.||++.+. ++.||+|.+...... ....+.+|+.++.+++|+||+++++.+. +..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677789999999999999886 789999998654332 2345778999999999999999999874 45889999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
|+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999998865432 45899999999999999999999987 9999999999999999999999999987654322
Q ss_pred CcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCH
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPT 703 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 703 (816)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||......... ......+......++.
T Consensus 157 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~---~~~~~~~~~~~~~~~~ 226 (285)
T cd05630 157 -------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEVQEEYSE 226 (285)
T ss_pred -------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH---HHHHhhhhhhhhhcCc
Confidence 113346999999999999999999999999999999999999999743210000 0000011111112233
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCC
Q 003481 704 FVARRLVDLGLQCCELYGRERPDI 727 (816)
Q Consensus 704 ~~~~~l~~Li~~cl~~dP~~RPs~ 727 (816)
..+..+.+|+.+||+.||.+||++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~R~s~ 250 (285)
T cd05630 227 KFSPDARSLCKMLLCKDPKERLGC 250 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHccCC
Confidence 455678999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=326.80 Aligned_cols=255 Identities=26% Similarity=0.430 Sum_probs=210.0
Q ss_pred HHhcCCCccceeeeecceEEEEEEEc----C--eEEEEEEeccC-CcccHHHHHHHHHHHhcCCCCceeeEeccccCC-c
Q 003481 467 TATCNFSESFKVGQGGFGCVYKGEML----G--RTVAIKMLYSH-NMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEA-W 538 (816)
Q Consensus 467 ~~t~~f~~~~~LG~G~~g~Vy~~~~~----g--~~vAiK~l~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~ 538 (816)
.........+.||.|.||.||+|.+. | -.||||..+.+ ...+.+.|..|..+|++++|||||+|+|+|.+. .
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~ 465 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPM 465 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccce
Confidence 33344455678999999999999885 2 35999998875 445567899999999999999999999999664 7
Q ss_pred cceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccccee
Q 003481 539 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 539 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 618 (816)
+||||.++.|.|..+|.... ..|+......++.||+.||.|||+.. +|||||...|||+...--+||+|||+++.
T Consensus 466 WivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred eEEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence 89999999999999998766 46888889999999999999999987 99999999999999999999999999999
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHHHHHHhhcCccccccCCC
Q 003481 619 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDPL 697 (816)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~ 697 (816)
+.++..+ ..+...-..-|||||.+....+|.++|||.|||++||++. |..||...... ..+..+-...
T Consensus 541 ~ed~~yY-----kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs------DVI~~iEnGe 609 (974)
T KOG4257|consen 541 LEDDAYY-----KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS------DVIGHIENGE 609 (974)
T ss_pred ccccchh-----hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc------ceEEEecCCC
Confidence 9876644 3344455678999999999999999999999999999988 99999754431 1111111222
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 698 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 698 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
....|+.+++.|..|+.+||.++|.+||.+. ++...|..+
T Consensus 610 RlP~P~nCPp~LYslmskcWayeP~kRPrft-ei~~~lsdv 649 (974)
T KOG4257|consen 610 RLPCPPNCPPALYSLMSKCWAYEPSKRPRFT-EIKAILSDV 649 (974)
T ss_pred CCCCCCCCChHHHHHHHHHhccCcccCCcHH-HHHHHHHHH
Confidence 3345777888999999999999999999998 565555544
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.91 Aligned_cols=255 Identities=28% Similarity=0.448 Sum_probs=200.8
Q ss_pred HhcCCCccceeeeecceEEEEEEEc-------CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEeccccC--C
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--A 537 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~-------g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~ 537 (816)
.+++|.+.+.||+|+||.||+|... +..||+|.+..... .....+.+|+.+++.++||||+++++++.+ .
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4568999999999999999999653 45799998865432 233468899999999999999999998843 5
Q ss_pred ccceeeccCCCchhhhhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeE
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSN-------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI 610 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL 610 (816)
.++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 7999999999999999975321 245678889999999999999999987 999999999999999999999
Q ss_pred eecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhc
Q 003481 611 CDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSC 687 (816)
Q Consensus 611 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~ 687 (816)
+|||+++........ .......++..|+|||.+.++.++.++|||||||++|||++ |..||..... ....+..
T Consensus 161 ~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (288)
T cd05061 161 GDFGMTRDIYETDYY----RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236 (288)
T ss_pred CcCCccccccccccc----cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999865433211 11223345778999999998899999999999999999999 7889864332 2222222
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 688 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 688 ~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
+.. ...+...+..+.+++.+||+.+|.+||++. .+++.|+..
T Consensus 237 ~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~ll~~l~~~ 278 (288)
T cd05061 237 GGY--------LDQPDNCPERVTDLMRMCWQFNPKMRPTFL-EIVNLLKDD 278 (288)
T ss_pred CCC--------CCCCCCCCHHHHHHHHHHcCCChhHCcCHH-HHHHHHHhh
Confidence 211 112333456899999999999999999999 566666653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=311.57 Aligned_cols=246 Identities=26% Similarity=0.356 Sum_probs=201.4
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeecc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 545 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 545 (816)
++|...+.||.|+||.||+|... +..|++|.+..... ...+.+|+.++++++||||+++++++.+ ..++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 57888899999999999999886 68899999865433 6689999999999999999999998844 588999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999999986543 46899999999999999999999988 99999999999999999999999999987654321
Q ss_pred CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHH
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 705 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 705 (816)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||............... .+.....+...
T Consensus 155 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~ 225 (256)
T cd06612 155 -----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK----PPPTLSDPEKW 225 (256)
T ss_pred -----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC----CCCCCCchhhc
Confidence 123445889999999999889999999999999999999999999754433222111110 00111223445
Q ss_pred HHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 706 ARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 706 ~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
+..+.+++.+||+.+|.+||++.+.+.
T Consensus 226 ~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 226 SPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 678999999999999999999986553
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=317.49 Aligned_cols=252 Identities=29% Similarity=0.478 Sum_probs=200.8
Q ss_pred hcCCCccceeeeecceEEEEEEEc-------CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEeccccC--Cc
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AW 538 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~-------g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~ 538 (816)
.++|.....||.|+||.||++.+. +..||+|++..... .....|.+|+.++++++||||++++++|.+ ..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999863 57899999875432 334568899999999999999999999854 47
Q ss_pred cceeeccCCCchhhhhhhcC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCc
Q 003481 539 SLVYEYLPNGSLQDRLFRKS-------------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQN 599 (816)
Q Consensus 539 ~lV~E~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~N 599 (816)
++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986432 1235789999999999999999999987 9999999999
Q ss_pred eEecCCCCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCCh
Q 003481 600 ILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLA 678 (816)
Q Consensus 600 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~ 678 (816)
||++.++.++|+|||++......... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYY----KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred eEecCCCceEECccccceecccCccc----cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999998865433211 11222345678999999988899999999999999999998 88888533
Q ss_pred H--HHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 679 G--EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 679 ~--~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
. .....+..+... ..+...+..+.+|+.+||+.+|.+||++. ++.+.|+
T Consensus 237 ~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~-el~~~l~ 287 (288)
T cd05050 237 AHEEVIYYVRDGNVL--------SCPDNCPLELYNLMRLCWSKLPSDRPSFA-SINRILQ 287 (288)
T ss_pred CHHHHHHHHhcCCCC--------CCCCCCCHHHHHHHHHHcccCcccCCCHH-HHHHHhh
Confidence 2 222333333321 12333557899999999999999999999 5777665
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=326.98 Aligned_cols=247 Identities=29% Similarity=0.438 Sum_probs=211.0
Q ss_pred HhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCccc---HHHHHHHHHHHhcCC-CCceeeEeccccC--Ccc
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQ-HPHLVTLLGACPE--AWS 539 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~---~~~~~~E~~il~~l~-HpnIv~l~g~~~~--~~~ 539 (816)
....|.+.+.||.|.||.||+++.. |+.+|+|++.+....+ ...+.+|+.+|+++. |||||.++++|++ ..+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4457888899999999999999885 8899999998776643 357899999999998 9999999999965 479
Q ss_pred ceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCC----CCeeEeeccc
Q 003481 540 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE----LSSKICDFGI 615 (816)
Q Consensus 540 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~----~~vkL~DFGl 615 (816)
+|||++.||.|.+.+... . +++.++..++.|++.|+.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999776 2 899999999999999999999988 9999999999999543 5799999999
Q ss_pred ceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccc
Q 003481 616 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSI 693 (816)
Q Consensus 616 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~ 693 (816)
+.....+. .....+||+.|+|||++....|+..+||||+||++|.|++|.+||....+ ....+..+.+
T Consensus 186 a~~~~~~~-------~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~--- 255 (382)
T KOG0032|consen 186 AKFIKPGE-------RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF--- 255 (382)
T ss_pred ceEccCCc-------eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC---
Confidence 99887632 35678999999999999999999999999999999999999999976553 3344555554
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 694 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 694 ~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
+.....|+ .++..+.++|..|+..||..|+++.+.|.|
T Consensus 256 -~f~~~~w~-~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -DFTSEPWD-DISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -CCCCCCcc-ccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 22233444 468899999999999999999999966653
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=319.12 Aligned_cols=244 Identities=26% Similarity=0.376 Sum_probs=191.3
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeecc
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 545 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 545 (816)
+|...+.||+|+||.||+|.+. +..||+|++.... ......|.+|+.++.+++||||++++++|. +..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5777889999999999999874 7889999986543 233456889999999999999999999884 4578999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 999996542 4678889999999999999999987 9999999999999999999999999998664322
Q ss_pred CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHh-hcCccccccCCCCCCC-CH
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV-SCGKLSSILDPLAGDW-PT 703 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~-~~~~~~~~~d~~~~~~-~~ 703 (816)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||.......... ..+....+.+...... ..
T Consensus 150 ------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (279)
T cd06619 150 ------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVG 223 (279)
T ss_pred ------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCC
Confidence 234578999999999998899999999999999999999999995321100000 0000000011111111 12
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 704 FVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 704 ~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
..+..+.+++.+||+.+|.+||++.+.+.
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 24567899999999999999999985443
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=319.77 Aligned_cols=252 Identities=27% Similarity=0.420 Sum_probs=200.8
Q ss_pred hcCCCccceeeeecceEEEEEEEc-------CeEEEEEEeccCCc-ccHHHHHHHHHHHhcC-CCCceeeEecccc--CC
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACP--EA 537 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~-------g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~~--~~ 537 (816)
.++|...+.||+|+||.||++... +..||+|++..... .....+.+|+.+++++ +||||++++++|. +.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 357899999999999999999752 45799999875532 2345688999999999 7999999999984 35
Q ss_pred ccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccce
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 617 (816)
.++||||+++|+|.+++..... ..+++.++..|+.+++.||.|||+.+ |+|+||||+|||++.++.++|+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 8899999999999999875432 34899999999999999999999987 9999999999999999999999999998
Q ss_pred eccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH---HHHHhhcCccccc
Q 003481 618 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE---VRRAVSCGKLSSI 693 (816)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~---~~~~~~~~~~~~~ 693 (816)
........ .......++..|+|||++....++.++|||||||++|+|++ |..||..... ....+..+..
T Consensus 190 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~--- 262 (302)
T cd05055 190 DIMNDSNY----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR--- 262 (302)
T ss_pred cccCCCce----eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc---
Confidence 66543211 11223456788999999998899999999999999999998 9999864332 1122222211
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHH
Q 003481 694 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 737 (816)
Q Consensus 694 ~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~ 737 (816)
...+...+..+.+|+.+||..+|++||++. +++..|+.
T Consensus 263 -----~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~-ell~~l~~ 300 (302)
T cd05055 263 -----MAQPEHAPAEIYDIMKTCWDADPLKRPTFK-QIVQLIGK 300 (302)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCchhCcCHH-HHHHHHHh
Confidence 111223456899999999999999999999 67677665
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=310.85 Aligned_cols=249 Identities=26% Similarity=0.348 Sum_probs=202.2
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeecc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 545 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 545 (816)
++|.....||.|+||.||+|... +..+++|++..........+.+|+.++++++||||+++++++. +..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888899999999999999875 6889999998766556678999999999999999999999874 4588999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 83 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 155 (262)
T cd06613 83 GGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-- 155 (262)
T ss_pred CCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence 9999999886642 35889999999999999999999987 9999999999999999999999999987664322
Q ss_pred CCCccccCCCCCCCCCCCccccccC---CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCC
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTG---VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 702 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~ 702 (816)
.......++..|+|||.+.+. .++.++|||||||++|+|+||+.||.............. .. +.+.....+
T Consensus 156 ----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~-~~-~~~~~~~~~ 229 (262)
T cd06613 156 ----AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK-SN-FPPPKLKDK 229 (262)
T ss_pred ----hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cc-CCCccccch
Confidence 122345688899999998776 889999999999999999999999975443222111110 00 111111223
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 703 TFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 703 ~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
...+..+.+++.+||..+|.+||++.+.+
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il 258 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLL 258 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 45677899999999999999999998544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=311.56 Aligned_cols=243 Identities=28% Similarity=0.447 Sum_probs=198.4
Q ss_pred cCCCccceeeeecceEEEEEEEcCeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc-CCccceeeccCCC
Q 003481 470 CNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP-EAWSLVYEYLPNG 548 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~lV~E~~~~g 548 (816)
++|.+.+.||+|+||.||+|...+..||+|.+.... ....+.+|+.++.+++||||+++++++. +..++||||++++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~ 83 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKG 83 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCC
Confidence 457888999999999999999889999999986532 3457889999999999999999999874 4588999999999
Q ss_pred chhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCC
Q 003481 549 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 628 (816)
Q Consensus 549 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 628 (816)
+|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----- 154 (254)
T cd05083 84 NLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----- 154 (254)
T ss_pred CHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-----
Confidence 99999976542 45889999999999999999999987 9999999999999999999999999987653321
Q ss_pred ccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCCCCCCHHH
Q 003481 629 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFV 705 (816)
Q Consensus 629 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~~ 705 (816)
.....+..|+|||++.++.++.++|||||||++|+|++ |+.||..... ....+..+... ..+...
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~ 222 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM--------EPPEGC 222 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCC--------CCCCcC
Confidence 12234578999999988899999999999999999998 9999964432 22333222111 112335
Q ss_pred HHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 706 ARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 706 ~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
+..+.+++.+||+.+|..||++. .|...|+
T Consensus 223 ~~~~~~li~~~l~~~p~~Rp~~~-~l~~~l~ 252 (254)
T cd05083 223 PADVYVLMTSCWETEPKKRPSFH-KLREKLE 252 (254)
T ss_pred CHHHHHHHHHHcCCChhhCcCHH-HHHHHHc
Confidence 56889999999999999999998 5655554
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=329.71 Aligned_cols=251 Identities=22% Similarity=0.258 Sum_probs=194.2
Q ss_pred HhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCceeeEeccccC-------
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE------- 536 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------- 536 (816)
..++|...+.||+|+||.||++.+. +..||||++.... ......+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999875 7889999987542 2334567899999999999999999987632
Q ss_pred -CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccc
Q 003481 537 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 615 (816)
Q Consensus 537 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 615 (816)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 25899999965 67666632 4788999999999999999999987 99999999999999999999999999
Q ss_pred ceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH---hhc-C---
Q 003481 616 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VSC-G--- 688 (816)
Q Consensus 616 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~---~~~-~--- 688 (816)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..... +.. +
T Consensus 173 a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (364)
T cd07875 173 ARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245 (364)
T ss_pred ccccCCCC-------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 98654322 123456899999999999999999999999999999999999999644321110 000 0
Q ss_pred -------------------cc---------ccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 689 -------------------KL---------SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 689 -------------------~~---------~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
.. ....-+............+.+|+.+||+.||.+|||+.+.+.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 00 00000000111112345789999999999999999999766543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=316.33 Aligned_cols=251 Identities=24% Similarity=0.288 Sum_probs=193.4
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeec
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 544 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 544 (816)
+|...+.||.|+||.||+|... +..||||.+..... .....+.+|+.++.+++||||+++++++. +..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778889999999999999885 78999999865432 23456889999999999999999999984 458899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+. ++|.+++........+++..++.++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 688888865544456899999999999999999999987 99999999999999999999999999976543221
Q ss_pred cCCCccccCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhc----Ccc---------
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----GKL--------- 690 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~----~~~--------- 690 (816)
......+++.|+|||++.+. .++.++|||||||++|+|+||++||............ +..
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 157 ------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred ------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence 12334678999999987654 5789999999999999999999999754332111110 000
Q ss_pred -----cccc----CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 691 -----SSIL----DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 691 -----~~~~----d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
...+ ...........+..+.+|+.+||+.||.+||++.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll 280 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKAL 280 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 0000 0000001112456788999999999999999998544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.19 Aligned_cols=250 Identities=27% Similarity=0.378 Sum_probs=197.7
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeecc
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 545 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 545 (816)
+|++.+.||+|+||.||++.+. +..||+|.+.... ......+.+|+.++.+++||||+++++++. +..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5788889999999999999986 8899999886542 233457889999999999999999999874 4588999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
++++|..++........+++..+..++.+++.||.|||+.. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 99999998866433346899999999999999999999742 39999999999999999999999999987654322
Q ss_pred CCCccccCCCCCCCCCCCccccccC------CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCC
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTG------VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAG 699 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~------~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~ 699 (816)
.....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.......... .+..+.+....
T Consensus 158 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~ 228 (286)
T cd06622 158 ------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA---QLSAIVDGDPP 228 (286)
T ss_pred ------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH---HHHHHhhcCCC
Confidence 2334688899999988554 35889999999999999999999996432211100 01111121222
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 700 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 700 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
..+..++..+.+|+.+||+.+|.+||++.+.+.+
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 229 TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 3445577889999999999999999999865543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=319.20 Aligned_cols=244 Identities=25% Similarity=0.352 Sum_probs=207.5
Q ss_pred cCCCccceeeeecceEEEEEEE--cCeEEEEEEeccCCcccH--HHHHHHHHHHhcCCCCceeeEecccc--CCccceee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQ--LEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYE 543 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~--~g~~vAiK~l~~~~~~~~--~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E 543 (816)
+-|...+.||+|.|+.|-++++ .|..||||++.+...... ..+.+|++.|+.++|||||+||.+.. ..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 3467778899999999999876 599999999988766543 46889999999999999999999985 45999999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEec-CCCCeeEeecccceeccCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD-SELSSKICDFGICRLVTED 622 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~-~~~~vkL~DFGla~~~~~~ 622 (816)
+-++|+|.++|.++. ..+.+....+++.||+.|+.|+|+.+ +|||||||+||.+- .-|-+||.|||++..+.++
T Consensus 98 LGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 999999999998876 46889999999999999999999998 99999999999875 5688999999999888766
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccCCCC-cchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLT-PKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 701 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~ 701 (816)
. ..+..+|++.|.|||++.+..|+ +++||||||||||-|++|++||...++... +.-++|- ....
T Consensus 173 ~-------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET------LTmImDC-KYtv 238 (864)
T KOG4717|consen 173 K-------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET------LTMIMDC-KYTV 238 (864)
T ss_pred c-------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh------hhhhhcc-cccC
Confidence 5 34677899999999999999886 799999999999999999999975443221 2222221 2245
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 702 PTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 702 ~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
|..++.++.+||..||..||.+|.++.+++-
T Consensus 239 PshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 239 PSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred chhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 8889999999999999999999999985443
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=326.05 Aligned_cols=254 Identities=29% Similarity=0.455 Sum_probs=199.0
Q ss_pred cCCCccceeeeecceEEEEEEE-------cCeEEEEEEeccCCcc-cHHHHHHHHHHHhcC-CCCceeeEeccccC---C
Q 003481 470 CNFSESFKVGQGGFGCVYKGEM-------LGRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKL-QHPHLVTLLGACPE---A 537 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~-------~g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l-~HpnIv~l~g~~~~---~ 537 (816)
++|.+.+.||+|+||.||+|.+ .++.||||++...... ....+.+|+.+|.++ +||||++++++|.. .
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4788899999999999999974 2578999999754332 344688999999999 78999999998743 3
Q ss_pred ccceeeccCCCchhhhhhhcCC----------------------------------------------------------
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSN---------------------------------------------------------- 559 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 559 (816)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 6899999999999998864321
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCccccC
Q 003481 560 ------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 633 (816)
Q Consensus 560 ------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~ 633 (816)
...++|..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......... ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~ 239 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----VRKG 239 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcch----hhcC
Confidence 124788999999999999999999987 999999999999999999999999999876432211 1123
Q ss_pred CCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChH---HHHHHhhcCccccccCCCCCCCCHHHHHHH
Q 003481 634 APKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG---EVRRAVSCGKLSSILDPLAGDWPTFVARRL 709 (816)
Q Consensus 634 ~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~---~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l 709 (816)
...+++.|+|||++.+..++.++||||||+++|+|++ |..||.... .....+..+... ..+...+..+
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 311 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--------RAPDYTTPEM 311 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC--------CCCCCCCHHH
Confidence 3446778999999988899999999999999999997 999986432 222222222211 1122234578
Q ss_pred HHHHHHhhccCCCCCCCChHHHHHHHHHhh
Q 003481 710 VDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 710 ~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~ 739 (816)
.+++..||+.+|.+||++. +|++.|+.+.
T Consensus 312 ~~~~~~cl~~~p~~Rps~~-eil~~l~~~~ 340 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFS-ELVEHLGNLL 340 (343)
T ss_pred HHHHHHHccCChhhCcCHH-HHHHHHHHHH
Confidence 9999999999999999999 6667777653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=328.50 Aligned_cols=250 Identities=21% Similarity=0.285 Sum_probs=193.0
Q ss_pred HHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEeccccC------
Q 003481 467 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE------ 536 (816)
Q Consensus 467 ~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------ 536 (816)
...++|.....||.|+||.||+|.+. +..||||++..... .....+.+|+.+|++++||||+++++++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 44578999999999999999999875 78899999865432 233467789999999999999999988732
Q ss_pred --CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecc
Q 003481 537 --AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 614 (816)
Q Consensus 537 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 614 (816)
..+++++++ +++|.+++.. ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 257899988 7899887743 35899999999999999999999988 9999999999999999999999999
Q ss_pred cceeccCCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH--h-h-cCc
Q 003481 615 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--V-S-CGK 689 (816)
Q Consensus 615 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~--~-~-~~~ 689 (816)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..... + . .+.
T Consensus 164 ~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (343)
T cd07878 164 LARQADDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGT 234 (343)
T ss_pred cceecCCC---------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99875432 234568999999998876 57899999999999999999999999643321111 0 0 000
Q ss_pred -------------cccccCCCCCCCC--------HHHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 690 -------------LSSILDPLAGDWP--------TFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 690 -------------~~~~~d~~~~~~~--------~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
....+.. ....+ ....+.+.+|+.+||+.||.+|||+.+.+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp 299 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299 (343)
T ss_pred CCHHHHHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 0000000 00001 11234578999999999999999999766543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=320.03 Aligned_cols=248 Identities=25% Similarity=0.366 Sum_probs=202.3
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeecc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 545 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 545 (816)
.+|...+.||.|+||.||+|... +..||+|.+..........+.+|+.+++.++||||++++++|. +..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 57888899999999999999874 8899999997766556667889999999999999999999884 3588999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~- 170 (297)
T cd06656 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (297)
T ss_pred CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence 99999998854 24788999999999999999999987 99999999999999999999999999987644321
Q ss_pred CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHH
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 705 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 705 (816)
......+++.|+|||.+.+..++.++|||||||++|+|++|..||...+........... .......+...
T Consensus 171 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~ 241 (297)
T cd06656 171 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN----GTPELQNPERL 241 (297)
T ss_pred -----CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC----CCCCCCCcccc
Confidence 123446889999999999888999999999999999999999999654432211110000 00111234455
Q ss_pred HHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 706 ARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 706 ~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
+..+.+|+.+||..+|.+||++.+.+.+.
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~ 270 (297)
T cd06656 242 SAVFRDFLNRCLEMDVDRRGSAKELLQHP 270 (297)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 67789999999999999999999655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=309.57 Aligned_cols=244 Identities=36% Similarity=0.589 Sum_probs=200.0
Q ss_pred ceeeeecceEEEEEEEc-----CeEEEEEEeccCCccc-HHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccCC
Q 003481 476 FKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNMQG-QLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPN 547 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~-----g~~vAiK~l~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~ 547 (816)
+.||+|+||.||+|... +..|++|.+....... ...+.+|+.++..++|+||+++++++.. ..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 36999999999999886 6789999997765443 5678999999999999999999998854 58899999999
Q ss_pred CchhhhhhhcCC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 548 GSLQDRLFRKSN------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 548 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
++|.+++..... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999977521 256899999999999999999999987 99999999999999999999999999988765
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLA 698 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~ 698 (816)
... ........+++.|+|||.+....++.++|||||||++|+|++ |..||..... ....+..+. .
T Consensus 158 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--------~ 225 (262)
T cd00192 158 DDY----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY--------R 225 (262)
T ss_pred ccc----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------C
Confidence 432 112345567889999999988889999999999999999999 6999975432 222222211 1
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 699 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 699 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
...+...+..+.+++.+||..+|.+||++. .++..|
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~l~~~l 261 (262)
T cd00192 226 LPKPEYCPDELYELMLSCWQLDPEDRPTFS-ELVERL 261 (262)
T ss_pred CCCCccCChHHHHHHHHHccCCcccCcCHH-HHHHhh
Confidence 223444577899999999999999999998 454443
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=318.06 Aligned_cols=252 Identities=29% Similarity=0.480 Sum_probs=200.0
Q ss_pred cCCCccceeeeecceEEEEEEEc--Ce----EEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEeccccC-Cccce
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GR----TVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLV 541 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~----~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV 541 (816)
++|...+.||+|+||.||+|.+. |. .||+|.+..... .....+.+|+.++..++||||++++|+|.. ..+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v 86 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV 86 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence 45677789999999999999873 43 579998865433 223468899999999999999999999843 57799
Q ss_pred eeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
++|+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 87 TQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred ehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence 99999999999987543 35889999999999999999999987 99999999999999999999999999987653
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCCh--HHHHHHhhcCccccccCCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLA--GEVRRAVSCGKLSSILDPLA 698 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~--~~~~~~~~~~~~~~~~d~~~ 698 (816)
.... .......++..|+|||++.+..++.++|||||||++|||++ |..||... ......+..+... +
T Consensus 162 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~----~-- 231 (303)
T cd05110 162 DEKE----YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL----P-- 231 (303)
T ss_pred cccc----cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC----C--
Confidence 3211 11223446788999999988899999999999999999997 99999643 2233333322211 1
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhh
Q 003481 699 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 699 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~ 739 (816)
.+...+..+.+++..||..+|.+||++. .++..|+.+.
T Consensus 232 --~~~~~~~~~~~li~~c~~~~p~~Rp~~~-~l~~~l~~~~ 269 (303)
T cd05110 232 --QPPICTIDVYMVMVKCWMIDADSRPKFK-ELAAEFSRMA 269 (303)
T ss_pred --CCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHH
Confidence 1122345789999999999999999999 6777787764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=311.08 Aligned_cols=243 Identities=23% Similarity=0.308 Sum_probs=198.7
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeecc
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 545 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 545 (816)
+|.+.+.||.|+||.||++.+. +..||+|.+.... ......+.+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999875 7889999986433 2344568899999999999999999998843 588999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 9999999886533 245789999999999999999999988 99999999999999999999999999987654321
Q ss_pred CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCccccccCCCCCCCCH
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPT 703 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~~~~~ 703 (816)
......|++.|+|||++.+..++.++||||||+++|+|++|..||...+.. ...+..+... ..+.
T Consensus 156 -----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~ 222 (255)
T cd08219 156 -----YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK--------PLPS 222 (255)
T ss_pred -----ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC--------CCCc
Confidence 123456899999999998888999999999999999999999999754432 1222222221 1233
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 704 FVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 704 ~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
..+..+.+|+.+||+.||.+||++.+.+
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il 250 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTIL 250 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHh
Confidence 4556789999999999999999999544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.33 Aligned_cols=246 Identities=23% Similarity=0.319 Sum_probs=196.0
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeecc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 545 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 545 (816)
++|...+.||+|+||.||+|.+. +..||+|.+..........+.+|+.++..++||||+++++++. +..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777888999999999999874 7899999987665555566889999999999999999999874 4588999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
++++|.+++.... .+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 89 GGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 9999999886543 5889999999999999999999988 9999999999999999999999999987664322
Q ss_pred CCCccccCCCCCCCCCCCccccc---cCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH--hhcCccccccCCCCCC
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCGKLSSILDPLAGD 700 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~--~~~~~~~~~~d~~~~~ 700 (816)
.......|++.|+|||++. .+.++.++|||||||++|+|++|..||......... ....... .+.. .
T Consensus 161 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~-~ 232 (267)
T cd06645 161 ----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ---PPKL-K 232 (267)
T ss_pred ----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC---CCcc-c
Confidence 1223457899999999874 456889999999999999999999998543321111 1111111 1111 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
....++..+.+++.+||..+|.+||++.+.+
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll 263 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLL 263 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHh
Confidence 1112345789999999999999999998544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=307.83 Aligned_cols=240 Identities=28% Similarity=0.463 Sum_probs=192.4
Q ss_pred eeeeecceEEEEEEEc-CeEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccCCCchhh
Q 003481 477 KVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSLQD 552 (816)
Q Consensus 477 ~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL~~ 552 (816)
+||.|+||.||+|... +..||+|.+...... ....|.+|+.++..++||||++++++|.. ..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 6899999999999875 678999998765432 23468899999999999999999999844 5889999999999999
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCcccc
Q 003481 553 RLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRS 632 (816)
Q Consensus 553 ~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 632 (816)
++.... ..+++..++.++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++......... ..
T Consensus 82 ~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-----~~ 151 (250)
T cd05085 82 FLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-----SS 151 (250)
T ss_pred HHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-----cC
Confidence 886543 35889999999999999999999987 999999999999999999999999998765432211 11
Q ss_pred CCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCCCCCCHHHHHHH
Q 003481 633 TAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARRL 709 (816)
Q Consensus 633 ~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~~~~~l 709 (816)
....+++.|+|||++.++.++.++||||||+++|+|++ |..||..... ....+..+.. ...+...+..+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 223 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR--------MSCPQKCPDDV 223 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC--------CCCCCCCCHHH
Confidence 22345678999999998899999999999999999999 9999964332 2222222211 11223356789
Q ss_pred HHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 710 VDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 710 ~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
.+++.+||..+|.+||++. ++...|
T Consensus 224 ~~li~~~l~~~p~~Rp~~~-~l~~~l 248 (250)
T cd05085 224 YKVMQRCWDYKPENRPKFS-ELQKEL 248 (250)
T ss_pred HHHHHHHcccCcccCCCHH-HHHHHh
Confidence 9999999999999999999 555544
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=320.43 Aligned_cols=251 Identities=28% Similarity=0.427 Sum_probs=195.2
Q ss_pred cCCCccceeeeecceEEEEEEEc--Ce--EEEEEEeccCC-cccHHHHHHHHHHHhcC-CCCceeeEeccccC--Cccce
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GR--TVAIKMLYSHN-MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLV 541 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~--~vAiK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV 541 (816)
++|.+.+.||+|+||.||+|.+. +. .+++|.+.... ......|.+|+.++.++ +||||+++++++.. ..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46788889999999999999874 43 46777775432 23345788999999999 89999999999843 48899
Q ss_pred eeccCCCchhhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCe
Q 003481 542 YEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 608 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 608 (816)
|||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999875431 235889999999999999999999987 9999999999999999999
Q ss_pred eEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHHH--HHHh
Q 003481 609 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEV--RRAV 685 (816)
Q Consensus 609 kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~--~~~~ 685 (816)
||+|||++....... ......++..|+|||++....++.++|||||||++|+|+| |..||...... ...+
T Consensus 164 kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 164 KIADFGLSRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred EeCccccCcccchhh-------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 999999986432111 1122334678999999988889999999999999999998 99999643321 1111
Q ss_pred hcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhh
Q 003481 686 SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 686 ~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~ 739 (816)
..+ .....+...+..+.+|+.+||+.+|.+||++. .++..|+.+.
T Consensus 237 ~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-~il~~l~~~~ 281 (303)
T cd05088 237 PQG--------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFA-QILVSLNRML 281 (303)
T ss_pred hcC--------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHH
Confidence 111 01112223456789999999999999999999 4555566553
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=323.39 Aligned_cols=258 Identities=27% Similarity=0.426 Sum_probs=205.6
Q ss_pred cCCCccceeeeecceEEEEEEEcC-eEEEEEEeccCCcccH-HHHHHHHHHHhcCCCCceeeEeccc--cCCccceeecc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEMLG-RTVAIKMLYSHNMQGQ-LEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYL 545 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~g-~~vAiK~l~~~~~~~~-~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~E~~ 545 (816)
....+.++||+|-||.|.++...+ ..||+|.++....... .+|..|+++|.+|+|||||.|+|+| ++.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 345667889999999999999986 8999999998866544 7899999999999999999999999 55689999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
++|+|.++|..+.... +.-....+|+.||+.|++||.+.+ +|||||.+.|+|+|.++++||+|||+++.+-.+..+
T Consensus 618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999998875322 445667789999999999999988 999999999999999999999999999976555432
Q ss_pred CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh--CCCCCCChHHHHHHhhcCccccccCC-CCCCCC
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT--GRLPVGLAGEVRRAVSCGKLSSILDP-LAGDWP 702 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt--G~~Pf~~~~~~~~~~~~~~~~~~~d~-~~~~~~ 702 (816)
+.....+-...|||||.+..+++|+++|||+||++|||+++ ...||.....-.-.-..+.+..--.+ .....|
T Consensus 694 ----~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 694 ----RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred ----eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence 22344556788999999999999999999999999999876 78899644331111111111110000 112345
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 703 TFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 703 ~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
.-++..+.+|+++||..+-.+||++.+ |...|.
T Consensus 770 ~~cp~~lyelml~Cw~~es~~RPsFe~-lh~~lq 802 (807)
T KOG1094|consen 770 PACPQGLYELMLRCWRRESEQRPSFEQ-LHLFLQ 802 (807)
T ss_pred CcCcHHHHHHHHHHhchhhhcCCCHHH-HHHHHH
Confidence 567778999999999999999999994 444443
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=325.65 Aligned_cols=243 Identities=27% Similarity=0.354 Sum_probs=199.1
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccH---HHHHHHHHHHhcCCCCceeeEeccc--cCCccceee
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ---LEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYE 543 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~---~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~E 543 (816)
-|...+.||.|+||.||-+++. ...||||.+.....+.. .++..|+..|.+++|||+|.+-|+| ....+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 3667788999999999999885 77899999977655443 4678999999999999999999998 345889999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
|| -||-.|+|.-.. .++-..++..|+.+.+.||.|||+++ .||||||..||||++.|.|||+|||.|....+.
T Consensus 107 YC-lGSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 107 YC-LGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred HH-hccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 99 568888886655 47888999999999999999999998 999999999999999999999999999877643
Q ss_pred CcCCCccccCCCCCCCCCCCccccc---cCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCC
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 700 (816)
..++|||.|||||++. .|.|+-++|||||||+..||.-.++|+...+.....+... ..-.|..
T Consensus 180 ---------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA---QNesPtL-- 245 (948)
T KOG0577|consen 180 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---QNESPTL-- 245 (948)
T ss_pred ---------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH---hcCCCCC--
Confidence 4568999999999774 5789999999999999999999999976555433322211 0011111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
.....+..|.+++..||++-|.+|||..+.|.+.
T Consensus 246 qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 246 QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcc
Confidence 1345678899999999999999999998655443
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=312.48 Aligned_cols=252 Identities=27% Similarity=0.420 Sum_probs=199.9
Q ss_pred cCCCccceeeeecceEEEEEEEc-----CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccce
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLV 541 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~-----g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV 541 (816)
++|.+.+.||+|+||.||+|.+. +..||+|.+..... .....|.+|+.++.+++||||+++++++. +..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999873 33799999865432 23457899999999999999999999984 357899
Q ss_pred eeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
|||+++++|.+++.... ..+++.+++.|+.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999997653 35899999999999999999999987 99999999999999999999999999987654
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLA 698 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~ 698 (816)
..... .......++..|+|||++.+..++.++|||||||++|++++ |..||..... ....+..+..
T Consensus 159 ~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-------- 227 (267)
T cd05066 159 DPEAA---YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-------- 227 (267)
T ss_pred cccee---eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc--------
Confidence 32111 11122334568999999998899999999999999999887 9999964332 2222222210
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 699 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 699 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
...+...+..+.+++.+||+.+|.+||++. .+.+.|+.+
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~~ 266 (267)
T cd05066 228 LPAPMDCPAALHQLMLDCWQKDRNERPKFE-QIVSILDKL 266 (267)
T ss_pred CCCCCCCCHHHHHHHHHHcccCchhCCCHH-HHHHHHHhh
Confidence 111223456789999999999999999999 677777653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=310.34 Aligned_cols=244 Identities=30% Similarity=0.455 Sum_probs=196.2
Q ss_pred eeeeecceEEEEEEEc---C--eEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEeccccC-CccceeeccCCCc
Q 003481 477 KVGQGGFGCVYKGEML---G--RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPNGS 549 (816)
Q Consensus 477 ~LG~G~~g~Vy~~~~~---g--~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~~~gs 549 (816)
.||+|++|.||+|.+. + ..||||.+..... .....|.+|+.++++++||||+++++++.+ ..++||||+++|+
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~ 81 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGS 81 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCCc
Confidence 6899999999999874 2 3699999987766 455679999999999999999999998754 5789999999999
Q ss_pred hhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCc
Q 003481 550 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 629 (816)
Q Consensus 550 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 629 (816)
|.+++..... ..++|..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......... .
T Consensus 82 L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~---~ 154 (257)
T cd05040 82 LLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH---Y 154 (257)
T ss_pred HHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc---e
Confidence 9999976543 46899999999999999999999987 999999999999999999999999999877543211 1
Q ss_pred cccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHHH--HHHhhcCccccccCCCCCCCCHHHH
Q 003481 630 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPTFVA 706 (816)
Q Consensus 630 ~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~~~~~~~~ 706 (816)
.......++..|+|||++.+..++.++|||||||++|+|++ |..||...... ...+.. . ......+...+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~-~------~~~~~~~~~~~ 227 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK-E------GERLERPEACP 227 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-c------CCcCCCCccCC
Confidence 11224567889999999998899999999999999999999 99999643322 111111 0 00111233355
Q ss_pred HHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 707 RRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 707 ~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
..+.+++.+||+.+|.+||++. .+...|
T Consensus 228 ~~~~~li~~~l~~~p~~Rps~~-~~~~~l 255 (257)
T cd05040 228 QDIYNVMLQCWAHNPADRPTFA-ALREFL 255 (257)
T ss_pred HHHHHHHHHHCCCCcccCCCHH-HHHHHh
Confidence 7899999999999999999999 455444
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=311.36 Aligned_cols=233 Identities=25% Similarity=0.392 Sum_probs=183.3
Q ss_pred eeeeecceEEEEEEEc--------------CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccc
Q 003481 477 KVGQGGFGCVYKGEML--------------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 540 (816)
Q Consensus 477 ~LG~G~~g~Vy~~~~~--------------g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 540 (816)
.||+|+||.||+|... ...|++|.+..........|..|+.++..++||||++++++|.. ..++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 5899999999999753 23589999876555555678899999999999999999999843 5789
Q ss_pred eeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCC-------eeEeec
Q 003481 541 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS-------SKICDF 613 (816)
Q Consensus 541 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~-------vkL~DF 613 (816)
||||+++|+|..++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++. ++++||
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999998876543 35899999999999999999999987 999999999999987664 899999
Q ss_pred ccceeccCCCCcCCCccccCCCCCCCCCCCccccc-cCCCCcchhHhHHHHHHHHHH-hCCCCCCChHHHHH-HhhcCcc
Q 003481 614 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR-TGVLTPKSDSYSFGLIILQLL-TGRLPVGLAGEVRR-AVSCGKL 690 (816)
Q Consensus 614 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDVwSlGviL~ell-tG~~Pf~~~~~~~~-~~~~~~~ 690 (816)
|++...... ....++..|+|||++. +..++.++|||||||++|+|+ +|..||........ ....+..
T Consensus 157 g~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 226 (262)
T cd05077 157 GIPITVLSR----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQC 226 (262)
T ss_pred CCCccccCc----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCc
Confidence 998654321 2345788999999886 467899999999999999998 58888864322111 1111111
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 691 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 691 ~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
. . .......+.+|+.+||+.||.+||++. ++++.
T Consensus 227 ~-~--------~~~~~~~~~~li~~cl~~dp~~Rp~~~-~il~~ 260 (262)
T cd05077 227 M-L--------VTPSCKELADLMTHCMNYDPNQRPFFR-AIMRD 260 (262)
T ss_pred c-C--------CCCChHHHHHHHHHHcCCChhhCcCHH-HHHHh
Confidence 0 0 111245789999999999999999998 45443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=318.06 Aligned_cols=259 Identities=26% Similarity=0.404 Sum_probs=196.4
Q ss_pred cCCCccceeeeecceEEEEEEEc------------------CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeE
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML------------------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTL 530 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~------------------g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l 530 (816)
++|++.++||+|+||.||++... +..||+|++..... .....|.+|+.++..++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56888999999999999998542 24689999875432 334578999999999999999999
Q ss_pred ecccc--CCccceeeccCCCchhhhhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCce
Q 003481 531 LGACP--EAWSLVYEYLPNGSLQDRLFRKSN--------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNI 600 (816)
Q Consensus 531 ~g~~~--~~~~lV~E~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NI 600 (816)
++++. +..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 99984 458899999999999999876431 134788899999999999999999988 99999999999
Q ss_pred EecCCCCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh--CCCCCCCh
Q 003481 601 LLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT--GRLPVGLA 678 (816)
Q Consensus 601 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt--G~~Pf~~~ 678 (816)
|++.++.++|+|||+++.+...... .......+++.|++||....+.++.++|||||||++|||++ |..||...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYY----RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcce----eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999865433211 11223345678999999888889999999999999999998 77888643
Q ss_pred HHHHHHhhcCccc-cccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 679 GEVRRAVSCGKLS-SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 679 ~~~~~~~~~~~~~-~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
.........+... ..........+..++..+.+|+.+||+.||.+||++. .+.+.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~-~i~~~l~ 295 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQ-EIHATLL 295 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHH-HHHHHHh
Confidence 2211110000000 0000000111223457899999999999999999999 5656554
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=316.82 Aligned_cols=248 Identities=23% Similarity=0.314 Sum_probs=200.7
Q ss_pred hcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeec
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 544 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 544 (816)
.++|.+.+.||.|+||.||+|.+. +..||+|++..........|.+|+.++++++||||+++++++. ...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888899999999999999885 7889999997766556667999999999999999999999984 357899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 99999999886644 35899999999999999999999988 99999999999999999999999998876543221
Q ss_pred cCCCccccCCCCCCCCCCCccccc-----cCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH--hhcCccccccCCC
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCGKLSSILDPL 697 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~--~~~~~~~~~~d~~ 697 (816)
......|++.|+|||++. ...++.++|||||||++|+|++|+.||......... +..+...
T Consensus 159 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------ 226 (280)
T cd06611 159 ------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPP------ 226 (280)
T ss_pred ------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCC------
Confidence 223456899999999874 345788999999999999999999999755432221 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 698 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 698 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
....+...+..+.+++.+||+.+|.+||++.+.+.+
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 111233455688999999999999999999966544
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=332.25 Aligned_cols=252 Identities=23% Similarity=0.307 Sum_probs=195.0
Q ss_pred HHHHHHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC
Q 003481 462 LADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE 536 (816)
Q Consensus 462 ~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 536 (816)
+.++....++|.+.+.||+|+||.||++.+. +..||+|++..... .....+.+|+.++..++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3444555688999999999999999999886 78899999864322 233457889999999999999999999854
Q ss_pred --CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecc
Q 003481 537 --AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 614 (816)
Q Consensus 537 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 614 (816)
..++||||+++|+|.+++... .++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 478999999999999988543 3788889999999999999999988 9999999999999999999999999
Q ss_pred cceeccCCCCcCCCccccCCCCCCCCCCCccccccC----CCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcC
Q 003481 615 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG----VLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCG 688 (816)
Q Consensus 615 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~ 688 (816)
++........ .......||+.|+|||++... .++.++|||||||+||||++|..||...+.. ...+...
T Consensus 188 ~a~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 262 (371)
T cd05622 188 TCMKMNKEGM-----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 262 (371)
T ss_pred ceeEcCcCCc-----ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 9987653321 122456799999999988653 3789999999999999999999999754432 1222111
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCC---CCCChHHH
Q 003481 689 KLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRE---RPDITPSL 731 (816)
Q Consensus 689 ~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~---RPs~~e~l 731 (816)
.- ......+...+..+.+||.+||. +|.. ||++.+.+
T Consensus 263 ~~-----~~~~~~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~ 302 (371)
T cd05622 263 KN-----SLTFPDDNDISKEAKNLICAFLT-DREVRLGRNGVEEIK 302 (371)
T ss_pred CC-----cccCCCcCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHh
Confidence 10 00001112356788999999998 5554 56666433
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=309.56 Aligned_cols=246 Identities=28% Similarity=0.490 Sum_probs=191.0
Q ss_pred eeeeecceEEEEEEEc-----CeEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCceeeEecccc--C-CccceeeccCC
Q 003481 477 KVGQGGFGCVYKGEML-----GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACP--E-AWSLVYEYLPN 547 (816)
Q Consensus 477 ~LG~G~~g~Vy~~~~~-----g~~vAiK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~-~~~lV~E~~~~ 547 (816)
.||+|+||.||+|.+. +..||||.+.... ......+.+|+.+++.++||||++++++|. + ..++||||+.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 5899999999999863 3579999985432 234557889999999999999999999763 2 37899999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 82 GDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 99999986543 34678888999999999999999987 99999999999999999999999999986543221110
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhC-CCCCCChHH--HHHHhhcCccccccCCCCCCCCHH
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTG-RLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTF 704 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG-~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~ 704 (816)
.......+++.|+|||++.+..++.++|||||||++|||++| .+||..... ....+..+. ....+..
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 226 (262)
T cd05058 157 --HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR--------RLLQPEY 226 (262)
T ss_pred --cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC--------CCCCCCc
Confidence 112234567789999999888999999999999999999995 566653322 112222211 1111223
Q ss_pred HHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 705 VARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 705 ~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
.+..+.+++.+||..+|++||++. .++..|+.+
T Consensus 227 ~~~~~~~li~~cl~~~p~~Rp~~~-~il~~l~~~ 259 (262)
T cd05058 227 CPDPLYEVMLSCWHPKPEMRPTFS-ELVSRIEQI 259 (262)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHH-HHHHHHHHH
Confidence 456899999999999999999998 677777765
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=314.86 Aligned_cols=242 Identities=26% Similarity=0.340 Sum_probs=198.9
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeec
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 544 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 544 (816)
++|.....||.|+||.||+|.+. +..||+|.+.... ......+.+|+.+++.++||||+++++++.+ ..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36788889999999999999885 7899999987654 3334568899999999999999999998844 47899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+++++|.+++... ++++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999998653 6899999999999999999999987 99999999999999999999999999988764321
Q ss_pred cCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHH--HhhcCccccccCCCCCCCC
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVSCGKLSSILDPLAGDWP 702 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~--~~~~~~~~~~~d~~~~~~~ 702 (816)
......|++.|+|||++.+..++.++|||||||++|+|+||+.||...+.... .+..+.. + ..+
T Consensus 154 ------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-----~---~~~ 219 (274)
T cd06609 154 ------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP-----P---SLE 219 (274)
T ss_pred ------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC-----C---CCc
Confidence 22445688999999999988899999999999999999999999965432211 1111111 1 111
Q ss_pred HH-HHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 703 TF-VARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 703 ~~-~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
.. ++..+.+++.+||..+|.+||++.+.+.
T Consensus 220 ~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 220 GNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11 5567999999999999999999986554
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=327.71 Aligned_cols=247 Identities=27% Similarity=0.406 Sum_probs=204.8
Q ss_pred eeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccCC--ccceeeccCCCchhh
Q 003481 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEA--WSLVYEYLPNGSLQD 552 (816)
Q Consensus 477 ~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~--~~lV~E~~~~gsL~~ 552 (816)
.||+|.||+||-|++. ...+|||-+.........-+..|+.+-++|+|.|||+++|.|.++ .-+.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 5999999999999987 456899998777666666788999999999999999999999655 447999999999999
Q ss_pred hhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEec-CCCCeeEeecccceeccCCCCcCCCc
Q 003481 553 RLFRKSNVSPL--LWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD-SELSSKICDFGICRLVTEDTLYLPSF 629 (816)
Q Consensus 553 ~l~~~~~~~~l--~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~~ 629 (816)
+|...= .++ .+..+-.+..||+.||.|||.+. |||||||-+|||++ -.|.+||+|||.++.+..-..
T Consensus 662 LLrskW--GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP----- 731 (1226)
T KOG4279|consen 662 LLRSKW--GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP----- 731 (1226)
T ss_pred HHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCc-----
Confidence 996543 355 77888889999999999999998 99999999999995 578999999999998754332
Q ss_pred cccCCCCCCCCCCCccccccC--CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHH-HhhcCccccccCCCCCCCCHHHH
Q 003481 630 HRSTAPKGSFPYADPEYHRTG--VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR-AVSCGKLSSILDPLAGDWPTFVA 706 (816)
Q Consensus 630 ~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~-~~~~~~~~~~~d~~~~~~~~~~~ 706 (816)
.+....||..|||||++..+ .|+.++|||||||++.||.||++||...+.... .+.-|.+. ..++.|.+.+
T Consensus 732 -~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyK-----vHP~iPeels 805 (1226)
T KOG4279|consen 732 -CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYK-----VHPPIPEELS 805 (1226)
T ss_pred -cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhccee-----cCCCCcHHHH
Confidence 23566799999999999765 689999999999999999999999964333222 22333322 2356789999
Q ss_pred HHHHHHHHHhhccCCCCCCCChHHHHHHHHHhh
Q 003481 707 RRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 707 ~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~ 739 (816)
.....+|++|+.++|.+||++.+.|.+.+-+-.
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 999999999999999999999988877775443
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=315.64 Aligned_cols=260 Identities=25% Similarity=0.387 Sum_probs=198.3
Q ss_pred cCCCccceeeeecceEEEEEEE------cCeEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCceeeEeccccC----Cc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEM------LGRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AW 538 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~------~g~~vAiK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~ 538 (816)
..|.+.+.||+|+||.||++.+ .+..||+|.+.... ......+.+|+.++++++||||+++++++.+ ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3578889999999999999974 26789999987553 2334578999999999999999999998843 37
Q ss_pred cceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccccee
Q 003481 539 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 539 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 618 (816)
++||||+++++|.+++.... ..++|..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 89999999999999986543 35899999999999999999999987 99999999999999999999999999987
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhh---cCc------
Q 003481 619 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS---CGK------ 689 (816)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~---~~~------ 689 (816)
........ .......++..|+|||++.+..++.++|||||||++|+|+|+..|+........... .+.
T Consensus 159 ~~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 159 IETDKEYY---TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred cccCccce---eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 65432110 112344577789999999888899999999999999999998776532111000000 000
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 690 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 690 ~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
...+.+......+..++..+.+|+.+||+.+|.+||++. .++..|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~il~~l~~~ 283 (284)
T cd05079 236 VRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQ-NLIEGFEAI 283 (284)
T ss_pred HHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHH-HHHHHHHhh
Confidence 000000001111233567899999999999999999998 666666653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=324.10 Aligned_cols=249 Identities=28% Similarity=0.447 Sum_probs=211.7
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccC
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLP 546 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~ 546 (816)
+..-.++||.|.||.||.|.|. .-.||||.++.+.+ ...+|..|..+|+.++|||+|+|+|+|.. .+|||.|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 4455678999999999999997 67899999976554 46789999999999999999999999954 4899999999
Q ss_pred CCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcC
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626 (816)
Q Consensus 547 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 626 (816)
+|+|.++|...+. ..++--..+.++.||..|+.||...+ +|||||...|+|+.++..+|++|||+++++..+....
T Consensus 347 yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 347 YGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred CccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence 9999999988764 45777778899999999999999988 9999999999999999999999999999987665321
Q ss_pred CCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChH--HHHHHhhcCccccccCCCCCCCCH
Q 003481 627 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPT 703 (816)
Q Consensus 627 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~--~~~~~~~~~~~~~~~d~~~~~~~~ 703 (816)
.....-.+-|.|||-+....++.|+|||+|||+|||+.| |..||...+ ++..++..|... +.|.
T Consensus 423 -----HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM--------~~Pe 489 (1157)
T KOG4278|consen 423 -----HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRM--------DGPE 489 (1157)
T ss_pred -----ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccc--------cCCC
Confidence 122334567999999999999999999999999999999 889997544 566666665432 3466
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 704 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 704 ~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
.+++.+.+|++.||+++|.+||+++ ++-..|+.+
T Consensus 490 GCPpkVYeLMraCW~WsPsDRPsFa-eiHqafEtm 523 (1157)
T KOG4278|consen 490 GCPPKVYELMRACWNWSPSDRPSFA-EIHQAFETM 523 (1157)
T ss_pred CCCHHHHHHHHHHhcCCcccCccHH-HHHHHHHHH
Confidence 6778999999999999999999999 677777766
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=318.42 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=195.9
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeec
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 544 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 544 (816)
++|.+.+.||+|+||.||++.+. +..||+|.+..... .....+.+|++++.+++||||++++++|. +..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999885 77899998865432 23456889999999999999999999984 458999999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+++++|.+++... ..+++..+..++.|++.||.|||+.. +++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 9999999999765 35889999999999999999999842 39999999999999999999999999987653321
Q ss_pred cCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHH--HHhhcCccccccC-------
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILD------- 695 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~--~~~~~~~~~~~~d------- 695 (816)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||....... ..+.. .......
T Consensus 155 -------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 226 (308)
T cd06615 155 -------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR-PVSEGEAKESHRPV 226 (308)
T ss_pred -------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcC-ccccccccCCcccc
Confidence 234568999999999988889999999999999999999999985332211 11100 0000000
Q ss_pred ----------------------CCCCCCC-HHHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 696 ----------------------PLAGDWP-TFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 696 ----------------------~~~~~~~-~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
......| ..++..+.+|+.+||..+|++||++.+.+.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0000001 12456799999999999999999998655433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=310.27 Aligned_cols=254 Identities=24% Similarity=0.331 Sum_probs=197.7
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCCc-eeeEeccccC--------
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPH-LVTLLGACPE-------- 536 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l~Hpn-Iv~l~g~~~~-------- 536 (816)
..|...++||+|.||+||+|+.. |+.||+|+++..... ......+|+.+|..|+|+| ||.|++++..
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34666678999999999999885 889999999776542 2234679999999999999 9999999832
Q ss_pred CccceeeccCCCchhhhhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccc
Q 003481 537 AWSLVYEYLPNGSLQDRLFRKSNV-SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 615 (816)
Q Consensus 537 ~~~lV~E~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 615 (816)
..++|+||++ .+|..++...... ..++...+..++.||+.||+|||+++ |+||||||.||||+.+|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 4679999995 4899998766532 34667889999999999999999998 99999999999999999999999999
Q ss_pred ceeccCCCCcCCCccccCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCc-----
Q 003481 616 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGK----- 689 (816)
Q Consensus 616 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~----- 689 (816)
|+...-... ..+..++|..|.|||++.+. .|++..||||+|||+.||+++++.|....+..+......
T Consensus 167 Ara~~ip~~------~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 167 ARAFSIPMR------TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP 240 (323)
T ss_pred HHHhcCCcc------cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence 997653321 24566799999999988776 799999999999999999999999976665444322111
Q ss_pred ----ccccc---C--CCCCCCC--H----H---HHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 690 ----LSSIL---D--PLAGDWP--T----F---VARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 690 ----~~~~~---d--~~~~~~~--~----~---~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
+..+. + +....|+ . . ......+++.+||+.+|.+|.++..+|.+
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11100 0 0011111 1 1 12378999999999999999999965543
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=306.73 Aligned_cols=244 Identities=24% Similarity=0.298 Sum_probs=199.5
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEeccccC---Cccceee
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE---AWSLVYE 543 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~lV~E 543 (816)
+|.+.+.||.|++|.||++... +..||+|.+..... .....+.+|+.++++++|||++++++.+.. ..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999875 78899999865432 334568899999999999999999988742 2689999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
|+++++|.+++.... ...+++.+++.++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999987643 246899999999999999999999988 9999999999999999999999999998764322
Q ss_pred CcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCccccccCCCCCCC
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDW 701 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~~~ 701 (816)
. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...+.. ...+..+.+ ...
T Consensus 157 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~--------~~~ 222 (257)
T cd08223 157 D------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL--------PPM 222 (257)
T ss_pred C------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCC--------CCC
Confidence 1 223456899999999999999999999999999999999999999644321 112222222 122
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 702 PTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 702 ~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
+...+..+.+++.+||+.+|.+||++.+.+.
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 223 PKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 3446678999999999999999999986553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=312.10 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=197.6
Q ss_pred CCCccceeeeecceEEEEEEEc--C---eEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--G---RTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g---~~vAiK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
+|...+.||+|+||.||+|.+. + ..||||.+.... ......|..|+.++..++||||+++++++.+ ..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4677889999999999999875 3 369999987543 3345679999999999999999999999844 478999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999986543 45899999999999999999999987 999999999999999999999999998866443
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCCC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAG 699 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~ 699 (816)
... ...........+..|+|||++.+..++.++|||||||++|||++ |..||..... ....+..+. ..
T Consensus 160 ~~~-~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~--------~~ 230 (269)
T cd05065 160 TSD-PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY--------RL 230 (269)
T ss_pred ccc-cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC--------cC
Confidence 211 01111111122457999999999999999999999999999887 9999964332 222221110 01
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 700 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 700 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
..+...+..+.+++.+||..+|.+||++. .+...|+.+
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~~ 268 (269)
T cd05065 231 PPPMDCPTALHQLMLDCWQKDRNARPKFG-QIVSTLDKM 268 (269)
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHhh
Confidence 11223456789999999999999999998 666667653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=309.06 Aligned_cols=250 Identities=28% Similarity=0.444 Sum_probs=201.7
Q ss_pred hcCCCccceeeeecceEEEEEEEc-CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC-CccceeeccC
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLP 546 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~~ 546 (816)
..+|...++||+|+||.||++.+. +..+|+|.+.... .....|.+|+.++++++|+||+++++++.+ ..+++|||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCC
Confidence 357888899999999999999875 6679999886543 234578899999999999999999998754 4789999999
Q ss_pred CCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcC
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626 (816)
Q Consensus 547 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 626 (816)
+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 158 (260)
T cd05073 84 KGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT- 158 (260)
T ss_pred CCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-
Confidence 9999999976432 45889999999999999999999987 999999999999999999999999999876543211
Q ss_pred CCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCCCCCCH
Q 003481 627 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPT 703 (816)
Q Consensus 627 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~ 703 (816)
......++..|+|||++..+.++.++|||||||++|+++| |..||..... ....+..+... ..+.
T Consensus 159 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~ 226 (260)
T cd05073 159 ----AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM--------PRPE 226 (260)
T ss_pred ----cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC--------CCcc
Confidence 1223346678999999998889999999999999999999 9999964332 22222222111 1123
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHH
Q 003481 704 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 737 (816)
Q Consensus 704 ~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~ 737 (816)
..+..+.+++.+||+.+|.+||++. .+...|+.
T Consensus 227 ~~~~~~~~~i~~~l~~~p~~Rp~~~-~l~~~L~~ 259 (260)
T cd05073 227 NCPEELYNIMMRCWKNRPEERPTFE-YIQSVLDD 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHH-HHHHHHhc
Confidence 3456899999999999999999998 77777764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=308.85 Aligned_cols=250 Identities=34% Similarity=0.498 Sum_probs=201.9
Q ss_pred hcCCCccceeeeecceEEEEEEEc-CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeecc
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 545 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 545 (816)
.++|.+.+.||.|+||.||++.+. +..||||.+.... .....+.+|+.++++++||||+++++++.. ..++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 467888999999999999999876 5779999987544 345678999999999999999999999853 588999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
++++|.+++..... ..+++..+..|+.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (261)
T cd05034 84 SKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY- 158 (261)
T ss_pred CCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh-
Confidence 99999999976432 45899999999999999999999988 99999999999999999999999999987654221
Q ss_pred CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCCCCCC
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWP 702 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~ 702 (816)
.......++..|+|||.+.+..++.++||||||+++|+|++ |+.||..... ....+..+. ....+
T Consensus 159 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~--------~~~~~ 226 (261)
T cd05034 159 ----TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY--------RMPRP 226 (261)
T ss_pred ----hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------CCCCC
Confidence 11122335678999999998889999999999999999999 9999964332 222221111 01112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHH
Q 003481 703 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 737 (816)
Q Consensus 703 ~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~ 737 (816)
...+..+.+++.+||..+|.+||++. .+...|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~-~l~~~l~~ 260 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFE-YLQSFLED 260 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHH-HHHHHHhc
Confidence 22356899999999999999999998 67777764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=322.59 Aligned_cols=250 Identities=25% Similarity=0.271 Sum_probs=191.3
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++|.+.+.||+|+||.||+++.. ++.||+|++..... .....|.+|+.++..++||||++++++|.+ ..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999885 78999999865321 233458899999999999999999998844 589999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999996543 35888999999999999999999988 999999999999999999999999999776543
Q ss_pred CCcCCCccccCCCCCCCCCCCcccccc-----CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHH--HHhhcCccccccC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRT-----GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILD 695 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~--~~~~~~~~~~~~d 695 (816)
... ......||+.|+|||++.. +.++.++|||||||++|+|++|+.||....... ..+..... .+.
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~--~~~ 228 (331)
T cd05597 156 GTV-----QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--HFQ 228 (331)
T ss_pred CCc-----cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCC--ccc
Confidence 211 1233469999999998863 457889999999999999999999996543221 11111110 000
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCC--CCCCCChHHHHH
Q 003481 696 PLAGDWPTFVARRLVDLGLQCCELYG--RERPDITPSLVK 733 (816)
Q Consensus 696 ~~~~~~~~~~~~~l~~Li~~cl~~dP--~~RPs~~e~l~~ 733 (816)
........+..+.+|+.+|+..++ ..||++.+.+.+
T Consensus 229 --~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 --FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred --CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 011111245678888988776533 337777755544
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=318.01 Aligned_cols=255 Identities=27% Similarity=0.442 Sum_probs=201.8
Q ss_pred cCCCccceeeeecceEEEEEEEc---------CeEEEEEEeccCCc-ccHHHHHHHHHHHhcC-CCCceeeEeccccC--
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML---------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE-- 536 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~---------g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-- 536 (816)
.+|.+.+.||+|+||.||+++.. ...||+|.+..... .....+.+|+.++.++ +||||++++++|.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46788899999999999999752 35699999875432 3345688999999999 69999999998853
Q ss_pred CccceeeccCCCchhhhhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEec
Q 003481 537 AWSLVYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD 603 (816)
Q Consensus 537 ~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~ 603 (816)
..++||||+++|+|.+++..... ...++|..+..++.||+.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 47899999999999999965421 235899999999999999999999987 99999999999999
Q ss_pred CCCCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChH--H
Q 003481 604 SELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--E 680 (816)
Q Consensus 604 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~--~ 680 (816)
.++.+||+|||+++......... ......++..|+|||++.++.++.++|||||||++|+|++ |..||.... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYK----KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred CCCcEEEcccccccccccccccc----ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999998765322110 1122234568999999988899999999999999999999 889986432 2
Q ss_pred HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhhh
Q 003481 681 VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740 (816)
Q Consensus 681 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~~ 740 (816)
....+..+.. ...+...+..+.+|+.+||..+|.+||++. .+...|+.+..
T Consensus 245 ~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~ll~~l~~~~~ 295 (314)
T cd05099 245 LFKLLREGHR--------MDKPSNCTHELYMLMRECWHAVPTQRPTFK-QLVEALDKVLA 295 (314)
T ss_pred HHHHHHcCCC--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHHHHH
Confidence 2333332221 112333456888999999999999999998 67788887754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=314.25 Aligned_cols=246 Identities=27% Similarity=0.378 Sum_probs=198.1
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeecc
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 545 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 545 (816)
.|...+.||.|+||.||+|.+. +..||+|.+..... .....+.+|+.++++++||||++++++|.. ..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3556678999999999999875 78899999875432 334568899999999999999999999843 489999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 99999998853 35889999999999999999999987 99999999999999999999999999877653221
Q ss_pred CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHH
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 705 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 705 (816)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||........... +........+...
T Consensus 157 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~------~~~~~~~~~~~~~ 225 (277)
T cd06642 157 -----KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL------IPKNSPPTLEGQY 225 (277)
T ss_pred -----hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh------hhcCCCCCCCccc
Confidence 12334688999999999988999999999999999999999999864332111110 0111112233345
Q ss_pred HHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 706 ARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 706 ~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
+..+.+++.+||+.+|.+||++.+.+.+.+
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 226 SKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 678999999999999999999997776553
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=328.73 Aligned_cols=246 Identities=24% Similarity=0.341 Sum_probs=191.2
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++|...+.||+|+||.||++... +..||||++..... .....+.+|+.++..++||||+++++++.+ ..+|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999885 78999999975322 233467889999999999999999998854 479999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999987543 5888999999999999999999988 999999999999999999999999998755321
Q ss_pred CCcC-----------------------------CCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCC
Q 003481 623 TLYL-----------------------------PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRL 673 (816)
Q Consensus 623 ~~~~-----------------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~ 673 (816)
.... ..........||+.|+|||++.+..++.++|||||||++|||+||+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 1000 00001124579999999999999999999999999999999999999
Q ss_pred CCCChHHH--HHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCC
Q 003481 674 PVGLAGEV--RRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDI 727 (816)
Q Consensus 674 Pf~~~~~~--~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~ 727 (816)
||...... ...+..... .+.-+. . ...+..+.+|+.+|+. ||.+|++.
T Consensus 235 Pf~~~~~~~~~~~i~~~~~-~~~~p~--~--~~~s~~~~~li~~l~~-~p~~R~~~ 284 (360)
T cd05627 235 PFCSETPQETYRKVMNWKE-TLVFPP--E--VPISEKAKDLILRFCT-DSENRIGS 284 (360)
T ss_pred CCCCCCHHHHHHHHHcCCC-ceecCC--C--CCCCHHHHHHHHHhcc-ChhhcCCC
Confidence 99644332 122211110 000010 0 1145678889988774 99999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=314.74 Aligned_cols=256 Identities=26% Similarity=0.364 Sum_probs=202.5
Q ss_pred cCHHHHHHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCceeeEecccc-
Q 003481 460 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACP- 535 (816)
Q Consensus 460 ~~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~- 535 (816)
.++.++....+.|+....||.|+||.||+|.+. +..||+|++.... .....+..|+.++.++ +||||+++++++.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 456777778899999999999999999999985 7899999986543 2345688899999999 7999999999873
Q ss_pred -------CCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCe
Q 003481 536 -------EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 608 (816)
Q Consensus 536 -------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 608 (816)
+..+++|||+++|+|.+++..... ..+++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.+
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 246899999999999998865432 45888889999999999999999988 9999999999999999999
Q ss_pred eEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccc-----cCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHH
Q 003481 609 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR 683 (816)
Q Consensus 609 kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~ 683 (816)
+|+|||++....... .......|++.|+|||.+. ...++.++|||||||++|+|++|..||........
T Consensus 161 ~l~dfg~~~~~~~~~------~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~ 234 (282)
T cd06636 161 KLVDFGVSAQLDRTV------GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234 (282)
T ss_pred EEeeCcchhhhhccc------cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence 999999987654221 1123456899999999875 34678899999999999999999999964433222
Q ss_pred HhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 684 AVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 684 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
...... ...+ ......++..+.+|+.+||+.||.+||++.+.+
T Consensus 235 ~~~~~~---~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell 277 (282)
T cd06636 235 LFLIPR---NPPP--KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLL 277 (282)
T ss_pred hhhHhh---CCCC--CCcccccCHHHHHHHHHHhCCChhhCcCHHHHh
Confidence 211110 0001 111223556899999999999999999998544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=319.71 Aligned_cols=193 Identities=26% Similarity=0.356 Sum_probs=157.4
Q ss_pred cceeeeecceEEEEEEEc----CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC----CccceeeccC
Q 003481 475 SFKVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLVYEYLP 546 (816)
Q Consensus 475 ~~~LG~G~~g~Vy~~~~~----g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~lV~E~~~ 546 (816)
..+||+|+||.||+|+.. +..||+|.+.... ....+.+|+.+|++++||||+++++++.. ..++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999864 5789999986543 23457789999999999999999998732 3689999985
Q ss_pred CCchhhhhhhcC------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEe----cCCCCeeEeecccc
Q 003481 547 NGSLQDRLFRKS------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL----DSELSSKICDFGIC 616 (816)
Q Consensus 547 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl----~~~~~vkL~DFGla 616 (816)
++|.+++.... ....+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 57877765321 1235889999999999999999999988 9999999999999 45678999999999
Q ss_pred eeccCCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCC
Q 003481 617 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVG 676 (816)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~ 676 (816)
+........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.
T Consensus 160 ~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 160 RLFNSPLKP---LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred eccCCCCcc---ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 876533211 112345678999999998876 458999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=317.02 Aligned_cols=249 Identities=21% Similarity=0.307 Sum_probs=198.0
Q ss_pred CccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeeccCCC
Q 003481 473 SESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPNG 548 (816)
Q Consensus 473 ~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~~g 548 (816)
.....||.|+||.||++... +..||||.+..........+.+|+.++..++||||+++++.+. +..++||||++++
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 33456999999999999874 7899999987655555667889999999999999999999874 4589999999999
Q ss_pred chhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCC
Q 003481 549 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 628 (816)
Q Consensus 549 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 628 (816)
+|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 105 ~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~---- 173 (292)
T cd06658 105 ALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP---- 173 (292)
T ss_pred cHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc----
Confidence 99998743 24889999999999999999999987 99999999999999999999999999876543221
Q ss_pred ccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHHHHH
Q 003481 629 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARR 708 (816)
Q Consensus 629 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 708 (816)
......|++.|+|||++.+..++.++||||||+++|||++|+.||........... +...+.+... .....+..
T Consensus 174 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~~~~~~~~-~~~~~~~~ 247 (292)
T cd06658 174 --KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR---IRDNLPPRVK-DSHKVSSV 247 (292)
T ss_pred --cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcCCCccc-cccccCHH
Confidence 12345689999999999888899999999999999999999999965433211111 0111111111 11234567
Q ss_pred HHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 709 LVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 709 l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
+.+++.+||..||.+||++.+.+.+.+-..
T Consensus 248 ~~~li~~~l~~~P~~Rpt~~~il~~~~~~~ 277 (292)
T cd06658 248 LRGFLDLMLVREPSQRATAQELLQHPFLKL 277 (292)
T ss_pred HHHHHHHHccCChhHCcCHHHHhhChhhhc
Confidence 889999999999999999997776655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=318.15 Aligned_cols=251 Identities=23% Similarity=0.314 Sum_probs=192.7
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeec
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 544 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 544 (816)
++|...+.||.|+||.||+|.+. +..||+|.+..... .....+.+|+.++..++||||+++++++. +..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999885 78899999865433 23346778999999999999999999984 357899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
++ ++|.+++.... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 58888886543 35889999999999999999999988 99999999999999999999999999876543221
Q ss_pred cCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH--hh-------cCcccccc
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VS-------CGKLSSIL 694 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~--~~-------~~~~~~~~ 694 (816)
......+++.|+|||++.+ ..++.++|||||||++|+|+||++||...+..... +. ...+..++
T Consensus 160 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 160 ------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred ------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence 1233457899999998765 45788999999999999999999999643321110 00 00000000
Q ss_pred C---------CC-----CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 695 D---------PL-----AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 695 d---------~~-----~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
. +. ........+..+.+||.+||+.||.+|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 00 00011234567899999999999999999986553
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=309.37 Aligned_cols=247 Identities=27% Similarity=0.384 Sum_probs=186.9
Q ss_pred eeeeecceEEEEEEEc----CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccCCCc
Q 003481 477 KVGQGGFGCVYKGEML----GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGS 549 (816)
Q Consensus 477 ~LG~G~~g~Vy~~~~~----g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gs 549 (816)
.||+|+||.||+|.+. +..+|+|.+..... .....|.+|+.++.+++||||++++|+|.+ ..++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 5899999999999864 35799998866543 334578899999999999999999999854 4789999999999
Q ss_pred hhhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 550 LQDRLFRKSN--VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 550 L~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~-- 156 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY-- 156 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCccee--
Confidence 9999975432 234677888899999999999999987 999999999999999999999999998764433211
Q ss_pred CccccCCCCCCCCCCCccccccC-------CCCcchhHhHHHHHHHHHHh-CCCCCCChHHHH--HHhhcCccccccCCC
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTG-------VLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVR--RAVSCGKLSSILDPL 697 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~-------~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~--~~~~~~~~~~~~d~~ 697 (816)
.......++..|+|||++... .++.++||||||+++|||++ |..||....... .....+......++
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~- 233 (269)
T cd05087 157 --VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP- 233 (269)
T ss_pred --ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC-
Confidence 112344578889999987532 35789999999999999996 999996433221 11111111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 698 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 698 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
......+..+.+++..|+ .+|.+||++. +|...|
T Consensus 234 --~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~-~l~~~l 267 (269)
T cd05087 234 --RLKLPLSDRWYEVMQFCW-LQPEQRPSAE-EVHLLL 267 (269)
T ss_pred --ccCCCCChHHHHHHHHHh-cCcccCCCHH-HHHHHh
Confidence 112224456888999998 6899999999 555544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=310.07 Aligned_cols=243 Identities=29% Similarity=0.456 Sum_probs=190.4
Q ss_pred eeeeecceEEEEEEEc--Ce--EEEEEEeccCC-cccHHHHHHHHHHHhcC-CCCceeeEeccccC--CccceeeccCCC
Q 003481 477 KVGQGGFGCVYKGEML--GR--TVAIKMLYSHN-MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVYEYLPNG 548 (816)
Q Consensus 477 ~LG~G~~g~Vy~~~~~--g~--~vAiK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV~E~~~~g 548 (816)
.||+|+||.||+|.+. +. .+++|.+.... ......+.+|+.++.++ +||||++++++|.. ..++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 5899999999999875 33 57888887433 23445788999999999 89999999999854 478999999999
Q ss_pred chhhhhhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccc
Q 003481 549 SLQDRLFRKS-------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 615 (816)
Q Consensus 549 sL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 615 (816)
+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCC
Confidence 9999986532 1235889999999999999999999977 99999999999999999999999999
Q ss_pred ceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCcccc
Q 003481 616 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSS 692 (816)
Q Consensus 616 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~ 692 (816)
+....... .......++.|+|||++....++.++|||||||++|+|++ |..||..... ....+..+.
T Consensus 159 ~~~~~~~~-------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~--- 228 (270)
T cd05047 159 SRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--- 228 (270)
T ss_pred ccccchhh-------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC---
Confidence 86332111 1122234667999999988899999999999999999997 9999954322 222221111
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 693 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 693 ~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
....+...+..+.+|+.+||..+|.+||++. +++..|+.+
T Consensus 229 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~il~~l~~~ 268 (270)
T cd05047 229 -----RLEKPLNCDDEVYDLMRQCWREKPYERPSFA-QILVSLNRM 268 (270)
T ss_pred -----CCCCCCcCCHHHHHHHHHHcccChhhCCCHH-HHHHHHHHh
Confidence 1112223456789999999999999999999 666676654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=314.05 Aligned_cols=258 Identities=26% Similarity=0.306 Sum_probs=205.0
Q ss_pred ccCHHHHHHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCceeeEecccc
Q 003481 459 EFSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACP 535 (816)
Q Consensus 459 ~~~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~ 535 (816)
.+.+.++..++++|.....||+|+||.||++... ++.+|+|++.... .....+.+|+.++.++ +||||++++++|.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 3666788888999999999999999999999884 7899999986543 2345678899999999 8999999999873
Q ss_pred -------CCccceeeccCCCchhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCC
Q 003481 536 -------EAWSLVYEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS 607 (816)
Q Consensus 536 -------~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 607 (816)
+..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 23789999999999999886421 2346899999999999999999999987 999999999999999999
Q ss_pred eeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccC-----CCCcchhHhHHHHHHHHHHhCCCCCCChHHHH
Q 003481 608 SKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-----VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR 682 (816)
Q Consensus 608 vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~ 682 (816)
+||+|||++........ ......|+..|+|||++... .++.++|||||||++|+|++|+.||.......
T Consensus 167 ~kl~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~ 240 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240 (291)
T ss_pred EEEeecccchhcccccc------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH
Confidence 99999999887643221 12345689999999987643 36889999999999999999999997544322
Q ss_pred HHh--hcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 683 RAV--SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 683 ~~~--~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
... ..+....+ ..+......+.+||.+||+.+|.+||++.+.+.
T Consensus 241 ~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 241 TLFKIPRNPPPTL------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHHhcCCCCCC------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 221 11111111 112334567999999999999999999996554
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=318.43 Aligned_cols=255 Identities=27% Similarity=0.452 Sum_probs=201.7
Q ss_pred cCCCccceeeeecceEEEEEEEc---------CeEEEEEEeccCCc-ccHHHHHHHHHHHhcC-CCCceeeEeccccC--
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML---------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE-- 536 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~---------g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-- 536 (816)
.+|.+.+.||+|+||.||++... +..||+|.+..... .....+.+|+.++.++ +||||++++++|.+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46888999999999999999753 23689998875432 2345788999999999 89999999999854
Q ss_pred CccceeeccCCCchhhhhhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEec
Q 003481 537 AWSLVYEYLPNGSLQDRLFRKS-------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD 603 (816)
Q Consensus 537 ~~~lV~E~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~ 603 (816)
..++||||+++|+|.+++.... ....++|..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 4789999999999999987532 1235889999999999999999999987 99999999999999
Q ss_pred CCCCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChH--H
Q 003481 604 SELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--E 680 (816)
Q Consensus 604 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~--~ 680 (816)
.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred CCCcEEECCcccceeccccccc----ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999876433211 11223345678999999998899999999999999999998 889986433 2
Q ss_pred HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhhh
Q 003481 681 VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740 (816)
Q Consensus 681 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~~ 740 (816)
....+..+.. ...+...+..+.+|+.+||+.+|.+||++. +++..|+.+..
T Consensus 245 ~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~-ell~~l~~~~~ 295 (334)
T cd05100 245 LFKLLKEGHR--------MDKPANCTHELYMIMRECWHAVPSQRPTFK-QLVEDLDRVLT 295 (334)
T ss_pred HHHHHHcCCC--------CCCCCCCCHHHHHHHHHHcccChhhCcCHH-HHHHHHHHHhh
Confidence 2222222211 122333456899999999999999999998 67777877654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=333.13 Aligned_cols=250 Identities=19% Similarity=0.236 Sum_probs=192.1
Q ss_pred hcCCCccceeeeecceEEEEEEEc----CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc--CCcccee
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVY 542 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~----g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~ 542 (816)
..+|.+...||.|+||.||++... +..||+|.+... ..+.+|+.+|.+++||||+++++++. ...++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357999999999999999999764 467999987643 23568999999999999999999884 3588999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
|++. ++|.+++... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 166 e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9995 6888888432 46899999999999999999999987 999999999999999999999999999866543
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChH------HHHHHhhc---Ccc---
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG------EVRRAVSC---GKL--- 690 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~------~~~~~~~~---~~~--- 690 (816)
... .......||+.|+|||++....++.++|||||||+||||++|+.||.... .....+.. ...
T Consensus 239 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 239 PDT----PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred ccc----ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 211 12235679999999999999999999999999999999999999985321 11111100 000
Q ss_pred -----------ccccCCCCCC--CC-----HHHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 691 -----------SSILDPLAGD--WP-----TFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 691 -----------~~~~d~~~~~--~~-----~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
.......... .+ ...+..+.++|.+||..||.+||++.+.+.+.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p 376 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0000000000 01 12345788999999999999999999766543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=335.60 Aligned_cols=252 Identities=27% Similarity=0.435 Sum_probs=210.9
Q ss_pred CCccceeeeecceEEEEEEEc--C---eEEEEEEeccCCccc-HHHHHHHHHHHhcCCCCceeeEeccccC--Cccceee
Q 003481 472 FSESFKVGQGGFGCVYKGEML--G---RTVAIKMLYSHNMQG-QLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 543 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~--g---~~vAiK~l~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 543 (816)
..+.+.||.|-||.|++|++. | ..||||.|+...... +.+|+.|..||.++.||||++|.|+... ..+||.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 346778999999999999986 3 569999998876543 4579999999999999999999999854 4789999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
||+||+|+.+|..+. ..+++-+...++++||.|+.||-+++ +|||||...|||++.|..+|++|||+++.+.++.
T Consensus 711 yMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 711 YMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 999999999998876 45999999999999999999999998 9999999999999999999999999999876554
Q ss_pred CcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCC--hHHHHHHhhcCccccccCCCCCC
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGL--AGEVRRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~--~~~~~~~~~~~~~~~~~d~~~~~ 700 (816)
. ..+......-...|.|||.+...++|.+||||||||+|||.++ |..||-. ..++...+..|... .
T Consensus 786 ~---~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRL--------P 854 (996)
T KOG0196|consen 786 E---AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRL--------P 854 (996)
T ss_pred C---ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCC--------C
Confidence 1 2222233333567999999999999999999999999999888 9999853 33455666655321 2
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhhh
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~~ 740 (816)
-|.+++..|.+|++.||++|..+||.+. .|+..|+.+-.
T Consensus 855 pPmDCP~aL~qLMldCWqkdR~~RP~F~-qiV~~lDklIr 893 (996)
T KOG0196|consen 855 PPMDCPAALYQLMLDCWQKDRNRRPKFA-QIVSTLDKLIR 893 (996)
T ss_pred CCCCCcHHHHHHHHHHHHHHhhcCCCHH-HHHHHHHHHhc
Confidence 2455677999999999999999999999 67788887743
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=308.76 Aligned_cols=248 Identities=26% Similarity=0.380 Sum_probs=196.3
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-----ccHHHHHHHHHHHhcCCCCceeeEeccccC----Cc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-----QGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AW 538 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~ 538 (816)
.+|...+.||+|+||.||+|... +..|++|.+..... .....+.+|+.++++++||||+++++++.+ ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47899999999999999999874 78999999865432 123458899999999999999999998743 36
Q ss_pred cceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccccee
Q 003481 539 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 539 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 618 (816)
++++||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 78999999999999986543 4889999999999999999999987 99999999999999999999999999876
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCC
Q 003481 619 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLA 698 (816)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~ 698 (816)
........ .......++..|+|||++.+..++.++|||||||++|+|++|+.||............. ..+..
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~-----~~~~~ 227 (266)
T cd06651 156 LQTICMSG---TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA-----TQPTN 227 (266)
T ss_pred cccccccC---CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh-----cCCCC
Confidence 54321110 01123458899999999998889999999999999999999999997543322211111 11112
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 699 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 699 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
..++......+..++ +||..+|.+||++.+.+.
T Consensus 228 ~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 228 PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 334555666777887 788899999999996554
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=309.94 Aligned_cols=252 Identities=27% Similarity=0.448 Sum_probs=201.9
Q ss_pred cCCCccceeeeecceEEEEEEEc--C----eEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEecccc-CCccce
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--G----RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP-EAWSLV 541 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g----~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~lV 541 (816)
.+|...+.||+|+||.||+|.+. | ..||+|.+..... .....+.+|+.++.+++||||++++++|. ...++|
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 45777889999999999999864 3 2689998876543 23457889999999999999999999884 458899
Q ss_pred eeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
|||+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 87 TQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 99999999999987654 35899999999999999999999977 99999999999999999999999999987654
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChH--HHHHHhhcCccccccCCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLA 698 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~--~~~~~~~~~~~~~~~d~~~ 698 (816)
..... ......++..|+|||.+....++.++|||||||++|||++ |+.||.... .+...+..+...
T Consensus 162 ~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------- 230 (279)
T cd05057 162 DEKEY----HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL------- 230 (279)
T ss_pred cccce----ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC-------
Confidence 33211 1122334678999999988889999999999999999999 999997533 223333322111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhh
Q 003481 699 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 699 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~ 739 (816)
..+...+..+.+++.+||..+|..||++. .+...|+.+.
T Consensus 231 -~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~-~l~~~l~~~~ 269 (279)
T cd05057 231 -PQPPICTIDVYMVLVKCWMIDAESRPTFK-ELINEFSKMA 269 (279)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCCCHH-HHHHHHHHHH
Confidence 11222445789999999999999999999 6888888763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=312.85 Aligned_cols=229 Identities=24% Similarity=0.368 Sum_probs=179.9
Q ss_pred eeeeecceEEEEEEEc--------------------------CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeE
Q 003481 477 KVGQGGFGCVYKGEML--------------------------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTL 530 (816)
Q Consensus 477 ~LG~G~~g~Vy~~~~~--------------------------g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l 530 (816)
+||+|+||.||+|.+. ...|++|++..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 6999999999999752 13589999876554445578899999999999999999
Q ss_pred eccccC--CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCC--
Q 003481 531 LGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-- 606 (816)
Q Consensus 531 ~g~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~-- 606 (816)
+|+|.+ ..++||||+++|+|..++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 999844 4789999999999999886543 36889999999999999999999977 99999999999997644
Q ss_pred -----CeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHH-hCCCCCCChH
Q 003481 607 -----SSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLL-TGRLPVGLAG 679 (816)
Q Consensus 607 -----~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~ell-tG~~Pf~~~~ 679 (816)
.+||+|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|..||....
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cCccceeeecCCccccccccc----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 3899999987644221 22357888999998865 56899999999999999995 6999986432
Q ss_pred HH--HHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHH
Q 003481 680 EV--RRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPS 730 (816)
Q Consensus 680 ~~--~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~ 730 (816)
.. ....... ...+......+.+++.+||+.+|.+||++.+.
T Consensus 227 ~~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i 269 (274)
T cd05076 227 PSEKERFYEKK----------HRLPEPSCKELATLISQCLTYEPTQRPSFRTI 269 (274)
T ss_pred hHHHHHHHHhc----------cCCCCCCChHHHHHHHHHcccChhhCcCHHHH
Confidence 21 1111110 01111223578999999999999999999843
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=314.01 Aligned_cols=259 Identities=28% Similarity=0.440 Sum_probs=200.9
Q ss_pred CCCccceeeeecceEEEEEEEc------CeEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCceeeEeccccC----Ccc
Q 003481 471 NFSESFKVGQGGFGCVYKGEML------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWS 539 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~------g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~ 539 (816)
.|...+.||+|+||.||++++. +..||||++...... ....|.+|+.+++.++||||+++++++.. ..+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4667788999999999999864 578999999765543 45679999999999999999999998854 478
Q ss_pred ceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceec
Q 003481 540 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 619 (816)
Q Consensus 540 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 619 (816)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...
T Consensus 85 lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 9999999999999997644 35899999999999999999999987 999999999999999999999999999877
Q ss_pred cCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHh--------hcCccc
Q 003481 620 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV--------SCGKLS 691 (816)
Q Consensus 620 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~--------~~~~~~ 691 (816)
....... .......++..|++||++.+..++.++||||||+++|+|+||..|+.........+ ....+.
T Consensus 160 ~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 160 PEDKDYY---YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred ccCCcce---eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 6332110 11223345667999999988899999999999999999999999985322110000 000000
Q ss_pred cccCC-CCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 692 SILDP-LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 692 ~~~d~-~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
..+.. .....+...+..+.+|+.+||+.+|.+||++. +++..|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~-ei~~~l~~i 283 (284)
T cd05038 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFA-DLILIVDRL 283 (284)
T ss_pred HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHH-HHHHHHhhc
Confidence 00000 00111223446899999999999999999999 777777754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=309.91 Aligned_cols=246 Identities=26% Similarity=0.363 Sum_probs=200.6
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeecc
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 545 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 545 (816)
.|...+.||.|+||.||+|.+. +..||||++.... ......+.+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4677788999999999999874 7899999987543 2334578899999999999999999999853 589999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
++|+|.+++.. .++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 99999998854 35888999999999999999999987 99999999999999999999999999987654321
Q ss_pred CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHH
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 705 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 705 (816)
......++..|+|||++.+..++.++|||||||++|+|+||..||........... +........+...
T Consensus 157 -----~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~------~~~~~~~~~~~~~ 225 (277)
T cd06640 157 -----KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL------IPKNNPPTLTGEF 225 (277)
T ss_pred -----ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh------hhcCCCCCCchhh
Confidence 12344688899999999888899999999999999999999999964432211110 0001122344567
Q ss_pred HHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 706 ARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 706 ~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
+..+.+++.+||+.+|.+||++.+.+.+.+
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 788999999999999999999997665544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=309.43 Aligned_cols=244 Identities=28% Similarity=0.453 Sum_probs=193.9
Q ss_pred eeeeecceEEEEEEEcC--------eEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeecc
Q 003481 477 KVGQGGFGCVYKGEMLG--------RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 545 (816)
Q Consensus 477 ~LG~G~~g~Vy~~~~~g--------~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 545 (816)
.||+|+||.||+|+... ..||||.+..... .....|.+|+.+++.++||||++++++|. +..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998742 5799998865432 34567889999999999999999999884 3588999999
Q ss_pred CCCchhhhhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCC-----CeeEeecccc
Q 003481 546 PNGSLQDRLFRKS----NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-----SSKICDFGIC 616 (816)
Q Consensus 546 ~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~-----~vkL~DFGla 616 (816)
++++|.+++.... ....++|..++.++.|++.||.|||+.+ ++|+||||+||+++.++ .++|+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999997532 1234789999999999999999999987 99999999999999877 8999999999
Q ss_pred eeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHHH--HHHhhcCccccc
Q 003481 617 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEV--RRAVSCGKLSSI 693 (816)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~ 693 (816)
......... .......++..|+|||++.++.++.++|||||||++|+|+| |..||...... ...+..+.
T Consensus 159 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~---- 230 (269)
T cd05044 159 RDIYKSDYY----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG---- 230 (269)
T ss_pred ccccccccc----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC----
Confidence 866433211 11233456788999999999999999999999999999998 99998643322 12221111
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 694 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 694 ~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
....+...+..+.+|+.+||..+|.+||++. .+.+.|+
T Consensus 231 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~ 268 (269)
T cd05044 231 ----RLQKPENCPDKIYQLMTNCWAQDPSERPTFD-RIQEILQ 268 (269)
T ss_pred ----ccCCcccchHHHHHHHHHHcCCCcccCCCHH-HHHHHHh
Confidence 1122334567899999999999999999999 6666654
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=312.45 Aligned_cols=235 Identities=25% Similarity=0.381 Sum_probs=185.0
Q ss_pred eeeeecceEEEEEEEc---------CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeecc
Q 003481 477 KVGQGGFGCVYKGEML---------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 545 (816)
Q Consensus 477 ~LG~G~~g~Vy~~~~~---------g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 545 (816)
.||.|+||.||+|... ...|++|.+..........|.+|+.++..++||||+++++++. +..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 5999999999999764 2348888886555445567889999999999999999999984 4688999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCC--------eeEeecccce
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS--------SKICDFGICR 617 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~--------vkL~DFGla~ 617 (816)
++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. ++|+|||++.
T Consensus 82 ~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 82 KFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 9999999987654 35889999999999999999999987 999999999999987765 5899999876
Q ss_pred eccCCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCC-CCCCChHHHHHHhhcCccccccC
Q 003481 618 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGR-LPVGLAGEVRRAVSCGKLSSILD 695 (816)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~-~Pf~~~~~~~~~~~~~~~~~~~d 695 (816)
..... ....+++.|+|||++.+ ..++.++|||||||++|+|++|. .||..............
T Consensus 157 ~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~------ 220 (258)
T cd05078 157 TVLPK----------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED------ 220 (258)
T ss_pred ccCCc----------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc------
Confidence 54321 23457889999999876 45899999999999999999985 66654333211111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 696 PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 696 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
....|......+.+|+.+||+.+|.+||++. ++++.|
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~il~~l 257 (258)
T cd05078 221 --RHQLPAPKWTELANLINQCMDYEPDFRPSFR-AIIRDL 257 (258)
T ss_pred --cccCCCCCcHHHHHHHHHHhccChhhCCCHH-HHHHhc
Confidence 1122323446789999999999999999999 455544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.18 Aligned_cols=242 Identities=22% Similarity=0.356 Sum_probs=201.2
Q ss_pred ceeeeecceEEEEEEEc--CeEEEEEEeccC----CcccHHHHHHHHHHHhcCCCCceeeEeccccC----Cccceeecc
Q 003481 476 FKVGQGGFGCVYKGEML--GRTVAIKMLYSH----NMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLVYEYL 545 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~lV~E~~ 545 (816)
..||+|+|-+||+|.+. |-.||--.++.. ......+|..|+.+|+.|+|||||++|.++.+ ...+|+|.+
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 35999999999999886 666775433222 22344679999999999999999999998843 266899999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCC-CCeeEeecccceeccCCCC
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DFGla~~~~~~~~ 624 (816)
..|+|..|+.+.. .++...+..|+.||+.||.|||++. +||||||||.+||||+.+ |.|||+|+|+|.......
T Consensus 126 TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 126 TSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred cCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence 9999999998876 4777999999999999999999998 589999999999999765 899999999999876533
Q ss_pred cCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCC---ChHHHHHHhhcCccccccCCCCCCC
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVG---LAGEVRRAVSCGKLSSILDPLAGDW 701 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~---~~~~~~~~~~~~~~~~~~d~~~~~~ 701 (816)
.....|||.|||||.+. ..|+..+||||||++++||+|+..||. ...++++.+..|.....+...
T Consensus 201 -------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV---- 268 (632)
T KOG0584|consen 201 -------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV---- 268 (632)
T ss_pred -------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc----
Confidence 34578999999999887 679999999999999999999999995 556677777777655443322
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 702 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 702 ~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
-.+.+.++|.+||.. ..+||++.+.|.+.|-..
T Consensus 269 ---~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 269 ---KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred ---CCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 135789999999999 999999998887777543
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=306.21 Aligned_cols=247 Identities=26% Similarity=0.329 Sum_probs=197.1
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-----ccHHHHHHHHHHHhcCCCCceeeEeccccC----Cc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-----QGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AW 538 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~ 538 (816)
.+|...+.||+|+||.||+|.+. +..||||.+..... .....+.+|+.++.+++||||+++++++.+ ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888999999999999999875 78999998864321 123467889999999999999999998743 36
Q ss_pred cceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccccee
Q 003481 539 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 539 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 618 (816)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 78999999999999987543 4788899999999999999999988 99999999999999999999999999886
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCC
Q 003481 619 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLA 698 (816)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~ 698 (816)
........ .......|+..|+|||++.+..++.++|||||||++|+|++|+.||............ . ..+..
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~-~----~~~~~ 227 (265)
T cd06652 156 LQTICLSG---TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI-A----TQPTN 227 (265)
T ss_pred cccccccc---cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH-h----cCCCC
Confidence 54321110 1123346889999999998888999999999999999999999999754332221111 0 11222
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 699 GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 699 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
...|...+..+.+++.+||. +|.+||++.+.+
T Consensus 228 ~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il 259 (265)
T cd06652 228 PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELL 259 (265)
T ss_pred CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHh
Confidence 33466677889999999995 999999998544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.38 Aligned_cols=242 Identities=24% Similarity=0.353 Sum_probs=194.3
Q ss_pred cceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeeccCCCch
Q 003481 475 SFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPNGSL 550 (816)
Q Consensus 475 ~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~~gsL 550 (816)
...||.|+||.||++... +..||+|.+..........+.+|+.++..++||||++++++|. +..++||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 346999999999999874 8899999997655555667889999999999999999999874 458999999999999
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCcc
Q 003481 551 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 630 (816)
Q Consensus 551 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 630 (816)
..++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 106 ~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~------ 172 (297)
T cd06659 106 TDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP------ 172 (297)
T ss_pred HHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc------
Confidence 987744 34889999999999999999999988 99999999999999999999999999876543221
Q ss_pred ccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHHHHHHH
Q 003481 631 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 710 (816)
Q Consensus 631 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~ 710 (816)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||................ .+. ...+...+..+.
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~l~ 248 (297)
T cd06659 173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP---PPK-LKNAHKISPVLR 248 (297)
T ss_pred cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC---CCC-ccccCCCCHHHH
Confidence 1234568999999999998889999999999999999999999996444322211110000 000 011123456789
Q ss_pred HHHHHhhccCCCCCCCChHHHHH
Q 003481 711 DLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 711 ~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
+++.+||+.+|.+||++.+.+.+
T Consensus 249 ~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 249 DFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHhcCCcccCcCHHHHhhC
Confidence 99999999999999999965554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=304.21 Aligned_cols=245 Identities=28% Similarity=0.532 Sum_probs=196.3
Q ss_pred cCCCccceeeeecceEEEEEEEc-CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccC
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLP 546 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~ 546 (816)
.+|...+.||.|+||.||++.+. +..+|+|.+.... .....|.+|+.++++++||||+++++++.. ..++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35777889999999999999886 7889999886543 234578999999999999999999999843 5789999999
Q ss_pred CCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcC
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626 (816)
Q Consensus 547 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 626 (816)
+++|.+++.... ..+++..++.++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc-
Confidence 999999986543 35889999999999999999999988 999999999999999999999999999866433211
Q ss_pred CCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCCCCCCH
Q 003481 627 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPT 703 (816)
Q Consensus 627 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~ 703 (816)
......++..|+|||++.++.++.++||||||+++|+|++ |..||..... ....+..+. .... +.
T Consensus 157 ----~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~~------~~ 224 (256)
T cd05112 157 ----SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF--RLYK------PR 224 (256)
T ss_pred ----ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC--CCCC------CC
Confidence 1123345678999999998899999999999999999998 9999964332 222222221 1111 12
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 704 FVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 704 ~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
..+..+.+|+.+||+.+|.+||++. ++++.
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~-~~l~~ 254 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFS-LLLHQ 254 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHH-HHHHh
Confidence 2346899999999999999999998 44443
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.54 Aligned_cols=247 Identities=28% Similarity=0.384 Sum_probs=185.6
Q ss_pred eeeeecceEEEEEEEc----CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccCCCc
Q 003481 477 KVGQGGFGCVYKGEML----GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGS 549 (816)
Q Consensus 477 ~LG~G~~g~Vy~~~~~----g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gs 549 (816)
.||+|+||.||+|... ...+++|.+..... .....|.+|+.+++.++||||++++++|.+ ..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 5899999999999753 35788898764432 234568899999999999999999998853 4889999999999
Q ss_pred hhhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 550 LQDRLFRKSN--VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 550 L~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
|.+++..... ....++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-- 156 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY-- 156 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhe--
Confidence 9999976532 233567888999999999999999987 999999999999999999999999998764432211
Q ss_pred CccccCCCCCCCCCCCcccccc-------CCCCcchhHhHHHHHHHHHHh-CCCCCCChHHH--HHHhhcCccccccCCC
Q 003481 628 SFHRSTAPKGSFPYADPEYHRT-------GVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEV--RRAVSCGKLSSILDPL 697 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~-------~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~--~~~~~~~~~~~~~d~~ 697 (816)
.......+++.|+|||++.. ..++.++|||||||++|||++ |..||...... ...........+..
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-- 232 (269)
T cd05042 157 --ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK-- 232 (269)
T ss_pred --eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCC--
Confidence 11233456778999998642 356889999999999999999 78888644321 11111111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 698 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 698 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
...+...+..+.+++..|| .||.+||++. +|.+.|
T Consensus 233 -~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~-~v~~~l 267 (269)
T cd05042 233 -PQLDLKYSDRWYEVMQFCW-LDPETRPTAE-EVHELL 267 (269)
T ss_pred -CcccccCCHHHHHHHHHHh-cCcccccCHH-HHHHHh
Confidence 2233345567788888888 5999999998 555544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=325.37 Aligned_cols=238 Identities=25% Similarity=0.335 Sum_probs=186.4
Q ss_pred eeeecceEEEEEEEc--CeEEEEEEeccCCcc---cHHHHHHHHHHHhcC---CCCceeeEecccc--CCccceeeccCC
Q 003481 478 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKL---QHPHLVTLLGACP--EAWSLVYEYLPN 547 (816)
Q Consensus 478 LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~---~~~~~~~E~~il~~l---~HpnIv~l~g~~~--~~~~lV~E~~~~ 547 (816)
||+|+||.||+|++. +..||||++...... ....+..|..++.++ +||||+++++++. +..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999885 889999998654322 223455677777665 6999999999884 358999999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--- 151 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--- 151 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---
Confidence 99999886543 5889999999999999999999988 99999999999999999999999999875432221
Q ss_pred CccccCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCCCCC-H
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWP-T 703 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~-~ 703 (816)
......||+.|+|||++.+. .++.++|||||||++|+|+||+.||..... ....+..+... ++ .
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------~~~~ 219 (330)
T cd05586 152 ---TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR---------FPKN 219 (330)
T ss_pred ---CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC---------CCCc
Confidence 12345799999999988654 489999999999999999999999965432 22233322211 11 1
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 704 FVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 704 ~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
..+..+.+|+.+||+.||.+||+..+.+.+.++
T Consensus 220 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 220 VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 245678899999999999999976544444443
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=321.01 Aligned_cols=250 Identities=25% Similarity=0.281 Sum_probs=192.3
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++|...+.||+|+||.||++++. +..||+|++..... .....|.+|+.++..++|+||+++++++.+ ..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999886 67899999864321 223357889999999999999999998843 588999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 9999999999997643 35889999999999999999999988 999999999999999999999999999765432
Q ss_pred CCcCCCccccCCCCCCCCCCCccccc-----cCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHH--HHhhcCccccccC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILD 695 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~--~~~~~~~~~~~~d 695 (816)
.. .......||+.|+|||++. ...++.++|||||||+||||++|+.||....... ..+...... .
T Consensus 156 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-~-- 227 (332)
T cd05623 156 GT-----VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER-F-- 227 (332)
T ss_pred Cc-----ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcc-c--
Confidence 21 1123457999999999885 3468899999999999999999999997543322 112111100 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCC--CCCChHHHHH
Q 003481 696 PLAGDWPTFVARRLVDLGLQCCELYGRE--RPDITPSLVK 733 (816)
Q Consensus 696 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~--RPs~~e~l~~ 733 (816)
.........+..+.+|+.+|+..++.. ||++.+.+.+
T Consensus 228 -~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 -QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 011112235678899999988654443 6777754443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.34 Aligned_cols=193 Identities=25% Similarity=0.356 Sum_probs=157.0
Q ss_pred cceeeeecceEEEEEEEc----CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc----CCccceeeccC
Q 003481 475 SFKVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP----EAWSLVYEYLP 546 (816)
Q Consensus 475 ~~~LG~G~~g~Vy~~~~~----g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~----~~~~lV~E~~~ 546 (816)
..+||+|+||.||+|+.. +..||+|.+.... ....+.+|+.+|++++||||++++++|. ...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 357999999999999864 4689999986543 2345788999999999999999999873 24689999986
Q ss_pred CCchhhhhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEe----cCCCCeeEeecccc
Q 003481 547 NGSLQDRLFRK------SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL----DSELSSKICDFGIC 616 (816)
Q Consensus 547 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl----~~~~~vkL~DFGla 616 (816)
+ +|.+++... .....+++..+..|+.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4 777766422 12235889999999999999999999987 9999999999999 56678999999999
Q ss_pred eeccCCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCC
Q 003481 617 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVG 676 (816)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~ 676 (816)
+........ ........||+.|+|||++.+ ..++.++|||||||++|||+||++||.
T Consensus 160 ~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 160 RLFNSPLKP---LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred eccCCCccc---ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 876543211 112244578999999998876 458999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=313.31 Aligned_cols=248 Identities=25% Similarity=0.386 Sum_probs=195.6
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeec
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 544 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 544 (816)
++|+..+.||+|+||.||++... +..||+|++.... ......+.+|+.++..++||||+++++++. ...++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46777889999999999999886 8899999886543 234567899999999999999999999984 358899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+++++|.+++... ..+++..+..++.+++.||.|||+.. +++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 9999999988654 35899999999999999999999742 39999999999999999999999999987553221
Q ss_pred cCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH------HHHhhcCccccccCCCC
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV------RRAVSCGKLSSILDPLA 698 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~------~~~~~~~~~~~~~d~~~ 698 (816)
.....|+..|+|||++.+..++.++|||||||++|+|+||..||...... ...+. ..+..+.....
T Consensus 159 -------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 230 (284)
T cd06620 159 -------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL-DLLQQIVQEPP 230 (284)
T ss_pred -------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHH-HHHHHHhhccC
Confidence 13456899999999998889999999999999999999999999643221 00000 00111111111
Q ss_pred CCCCH-HHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 699 GDWPT-FVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 699 ~~~~~-~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
...+. ..+..+.+|+.+||+.||.+||++.+.+
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~ 264 (284)
T cd06620 231 PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLC 264 (284)
T ss_pred CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 11222 2556899999999999999999998544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.91 Aligned_cols=231 Identities=30% Similarity=0.460 Sum_probs=184.3
Q ss_pred eeeeecceEEEEEEEcCe------------EEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc-CCccceee
Q 003481 477 KVGQGGFGCVYKGEMLGR------------TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP-EAWSLVYE 543 (816)
Q Consensus 477 ~LG~G~~g~Vy~~~~~g~------------~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~lV~E 543 (816)
.||+|+||.||+|.+.+. .|++|.+...... ...|.+|+.++++++||||++++|+|. ...++|||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e 80 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEE 80 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEEE
Confidence 699999999999988632 4888887654433 667899999999999999999999874 45789999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCC-------CeeEeecccc
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-------SSKICDFGIC 616 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~-------~vkL~DFGla 616 (816)
|+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 81 ~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 81 YVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred cCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999876542 6889999999999999999999987 99999999999999887 7999999998
Q ss_pred eeccCCCCcCCCccccCCCCCCCCCCCccccccC--CCCcchhHhHHHHHHHHHHh-CCCCCCChHHH--HHHhhcCccc
Q 003481 617 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG--VLTPKSDSYSFGLIILQLLT-GRLPVGLAGEV--RRAVSCGKLS 691 (816)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~--~~~~~~~~~~ 691 (816)
...... ....++..|+|||++... .++.++|||||||++|+|++ |..||...... ...+....
T Consensus 156 ~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~-- 223 (259)
T cd05037 156 ITVLSR----------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH-- 223 (259)
T ss_pred cccccc----------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC--
Confidence 865431 233467789999998776 78999999999999999999 57787544221 11111100
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 692 SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 692 ~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
..+......+.+++.+||..+|.+||++. ++++.
T Consensus 224 --------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~il~~ 257 (259)
T cd05037 224 --------RLPMPDCAELANLINQCWTYDPTKRPSFR-AILRD 257 (259)
T ss_pred --------CCCCCCchHHHHHHHHHhccChhhCCCHH-HHHHh
Confidence 01111126899999999999999999998 44443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=317.55 Aligned_cols=255 Identities=18% Similarity=0.213 Sum_probs=190.5
Q ss_pred cceeeee--cceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeeccC
Q 003481 475 SFKVGQG--GFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLP 546 (816)
Q Consensus 475 ~~~LG~G--~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~ 546 (816)
..+||+| +||+||++... |..||+|.+..... .....+.+|+.+++.++||||++++++|. +..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 78999999875 88999999876532 22345778999999999999999999984 45889999999
Q ss_pred CCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcC
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626 (816)
Q Consensus 547 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 626 (816)
+|+|.+++..... ..+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.++++|||.+..........
T Consensus 83 ~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 83 YGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 9999999865432 35899999999999999999999987 9999999999999999999999998765432211100
Q ss_pred -CCccccCCCCCCCCCCCcccccc--CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHH--HHhhcCccccccCCC----
Q 003481 627 -PSFHRSTAPKGSFPYADPEYHRT--GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPL---- 697 (816)
Q Consensus 627 -~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~--~~~~~~~~~~~~d~~---- 697 (816)
..........++..|+|||++.+ ..++.++|||||||++|+|++|+.||....... .....+.+...++..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 00001123457788999999875 468999999999999999999999996432211 111111111111100
Q ss_pred ---------------------------------CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 698 ---------------------------------AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 698 ---------------------------------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
...+....+..+.+|+.+||+.||.+|||+.+.+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 001122356689999999999999999999965543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=306.83 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=208.3
Q ss_pred CCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccc--cCCccceeeccCC
Q 003481 472 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPN 547 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~E~~~~ 547 (816)
|.+..+||+|+||.||++.+. |..||||.+... .+..++..|+.+++++..|++|++||.+ ..++++|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 566778999999999999875 899999988543 3566889999999999999999999976 3469999999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
|+..+++.-+. .+|++.++..++...+.||+|||... -||||||..||||+.+|.+||+|||.|..+.+..
T Consensus 113 GSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM---- 183 (502)
T KOG0574|consen 113 GSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM---- 183 (502)
T ss_pred CcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH----
Confidence 99999997665 57999999999999999999999987 8999999999999999999999999998876543
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHHHH
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVAR 707 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 707 (816)
.....+.|||.|||||++..-.|+.++||||||++..||.-|++||......+..+. +... .|..-.-|...+.
T Consensus 184 --AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM---IPT~-PPPTF~KPE~WS~ 257 (502)
T KOG0574|consen 184 --AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM---IPTK-PPPTFKKPEEWSS 257 (502)
T ss_pred --HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe---ccCC-CCCCCCChHhhhh
Confidence 245678899999999999999999999999999999999999999976655322110 0000 0111123667888
Q ss_pred HHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 708 RLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 708 ~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
.+.+++.+||-..|++|-|+.+.+.+.+
T Consensus 258 ~F~DFi~~CLiK~PE~R~TA~~L~~H~F 285 (502)
T KOG0574|consen 258 EFNDFIRSCLIKKPEERKTALRLCEHTF 285 (502)
T ss_pred HHHHHHHHHhcCCHHHHHHHHHHhhhhh
Confidence 9999999999999999999987666654
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=321.54 Aligned_cols=245 Identities=26% Similarity=0.303 Sum_probs=189.9
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++|.+.+.||+|+||.||+++.. ++.||+|++..... .....+.+|..++..++|+||+++++++.+ ..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999885 78899999865321 223457889999999999999999999843 478999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999997643 35889999999999999999999988 999999999999999999999999999876543
Q ss_pred CCcCCCccccCCCCCCCCCCCcccccc-----CCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCccccccC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRT-----GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILD 695 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~d 695 (816)
... ......||+.|+|||++.+ +.++.++|||||||+||+|++|+.||...... ...+...... +
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~--~- 227 (331)
T cd05624 156 GTV-----QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER--F- 227 (331)
T ss_pred Cce-----eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc--c-
Confidence 211 1234569999999998865 56889999999999999999999999644322 1111111100 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCC--CCCCh
Q 003481 696 PLAGDWPTFVARRLVDLGLQCCELYGRE--RPDIT 728 (816)
Q Consensus 696 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~--RPs~~ 728 (816)
.........+..+.+|+.+|+..++.+ |+++.
T Consensus 228 -~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~ 261 (331)
T cd05624 228 -QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIE 261 (331)
T ss_pred -cCCCccccCCHHHHHHHHHHccCchhhcCCCCHH
Confidence 001111234568899999999865543 34554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=331.45 Aligned_cols=249 Identities=20% Similarity=0.277 Sum_probs=191.5
Q ss_pred hcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeec
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 544 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 544 (816)
..+|.+...||+|+||.||++.+. +..||||... ...+.+|+.+|++|+|||||++++++. +..+|||++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457899999999999999999986 6889999642 224678999999999999999999874 457899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+. ++|.+++.... ..++|..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 94 68888876543 36999999999999999999999988 99999999999999999999999999987643221
Q ss_pred cCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCC----------hHHHHHHhhcCcccc-c
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGL----------AGEVRRAVSCGKLSS-I 693 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~----------~~~~~~~~~~~~~~~-~ 693 (816)
. .......||+.|+|||++.+..++.++|||||||+||||++|..|+.. ...+...+....+.. .
T Consensus 316 ~----~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 316 T----PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred c----ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 1 112345799999999999999999999999999999999998865421 112222222221110 0
Q ss_pred cC--------------------C--CCCCCCH--HHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 694 LD--------------------P--LAGDWPT--FVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 694 ~d--------------------~--~~~~~~~--~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
+. + ....|.. .....+.+||.+||+.||.+||++.++|.+
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 0 0001111 233478899999999999999999965543
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.68 Aligned_cols=245 Identities=25% Similarity=0.338 Sum_probs=205.6
Q ss_pred cCCCccceeeeecceEEEEEEE--cCeEEEEEEeccCCcc---cHHHHHHHHHHHhcCCCCceeeEeccc--cCCcccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~--~g~~vAiK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~ 542 (816)
+.|+.-+.||+||||.||-++. +|+-+|.|.+.+.... +..-..+|-.+|.+++.+.||.|-.+| .+.+|||+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 4577888999999999998865 4899999998765443 334567999999999999999998887 46799999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
..|+||+|.-+|.+.++ +.++++.+.-++.+|+.||.+||... ||.|||||+|||||++|+++|+|+|+|..++.+
T Consensus 265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999988876 56999999999999999999999988 999999999999999999999999999998876
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 702 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~ 702 (816)
.. ....+||.+|||||++.++.|+...|+|||||+||||+.|+.||....+- +....+...+-.....++
T Consensus 341 ~~-------~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK---vk~eEvdrr~~~~~~ey~ 410 (591)
T KOG0986|consen 341 KP-------IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK---VKREEVDRRTLEDPEEYS 410 (591)
T ss_pred Cc-------cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh---hhHHHHHHHHhcchhhcc
Confidence 52 34558999999999999999999999999999999999999999643321 111111111112234567
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCCh
Q 003481 703 TFVARRLVDLGLQCCELYGRERPDIT 728 (816)
Q Consensus 703 ~~~~~~l~~Li~~cl~~dP~~RPs~~ 728 (816)
...+++...|....|..||.+|-..+
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhccCC
Confidence 78888999999999999999998766
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.64 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=200.6
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEecccc----CCcccee
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP----EAWSLVY 542 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~----~~~~lV~ 542 (816)
+|...+.||.|+||.||++... +..||+|.+..... .....+.+|+.++++++||||+++++++. ...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4778889999999999999875 78899999875433 23456889999999999999999998763 2368999
Q ss_pred eccCCCchhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCceeeCCCCCCceEecCCCCeeEeecccceec
Q 003481 543 EYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSK--PEKIVHGDLKPQNILLDSELSSKICDFGICRLV 619 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 619 (816)
||+++++|.+++.... ...++++..++.++.||+.||.|||..+ ..+|+|+||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999987542 2357899999999999999999999321 134999999999999999999999999999877
Q ss_pred cCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCC
Q 003481 620 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPL 697 (816)
Q Consensus 620 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~ 697 (816)
..... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ....+..+.
T Consensus 161 ~~~~~------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------- 226 (265)
T cd08217 161 GHDSS------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK-------- 226 (265)
T ss_pred cCCcc------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC--------
Confidence 54331 12345689999999999988899999999999999999999999975432 222222222
Q ss_pred CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 698 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 698 ~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
....+...+..+.+++.+||+.+|.+||++.+.+.+
T Consensus 227 ~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 123445566789999999999999999999965543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.95 Aligned_cols=243 Identities=29% Similarity=0.404 Sum_probs=198.0
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-----ccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccce
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-----QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 541 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-----~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 541 (816)
+|...+.||+|+||.||+|... +..|++|.+..... .....+.+|+.+++.++||||+++++++.+ ..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677788999999999999885 88999999865432 234568899999999999999999999854 58899
Q ss_pred eeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
|||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998654 35889999999999999999999988 99999999999999999999999999887643
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCC-CCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGV-LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 700 (816)
.. ......|++.|++||.+.... ++.++|+|||||++|+|++|+.||............+.... ...
T Consensus 155 ~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-----~~~ 222 (258)
T cd06632 155 FS-------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-----LPP 222 (258)
T ss_pred cc-------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-----CCC
Confidence 32 123456889999999887766 89999999999999999999999975543322222221111 112
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
.+...+..+.+++.+||+.+|.+||++.+.+
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l 253 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELL 253 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHHHh
Confidence 3344567889999999999999999998554
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=324.84 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=206.7
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccc--cCCccceeeccC
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLP 546 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~E~~~ 546 (816)
.|.++..||.|+||.||++... +-..|.|++........+.|.-|++||..+.||+||+|++.| .+.++++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 3555667999999999999876 445678888777777778899999999999999999999864 667999999999
Q ss_pred CCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcC
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626 (816)
Q Consensus 547 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 626 (816)
||-...++..-+ .+|+..++.-+++|++.||.|||+.+ |||||||..|||++-+|.++|+|||.+......
T Consensus 113 GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t---- 183 (1187)
T KOG0579|consen 113 GGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST---- 183 (1187)
T ss_pred CchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH----
Confidence 999999887765 47999999999999999999999988 999999999999999999999999987654322
Q ss_pred CCccccCCCCCCCCCCCcccc-----ccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCC
Q 003481 627 PSFHRSTAPKGSFPYADPEYH-----RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 701 (816)
Q Consensus 627 ~~~~~~~~~~gt~~Y~aPE~~-----~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~ 701 (816)
........|||+|||||+. ...+|+.++||||||++|.||..+.+|-...+..+-.+...+- +|...-.
T Consensus 184 --~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS----ePPTLlq 257 (1187)
T KOG0579|consen 184 --RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS----EPPTLLQ 257 (1187)
T ss_pred --HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc----CCCcccC
Confidence 2345677899999999975 4568999999999999999999999998766655444332211 1111123
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 702 PTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 702 ~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
|...+..+.+++.+||..||..||++.+.+.+.+
T Consensus 258 PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf 291 (1187)
T KOG0579|consen 258 PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF 291 (1187)
T ss_pred cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence 5567789999999999999999999997776544
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=311.10 Aligned_cols=246 Identities=32% Similarity=0.480 Sum_probs=195.1
Q ss_pred CCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHH--HHHHHHHHHhcCCCCceeeEecccc--CCccceeecc
Q 003481 472 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 545 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~--~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 545 (816)
|+..+.||+|+||+||+++.. +..||+|++......... ...+|+.++.+++||||+++++++. ...++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567789999999999999997 678999999877654333 3456999999999999999999984 4578999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
++++|.+++... ..+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~-- 152 (260)
T PF00069_consen 81 PGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENN-- 152 (260)
T ss_dssp TTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTT--
T ss_pred cccccccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--
Confidence 999999999733 35899999999999999999999987 9999999999999999999999999998642111
Q ss_pred CCCccccCCCCCCCCCCCccccc-cCCCCcchhHhHHHHHHHHHHhCCCCCCChH--HHHHHhhcCccccccCCCCCCCC
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHR-TGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWP 702 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDVwSlGviL~elltG~~Pf~~~~--~~~~~~~~~~~~~~~d~~~~~~~ 702 (816)
.......++..|+|||++. +..++.++||||||+++|+|++|..||.... .....+............. ..
T Consensus 153 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 226 (260)
T PF00069_consen 153 ----ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ--QS 226 (260)
T ss_dssp ----SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT--SH
T ss_pred ----cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc--cc
Confidence 1235567899999999998 7889999999999999999999999997651 1111111111101000000 00
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 703 TFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 703 ~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
......+.+++.+||+.||.+||++.+.+
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~ 255 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEELL 255 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHHH
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHHh
Confidence 01137899999999999999999998544
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.22 Aligned_cols=251 Identities=25% Similarity=0.320 Sum_probs=198.7
Q ss_pred cCCCccceeeeecceEEEEEEEc-CeEEEEEEeccC--CcccHHHHHHHHHHHhcC-CCCceeeEeccc--cCCccceee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSH--NMQGQLEFQQEVRVLSKL-QHPHLVTLLGAC--PEAWSLVYE 543 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~--~~~~~lV~E 543 (816)
..|++.++||+||.+.||++... .+.||+|++... +.+....|.+|+..|.+| .|.+||+||+|- ++.+|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 45888999999999999999886 466888876544 334556799999999999 599999999986 455899999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
|- ..+|..+|.+.... ...| .+..+..|++.|+.++|.++ |||.||||.|+|+-. |.+||+|||+|..+..+.
T Consensus 441 ~G-d~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred cc-cccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 87 56999999876542 3335 67888999999999999998 999999999999954 689999999999998776
Q ss_pred CcCCCccccCCCCCCCCCCCccccccC-----------CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCcccc
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTG-----------VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSS 692 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~ 692 (816)
... .....+||+.||+||.+... +.++++||||||||||+|+.|++||+.....+. ++..
T Consensus 514 TsI----~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a-----Kl~a 584 (677)
T KOG0596|consen 514 TSI----VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA-----KLHA 584 (677)
T ss_pred cce----eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH-----HHHh
Confidence 433 34567899999999987532 256799999999999999999999975554332 3455
Q ss_pred ccCCCC-CCCCHHHH-HHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 693 ILDPLA-GDWPTFVA-RRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 693 ~~d~~~-~~~~~~~~-~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
+.+|.. ..||..-. ..+.++++.||..||.+||++.+.|.+.+-
T Consensus 585 I~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl 630 (677)
T KOG0596|consen 585 ITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFL 630 (677)
T ss_pred hcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccc
Confidence 566632 22332111 129999999999999999999976655544
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=308.68 Aligned_cols=251 Identities=26% Similarity=0.343 Sum_probs=198.0
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEeccccC----Ccccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~lV~ 542 (816)
++|...+.||.|++|.||++.+. +..||+|.+..... .....+.+|++++++++||||++++++|.+ ..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888899999999999999984 78999999875433 345578999999999999999999998732 478999
Q ss_pred eccCCCchhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 543 EYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
||+++++|.+++.... ....+++..+..|+.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999998875422 2346888999999999999999999987 99999999999999999999999999876543
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChH-------HHHHHhhcCcccccc
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG-------EVRRAVSCGKLSSIL 694 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~-------~~~~~~~~~~~~~~~ 694 (816)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|..||.... .....+.......+.
T Consensus 158 ~~--------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd06621 158 SL--------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK 229 (287)
T ss_pred cc--------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhc
Confidence 22 123457889999999998899999999999999999999999997441 111111111111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 695 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 695 d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
+... .....+..+.+++.+||..+|.+||++.+.+.+
T Consensus 230 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 230 DEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred cCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1101 011245789999999999999999999865543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=302.31 Aligned_cols=243 Identities=28% Similarity=0.463 Sum_probs=194.4
Q ss_pred ceeeeecceEEEEEEEc-CeEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccCCCchh
Q 003481 476 FKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSLQ 551 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL~ 551 (816)
++||.|+||.||++.+. ++.||+|.+...... ....|.+|+.++++++||||+++++++.+ ..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36999999999999886 899999998765443 45678999999999999999999998844 478999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCccc
Q 003481 552 DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 631 (816)
Q Consensus 552 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 631 (816)
+++.... ..+++..++.++.+++.||.|||+++ ++||||||+|||++.++.+||+|||++.......... .
T Consensus 81 ~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~----~ 151 (251)
T cd05041 81 TFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV----S 151 (251)
T ss_pred HHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCccee----c
Confidence 9986543 35889999999999999999999988 9999999999999999999999999998654322110 1
Q ss_pred cCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCCCCCCHHHHHH
Q 003481 632 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARR 708 (816)
Q Consensus 632 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 708 (816)
.....++..|+|||++.++.++.++|||||||++|+|+| |..||..... ....+..+. ....+...+..
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 223 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY--------RMPAPQLCPEE 223 (251)
T ss_pred cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC--------CCCCCccCCHH
Confidence 122234667999999988899999999999999999999 8889864432 222222111 01123345668
Q ss_pred HHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 709 LVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 709 l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
+.+++.+||..+|.+||++. +|+..|+
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~-ell~~l~ 250 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFS-EIYNELQ 250 (251)
T ss_pred HHHHHHHHhccChhhCcCHH-HHHHHhh
Confidence 99999999999999999998 5555553
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.70 Aligned_cols=244 Identities=26% Similarity=0.372 Sum_probs=198.1
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeec
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 544 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 544 (816)
+|...+.||+|+||.||++... +..+|+|.+..... .....+.+|+.++++++||||+++++.+. +..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5788899999999999998874 78899999876532 23457889999999999999999999874 348899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCC-CCeeEeecccceeccCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDT 623 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DFGla~~~~~~~ 623 (816)
+++++|.+++.... ...+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.+ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999997643 245899999999999999999999987 9999999999999865 458999999998765432
Q ss_pred CcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHH--HhhcCccccccCCCCCCC
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVSCGKLSSILDPLAGDW 701 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~--~~~~~~~~~~~d~~~~~~ 701 (816)
......|+..|+|||.+....++.++||||||+++|+|++|+.||...+.... .+..+. ....
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~--------~~~~ 221 (256)
T cd08220 157 -------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGT--------FAPI 221 (256)
T ss_pred -------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcC--------CCCC
Confidence 12335688999999999888899999999999999999999999965432211 111111 1122
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 702 PTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 702 ~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
+...+..+.+++.+||..+|.+||++.+.+.+
T Consensus 222 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 33456789999999999999999999976644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=324.33 Aligned_cols=189 Identities=21% Similarity=0.305 Sum_probs=160.4
Q ss_pred HhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceee
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 543 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 543 (816)
...+|.+.+.||+|+||.||+|... +..||+|+.... ....|+.++.+++||||++++++|.. ..++|+|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3457999999999999999999986 578999975432 23569999999999999999999843 4789999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
|+. ++|.+++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 138 ~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 211 (357)
T PHA03209 138 HYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211 (357)
T ss_pred ccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc
Confidence 995 68888876543 46899999999999999999999988 9999999999999999999999999987543221
Q ss_pred CcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCC
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 675 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf 675 (816)
......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 212 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 -------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -------ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 123456999999999999999999999999999999999865543
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=303.10 Aligned_cols=243 Identities=21% Similarity=0.283 Sum_probs=199.0
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeec
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 544 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 544 (816)
+|+..+.||.|+||.||.++.. +..|++|.+.... ......+.+|+.++++++|+||+++++++.+ ..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888899999999999888764 7889999986543 3344578899999999999999999999854 47899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999987653 246899999999999999999999987 99999999999999999999999999987654331
Q ss_pred cCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCccccccCCCCCCCC
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWP 702 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~~~~ 702 (816)
......|++.|+|||++.+..++.++||||||+++|+|++|..||...... ...+..+... ..+
T Consensus 157 ------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~--------~~~ 222 (256)
T cd08221 157 ------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT--------PVV 222 (256)
T ss_pred ------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC--------CCc
Confidence 123456899999999998888999999999999999999999999653321 1122222221 112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 703 TFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 703 ~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
...+..+.+++.+||..+|.+||++.+.+
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll 251 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTADEVL 251 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHh
Confidence 34566899999999999999999998544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=312.80 Aligned_cols=251 Identities=25% Similarity=0.283 Sum_probs=198.4
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc---cHHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++|...+.||+|+||.||++... +..||+|.+...... ....+..|+.++..++||||+++++.+.+ ..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999885 789999999765433 34468899999999999999999998844 478999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+.+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999886543 246899999999999999999999988 999999999999999999999999998765432
Q ss_pred CCcCC-----------------------CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChH
Q 003481 623 TLYLP-----------------------SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG 679 (816)
Q Consensus 623 ~~~~~-----------------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~ 679 (816)
..... .........||..|+|||++.+..++.++||||||+++|+|++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 21100 0011123468999999999998889999999999999999999999997554
Q ss_pred HHHHHhhcCccccccCCCCCCCC--HHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 680 EVRRAVSCGKLSSILDPLAGDWP--TFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 680 ~~~~~~~~~~~~~~~d~~~~~~~--~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
........ .... ..++ ...+..+.+++.+||..+|.+||+....+
T Consensus 237 ~~~~~~~~------~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~ 283 (316)
T cd05574 237 RDETFSNI------LKKE-VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGA 283 (316)
T ss_pred hHHHHHHH------hcCC-ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhH
Confidence 32222110 1100 0111 11567899999999999999999955333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=306.48 Aligned_cols=245 Identities=24% Similarity=0.324 Sum_probs=199.2
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeec
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 544 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 544 (816)
+|+..+.||+|+||.||++... |..||+|.+.... ......+.+|+.++++++||||+++++++.+ ..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788899999999999999875 7899999986543 2334578899999999999999999999854 58899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+++++|.+++..... ..+++..++.|+.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999998865432 35789999999999999999999987 99999999999999999999999999987644221
Q ss_pred cCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCccccccCCCCCCCC
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWP 702 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~~~~ 702 (816)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+..+.. ...+
T Consensus 157 ------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~--------~~~~ 222 (256)
T cd08218 157 ------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSY--------PPVS 222 (256)
T ss_pred ------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCC--------CCCc
Confidence 122345889999999999888999999999999999999999999643321 111222221 1223
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 703 TFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 703 ~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
...+..+.+++.+||+.+|.+||++.+.+.+
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 3456789999999999999999999966543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.52 Aligned_cols=250 Identities=27% Similarity=0.354 Sum_probs=199.4
Q ss_pred HHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCceeeEeccccC-------
Q 003481 467 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE------- 536 (816)
Q Consensus 467 ~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~------- 536 (816)
..+++|...+.||.|+||.||+|... +..|++|++..... ....|.+|+.++.++ .||||++++++|..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45789999999999999999999985 67899999875543 345789999999999 79999999999832
Q ss_pred -CccceeeccCCCchhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecc
Q 003481 537 -AWSLVYEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 614 (816)
Q Consensus 537 -~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 614 (816)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 2689999999999999886532 2356899999999999999999999988 9999999999999999999999999
Q ss_pred cceeccCCCCcCCCccccCCCCCCCCCCCcccccc-----CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH--hhc
Q 003481 615 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-----GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSC 687 (816)
Q Consensus 615 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~--~~~ 687 (816)
++....... .......|++.|+|||++.. ..++.++|||||||+||+|++|+.||......... +..
T Consensus 159 ~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 232 (275)
T cd06608 159 VSAQLDSTL------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR 232 (275)
T ss_pred cceecccch------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc
Confidence 987654322 12244568999999998753 34678999999999999999999999643322211 111
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 688 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 688 ~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
+... ....+...+..+.+|+.+||..||.+|||+.+.+.
T Consensus 233 ~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 233 NPPP------TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred cCCC------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111 11123345678999999999999999999986543
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=304.35 Aligned_cols=255 Identities=24% Similarity=0.269 Sum_probs=201.4
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeec
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 544 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 544 (816)
++|.+.+.||.|+||.||+|... +..|++|++..... .....+.+|+.+++.++|+||+++++.+. +..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47888999999999999999874 78899999875432 34567899999999999999999999874 458899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+++++|.+++........+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976543346899999999999999999999987 99999999999999999999999999987654332
Q ss_pred cCCCccccCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCC--C
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGD--W 701 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~--~ 701 (816)
.. ........|+..|+|||++... .++.++|||||||++|+|++|+.||............. .. ..+.... .
T Consensus 158 ~~--~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~--~~-~~~~~~~~~~ 232 (267)
T cd06610 158 RT--RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTL--QN-DPPSLETGAD 232 (267)
T ss_pred cc--ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHh--cC-CCCCcCCccc
Confidence 11 0122344689999999998777 78999999999999999999999997544321111100 00 0111111 1
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 702 PTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 702 ~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
....+..+.+++.+||..||.+||++.+.+.
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1245678999999999999999999986553
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=308.59 Aligned_cols=250 Identities=24% Similarity=0.325 Sum_probs=194.2
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 543 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 543 (816)
++|.....||+|+||.||+|.+. +..||+|++..... .....+.+|+.++.+++||||+++++++.. ..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999885 78999999865432 233567899999999999999999999844 4789999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
|+++++|..++... ..+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 99998888776443 35899999999999999999999987 9999999999999999999999999998765432
Q ss_pred CcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhh--c--Ccc--------
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS--C--GKL-------- 690 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~--~--~~~-------- 690 (816)
. ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||........... . +.+
T Consensus 155 ~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 155 D------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred c------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 1 1223457889999998865 5688999999999999999999999964433211110 0 000
Q ss_pred ------ccccCCCCCC------CCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 691 ------SSILDPLAGD------WPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 691 ------~~~~d~~~~~------~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
.....+.... .....+..+.+|+.+||+.+|++||++.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil 281 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELL 281 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHh
Confidence 0000010000 0112456789999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.75 Aligned_cols=247 Identities=27% Similarity=0.403 Sum_probs=203.0
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeec
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 544 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 544 (816)
++|...+.||.|++|.||++... +..|++|++..... .....+.+|+.++.+++||||+++++++.. ..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888899999999999999886 88999999876654 345679999999999999999999999844 58899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS-SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
+++++|.+++... ..+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999765 468999999999999999999999 88 9999999999999999999999999998775433
Q ss_pred CcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChH--HHHHHhhcCccccccCCCCCCC
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAGDW 701 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~--~~~~~~~~~~~~~~~d~~~~~~ 701 (816)
. ......++..|+|||.+.+..++.++||||||+++|+|+||..||.... ........ +........
T Consensus 155 ~------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-----~~~~~~~~~ 223 (264)
T cd06623 155 D------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQA-----ICDGPPPSL 223 (264)
T ss_pred C------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHH-----HhcCCCCCC
Confidence 2 1134568899999999999999999999999999999999999996553 11111111 011111222
Q ss_pred CHH-HHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 702 PTF-VARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 702 ~~~-~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
+.. .+..+.+++.+||..+|.+||++.+.+.+
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 333 56789999999999999999999966544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=310.16 Aligned_cols=250 Identities=26% Similarity=0.368 Sum_probs=202.8
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeecc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 545 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 545 (816)
++|...+.||.|+||.||+|... +..|++|.+..........+.+|+.++..++||||++++++|. +..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888899999999999999864 7889999987655555667899999999999999999999884 4589999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
++++|.+++... .+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 999999988643 4788999999999999999999988 99999999999999999999999999876654321
Q ss_pred CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHH
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 705 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 705 (816)
......|++.|++||.+....++.++|||||||++|+|++|+.||............+... ......+...
T Consensus 171 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~----~~~~~~~~~~ 241 (293)
T cd06647 171 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG----TPELQNPEKL 241 (293)
T ss_pred -----ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC----CCCCCCcccc
Confidence 1234468899999999988889999999999999999999999997544322211111000 0001123345
Q ss_pred HHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 706 ARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 706 ~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
+..+.+++.+||..+|.+||++.+.+.+.+-
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~ 272 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHH
Confidence 6689999999999999999999977766544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=306.44 Aligned_cols=248 Identities=24% Similarity=0.404 Sum_probs=197.8
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc------cHHHHHHHHHHHhcCCCCceeeEeccccC--Cccc
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ------GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 540 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~------~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 540 (816)
+|+....||+|+||.||+|... +..||+|++...... ....+.+|+.++++++||||+++++++.+ ..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 5778889999999999999874 889999998654321 23568899999999999999999999854 5789
Q ss_pred eeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCC-CeeEeecccceec
Q 003481 541 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICDFGICRLV 619 (816)
Q Consensus 541 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~ 619 (816)
||||+++++|.+++.... ++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999986543 5889999999999999999999988 99999999999998776 5999999999876
Q ss_pred cCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH---HHHHhhcCccccccCC
Q 003481 620 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE---VRRAVSCGKLSSILDP 696 (816)
Q Consensus 620 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~---~~~~~~~~~~~~~~d~ 696 (816)
........ .......|+..|+|||++.+..++.++||||||+++|+|++|..||..... ......... ..
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~ 227 (268)
T cd06630 155 AAKGTGAG--EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIAS-----AT 227 (268)
T ss_pred ccccccCC--ccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhc-----cC
Confidence 54321110 112334688999999999888899999999999999999999999963221 111100000 01
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 697 LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 697 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
.....+...+..+.+++.+||..+|.+||++.+.+
T Consensus 228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll 262 (268)
T cd06630 228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262 (268)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHh
Confidence 12345556778999999999999999999998554
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=311.88 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=194.5
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 543 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 543 (816)
++|...+.||+|+||.||+|.+. ++.||+|++...... ....+.+|+.++..++||||++++++|.. ..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999985 789999998654332 34568899999999999999999999854 4899999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
|+++++|..+.... ..++|..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 99999998876543 24899999999999999999999987 9999999999999999999999999998764432
Q ss_pred CcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhh----cCccc-------
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGKLS------- 691 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~----~~~~~------- 691 (816)
. ......++..|+|||++.+ ..++.++||||||+++|+|++|++||........... .+.+.
T Consensus 155 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 155 E------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred c------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence 1 1233468899999998865 4578899999999999999999999964332211100 00000
Q ss_pred -------cccCCCCC------CCCHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 692 -------SILDPLAG------DWPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 692 -------~~~d~~~~------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
....+... ......+..+.+|+.+||+.+|.+||++.+.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000 011234678999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=305.39 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=195.0
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---c-------cHHHHHHHHHHHhcCCCCceeeEecccc--C
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---Q-------GQLEFQQEVRVLSKLQHPHLVTLLGACP--E 536 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~-------~~~~~~~E~~il~~l~HpnIv~l~g~~~--~ 536 (816)
+|...+.||.|+||.||+|... |..||+|.+..... . ..+.+..|+.++.+++||||+++++++. +
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999764 78999998754211 0 1235788999999999999999999984 4
Q ss_pred CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccc
Q 003481 537 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 616 (816)
Q Consensus 537 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 616 (816)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 588999999999999998765 35889999999999999999999987 999999999999999999999999998
Q ss_pred eeccCCCCcCCCccccCCCCCCCCCCCccccccCC--CCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhc--Ccccc
Q 003481 617 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV--LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC--GKLSS 692 (816)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~--~~~~~ 692 (816)
........ ........|+..|+|||.+.... ++.++||||||+++|+|++|..||............ .....
T Consensus 156 ~~~~~~~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (272)
T cd06629 156 KKSDDIYD----NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP 231 (272)
T ss_pred cccccccc----ccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCC
Confidence 76543211 01223456889999999887654 889999999999999999999999654433222211 11111
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 693 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 693 ~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
.+ .......++..+.+++.+||..+|.+||++.+.+.
T Consensus 232 ~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 232 PI---PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cC---CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 11 11122235678999999999999999999986543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=309.01 Aligned_cols=250 Identities=25% Similarity=0.313 Sum_probs=192.0
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeec
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 544 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 544 (816)
+|+..+.||.|+||.||+|++. +..||||.+..... .....+.+|+.++++++||||+++++++.+ ..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5888899999999999999885 78999999865432 223468899999999999999999999843 58899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+. ++|..++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 95 688888865432 46899999999999999999999987 99999999999999999999999999876543221
Q ss_pred cCCCccccCCCCCCCCCCCccccccCC-CCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH---hhc-Ccc---------
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTGV-LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VSC-GKL--------- 690 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~---~~~-~~~--------- 690 (816)
......+++.|+|||++.+.. ++.++|||||||++|+|+||+.||......... ... +..
T Consensus 156 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 156 ------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred ------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence 123345788999999886644 688999999999999999999999644332111 110 000
Q ss_pred ---------ccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 691 ---------SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 691 ---------~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
...............+..+.+++.+||+.||.+||++.+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 279 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAAL 279 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 00000000011122456788999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=304.86 Aligned_cols=251 Identities=24% Similarity=0.407 Sum_probs=196.7
Q ss_pred CCccceeeeecceEEEEEEEc-----CeEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCceeeEeccccC--------
Q 003481 472 FSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------- 536 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~-----g~~vAiK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------- 536 (816)
|.+.+.||+|+||.||+|.+. +..||||++.... ......+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556778999999999999863 5789999986543 2335568899999999999999999998732
Q ss_pred CccceeeccCCCchhhhhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeec
Q 003481 537 AWSLVYEYLPNGSLQDRLFRKS---NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 613 (816)
Q Consensus 537 ~~~lV~E~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 613 (816)
..+++++|+.+|+|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 1368899999999998875322 2235789999999999999999999987 999999999999999999999999
Q ss_pred ccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCcc
Q 003481 614 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKL 690 (816)
Q Consensus 614 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~ 690 (816)
|+++........ .......+++.|++||.+....++.++|||||||++|+|++ |++||..... ....+..+..
T Consensus 158 g~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 233 (273)
T cd05074 158 GLSKKIYSGDYY----RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR 233 (273)
T ss_pred cccccccCCcce----ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 999876433211 11223445678999999988889999999999999999999 8899864432 2222222211
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 691 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 691 ~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
. ..+...+..+.+++.+||+.+|.+||++. ++...|+.+
T Consensus 234 ~--------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~-~~~~~l~~~ 272 (273)
T cd05074 234 L--------KQPPDCLEDVYELMCQCWSPEPKCRPSFQ-HLRDQLELI 272 (273)
T ss_pred C--------CCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHhh
Confidence 1 11223456899999999999999999999 677777654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=304.77 Aligned_cols=242 Identities=27% Similarity=0.384 Sum_probs=197.0
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeecc
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 545 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 545 (816)
-|...+.||.|+||.||+|.+. +..||||.+..... .....|.+|+.++.+++||||+++++++. +..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667788999999999999874 78999999865432 23456889999999999999999999984 3488999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 99999998853 35889999999999999999999987 99999999999999999999999999887654321
Q ss_pred CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHH--HHhhcCccccccCCCCCCCCH
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDWPT 703 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~--~~~~~~~~~~~~d~~~~~~~~ 703 (816)
......++..|+|||++.+..++.++|||||||++|+|++|..||....... ..+..+. ....+.
T Consensus 157 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 223 (277)
T cd06641 157 -----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN--------PPTLEG 223 (277)
T ss_pred -----hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCC--------CCCCCc
Confidence 1233468899999999988889999999999999999999999996443221 1111111 112233
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 704 FVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 704 ~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
.++..+.+++.+||+.+|.+||++.+.+.+
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 224 NYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 456788999999999999999999976654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=305.30 Aligned_cols=250 Identities=28% Similarity=0.439 Sum_probs=198.5
Q ss_pred cCCCccceeeeecceEEEEEEEc-------CeEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCceeeEeccccC--Ccc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWS 539 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~-------g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~ 539 (816)
.+|.....||.|+||.||+|+.. ...|++|.+...... ....|.+|+.++.+++||||++++++|.+ ..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46888899999999999999863 457999988654433 34578999999999999999999999854 588
Q ss_pred ceeeccCCCchhhhhhhcCCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeec
Q 003481 540 LVYEYLPNGSLQDRLFRKSNV------SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 613 (816)
Q Consensus 540 lV~E~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 613 (816)
+||||+++|+|.+++...... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998755421 25899999999999999999999988 999999999999999999999999
Q ss_pred ccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCcc
Q 003481 614 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKL 690 (816)
Q Consensus 614 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~ 690 (816)
|++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||..... .......+.+
T Consensus 162 ~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 236 (275)
T cd05046 162 SLSKDVYNSEY-----YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236 (275)
T ss_pred ccccccCcccc-----cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc
Confidence 99875432221 12233456778999999988889999999999999999999 8889864322 2222222222
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 691 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 691 ~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
... .+...+..+.+++.+||+.+|.+||++. +++..|
T Consensus 237 ~~~-------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~-~~l~~l 273 (275)
T cd05046 237 ELP-------VPEGCPSRLYKLMTRCWAVNPKDRPSFS-ELVSAL 273 (275)
T ss_pred CCC-------CCCCCCHHHHHHHHHHcCCCcccCCCHH-HHHHHh
Confidence 111 1223456899999999999999999999 455444
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=309.00 Aligned_cols=254 Identities=21% Similarity=0.236 Sum_probs=196.9
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++|...+.||+|+||.||++... +..|++|.+..... .....+.+|+.++..++||||+++++.+.. ..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47888999999999999999886 68899999876542 223467899999999999999999998854 368999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999996543 5899999999999999999999987 999999999999999999999999998742211
Q ss_pred CCc---------CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChH--HHHHHhhcCccc
Q 003481 623 TLY---------LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLS 691 (816)
Q Consensus 623 ~~~---------~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~--~~~~~~~~~~~~ 691 (816)
... ...........|+..|+|||++....++.++|||||||++|+|++|..||.... ........+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 234 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 100 000011123467889999999988889999999999999999999999996432 222222222111
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 692 SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 692 ~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
.+.. +...+..+.+++.+||+.+|.+||+.. .+.+.|+
T Consensus 235 ---~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~-~~~~ll~ 272 (305)
T cd05609 235 ---WPEG---DEALPADAQDLISRLLRQNPLERLGTG-GAFEVKQ 272 (305)
T ss_pred ---CCCc---cccCCHHHHHHHHHHhccChhhccCcc-CHHHHHh
Confidence 1111 113456789999999999999999975 3444444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=305.39 Aligned_cols=257 Identities=26% Similarity=0.396 Sum_probs=203.5
Q ss_pred HHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-cc------HHHHHHHHHHHhcCCCCceeeEeccc--
Q 003481 466 QTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QG------QLEFQQEVRVLSKLQHPHLVTLLGAC-- 534 (816)
Q Consensus 466 ~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~------~~~~~~E~~il~~l~HpnIv~l~g~~-- 534 (816)
....++|-..++||+|||+.||++.+. .+.||+|+-..... .+ .+...+|.+|-..|.||.||++|++|
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 345567888899999999999999875 78899998644322 11 12356899999999999999999998
Q ss_pred -cCCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecC---CCCeeE
Q 003481 535 -PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS---ELSSKI 610 (816)
Q Consensus 535 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkL 610 (816)
.+.+|-|+|||+|.+|.-+|..+. .+++.++..|+.||+.||.||.... .||||-||||.||||.. -|.+||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEe
Confidence 356899999999999999997764 5889999999999999999999988 68999999999999953 478999
Q ss_pred eecccceeccCCCCc-CCCccccCCCCCCCCCCCccccccC----CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHh
Q 003481 611 CDFGICRLVTEDTLY-LPSFHRSTAPKGSFPYADPEYHRTG----VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV 685 (816)
Q Consensus 611 ~DFGla~~~~~~~~~-~~~~~~~~~~~gt~~Y~aPE~~~~~----~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~ 685 (816)
+|||+++.+..+... ......+....||.+|++||.|.-+ ..+.|+||||+|||+|.++.|+.||+....-...+
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdIL 694 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDIL 694 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHH
Confidence 999999998765543 2233345667899999999977533 57889999999999999999999998554433333
Q ss_pred hcCccccccCCCCCCCC--HHHHHHHHHHHHHhhccCCCCCCCChH
Q 003481 686 SCGKLSSILDPLAGDWP--TFVARRLVDLGLQCCELYGRERPDITP 729 (816)
Q Consensus 686 ~~~~~~~~~d~~~~~~~--~~~~~~l~~Li~~cl~~dP~~RPs~~e 729 (816)
....+. ....-.|| +.++.....+|.+||++.-++|.+..+
T Consensus 695 qeNTIl---kAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~q 737 (775)
T KOG1151|consen 695 QENTIL---KATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQ 737 (775)
T ss_pred hhhchh---cceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHH
Confidence 333222 11111222 346778899999999999999987763
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=300.09 Aligned_cols=241 Identities=34% Similarity=0.543 Sum_probs=196.4
Q ss_pred CCccceeeeecceEEEEEEEcC------eEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 472 FSESFKVGQGGFGCVYKGEMLG------RTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~g------~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
|.+.+.||.|+||.||++.+.. ..||+|++...... ....+..|+.++..++||||+++++++.+ ..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456789999999999998863 78999999766544 45678999999999999999999999854 588999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999999876442 12899999999999999999999987 999999999999999999999999999877654
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChH--HHHHHhhcCccccccCCCCC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAG 699 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~--~~~~~~~~~~~~~~~d~~~~ 699 (816)
... ......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||.... .....+..+...
T Consensus 157 ~~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------- 223 (258)
T smart00219 157 DYY-----KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL-------- 223 (258)
T ss_pred ccc-----ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--------
Confidence 321 1112347889999999988889999999999999999998 888886432 222222222211
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCChH
Q 003481 700 DWPTFVARRLVDLGLQCCELYGRERPDITP 729 (816)
Q Consensus 700 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e 729 (816)
..+...+..+.+++.+||..+|.+||++.+
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 253 (258)
T smart00219 224 PKPENCPPEIYKLMLQCWAEDPEDRPTFSE 253 (258)
T ss_pred CCCCcCCHHHHHHHHHHCcCChhhCcCHHH
Confidence 122235678999999999999999999984
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=305.12 Aligned_cols=245 Identities=24% Similarity=0.410 Sum_probs=196.3
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCC---CCceeeEeccccC--Ccccee
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQ---HPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~---HpnIv~l~g~~~~--~~~lV~ 542 (816)
.|+..+.||.|+||.||+|.+. +..||+|.+..... .....+.+|+.++++++ |||+++++++|.+ ..++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4777889999999999999974 78999999875432 34457889999999996 9999999998844 478999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999988542 5899999999999999999999988 999999999999999999999999999877543
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 701 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~ 701 (816)
.. ......|+..|+|||++.++ .++.++|||||||++|+|++|..||............. .. ....+
T Consensus 155 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~---~~---~~~~~ 222 (277)
T cd06917 155 SS------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP---KS---KPPRL 222 (277)
T ss_pred cc------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccc---cC---CCCCC
Confidence 31 12345689999999988654 56899999999999999999999997544322211111 10 01111
Q ss_pred CH-HHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 702 PT-FVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 702 ~~-~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
+. ..+..+.+++.+||+.||.+||++.+.+.+.
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 223 EDNGYSKLLREFVAACLDEEPKERLSAEELLKSK 256 (277)
T ss_pred CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence 11 1456899999999999999999998665443
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=306.21 Aligned_cols=248 Identities=24% Similarity=0.369 Sum_probs=190.2
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-ccHHHHHHHHHH-HhcCCCCceeeEecccc--CCccceee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRV-LSKLQHPHLVTLLGACP--EAWSLVYE 543 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~i-l~~l~HpnIv~l~g~~~--~~~~lV~E 543 (816)
++|.+.+.||+|+||.||++.+. |..||||++..... .....+..|+.+ ++.++||||+++++++. ...++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47888999999999999999885 88999999876532 234456667665 55668999999999984 45899999
Q ss_pred ccCCCchhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 544 YLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSS-KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 544 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
|++ |+|.+++... .....+++..++.++.||+.||.|||+. + ++||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6888877543 2235689999999999999999999986 5 99999999999999999999999999886643
Q ss_pred CCCcCCCccccCCCCCCCCCCCcccccc----CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRT----GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPL 697 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~ 697 (816)
.. ......|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||.........+.. .+...
T Consensus 157 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-----~~~~~ 224 (283)
T cd06617 157 SV-------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ-----VVEEP 224 (283)
T ss_pred cc-------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH-----HHhcC
Confidence 22 1233468899999998754 45789999999999999999999999643211111110 00110
Q ss_pred CCCCC-HHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 698 AGDWP-TFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 698 ~~~~~-~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
....+ ..++..+.+++.+||..+|.+||++.+.+.+
T Consensus 225 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 225 SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111 2345689999999999999999999865543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=307.32 Aligned_cols=243 Identities=23% Similarity=0.337 Sum_probs=196.2
Q ss_pred CCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccc--cCCccceeeccCC
Q 003481 472 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPN 547 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~E~~~~ 547 (816)
|...+.||.|++|.||++... +..|++|++..........+.+|+.++..++||||+++++++ .+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444568999999999999874 788999998765555556788999999999999999999987 3568999999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
++|.+++.. ..+++..+..|+.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--- 170 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--- 170 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc---
Confidence 999998865 24889999999999999999999988 99999999999999999999999998876543221
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHH--HHhhcCccccccCCCCCCCCHHH
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDWPTFV 705 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~--~~~~~~~~~~~~d~~~~~~~~~~ 705 (816)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....... ..+..+.. +. ...+...
T Consensus 171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~-----~~-~~~~~~~ 241 (285)
T cd06648 171 ---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP-----PK-LKNLHKV 241 (285)
T ss_pred ---ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCC-----CC-CcccccC
Confidence 1233568999999999988889999999999999999999999986443221 11111111 11 1112235
Q ss_pred HHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 706 ARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 706 ~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
+..+.+++.+||+.+|.+||++.+.+.+
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 5689999999999999999999865543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=307.95 Aligned_cols=252 Identities=25% Similarity=0.355 Sum_probs=196.0
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeec
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 544 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 544 (816)
+|.+.+.||.|+||.||+|.+. |..||+|++..... .....+.+|+.++++++||||+++++++.. ..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778889999999999999875 78999999876543 234578899999999999999999998843 47899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+ +++|.+++.... ..+++..++.++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999886544 46899999999999999999999988 99999999999999999999999999987654321
Q ss_pred cCCCccccCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH---hhc-Cc----------
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VSC-GK---------- 689 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~---~~~-~~---------- 689 (816)
.......|+..|+|||++.+. .++.++|||||||++|+|+||.+||......... +.. +.
T Consensus 155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 155 -----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred -----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence 112345689999999988654 4689999999999999999998888643321110 000 00
Q ss_pred ----cccccCCCC-----CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 690 ----LSSILDPLA-----GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 690 ----~~~~~d~~~-----~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
...+..+.. .......+..+.+|+.+||+.+|.+||++.+.+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 01112345789999999999999999999965543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=309.47 Aligned_cols=250 Identities=25% Similarity=0.320 Sum_probs=193.7
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc-----cHHHHHHHHHHHhcCCCCceeeEeccccC--Cccce
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-----GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 541 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~-----~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV 541 (816)
+|...+.||.|+||.||+|.+. +..||||.+...... ....+..|+.++.+++|+||+++++++.+ ..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4777889999999999999875 789999999765433 23356789999999999999999999854 57899
Q ss_pred eeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
|||+ +|+|.+++.... ..+++..++.|+.||+.||.|||+.+ |+|+||+|+|||++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999986543 36899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH---hhc-C--------
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VSC-G-------- 688 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~---~~~-~-------- 688 (816)
... ......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||......... ... +
T Consensus 155 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 155 PNR------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP 228 (298)
T ss_pred CCc------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence 321 1233456888999998854 46789999999999999999998887543322111 000 0
Q ss_pred ---ccccccCC------CCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 689 ---KLSSILDP------LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 689 ---~~~~~~d~------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
........ .........+..+.+++.+||..+|.+||++.+.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000000 000111234678999999999999999999996553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.27 Aligned_cols=245 Identities=28% Similarity=0.386 Sum_probs=198.4
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeec
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 544 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 544 (816)
++|...+.||.|+||.||++.+. +..||+|.+..... .....+.+|+.++++++||||+++++++. ...++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999986 78999999876543 34457889999999999999999999874 358899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS-SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
+++++|.+++.... ..+++..+..++.|++.||.|||+ .+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999987653 468889999999999999999999 77 9999999999999999999999999987654322
Q ss_pred CcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChH----HHHHHhhcCccccccCCCCC
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG----EVRRAVSCGKLSSILDPLAG 699 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~----~~~~~~~~~~~~~~~d~~~~ 699 (816)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||.... ....... .+......
T Consensus 156 --------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~ 222 (265)
T cd06605 156 --------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ-----YIVNEPPP 222 (265)
T ss_pred --------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHH-----HHhcCCCC
Confidence 112568899999999998899999999999999999999999996442 1111111 11111111
Q ss_pred CCCHH-HHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 700 DWPTF-VARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 700 ~~~~~-~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
..+.. .+..+.++|.+||..+|.+||++.+.+.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 22222 6678999999999999999999986553
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.79 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=192.1
Q ss_pred HhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCccc-HHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG-QLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++++|...+.||+|+||.||+|... +..||+|++....... ...+.+|+.++..++|+||+++++++.+ ..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999874 8899999986554332 3467789999999999999999998844 478999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+. ++|.+.+.... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 67766665433 35788899999999999999999987 999999999999999999999999998764332
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhc-----C--------
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC-----G-------- 688 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~-----~-------- 688 (816)
.. ......+++.|+|||++.+. .++.++|||||||++|+|++|..||.........+.. +
T Consensus 157 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 157 SQ------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred CC------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence 21 12334578999999988654 5789999999999999999999999654432111110 0
Q ss_pred ---ccc----cccCCC-CCCCC-----HHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 689 ---KLS----SILDPL-AGDWP-----TFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 689 ---~~~----~~~d~~-~~~~~-----~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
.+. ...... ..... ...+..+.+++.+|+..||.+|||+.+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000 000000 00000 012457889999999999999999986553
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=307.90 Aligned_cols=234 Identities=29% Similarity=0.384 Sum_probs=194.8
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++|...+.||.|+||.||++.+. ++.||+|++..... .....+.+|+.++++++||||+++++++.+ ..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888899999999999999885 78999999865432 234568899999999999999999998844 478999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+|+||+|+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999987653 5889999999999999999999987 999999999999999999999999998876543
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCccccccCCCCCC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~~ 700 (816)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ...+..+. ..
T Consensus 155 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------~~ 216 (290)
T cd05580 155 ---------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK---------VR 216 (290)
T ss_pred ---------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---------cc
Confidence 13446899999999998888999999999999999999999999754422 12222221 12
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCC
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDI 727 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~cl~~dP~~RPs~ 727 (816)
++...+..+.+++.+||..||.+||+.
T Consensus 217 ~~~~~~~~l~~li~~~l~~~p~~R~~~ 243 (290)
T cd05580 217 FPSFFSPDAKDLIRNLLQVDLTKRLGN 243 (290)
T ss_pred CCccCCHHHHHHHHHHccCCHHHccCc
Confidence 333446789999999999999999943
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=312.38 Aligned_cols=242 Identities=29% Similarity=0.488 Sum_probs=203.1
Q ss_pred cceeeeecceEEEEEEEc---Ce--EEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCceeeEeccccC-CccceeeccCC
Q 003481 475 SFKVGQGGFGCVYKGEML---GR--TVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPN 547 (816)
Q Consensus 475 ~~~LG~G~~g~Vy~~~~~---g~--~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~~~ 547 (816)
.++||+|.||.|++|.|+ |+ .||||++...... ....|.+|+.+|.+|+|||+|+|||+..+ ...+|+|+++.
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELapl 194 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELAPL 194 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhccc
Confidence 356999999999999997 33 5999999887665 56689999999999999999999999864 57899999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
|+|.+.|.+ .....|.......++.|||.|+.||.+.+ +|||||...||||.....|||+|||+.+.+.......
T Consensus 195 GSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y- 269 (1039)
T KOG0199|consen 195 GSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY- 269 (1039)
T ss_pred chHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcce-
Confidence 999999988 33456788888999999999999999987 9999999999999999999999999999887655321
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCCCCCCHH
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTF 704 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~ 704 (816)
.......-.+.|+|||.++...++.++|||+|||+||||+| |..||.+... +...+..|. ....|..
T Consensus 270 --vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~e--------rLpRPk~ 339 (1039)
T KOG0199|consen 270 --VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGE--------RLPRPKY 339 (1039)
T ss_pred --EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccc--------cCCCCCC
Confidence 12334445678999999999999999999999999999999 8899965443 333333322 2234667
Q ss_pred HHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 705 VARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 705 ~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
+++.+.++++.||..+|.+||++. .|.
T Consensus 340 csedIY~imk~cWah~paDRptFs-air 366 (1039)
T KOG0199|consen 340 CSEDIYQIMKNCWAHNPADRPTFS-AIR 366 (1039)
T ss_pred ChHHHHHHHHHhccCCccccccHH-HHH
Confidence 889999999999999999999999 443
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=301.24 Aligned_cols=250 Identities=28% Similarity=0.373 Sum_probs=197.7
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeec
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 544 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 544 (816)
+|...+.||+|+||.||+|... +..|++|.+...... ....+.+|+.++++++|+||+++++++. +..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4778889999999999999874 789999998766543 4567899999999999999999999874 458899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+++++|.+++.... .+++..+..|+.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999986542 4788999999999999999999988 99999999999999999999999999987754432
Q ss_pred cCCCccccCCCCCCCCCCCccccccCC---CCcchhHhHHHHHHHHHHhCCCCCCChHHHH-HHhhcCccccccCCCCCC
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTGV---LTPKSDSYSFGLIILQLLTGRLPVGLAGEVR-RAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~s~ksDVwSlGviL~elltG~~Pf~~~~~~~-~~~~~~~~~~~~d~~~~~ 700 (816)
... .......+++.|+|||++.... ++.++||||||+++|+|++|+.||....... ....... ...+....
T Consensus 155 ~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~ 229 (264)
T cd06626 155 TMG--EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA---GHKPPIPD 229 (264)
T ss_pred ccc--ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc---CCCCCCCc
Confidence 110 0012356889999999988766 8899999999999999999999996432111 1111111 00111111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
+ ...+..+.+++.+||+.+|.+||++.+.+.
T Consensus 230 ~-~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 S-LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred c-cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1 123678899999999999999999996543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=307.51 Aligned_cols=249 Identities=22% Similarity=0.272 Sum_probs=189.5
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeec
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 544 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 544 (816)
+|...+.||.|+||.||+|.+. |..||+|.+...... ....+.+|+.++++++||||+++++++.+ ..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778889999999999999985 889999998654322 23457789999999999999999999844 48899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+. ++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 96 57877775533 35899999999999999999999988 99999999999999999999999999986543221
Q ss_pred cCCCccccCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhh---c--C--------cc
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS---C--G--------KL 690 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~---~--~--------~~ 690 (816)
......+++.|+|||++.+. .++.++|||||||++|+|+||..||.........+. . + .+
T Consensus 155 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 155 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred ------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence 12344678999999988664 478999999999999999999988632221111100 0 0 00
Q ss_pred ccccCCC-CC---------CCCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 691 SSILDPL-AG---------DWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 691 ~~~~d~~-~~---------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
....+.. .. ......+..+.+|+.+||+.||.+|||+.+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il 279 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEAL 279 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHh
Confidence 0000000 00 01123456889999999999999999998554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=304.95 Aligned_cols=248 Identities=24% Similarity=0.360 Sum_probs=202.6
Q ss_pred HHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc--CCcccee
Q 003481 467 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVY 542 (816)
Q Consensus 467 ~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~ 542 (816)
..+++|.....||.|+||.||+|.+. +..|++|++..... ....+.+|+.++..++|+||+++++++. +..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 35567888889999999999999986 88999999976554 5567889999999999999999999874 4588999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++++|.+++.... ..+++..++.++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999997654 36899999999999999999999977 999999999999999999999999998765432
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhh--cCccccccCCCCCC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS--CGKLSSILDPLAGD 700 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~--~~~~~~~~d~~~~~ 700 (816)
.. ......++..|++||++.+..++.++|||||||++|+|++|+.||........... ...... ..
T Consensus 170 ~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------~~ 237 (286)
T cd06614 170 KS------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP------LK 237 (286)
T ss_pred hh------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------Cc
Confidence 21 12334578899999999888899999999999999999999999975443322211 111111 11
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
.+..++..+.+++.+||+.+|..||++.+.+.
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 12224568999999999999999999996554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=296.54 Aligned_cols=246 Identities=27% Similarity=0.413 Sum_probs=200.8
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeeccC
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLP 546 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~ 546 (816)
+|...+.||.|++|.||++.+. +..|++|++..........+.+|+.++++++||||+++++++. +..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999986 7889999997766555678999999999999999999999884 45889999999
Q ss_pred CCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcC
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626 (816)
Q Consensus 547 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 626 (816)
+++|.+++.... ..+++..+..++.+++.||.|||..+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999987653 46899999999999999999999977 99999999999999999999999999987654331
Q ss_pred CCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHHH
Q 003481 627 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVA 706 (816)
Q Consensus 627 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 706 (816)
.....++..|++||++....++.++||||||+++|+|++|+.||...+........... .......+...+
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~ 224 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN----GPPGLRNPEKWS 224 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc----CCCCcCcccccC
Confidence 23456889999999998888999999999999999999999999755322221111110 000011122235
Q ss_pred HHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 707 RRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 707 ~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
..+.+++.+||+.||.+||++.+.+.
T Consensus 225 ~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 225 DEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhc
Confidence 68999999999999999999986543
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=306.97 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=196.4
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYE 543 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E 543 (816)
++|+..+.||.|+||.||+|.+. +..||+|++..... .....+.+|+.++++++|+||++++++|. +..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46888999999999999999885 78899999865432 33467889999999999999999999984 34899999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
|++++.|..++... ..+++..+..++.+|+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99987776655432 34889999999999999999999988 9999999999999999999999999988765433
Q ss_pred CcCCCccccCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhc----Cc---------
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----GK--------- 689 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~----~~--------- 689 (816)
. .......++..|+|||++.+. .++.++||||||+++|+|++|++||............ +.
T Consensus 155 ~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07833 155 A-----SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229 (288)
T ss_pred c-----ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence 1 112345688999999999888 8899999999999999999999999644332211110 00
Q ss_pred -----cc--cccCCCC-----CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 690 -----LS--SILDPLA-----GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 690 -----~~--~~~d~~~-----~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
+. ...+... ..++..++..+.+||.+||..+|.+||++.+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 283 (288)
T cd07833 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283 (288)
T ss_pred ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHh
Confidence 00 0000000 012333477899999999999999999998544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=319.57 Aligned_cols=252 Identities=26% Similarity=0.318 Sum_probs=198.9
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCC-C-----CceeeEeccc--cCCccc
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-H-----PHLVTLLGAC--PEAWSL 540 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~-H-----pnIv~l~g~~--~~~~~l 540 (816)
+|.+.+.||+|.||.|.+|.+. ++.||||+++.... -..+-..|+.+|..|+ | -|+|+++++| .++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7899999999999999999886 78999999976543 2334567999999996 4 3899999997 568999
Q ss_pred eeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCC--CCeeEeeccccee
Q 003481 541 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE--LSSKICDFGICRL 618 (816)
Q Consensus 541 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~--~~vkL~DFGla~~ 618 (816)
|+|.+ ..+|.++|.... +..|+...+..|+.||+.||.+||..+ |||+||||+||||..- ..+||+|||.|..
T Consensus 266 VfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99999 569999997654 567999999999999999999999988 9999999999999643 3699999999988
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH--------------
Q 003481 619 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA-------------- 684 (816)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~-------------- 684 (816)
..... ....-+..|.|||++.+.+|+.+.||||||||+.||++|.+.|.+.++..+.
T Consensus 341 ~~q~v---------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~m 411 (586)
T KOG0667|consen 341 ESQRV---------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKM 411 (586)
T ss_pred cCCcc---------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHH
Confidence 76533 2445678899999999999999999999999999999998888644432211
Q ss_pred hhcC-cccccc------------------------------------CC-CCCC----CCHHHHHHHHHHHHHhhccCCC
Q 003481 685 VSCG-KLSSIL------------------------------------DP-LAGD----WPTFVARRLVDLGLQCCELYGR 722 (816)
Q Consensus 685 ~~~~-~~~~~~------------------------------------d~-~~~~----~~~~~~~~l~~Li~~cl~~dP~ 722 (816)
+..+ +....+ .| .... .+......+.+++++||.+||.
T Consensus 412 L~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~ 491 (586)
T KOG0667|consen 412 LDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPA 491 (586)
T ss_pred HHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCch
Confidence 0000 000000 01 0000 1113445789999999999999
Q ss_pred CCCCChHHHHHHHHH
Q 003481 723 ERPDITPSLVKELEQ 737 (816)
Q Consensus 723 ~RPs~~e~l~~~Le~ 737 (816)
+|+|..+++.|.+-.
T Consensus 492 ~R~tp~qal~Hpfl~ 506 (586)
T KOG0667|consen 492 ERITPAQALNHPFLT 506 (586)
T ss_pred hcCCHHHHhcCcccc
Confidence 999999888877654
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=304.77 Aligned_cols=251 Identities=22% Similarity=0.296 Sum_probs=194.3
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeecc
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 545 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 545 (816)
+|+..+.||.|++|.||+|++. |..||||++...... ....+.+|+.++++++||||++++++|.+ ..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788899999999999999985 889999998765433 34567789999999999999999999844 589999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
++ +|.+++........+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 75 88888866554456899999999999999999999987 99999999999999999999999999976543221
Q ss_pred CCCccccCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHH---HhhcC------------c
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVSCG------------K 689 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~---~~~~~------------~ 689 (816)
......+++.|++||++.+. .++.++|||||||++|+|++|+.||........ ..... .
T Consensus 156 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 156 -----TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred -----ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 12334578899999987654 578999999999999999999999964432111 00000 0
Q ss_pred cccccC-------CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 690 LSSILD-------PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 690 ~~~~~d-------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
...... .....+....+..+.+++.+||+.||.+||++.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l 279 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDAL 279 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHh
Confidence 000000 000111123456789999999999999999998544
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=302.64 Aligned_cols=238 Identities=26% Similarity=0.309 Sum_probs=197.2
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceee
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 543 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 543 (816)
+|...+.||.|+||.||+|.+. +..||+|.+..... .....+.+|+.++++++||||+++++++.+ ..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5788899999999999999886 88999999976432 335678899999999999999999998843 5899999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
|+.+++|.+++... .++++..+..|+.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998664 36889999999999999999999987 9999999999999999999999999988765432
Q ss_pred CcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCCCC
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDW 701 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~ 701 (816)
......|+..|+|||++.+..++.++||||||+++|+|++|..||..... ......... ......
T Consensus 155 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------~~~~~~ 221 (258)
T cd05578 155 -------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE------TADVLY 221 (258)
T ss_pred -------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc------cccccC
Confidence 12345688899999999888899999999999999999999999975432 111111111 011223
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCC
Q 003481 702 PTFVARRLVDLGLQCCELYGRERPDI 727 (816)
Q Consensus 702 ~~~~~~~l~~Li~~cl~~dP~~RPs~ 727 (816)
+...+..+.+++.+||..||.+||++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~~~ 247 (258)
T cd05578 222 PATWSTEAIDAINKLLERDPQKRLGD 247 (258)
T ss_pred cccCcHHHHHHHHHHccCChhHcCCc
Confidence 44456789999999999999999999
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.43 Aligned_cols=247 Identities=25% Similarity=0.361 Sum_probs=184.4
Q ss_pred eeeeecceEEEEEEEc-C---eEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccCCCc
Q 003481 477 KVGQGGFGCVYKGEML-G---RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGS 549 (816)
Q Consensus 477 ~LG~G~~g~Vy~~~~~-g---~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gs 549 (816)
.||+|+||.||+|... + ..+++|.+..... .....|.+|+.++..++||||++++++|.+ ..++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5999999999999754 2 3466777655432 345679999999999999999999999854 4789999999999
Q ss_pred hhhhhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCC
Q 003481 550 LQDRLFRKSN-VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 628 (816)
Q Consensus 550 L~~~l~~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 628 (816)
|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~--- 155 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI--- 155 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhh---
Confidence 9999976432 245677788899999999999999987 999999999999999999999999998643221110
Q ss_pred ccccCCCCCCCCCCCcccccc-------CCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--HHHHhhcCccccccCCCC
Q 003481 629 FHRSTAPKGSFPYADPEYHRT-------GVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLA 698 (816)
Q Consensus 629 ~~~~~~~~gt~~Y~aPE~~~~-------~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~~~~~~~~~~~~~~d~~~ 698 (816)
.......++..|+|||++.. ..++.++|||||||++|||++ |..||..... ....+..+....+.++.
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 233 (268)
T cd05086 156 -ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQ- 233 (268)
T ss_pred -hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCc-
Confidence 11234568899999998743 245789999999999999997 5778854332 11222222222233332
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 699 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 699 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
.+...+..+.+++..|| .+|.+||++. ++++.|
T Consensus 234 --~~~~~~~~~~~l~~~c~-~~P~~Rp~~~-~i~~~l 266 (268)
T cd05086 234 --LELPYSERWYEVLQFCW-LSPEKRATAE-EVHRLL 266 (268)
T ss_pred --cCCCCcHHHHHHHHHHh-hCcccCCCHH-HHHHHh
Confidence 22234567888999999 6899999999 455544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.74 Aligned_cols=243 Identities=27% Similarity=0.350 Sum_probs=192.3
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc---cHHHHHHHHHHHhcCCCCceeeEecccc--CCcccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~ 542 (816)
..|...+.||+|+||.||+|... +..||+|.+...... ....+.+|+.++..++||||++++++|. +..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888889999999999999874 889999998654332 2346889999999999999999999984 4588999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+. |+|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9996 57777665433 35899999999999999999999987 999999999999999999999999998765432
Q ss_pred CCcCCCccccCCCCCCCCCCCccccc---cCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAG 699 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~ 699 (816)
....+++.|+|||++. .+.++.++||||||+++|+|+||++||...+..........- . .+.
T Consensus 169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~-~--~~~-- 233 (307)
T cd06607 169 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN-D--SPT-- 233 (307)
T ss_pred ----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC-C--CCC--
Confidence 2345788999999874 456889999999999999999999999654432221111000 0 000
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 700 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 700 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
-.+...+..+.+++.+||..+|.+||++.+.+.+
T Consensus 234 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1122356689999999999999999999965543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=305.81 Aligned_cols=250 Identities=22% Similarity=0.336 Sum_probs=190.1
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeec
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 544 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 544 (816)
++|.....||.|+||.||+|... ++.||||.+...... ....+.+|+.++++++||||+++++++.+ ..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888999999999999999875 789999998654322 23457789999999999999999999854 48899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+.+ +|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 975 8999886544 36889999999999999999999988 99999999999999999999999999875432111
Q ss_pred cCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHh----h---c---Cccccc
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV----S---C---GKLSSI 693 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~----~---~---~~~~~~ 693 (816)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.........+ . . ..+...
T Consensus 159 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred ------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhh
Confidence 1123356889999998865 458899999999999999999999996443111110 0 0 000000
Q ss_pred c---------CCCCC-----CCCHHH--HHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 694 L---------DPLAG-----DWPTFV--ARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 694 ~---------d~~~~-----~~~~~~--~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
. .+... ...... ...+.+++.+||+.+|.+||++.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l 286 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHh
Confidence 0 00000 000011 26788999999999999999998544
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=301.12 Aligned_cols=244 Identities=27% Similarity=0.382 Sum_probs=197.0
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeec
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 544 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 544 (816)
+|...+.||.|+||.||+|... |..||+|.+..... .....+.+|+.+++.++||||+++++.+.+ ..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5778889999999999999885 78899999865432 334568899999999999999999998844 47899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCC-CeeEeecccceeccCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICDFGICRLVTEDT 623 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~~~~ 623 (816)
+++++|.+++..... ..+++..+..|+.|++.||.|||+.+ ++|+||||+||+++.++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999876432 35899999999999999999999988 99999999999999885 46999999988765432
Q ss_pred CcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH--hhcCccccccCCCCCCC
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCGKLSSILDPLAGDW 701 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~--~~~~~~~~~~d~~~~~~ 701 (816)
. ......|++.|+|||++.+..++.++||||||+++|+|++|..||......... ...+. +. ..
T Consensus 157 ~------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~----~~ 222 (257)
T cd08225 157 E------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY----FA----PI 222 (257)
T ss_pred c------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc----CC----CC
Confidence 1 123346899999999998888999999999999999999999999754322111 11111 11 12
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 702 PTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 702 ~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
+...+..+.+++.+||..+|++||++.+.+.
T Consensus 223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 2234568999999999999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=305.10 Aligned_cols=249 Identities=23% Similarity=0.299 Sum_probs=191.8
Q ss_pred CCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeecc
Q 003481 472 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 545 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 545 (816)
|...+.||.|++|.||+|.+. |..||+|++..... .....+.+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567789999999999999874 89999999875532 223568899999999999999999999844 478999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
+ ++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 689998865432 35899999999999999999999987 99999999999999999999999999976543221
Q ss_pred CCCccccCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhh---c-Cc-----------
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS---C-GK----------- 689 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~---~-~~----------- 689 (816)
......+++.|+|||++.+. .++.++||||||+++|+|++|++||........... . +.
T Consensus 155 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 155 -----TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred -----ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence 12333578899999987654 578999999999999999999999964443221111 0 00
Q ss_pred -------cccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 690 -------LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 690 -------~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
+.....+.........+..+.+++.+||+.+|.+||++.+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il 278 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAAL 278 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 000000011111223456889999999999999999998554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=289.25 Aligned_cols=243 Identities=23% Similarity=0.340 Sum_probs=191.3
Q ss_pred ceeeeecceEEEEEEEc--CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCC-CCceeeEecccc--CCccceeeccCCCc
Q 003481 476 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQ-HPHLVTLLGACP--EAWSLVYEYLPNGS 549 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~g~~~--~~~~lV~E~~~~gs 549 (816)
..||.|..|.|++++.. |...|||.+..... ...+++...++++...+ +|+||+.+|+|- .+.++.||.| ...
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C 176 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STC 176 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHH
Confidence 45999999999999987 68999999977644 44567888888887775 999999999983 4578999988 345
Q ss_pred hhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCc
Q 003481 550 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 629 (816)
Q Consensus 550 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 629 (816)
++.+|.+.. .++++..+-++...++.||.||...+ +|+|||+||+|||||..|++||||||++-.+.+...
T Consensus 177 ~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA----- 247 (391)
T KOG0983|consen 177 AEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA----- 247 (391)
T ss_pred HHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc-----
Confidence 566665544 46888888899999999999999865 699999999999999999999999999988765542
Q ss_pred cccCCCCCCCCCCCcccccc---CCCCcchhHhHHHHHHHHHHhCCCCCCChHH---HHHHhhcCccccccCCCCCCCCH
Q 003481 630 HRSTAPKGSFPYADPEYHRT---GVLTPKSDSYSFGLIILQLLTGRLPVGLAGE---VRRAVSCGKLSSILDPLAGDWPT 703 (816)
Q Consensus 630 ~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVwSlGviL~elltG~~Pf~~~~~---~~~~~~~~~~~~~~d~~~~~~~~ 703 (816)
.+..+|-+.|||||.+.. ..|+..+||||||+.|+||.||+.||...+. +...+.. ... |.. ....
T Consensus 248 --htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~eP----P~L-~~~~ 319 (391)
T KOG0983|consen 248 --HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEP----PLL-PGHM 319 (391)
T ss_pred --cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCC----CCC-Cccc
Confidence 355679999999998853 4688999999999999999999999976332 2222222 111 111 1122
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 704 FVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 704 ~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
..++.+.+++..||..|+.+||...+.+.+.+-
T Consensus 320 gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi 352 (391)
T KOG0983|consen 320 GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFI 352 (391)
T ss_pred CcCHHHHHHHHHHhhcCcccCcchHHHhcCcce
Confidence 367899999999999999999999976655543
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.80 Aligned_cols=248 Identities=24% Similarity=0.401 Sum_probs=194.9
Q ss_pred CCCccceeeeecceEEEEEEEc---CeEEEEEEeccCCc----------ccHHHHHHHHHHHhc-CCCCceeeEeccccC
Q 003481 471 NFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHNM----------QGQLEFQQEVRVLSK-LQHPHLVTLLGACPE 536 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~---g~~vAiK~l~~~~~----------~~~~~~~~E~~il~~-l~HpnIv~l~g~~~~ 536 (816)
+|.+...||+|+||.||+|.+. +..+|+|.+..... .....+.+|+.++.+ ++||||++++++|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4778889999999999999985 47899998854321 123457788888875 799999999998843
Q ss_pred --CccceeeccCCCchhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeec
Q 003481 537 --AWSLVYEYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 613 (816)
Q Consensus 537 --~~~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 613 (816)
..++||||+++++|.+++... .....+++..++.++.|++.||.|||+.+ +++|+||+|+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 588999999999999987542 22346899999999999999999999632 3999999999999999999999999
Q ss_pred ccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHH--HHhhcCccc
Q 003481 614 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLS 691 (816)
Q Consensus 614 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~--~~~~~~~~~ 691 (816)
|++....... ......|+..|++||++.++.++.++||||||+++|+|++|+.||....... ..+..+...
T Consensus 159 g~~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (269)
T cd08528 159 GLAKQKQPES-------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231 (269)
T ss_pred cceeeccccc-------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC
Confidence 9998765432 1234568999999999998889999999999999999999999996543321 122222211
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 692 SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 692 ~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
+.. ....+..+.+++.+||+.||.+||++. ++..++
T Consensus 232 ----~~~---~~~~~~~l~~li~~cl~~~p~~Rp~~~-e~~~~~ 267 (269)
T cd08528 232 ----PLP---EGMYSEDVTDVITSCLTPDAEARPDII-QVSAMI 267 (269)
T ss_pred ----cCC---cccCCHHHHHHHHHHCCCCCccCCCHH-HHHHHh
Confidence 111 112456899999999999999999999 455444
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=295.92 Aligned_cols=248 Identities=26% Similarity=0.393 Sum_probs=203.2
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEeccccC----Ccccee
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLVY 542 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~lV~ 542 (816)
+|...+.||+|++|.||+|... +..|++|++..... .....+.+|+.++++++||||+++++.+.+ ..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777889999999999999986 88999999876553 345678899999999999999999998843 478999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||+++++|.+++.... .+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999987654 6899999999999999999999977 999999999999999999999999999887654
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHH-HhhcCccccccCCCCCCC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR-AVSCGKLSSILDPLAGDW 701 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~-~~~~~~~~~~~d~~~~~~ 701 (816)
... .......++..|+|||.+....++.++||||||+++|+|++|..||........ ...... .......
T Consensus 155 ~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~ 225 (260)
T cd06606 155 ETG----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-----SGEPPEI 225 (260)
T ss_pred ccc----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-----cCCCcCC
Confidence 321 012345688999999999888899999999999999999999999975442111 111110 0112234
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 702 PTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 702 ~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
+...+..+.+++.+|+..+|.+||++.+.+.+
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 44557899999999999999999999965543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=306.22 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=191.0
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCC-CCceeeEecccc--CCccceeec
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQ-HPHLVTLLGACP--EAWSLVYEY 544 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~g~~~--~~~~lV~E~ 544 (816)
+|.....||+|+||.||++.+. +..||+|.+..... .....+.+|+.++.++. ||||+++++++. ...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3455678999999999999885 78999999875433 34456889999999996 999999999873 357899999
Q ss_pred cCCCchhhhh---hhcCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCceeeCCCCCCceEecCCCCeeEeecccceecc
Q 003481 545 LPNGSLQDRL---FRKSNVSPLLWKDRARIAAEIASGLCFLHSS-KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 620 (816)
Q Consensus 545 ~~~gsL~~~l---~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~-~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 620 (816)
+.. +|.++. ... ....+++..+..++.+++.||.|||+. + |+||||||+|||++.++.+||+|||++....
T Consensus 85 ~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 854 555433 222 124689999999999999999999985 5 9999999999999999999999999997654
Q ss_pred CCCCcCCCccccCCCCCCCCCCCccccccC---CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCC
Q 003481 621 EDTLYLPSFHRSTAPKGSFPYADPEYHRTG---VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPL 697 (816)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~ 697 (816)
... ......|++.|+|||++.+. .++.++|||||||++|+|++|+.||.........+.... . ...+.
T Consensus 160 ~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~-~~~~~ 230 (288)
T cd06616 160 DSI-------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV-K-GDPPI 230 (288)
T ss_pred cCC-------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc-C-CCCCc
Confidence 322 12334688999999998766 689999999999999999999999965432222211110 0 00011
Q ss_pred -CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 698 -AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 698 -~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
....+..++..+.+|+.+||+.+|.+||++.+.+.+.+
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~ 269 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPF 269 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 11122336678999999999999999999996665443
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=306.98 Aligned_cols=253 Identities=23% Similarity=0.248 Sum_probs=192.0
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCC-CCceeeEeccccC--C-----
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQ-HPHLVTLLGACPE--A----- 537 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~--~----- 537 (816)
++|...+.||.|+||.||+|.+. +..||||.+..... .....+.+|+.++..+. ||||+++++++.. .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888999999999999999885 78999998765432 23356888999999995 6999999998732 2
Q ss_pred ccceeeccCCCchhhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecC-CCCeeEeecc
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSN--VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-ELSSKICDFG 614 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkL~DFG 614 (816)
.++||||+++ +|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 6899999985 78888765432 246899999999999999999999987 999999999999998 8899999999
Q ss_pred cceeccCCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhc----C-
Q 003481 615 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----G- 688 (816)
Q Consensus 615 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~----~- 688 (816)
++........ ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||............ +
T Consensus 157 ~~~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 230 (295)
T cd07837 157 LGRAFSIPVK------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT 230 (295)
T ss_pred cceecCCCcc------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9886543211 1233457889999998764 45799999999999999999999999654433221110 0
Q ss_pred -cc---cccc---C----C-----CCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 689 -KL---SSIL---D----P-----LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 689 -~~---~~~~---d----~-----~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
.. .... + + .........+..+.++|.+||..||.+||++.+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0000 0 0 000001235667999999999999999999986553
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=304.41 Aligned_cols=236 Identities=25% Similarity=0.362 Sum_probs=190.1
Q ss_pred eeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeeccCCCch
Q 003481 478 VGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPNGSL 550 (816)
Q Consensus 478 LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~~gsL 550 (816)
||+|+||+||++... |..||+|.+..... .....+.+|+.+|++++||||+++++++. +..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999875 88999999865432 22345678999999999999999999874 458999999999999
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCcc
Q 003481 551 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 630 (816)
Q Consensus 551 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 630 (816)
.+++..... ..+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~------- 149 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK------- 149 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC-------
Confidence 999876543 46899999999999999999999987 9999999999999999999999999987654322
Q ss_pred ccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCCCCCHHHHHH
Q 003481 631 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARR 708 (816)
Q Consensus 631 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 708 (816)
......++..|+|||++.++.++.++|||||||++|+|++|+.||..... ....+..... ......+...+..
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~ 224 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL-----EMAVEYPDKFSPE 224 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc-----cccccCCccCCHH
Confidence 12344678899999999888899999999999999999999999964432 1111111111 1112233445678
Q ss_pred HHHHHHHhhccCCCCCCCChH
Q 003481 709 LVDLGLQCCELYGRERPDITP 729 (816)
Q Consensus 709 l~~Li~~cl~~dP~~RPs~~e 729 (816)
+.+++.+||+.+|.+||++.+
T Consensus 225 ~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHHHHccCChhHccCCCc
Confidence 999999999999999997765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.53 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=193.9
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCCceeeEecccc----CCccce
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACP----EAWSLV 541 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~----~~~~lV 541 (816)
++|...+.||.|+||.||+|.+. +..|++|.+...... ....+.+|+.++.+++||||+++++++. ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888889999999999999986 788999998754332 2235678999999999999999999873 458999
Q ss_pred eeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
|||+. ++|.+++.... ..+++..++.|+.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 58988886644 36899999999999999999999987 99999999999999999999999999987654
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH--hhc-----------
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSC----------- 687 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~--~~~----------- 687 (816)
... ......+++.|+|||++.+. .++.++||||||+++|+|++|.+||......... +..
T Consensus 159 ~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 159 PLK------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred Ccc------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence 321 12334578899999988654 4689999999999999999999999643321110 000
Q ss_pred ----------CccccccC-CCCCCCCHH-HHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 688 ----------GKLSSILD-PLAGDWPTF-VARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 688 ----------~~~~~~~d-~~~~~~~~~-~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
........ .....++.. .+..+.+|+.+||+.+|++||++.+.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000 001112222 4678899999999999999999986553
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=298.87 Aligned_cols=247 Identities=26% Similarity=0.328 Sum_probs=197.7
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC-----cccHHHHHHHHHHHhcCCCCceeeEeccccC----Cc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-----MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AW 538 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~ 538 (816)
.+|.+.+.||+|+||.||+|.+. +..||+|.+.... ......+.+|+.++++++||||+++++++.+ ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999874 7899999875431 1233468899999999999999999998743 36
Q ss_pred cceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccccee
Q 003481 539 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 539 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 618 (816)
++|+||+++++|.+++.... .+++..+..|+.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 78999999999999986543 4788999999999999999999988 99999999999999999999999999986
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCC
Q 003481 619 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLA 698 (816)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~ 698 (816)
....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||............. ..+..
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----~~~~~ 227 (264)
T cd06653 156 IQTICMS---GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA-----TQPTK 227 (264)
T ss_pred ccccccc---CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH-----cCCCC
Confidence 5432110 011233568999999999988889999999999999999999999997544332221111 11122
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 699 GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 699 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
...|...+..+.+++.+||. +|..||+..+.+
T Consensus 228 ~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~ 259 (264)
T cd06653 228 PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLL 259 (264)
T ss_pred CCCCcccCHHHHHHHHHHhc-CcccCccHHHHh
Confidence 33566677889999999999 579999998544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=312.47 Aligned_cols=252 Identities=21% Similarity=0.264 Sum_probs=195.9
Q ss_pred HhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCceeeEeccccC-------
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE------- 536 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------- 536 (816)
..++|...+.||+|+||.||+|... +..||||.+.... ......+.+|+.++.+++||||++++++|..
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999875 8899999986432 2334567789999999999999999998732
Q ss_pred -CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccc
Q 003481 537 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 615 (816)
Q Consensus 537 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 615 (816)
..++||||+. ++|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 3589999995 578877743 2788899999999999999999987 99999999999999999999999999
Q ss_pred ceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH--h-h-cC---
Q 003481 616 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--V-S-CG--- 688 (816)
Q Consensus 616 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~--~-~-~~--- 688 (816)
++...... ......+++.|+|||++.+..++.++|||||||++|+|++|+.||...+..... + . .+
T Consensus 165 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 165 ARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237 (353)
T ss_pred ceeCCCCC-------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 98764332 123346889999999999999999999999999999999999999643321110 0 0 00
Q ss_pred ------------------c------cccccC----CC-CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 689 ------------------K------LSSILD----PL-AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 689 ------------------~------~~~~~d----~~-~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
. +..++. +. ....+...+..+.+|+.+||+.||.+||++.++|.+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~ 313 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPY 313 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChh
Confidence 0 000000 00 00012234667899999999999999999998776654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=331.43 Aligned_cols=247 Identities=28% Similarity=0.334 Sum_probs=201.5
Q ss_pred HHHHHHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC
Q 003481 462 LADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE 536 (816)
Q Consensus 462 ~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 536 (816)
+.+++.-..+|.+.+.||+|+||.|..++.. ++.||+|++++..+ ....-|..|-++|..-+.+.|++|+.+|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3455555678899999999999999999886 78899999987543 334568999999999999999999999965
Q ss_pred --CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecc
Q 003481 537 --AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 614 (816)
Q Consensus 537 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 614 (816)
++|+||+||+||+|-.+|.+.. ++++..+..++..|..||.-||+.| +|||||||+|||||.+|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 5899999999999999997654 6888999999999999999999998 9999999999999999999999999
Q ss_pred cceeccCCCCcCCCccccCCCCCCCCCCCccccc----c-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCc
Q 003481 615 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR----T-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGK 689 (816)
Q Consensus 615 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~ 689 (816)
.|-.+..+.. -.....+|||.|++||++. + +.|++.+|+||+||++|||+.|..||....-+..+ |+
T Consensus 221 sClkm~~dG~-----V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY---~K 292 (1317)
T KOG0612|consen 221 SCLKMDADGT-----VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY---GK 292 (1317)
T ss_pred hHHhcCCCCc-----EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH---HH
Confidence 9988875442 2457789999999999885 2 57999999999999999999999999644333222 11
Q ss_pred cccccCC-CCCCCC--HHHHHHHHHHHHHhhccCCCCCCC
Q 003481 690 LSSILDP-LAGDWP--TFVARRLVDLGLQCCELYGRERPD 726 (816)
Q Consensus 690 ~~~~~d~-~~~~~~--~~~~~~l~~Li~~cl~~dP~~RPs 726 (816)
+++. ..-.|| ..++....+||.+.+. +|..|-.
T Consensus 293 ---Im~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLg 328 (1317)
T KOG0612|consen 293 ---IMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLG 328 (1317)
T ss_pred ---HhchhhhcCCCcccccCHHHHHHHHHHhc-Chhhhcc
Confidence 1111 112334 3478889999988776 5777776
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=342.04 Aligned_cols=257 Identities=26% Similarity=0.326 Sum_probs=207.7
Q ss_pred HHHHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCCceeeEeccc--cCC
Q 003481 464 DLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGAC--PEA 537 (816)
Q Consensus 464 el~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~ 537 (816)
-+...+-+|.....||.|.||.||.|... |...|+|-+...... ....+.+|+.+|..|+|||+|++||+- .+.
T Consensus 1229 ~lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1229 SLSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred HhccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH
Confidence 45667788999999999999999999875 888999987655433 334578999999999999999999985 456
Q ss_pred ccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccce
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 617 (816)
.+|.||||.+|+|.+.+.... -.++.....+..|++.||.|||++| ||||||||.||||+.+|.+|++|||.|.
T Consensus 1309 v~IFMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeeccccee
Confidence 899999999999999886543 2445556677899999999999998 9999999999999999999999999999
Q ss_pred eccCCCCcCCCccccCCCCCCCCCCCccccccC---CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHH---HhhcCccc
Q 003481 618 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG---VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVSCGKLS 691 (816)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~---~~~~~~~~ 691 (816)
.+.......+ ..-....||+.|||||++.+. ...-+.||||||||++||+||+.||...+.-+. .+..|..
T Consensus 1383 ki~~~~~~~~--~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~- 1459 (1509)
T KOG4645|consen 1383 KIKNNAQTMP--GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK- 1459 (1509)
T ss_pred EecCchhcCC--HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC-
Confidence 8876542222 223467899999999998643 456799999999999999999999974443222 2333333
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 692 SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 692 ~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
+++|...+..-.+++..||..||+.|.++.|.+.+.+-
T Consensus 1460 -------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1460 -------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred -------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcc
Confidence 34577788999999999999999999888766655543
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=295.59 Aligned_cols=239 Identities=27% Similarity=0.314 Sum_probs=200.0
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHH---HHHHHHHHHhcCCCCceeeEeccc--cCCcccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL---EFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~---~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~ 542 (816)
++|...+.||+|.||.|.+++-. ++.+|||++++.-..... .-..|-++|...+||.+..|-..| .+.+|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 67888899999999999999875 899999999887654444 356789999999999999987777 45699999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
||..||.|.-+|.+.. .+++....-+-.+|+.||.|||+.+ ||.||||.+|+|||.+|++||+|||+++.--..
T Consensus 248 eyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 248 EYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccc
Confidence 9999999999987754 4666777778999999999999988 999999999999999999999999999864332
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 702 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~ 702 (816)
. ......+|||.|+|||++....|+.++|+|.+||++|||++|+.||...+. +++.+++-.....+|
T Consensus 322 g------~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-------~kLFeLIl~ed~kFP 388 (516)
T KOG0690|consen 322 G------DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-------EKLFELILMEDLKFP 388 (516)
T ss_pred c------ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch-------hHHHHHHHhhhccCC
Confidence 2 235678999999999999999999999999999999999999999964443 122222222223567
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCC
Q 003481 703 TFVARRLVDLGLQCCELYGRERPDI 727 (816)
Q Consensus 703 ~~~~~~l~~Li~~cl~~dP~~RPs~ 727 (816)
...+++...|+...|..||.+|-.-
T Consensus 389 r~ls~eAktLLsGLL~kdP~kRLGg 413 (516)
T KOG0690|consen 389 RTLSPEAKTLLSGLLKKDPKKRLGG 413 (516)
T ss_pred ccCCHHHHHHHHHHhhcChHhhcCC
Confidence 7788899999999999999999643
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=304.92 Aligned_cols=258 Identities=18% Similarity=0.212 Sum_probs=194.7
Q ss_pred ccceeeeecceEEEEEEEcCeEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeeccCCCc
Q 003481 474 ESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPNGS 549 (816)
Q Consensus 474 ~~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~~gs 549 (816)
+.+.+|.|+++.||++...+..||||++.... ......+.+|+.+++.++||||+++++++. +..+++|||+++|+
T Consensus 6 i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 33445666777777777789999999997652 334467899999999999999999999884 35889999999999
Q ss_pred hhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc-CCC
Q 003481 550 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY-LPS 628 (816)
Q Consensus 550 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~ 628 (816)
|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||.+......... ...
T Consensus 86 l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 9999876532 35888999999999999999999988 999999999999999999999999998765432211 001
Q ss_pred ccccCCCCCCCCCCCcccccc--CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhh--cCccccccC---------
Q 003481 629 FHRSTAPKGSFPYADPEYHRT--GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS--CGKLSSILD--------- 695 (816)
Q Consensus 629 ~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~--~~~~~~~~d--------- 695 (816)
........++..|+|||++.. ..++.++|||||||++|+|++|..||........... .+.....++
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED 241 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence 111234557889999999865 3588999999999999999999999975443222211 111111110
Q ss_pred -----------C-----CCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 696 -----------P-----LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 696 -----------~-----~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
+ .....+...+..+.+|+.+||..||.+||++.+.+.+.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 0 011223345678999999999999999999997665444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=296.55 Aligned_cols=232 Identities=26% Similarity=0.345 Sum_probs=191.3
Q ss_pred eeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccCCCch
Q 003481 478 VGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSL 550 (816)
Q Consensus 478 LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL 550 (816)
||.|+||.||++++. +..||+|++..... .....+.+|+.+++.++||||+++++++.+ ..++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999997 88999999875433 234568999999999999999999998843 48899999999999
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCcc
Q 003481 551 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 630 (816)
Q Consensus 551 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 630 (816)
.+++.+.. .+++..+..++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------- 147 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------- 147 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------
Confidence 99996643 4888999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChH--H--HHHHhhcCccccccCCCCCCCCHHHH
Q 003481 631 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--E--VRRAVSCGKLSSILDPLAGDWPTFVA 706 (816)
Q Consensus 631 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~--~--~~~~~~~~~~~~~~d~~~~~~~~~~~ 706 (816)
......|++.|++||.+....++.++|+||||+++|+|++|..||.... . ....+..+ .....+|...+
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 220 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG-------NGKLEFPNYID 220 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhcc-------CCCCCCCcccC
Confidence 1233468899999999988889999999999999999999999997544 1 11111111 11223344446
Q ss_pred HHHHHHHHHhhccCCCCCCCChH
Q 003481 707 RRLVDLGLQCCELYGRERPDITP 729 (816)
Q Consensus 707 ~~l~~Li~~cl~~dP~~RPs~~e 729 (816)
..+.+++.+||+.+|.+||++.+
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~ 243 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLK 243 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcc
Confidence 78999999999999999999643
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=309.20 Aligned_cols=256 Identities=21% Similarity=0.301 Sum_probs=193.4
Q ss_pred HhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEeccccC-------C
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------A 537 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------~ 537 (816)
.+++|.+.+.||+|+||.||+|.+. |..||||.+..... .....+.+|+.++.+++||||+++++++.. .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3568999999999999999999875 78999999864322 234567889999999999999999987632 3
Q ss_pred ccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccce
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 617 (816)
.++|+||+. ++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~-~~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEEehhcc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 689999996 477777643 35899999999999999999999988 9999999999999999999999999998
Q ss_pred eccCCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH------hhc---
Q 003481 618 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA------VSC--- 687 (816)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~------~~~--- 687 (816)
......... .......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...+..... +..
T Consensus 155 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHT---GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQ 231 (336)
T ss_pred ecccccccc---CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 764432111 11234568999999998654 56899999999999999999999999643221100 000
Q ss_pred CccccccCC----------C--CCCC---CHHHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 688 GKLSSILDP----------L--AGDW---PTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 688 ~~~~~~~d~----------~--~~~~---~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
..+..+.+. . ...+ ....+..+.+|+.+||+.+|.+||++.+.+.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp 293 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHP 293 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 000000000 0 0000 112356789999999999999999999666543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=303.93 Aligned_cols=242 Identities=25% Similarity=0.347 Sum_probs=191.7
Q ss_pred CCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc---cHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeec
Q 003481 472 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 544 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 544 (816)
|...+.||+|+||.||+|++. +..||+|.+...... ....+.+|+.++++++|||+++++++|.+ ..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667788999999999999874 789999998754322 23468899999999999999999999843 47899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+. |+|.+.+.... .+++|..+..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~-g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 107 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 96 47777775443 45899999999999999999999988 999999999999999999999999998654321
Q ss_pred cCCCccccCCCCCCCCCCCccccc---cCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHH--HHhhcCccccccCCCCC
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAG 699 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~--~~~~~~~~~~~~d~~~~ 699 (816)
....|++.|+|||++. .+.++.++|||||||++|+|++|+.||....... ..+..+... .
T Consensus 179 --------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~-------~ 243 (317)
T cd06635 179 --------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP-------T 243 (317)
T ss_pred --------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCC-------C
Confidence 2346889999999873 4578999999999999999999999986443221 111111111 0
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 700 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 700 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
..+...+..+.+|+.+||+.+|.+||++.+.+.+.+.
T Consensus 244 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 1122345679999999999999999999965554443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=292.14 Aligned_cols=243 Identities=27% Similarity=0.405 Sum_probs=200.6
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeec
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 544 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 544 (816)
+|.....||+|++|.||++... +..|++|.+..... .....+.+|++++.+++|||++++++++.+ ..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778889999999999999875 78899999977654 344578999999999999999999998843 47899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998655 36899999999999999999999987 99999999999999999999999999987765432
Q ss_pred cCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHH
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTF 704 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 704 (816)
. .....++..|+|||.+.+..++.++||||||+++|+|++|..||.............. ......+..
T Consensus 155 ~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~ 222 (254)
T cd06627 155 D------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ------DDHPPLPEG 222 (254)
T ss_pred c------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc------cCCCCCCCC
Confidence 1 2345688999999999888889999999999999999999999975443322222110 111223444
Q ss_pred HHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 705 VARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 705 ~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
.+..+.+++.+||..+|++||++.+.+
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l 249 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQLL 249 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHHh
Confidence 567899999999999999999998544
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=302.60 Aligned_cols=253 Identities=23% Similarity=0.273 Sum_probs=190.9
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 543 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 543 (816)
++|.....||.|++|.||+|.+. |+.||+|.+..... .....+.+|+.++++++||||+++++++.+ ..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999875 78999999865432 223568899999999999999999999843 5889999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecC-CCCeeEeecccceeccCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-ELSSKICDFGICRLVTED 622 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~~~~~ 622 (816)
|++ ++|.+++..... ..+++..+..++.||+.||.|||+.+ |+|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 995 578777754432 34678888999999999999999987 999999999999985 557999999999765432
Q ss_pred CCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhc----Cc-ccccc--
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----GK-LSSIL-- 694 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~----~~-~~~~~-- 694 (816)
.. ......+++.|+|||++.+ ..++.++|||||||++|+|+||.+||............ +. .....
T Consensus 157 ~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 157 VR------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred cc------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 21 1233467899999998865 45789999999999999999999999644322111100 00 00000
Q ss_pred -----C----------CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 695 -----D----------PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 695 -----d----------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
+ ..........+..+.+++.+||+.+|.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00000112345678999999999999999999966543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=305.10 Aligned_cols=244 Identities=22% Similarity=0.317 Sum_probs=184.4
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCccc---HHHHHHHHHHHhcCCCCceeeEeccccC--Cccceee
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 543 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 543 (816)
-|..++.||-|+||.|-+++.. ...||+|.|.+.+.-. ...+..|.+||....++.||+||..|.+ .+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 4667788999999999998653 6679999998765432 2357789999999999999999999954 5999999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC-
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED- 622 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~- 622 (816)
|++||++..+|.+.+ .+.+..+..++.++..|+++.|..| +|||||||+|||||.+|++||+|||||.-+...
T Consensus 710 YIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred ccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999998876 4667778888999999999999998 999999999999999999999999999754321
Q ss_pred -C-CcCCCc---------------------------------cccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHH
Q 003481 623 -T-LYLPSF---------------------------------HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQ 667 (816)
Q Consensus 623 -~-~~~~~~---------------------------------~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~e 667 (816)
. .+-... ......+||+.|+|||++....|+..+|+||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 1 000000 00114579999999999999999999999999999999
Q ss_pred HHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHH-hhccCCCCCC
Q 003481 668 LLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQ-CCELYGRERP 725 (816)
Q Consensus 668 lltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~-cl~~dP~~RP 725 (816)
|+.|++||.............++...++- .+....+.+..+||.+ |+. ++.|-
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~---~~~~~ls~e~~~li~kLc~s--ad~RL 917 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWRNFLHI---PYQGNLSKEALDLIQKLCCS--ADSRL 917 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehhhcccc---ccccccCHHHHHHHHHHhcC--hhhhh
Confidence 99999999643322222222223333332 1223345566666655 444 34454
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=301.26 Aligned_cols=256 Identities=21% Similarity=0.280 Sum_probs=181.2
Q ss_pred cCCCccceeeeecceEEEEEEEcC-----eEEEEEEeccCCcccH-----------HHHHHHHHHHhcCCCCceeeEecc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEMLG-----RTVAIKMLYSHNMQGQ-----------LEFQQEVRVLSKLQHPHLVTLLGA 533 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~g-----~~vAiK~l~~~~~~~~-----------~~~~~E~~il~~l~HpnIv~l~g~ 533 (816)
+.|.+.+.||+|+||.||+|.+.+ ..+|+|+......... .....+...+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 579999999999999999998753 3567776433322111 012234455667799999999987
Q ss_pred ccCC------ccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCC
Q 003481 534 CPEA------WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS 607 (816)
Q Consensus 534 ~~~~------~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~ 607 (816)
+... .+++++++. .++.+.+... ...++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 6322 356777763 3566655432 23578889999999999999999987 999999999999999999
Q ss_pred eeEeecccceeccCCCCcCC-CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH---HHH
Q 003481 608 SKICDFGICRLVTEDTLYLP-SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE---VRR 683 (816)
Q Consensus 608 vkL~DFGla~~~~~~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~---~~~ 683 (816)
++|+|||+|+.+........ .........||+.|+|||++.+..++.++|||||||+||||++|+.||..... ...
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 99999999987643221110 01112345699999999999999999999999999999999999999964421 111
Q ss_pred HhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 684 AVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 684 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
....+.+..+..+.. . ....+..+.+++..|+..+|.+||++. .|.+.|
T Consensus 245 ~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~rp~~~-~l~~~~ 293 (294)
T PHA02882 245 AAKCDFIKRLHEGKI-K-IKNANKFIYDFIECVTKLSYEEKPDYD-ALIKIF 293 (294)
T ss_pred HhHHHHHHHhhhhhh-c-cCCCCHHHHHHHHHHHhCCCCCCCCHH-HHHHhh
Confidence 111111111111100 0 112356799999999999999999998 565544
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=301.51 Aligned_cols=241 Identities=22% Similarity=0.338 Sum_probs=194.0
Q ss_pred ceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeeccCCCchh
Q 003481 476 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPNGSLQ 551 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~~gsL~ 551 (816)
.+||+|+||.||++... +..||||.+..........+.+|+.+++.++||||+++++++. +..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 56999999999999884 7899999986555455567899999999999999999999873 4689999999999999
Q ss_pred hhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCccc
Q 003481 552 DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 631 (816)
Q Consensus 552 ~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 631 (816)
+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........ .
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~------~ 172 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP------R 172 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc------c
Confidence 97743 24789999999999999999999987 99999999999999999999999999876543221 1
Q ss_pred cCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHH--HHhhcCccccccCCCCCCCCHHHHHHH
Q 003481 632 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDWPTFVARRL 709 (816)
Q Consensus 632 ~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~--~~~~~~~~~~~~d~~~~~~~~~~~~~l 709 (816)
.....|++.|+|||++.+..++.++||||||+++|+|++|..||....... ..+..+ +. +... .....+..+
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~----~~~~-~~~~~~~~l 246 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-LP----PKLK-NLHKVSPSL 246 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-CC----cccC-CcccCCHHH
Confidence 234568899999999988889999999999999999999999996543321 111111 11 1111 112245678
Q ss_pred HHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 710 VDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 710 ~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
.+++.+||+.+|.+||++.+.+.+.+
T Consensus 247 ~~li~~~l~~~P~~R~~~~~ll~~~~ 272 (292)
T cd06657 247 KGFLDRLLVRDPAQRATAAELLKHPF 272 (292)
T ss_pred HHHHHHHHhCCcccCcCHHHHhcChH
Confidence 89999999999999999997665443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=305.63 Aligned_cols=200 Identities=25% Similarity=0.298 Sum_probs=164.2
Q ss_pred CCCccceeeeecceEEEEEEE----cCeEEEEEEeccCC---cccHHHHHHHHHHHhcCCCCceeeEeccccC----Ccc
Q 003481 471 NFSESFKVGQGGFGCVYKGEM----LGRTVAIKMLYSHN---MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWS 539 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~----~g~~vAiK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~ 539 (816)
.|.....||+|+||.||+|.. .+..||+|.+.... ......+.+|+.++..++||||++++++|.+ ..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 477888999999999999988 46899999997743 2334567889999999999999999999843 478
Q ss_pred ceeeccCCCchhhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecC----CCCeeEeec
Q 003481 540 LVYEYLPNGSLQDRLFRKS--NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS----ELSSKICDF 613 (816)
Q Consensus 540 lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~----~~~vkL~DF 613 (816)
+||||+++ +|.+.+.... ....+++..++.|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 6666664332 1236889999999999999999999987 999999999999999 899999999
Q ss_pred ccceeccCCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCC
Q 003481 614 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGL 677 (816)
Q Consensus 614 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~ 677 (816)
|++......... ........+++.|+|||++.+ ..++.++|||||||++|+|++|++||..
T Consensus 157 g~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 218 (316)
T cd07842 157 GLARLFNAPLKP---LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218 (316)
T ss_pred ccccccCCCccc---ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 999876443211 112344568899999998765 4588999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=303.48 Aligned_cols=253 Identities=23% Similarity=0.304 Sum_probs=193.3
Q ss_pred hcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCccc--HHHHHHHHHHHhcCCCCceeeEeccccC----Cccc
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSL 540 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~l 540 (816)
.++|...+.||.|+||.||+|.+. |..||+|.+....... ...+.+|+.++.+++|+||+++++++.+ ..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357889999999999999999885 8899999986543222 2346689999999999999999998742 3789
Q ss_pred eeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceecc
Q 003481 541 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 620 (816)
Q Consensus 541 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 620 (816)
||||+. ++|.+++.... ..+++..++.++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 47888876543 46899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH--hhc--C----ccc
Q 003481 621 EDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSC--G----KLS 691 (816)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~--~~~--~----~~~ 691 (816)
.... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|++||...+..... +.. + ...
T Consensus 160 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07845 160 LPAK------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW 233 (309)
T ss_pred CccC------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 4321 1233346888999998865 46789999999999999999999999644432111 110 0 000
Q ss_pred ---------cccCCCCCCC------CHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 692 ---------SILDPLAGDW------PTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 692 ---------~~~d~~~~~~------~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
..+.-....+ ....+..+.+||.+||+.||.+||++.+.+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000 01236678899999999999999999965543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=299.35 Aligned_cols=247 Identities=24% Similarity=0.300 Sum_probs=187.4
Q ss_pred CCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCC-CCceeeEecccc----CCccceee
Q 003481 472 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQ-HPHLVTLLGACP----EAWSLVYE 543 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~g~~~----~~~~lV~E 543 (816)
|...+.||+|+||.||+|... +..||+|.+..... .......+|+.++.++. ||||+++++++. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 566788999999999999874 78999999875432 22234557899999885 999999999884 34789999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
|+. |+|.+.+.... ..++|..++.++.|++.||.|||+.+ ++||||+|+||+++. +.+||+|||++.......
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 996 57777775543 46899999999999999999999987 999999999999999 999999999998764332
Q ss_pred CcCCCccccCCCCCCCCCCCccccc-cCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHH--Hhh--cC----------
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHR-TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVS--CG---------- 688 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~--~~~--~~---------- 688 (816)
. .....++..|+|||++. ++.++.++|||||||++|+|++|.+||...+.... .+. .+
T Consensus 154 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 154 P-------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred C-------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 1 12345789999999764 45678999999999999999999999964432111 000 00
Q ss_pred ---ccccccCCC-C----CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 689 ---KLSSILDPL-A----GDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 689 ---~~~~~~d~~-~----~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
.......+. . .......+..+.+|+.+||+.+|.+||++.+.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000 0 0011235678999999999999999999986543
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=308.90 Aligned_cols=257 Identities=19% Similarity=0.262 Sum_probs=196.5
Q ss_pred hcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEecccc------CCc
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP------EAW 538 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~------~~~ 538 (816)
..+|...+.||.|+||.||+|... |..||+|++..... .....+.+|+.+|.+++||||++++++|. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 468999999999999999999875 88999999875432 33456778999999999999999998873 236
Q ss_pred cceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccccee
Q 003481 539 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 539 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 618 (816)
++||||+. |+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 89999995 68988886443 4899999999999999999999987 99999999999999999999999999987
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH-------------
Q 003481 619 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA------------- 684 (816)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~------------- 684 (816)
....... .........|+..|+|||.+.. ..++.++|||||||++|+|++|+.||...+.....
T Consensus 157 ~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 157 LSSSPTE--HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred ecccCcC--CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 6543211 1111234578999999998765 46899999999999999999999999643321110
Q ss_pred ----hhcCccccccCC--CCCCC-----CHHHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 685 ----VSCGKLSSILDP--LAGDW-----PTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 685 ----~~~~~~~~~~d~--~~~~~-----~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
.....+....+. ..... ....+..+.+++.+||+.+|.+||++.+.+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~ 295 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP 295 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence 000001100000 00011 123467899999999999999999999666543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=300.51 Aligned_cols=231 Identities=25% Similarity=0.347 Sum_probs=179.1
Q ss_pred eeeeecceEEEEEEEc--CeEEEEEEeccCCcc---cHHHHHHHHHHHh---cCCCCceeeEecccc--CCccceeeccC
Q 003481 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLS---KLQHPHLVTLLGACP--EAWSLVYEYLP 546 (816)
Q Consensus 477 ~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~---~~~~~~~E~~il~---~l~HpnIv~l~g~~~--~~~~lV~E~~~ 546 (816)
.||+|+||.||++... +..||+|.+...... ....+.+|..++. ..+||||+.+++++. +..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999875 789999998654322 1223445544433 347999999998874 45889999999
Q ss_pred CCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcC
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626 (816)
Q Consensus 547 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 626 (816)
+|+|.+++.... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999999886543 5899999999999999999999988 9999999999999999999999999987654321
Q ss_pred CCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHH-HHHHhhcCccccccCCCCCCCCHH
Q 003481 627 PSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGE-VRRAVSCGKLSSILDPLAGDWPTF 704 (816)
Q Consensus 627 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~-~~~~~~~~~~~~~~d~~~~~~~~~ 704 (816)
.....||+.|+|||.+.+ ..++.++|||||||++|+|++|..||..... ....+..... ......+..
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~~~ 221 (279)
T cd05633 152 -----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-----TVNVELPDS 221 (279)
T ss_pred -----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh-----cCCcCCccc
Confidence 123468999999998864 5689999999999999999999999963221 1111111110 111223445
Q ss_pred HHHHHHHHHHHhhccCCCCCCC
Q 003481 705 VARRLVDLGLQCCELYGRERPD 726 (816)
Q Consensus 705 ~~~~l~~Li~~cl~~dP~~RPs 726 (816)
.+..+.+++.+||+.||.+||+
T Consensus 222 ~~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 222 FSPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred cCHHHHHHHHHHhcCCHHHhcC
Confidence 6678999999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=302.75 Aligned_cols=248 Identities=22% Similarity=0.328 Sum_probs=191.2
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCC-CCceeeEeccccC--Cccceee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQ-HPHLVTLLGACPE--AWSLVYE 543 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~--~~~lV~E 543 (816)
++|...+.||.|+||.||+|.+. +..||||.+..... .....+..|+.++.++. ||||++++++|.+ ..++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 56788899999999999999987 88999999976433 23445677887777774 9999999999844 5889999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
|+. ++|.+++.... ..+++..+..++.|++.||.|||+.. +|+||||+|+||+++.++.+||+|||++..+....
T Consensus 95 ~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 985 57777665533 36899999999999999999999742 39999999999999999999999999987654322
Q ss_pred CcCCCccccCCCCCCCCCCCccccccCC----CCcchhHhHHHHHHHHHHhCCCCCCChHHHHH---HhhcCccccccCC
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTGV----LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVSCGKLSSILDP 696 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~---~~~~~~~~~~~d~ 696 (816)
......++..|+|||++.+.. ++.++||||||+++|+|++|+.||........ .+..+.....
T Consensus 170 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 239 (296)
T cd06618 170 -------AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL--- 239 (296)
T ss_pred -------cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC---
Confidence 123345788999999987543 78899999999999999999999965322111 1111111110
Q ss_pred CCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 697 LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 697 ~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
.....++..+.+|+.+||+.||.+||++.+.+.+.+
T Consensus 240 ---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 240 ---PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 111124567999999999999999999997665554
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=318.62 Aligned_cols=248 Identities=29% Similarity=0.407 Sum_probs=195.9
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCceeeEeccccC--------Ccc
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--------AWS 539 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--------~~~ 539 (816)
.|.....||+||||.||+|+.. |+.||||.++... ....+...+|+++|++|+|||||++++.-++ ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 4556678999999999999975 9999999997754 3456678899999999999999999987533 357
Q ss_pred ceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEec--CCC--CeeEeeccc
Q 003481 540 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD--SEL--SSKICDFGI 615 (816)
Q Consensus 540 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~--~~~--~vkL~DFGl 615 (816)
+|||||.||||...|....+...|++.+.+.++.+++.||.|||.++ |+||||||.||++- .+| ..||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999999888888999999999999999999999988 99999999999993 223 489999999
Q ss_pred ceeccCCCCcCCCccccCCCCCCCCCCCccccc-cCCCCcchhHhHHHHHHHHHHhCCCCCCChHH-------HHHHhhc
Q 003481 616 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR-TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE-------VRRAVSC 687 (816)
Q Consensus 616 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~-------~~~~~~~ 687 (816)
|+.+.++. .....+||..|++||.+. .+.|+..+|.|||||++|+++||..||..... .+..+..
T Consensus 171 Arel~d~s-------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tk 243 (732)
T KOG4250|consen 171 ARELDDNS-------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITK 243 (732)
T ss_pred cccCCCCC-------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhcc
Confidence 99988766 346788999999999988 48899999999999999999999999942211 1111100
Q ss_pred ---Ccccccc----CC--------CCCCCCHHHHHHHHHHHHHhhccCCCCCC--CCh
Q 003481 688 ---GKLSSIL----DP--------LAGDWPTFVARRLVDLGLQCCELYGRERP--DIT 728 (816)
Q Consensus 688 ---~~~~~~~----d~--------~~~~~~~~~~~~l~~Li~~cl~~dP~~RP--s~~ 728 (816)
+...... +| ............+-..+..+|..+|.+|. ...
T Consensus 244 kp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~ 301 (732)
T KOG4250|consen 244 KPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFD 301 (732)
T ss_pred CCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcc
Confidence 0000000 00 01112234455677788889999999998 444
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=327.62 Aligned_cols=261 Identities=16% Similarity=0.235 Sum_probs=183.8
Q ss_pred HHHhcCCCccceeeeecceEEEEEEEc---CeEEEEEEe--------------cc---CCcccHHHHHHHHHHHhcCCCC
Q 003481 466 QTATCNFSESFKVGQGGFGCVYKGEML---GRTVAIKML--------------YS---HNMQGQLEFQQEVRVLSKLQHP 525 (816)
Q Consensus 466 ~~~t~~f~~~~~LG~G~~g~Vy~~~~~---g~~vAiK~l--------------~~---~~~~~~~~~~~E~~il~~l~Hp 525 (816)
....++|.+...||+|+||.||++.+. +..+++|.+ .+ ........+.+|+.+|.+++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 345678999999999999999998764 222222211 00 1112234578999999999999
Q ss_pred ceeeEecccc--CCccceeeccCCCchhhhhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceE
Q 003481 526 HLVTLLGACP--EAWSLVYEYLPNGSLQDRLFRKSN--VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNIL 601 (816)
Q Consensus 526 nIv~l~g~~~--~~~~lV~E~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NIL 601 (816)
||+++++++. +..++|++++. ++|.+++..... ........+..|+.||+.||.|||+.+ |+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 9999999984 45789999985 567776654321 122345677889999999999999987 999999999999
Q ss_pred ecCCCCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCC-CCCCh--
Q 003481 602 LDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRL-PVGLA-- 678 (816)
Q Consensus 602 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~-Pf~~~-- 678 (816)
|+.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||+||||++|.. ||...
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~ 374 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREA-----FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGG 374 (501)
T ss_pred ECCCCCEEEEeCCCceecCccccc-----ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCC
Confidence 999999999999999877543211 2234579999999999999999999999999999999999875 44311
Q ss_pred ---HHHHHHhhcC-----ccc-------cccCC-----CCCCCCH-----HHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 679 ---GEVRRAVSCG-----KLS-------SILDP-----LAGDWPT-----FVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 679 ---~~~~~~~~~~-----~~~-------~~~d~-----~~~~~~~-----~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
......+..- .+. ..++. .....+. ..+..+.+++.+||+.||.+||++.+.|.+
T Consensus 375 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 375 KPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred CHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111111100 000 00000 0000111 123467888999999999999999976654
Q ss_pred HH
Q 003481 734 EL 735 (816)
Q Consensus 734 ~L 735 (816)
.+
T Consensus 455 p~ 456 (501)
T PHA03210 455 PL 456 (501)
T ss_pred hh
Confidence 43
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=307.08 Aligned_cols=258 Identities=24% Similarity=0.316 Sum_probs=195.3
Q ss_pred HhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccC--CcccHHHHHHHHHHHhcC-CCCceeeEeccccC----Cc
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSH--NMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE----AW 538 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~--~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~----~~ 538 (816)
..++|...+.||.|+||.||+|.+. +..||+|++... .......+..|+.++.++ +||||++++++|.. ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888899999999999999875 788999988543 223344677899999999 99999999998732 36
Q ss_pred cceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccccee
Q 003481 539 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 539 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 618 (816)
++||||++ ++|..++... .++|..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 89999997 5898887543 5789999999999999999999987 99999999999999999999999999987
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHH---Hhhc-Cc----
Q 003481 619 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVSC-GK---- 689 (816)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~---~~~~-~~---- 689 (816)
........ .........||+.|+|||++.+ ..++.++||||||+++|+|+||+.||........ .... +.
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 157 LSELEENP-ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred cccccccc-cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 65433110 0012234568999999998754 5678999999999999999999999964332111 0000 00
Q ss_pred ---------cccccC----C---CCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 690 ---------LSSILD----P---LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 690 ---------~~~~~d----~---~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
...+++ . .........+..+.+++.+||+.+|.+||++.+++.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~ 296 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP 296 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhCh
Confidence 000000 0 00111112467899999999999999999999777653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=308.84 Aligned_cols=259 Identities=23% Similarity=0.264 Sum_probs=198.4
Q ss_pred ccCHHHHHHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCceeeEeccc
Q 003481 459 EFSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534 (816)
Q Consensus 459 ~~~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~ 534 (816)
.....++..++++|...+.||+|+||.||+|.+. +..||+|++.... ......+.+|+.++.+++||||+++++++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 3456778889999999999999999999999864 8899999986532 22345678899999999999999999887
Q ss_pred cC--------CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCC
Q 003481 535 PE--------AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL 606 (816)
Q Consensus 535 ~~--------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~ 606 (816)
.. ..+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDC 157 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCC
Confidence 32 256777776 7899887753 24889999999999999999999988 99999999999999999
Q ss_pred CeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHH--
Q 003481 607 SSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR-- 683 (816)
Q Consensus 607 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~-- 683 (816)
.+||+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........
T Consensus 158 ~~kl~dfg~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 228 (345)
T cd07877 158 ELKILDFGLARHTDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 228 (345)
T ss_pred CEEEeccccccccccc---------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999998764322 234468899999998765 5688999999999999999999999964332111
Q ss_pred Hhhc--Cc--------------------cccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 684 AVSC--GK--------------------LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 684 ~~~~--~~--------------------~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
.+.. +. +.........+.....+..+.+|+.+||+.||.+||++.+.+.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 229 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred HHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 0000 00 000000000001112356789999999999999999998666554
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=295.92 Aligned_cols=247 Identities=21% Similarity=0.294 Sum_probs=189.7
Q ss_pred CHHHHHHHhcCCCcccee--eeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCceeeEeccc-
Q 003481 461 SLADLQTATCNFSESFKV--GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGAC- 534 (816)
Q Consensus 461 ~~~el~~~t~~f~~~~~L--G~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~- 534 (816)
++.++....++|.+.+.+ |.|+||.||++... +..+|+|.+........ |+.+...+ +||||++++++|
T Consensus 5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEe
Confidence 345556666778777776 99999999999875 78899999865432221 22222222 799999999988
Q ss_pred -cCCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCC-CeeEee
Q 003481 535 -PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICD 612 (816)
Q Consensus 535 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~D 612 (816)
.+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++ .++|+|
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 80 TLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred cCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEec
Confidence 345899999999999999986543 6899999999999999999999988 99999999999999998 999999
Q ss_pred cccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCcccc
Q 003481 613 FGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSS 692 (816)
Q Consensus 613 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~ 692 (816)
||++...... ....|+..|+|||++.+..++.++|||||||++|+|++|+.||......... ...+..
T Consensus 154 fg~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~--~~~~~~ 221 (267)
T PHA03390 154 YGLCKIIGTP----------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD--LESLLK 221 (267)
T ss_pred CccceecCCC----------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh--HHHHHH
Confidence 9998766432 2235889999999999889999999999999999999999999633211000 000000
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCC-hHHH
Q 003481 693 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDI-TPSL 731 (816)
Q Consensus 693 ~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~-~e~l 731 (816)
.. ......+...+..+.+++.+||+.+|.+||+. .+.+
T Consensus 222 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 222 RQ-QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred hh-cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 01 11112233567789999999999999999964 5433
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=297.28 Aligned_cols=249 Identities=25% Similarity=0.364 Sum_probs=191.4
Q ss_pred CCccceeeeecceEEEEEEEc--CeEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCceeeEecccc----CCccceee
Q 003481 472 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACP----EAWSLVYE 543 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~----~~~~lV~E 543 (816)
|.+.+.||.|+||.||+|... +..||+|++.... ......+.+|+.++.+++|||++++++++. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566788999999999999886 6899999998663 233456889999999999999999999984 34889999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
|+++ +|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9974 8888886543 36899999999999999999999987 9999999999999999999999999998765432
Q ss_pred CcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH---hhc-C-----ccccc
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VSC-G-----KLSSI 693 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~---~~~-~-----~~~~~ 693 (816)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|+||+.||......... ... + .+...
T Consensus 155 ~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 155 SA-----DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred cc-----cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence 10 1233457889999997754 46799999999999999999999999644322111 000 0 00000
Q ss_pred --------cCCCC-------CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 694 --------LDPLA-------GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 694 --------~d~~~-------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
..+.. ..+...++..+.+++.+||..+|.+||++.+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l 282 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQAL 282 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 00000 000111267889999999999999999998544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=296.55 Aligned_cols=249 Identities=24% Similarity=0.300 Sum_probs=195.1
Q ss_pred CCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeecc
Q 003481 472 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 545 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~ 545 (816)
|...+.||.|++|.||+|... +..+++|.+...... ....+.+|+.++++++||||+++++++. +..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 556778999999999999875 888999998765433 3456889999999999999999999884 4578999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
++ +|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 75 8888876643 46899999999999999999999988 99999999999999999999999999987754331
Q ss_pred CCCccccCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhc----Cc-----cccccC
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----GK-----LSSILD 695 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~----~~-----~~~~~d 695 (816)
......++..|+|||.+.+. .++.++||||||+++|+|+||+.||...+........ +. +....+
T Consensus 154 -----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 154 -----PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred -----cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence 12334588899999988776 7899999999999999999999999654432211100 00 000000
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 696 --------------PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 696 --------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
..........+..+.++|.+||+.||.+||++.+.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0001112345678999999999999999999996553
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=293.93 Aligned_cols=245 Identities=26% Similarity=0.382 Sum_probs=201.2
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeec
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 544 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 544 (816)
+|...+.||.|+||.||++.+. +..|++|++..... .....+.+|+++++.++|||++++++.+. +..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5778889999999999999986 88999999876544 44567889999999999999999998874 457899999
Q ss_pred cCCCchhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 545 LPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 545 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
+++++|.+++.... ....+++..+..|+.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999987642 1356899999999999999999999987 9999999999999999999999999998765432
Q ss_pred CcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCCCC
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDW 701 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~~~ 701 (816)
. ......|++.|+|||.+....++.++||||||+++|+|++|..||..... .......+. ....
T Consensus 158 ~------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--------~~~~ 223 (258)
T cd08215 158 D------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ--------YPPI 223 (258)
T ss_pred c------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC--------CCCC
Confidence 1 12344688999999999888899999999999999999999999965432 111111111 1122
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 702 PTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 702 ~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
+...+..+.+++.+||..+|.+||++.+.+.
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 3345568999999999999999999996553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=297.74 Aligned_cols=245 Identities=29% Similarity=0.372 Sum_probs=198.6
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCC-CCceeeEeccccC--Cccce
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQ-HPHLVTLLGACPE--AWSLV 541 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~--~~~lV 541 (816)
++|.....||.|+||.||+|... +..||+|++..... .....+..|+.++.+++ ||||+++++++.+ ..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999884 88999999876432 23456889999999998 9999999999844 58899
Q ss_pred eeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
|||+++++|.+++.... .+++..++.|+.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999997653 6999999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCcCC--------------CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhc
Q 003481 622 DTLYLP--------------SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC 687 (816)
Q Consensus 622 ~~~~~~--------------~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~ 687 (816)
...... .........++..|+|||.+....++.++||||||+++|+|++|+.||............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 331100 011223456789999999998888999999999999999999999999765432211110
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCC
Q 003481 688 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDI 727 (816)
Q Consensus 688 ~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~ 727 (816)
. .....++...+..+.+|+.+||+.+|.+||++
T Consensus 235 ~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 267 (280)
T cd05581 235 L-------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGV 267 (280)
T ss_pred H-------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCc
Confidence 0 11122344456789999999999999999999
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=308.98 Aligned_cols=254 Identities=22% Similarity=0.281 Sum_probs=195.6
Q ss_pred hcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCceeeEeccccC-------C
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------A 537 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------~ 537 (816)
.++|.....||.|+||.||+|... +..||||.+.... ......+.+|+.+++.++||||+++++++.. .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457899999999999999999875 8899999986532 2234467789999999999999999998732 3
Q ss_pred ccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccce
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 617 (816)
.++||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 689999995 6888887643 35899999999999999999999987 9999999999999999999999999998
Q ss_pred eccCCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH------------
Q 003481 618 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA------------ 684 (816)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~------------ 684 (816)
....... ......++..|+|||.+.. ..++.++|||||||++|+|++|++||...+.....
T Consensus 157 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (337)
T cd07858 157 TTSEKGD------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230 (337)
T ss_pred ccCCCcc------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 7644321 1234467889999998764 46899999999999999999999999643221100
Q ss_pred -----hhcCcccccc-------CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 685 -----VSCGKLSSIL-------DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 685 -----~~~~~~~~~~-------d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
+..+.....+ ++.........+..+.+|+.+||+.+|.+||++.+.+.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~ 293 (337)
T cd07858 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPY 293 (337)
T ss_pred HHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcc
Confidence 0000000000 00001111235678899999999999999999997665543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=291.41 Aligned_cols=242 Identities=27% Similarity=0.400 Sum_probs=199.3
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeec
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 544 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 544 (816)
+|.+.+.||.|+||.||++... +..+++|.+..... .....+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778889999999999999875 78899999876432 234467889999999999999999988743 58899999
Q ss_pred cCCCchhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 545 LPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 545 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
+++++|.+++.... ....+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999886632 2246899999999999999999999988 9999999999999999999999999998765431
Q ss_pred CcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCccccccCCCCCCC
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDW 701 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~~~ 701 (816)
.....+++.|++||.+.+..++.++|+||||+++|+|++|+.||...+.. ...+..+.. ...
T Consensus 158 --------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~ 221 (256)
T cd08530 158 --------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKY--------PPI 221 (256)
T ss_pred --------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC--------CCC
Confidence 12345889999999999889999999999999999999999999754432 222222222 223
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 702 PTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 702 ~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
+...+..+.+++.+||..+|.+||++.+.+
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l 251 (256)
T cd08530 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251 (256)
T ss_pred chhhCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 345667899999999999999999998654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=299.86 Aligned_cols=254 Identities=25% Similarity=0.357 Sum_probs=189.6
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCCceeeEeccccC---------
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE--------- 536 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~--------- 536 (816)
++|.....||+|+||.||+|... +..||||.+...... ....+.+|+.++++++||||++++++|..
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 47889999999999999999885 789999988654322 23356789999999999999999998732
Q ss_pred -CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccc
Q 003481 537 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 615 (816)
Q Consensus 537 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 615 (816)
..++||||+. ++|.+.+.... ..+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 2489999996 47888775543 35899999999999999999999987 99999999999999999999999999
Q ss_pred ceeccCCCCcCCCccccCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHH--Hhh--cCcc
Q 003481 616 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVS--CGKL 690 (816)
Q Consensus 616 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~--~~~--~~~~ 690 (816)
+.......... ........++..|+|||++.+. .++.++||||||+++|+|+||.+||........ .+. .+.+
T Consensus 166 ~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 166 ARAFSLSKNSK--PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred cccccCCcccC--CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 98764332110 0112344678899999987654 478899999999999999999999964432111 000 0111
Q ss_pred ccccCCC------------CCC---------CCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 691 SSILDPL------------AGD---------WPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 691 ~~~~d~~------------~~~---------~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
..-+-+. ... .+......+.+||.+||..||.+||++.+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l 305 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTAL 305 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHh
Confidence 0000000 000 0011235678999999999999999998554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=344.95 Aligned_cols=255 Identities=30% Similarity=0.462 Sum_probs=199.7
Q ss_pred cCHHHHHHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC-
Q 003481 460 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE- 536 (816)
Q Consensus 460 ~~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~- 536 (816)
+++.++ ...|.....||+|+||.||+|.+. +..||||.+...... ...|+.++++++|||||+++|+|.+
T Consensus 683 ~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 683 ITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred hhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 444444 345778889999999999999874 889999998643322 2346889999999999999999943
Q ss_pred -CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccc
Q 003481 537 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 615 (816)
Q Consensus 537 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 615 (816)
..++||||+++|+|.+++. .++|..+.+|+.|++.||.|||..+.++|+||||||+||+++.++.+++. ||.
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~ 828 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL 828 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence 5789999999999999994 38999999999999999999997654669999999999999999888876 665
Q ss_pred ceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCCh--------HHHHHHhhc
Q 003481 616 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLA--------GEVRRAVSC 687 (816)
Q Consensus 616 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~--------~~~~~~~~~ 687 (816)
...... .....||+.|+|||++.+..++.++|||||||++|||+||+.||... .+.......
T Consensus 829 ~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 898 (968)
T PLN00113 829 PGLLCT----------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD 898 (968)
T ss_pred cccccc----------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc
Confidence 543321 12336889999999999999999999999999999999999998421 122222222
Q ss_pred CccccccCCCCC---CCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhh
Q 003481 688 GKLSSILDPLAG---DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 688 ~~~~~~~d~~~~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~ 739 (816)
......+|+... ..+......+.+++.+||+.+|.+||++. ++++.|+.+.
T Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~-evl~~L~~~~ 952 (968)
T PLN00113 899 CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAN-DVLKTLESAS 952 (968)
T ss_pred cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHH-HHHHHHHHhh
Confidence 333344454431 23445666889999999999999999999 6777787664
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=299.92 Aligned_cols=254 Identities=24% Similarity=0.328 Sum_probs=193.8
Q ss_pred HHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEeccccC------
Q 003481 467 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE------ 536 (816)
Q Consensus 467 ~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------ 536 (816)
...++|.+...||.|+||.||+|.+. |..||+|++..... .....+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999985 78999999875432 233467789999999999999999998743
Q ss_pred ------CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeE
Q 003481 537 ------AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI 610 (816)
Q Consensus 537 ------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL 610 (816)
..++|+||+++ +|.+.+... ...+++..+..|+.||+.||.|||+.+ |+|+||||+||+++.++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 46899999976 676766543 246899999999999999999999988 999999999999999999999
Q ss_pred eecccceeccCCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH--hh-
Q 003481 611 CDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VS- 686 (816)
Q Consensus 611 ~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~--~~- 686 (816)
+|||++......... ......++..|+|||++.+ ..++.++|||||||++|+|++|++||......... +.
T Consensus 158 ~dfg~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 158 ADFGLARLYNSEESR-----PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred CcccccccccCCccc-----ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 999999876543310 1123356788999998754 45789999999999999999999999754432211 00
Q ss_pred --cCcc----ccc--------cCCCC------CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 687 --CGKL----SSI--------LDPLA------GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 687 --~~~~----~~~--------~d~~~------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
.+.. ..+ .++.. .......+..+.+++.+||+.+|.+||++.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il 297 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEAL 297 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 0000 000 00000 000112457899999999999999999998544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=307.99 Aligned_cols=253 Identities=22% Similarity=0.280 Sum_probs=194.8
Q ss_pred HHHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEeccccC----
Q 003481 465 LQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE---- 536 (816)
Q Consensus 465 l~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---- 536 (816)
+...+++|...+.||+|+||.||++... +..||||++..... .....+.+|+.+|.+++||||+++++++..
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 3446788999999999999999999875 88999999864322 223467899999999999999999998742
Q ss_pred ----CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEee
Q 003481 537 ----AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICD 612 (816)
Q Consensus 537 ----~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~D 612 (816)
..++||+|+ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d 161 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD 161 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence 247999999 7789888753 35899999999999999999999988 99999999999999999999999
Q ss_pred cccceeccCCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHh---hc-
Q 003481 613 FGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV---SC- 687 (816)
Q Consensus 613 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~---~~- 687 (816)
||++...... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.......... ..
T Consensus 162 fg~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~ 232 (343)
T cd07880 162 FGLARQTDSE---------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT 232 (343)
T ss_pred cccccccccC---------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 9998765432 133467899999998865 458899999999999999999999997543221110 00
Q ss_pred -------------CccccccCCC-------CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 688 -------------GKLSSILDPL-------AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 688 -------------~~~~~~~d~~-------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
.......... ........+..+.+++.+||+.||.+||++.+.+.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~ 299 (343)
T cd07880 233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHP 299 (343)
T ss_pred CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 0000000000 0011123455789999999999999999999655443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=310.28 Aligned_cols=251 Identities=28% Similarity=0.417 Sum_probs=209.4
Q ss_pred HHHHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCCceeeEecccc--CC
Q 003481 464 DLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACP--EA 537 (816)
Q Consensus 464 el~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~ 537 (816)
+...-.+.|.+..+||+|.|+.|.+++.. +..||||.+.+.... ....+.+|+++|..|+|||||+++.+.. ..
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 33455678999999999999999999885 899999999876543 2345889999999999999999999874 56
Q ss_pred ccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccce
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 617 (816)
+|+||||+.+|.+.++|.+.+. +.......++.|+.+|++|||+.+ |||||||++||||+.+.++||+|||++.
T Consensus 130 lylV~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFST 203 (596)
T ss_pred eEEEEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccce
Confidence 9999999999999999988764 445788899999999999999988 9999999999999999999999999999
Q ss_pred eccCCCCcCCCccccCCCCCCCCCCCccccccCCC-CcchhHhHHHHHHHHHHhCCCCCCChH--HHHHHhhcCcccccc
Q 003481 618 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL-TPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSIL 694 (816)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGviL~elltG~~Pf~~~~--~~~~~~~~~~~~~~~ 694 (816)
.+..+. .....+|++.|.|||++.+..| ++.+|+||+|++||-|+.|..||.+.. ........|++
T Consensus 204 ~~~~~~-------~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~---- 272 (596)
T KOG0586|consen 204 FFDYGL-------MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY---- 272 (596)
T ss_pred eecccc-------cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee----
Confidence 887544 3466789999999999998876 589999999999999999999997332 22222222222
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 695 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 695 d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
..|-.++.++.+|+.++|-++|.+|+++.+...+..-
T Consensus 273 -----rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 273 -----RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred -----cccceeechhHHHHHHhhccCccccCCHHHhhhhccc
Confidence 2345567789999999999999999999976665543
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=307.07 Aligned_cols=247 Identities=26% Similarity=0.319 Sum_probs=188.8
Q ss_pred hcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEeccccC--------
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------- 536 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------- 536 (816)
.++|.....||+|+||.||+|.+. |..||||++..... .....+.+|+.++.+++||||++++++|..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478999999999999999999874 88999999865322 223457899999999999999999998742
Q ss_pred CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccc
Q 003481 537 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 616 (816)
Q Consensus 537 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 616 (816)
..++|+||+.. +|..++. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 25899999964 6766541 25889999999999999999999988 999999999999999999999999998
Q ss_pred eeccCCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH---hhc-----
Q 003481 617 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VSC----- 687 (816)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~---~~~----- 687 (816)
+..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+..... +..
T Consensus 165 ~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (342)
T cd07879 165 RHADAE---------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 235 (342)
T ss_pred cCCCCC---------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 764321 133467889999998866 46889999999999999999999999754321111 100
Q ss_pred ---------CccccccC--CC--CCCC---CHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 688 ---------GKLSSILD--PL--AGDW---PTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 688 ---------~~~~~~~d--~~--~~~~---~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
........ +. ...+ ....+..+.+|+.+||+.||.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 00 0000 11244578999999999999999999966544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=296.95 Aligned_cols=248 Identities=25% Similarity=0.335 Sum_probs=190.4
Q ss_pred CCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCC-CCceeeEecccc--CCccceeecc
Q 003481 472 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQ-HPHLVTLLGACP--EAWSLVYEYL 545 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~-HpnIv~l~g~~~--~~~~lV~E~~ 545 (816)
|.+.+.||.|+||.||+|... +..|+||.+..... .......+|+..+.+++ ||||+++++++. +..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567788999999999999985 78899999865433 22334567999999998 999999999984 3588999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
+|+|.+++.... ...+++..++.++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 889998886654 246899999999999999999999987 99999999999999999999999999987644321
Q ss_pred CCCccccCCCCCCCCCCCccccc-cCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhc-----------------
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHR-TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----------------- 687 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~----------------- 687 (816)
.....++..|+|||++. ...++.++||||||+++|+|++|++||............
T Consensus 155 ------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 155 ------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred ------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 13345888999999874 456799999999999999999999999644322111100
Q ss_pred --CccccccCCC----CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 688 --GKLSSILDPL----AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 688 --~~~~~~~d~~----~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
..+...+... ........+..+.+++.+||+.+|.+||++.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~ 278 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQAL 278 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHh
Confidence 0000000000 0011111246799999999999999999998554
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=292.26 Aligned_cols=242 Identities=28% Similarity=0.341 Sum_probs=192.3
Q ss_pred eeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccCCCch
Q 003481 478 VGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSL 550 (816)
Q Consensus 478 LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL 550 (816)
||.|+||.||++.+. |..|++|++..... .....+.+|+.++.+++||||+++++.+.. ..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 88999999876544 344568899999999999999999988743 47899999999999
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcC--CC
Q 003481 551 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL--PS 628 (816)
Q Consensus 551 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~--~~ 628 (816)
.+++.... .+++..+..|+.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......... ..
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99987654 5899999999999999999999987 9999999999999999999999999987654321100 00
Q ss_pred ccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCccccccCCCCCCCCHH--
Q 003481 629 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPTF-- 704 (816)
Q Consensus 629 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~~~~~~-- 704 (816)
........++..|++||.+....++.++||||||+++|+|++|..||...... ...+..+.. .++..
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~ 225 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI---------EWPEDVE 225 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc---------CCCcccc
Confidence 01223456788999999998888999999999999999999999999644322 111222111 12222
Q ss_pred HHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 705 VARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 705 ~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
.+..+.+++.+||+.+|.+||++. .+.+.|
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~-~~~~~l 255 (265)
T cd05579 226 VSDEAIDLISKLLVPDPEKRLGAK-SIEEIK 255 (265)
T ss_pred CCHHHHHHHHHHhcCCHhhcCCCc-cHHHHh
Confidence 267899999999999999999995 343444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=294.13 Aligned_cols=249 Identities=28% Similarity=0.382 Sum_probs=190.5
Q ss_pred CCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc--cHHHHHHHHHHHhcC---CCCceeeEecccc--CC-----
Q 003481 472 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKL---QHPHLVTLLGACP--EA----- 537 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l---~HpnIv~l~g~~~--~~----- 537 (816)
|.+.+.||.|+||.||+|++. +..||+|++...... ....+.+|+.++.++ +||||++++++|. +.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999985 789999999754322 223566788777666 6999999999983 23
Q ss_pred ccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccce
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 617 (816)
.+++|||+.+ +|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 7899999974 78888865432 35899999999999999999999987 9999999999999999999999999998
Q ss_pred eccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHH---HhhcCcc----
Q 003481 618 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVSCGKL---- 690 (816)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~---~~~~~~~---- 690 (816)
....... .....+++.|+|||++.+..++.++|||||||++|+|++|.+||........ ....-..
T Consensus 156 ~~~~~~~-------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 156 IYSFEMA-------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE 228 (287)
T ss_pred eccCCcc-------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChH
Confidence 7654321 1233578899999999988999999999999999999999999964432211 1110000
Q ss_pred --c-------cccCCC----CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 691 --S-------SILDPL----AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 691 --~-------~~~d~~----~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
. ...... ........+..+.+++.+||+.||.+||++.+.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 000000 01111245678899999999999999999996553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=300.05 Aligned_cols=257 Identities=25% Similarity=0.356 Sum_probs=191.2
Q ss_pred hcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCccc--HHHHHHHHHHHhcCCCCceeeEeccccC--------
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLGACPE-------- 536 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~g~~~~-------- 536 (816)
.++|...+.||.|+||.||+|.+. +..||||++....... ...+.+|+.++.+++||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999885 7889999986543322 2457789999999999999999987622
Q ss_pred --CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecc
Q 003481 537 --AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 614 (816)
Q Consensus 537 --~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 614 (816)
..++|++|+.+ +|...+.... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 25899999965 6766665432 36899999999999999999999988 9999999999999999999999999
Q ss_pred cceeccCCCCcCC-----CccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHH---Hh
Q 003481 615 ICRLVTEDTLYLP-----SFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AV 685 (816)
Q Consensus 615 la~~~~~~~~~~~-----~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~---~~ 685 (816)
++........... .....+...+++.|+|||++.+ ..++.++|||||||++|+|++|++||........ .+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9986643321110 1112234567889999998765 4588999999999999999999999964332211 00
Q ss_pred h-cCc-----------cccccC-CCCCCCC-------HHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 686 S-CGK-----------LSSILD-PLAGDWP-------TFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 686 ~-~~~-----------~~~~~d-~~~~~~~-------~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
. .+. +....+ ......+ ......+.+++.+||+.||.+||++.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell 306 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHh
Confidence 0 000 000000 0000111 11235788999999999999999998544
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=298.70 Aligned_cols=241 Identities=27% Similarity=0.357 Sum_probs=189.9
Q ss_pred CCCccceeeeecceEEEEEEE-----cCeEEEEEEeccCCc----ccHHHHHHHHHHHhcC-CCCceeeEeccccC--Cc
Q 003481 471 NFSESFKVGQGGFGCVYKGEM-----LGRTVAIKMLYSHNM----QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AW 538 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~-----~g~~vAiK~l~~~~~----~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~ 538 (816)
+|+..+.||.|+||.||++.. .|..||+|++..... .....+.+|+.++.++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477888999999999999986 478899999875432 2345678999999999 69999999988854 46
Q ss_pred cceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccccee
Q 003481 539 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 539 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 618 (816)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 89999999999999987643 5788999999999999999999987 99999999999999999999999999987
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCCccccccC--CCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCcccccc
Q 003481 619 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG--VLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSIL 694 (816)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~ 694 (816)
....... ......|+..|+|||++... .++.++||||||+++|+|++|..||...... ...+.. .+
T Consensus 155 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-----~~ 224 (290)
T cd05613 155 FHEDEVE-----RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR-----RI 224 (290)
T ss_pred ccccccc-----ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH-----Hh
Confidence 6443211 12345689999999988653 4788999999999999999999999632210 011100 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCC
Q 003481 695 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDI 727 (816)
Q Consensus 695 d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~ 727 (816)
......++...+..+.+++.+||+.+|.+||+.
T Consensus 225 ~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~ 257 (290)
T cd05613 225 LKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGC 257 (290)
T ss_pred hccCCCCCccCCHHHHHHHHHHhcCCHHHhcCC
Confidence 011122344566789999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=289.75 Aligned_cols=232 Identities=25% Similarity=0.283 Sum_probs=183.3
Q ss_pred ceeeeecceEEEEEEEc--CeEEEEEEeccCCccc---HHHHHHHHHHH-hcCCCCceeeEeccccC--CccceeeccCC
Q 003481 476 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---QLEFQQEVRVL-SKLQHPHLVTLLGACPE--AWSLVYEYLPN 547 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~---~~~~~~E~~il-~~l~HpnIv~l~g~~~~--~~~lV~E~~~~ 547 (816)
+.||.|+||.||+|... ++.||+|++....... ...+..|..++ ...+||||+++++++.+ ..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999884 7899999987543322 22344555544 45589999999999854 58999999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
++|.+++.... .+++..+..|+.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 99999986543 5888999999999999999999987 99999999999999999999999999876432
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCccccccCCCCCCCCHHH
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPTFV 705 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~~~~~~~ 705 (816)
.....|++.|++||.+.+..++.++||||||+++|+|++|..||...... ...+..+.... .......+
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~ 220 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW-----PEEVKEFC 220 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCC-----CCcccccC
Confidence 12345889999999998888999999999999999999999999644321 12222221110 01112235
Q ss_pred HHHHHHHHHHhhccCCCCCCCCh
Q 003481 706 ARRLVDLGLQCCELYGRERPDIT 728 (816)
Q Consensus 706 ~~~l~~Li~~cl~~dP~~RPs~~ 728 (816)
+..+.+++.+||+.+|.+||++.
T Consensus 221 ~~~~~~~i~~~l~~~p~~R~~~~ 243 (260)
T cd05611 221 SPEAVDLINRLLCMDPAKRLGAN 243 (260)
T ss_pred CHHHHHHHHHHccCCHHHccCCC
Confidence 67899999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=283.94 Aligned_cols=246 Identities=24% Similarity=0.348 Sum_probs=198.6
Q ss_pred HHhcCCCcc-ceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCceeeEeccccCC-----
Q 003481 467 TATCNFSES-FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPEA----- 537 (816)
Q Consensus 467 ~~t~~f~~~-~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~~----- 537 (816)
..|++|.+. .+||-|-.|.|-.+... +..+|+|++... ....+|+++--.. .|||||.++++|.+.
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 356777664 47999999999998775 889999998543 2345777765544 699999999998542
Q ss_pred -ccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecC---CCCeeEeec
Q 003481 538 -WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS---ELSSKICDF 613 (816)
Q Consensus 538 -~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~---~~~vkL~DF 613 (816)
+.+|||+|+||.|...+..++. ..+++.++..|+.||+.|+.|||+.+ |.||||||+|+|... |..+||+||
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence 5689999999999999987764 56999999999999999999999998 999999999999964 557999999
Q ss_pred ccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCCh------HHHHHHhhc
Q 003481 614 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLA------GEVRRAVSC 687 (816)
Q Consensus 614 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~------~~~~~~~~~ 687 (816)
|+|+...... .....+-||.|.|||++...+|+..+|+||+||++|-|++|.+||... ......+..
T Consensus 209 GFAK~t~~~~-------~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~ 281 (400)
T KOG0604|consen 209 GFAKETQEPG-------DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT 281 (400)
T ss_pred ccccccCCCc-------cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc
Confidence 9999765332 235677899999999999999999999999999999999999999533 234444444
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 688 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 688 ~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
|.+.- ...+| ..+++...++|..+|..+|.+|.|+.+.+.+
T Consensus 282 gqy~F----P~pEW-s~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 282 GQYEF----PEPEW-SCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred cCccC----CChhH-hHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 44321 11223 3578899999999999999999999865443
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=295.55 Aligned_cols=230 Identities=26% Similarity=0.344 Sum_probs=178.5
Q ss_pred eeeeecceEEEEEEEc--CeEEEEEEeccCCcc---cHHHHHHHHH---HHhcCCCCceeeEecccc--CCccceeeccC
Q 003481 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVR---VLSKLQHPHLVTLLGACP--EAWSLVYEYLP 546 (816)
Q Consensus 477 ~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~---~~~~~~~E~~---il~~l~HpnIv~l~g~~~--~~~~lV~E~~~ 546 (816)
.||+|+||.||++... ++.||+|.+...... ....+..|.. .+....||||+++++++. +..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999874 789999998764322 1222444443 344458999999999884 35789999999
Q ss_pred CCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcC
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626 (816)
Q Consensus 547 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 626 (816)
+|+|.+++... ..+++..+..|+.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 99999988653 36899999999999999999999987 9999999999999999999999999987654321
Q ss_pred CCccccCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHhCCCCCCChHHHH-HHhhcCccccccCCCCCCCCHH
Q 003481 627 PSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR-RAVSCGKLSSILDPLAGDWPTF 704 (816)
Q Consensus 627 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~-~~~~~~~~~~~~d~~~~~~~~~ 704 (816)
.....|+..|+|||++.++ .++.++|||||||++|+|++|+.||....... ...... .......++..
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 221 (278)
T cd05606 152 -----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-----TLTMAVELPDS 221 (278)
T ss_pred -----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH-----hhccCCCCCCc
Confidence 1234689999999998754 68999999999999999999999996442110 000000 00111223444
Q ss_pred HHHHHHHHHHHhhccCCCCCC
Q 003481 705 VARRLVDLGLQCCELYGRERP 725 (816)
Q Consensus 705 ~~~~l~~Li~~cl~~dP~~RP 725 (816)
.+..+.+++.+||..+|.+||
T Consensus 222 ~s~~~~~li~~~l~~~p~~R~ 242 (278)
T cd05606 222 FSPELRSLLEGLLQRDVNRRL 242 (278)
T ss_pred CCHHHHHHHHHHhhcCHHhcc
Confidence 567899999999999999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=299.62 Aligned_cols=255 Identities=18% Similarity=0.246 Sum_probs=189.1
Q ss_pred eeeee--cceEEEEEEE--cCeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeeccCCC
Q 003481 477 KVGQG--GFGCVYKGEM--LGRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPNG 548 (816)
Q Consensus 477 ~LG~G--~~g~Vy~~~~--~g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~~g 548 (816)
.||.| +||+||++.+ .|+.||+|++..... ...+.+.+|+.++..++||||++++++|. +..++|+||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999988 489999999875432 23456889999999999999999999984 3578999999999
Q ss_pred chhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC-
Q 003481 549 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP- 627 (816)
Q Consensus 549 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~- 627 (816)
+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++++|||.+...........
T Consensus 85 ~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99998876532 35889999999999999999999987 99999999999999999999999986543322111000
Q ss_pred CccccCCCCCCCCCCCccccccC--CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhh--cCccc------------
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTG--VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS--CGKLS------------ 691 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~--~~~~~------------ 691 (816)
.........++..|+|||++.+. .++.++|||||||++|+|++|+.||........... .+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 00011122356779999998763 478999999999999999999999964432111110 00000
Q ss_pred -------------------------cccCC-CCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 692 -------------------------SILDP-LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 692 -------------------------~~~d~-~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
.+.+. .....+..++..+.+|+.+||+.||.+|||+.+.+.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 00000 001112346778999999999999999999997775554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=289.48 Aligned_cols=246 Identities=24% Similarity=0.306 Sum_probs=192.7
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC-----cccHHHHHHHHHHHhcCCCCceeeEecccc--CCccce
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-----MQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLV 541 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~-----~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV 541 (816)
+|.+.+.||+|+||.||++.+. +..+++|+++... ......+..|+.++..++||||+++++++. +..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4778889999999999999886 4456666654322 123345778999999999999999999884 357899
Q ss_pred eeccCCCchhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceecc
Q 003481 542 YEYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 620 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 620 (816)
|||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988653 22356899999999999999999999987 999999999999975 569999999988764
Q ss_pred CCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCC
Q 003481 621 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 700 (816)
.... ......|++.|+|||++.+..++.++||||||+++|+|++|..||........... ........
T Consensus 157 ~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~------~~~~~~~~ 224 (260)
T cd08222 157 GSCD------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR------IVEGPTPS 224 (260)
T ss_pred CCcc------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH------HHcCCCCC
Confidence 3321 12345688999999999888899999999999999999999999964333211111 01111222
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
.+..++..+.+++.+||..+|.+||++.+.+.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 225 LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 34556778999999999999999999986554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=301.42 Aligned_cols=253 Identities=26% Similarity=0.306 Sum_probs=196.7
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCceeeEeccccC-------Ccc
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------AWS 539 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------~~~ 539 (816)
+|.+.+.||.|+||.||+|+.. +..||||++.... ......+.+|+.+++.++||||+++++++.. ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788899999999999999985 7899999987643 3344578899999999999999999998843 468
Q ss_pred ceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceec
Q 003481 540 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 619 (816)
Q Consensus 540 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 619 (816)
+||+|+. ++|.+++.... .+++..++.++.+|+.||.|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 58888885543 6899999999999999999999988 999999999999999999999999999887
Q ss_pred cCCCCcCCCccccCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH---hhc-C------
Q 003481 620 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VSC-G------ 688 (816)
Q Consensus 620 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~---~~~-~------ 688 (816)
...... ........+++.|+|||++.+. .++.++||||||+++|+|++|.+||......... ... +
T Consensus 154 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 154 DPDEDE---KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred cccccc---cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 554310 0112344688999999999887 8899999999999999999999999654432110 000 0
Q ss_pred -------ccccccC---CC----CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 689 -------KLSSILD---PL----AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 689 -------~~~~~~d---~~----~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
.....+. .. ........+..+.+++.+||+.+|.+||++.+.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000000 00 000112245688999999999999999999966644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=297.07 Aligned_cols=239 Identities=26% Similarity=0.344 Sum_probs=188.9
Q ss_pred CCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc---cHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeec
Q 003481 472 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 544 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 544 (816)
|.....||+|+||.||+|+.. +..|++|.+...... ....+.+|+.+++.++|||++++++++.+ ..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 556678999999999999874 889999998654332 23467889999999999999999999854 47899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
+. |+|.+++.... .++++..++.++.||+.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 95 57777775543 46899999999999999999999987 99999999999999999999999998864321
Q ss_pred cCCCccccCCCCCCCCCCCccccc---cCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHh--hcCccccccCCCCC
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV--SCGKLSSILDPLAG 699 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~--~~~~~~~~~d~~~~ 699 (816)
.....|+..|+|||++. .+.++.++|||||||++|+|++|..||.......... ........
T Consensus 174 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 240 (313)
T cd06633 174 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL------ 240 (313)
T ss_pred -------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------
Confidence 23456889999999874 4668899999999999999999999986543322111 11111110
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 700 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 700 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
.....+..+.+|+.+||+.+|.+||++.+.+.+
T Consensus 241 -~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 241 -QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred -CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112234578999999999999999999965544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=299.76 Aligned_cols=252 Identities=25% Similarity=0.326 Sum_probs=193.8
Q ss_pred HHHHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEecccc---C
Q 003481 464 DLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP---E 536 (816)
Q Consensus 464 el~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~---~ 536 (816)
++..++++|...+.||.|+||.||++... +..||+|++..... .....+.+|+.++..++||||++++++|. +
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 44567889999999999999999999875 78999998864322 23456789999999999999999999873 3
Q ss_pred CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccc
Q 003481 537 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 616 (816)
Q Consensus 537 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 616 (816)
..++|+||+ +++|..++.. .++++..+..++.|++.||.|||+.+ |+||||+|+|||++.++.++|+|||++
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccc
Confidence 478999998 5688887753 24788889999999999999999988 999999999999999999999999998
Q ss_pred eeccCCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHH------------
Q 003481 617 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR------------ 683 (816)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~------------ 683 (816)
...... .....++..|+|||++.+ ..++.++|||||||++|+|+||++||........
T Consensus 156 ~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 226 (328)
T cd07856 156 RIQDPQ---------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP 226 (328)
T ss_pred cccCCC---------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 754321 123457889999998765 5689999999999999999999999964332110
Q ss_pred -----HhhcCccccccCCC--CCCCC-----HHHHHHHHHHHHHhhccCCCCCCCChHHHH
Q 003481 684 -----AVSCGKLSSILDPL--AGDWP-----TFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 684 -----~~~~~~~~~~~d~~--~~~~~-----~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~ 732 (816)
.+..+.....+... ....+ ...+..+.++|.+||+.+|.+||++.+.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 227 DDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred HHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000000 00111 124568999999999999999999986543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=297.30 Aligned_cols=241 Identities=26% Similarity=0.348 Sum_probs=190.2
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEecccc--CCccceee
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYE 543 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E 543 (816)
.|...+.||.|+||.||+|+.. +..||+|.+..... .....+.+|+.+++.++|||++++++++. +..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666788999999999999885 78899999864322 23346788999999999999999999874 35789999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
|+. |+|.+.+.... .++++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 96 YCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred ccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 996 57877775443 35889999999999999999999987 999999999999999999999999998765432
Q ss_pred CcCCCccccCCCCCCCCCCCccccc---cCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHH--HHhhcCccccccCCCC
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLA 698 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~--~~~~~~~~~~~~d~~~ 698 (816)
....|++.|+|||++. .+.++.++|||||||++|+|++|..||....... ..+..+....
T Consensus 169 ---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~------ 233 (308)
T cd06634 169 ---------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA------ 233 (308)
T ss_pred ---------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCC------
Confidence 2345888999999874 3568899999999999999999999986443221 1122111111
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 699 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 699 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
..+...+..+.+||.+||..+|.+||++.+.+.+.
T Consensus 234 -~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 234 -LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 11223556789999999999999999998655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=305.52 Aligned_cols=248 Identities=29% Similarity=0.448 Sum_probs=208.1
Q ss_pred CccceeeeecceEEEEEEEc------CeEEEEEEeccCC-cccHHHHHHHHHHHhcCCCCceeeEeccccC-Cccceeec
Q 003481 473 SESFKVGQGGFGCVYKGEML------GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEY 544 (816)
Q Consensus 473 ~~~~~LG~G~~g~Vy~~~~~------g~~vAiK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~ 544 (816)
...++||+|+||+||+|.+- .-+||||++.... .+...+|..|+-+|.+|+|||+++|+|+|.. ...||++|
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~ 778 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQL 778 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHh
Confidence 34578999999999999884 3579999986654 3456689999999999999999999999954 58899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
|+.|+|.+++..+. ..+-.+..+.|..|||+|+.|||... ++||||-..|||+..-..+||.|||+++....+..
T Consensus 779 mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred cccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 99999999998765 46777999999999999999999977 99999999999999999999999999999877653
Q ss_pred cCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCC--hHHHHHHhhcCccccccCCCCCCC
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGL--AGEVRRAVSCGKLSSILDPLAGDW 701 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~--~~~~~~~~~~~~~~~~~d~~~~~~ 701 (816)
. +......-.+-|||=|.+....|+.++|||||||++|||+| |..|+.. ..++...+..|.. -..
T Consensus 854 e----y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR--------Lsq 921 (1177)
T KOG1025|consen 854 E----YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER--------LSQ 921 (1177)
T ss_pred c----ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc--------CCC
Confidence 2 22334445667999999999999999999999999999999 9999863 4456666665543 134
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 702 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 702 ~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
|+..+.++..++.+||..|+..||+++ ++...+..+
T Consensus 922 PpiCtiDVy~~mvkCwmid~~~rp~fk-el~~~fs~~ 957 (1177)
T KOG1025|consen 922 PPICTIDVYMVMVKCWMIDADSRPTFK-ELAEEFSRM 957 (1177)
T ss_pred CCCccHHHHHHHHHHhccCcccCccHH-HHHHHHHHH
Confidence 566778999999999999999999999 666666554
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=284.54 Aligned_cols=252 Identities=26% Similarity=0.349 Sum_probs=197.6
Q ss_pred cccCHHHHHHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-ccHHHHHHHHHHHhcC-CCCceeeEecc
Q 003481 458 AEFSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGA 533 (816)
Q Consensus 458 ~~~~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~ 533 (816)
-.|+-++|+.. ..||.|.||+|++-.+. |+..|||+++.... ..+.+|..|.+...+- +.||||++||+
T Consensus 59 ~~F~~~~Lqdl-------g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 59 HTFTSDNLQDL-------GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred cccccchHHHH-------HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 44666666655 45999999999999886 89999999987765 5667888998876665 79999999998
Q ss_pred c--cCCccceeeccCCCchhhhhh---hcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCe
Q 003481 534 C--PEAWSLVYEYLPNGSLQDRLF---RKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 608 (816)
Q Consensus 534 ~--~~~~~lV~E~~~~gsL~~~l~---~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 608 (816)
+ ++..++.||+|+ .||..+-. ... ...+++.-+-.|......||.||...- .||||||||+||||+..|.+
T Consensus 132 ~F~EGdcWiCMELMd-~SlDklYk~vy~vq-~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~v 207 (361)
T KOG1006|consen 132 LFSEGDCWICMELMD-ISLDKLYKRVYSVQ-KSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDV 207 (361)
T ss_pred hhcCCceeeeHHHHh-hhHHHHHHHHHHHH-hccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCE
Confidence 7 445889999994 46654332 222 245888888889999999999998864 49999999999999999999
Q ss_pred eEeecccceeccCCCCcCCCccccCCCCCCCCCCCcccccc--CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHh-
Q 003481 609 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT--GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV- 685 (816)
Q Consensus 609 kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~- 685 (816)
||||||++-.+.... ..+..+|-..|||||.+.. ..|+.+|||||||++|||+.||..|+...+.+...+
T Consensus 208 KLCDFGIcGqLv~Si-------AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~ 280 (361)
T KOG1006|consen 208 KLCDFGICGQLVDSI-------AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLC 280 (361)
T ss_pred eeecccchHhHHHHH-------HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHH
Confidence 999999998775433 2355678899999998753 358999999999999999999999998777665543
Q ss_pred --hcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHH
Q 003481 686 --SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPS 730 (816)
Q Consensus 686 --~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~ 730 (816)
..|....++.+. -...++..+..+|..||.+|-.+||...+.
T Consensus 281 ~Vv~gdpp~l~~~~---~~~~~s~~~~~fintCl~Kd~~~Rpky~~L 324 (361)
T KOG1006|consen 281 QVVIGDPPILLFDK---ECVHYSFSMVRFINTCLIKDRSDRPKYDDL 324 (361)
T ss_pred HHHcCCCCeecCcc---cccccCHHHHHHHHHHhhcccccCcchhhh
Confidence 334333322111 112367789999999999999999999843
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=291.71 Aligned_cols=248 Identities=26% Similarity=0.349 Sum_probs=193.0
Q ss_pred CCccceeeeecceEEEEEEEc--CeEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeecc
Q 003481 472 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 545 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 545 (816)
|+....||+|+||.||+|+.. +..||+|++.... ......+.+|+.++++++||||+++++++.+ ..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556678999999999999886 7899999997654 2334567889999999999999999999854 588999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
. ++|.+++.... ..+++..++.++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 7 58999987653 35899999999999999999999988 99999999999999999999999999987654321
Q ss_pred CCCccccCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhc---------------Cc
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC---------------GK 689 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~---------------~~ 689 (816)
......++..|+|||.+.+. .++.++|||||||++|+|++|.+||............ ..
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 154 -----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred -----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence 12233467889999988766 8899999999999999999999999654432111000 00
Q ss_pred c---ccccCCC----CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 690 L---SSILDPL----AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 690 ~---~~~~d~~----~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
+ ...+... ........+..+.+++.+||..+|.+||++.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l 277 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEAL 277 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHh
Confidence 0 0000000 0000112356899999999999999999998554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.53 Aligned_cols=250 Identities=26% Similarity=0.355 Sum_probs=194.2
Q ss_pred CCCccceeeeecceEEEEEEEc-----CeEEEEEEeccCCc----ccHHHHHHHHHHHhcC-CCCceeeEeccccC--Cc
Q 003481 471 NFSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNM----QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AW 538 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~-----g~~vAiK~l~~~~~----~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~ 538 (816)
+|...+.||+|+||.||+++.. +..||||++..... .....+.+|+.++.++ +||||+++++.+.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4777889999999999998753 57899999875422 2334688999999999 69999999988743 47
Q ss_pred cceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccccee
Q 003481 539 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 539 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 618 (816)
++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|.||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 89999999999999886543 5889999999999999999999977 99999999999999999999999999877
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCCccccccCC--CCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCcccccc
Q 003481 619 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV--LTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSIL 694 (816)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~ 694 (816)
....... ......|+..|+|||.+.+.. ++.++||||||+++|+|++|..||...+.. ...+......
T Consensus 155 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--- 226 (288)
T cd05583 155 FLAEEEE-----RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK--- 226 (288)
T ss_pred ccccccc-----ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc---
Confidence 6443211 123346889999999987654 788999999999999999999999532211 0111111000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHH
Q 003481 695 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 737 (816)
Q Consensus 695 d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~ 737 (816)
.....+...+..+.+++.+||+.+|++|||+. .+...|+.
T Consensus 227 --~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~-~~~~~l~~ 266 (288)
T cd05583 227 --SKPPFPKTMSAEARDFIQKLLEKDPKKRLGAN-GADEIKNH 266 (288)
T ss_pred --cCCCCCcccCHHHHHHHHHHhcCCHhhccCcc-hHHHHhcC
Confidence 11123334556889999999999999999987 45555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=304.50 Aligned_cols=254 Identities=22% Similarity=0.292 Sum_probs=192.2
Q ss_pred hcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC----------
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE---------- 536 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---------- 536 (816)
.++|...+.||.|+||.||+|... |..||+|.+..........+.+|+.++++++||||+++++++..
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 368999999999999999999885 78999999877666666678899999999999999999987632
Q ss_pred ------CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEec-CCCCee
Q 003481 537 ------AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD-SELSSK 609 (816)
Q Consensus 537 ------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~-~~~~vk 609 (816)
..++||||+. ++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++ .++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 2579999996 588887743 25889999999999999999999988 99999999999997 456789
Q ss_pred EeecccceeccCCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhc-
Q 003481 610 ICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC- 687 (816)
Q Consensus 610 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~- 687 (816)
|+|||++.......... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||............
T Consensus 156 l~dfg~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 156 IGDFGLARIVDPHYSHK---GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred ECCcccceecCCccccc---cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999998764322110 11123457889999997644 56888999999999999999999999644322111100
Q ss_pred -C--------------cccccc--CCCCC-----CCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 688 -G--------------KLSSIL--DPLAG-----DWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 688 -~--------------~~~~~~--d~~~~-----~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
. .+...+ ..... ......+..+.+|+.+||+.||.+||++.+.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0 000000 00000 0111245678899999999999999999965543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=323.43 Aligned_cols=256 Identities=29% Similarity=0.369 Sum_probs=191.6
Q ss_pred HHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc-ccHHHHHHHHHHHhcCCCCceeeEeccccC------
Q 003481 466 QTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE------ 536 (816)
Q Consensus 466 ~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------ 536 (816)
...-++|.....||+||||.||+++.. |..||||++..... .....+.+|+.+|++|+|||||++|..+.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 445677888899999999999999875 99999999976642 223457899999999999999998632100
Q ss_pred --------------------------------------------------------------------------------
Q 003481 537 -------------------------------------------------------------------------------- 536 (816)
Q Consensus 537 -------------------------------------------------------------------------------- 536 (816)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -----------------------------------CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 003481 537 -----------------------------------AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCF 581 (816)
Q Consensus 537 -----------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~y 581 (816)
.+||=||||+..+|.+++..+.... .-...++++.+|+.||.|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence 0245678887777777775543211 246789999999999999
Q ss_pred HhhcCCCceeeCCCCCCceEecCCCCeeEeecccceecc----C--------CCCcCCCccccCCCCCCCCCCCcccccc
Q 003481 582 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT----E--------DTLYLPSFHRSTAPKGSFPYADPEYHRT 649 (816)
Q Consensus 582 LH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~----~--------~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 649 (816)
+|+.+ ||||||||.||+||.+..|||+|||+|.... . ...........+..+||.-|+|||++.+
T Consensus 713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99988 9999999999999999999999999998721 0 0000111223467789999999999876
Q ss_pred C---CCCcchhHhHHHHHHHHHHhCCCCCCChHH---HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCC
Q 003481 650 G---VLTPKSDSYSFGLIILQLLTGRLPVGLAGE---VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRE 723 (816)
Q Consensus 650 ~---~~s~ksDVwSlGviL~elltG~~Pf~~~~~---~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~ 723 (816)
. .|+.|+|+|||||||+||+ .||+..-+ +...+..|.+..- .++.......-..+|.++++.||.+
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~-----~~f~~~~~~~e~slI~~Ll~hdP~k 861 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEP-----ADFFDPEHPEEASLIRWLLSHDPSK 861 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCC-----cccccccchHHHHHHHHHhcCCCcc
Confidence 5 4999999999999999999 46764333 2333444444332 3344445556788999999999999
Q ss_pred CCCChHHHHHH
Q 003481 724 RPDITPSLVKE 734 (816)
Q Consensus 724 RPs~~e~l~~~ 734 (816)
|||+.+.|...
T Consensus 862 RPtA~eLL~s~ 872 (1351)
T KOG1035|consen 862 RPTATELLNSE 872 (1351)
T ss_pred CCCHHHHhhcc
Confidence 99999765443
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=300.38 Aligned_cols=258 Identities=23% Similarity=0.282 Sum_probs=190.8
Q ss_pred cCCCc-cceeeeecceEEEEEEEc--CeEEEEEEeccCCccc--------------HHHHHHHHHHHhcCCCCceeeEec
Q 003481 470 CNFSE-SFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--------------QLEFQQEVRVLSKLQHPHLVTLLG 532 (816)
Q Consensus 470 ~~f~~-~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~--------------~~~~~~E~~il~~l~HpnIv~l~g 532 (816)
++|.. .+.||.|+||.||+|.+. +..||||.+....... ...+.+|+.++..++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 467999999999999875 8899999986543221 124678999999999999999999
Q ss_pred ccc--CCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeE
Q 003481 533 ACP--EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI 610 (816)
Q Consensus 533 ~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL 610 (816)
++. +..++||||+. |+|.+++... ..+++.....++.|++.||.|||+.+ |+|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 974 45789999996 6898888643 35888999999999999999999987 999999999999999999999
Q ss_pred eecccceeccCCCCcC--------CCccccCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHhCCCCCCChHHH
Q 003481 611 CDFGICRLVTEDTLYL--------PSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEV 681 (816)
Q Consensus 611 ~DFGla~~~~~~~~~~--------~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~ 681 (816)
+|||++.......... ..........+++.|+|||++.+. .++.++|||||||++|+|++|.+||...+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999998765211100 000112234578899999988654 4789999999999999999999999755432
Q ss_pred HHHh---h-cCc-----cccc--------cCCC----CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 682 RRAV---S-CGK-----LSSI--------LDPL----AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 682 ~~~~---~-~~~-----~~~~--------~d~~----~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
.... . .+. +... .... ........+..+.+++.+||+.+|.+||++.+.+.+.
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~ 314 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE 314 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence 2110 0 000 0000 0000 0000112356789999999999999999998666443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=292.69 Aligned_cols=247 Identities=27% Similarity=0.423 Sum_probs=191.7
Q ss_pred ccceeeeecceEEEEEEEcCeEEEEEEeccCCcccHHHHHHHHHHHhcC--CCCceeeEecccc------CCccceeecc
Q 003481 474 ESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL--QHPHLVTLLGACP------EAWSLVYEYL 545 (816)
Q Consensus 474 ~~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l--~HpnIv~l~g~~~------~~~~lV~E~~ 545 (816)
....||+|+||.||+|.+.++.||||++.. +....|++|-+|.+.. +|+||++++++-. -++.||++|.
T Consensus 214 l~eli~~Grfg~V~KaqL~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLDNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred hHHHhhcCccceeehhhccCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 345699999999999999999999999854 4456788888887754 8999999998852 1478999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC------CceeeCCCCCCceEecCCCCeeEeecccceec
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP------EKIVHGDLKPQNILLDSELSSKICDFGICRLV 619 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~------~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 619 (816)
+.|+|.++|..+ .++|....+|+..+++||+|||..-| ++|+|||||+.||||.+|++..|+|||+|..+
T Consensus 291 ~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 291 PKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred cCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 999999999764 59999999999999999999998553 46999999999999999999999999999998
Q ss_pred cCCCCcCCCccccCCCCCCCCCCCccccccC-CCC-----cchhHhHHHHHHHHHHhCCCCC------------C-----
Q 003481 620 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLT-----PKSDSYSFGLIILQLLTGRLPV------------G----- 676 (816)
Q Consensus 620 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s-----~ksDVwSlGviL~elltG~~Pf------------~----- 676 (816)
..+.... .....+||..|||||++.+. .+. .+.||||+|.|||||++.-.-+ .
T Consensus 367 ~p~~~~~----d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 367 EPGKPQG----DTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred cCCCCCc----chhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 7655322 23447899999999998653 122 3699999999999999964322 1
Q ss_pred --ChHHHHHHhhcCccccccCCCCCCCCH-----HHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhh
Q 003481 677 --LAGEVRRAVSCGKLSSILDPLAGDWPT-----FVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 677 --~~~~~~~~~~~~~~~~~~d~~~~~~~~-----~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~ 739 (816)
..++++..+...+. .+.+|. .....|.+.+..||+.||+.|.|+. =+.+.+..+.
T Consensus 443 hPt~e~mq~~VV~kK~-------RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~-Cv~eR~~~l~ 504 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQ-------RPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG-CVEERMAELM 504 (534)
T ss_pred CCCHHHHHHHHHhhcc-------CCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH-HHHHHHHHHh
Confidence 11222222222221 122222 2455789999999999999999997 5555555443
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-33 Score=299.34 Aligned_cols=234 Identities=23% Similarity=0.303 Sum_probs=201.8
Q ss_pred CccceeeeecceEEEEEEEcCeE--EEEEEeccCCcc---cHHHHHHHHHHHhcCCCCceeeEeccccC--Cccceeecc
Q 003481 473 SESFKVGQGGFGCVYKGEMLGRT--VAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 545 (816)
Q Consensus 473 ~~~~~LG~G~~g~Vy~~~~~g~~--vAiK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 545 (816)
..+..||-||||.|=++...+.. +|+|++++...- .++.+..|-+||..++.|.||+||-.|.+ ..|++||-|
T Consensus 423 ~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaC 502 (732)
T KOG0614|consen 423 KRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEAC 502 (732)
T ss_pred hhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhh
Confidence 34456999999999999887655 899999877553 34468899999999999999999999965 478999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 625 (816)
-||.|+..|..++. ++.....-++..+..|+.|||+.+ ||.|||||+|.+||.+|-+||.|||+|+.+..+.
T Consensus 503 lGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~-- 574 (732)
T KOG0614|consen 503 LGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR-- 574 (732)
T ss_pred cCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC--
Confidence 99999999987763 666778889999999999999988 9999999999999999999999999999987655
Q ss_pred CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHH--HHhhcCccccccCCCCCCCCH
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDWPT 703 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~--~~~~~~~~~~~~d~~~~~~~~ 703 (816)
.+.+.+|||.|.|||++.+...+.++|.||||+++|||+||.+||...+.+. ..+..|- | ...||.
T Consensus 575 -----KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi-----d--~i~~Pr 642 (732)
T KOG0614|consen 575 -----KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI-----D--KIEFPR 642 (732)
T ss_pred -----ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh-----h--hhhccc
Confidence 4577899999999999999999999999999999999999999999877643 3333331 1 235778
Q ss_pred HHHHHHHHHHHHhhccCCCCCCC
Q 003481 704 FVARRLVDLGLQCCELYGRERPD 726 (816)
Q Consensus 704 ~~~~~l~~Li~~cl~~dP~~RPs 726 (816)
.+.....+||++.|..+|.+|-.
T Consensus 643 ~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 643 RITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ccchhHHHHHHHHHhcCcHhhhc
Confidence 88889999999999999999987
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=303.47 Aligned_cols=250 Identities=24% Similarity=0.304 Sum_probs=192.8
Q ss_pred HHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC--cccHHHHHHHHHHHhcCCCCceeeEeccccC--C---
Q 003481 467 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--A--- 537 (816)
Q Consensus 467 ~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~--- 537 (816)
...++|.....||.|+||.||+|.+. +..||+|++.... ......+.+|+.++++++||||+++++++.. .
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 45678999999999999999999985 7889999986532 2233567789999999999999999987632 2
Q ss_pred ---ccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecc
Q 003481 538 ---WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 614 (816)
Q Consensus 538 ---~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFG 614 (816)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 78999998 6799988854 35899999999999999999999987 9999999999999999999999999
Q ss_pred cceeccCCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH--hhc--Cc
Q 003481 615 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSC--GK 689 (816)
Q Consensus 615 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~--~~~--~~ 689 (816)
++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......... +.. +.
T Consensus 164 ~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~ 234 (343)
T cd07851 164 LARHTDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234 (343)
T ss_pred cccccccc---------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Confidence 98865432 133467889999998765 36789999999999999999999999643322111 000 00
Q ss_pred c-------------ccccCCC----CCCC---CHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 690 L-------------SSILDPL----AGDW---PTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 690 ~-------------~~~~d~~----~~~~---~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
. ...+... ...+ ....+..+.+++.+||+.+|.+|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 0000000 0001 11236789999999999999999999965533
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=286.47 Aligned_cols=237 Identities=28% Similarity=0.357 Sum_probs=197.8
Q ss_pred cCCCccceeeeecceEEEEEEEcC--eEEEEEEeccCCcc---cHHHHHHHHHHHhcC-CCCceeeEecccc--CCccce
Q 003481 470 CNFSESFKVGQGGFGCVYKGEMLG--RTVAIKMLYSHNMQ---GQLEFQQEVRVLSKL-QHPHLVTLLGACP--EAWSLV 541 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~g--~~vAiK~l~~~~~~---~~~~~~~E~~il~~l-~HpnIv~l~g~~~--~~~~lV 541 (816)
.+|.....||+|+||.|.++...| ..+|||+++++... +.+--..|-++|... +-|.+++|+.+|. +.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 368888999999999999998875 56999999887542 222234677788776 6788999998884 679999
Q ss_pred eeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
|||+.||+|.-++.+-+. +-+..+.-++.+||-||-|||+.+ ||.||||.+|||||.+|++||+|||+++.---
T Consensus 429 MEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999999987764 445778889999999999999988 99999999999999999999999999986543
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccCCCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAG 699 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d~~~~ 699 (816)
+.. .+...+|||.|+|||++...+|+.++|+|||||+||||+.|++||...++ +...+...+ .
T Consensus 503 ~~~------TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn---------v 567 (683)
T KOG0696|consen 503 DGV------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN---------V 567 (683)
T ss_pred CCc------ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc---------C
Confidence 332 34677899999999999999999999999999999999999999986654 333333322 2
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCC
Q 003481 700 DWPTFVARRLVDLGLQCCELYGRERPDI 727 (816)
Q Consensus 700 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~ 727 (816)
.+|...+.+...++...|...|.+|-..
T Consensus 568 syPKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 568 SYPKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred cCcccccHHHHHHHHHHhhcCCccccCC
Confidence 4788889999999999999999999654
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-33 Score=297.27 Aligned_cols=240 Identities=29% Similarity=0.442 Sum_probs=201.3
Q ss_pred cceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEeccc--cCCccceeeccCCC
Q 003481 475 SFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNG 548 (816)
Q Consensus 475 ~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~E~~~~g 548 (816)
.+.||+|.||+||-|++. |+.||||++.+-.. .....+.+|+.||.++.||.||.|-..| .+..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 467999999999999875 99999999976543 3345789999999999999999998888 46789999999776
Q ss_pred chhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCC---CCeeEeecccceeccCCCCc
Q 003481 549 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE---LSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 549 sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~---~~vkL~DFGla~~~~~~~~~ 625 (816)
-|+-+|.... ..|+......++.||+.||.|||..+ |+|+||||+||||... -.+||||||+|+.+....
T Consensus 649 MLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 649 MLEMILSSEK--GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred HHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 6665555443 46888888889999999999999988 9999999999999654 469999999999998755
Q ss_pred CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHH
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 705 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 705 (816)
.....+|||.|+|||++++..|...-|+||.|||+|--++|..||....++...+.+..+.-.. ..| .++
T Consensus 722 -----FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp----~PW-~ei 791 (888)
T KOG4236|consen 722 -----FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPP----NPW-SEI 791 (888)
T ss_pred -----hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCC----Cch-hhc
Confidence 3567899999999999999999999999999999999999999998777777777665443221 122 356
Q ss_pred HHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 706 ARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 706 ~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
+...++||...|+..-.+|-+....+
T Consensus 792 s~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 792 SPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred CHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 77889999999999999999887544
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=296.76 Aligned_cols=255 Identities=22% Similarity=0.242 Sum_probs=189.8
Q ss_pred CCCccceeeeecceEEEEEEEc----CeEEEEEEeccCCc--ccHHHHHHHHHHHhcC-CCCceeeEecccc------CC
Q 003481 471 NFSESFKVGQGGFGCVYKGEML----GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKL-QHPHLVTLLGACP------EA 537 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~----g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l-~HpnIv~l~g~~~------~~ 537 (816)
+|...+.||+|+||.||++... +..||+|++..... .....+.+|+.++.++ +||||+++++++. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999885 55899999864322 2245678899999999 5999999998642 23
Q ss_pred ccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccce
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 617 (816)
.+++++|+. ++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888885 6898888543 35889999999999999999999988 9999999999999999999999999998
Q ss_pred eccCCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHH-------------
Q 003481 618 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR------------- 683 (816)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~------------- 683 (816)
......... ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+....
T Consensus 154 ~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 154 GFSENPGEN--AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231 (332)
T ss_pred ecccccccc--cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence 765432211 111234578999999998765 4689999999999999999999999964331100
Q ss_pred ----HhhcCccccc---cC----CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 684 ----AVSCGKLSSI---LD----PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 684 ----~~~~~~~~~~---~d----~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
.+........ .. ..........+..+.+|+.+||+.||.+||++.+.+.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~ 293 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHP 293 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000000 00 000000111356799999999999999999999766544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=283.43 Aligned_cols=230 Identities=28% Similarity=0.368 Sum_probs=191.1
Q ss_pred eeeecceEEEEEEEc--CeEEEEEEeccCCcc---cHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccCCCch
Q 003481 478 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSL 550 (816)
Q Consensus 478 LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL 550 (816)
||.|+||.||++... +..||+|++...... ....+..|+.++++++||||+++++.+.. ..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999885 789999998765432 34578899999999999999999998854 47999999999999
Q ss_pred hhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCcc
Q 003481 551 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 630 (816)
Q Consensus 551 ~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 630 (816)
.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~------ 148 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS------ 148 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC------
Confidence 99987553 5899999999999999999999987 99999999999999999999999999987654321
Q ss_pred ccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCccccccCCCCCCCCHHHHHH
Q 003481 631 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPTFVARR 708 (816)
Q Consensus 631 ~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~~~~~~~~~~ 708 (816)
......++..|++||.+.+..++.++|+||||+++|+|++|..||...+.. ...+..+ ...++...+..
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~---------~~~~~~~~~~~ 219 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKD---------PLRFPEFLSPE 219 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC---------CCCCCCCCCHH
Confidence 124456889999999998888999999999999999999999999655431 1111111 11233344678
Q ss_pred HHHHHHHhhccCCCCCCCCh
Q 003481 709 LVDLGLQCCELYGRERPDIT 728 (816)
Q Consensus 709 l~~Li~~cl~~dP~~RPs~~ 728 (816)
+.+++.+||..||.+||++.
T Consensus 220 l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 220 ARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred HHHHHHHHhcCCHhhCCCcc
Confidence 89999999999999999995
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=278.92 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=200.7
Q ss_pred HHHHHHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCceeeEeccccC--
Q 003481 462 LADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE-- 536 (816)
Q Consensus 462 ~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-- 536 (816)
|.|+-..|+ ..||+|+|+.|-.++.. |..||||++.+.......++.+|++++.+. .|+||++|+.||++
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 677777776 57999999999988764 899999999988777788899999999999 59999999999965
Q ss_pred CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCC---CeeEeec
Q 003481 537 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL---SSKICDF 613 (816)
Q Consensus 537 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkL~DF 613 (816)
..|||||.|.||+|..+|.++. .+++.++.+++.+|+.||.|||..+ |.||||||+|||-.... -+|||||
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred eEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence 4899999999999999998775 4788999999999999999999987 99999999999996543 4899999
Q ss_pred ccceeccCCCCcC-CCccccCCCCCCCCCCCccccc-----cCCCCcchhHhHHHHHHHHHHhCCCCCCChHH-------
Q 003481 614 GICRLVTEDTLYL-PSFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE------- 680 (816)
Q Consensus 614 Gla~~~~~~~~~~-~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~------- 680 (816)
.+..-+....... .+.-....++|+..|||||+.. ...|+.++|.||||||||-||+|.+||.+.-.
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 8876654322221 1222345778999999999642 23688999999999999999999999953221
Q ss_pred ----------HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 681 ----------VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 681 ----------~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
....+..|++.- ...+| ..++....+|+...+..++.+|-++.+.+
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkYeF----PdkdW-ahIS~eakdlisnLlvrda~~rlsa~~vl 359 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKYEF----PDKDW-AHISSEAKDLISNLLVRDAKQRLSAAQVL 359 (463)
T ss_pred CCccHHHHHHHHHHHhccCCcC----Chhhh-HHhhHHHHHHHHHHHhccHHhhhhhhhcc
Confidence 222233333321 01122 23677889999999999999999887544
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.3e-32 Score=285.49 Aligned_cols=262 Identities=26% Similarity=0.398 Sum_probs=200.9
Q ss_pred HHHhcCCCccceeeeecceEEEEEEEcCeEEEEEEeccCCcccHHHHHHHHHHHhcC--CCCceeeEecccc--C----C
Q 003481 466 QTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL--QHPHLVTLLGACP--E----A 537 (816)
Q Consensus 466 ~~~t~~f~~~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l--~HpnIv~l~g~~~--~----~ 537 (816)
++........+.||+|.||.||+|.+.|..||||++.... ...+.+|.+|++.. +|+||+.+++.-. . .
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccccCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 3444567778899999999999999999999999997543 34577888887754 9999999998752 1 3
Q ss_pred ccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-----cCCCceeeCCCCCCceEecCCCCeeEee
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS-----SKPEKIVHGDLKPQNILLDSELSSKICD 612 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-----~~~~~ivHrDIkp~NILl~~~~~vkL~D 612 (816)
++||.+|.+.|||.|+|.+. .++....++++..+|.||++||. .|.+.|.|||||+.|||+..|+...|+|
T Consensus 284 LwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 78999999999999999763 58889999999999999999995 3445699999999999999999999999
Q ss_pred cccceeccCCCCcCCCccccCCCCCCCCCCCccccccCC----CC--cchhHhHHHHHHHHHHhC----------CCCCC
Q 003481 613 FGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV----LT--PKSDSYSFGLIILQLLTG----------RLPVG 676 (816)
Q Consensus 613 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~s--~ksDVwSlGviL~elltG----------~~Pf~ 676 (816)
+|+|.....+..... -.....+||-.|||||++...- +. ..+||||||.|+||+... ++||.
T Consensus 360 LGLAv~h~~~t~~id--i~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTID--IPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred ceeeEEecccCCccc--CCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 999988776543321 2346678999999999885431 11 268999999999998763 35663
Q ss_pred Ch-------HHHHHHhhcCccccccCCCCCCC-CHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhhh
Q 003481 677 LA-------GEVRRAVSCGKLSSILDPLAGDW-PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740 (816)
Q Consensus 677 ~~-------~~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~~ 740 (816)
.. .+...-+...++...+++ .| .......+.+|+.-||..||.-|-|+- -+.+.|..+..
T Consensus 438 d~Vp~DPs~eeMrkVVCv~~~RP~ipn---rW~s~~~l~~m~klMkeCW~~Np~aRltAL-riKKtl~~l~~ 505 (513)
T KOG2052|consen 438 DVVPSDPSFEEMRKVVCVQKLRPNIPN---RWKSDPALRVMAKLMKECWYANPAARLTAL-RIKKTLAKLSN 505 (513)
T ss_pred cCCCCCCCHHHHhcceeecccCCCCCc---ccccCHHHHHHHHHHHHhhcCCchhhhHHH-HHHHHHHHHhc
Confidence 21 122222222222222221 22 234667899999999999999999988 67777776653
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=280.62 Aligned_cols=218 Identities=24% Similarity=0.207 Sum_probs=176.4
Q ss_pred ecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccCCCchhhhhhh
Q 003481 481 GGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSLQDRLFR 556 (816)
Q Consensus 481 G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL~~~l~~ 556 (816)
|.||.||++.+. ++.||+|.+.... .+.+|...+....||||+++++++.+ ..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999885 8899999986543 23445556666689999999998843 58899999999999999866
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCccccCCCC
Q 003481 557 KSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 636 (816)
Q Consensus 557 ~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 636 (816)
.. .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||.+....... ....
T Consensus 79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---------~~~~ 143 (237)
T cd05576 79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---------DGEA 143 (237)
T ss_pred hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc---------ccCC
Confidence 43 4899999999999999999999987 9999999999999999999999999876654321 2334
Q ss_pred CCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHh
Q 003481 637 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQC 716 (816)
Q Consensus 637 gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~c 716 (816)
++..|+|||++....++.++||||||+++|+|++|..|+...... + . .......|...+..+.+|+.+|
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---~-----~---~~~~~~~~~~~~~~~~~li~~~ 212 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---I-----N---THTTLNIPEWVSEEARSLLQQL 212 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---c-----c---cccccCCcccCCHHHHHHHHHH
Confidence 677899999998888999999999999999999999887532211 0 0 0001123444667899999999
Q ss_pred hccCCCCCCCChH
Q 003481 717 CELYGRERPDITP 729 (816)
Q Consensus 717 l~~dP~~RPs~~e 729 (816)
|+.||.+||++.+
T Consensus 213 l~~dp~~R~~~~~ 225 (237)
T cd05576 213 LQFNPTERLGAGV 225 (237)
T ss_pred ccCCHHHhcCCCc
Confidence 9999999999853
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=302.02 Aligned_cols=260 Identities=26% Similarity=0.373 Sum_probs=215.0
Q ss_pred cCHHHHHHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCceeeEeccc--
Q 003481 460 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGAC-- 534 (816)
Q Consensus 460 ~~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~-- 534 (816)
..++.+..-++.|.+...||.|.+|.||+++.. ++.+|+|++.... ...+++..|.++|..+ .|||++.+||+|
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 344555566788999999999999999998764 8899999987654 3345677899999888 799999999987
Q ss_pred -----cCCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCee
Q 003481 535 -----PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSK 609 (816)
Q Consensus 535 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vk 609 (816)
.+.++||||||.+||..|++.... ...+.|..+..|++.++.||.+||.+. ++|||||-.||||+.++.||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 346899999999999999987766 567999999999999999999999998 99999999999999999999
Q ss_pred EeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccC-----CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH
Q 003481 610 ICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-----VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA 684 (816)
Q Consensus 610 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~ 684 (816)
|+|||.+..+.... .+.....|||.|||||++... .|+..+|+||||++..||--|.+|+.....++.+
T Consensus 164 LvDFGvSaQldsT~------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL 237 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTV------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL 237 (953)
T ss_pred Eeeeeeeeeeeccc------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh
Confidence 99999998876433 456778899999999988543 4778999999999999999999999876665544
Q ss_pred hhcCccccccCCC-CCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 685 VSCGKLSSILDPL-AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 685 ~~~~~~~~~~d~~-~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
+..- . .|. ...-|...+..+.++|..||..|-..||++.+.|.+.+
T Consensus 238 F~Ip---R--NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpF 284 (953)
T KOG0587|consen 238 FLIP---R--NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPF 284 (953)
T ss_pred ccCC---C--CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCc
Confidence 3221 1 111 12236678889999999999999999999986554443
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=314.45 Aligned_cols=143 Identities=29% Similarity=0.405 Sum_probs=126.8
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc---cHHHHHHHHHHHhcCCCCceeeEecccc--CCcccee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~ 542 (816)
++|.+.++||+|+||.||+|.+. +..||||++...... ....+..|+.++..++||||+++++++. +..||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999987 889999999764332 2356889999999999999999998874 4589999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccccee
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 618 (816)
||+.+++|.+++.... .+++..++.|+.||+.||.|||..+ |+||||||+||||+.++.+||+|||+++.
T Consensus 84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 9999999999986543 5788999999999999999999987 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=310.40 Aligned_cols=253 Identities=30% Similarity=0.471 Sum_probs=207.4
Q ss_pred hcCCCccceeeeecceEEEEEEEc---------CeEEEEEEeccCCcc-cHHHHHHHHHHHhcC-CCCceeeEeccccC-
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML---------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKL-QHPHLVTLLGACPE- 536 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~---------g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l-~HpnIv~l~g~~~~- 536 (816)
.++..+.+.||.|.||.|++|... ...||||.++..... ....+..|+.+|..+ +||||+.++|+|..
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 344455568999999999999754 346999999766443 456799999999999 69999999999954
Q ss_pred -CccceeeccCCCchhhhhhhcC-----CC--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEe
Q 003481 537 -AWSLVYEYLPNGSLQDRLFRKS-----NV--------SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 602 (816)
Q Consensus 537 -~~~lV~E~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl 602 (816)
..++|+||+..|+|.++|.... .. ..++..+.+.++.|||.|++||++.. +|||||-..|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence 5889999999999999998765 00 13889999999999999999999977 9999999999999
Q ss_pred cCCCCeeEeecccceeccCCCCcCCCccccCCCCC--CCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCC--
Q 003481 603 DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG--SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGL-- 677 (816)
Q Consensus 603 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~-- 677 (816)
..+..+||+|||+|+.......+. .....| ...|||||.+....|+.++|||||||+||||+| |..||..
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~-----~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYR-----TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred cCCCEEEEccccceeccCCCCceE-----ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 999999999999999776654331 122223 334999999999999999999999999999999 8999975
Q ss_pred -hHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 678 -AGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 678 -~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
...+...+..|... ..|..+..++.++++.||+.+|.+||++. ++...|+..
T Consensus 527 ~~~~l~~~l~~G~r~--------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~-~~~~~~~~~ 579 (609)
T KOG0200|consen 527 PTEELLEFLKEGNRM--------EQPEHCSDEIYDLMKSCWNADPEDRPTFS-ECVEFFEKH 579 (609)
T ss_pred cHHHHHHHHhcCCCC--------CCCCCCCHHHHHHHHHHhCCCcccCCCHH-HHHHHHHHH
Confidence 33444455555443 23556678899999999999999999999 788888774
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=296.50 Aligned_cols=238 Identities=25% Similarity=0.327 Sum_probs=195.1
Q ss_pred HhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCceeeEeccccC--Ccccee
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++..|.....+|.|+|+.|-.+... ++..++|++.....+ ..+|+.++... +||||+++.+.|.+ +.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 3567888888999999999999875 788999999776322 33577666666 79999999999966 478999
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEe-cCCCCeeEeecccceeccC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL-DSELSSKICDFGICRLVTE 621 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl-~~~~~vkL~DFGla~~~~~ 621 (816)
|++.++-|.+.+..... +. ..+..|+.+|+.|+.|||..+ ||||||||+|||+ +..++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 99999988887765432 22 677789999999999999987 9999999999999 5889999999999998765
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChH---HHHHHhhcCccccccCCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG---EVRRAVSCGKLSSILDPLA 698 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~---~~~~~~~~~~~~~~~d~~~ 698 (816)
.. ...+-|..|.|||++....|+++|||||||++||+||+|+.||.... ++...+..+.
T Consensus 469 ~~---------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~--------- 530 (612)
T KOG0603|consen 469 SC---------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPK--------- 530 (612)
T ss_pred hh---------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCc---------
Confidence 41 34467889999999999999999999999999999999999996322 2333333322
Q ss_pred CCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHH
Q 003481 699 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 699 ~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le 736 (816)
+...++....+|+.+||+.||.+||++.+...+.+-
T Consensus 531 --~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 531 --FSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred --cccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 335678899999999999999999999977766655
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-32 Score=275.61 Aligned_cols=200 Identities=26% Similarity=0.353 Sum_probs=165.5
Q ss_pred cCCCccceeeeecceEEEEEEEc------CeEEEEEEeccCCcc-c-HHHHHHHHHHHhcCCCCceeeEeccccC---Cc
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML------GRTVAIKMLYSHNMQ-G-QLEFQQEVRVLSKLQHPHLVTLLGACPE---AW 538 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~------g~~vAiK~l~~~~~~-~-~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~ 538 (816)
..|.....||+|.||.||++... ...+|||.++..... + .....+|+.+++.++|||++.|..+|-. ..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 35778889999999999999553 236999998765322 1 2346789999999999999999988743 48
Q ss_pred cceeeccCCCchhhhhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCC----CCeeEee
Q 003481 539 SLVYEYLPNGSLQDRLFRKS--NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE----LSSKICD 612 (816)
Q Consensus 539 ~lV~E~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~----~~vkL~D 612 (816)
+|+++|.+. +|..+|..+. ....++-..+..|+.||+.|+.|||++. |+||||||.|||+..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 899999965 8888886443 2356888999999999999999999998 9999999999999887 8999999
Q ss_pred cccceeccCCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCC
Q 003481 613 FGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVG 676 (816)
Q Consensus 613 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~ 676 (816)
||+++.+..... .......++-|+.|.|||.+.+ ..||++.||||.|||+.||+|-.+.|.
T Consensus 180 lGlaR~~~~plk---pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 180 LGLARLFNNPLK---PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred ccHHHHhhcccc---ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 999999875442 2233456778999999998766 479999999999999999999888774
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=278.16 Aligned_cols=253 Identities=23% Similarity=0.282 Sum_probs=196.1
Q ss_pred HhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCC--CC----ceeeEecccc--CC
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ--HP----HLVTLLGACP--EA 537 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~--Hp----nIv~l~g~~~--~~ 537 (816)
.+++|.+..++|+|.||.|-.+.+. +..||||+++.-. .-.+...-|+++|.++. -| -+|++.+||+ ++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3789999999999999999999876 6789999986533 22334567999999993 22 3788888884 56
Q ss_pred ccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecC-------------
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS------------- 604 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~------------- 604 (816)
.|||+|.+ |-|+.++|..++ ..+++...+..|+.|++.+++|||+.+ ++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~-y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENN-YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhccCC-ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 88999998 669999996654 467899999999999999999999998 999999999999932
Q ss_pred -------CCCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCC
Q 003481 605 -------ELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGL 677 (816)
Q Consensus 605 -------~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~ 677 (816)
+..++|+|||.|....... ...+.|..|.|||++.+-+++..+||||+||||+||.||...|..
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h---------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH---------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc---------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 3458999999998765433 556789999999999999999999999999999999999998864
Q ss_pred hHHHHH-----------------------HhhcCccc-----------cccCCCC-----CCCCHHHHHHHHHHHHHhhc
Q 003481 678 AGEVRR-----------------------AVSCGKLS-----------SILDPLA-----GDWPTFVARRLVDLGLQCCE 718 (816)
Q Consensus 678 ~~~~~~-----------------------~~~~~~~~-----------~~~d~~~-----~~~~~~~~~~l~~Li~~cl~ 718 (816)
.+.... ....|.+. ...++.. ....+.....|.+|+.+||.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 332111 01111110 0011000 00122455679999999999
Q ss_pred cCCCCCCCChHHHHHHH
Q 003481 719 LYGRERPDITPSLVKEL 735 (816)
Q Consensus 719 ~dP~~RPs~~e~l~~~L 735 (816)
.||.+|+|+.|++.+.+
T Consensus 392 fDP~~RiTl~EAL~HpF 408 (415)
T KOG0671|consen 392 FDPARRITLREALSHPF 408 (415)
T ss_pred cCccccccHHHHhcCHH
Confidence 99999999998887655
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=268.25 Aligned_cols=246 Identities=22% Similarity=0.275 Sum_probs=194.3
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcC-CCCceeeEecccc--CCccce
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACP--EAWSLV 541 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l-~HpnIv~l~g~~~--~~~~lV 541 (816)
++|.....||+|+|+.|..+++. .+.+|+|++++.-. .+..-++.|-.+..+. +||.+|-|..+|. ..+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 46788899999999999999885 67899999877533 2333456787787776 7999999999984 358999
Q ss_pred eeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
.||++||+|.-++.+.. .|+++.+.-+..+|+.||.|||+.| ||.||||.+|+|||..|++||+|+|+++.--.
T Consensus 330 ieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence 99999999988876654 5888999999999999999999988 99999999999999999999999999987543
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCccccccCCCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAG 699 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~~~~~~d~~~~ 699 (816)
... .+...+|||.|+|||++.+..|+..+|+|+|||+++||+.|+.||...+.- .... ...+.+++-....
T Consensus 404 ~gd------~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nt-edylfqvilekqi 476 (593)
T KOG0695|consen 404 PGD------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNT-EDYLFQVILEKQI 476 (593)
T ss_pred CCc------ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccch-hHHHHHHHhhhcc
Confidence 332 346778999999999999999999999999999999999999999643210 0000 0011111111112
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCCh
Q 003481 700 DWPTFVARRLVDLGLQCCELYGRERPDIT 728 (816)
Q Consensus 700 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~ 728 (816)
..|...+-....+++.-|++||.+|....
T Consensus 477 riprslsvkas~vlkgflnkdp~erlgc~ 505 (593)
T KOG0695|consen 477 RIPRSLSVKASHVLKGFLNKDPKERLGCR 505 (593)
T ss_pred cccceeehhhHHHHHHhhcCCcHHhcCCC
Confidence 34555666778888999999999996543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=266.30 Aligned_cols=231 Identities=29% Similarity=0.382 Sum_probs=189.2
Q ss_pred cceEEEEEEEc--CeEEEEEEeccCCccc-HHHHHHHHHHHhcCCCCceeeEecccc--CCccceeeccCCCchhhhhhh
Q 003481 482 GFGCVYKGEML--GRTVAIKMLYSHNMQG-QLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPNGSLQDRLFR 556 (816)
Q Consensus 482 ~~g~Vy~~~~~--g~~vAiK~l~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~~gsL~~~l~~ 556 (816)
+||.||+|... +..|++|++....... ...+.+|+..+++++|+||+++++++. ...++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 68999999986 6899999998766555 678999999999999999999999985 458899999999999999865
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCccccCCCC
Q 003481 557 KSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 636 (816)
Q Consensus 557 ~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 636 (816)
.. .+++..++.++.+++.+|.|||..+ ++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~ 147 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-------LLTTFV 147 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc-------cccccc
Confidence 43 2889999999999999999999987 9999999999999999999999999998876542 124456
Q ss_pred CCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH---HHHHhhcCccccccCCCCCCCCHHHHHHHHHHH
Q 003481 637 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE---VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLG 713 (816)
Q Consensus 637 gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~---~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li 713 (816)
++..|++||.+....++.++||||||+++|+|++|..||..... .......+.... ......++..+.+++
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~i 221 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPF------PPPEWKISPEAKDLI 221 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCC------ccccccCCHHHHHHH
Confidence 88899999999888899999999999999999999999965222 222221111110 000001456899999
Q ss_pred HHhhccCCCCCCCChHHH
Q 003481 714 LQCCELYGRERPDITPSL 731 (816)
Q Consensus 714 ~~cl~~dP~~RPs~~e~l 731 (816)
.+||..+|.+||++.+.+
T Consensus 222 ~~~l~~~p~~Rp~~~~~~ 239 (244)
T smart00220 222 RKLLVKDPEKRLTAEEAL 239 (244)
T ss_pred HHHccCCchhccCHHHHh
Confidence 999999999999998544
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=261.92 Aligned_cols=256 Identities=23% Similarity=0.389 Sum_probs=192.6
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc--ccHHHHHHHHHHHhcCCCCceeeEeccccC----------
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE---------- 536 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---------- 536 (816)
.|....+||+|.||.||+++.. |+.||+|++...+. .-...-.+|+++|..|+|+|++.++..|..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4566678999999999999775 78899987654332 122345789999999999999999998821
Q ss_pred CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccc
Q 003481 537 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 616 (816)
Q Consensus 537 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 616 (816)
..||||.+|+. +|..+|.... ..++..++.+++.++..||.|+|.+. |+|||+||.|+||+.+|.+||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 27899999964 7888875543 46888999999999999999999998 999999999999999999999999999
Q ss_pred eeccCCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHH--h--hcCccc
Q 003481 617 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--V--SCGKLS 691 (816)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~--~--~~~~~~ 691 (816)
+.+........ ...+..+-|..|.+||.+.+ ..|+++.|||+-|||+.||+||.+-|....+.... + ..|.+.
T Consensus 172 r~fs~~~n~~k--prytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 172 RAFSTSKNVVK--PRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cceecccccCC--CCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 87764432211 23466778999999997765 57999999999999999999999998755442221 1 122221
Q ss_pred cccCCCCCCC-----------CH-------------HHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 692 SILDPLAGDW-----------PT-------------FVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 692 ~~~d~~~~~~-----------~~-------------~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
.-+-|...++ +. .-.+...+|+.+++..||.+||+..+++-+.
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 1111111110 00 0122578999999999999999999655443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=289.26 Aligned_cols=258 Identities=21% Similarity=0.240 Sum_probs=181.1
Q ss_pred HhcCCCccceeeeecceEEEEEEE------------------cCeEEEEEEeccCCcccHHH--------------HHHH
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEM------------------LGRTVAIKMLYSHNMQGQLE--------------FQQE 515 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~------------------~g~~vAiK~l~~~~~~~~~~--------------~~~E 515 (816)
.+++|.+.++||+|+||.||+|.+ .++.||||++.......... +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 14679999986544322223 3346
Q ss_pred HHHHhcCCCCce-----eeEecccc----------CCccceeeccCCCchhhhhhhcCC---------------------
Q 003481 516 VRVLSKLQHPHL-----VTLLGACP----------EAWSLVYEYLPNGSLQDRLFRKSN--------------------- 559 (816)
Q Consensus 516 ~~il~~l~HpnI-----v~l~g~~~----------~~~~lV~E~~~~gsL~~~l~~~~~--------------------- 559 (816)
+.++.+++|.++ ++++++|. +..+|||||+++++|.++|.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766654 67777763 236899999999999998864321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCccccCCCCCCC
Q 003481 560 VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 639 (816)
Q Consensus 560 ~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~ 639 (816)
...++|..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......... ......+|+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-----~~~~g~~tp 374 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-----NPLYGMLDP 374 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-----CccccCCCc
Confidence 123578889999999999999999987 999999999999999999999999999765433211 112334588
Q ss_pred CCCCccccccCC--------------------C--CcchhHhHHHHHHHHHHhCCC-CCCChHHHHHHhhc--Cccc--c
Q 003481 640 PYADPEYHRTGV--------------------L--TPKSDSYSFGLIILQLLTGRL-PVGLAGEVRRAVSC--GKLS--S 692 (816)
Q Consensus 640 ~Y~aPE~~~~~~--------------------~--s~ksDVwSlGviL~elltG~~-Pf~~~~~~~~~~~~--~~~~--~ 692 (816)
.|+|||.+.... + ..+.||||+||++|+|++|.. ||............ ..+. .
T Consensus 375 ~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r 454 (507)
T PLN03224 375 RYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR 454 (507)
T ss_pred ceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH
Confidence 999999875332 1 235799999999999999885 76532211111100 0000 0
Q ss_pred ccCCCCCCC--CHHHHHHHHHHHHHhhccCC---CCCCCChHHHHH
Q 003481 693 ILDPLAGDW--PTFVARRLVDLGLQCCELYG---RERPDITPSLVK 733 (816)
Q Consensus 693 ~~d~~~~~~--~~~~~~~l~~Li~~cl~~dP---~~RPs~~e~l~~ 733 (816)
.......++ ....+....+|+.+||..+| .+|+|+.+.|.|
T Consensus 455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000001111 22356789999999999866 689999976643
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=240.62 Aligned_cols=249 Identities=22% Similarity=0.273 Sum_probs=188.5
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc--cHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeec
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 544 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~ 544 (816)
+|...++||+|.||+||+|+.. +..||+|.++.+... -.....+|+-+|+.++|.|||++++... ....||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4666788999999999999875 788999998765432 2345789999999999999999999874 458899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
|.. +|..++...+ ..++.+.+..++.|+++||.|+|+++ +.||||||.|+||+.||.+||+|||+++.+.-...
T Consensus 83 cdq-dlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 954 7888776654 46888999999999999999999998 99999999999999999999999999998764331
Q ss_pred cCCCccccCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHh-CCCCCCChHHHHHH---h-hcCc-----cc--
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRA---V-SCGK-----LS-- 691 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~---~-~~~~-----~~-- 691 (816)
.....+-|..|.+|.++.+. -|++..|+||-|||+.|+.. |++.|...+-..+. + .-|. +.
T Consensus 157 ------cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 157 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred ------eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence 23455679999999987664 58999999999999999998 55556433321111 1 1111 11
Q ss_pred -cccCCCC-CCCCH---------HHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 692 -SILDPLA-GDWPT---------FVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 692 -~~~d~~~-~~~~~---------~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
.+.|... +-+|. .....-.+|+.+.+.-+|..|.++...+
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaal 281 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAAL 281 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHh
Confidence 1111110 11111 1222447889999999999999988544
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=295.12 Aligned_cols=256 Identities=24% Similarity=0.232 Sum_probs=168.8
Q ss_pred HhcCCCccceeeeecceEEEEEEEc------CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecc--------
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEML------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA-------- 533 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~------g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~-------- 533 (816)
..++|...+.||+|+||.||+|++. +..||+|++..... .+.+.++ .+....+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678999999999999999999885 56899998764321 1111121 1222223333333222
Q ss_pred ccCCccceeeccCCCchhhhhhhcCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCC
Q 003481 534 CPEAWSLVYEYLPNGSLQDRLFRKSNV-----------------SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLK 596 (816)
Q Consensus 534 ~~~~~~lV~E~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIk 596 (816)
.....+|||||+.+++|.+++...... .......+..|+.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 123578999999999999988654210 01123345679999999999999987 9999999
Q ss_pred CCceEecC-CCCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccC----------------------CCC
Q 003481 597 PQNILLDS-ELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG----------------------VLT 653 (816)
Q Consensus 597 p~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~s 653 (816)
|+||||+. ++.+||+|||+|+.+...... ......+|+.|+|||.+... .++
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-----~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-----IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-----CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 99999985 579999999999866443221 23456789999999965322 234
Q ss_pred cchhHhHHHHHHHHHHhCCCCCCChHH-HHHHhhcCc-----cccccCCCC-CC------CCHHHHHHHHHHHHHhhccC
Q 003481 654 PKSDSYSFGLIILQLLTGRLPVGLAGE-VRRAVSCGK-----LSSILDPLA-GD------WPTFVARRLVDLGLQCCELY 720 (816)
Q Consensus 654 ~ksDVwSlGviL~elltG~~Pf~~~~~-~~~~~~~~~-----~~~~~d~~~-~~------~~~~~~~~l~~Li~~cl~~d 720 (816)
.++|||||||+||||+++..|+..... ....+.... +...+.+.. .+ ..........+|+.+||+.|
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 567999999999999998877643211 111111110 001111110 00 00011234568999999999
Q ss_pred CCCCCCChHHHHHHH
Q 003481 721 GRERPDITPSLVKEL 735 (816)
Q Consensus 721 P~~RPs~~e~l~~~L 735 (816)
|.+|||+.+.+.+.+
T Consensus 438 P~kR~ta~e~L~Hpf 452 (566)
T PLN03225 438 GRQRISAKAALAHPY 452 (566)
T ss_pred cccCCCHHHHhCCcC
Confidence 999999997665543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-30 Score=294.45 Aligned_cols=248 Identities=31% Similarity=0.405 Sum_probs=191.8
Q ss_pred CCccceeeeecceE-EEEEEEcCeEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCceeeEeccccC--CccceeeccCC
Q 003481 472 FSESFKVGQGGFGC-VYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVYEYLPN 547 (816)
Q Consensus 472 f~~~~~LG~G~~g~-Vy~~~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV~E~~~~ 547 (816)
|...+.+|.|..|+ ||+|.+.|+.||||++.... .....+|+..|+.- .|||||++|+.-.+ ..||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~- 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA- 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-
Confidence 44556689999875 69999999999999985433 22456899999888 69999999987644 3789999994
Q ss_pred CchhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecC---C--CCeeEeecccceeccC
Q 003481 548 GSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS---E--LSSKICDFGICRLVTE 621 (816)
Q Consensus 548 gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~---~--~~vkL~DFGla~~~~~ 621 (816)
.+|.+++.... ......--..+.+..|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++.+..
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 59999997631 1111111335678999999999999988 999999999999975 3 4699999999999887
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhC-CCCCCChHHHHHHhhcCccccccCCCCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTG-RLPVGLAGEVRRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG-~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~ 700 (816)
+... +.+.....||-+|+|||++....-+.++|||||||++|+.++| .+||+..-.-...+..|+..-.. . ..
T Consensus 664 ~~sS---~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~--L-~~ 737 (903)
T KOG1027|consen 664 GKSS---FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVH--L-EP 737 (903)
T ss_pred Ccch---hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceee--e-cc
Confidence 6543 3346778899999999999998888899999999999999995 89998665544445545432111 0 11
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
.+.. ...+||.+|++++|..||++.+.|.|.|
T Consensus 738 ~~d~---eA~dLI~~ml~~dP~~RPsa~~VL~HPl 769 (903)
T KOG1027|consen 738 LPDC---EAKDLISRMLNPDPQLRPSATDVLNHPL 769 (903)
T ss_pred CchH---HHHHHHHHhcCCCcccCCCHHHHhCCCc
Confidence 1111 7889999999999999999997776544
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=243.81 Aligned_cols=205 Identities=25% Similarity=0.401 Sum_probs=164.5
Q ss_pred HHHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCC-cccHHHHHHHHHHHhcC-CCCceeeEeccc--cCCc
Q 003481 465 LQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKL-QHPHLVTLLGAC--PEAW 538 (816)
Q Consensus 465 l~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~-~~~~~~~~~E~~il~~l-~HpnIv~l~g~~--~~~~ 538 (816)
+....+....+..||+|+||.|-+-++. |...|+|.+...- .+.+++..+|+++..+. .+|.+|.+||.. +.+.
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 3333444555667999999998777664 9999999997653 35566788999987766 799999999986 4468
Q ss_pred cceeeccCCCchhhhhhhc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccce
Q 003481 539 SLVYEYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617 (816)
Q Consensus 539 ~lV~E~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 617 (816)
++.||.|+ .||..+-.+. .....+++..+-+|+..+..||.|||+.- .+||||+||+|||++.+|++|+||||++-
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccce
Confidence 89999994 5776654322 22356888888999999999999999975 59999999999999999999999999998
Q ss_pred eccCCCCcCCCccccCCCCCCCCCCCccccc----cCCCCcchhHhHHHHHHHHHHhCCCCCCChH
Q 003481 618 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHR----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAG 679 (816)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~----~~~~s~ksDVwSlGviL~elltG~~Pf~~~~ 679 (816)
.+.+... .+...|-..|||||.+. ...|+.++||||||++++||.+++.||....
T Consensus 198 ~L~dSiA-------kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 198 YLVDSIA-------KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred eehhhhH-------HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 8765442 24456888999999774 3479999999999999999999999997544
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=258.24 Aligned_cols=263 Identities=24% Similarity=0.345 Sum_probs=213.4
Q ss_pred CHHHHHHHhcCCCccceeeeecceEEEEEEEc-------CeEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCceeeEec
Q 003481 461 SLADLQTATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLG 532 (816)
Q Consensus 461 ~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~-------g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g 532 (816)
...+|..-.++++....+-+|.||.||.|.+. .+.|-+|.++....+ ....|..|.-.|..+.|||+..+.|
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 35677777788999999999999999999775 234667776554433 2345788999999999999999999
Q ss_pred cccC---CccceeeccCCCchhhhhh-----hcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecC
Q 003481 533 ACPE---AWSLVYEYLPNGSLQDRLF-----RKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS 604 (816)
Q Consensus 533 ~~~~---~~~lV~E~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~ 604 (816)
++.+ .++++|.++.-|+|..+|. .......++-.+...++.|++.|+.|||+++ |||.||...|.+||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 9843 4789999999999999998 3344556778888999999999999999988 999999999999999
Q ss_pred CCCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHH--H
Q 003481 605 ELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--V 681 (816)
Q Consensus 605 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~--~ 681 (816)
...+||+|=.+++.+-+.+... -...-.....||+||.+.+..|+.++|||||||+||||+| |+.|+...+. +
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhc----LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm 507 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHC----LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM 507 (563)
T ss_pred heeEEeccchhccccCcccccc----cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH
Confidence 9999999999999876655321 1223334567999999999999999999999999999999 9999975553 4
Q ss_pred HHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhh
Q 003481 682 RRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 682 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~ 739 (816)
...+..|... ..|.+++++|..++.-||...|++||++. .|++-|..+.
T Consensus 508 ~~ylkdGyRl--------aQP~NCPDeLf~vMacCWallpeeRPsf~-Qlv~cLseF~ 556 (563)
T KOG1024|consen 508 EHYLKDGYRL--------AQPFNCPDELFTVMACCWALLPEERPSFS-QLVICLSEFH 556 (563)
T ss_pred HHHHhcccee--------cCCCCCcHHHHHHHHHHHhcCcccCCCHH-HHHHHHHHHH
Confidence 4555555432 23556778999999999999999999999 6777776654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=237.57 Aligned_cols=247 Identities=21% Similarity=0.332 Sum_probs=191.8
Q ss_pred hcCCCccceeeeecceEEEEEEE--cCeEEEEEEeccCCcccHHHHHHHHHHHhcCC-CCceeeEeccccC----Cccce
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGACPE----AWSLV 541 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~--~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~----~~~lV 541 (816)
.++|++.+++|+|.|+.||.|.. .+..++||++++- ..+.+.+|+.||..|. ||||++|++...+ .+.||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 46788999999999999999985 4789999999754 3456789999999997 9999999999854 37899
Q ss_pred eeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCC-CCeeEeecccceecc
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVT 620 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DFGla~~~~ 620 (816)
+||+++.+...+. +.|+..++..++.+++.||.|+|+.| |+|||+||.|+++|.. -.++|+|+|+|....
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998887765 45777889999999999999999998 9999999999999864 569999999999887
Q ss_pred CCCCcCCCccccCCCCCCCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCC-h---------------HHHHH
Q 003481 621 EDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGL-A---------------GEVRR 683 (816)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~-~---------------~~~~~ 683 (816)
++.. ....+.+..|--||.+.. ..|+.+-|+|||||+|..|+..+.||.. . ++...
T Consensus 185 p~~e-------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~ 257 (338)
T KOG0668|consen 185 PGKE-------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA 257 (338)
T ss_pred CCce-------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence 6653 244567788999998754 4688999999999999999999999841 1 11111
Q ss_pred HhhcCc------cccccCCC-CCCCCH--------HHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 684 AVSCGK------LSSILDPL-AGDWPT--------FVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 684 ~~~~~~------~~~~~d~~-~~~~~~--------~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
.+..-. +..++... ...|.. -.+++..+|+.+.|..|-.+|||+.+.+.+.
T Consensus 258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence 111111 11111110 111211 2346889999999999999999999766544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-29 Score=248.86 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=189.5
Q ss_pred CCCccceeeeecceEEEEEEEc--CeEEEEEEeccC--CcccHHHHHHHHHHHhcCCCCceeeEecccc-------CCcc
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSH--NMQGQLEFQQEVRVLSKLQHPHLVTLLGACP-------EAWS 539 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~-------~~~~ 539 (816)
+....+.||.|+||.||.+++. |+.||+|++..- +....+.+.+|+.+|.-++|.|++..++... ++.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3455678999999999999885 899999988543 2334567889999999999999999887652 3478
Q ss_pred ceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceec
Q 003481 540 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 619 (816)
Q Consensus 540 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 619 (816)
+|.|.| ..+|..+|... ..|+-..+.-+++||++||.|||+.+ |.||||||.|+|++.|..+||||||+++..
T Consensus 134 V~TELm-QSDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHH-HhhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence 899988 45788877543 46888889999999999999999988 999999999999999999999999999987
Q ss_pred cCCCCcCCCccccCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHH---------------
Q 003481 620 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--------------- 683 (816)
Q Consensus 620 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~--------------- 683 (816)
..+... .++.-+-|..|.|||++.+. .|+.+.||||.|||+.||+..+..|...+.+.+
T Consensus 207 e~d~~~-----hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~Ea 281 (449)
T KOG0664|consen 207 DQRDRL-----NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEA 281 (449)
T ss_pred chhhhh-----hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHH
Confidence 654421 34555678899999988765 799999999999999999999888853322211
Q ss_pred --HhhcCccccccCCC--CCCC--------CHHHHHHHHHHHHHhhccCCCCCCCChHHHHHH
Q 003481 684 --AVSCGKLSSILDPL--AGDW--------PTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 684 --~~~~~~~~~~~d~~--~~~~--------~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~ 734 (816)
...+|.-..++... .+.+ +..-......+..+++..||..|.+..+.+.+.
T Consensus 282 Mr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 282 MKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 11222221121110 1111 112233567788889999999999887655443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-29 Score=272.39 Aligned_cols=251 Identities=25% Similarity=0.314 Sum_probs=207.9
Q ss_pred hcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccc--cCCccceeec
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEY 544 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~--~~~~~lV~E~ 544 (816)
.++|.....+|.|.||.||++++. +...|+|+++.....+..-.++|+-++...+|||||.++|.+ .+..+++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 357888899999999999999886 889999999988878888888999999999999999999998 4679999999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~ 624 (816)
|.+|+|.++-+-. .++++.++...++..+.||+|||+.+ -+|||||-.|||+++.|.+||.|||.+..+....
T Consensus 94 cgggslQdiy~~T---gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati- 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI- 166 (829)
T ss_pred cCCCcccceeeec---ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-
Confidence 9999999976543 47889999999999999999999988 8999999999999999999999999987765432
Q ss_pred cCCCccccCCCCCCCCCCCcccc---ccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCC
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYH---RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 701 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~---~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~ 701 (816)
.+.....||+.|||||+. ..+.|...+|||++|+...|+---++|.......+..... ....++|....-
T Consensus 167 -----~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm--TkS~~qpp~lkD 239 (829)
T KOG0576|consen 167 -----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM--TKSGFQPPTLKD 239 (829)
T ss_pred -----hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh--hccCCCCCcccC
Confidence 345778899999999965 5678999999999999999999888886544443322211 112233332233
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCChHHHHH
Q 003481 702 PTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 702 ~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~ 733 (816)
+......|.+|++.|+..+|++||+...+|.+
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 44566789999999999999999999865543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=262.00 Aligned_cols=258 Identities=23% Similarity=0.295 Sum_probs=199.6
Q ss_pred HHHHhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCC------CCceeeEeccc--
Q 003481 465 LQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ------HPHLVTLLGAC-- 534 (816)
Q Consensus 465 l~~~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~------HpnIv~l~g~~-- 534 (816)
.+...++|.+....|+|-|++|.+|.+. |..||||++....... +.=+.|+.||.+|+ --|+++|+-.|
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 3446678999999999999999999886 8899999997654332 23357999999995 33788888776
Q ss_pred cCCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCC-CCeeEeec
Q 003481 535 PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDF 613 (816)
Q Consensus 535 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DF 613 (816)
.+++|||+|-+ ..+|.++|.+.+..-.|....+..++.|+..||..|-..+ |+|.||||+|||++++ ..+|||||
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccC
Confidence 45799999988 5599999998877677888999999999999999999988 9999999999999865 56999999
Q ss_pred ccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHH--------
Q 003481 614 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRR-------- 683 (816)
Q Consensus 614 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~-------- 683 (816)
|.|........ +...-+..|.|||++.+-+|+...|+||.||+||||.||+..|.+... +..
T Consensus 582 GSA~~~~enei--------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 582 GSASFASENEI--------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK 653 (752)
T ss_pred ccccccccccc--------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC
Confidence 99988765442 233345679999999999999999999999999999999998853321 111
Q ss_pred ----HhhcCccc---------------------------cccCCC---------CCCCCH---HHHHHHHHHHHHhhccC
Q 003481 684 ----AVSCGKLS---------------------------SILDPL---------AGDWPT---FVARRLVDLGLQCCELY 720 (816)
Q Consensus 684 ----~~~~~~~~---------------------------~~~d~~---------~~~~~~---~~~~~l~~Li~~cl~~d 720 (816)
++..|.+. ..+.|. ...+|. ....+|.+|+.+||..|
T Consensus 654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld 733 (752)
T KOG0670|consen 654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD 733 (752)
T ss_pred CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence 11111110 001110 001222 34557899999999999
Q ss_pred CCCCCCChHHHHHHH
Q 003481 721 GRERPDITPSLVKEL 735 (816)
Q Consensus 721 P~~RPs~~e~l~~~L 735 (816)
|++|.+..++|.|.|
T Consensus 734 P~KRit~nqAL~HpF 748 (752)
T KOG0670|consen 734 PEKRITVNQALKHPF 748 (752)
T ss_pred hhhcCCHHHHhcCCc
Confidence 999999998887654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-26 Score=234.00 Aligned_cols=204 Identities=37% Similarity=0.545 Sum_probs=178.3
Q ss_pred eeeecceEEEEEEEc--CeEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccCCCchhh
Q 003481 478 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSLQD 552 (816)
Q Consensus 478 LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL~~ 552 (816)
||.|++|.||++... +..+++|++...... ....+.+|+..+..++|++|+++++++.. ..++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999997 899999999766543 34578999999999999999999999855 6889999999999999
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecC-CCCeeEeecccceeccCCCCcCCCccc
Q 003481 553 RLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-ELSSKICDFGICRLVTEDTLYLPSFHR 631 (816)
Q Consensus 553 ~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~ 631 (816)
++.... ..+++..++.++.+++.+|.|||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~------~ 149 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS------L 149 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc------h
Confidence 987653 35889999999999999999999987 999999999999999 89999999999987654321 1
Q ss_pred cCCCCCCCCCCCccccccC-CCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHHHHHHH
Q 003481 632 STAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 710 (816)
Q Consensus 632 ~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~ 710 (816)
.....+...|++||.+... .++.++|+|+||+++++| ..+.
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------~~~~ 191 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------PELK 191 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------HHHH
Confidence 2345688899999998877 888999999999999999 5788
Q ss_pred HHHHHhhccCCCCCCCChHH
Q 003481 711 DLGLQCCELYGRERPDITPS 730 (816)
Q Consensus 711 ~Li~~cl~~dP~~RPs~~e~ 730 (816)
+++..|++.+|.+||++.+.
T Consensus 192 ~~l~~~l~~~p~~R~~~~~l 211 (215)
T cd00180 192 DLIRKMLQKDPEKRPSAKEI 211 (215)
T ss_pred HHHHHHhhCCcccCcCHHHH
Confidence 99999999999999999843
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-27 Score=249.56 Aligned_cols=128 Identities=27% Similarity=0.363 Sum_probs=108.9
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCC-----C---CceeeEeccccC---
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-----H---PHLVTLLGACPE--- 536 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~-----H---pnIv~l~g~~~~--- 536 (816)
++|.+.++||.|.|++||++.+. .+.||+|+.+... .-.+....|+++|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 68999999999999999999886 6789999986533 23345678999999983 3 379999999832
Q ss_pred ---CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEe
Q 003481 537 ---AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 602 (816)
Q Consensus 537 ---~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl 602 (816)
+.|+|+|++ |.+|..+|..... ..++...+..|+.||+.||.|||..+ +|||-||||+||||
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 489999999 7788888876543 56899999999999999999999987 69999999999999
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=242.82 Aligned_cols=252 Identities=23% Similarity=0.258 Sum_probs=192.1
Q ss_pred hcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccC--CcccHHHHHHHHHHHhcCCCCceeeEecccc--------C
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSH--NMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--------E 536 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--------~ 536 (816)
..+|.....+|.|.- .|-.+-+. +++||+|.+... .........+|..++..++|+||++++.+|. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356777788899988 55555443 899999987543 2234456789999999999999999999982 1
Q ss_pred CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccc
Q 003481 537 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 616 (816)
Q Consensus 537 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 616 (816)
+.|+|||+|. .+|...+.. .++-..+..|+.|++.|+.|||+.+ |+||||||+||++..++.+||.|||+|
T Consensus 95 e~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 4799999994 588887763 3555778899999999999999998 999999999999999999999999999
Q ss_pred eeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhc---------
Q 003481 617 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC--------- 687 (816)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~--------- 687 (816)
+.-..+. ..+..+.|..|.|||++.+..|...+||||+||++.||++|+..|.+.+.+.+....
T Consensus 166 r~e~~~~-------~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 166 RTEDTDF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP 238 (369)
T ss_pred cccCccc-------ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence 8765431 456778999999999998888999999999999999999999988644332221100
Q ss_pred ----------------------CccccccC----CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHH
Q 003481 688 ----------------------GKLSSILD----PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 737 (816)
Q Consensus 688 ----------------------~~~~~~~d----~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~ 737 (816)
-.+.+.+. +...+.+......+.+|+.+||-.||++|.+..++|.|..-.
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 00111110 000111222345688999999999999999999777665443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=231.26 Aligned_cols=196 Identities=36% Similarity=0.515 Sum_probs=169.2
Q ss_pred CCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc-cHHHHHHHHHHHhcCCCCceeeEecccc--CCccceeeccC
Q 003481 472 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLP 546 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~ 546 (816)
|.....||.|++|.||++... +..+++|.+...... ....+.+|+..+.+++|+|++++++++. ...++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 556788999999999999986 689999999876655 5668899999999999999999999885 45889999999
Q ss_pred CCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcC
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626 (816)
Q Consensus 547 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 626 (816)
+++|.+++..... .+++..+..++.+++.+|.|||+.+ ++|+||+|.||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-- 153 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-- 153 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc--
Confidence 9999999876432 2789999999999999999999987 99999999999999999999999999988754320
Q ss_pred CCccccCCCCCCCCCCCcccc-ccCCCCcchhHhHHHHHHHHHHhCCCCCCC
Q 003481 627 PSFHRSTAPKGSFPYADPEYH-RTGVLTPKSDSYSFGLIILQLLTGRLPVGL 677 (816)
Q Consensus 627 ~~~~~~~~~~gt~~Y~aPE~~-~~~~~s~ksDVwSlGviL~elltG~~Pf~~ 677 (816)
.......++..|++||.+ ....++.++|||+||+++|+|++|+.||..
T Consensus 154 ---~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ---ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ---ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 012344678889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-27 Score=255.88 Aligned_cols=193 Identities=22% Similarity=0.328 Sum_probs=165.1
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcc------c--HHHHHHHHHHHhcCC---CCceeeEeccccC
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ------G--QLEFQQEVRVLSKLQ---HPHLVTLLGACPE 536 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~------~--~~~~~~E~~il~~l~---HpnIv~l~g~~~~ 536 (816)
.+|.....||.|+||.|+++.+. ...|+||.+.+...- + ...+-.|+.||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 35888999999999999999986 678999998765421 1 113557999999997 9999999999965
Q ss_pred --CccceeeccC-CCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeec
Q 003481 537 --AWSLVYEYLP-NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 613 (816)
Q Consensus 537 --~~~lV~E~~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DF 613 (816)
.+||+||--. +-+|.++|..+. .+++.+..-|+.||+.|+++||+.+ |||||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 4778888754 448899886653 5899999999999999999999998 999999999999999999999999
Q ss_pred ccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCC-CcchhHhHHHHHHHHHHhCCCCCC
Q 003481 614 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL-TPKSDSYSFGLIILQLLTGRLPVG 676 (816)
Q Consensus 614 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGviL~elltG~~Pf~ 676 (816)
|.|.....+. ....+||.+|.|||++.+.+| +..-|||++|++||.++....||.
T Consensus 715 gsaa~~ksgp--------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGP--------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCC--------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998876554 245689999999999998876 567899999999999999999984
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-26 Score=229.33 Aligned_cols=237 Identities=24% Similarity=0.356 Sum_probs=178.8
Q ss_pred cCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCceeeEecc-c--cCCccceee
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGA-C--PEAWSLVYE 543 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~-~--~~~~~lV~E 543 (816)
+.|.+.+.||+|.||.+.++.+. .+.+++|.+... .....+|.+|...--.| .|.||+.-|.. | .+.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 45888899999999999999997 578999987643 34567899998776566 59999998865 4 234678999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEe-cCC-CCeeEeecccceeccC
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL-DSE-LSSKICDFGICRLVTE 621 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl-~~~-~~vkL~DFGla~~~~~ 621 (816)
|++.|+|..-+... .+-+....+++.|+++||.|+|+.+ +||||||.+|||| +.+ ..+||||||+.+....
T Consensus 103 ~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999999877543 3667788999999999999999988 9999999999999 333 4799999999876543
Q ss_pred CCCcCCCccccCCCCCCCCCCCcccccc---C--CCCcchhHhHHHHHHHHHHhCCCCCCChH------HHHHHhhcCcc
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRT---G--VLTPKSDSYSFGLIILQLLTGRLPVGLAG------EVRRAVSCGKL 690 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~--~~s~ksDVwSlGviL~elltG~~Pf~~~~------~~~~~~~~~~~ 690 (816)
.. ....-+..|.+||.... + ...+.+|||.||+++|.++||.+||.... +-+..+..+..
T Consensus 176 tV---------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 176 TV---------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN 246 (378)
T ss_pred ee---------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC
Confidence 22 23345677999996543 2 35689999999999999999999996211 12333444433
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCCh
Q 003481 691 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 728 (816)
Q Consensus 691 ~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~ 728 (816)
..+ +..-...++.+..+.++-|..+|++|=-+.
T Consensus 247 ~~~-----P~~F~~fs~~a~r~Fkk~lt~~~~drcki~ 279 (378)
T KOG1345|consen 247 PAL-----PKKFNPFSEKALRLFKKSLTPRFKDRCKIW 279 (378)
T ss_pred ccC-----chhhcccCHHHHHHHHHhcCCcccccchhH
Confidence 322 111122556788888999999999994333
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=237.27 Aligned_cols=260 Identities=24% Similarity=0.348 Sum_probs=192.7
Q ss_pred HHHHhcCCCccceeeeecceEEEEEEEc-----CeEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCceeeEeccc--cC
Q 003481 465 LQTATCNFSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGAC--PE 536 (816)
Q Consensus 465 l~~~t~~f~~~~~LG~G~~g~Vy~~~~~-----g~~vAiK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~--~~ 536 (816)
+....+.|...++||.|.|++||++.+. ...||+|.+.... ....+.+|+++|..+ -+.||+++.+++ .+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3345567889999999999999999764 5689999986543 334688999999999 599999999998 45
Q ss_pred CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCC-CCeeEeeccc
Q 003481 537 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGI 615 (816)
Q Consensus 537 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DFGl 615 (816)
...+|+||++.....+++. .++..++..+++.++.||.++|.+| ||||||||+|+|.+.. +.-.|+|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 6899999999998888874 3667889999999999999999988 9999999999999754 6789999999
Q ss_pred ceeccCCC------C-----cC-----------------C-C---------ccccCCCCCCCCCCCccccc-cCCCCcch
Q 003481 616 CRLVTEDT------L-----YL-----------------P-S---------FHRSTAPKGSFPYADPEYHR-TGVLTPKS 656 (816)
Q Consensus 616 a~~~~~~~------~-----~~-----------------~-~---------~~~~~~~~gt~~Y~aPE~~~-~~~~s~ks 656 (816)
|....... . .. + . .......+||++|.|||++. ...-++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 98211000 0 00 0 0 00112457999999999775 45678999
Q ss_pred hHhHHHHHHHHHHhCCCCCCCh----------------HHHHH-HhhcCc--ccc----------------c----cCC-
Q 003481 657 DSYSFGLIILQLLTGRLPVGLA----------------GEVRR-AVSCGK--LSS----------------I----LDP- 696 (816)
Q Consensus 657 DVwSlGviL~elltG~~Pf~~~----------------~~~~~-~~~~~~--~~~----------------~----~d~- 696 (816)
||||.|||++-+++++.||... ..++. +...|. +.+ + +.+
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 9999999999999999998311 11111 111122 111 0 000
Q ss_pred -----CCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 697 -----LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 697 -----~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
....+.+..+..+.+|+.+|+..||.+|.++.++|.+.+
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpF 383 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPF 383 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcC
Confidence 011233344558899999999999999999998776543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-25 Score=272.21 Aligned_cols=201 Identities=17% Similarity=0.136 Sum_probs=141.1
Q ss_pred cCCC-CceeeEecccc---------CCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCce
Q 003481 521 KLQH-PHLVTLLGACP---------EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590 (816)
Q Consensus 521 ~l~H-pnIv~l~g~~~---------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~i 590 (816)
.++| +||+.++++|. +..++++||+ +++|.++|.... ..+++.+++.|+.||+.||.|||+.+ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4556 68888888771 1356778887 669999996532 45899999999999999999999987 9
Q ss_pred eeCCCCCCceEecCC-------------------CCeeEeecccceeccCCCC----c------CCCccccCCCCCCCCC
Q 003481 591 VHGDLKPQNILLDSE-------------------LSSKICDFGICRLVTEDTL----Y------LPSFHRSTAPKGSFPY 641 (816)
Q Consensus 591 vHrDIkp~NILl~~~-------------------~~vkL~DFGla~~~~~~~~----~------~~~~~~~~~~~gt~~Y 641 (816)
+||||||+||||+.. +.+||+|||+++....... . .+.........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 999999999999654 4455666666553211000 0 0000011224689999
Q ss_pred CCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCC
Q 003481 642 ADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYG 721 (816)
Q Consensus 642 ~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP 721 (816)
+|||++.+..++.++|||||||+||||++|.+|+.........+.... +.+. ..........++.+||+++|
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~----~~~~----~~~~~~~~~~~~~~~L~~~P 253 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRV----LPPQ----ILLNWPKEASFCLWLLHPEP 253 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhh----cChh----hhhcCHHHHHHHHHhCCCCh
Confidence 999999999999999999999999999999999764332222221111 1111 01122346788999999999
Q ss_pred CCCCCChHHHHHHH
Q 003481 722 RERPDITPSLVKEL 735 (816)
Q Consensus 722 ~~RPs~~e~l~~~L 735 (816)
.+||++.+++.+.+
T Consensus 254 ~~Rps~~eil~h~~ 267 (793)
T PLN00181 254 SCRPSMSELLQSEF 267 (793)
T ss_pred hhCcChHHHhhchh
Confidence 99999997765443
|
|
| >cd01989 STK_N The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-24 Score=206.54 Aligned_cols=144 Identities=40% Similarity=0.618 Sum_probs=121.3
Q ss_pred EEEEEecCCcccchhhHHHHhhccCC-CCcEEEEEecCCCCCCCCCCCCCCCCcccHHHHHHHHHHHHHHHHHHHHHHHH
Q 003481 24 KVYVALGKCVEKGLSLLHWTLQRFGS-SREICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQKMKKLLDNYLR 102 (816)
Q Consensus 24 ~VlVavD~s~~~s~~Al~wal~~~~~-~~~v~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~ 102 (816)
+||||||+| +.|.+||+||++++.. ++++++|||.+++.......+. .+....+....++.++++++++..
T Consensus 1 ~ILVavD~S-~~s~~al~~a~~~a~~~~~~l~ll~v~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~~~~ 72 (146)
T cd01989 1 SVAVAVDKD-KKSKNALKWALDNLATKGQTIVLVHVHPPITSIPSSSGK-------LEVASAYKQEEDKEAKELLLPYRC 72 (146)
T ss_pred CEEEEecCc-cccHHHHHHHHHhccCCCCcEEEEEeccCcccCCCCccc-------hHHHHHHHHHHHHHHHHHHHHHHH
Confidence 599999995 4599999999999887 8999999999765432221110 122333445556788999999999
Q ss_pred HHHHhccceEEEEEecCCHHHHHHHHHHHhCCCEEEeccCCCCcchhhcCC-cchhhhhhcCCCCceEEEEeCC
Q 003481 103 ICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAFPDNCMKVKMGS-RKASYAAKNAPMFCEIWFVNKG 175 (816)
Q Consensus 103 ~c~~~~v~~~~~v~e~~d~~~~Iv~~a~~~~id~lVmGs~g~~~~~R~~~g-sVs~~V~~~ap~~C~V~vv~~g 175 (816)
.|...+++++..++++++|+++|+++|+++++|+||||+||++++.|.++| ||+++|++++|++|+|+||++|
T Consensus 73 ~~~~~~~~~~~~~~~g~~~~~~I~~~a~~~~~dlIV~Gs~g~~~l~~~~~gssva~~Vi~~a~~~c~Vlvv~~~ 146 (146)
T cd01989 73 FCSRKGVQCEDVVLEDDDVAKAIVEYVADHGITKLVMGASSDNHFSMKFKKSDVASSVLKEAPDFCTVYVVSKG 146 (146)
T ss_pred HHhhcCCeEEEEEEeCCcHHHHHHHHHHHcCCCEEEEeccCCCceeecccCCchhHHHHhcCCCCceEEEEeCc
Confidence 999999999999988888999999999999999999999999999999776 7999999999999999999998
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=212.09 Aligned_cols=162 Identities=23% Similarity=0.209 Sum_probs=124.1
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
|+|.+++...+ ..++|..++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 68999987543 46999999999999999999999964 999999999999999 99988764321
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHH---HHhhcCccccccCCCCCCCCHH
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR---RAVSCGKLSSILDPLAGDWPTF 704 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~---~~~~~~~~~~~~d~~~~~~~~~ 704 (816)
..||+.|+|||++.+..++.++|||||||++|||+||+.||....... ..+..+... .++.....+..
T Consensus 64 -------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 134 (176)
T smart00750 64 -------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA--DDPRDRSNLES 134 (176)
T ss_pred -------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc--CCccccccHHH
Confidence 258999999999999999999999999999999999999996443221 111111111 11111112233
Q ss_pred HHH--HHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 705 VAR--RLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 705 ~~~--~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
... .+.+++.+||..+|.+||++.+.+.+..
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~ 167 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYLAHCR 167 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence 444 6999999999999999999996554443
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.1e-23 Score=224.90 Aligned_cols=173 Identities=18% Similarity=0.182 Sum_probs=133.3
Q ss_pred HHHHHHhcCCCccceeeeecceEEEEEEEc---CeEEEEEEeccCC-----cccHHHHHHHHHHHhcCCCCceee-Eecc
Q 003481 463 ADLQTATCNFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHN-----MQGQLEFQQEVRVLSKLQHPHLVT-LLGA 533 (816)
Q Consensus 463 ~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~---g~~vAiK~l~~~~-----~~~~~~~~~E~~il~~l~HpnIv~-l~g~ 533 (816)
+.+....++|.....||+|+||.||+|.+. +..||||++.... ......|.+|+.+|.+++|+|+++ ++++
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 345566778999999999999999999873 6778999875331 122456899999999999999985 5443
Q ss_pred ccCCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCC-CCCceEecCCCCeeEee
Q 003481 534 CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDL-KPQNILLDSELSSKICD 612 (816)
Q Consensus 534 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDI-kp~NILl~~~~~vkL~D 612 (816)
+..+|||||++|++|.. +. . .. ...++.+++.||.|||+.+ |+|||| ||+|||++.++.+||+|
T Consensus 91 --~~~~LVmE~~~G~~L~~-~~-~-----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHL-AR-P-----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred --CCcEEEEEccCCCCHHH-hC-c-----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence 45799999999999963 21 1 11 1467899999999999987 999999 99999999999999999
Q ss_pred cccceeccCCCCcCC--CccccCCCCCCCCCCCccccccC
Q 003481 613 FGICRLVTEDTLYLP--SFHRSTAPKGSFPYADPEYHRTG 650 (816)
Q Consensus 613 FGla~~~~~~~~~~~--~~~~~~~~~gt~~Y~aPE~~~~~ 650 (816)
||+|+.+........ ....-+...+++.|+|||++...
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999998765432110 01112466789999999988643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.3e-22 Score=216.71 Aligned_cols=261 Identities=23% Similarity=0.270 Sum_probs=192.9
Q ss_pred CCCccceeeeecceEEEEEEEcC---eEEEEEEeccCCcccHHHHHHHHHHHhcCCC----CceeeEecccc-C--Cccc
Q 003481 471 NFSESFKVGQGGFGCVYKGEMLG---RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH----PHLVTLLGACP-E--AWSL 540 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~g---~~vAiK~l~~~~~~~~~~~~~E~~il~~l~H----pnIv~l~g~~~-~--~~~l 540 (816)
+|.+..+||+|+||.||.+.... ..+|+|+...........+..|+.++..+.. +++..+++... . ..++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 89999999999999999999863 4699998876544333367889999998863 57888877762 2 4789
Q ss_pred eeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCC-----CCeeEeeccc
Q 003481 541 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-----LSSKICDFGI 615 (816)
Q Consensus 541 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~-----~~vkL~DFGl 615 (816)
||+.+ |.+|.++..... ...++..+.++|+.|++.+|.+||+.| ++||||||+|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 889999775554 467899999999999999999999988 9999999999999765 4699999999
Q ss_pred ce--eccCCCCc--CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH--HHHhhcCc
Q 003481 616 CR--LVTEDTLY--LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGK 689 (816)
Q Consensus 616 a~--~~~~~~~~--~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~~~~ 689 (816)
++ ........ .+.........||..|+++....+...+.+.|+||++.++.+++.|..||...... ...+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 99 33222211 11111123456999999999999999999999999999999999999999543321 11111111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhhhc
Q 003481 690 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVA 741 (816)
Q Consensus 690 ~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~~~ 741 (816)
....... .....+..+..+...+-..+...+|... .+...|......
T Consensus 254 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~-~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 254 RKLLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYE-KLAELLKDVFDS 300 (322)
T ss_pred hhhcccc----ccCCChHHHHHHHHHhhccCCcCCCCHH-HHHHHHHHHHHh
Confidence 1111111 1122334666666667779999999998 677777665543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.7e-22 Score=202.10 Aligned_cols=258 Identities=21% Similarity=0.264 Sum_probs=195.3
Q ss_pred hcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCceeeEeccccC--Cccceee
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVYE 543 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV~E 543 (816)
.-+|.++++||+|+||.++.|+.. +.+||||.-...+. .-++..|.+..+.| ..++|...|.|-.+ ...||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 348999999999999999999874 89999998654432 23567788888887 57888888766554 4679999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCC-----CCeeEeeccccee
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-----LSSKICDFGICRL 618 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~-----~~vkL~DFGla~~ 618 (816)
++ |-||+|++.-++ ..++.+.++.|+.|++.-++|+|+.. +|.|||||+|+||..- ..+.|+|||+|+.
T Consensus 105 LL-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 99 889999887655 46889999999999999999999988 9999999999999643 3489999999998
Q ss_pred ccCCCCc-CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH-----HHHHhhcCcccc
Q 003481 619 VTEDTLY-LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE-----VRRAVSCGKLSS 692 (816)
Q Consensus 619 ~~~~~~~-~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~-----~~~~~~~~~~~~ 692 (816)
+.+.... ...+.......||..||+--...+..-+...|.-|||-++++.|-|..||..... -.+.+...+-..
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 7654322 1233455677899999999998899999999999999999999999999974332 112222112111
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhh
Q 003481 693 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 693 ~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~ 739 (816)
.+..++..+| .++..-+.-.-..+-.+-|+.. -+...+..+.
T Consensus 259 ~i~~Lc~g~P----~efa~Yl~yvR~L~F~E~PDYd-ylr~Lf~dvl 300 (449)
T KOG1165|consen 259 PIEVLCEGFP----EEFATYLRYVRRLDFFETPDYD-YLRKLFDDVL 300 (449)
T ss_pred CHHHHHhcCH----HHHHHHHHHHHhcCcccCCCHH-HHHHHHHHHH
Confidence 1222223344 4556666667778888999987 6666665543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.3e-23 Score=204.63 Aligned_cols=253 Identities=24% Similarity=0.415 Sum_probs=194.6
Q ss_pred cCHHHHHHHhcCCCccceeeeecceEEEEEEEcCeEEEEEEeccCCccc--HHHHHHHHHHHhcCCCCceeeEeccccC-
Q 003481 460 FSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLGACPE- 536 (816)
Q Consensus 460 ~~~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~--~~~~~~E~~il~~l~HpnIv~l~g~~~~- 536 (816)
+++.+|...| +|.....|..|+|++.|..++.|++.-..... ...|..|.-.|+-+.||||+.++|.|..
T Consensus 187 id~~~lnl~t-------kl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp 259 (448)
T KOG0195|consen 187 IDVSSLNLIT-------KLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP 259 (448)
T ss_pred cchhhhhhhh-------hhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC
Confidence 4555555444 58999999999999999999999987654332 3468999999999999999999999954
Q ss_pred -CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccc
Q 003481 537 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 615 (816)
Q Consensus 537 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGl 615 (816)
++.++..||+.|+|...|+...+ -.++-.+..+++.++++|++|||+..| -|.---|.+..+++|++.+++|+- +-
T Consensus 260 pnlv~isq~mp~gslynvlhe~t~-vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-ad 336 (448)
T KOG0195|consen 260 PNLVIISQYMPFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-AD 336 (448)
T ss_pred CCceEeeeeccchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-cc
Confidence 57789999999999999987654 235667899999999999999999883 233446899999999999888752 11
Q ss_pred ceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCC---cchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCcccc
Q 003481 616 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLT---PKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSS 692 (816)
Q Consensus 616 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s---~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~ 692 (816)
+++. + ......-.|.||+||.++..+-+ .++|+|||.++||||.|...||........ |. .-
T Consensus 337 ~kfs---------f-qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec----gm-ki 401 (448)
T KOG0195|consen 337 TKFS---------F-QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC----GM-KI 401 (448)
T ss_pred ceee---------e-eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh----hh-hh
Confidence 1110 0 11233457899999998876543 489999999999999999999975554322 11 11
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 693 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 693 ~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
.+.......|+..+..+.+|+.-|+..||.+||.+. .++..|+.+
T Consensus 402 aleglrv~ippgis~hm~klm~icmnedpgkrpkfd-mivpilekm 446 (448)
T KOG0195|consen 402 ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFD-MIVPILEKM 446 (448)
T ss_pred hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcc-eehhhHHHh
Confidence 123334456788899999999999999999999998 677777764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.1e-21 Score=204.31 Aligned_cols=260 Identities=29% Similarity=0.410 Sum_probs=197.6
Q ss_pred CCccceeeeecceEEEEEEEcCeEEEEEEeccCCccc---HHHHHHHHHHHhcCCCC-ceeeEeccccCC--ccceeecc
Q 003481 472 FSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQHP-HLVTLLGACPEA--WSLVYEYL 545 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~---~~~~~~E~~il~~l~Hp-nIv~l~g~~~~~--~~lV~E~~ 545 (816)
|.....||.|+||.||++.+. ..+++|.+....... ...|.+|+.++..+.|+ +|+++++++... .+++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 566778999999999999988 889999987765443 56799999999999988 799999988443 58999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCC-CeeEeecccceeccCCCC
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICDFGICRLVTEDTL 624 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~~~~~~ 624 (816)
.+++|.+++........++......++.|++.++.|+|..+ ++||||||+||+++..+ .++++|||+++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999966654321125788999999999999999999988 99999999999999988 699999999986654332
Q ss_pred cCCCccccCCCCCCCCCCCcccccc---CCCCcchhHhHHHHHHHHHHhCCCCCCChH------HHHHHhhcCccccccC
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRT---GVLTPKSDSYSFGLIILQLLTGRLPVGLAG------EVRRAVSCGKLSSILD 695 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVwSlGviL~elltG~~Pf~~~~------~~~~~~~~~~~~~~~d 695 (816)
............||..|++||.+.. ..++...|+||+|++++++++|..||.... .....+..........
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 1100012466789999999999887 578999999999999999999999986543 2222222221110000
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 696 PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 696 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
......+......+.+++..|+..+|..|.+........+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~ 277 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDL 277 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchH
Confidence 1111111223457899999999999999999986555533
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=192.20 Aligned_cols=259 Identities=23% Similarity=0.277 Sum_probs=199.2
Q ss_pred hcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCC-CceeeEecccc--CCccceee
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH-PHLVTLLGACP--EAWSLVYE 543 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~g~~~--~~~~lV~E 543 (816)
.++|...++||.|+||.+|.|... |..||||+-+..... .++..|..+...|++ ..|..+..+.. +...+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 467999999999999999999874 899999997655433 346678899999975 45555555553 34779999
Q ss_pred ccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCC---CCeeEeecccceecc
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE---LSSKICDFGICRLVT 620 (816)
Q Consensus 544 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~---~~vkL~DFGla~~~~ 620 (816)
.+ |.||++++.-.. ..++..+++-++-|++.-++|+|..+ +|||||||+|+|..-+ ..+.|+|||+|+.+.
T Consensus 92 LL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 99 889999887665 36888999999999999999999988 9999999999999643 458999999999875
Q ss_pred CCCCc-CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHH-----HHHhhcCcccccc
Q 003481 621 EDTLY-LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV-----RRAVSCGKLSSIL 694 (816)
Q Consensus 621 ~~~~~-~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~-----~~~~~~~~~~~~~ 694 (816)
+.... ...+.......||..|.+--...+...+...|+-|+|.+|.++.-|..||...... ...+...++...+
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 43221 11334556778999999988887777889999999999999999999999754432 2233333444333
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhhh
Q 003481 695 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740 (816)
Q Consensus 695 d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~~ 740 (816)
...+..+|. ++.-.+.-|-...-++-|+.. -|.+.+.-|..
T Consensus 246 e~LC~G~P~----EF~myl~Y~R~L~F~E~Pdy~-ylrqlFriLfr 286 (341)
T KOG1163|consen 246 EVLCKGFPA----EFAMYLNYCRGLGFEEKPDYM-YLRQLFRILFR 286 (341)
T ss_pred HHHhCCCcH----HHHHHHHHHhhcCCCCCCcHH-HHHHHHHHHHh
Confidence 334445554 667778889999999999987 66666665543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.7e-21 Score=193.51 Aligned_cols=169 Identities=14% Similarity=0.089 Sum_probs=134.0
Q ss_pred HhcCCCccceeeeecceEEEEEEEcCeEEEEEEeccCCcccHHH---------HHHHHHHHhcCCCCceeeEecccc---
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLE---------FQQEVRVLSKLQHPHLVTLLGACP--- 535 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~~~~---------~~~E~~il~~l~HpnIv~l~g~~~--- 535 (816)
..++|...+.||.|+||.||+....+..+|||++.......... +.+|+..+.++.||+|..+..++.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 46889999999999999999987778899999997665443332 679999999999999999887742
Q ss_pred -------CCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCe
Q 003481 536 -------EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 608 (816)
Q Consensus 536 -------~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 608 (816)
...+|||||++|.+|.++.. ++. ....+++.+|..||..+ ++||||||+||+++.+| +
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence 23789999999999988631 222 34569999999999988 99999999999999988 9
Q ss_pred eEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHH
Q 003481 609 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLL 669 (816)
Q Consensus 609 kL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ell 669 (816)
+|+|||........... .-++....|..++|+|+||+++..+.
T Consensus 174 ~liDfg~~~~~~e~~a~------------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK------------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH------------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999987655322210 01444455778999999999987664
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.4e-20 Score=185.43 Aligned_cols=138 Identities=19% Similarity=0.247 Sum_probs=107.4
Q ss_pred cceeeeecceEEEEEEEc-CeEEEEEEeccCCcc--c-------HHHH-----------------HHHHHHHhcCCCCce
Q 003481 475 SFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQ--G-------QLEF-----------------QQEVRVLSKLQHPHL 527 (816)
Q Consensus 475 ~~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~--~-------~~~~-----------------~~E~~il~~l~HpnI 527 (816)
...||+|+||.||+|.+. |+.||||+++..... . ...| ..|+.+|.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 357999999999999885 899999999765321 1 1122 349999999987776
Q ss_pred eeEeccccCCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCceeeCCCCCCceEecCCC
Q 003481 528 VTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL-HSSKPEKIVHGDLKPQNILLDSEL 606 (816)
Q Consensus 528 v~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~ivHrDIkp~NILl~~~~ 606 (816)
.....+.....+|||||+++++|...+... ..+++.....++.|++.+|.|| |+.+ |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILLKSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEecCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CC
Confidence 433332233458999999988776553322 3588899999999999999999 6877 99999999999998 47
Q ss_pred CeeEeecccceec
Q 003481 607 SSKICDFGICRLV 619 (816)
Q Consensus 607 ~vkL~DFGla~~~ 619 (816)
.++|+|||+|...
T Consensus 155 ~v~LiDFG~a~~~ 167 (190)
T cd05147 155 KLYIIDVSQSVEH 167 (190)
T ss_pred cEEEEEccccccC
Confidence 8999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-20 Score=218.05 Aligned_cols=246 Identities=24% Similarity=0.264 Sum_probs=177.0
Q ss_pred CCCccceeeeecceEEEEEEEcCeEEEEEEeccCCc-ccHHHHHH---HHHHHhcCCCCceeeEeccc--cCCccceeec
Q 003481 471 NFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNM-QGQLEFQQ---EVRVLSKLQHPHLVTLLGAC--PEAWSLVYEY 544 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~-~~~~~~~~---E~~il~~l~HpnIv~l~g~~--~~~~~lV~E~ 544 (816)
+|...+.||.+.|=+|.+|+++...|+||++.+... -....|.+ |++ ...++|||++++.-+- ....|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 677778899999999999999866799999976653 23334443 444 4556999999987664 3347899999
Q ss_pred cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccccee--ccCC
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL--VTED 622 (816)
Q Consensus 545 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~--~~~~ 622 (816)
+.. +|.|.|..+ +.|..-+...|+.|++.||.-+|..+ |+|||||.+||||+.-.-+.|+||..-+. ++.+
T Consensus 103 vkh-nLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 954 899988543 34666778889999999999999988 99999999999999988899999976543 2333
Q ss_pred CCcCCCccccCCCCCCCCCCCcccccc----------CC-CCcchhHhHHHHHHHHHHh-CCCCCCChHHHHHHhhcCcc
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRT----------GV-LTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKL 690 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~----------~~-~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~ 690 (816)
......+...+.. .-.+|+|||.|.. .. ++++.||||+||++.||++ |++||....-. .++.|.
T Consensus 176 NPadf~fFFDTSr-RRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~--aYr~~~- 251 (1431)
T KOG1240|consen 176 NPADFTFFFDTSR-RRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLL--AYRSGN- 251 (1431)
T ss_pred CcccceEEEecCC-ceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHH--hHhccC-
Confidence 3222233333333 3457999997643 12 7889999999999999999 78888644322 122221
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 691 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 691 ~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
........... ....+.+|++.|++.||.+|-++.+.|
T Consensus 252 ~~~~e~~Le~I---ed~~~Rnlil~Mi~rdPs~RlSAedyL 289 (1431)
T KOG1240|consen 252 ADDPEQLLEKI---EDVSLRNLILSMIQRDPSKRLSAEDYL 289 (1431)
T ss_pred ccCHHHHHHhC---cCccHHHHHHHHHccCchhccCHHHHH
Confidence 10000001111 123689999999999999999998433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-20 Score=217.79 Aligned_cols=250 Identities=22% Similarity=0.267 Sum_probs=179.5
Q ss_pred CccceeeeecceEEEEEEEc--CeEEEEEEeccC--Cccc----HHHHHHHHHHHhcCCCCceeeEeccccC--Ccccee
Q 003481 473 SESFKVGQGGFGCVYKGEML--GRTVAIKMLYSH--NMQG----QLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 473 ~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~--~~~~----~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
.....+|.|.+|.|+..... ...++.|.+... .... ...+..|+-+-..+.|||++..+..+.+ ..+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34568999999988777553 333444433211 1111 1125567777888899999887766633 233459
Q ss_pred eccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCC
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~ 622 (816)
|||++ +|..++.... .+.-.++..++.|++.|+.|||..| |.||||||+|++++.+|.+||+|||.+..+.-.
T Consensus 401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 9999887652 4667888999999999999999998 999999999999999999999999999876533
Q ss_pred CCcCCCccccCCCCCCCCCCCccccccCCCCc-chhHhHHHHHHHHHHhCCCCCCChHHHHHHh--hcCccccccCCCCC
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTP-KSDSYSFGLIILQLLTGRLPVGLAGEVRRAV--SCGKLSSILDPLAG 699 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~-ksDVwSlGviL~elltG~~Pf~~~~~~~~~~--~~~~~~~~~d~~~~ 699 (816)
... .........|+..|+|||++.+..|.+ ..||||.|++++.|++|+.||.....-.... ..+.....+.....
T Consensus 474 ~e~--~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~ 551 (601)
T KOG0590|consen 474 WEK--NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN 551 (601)
T ss_pred cch--hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence 211 123456788999999999999998876 6999999999999999999996443321110 00100000000011
Q ss_pred CCCHHHHHHHHHHHHHhhccCCCCCCCChHHH
Q 003481 700 DWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 700 ~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l 731 (816)
..-...+.....++.++|+++|.+|.++.+++
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~ 583 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQIL 583 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHh
Confidence 11234566789999999999999999999544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-19 Score=181.46 Aligned_cols=189 Identities=17% Similarity=0.101 Sum_probs=142.1
Q ss_pred CccceeeeecceEEEEEEEcCeEEEEEEeccCCccc----HHHHHHHHHHHhcCC-CCceeeEeccccCCccceeeccCC
Q 003481 473 SESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQG----QLEFQQEVRVLSKLQ-HPHLVTLLGACPEAWSLVYEYLPN 547 (816)
Q Consensus 473 ~~~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~----~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~lV~E~~~~ 547 (816)
.+...|++|+||+||.+...+.+++.+.+.....-. ...|.+|+++|.+|. |+++++++++ +..+++|+|+.|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--~~~~lvmeyI~G 82 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--DGRHLDRSYLAG 82 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--cCEEEEEeeecC
Confidence 345679999999999888888999988876554311 124789999999995 5889999886 457999999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCC-CCCceEecCCCCeeEeecccceeccCCCCcC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDL-KPQNILLDSELSSKICDFGICRLVTEDTLYL 626 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDI-kp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 626 (816)
.+|...+.. ....++.|++.+|.++|..+ |+|||| ||+|||++.++.++|+|||+|..........
T Consensus 83 ~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 83 AAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 998654311 12457889999999999988 999999 7999999999999999999998655432100
Q ss_pred CCcc-------ccCCCCCCCCCCCccccccC-CCC-cchhHhHHHHHHHHHHhCCCCCC
Q 003481 627 PSFH-------RSTAPKGSFPYADPEYHRTG-VLT-PKSDSYSFGLIILQLLTGRLPVG 676 (816)
Q Consensus 627 ~~~~-------~~~~~~gt~~Y~aPE~~~~~-~~s-~ksDVwSlGviL~elltG~~Pf~ 676 (816)
.... .......++.|++|+...-- ..+ ...++++-|+.+|.++||..|.-
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0000 00112368889999844321 233 67899999999999999998863
|
|
| >PRK15456 universal stress protein UspG; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.9e-19 Score=170.73 Aligned_cols=139 Identities=12% Similarity=0.128 Sum_probs=106.7
Q ss_pred cEEEEEecCCc-ccchhhHHHHhhccCCCCcEEEEEecCCCCCCCCCCCCCCCCcccHHHHHHHHHHHHHHHHHHHHHHH
Q 003481 23 EKVYVALGKCV-EKGLSLLHWTLQRFGSSREICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQKMKKLLDNYL 101 (816)
Q Consensus 23 ~~VlVavD~s~-~~s~~Al~wal~~~~~~~~v~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~ 101 (816)
++||||||+|. +.|.+|++||+......+.+++|||.++...... .... .....+.+...+..++.++++.
T Consensus 3 ~~ILv~vD~S~~~~s~~al~~A~~la~~~~~l~llhv~~~~~~~~~--~~~~------~~~~~~~~~~~~~~~~~l~~~~ 74 (142)
T PRK15456 3 KTIIMPVDVFEMELSDKAVRHAEFLAQDDGVIHLLHVLPGSASLSL--HRFA------ADVRRFEEHLQHEAEERLQTMV 74 (142)
T ss_pred ccEEEeccCCchhHHHHHHHHHHHHHhcCCeEEEEEEecCcccccc--cccc------cchhhHHHHHHHHHHHHHHHHH
Confidence 68999999963 4589999999986554568999999976432111 1000 0112233444566777788887
Q ss_pred HHHHHhccceEEEEEecCCHHHHHHHHHHHhCCCEEEeccCCCCcchhhcCCcchhhhhhcCCCCceEEEEe
Q 003481 102 RICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFVN 173 (816)
Q Consensus 102 ~~c~~~~v~~~~~v~e~~d~~~~Iv~~a~~~~id~lVmGs~g~~~~~R~~~gsVs~~V~~~ap~~C~V~vv~ 173 (816)
......+++++..+.+| ++++.|+++|+++++|+||||+||++ +.+.++||++++|+++++ |+|+||+
T Consensus 75 ~~~~~~~~~v~~~v~~G-~~~~~I~~~a~~~~~DLIVmG~~g~~-~~~~llGS~a~~v~~~a~--~pVLvV~ 142 (142)
T PRK15456 75 SHFTIDPSRIKQHVRFG-SVRDEVNELAEELGADVVVIGSRNPS-ISTHLLGSNASSVIRHAN--LPVLVVR 142 (142)
T ss_pred HHhCCCCcceEEEEcCC-ChHHHHHHHHhhcCCCEEEEcCCCCC-ccceecCccHHHHHHcCC--CCEEEeC
Confidence 77766678888877665 67899999999999999999999976 888899999999999999 9999984
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.5e-19 Score=179.04 Aligned_cols=140 Identities=19% Similarity=0.200 Sum_probs=110.7
Q ss_pred cceeeeecceEEEEEEEc-CeEEEEEEeccCCccc--------------------------HHHHHHHHHHHhcCCCCce
Q 003481 475 SFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQG--------------------------QLEFQQEVRVLSKLQHPHL 527 (816)
Q Consensus 475 ~~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~~--------------------------~~~~~~E~~il~~l~HpnI 527 (816)
...||+|+||.||+|.+. |+.||||+++...... ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 457999999999999885 9999999997653210 1124578999999999987
Q ss_pred eeEeccccCCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceeeCCCCCCceEecCCC
Q 003481 528 VTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS-SKPEKIVHGDLKPQNILLDSEL 606 (816)
Q Consensus 528 v~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivHrDIkp~NILl~~~~ 606 (816)
.....+.....+|||||++|+++....... ..++......|+.+++.+|.+||+ .+ |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLKKNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEecCCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CC
Confidence 544333333468999999988654432222 246778899999999999999999 77 99999999999999 88
Q ss_pred CeeEeecccceeccC
Q 003481 607 SSKICDFGICRLVTE 621 (816)
Q Consensus 607 ~vkL~DFGla~~~~~ 621 (816)
.++|+|||++.....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.6e-20 Score=207.18 Aligned_cols=222 Identities=27% Similarity=0.340 Sum_probs=180.4
Q ss_pred eeeecceEEEEEE-----EcCeEEEEEEeccCCccc--HHHHHHHHHHHhcCC-CCceeeEecccc--CCccceeeccCC
Q 003481 478 VGQGGFGCVYKGE-----MLGRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQ-HPHLVTLLGACP--EAWSLVYEYLPN 547 (816)
Q Consensus 478 LG~G~~g~Vy~~~-----~~g~~vAiK~l~~~~~~~--~~~~~~E~~il~~l~-HpnIv~l~g~~~--~~~~lV~E~~~~ 547 (816)
+|.|.||.|++++ +.|..+|+|++++..... ......|..++..++ ||.+|++...+. ...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999753 347889999987664321 114567888999996 999999998873 468999999999
Q ss_pred CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCC
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 627 (816)
|.|...+.... .++......+...++-++.++|+.+ |+|||+|++||+++.+|++++.|||+++..-...
T Consensus 82 g~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 82 GDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred chhhhccccCC---chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 99988876554 3566777788899999999999998 9999999999999999999999999998875433
Q ss_pred CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHHHH
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVAR 707 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 707 (816)
..+||..|||||++. ....+.|+||||++++||+||..||.. ++...+.. .....|.+.+.
T Consensus 152 ------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--~~~~~Il~---------~~~~~p~~l~~ 212 (612)
T KOG0603|consen 152 ------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--DTMKRILK---------AELEMPRELSA 212 (612)
T ss_pred ------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--HHHHHHhh---------hccCCchhhhH
Confidence 127999999999998 578899999999999999999999975 22222211 12345778888
Q ss_pred HHHHHHHHhhccCCCCCCCCh
Q 003481 708 RLVDLGLQCCELYGRERPDIT 728 (816)
Q Consensus 708 ~l~~Li~~cl~~dP~~RPs~~ 728 (816)
....++..++..+|..|--..
T Consensus 213 ~a~~~~~~l~~r~p~nrLg~~ 233 (612)
T KOG0603|consen 213 EARSLFRQLFKRNPENRLGAG 233 (612)
T ss_pred HHHHHHHHHHhhCHHHHhccC
Confidence 899999999999999997764
|
|
| >PRK15005 universal stress protein F; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.6e-18 Score=166.68 Aligned_cols=140 Identities=13% Similarity=0.185 Sum_probs=104.1
Q ss_pred cEEEEEecCCccc-chhhHHHHhhccCC-CCcEEEEEecCCCCCCCCCCCCCCCCcccHHHHHHHHHHHHHHHHHHHHHH
Q 003481 23 EKVYVALGKCVEK-GLSLLHWTLQRFGS-SREICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQKMKKLLDNY 100 (816)
Q Consensus 23 ~~VlVavD~s~~~-s~~Al~wal~~~~~-~~~v~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 100 (816)
++||||||+|.++ +.+|++||++.+.. +++|++|||.++.+..... + ..... .... .....+.+++.++.+
T Consensus 3 ~~ILv~~D~s~~~~~~~a~~~a~~la~~~~~~l~ll~v~~~~~~~~~~-~-~~~~~-~~~~----~~~~~~~~~~~l~~~ 75 (144)
T PRK15005 3 RTILVPIDISDSELTQRVISHVEAEAKIDDAEVHFLTVIPSLPYYASL-G-LAYSA-ELPA----MDDLKAEAKSQLEEI 75 (144)
T ss_pred ccEEEecCCCchhHHHHHHHHHHHHHhccCCeEEEEEEEccCcccccc-c-ccccc-cchH----HHHHHHHHHHHHHHH
Confidence 6899999996553 57899999998876 8999999999764322111 1 10000 0001 112234455666666
Q ss_pred HHHHHHhccceEEEEEecCCHHHHHHHHHHHhCCCEEEeccCCCCcchhhcCCcchhhhhhcCCCCceEEEEe
Q 003481 101 LRICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFVN 173 (816)
Q Consensus 101 ~~~c~~~~v~~~~~v~e~~d~~~~Iv~~a~~~~id~lVmGs~g~~~~~R~~~gsVs~~V~~~ap~~C~V~vv~ 173 (816)
...+...+++++..+..| ++++.|+++|+++++|+||||+| ++++.|.++||++.+|++++| |+|+||.
T Consensus 76 ~~~~~~~~~~~~~~v~~G-~p~~~I~~~a~~~~~DLIV~Gs~-~~~~~~~llGS~a~~vl~~a~--cpVlvVr 144 (144)
T PRK15005 76 IKKFKLPTDRVHVHVEEG-SPKDRILELAKKIPADMIIIASH-RPDITTYLLGSNAAAVVRHAE--CSVLVVR 144 (144)
T ss_pred HHHhCCCCCceEEEEeCC-CHHHHHHHHHHHcCCCEEEEeCC-CCCchheeecchHHHHHHhCC--CCEEEeC
Confidence 666666778888877665 67899999999999999999999 467999999999999999999 9999984
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=183.53 Aligned_cols=229 Identities=22% Similarity=0.318 Sum_probs=148.8
Q ss_pred CCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCC---C-------ce------eeE
Q 003481 472 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQH---P-------HL------VTL 530 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~H---p-------nI------v~l 530 (816)
+.....||.|+++.||.+++. |+.+|+|++..... ...+.+.+|.-....+.+ | .+ +++
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 445678999999999999996 69999999865442 234567777655555432 1 11 111
Q ss_pred ec---cc---c--C-----CccceeeccCCCchhhhhh---hcCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeC
Q 003481 531 LG---AC---P--E-----AWSLVYEYLPNGSLQDRLF---RKSNV-SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 593 (816)
Q Consensus 531 ~g---~~---~--~-----~~~lV~E~~~~gsL~~~l~---~~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHr 593 (816)
-+ ++ . . +.+++|+-+ .++|.+++. ..... ..+....++.+..|+++.+++||..| ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 11 01 0 0 235788877 568877653 22221 23445556778899999999999988 9999
Q ss_pred CCCCCceEecCCCCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCcccccc--------CCCCcchhHhHHHHHH
Q 003481 594 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT--------GVLTPKSDSYSFGLII 665 (816)
Q Consensus 594 DIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~ksDVwSlGviL 665 (816)
||+|+|+|++.+|.+.|+||+.......... . ...+..|.+||.... -.++.+.|.|+||+++
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~--------~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l 240 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR--------C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL 240 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEE--------G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceee--------c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence 9999999999999999999998776543221 1 234578999996633 2578899999999999
Q ss_pred HHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCC
Q 003481 666 LQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRER 724 (816)
Q Consensus 666 ~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~R 724 (816)
|.|++|..||+....... . +.....+. ..++.+..||..+|+.||.+|
T Consensus 241 y~lWC~~lPf~~~~~~~~------~----~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 241 YSLWCGRLPFGLSSPEAD------P----EWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHSS-STCCCGGGST------S----GGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHccCCCCCCCcccc------c----cccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999999975432100 0 00122344 678899999999999999988
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.8e-18 Score=179.93 Aligned_cols=201 Identities=21% Similarity=0.278 Sum_probs=146.3
Q ss_pred CCCceeeEeccccCC-----------------------------ccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHH
Q 003481 523 QHPHLVTLLGACPEA-----------------------------WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA 573 (816)
Q Consensus 523 ~HpnIv~l~g~~~~~-----------------------------~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 573 (816)
+|||||++.++|.+. .|+||...+ .+|..++.... .+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence 599999999876221 467887774 48888886543 45566778899
Q ss_pred HHHHHHHHHhhcCCCceeeCCCCCCceEe--cCCC--CeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCcccccc
Q 003481 574 EIASGLCFLHSSKPEKIVHGDLKPQNILL--DSEL--SSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649 (816)
Q Consensus 574 qia~aL~yLH~~~~~~ivHrDIkp~NILl--~~~~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 649 (816)
|++.|+.|||.++ |.|||+|++|||| |+++ .+.|+|||++--........+-........|+..-||||++..
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 9999999999999 4443 4789999998654443333332233445678889999998865
Q ss_pred CCC------CcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCC
Q 003481 650 GVL------TPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRE 723 (816)
Q Consensus 650 ~~~------s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~ 723 (816)
.+- -.|+|.|+.|.+.||+++...||...++.. +....++ ....+..|..++..+.+|+...|+.||.+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~--L~~r~Yq---e~qLPalp~~vpp~~rqlV~~lL~r~psk 500 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML--LDTRTYQ---ESQLPALPSRVPPVARQLVFDLLKRDPSK 500 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe--echhhhh---hhhCCCCcccCChHHHHHHHHHhcCCccc
Confidence 321 138999999999999999999997544321 1111111 11223456667788999999999999999
Q ss_pred CCCChHHHHHHHHH
Q 003481 724 RPDITPSLVKELEQ 737 (816)
Q Consensus 724 RPs~~e~l~~~Le~ 737 (816)
||+.. +...+|+-
T Consensus 501 Rvsp~-iAANvl~L 513 (598)
T KOG4158|consen 501 RVSPN-IAANVLNL 513 (598)
T ss_pred cCCcc-HHHhHHHH
Confidence 99987 66666653
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.1e-18 Score=171.84 Aligned_cols=134 Identities=22% Similarity=0.285 Sum_probs=104.4
Q ss_pred CccceeeeecceEEEEEEEcCeEEEEEEeccCCcccHHHHHHHHHHHhcC-----CCCceeeEeccccCC-----cc-ce
Q 003481 473 SESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-----QHPHLVTLLGACPEA-----WS-LV 541 (816)
Q Consensus 473 ~~~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l-----~HpnIv~l~g~~~~~-----~~-lV 541 (816)
.....||+|+||.||.....+.. +||++..........+.+|+.++..+ .||||++++|++... .+ +|
T Consensus 5 ~~~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 5 SEQSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CCcceecCCCceEEEECCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 34568999999999963223444 69998766555567799999999999 579999999998553 12 68
Q ss_pred eec--cCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCceeeCCCCCCceEecC----CCCeeEeecc
Q 003481 542 YEY--LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL-CFLHSSKPEKIVHGDLKPQNILLDS----ELSSKICDFG 614 (816)
Q Consensus 542 ~E~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL-~yLH~~~~~~ivHrDIkp~NILl~~----~~~vkL~DFG 614 (816)
+|| +.+|+|.+++.+. .+++. ..++.+++.++ .|||+++ |+||||||+|||++. ++.++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 5579999999553 24444 45678888888 9999988 999999999999974 3479999954
Q ss_pred cc
Q 003481 615 IC 616 (816)
Q Consensus 615 la 616 (816)
.+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >cd01987 USP_OKCHK USP domain is located between the N-terminal sensor domain and C-terminal catalytic domain of this Osmosensitive K+ channel histidine kinase family | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.7e-17 Score=155.30 Aligned_cols=122 Identities=16% Similarity=0.231 Sum_probs=101.8
Q ss_pred EEEEEecCCcccchhhHHHHhhccCC-CCcEEEEEecCCCCCCCCCCCCCCCCcccHHHHHHHHHHHHHHHHHHHHHHHH
Q 003481 24 KVYVALGKCVEKGLSLLHWTLQRFGS-SREICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQKMKKLLDNYLR 102 (816)
Q Consensus 24 ~VlVavD~s~~~s~~Al~wal~~~~~-~~~v~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~ 102 (816)
+||||||++ +.+++|++||++.... +..+++|||.++... .. .+..++.++.+..
T Consensus 1 ~Ilv~vd~s-~~s~~al~~a~~la~~~~~~l~ll~v~~~~~~------~~-----------------~~~~~~~l~~~~~ 56 (124)
T cd01987 1 RILVCISGG-PNAERLIRRAARLADRLKAPWYVVYVETPRLN------RL-----------------SEAERRRLAEALR 56 (124)
T ss_pred CEEEEECCC-cchHHHHHHHHHHHHHhCCCEEEEEEecCccc------cC-----------------CHHHHHHHHHHHH
Confidence 599999995 5599999999998876 899999999974321 00 1334567788888
Q ss_pred HHHHhccceEEEEEecCCHHHHHHHHHHHhCCCEEEeccCCCCcchhhcCCcchhhhhhcCCCCceEEEE
Q 003481 103 ICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFV 172 (816)
Q Consensus 103 ~c~~~~v~~~~~v~e~~d~~~~Iv~~a~~~~id~lVmGs~g~~~~~R~~~gsVs~~V~~~ap~~C~V~vv 172 (816)
.+++.++.+ .++.+++++++|+++++++++|+||||+++++.++|.++||++++|+++| ..|+||||
T Consensus 57 ~~~~~~~~~--~~~~~~~~~~~I~~~~~~~~~dllviG~~~~~~~~~~~~Gs~~~~v~~~a-~~~~v~v~ 123 (124)
T cd01987 57 LAEELGAEV--VTLPGDDVAEAIVEFAREHNVTQIVVGKSRRSRWRELFRGSLVDRLLRRA-GNIDVHIV 123 (124)
T ss_pred HHHHcCCEE--EEEeCCcHHHHHHHHHHHcCCCEEEeCCCCCchHHHHhcccHHHHHHHhC-CCCeEEEe
Confidence 888887754 34567789999999999999999999999999999999999999999999 34999997
|
The family of KdpD sensor kinase proteins regulates the kdpFABC operon responsible for potassium transport. The USP domain is homologous to the universal stress protein Usp Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.1e-18 Score=189.38 Aligned_cols=210 Identities=30% Similarity=0.415 Sum_probs=155.9
Q ss_pred HhcCCCCceeeEeccccC--CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCC
Q 003481 519 LSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLK 596 (816)
Q Consensus 519 l~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIk 596 (816)
|+.+.|.|+.+++|.+.+ ..+.|.+||..|+|.|.+.... ..++|-....++.+|+.||.|||+.. -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 457899999999999844 4788999999999999998744 46899999999999999999999965 13999999
Q ss_pred CCceEecCCCCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccC-------CCCcchhHhHHHHHHHHHH
Q 003481 597 PQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-------VLTPKSDSYSFGLIILQLL 669 (816)
Q Consensus 597 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-------~~s~ksDVwSlGviL~ell 669 (816)
+.|.++|..+.+||+|||+......... ........-...|.|||.+... ..+.+.||||||++++|++
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~----~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAE----PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred cccceeeeeEEEEechhhhccccccccc----ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 9999999999999999999877643110 0011222345679999988653 1467899999999999999
Q ss_pred hCCCCCCChH------HHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHhh
Q 003481 670 TGRLPVGLAG------EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 670 tG~~Pf~~~~------~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l~ 739 (816)
+.+.||.... ++...+..+ -...+.|...... ...+.+..++..||..+|..||++. .+...++.+.
T Consensus 153 ~r~~~~~~~~~~~~~~eii~~~~~~-~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~-~i~~~~~~~~ 225 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDPDEIILRVKKG-GSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIE-QIRSKLLTIN 225 (484)
T ss_pred hccCccccccccCChHHHHHHHHhc-CCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHH-HHHhhhhhhc
Confidence 9999996422 222223221 1111222211111 3444799999999999999999998 5555555443
|
|
| >PRK15118 universal stress global response regulator UspA; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-17 Score=159.44 Aligned_cols=136 Identities=10% Similarity=0.122 Sum_probs=95.2
Q ss_pred ccEEEEEecCCcccchhhHHHHhhccCC-CCcEEEEEecCCCCCCCCCCCCCCCCcccHHHHHHHHHHHHHHHHHHHHHH
Q 003481 22 GEKVYVALGKCVEKGLSLLHWTLQRFGS-SREICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQKMKKLLDNY 100 (816)
Q Consensus 22 ~~~VlVavD~s~~~s~~Al~wal~~~~~-~~~v~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 100 (816)
-++||||||+|.. |.+||+||++.+.. ++.|++|||..+.... . .+... .....+.+...+...+.+
T Consensus 3 ~~~ILvavD~S~~-s~~al~~a~~la~~~~a~l~ll~v~~~~~~~-~-~~~~~------~~~~~~~~~~~~~~~~~l--- 70 (144)
T PRK15118 3 YKHILIAVDLSPE-SKVLVEKAVSMARPYNAKVSLIHVDVNYSDL-Y-TGLID------VNLGDMQKRISEETHHAL--- 70 (144)
T ss_pred ceEEEEEccCChh-HHHHHHHHHHHHHhhCCEEEEEEEccChhhh-h-hhhhh------cchHHHHHHHHHHHHHHH---
Confidence 3689999999555 89999999998876 8899999995332111 1 01000 001112222222333333
Q ss_pred HHHHHHhccceEEEEEecCCHHHHHHHHHHHhCCCEEEeccCCCCcchhhcCCcchhhhhhcCCCCceEEEEeC
Q 003481 101 LRICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFVNK 174 (816)
Q Consensus 101 ~~~c~~~~v~~~~~v~e~~d~~~~Iv~~a~~~~id~lVmGs~g~~~~~R~~~gsVs~~V~~~ap~~C~V~vv~~ 174 (816)
..++.+.|+.+...++..++|+++|+++|+++++|+||||+|| +.+++ +||||++|+++|+ |+|+||..
T Consensus 71 ~~~~~~~~~~~~~~~~~~G~p~~~I~~~a~~~~~DLIV~Gs~~-~~~~~--lgSva~~v~~~a~--~pVLvv~~ 139 (144)
T PRK15118 71 TELSTNAGYPITETLSGSGDLGQVLVDAIKKYDMDLVVCGHHQ-DFWSK--LMSSARQLINTVH--VDMLIVPL 139 (144)
T ss_pred HHHHHhCCCCceEEEEEecCHHHHHHHHHHHhCCCEEEEeCcc-cHHHH--HHHHHHHHHhhCC--CCEEEecC
Confidence 3445677888765555567889999999999999999999996 44444 4699999999999 99999963
|
|
| >PRK09982 universal stress protein UspD; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.8e-17 Score=157.86 Aligned_cols=134 Identities=13% Similarity=0.139 Sum_probs=99.3
Q ss_pred cEEEEEecCCcccchhhHHHHhhccCC-CCcEEEEEecCCCCCCCCCCCCCCCCcccHHHHHHHHHHHHHHHHHHHHHHH
Q 003481 23 EKVYVALGKCVEKGLSLLHWTLQRFGS-SREICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQKMKKLLDNYL 101 (816)
Q Consensus 23 ~~VlVavD~s~~~s~~Al~wal~~~~~-~~~v~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~ 101 (816)
++||||||+|.. |.+||+||++.+.. +++|++|||.++.+.... +..++ ..+ ...+..++.+++.++++.
T Consensus 4 k~ILvavD~S~~-s~~al~~A~~lA~~~~a~l~llhV~~~~~~~~~-~~~~~----~~~---~~~~~~~~~~~~~l~~~~ 74 (142)
T PRK09982 4 KHIGVAISGNEE-DALLVNKALELARHNDAHLTLIHIDDGLSELYP-GIYFP----ATE---DILQLLKNKSDNKLYKLT 74 (142)
T ss_pred eEEEEEecCCcc-hHHHHHHHHHHHHHhCCeEEEEEEccCcchhch-hhhcc----chH---HHHHHHHHHHHHHHHHHH
Confidence 689999999554 89999999998876 899999999976432111 11010 011 122333455666777776
Q ss_pred HHHHHhccceEEEEEecCCHHHHHHHHHHHhCCCEEEeccCCCCcchhhcCCcchhhhhhcCCCCceEEEEe
Q 003481 102 RICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFVN 173 (816)
Q Consensus 102 ~~c~~~~v~~~~~v~e~~d~~~~Iv~~a~~~~id~lVmGs~g~~~~~R~~~gsVs~~V~~~ap~~C~V~vv~ 173 (816)
..+.. ..++..+.. ++|++.|+++|++.++|+||||+| +++++|.+ | |++.|++|++ |+|+||.
T Consensus 75 ~~~~~--~~~~~~v~~-G~p~~~I~~~A~~~~aDLIVmG~~-~~~~~~~~-~-va~~V~~~s~--~pVLvv~ 138 (142)
T PRK09982 75 KNIQW--PKTKLRIER-GEMPETLLEIMQKEQCDLLVCGHH-HSFINRLM-P-AYRGMINKMS--ADLLIVP 138 (142)
T ss_pred HhcCC--CcceEEEEe-cCHHHHHHHHHHHcCCCEEEEeCC-hhHHHHHH-H-HHHHHHhcCC--CCEEEec
Confidence 65532 345555544 578999999999999999999986 89999988 5 9999999999 9999995
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.7e-17 Score=195.40 Aligned_cols=198 Identities=23% Similarity=0.281 Sum_probs=156.4
Q ss_pred HHHHHHhcCCCccceeeeecceEEEEEEEc-CeEEEEEEeccCCcccHHHHHHHHHHHhcCC---CCceeeEecc--ccC
Q 003481 463 ADLQTATCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ---HPHLVTLLGA--CPE 536 (816)
Q Consensus 463 ~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~---HpnIv~l~g~--~~~ 536 (816)
.+++.....|.+.+.||+|+||.||+|... |+.||||+-++.+... |.-=.+++.+|+ -+.|..+..+ |.+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 455556677899999999999999999875 8999999987765432 222234555565 2233333333 367
Q ss_pred CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecC-------CCCee
Q 003481 537 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-------ELSSK 609 (816)
Q Consensus 537 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~-------~~~vk 609 (816)
..+||++|.+.|+|.+++.. ...++|..+..|+.|++..+..||..+ |||+||||+|+||.. +..++
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~---~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINT---NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred cceeeeeccccccHHHhhcc---CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceE
Confidence 78999999999999999973 346899999999999999999999998 999999999999942 34599
Q ss_pred EeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCC
Q 003481 610 ICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRL 673 (816)
Q Consensus 610 L~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~ 673 (816)
|+|||.+-.+..-. .........+|-++-.+|...+.+++...|.|.|..+++-||.|+.
T Consensus 842 lIDfG~siDm~lfp----~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFP----DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEecccceeeeEcC----CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999987653211 1123456678999999999999999999999999999999999974
|
|
| >cd01988 Na_H_Antiporter_C The C-terminal domain of a subfamily of Na+ /H+ antiporter existed in bacteria and archea | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=150.38 Aligned_cols=131 Identities=18% Similarity=0.215 Sum_probs=110.9
Q ss_pred EEEEEecCCcccchhhHHHHhhccCC-CCcEEEEEecCCCCCCCCCCCCCCCCcccHHHHHHHHHHHHHHHHHHHHHHHH
Q 003481 24 KVYVALGKCVEKGLSLLHWTLQRFGS-SREICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQKMKKLLDNYLR 102 (816)
Q Consensus 24 ~VlVavD~s~~~s~~Al~wal~~~~~-~~~v~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~ 102 (816)
+||||||++ +.+..|++||...+.. +..|+++||.+++..... . ......+..++.++.+..
T Consensus 1 ~ILv~vd~s-~~~~~~l~~a~~la~~~~~~v~ll~v~~~~~~~~~-------~---------~~~~~~~~~~~~~~~~~~ 63 (132)
T cd01988 1 RILVPVANP-NTARDLLELAAALARAQNGEIIPLNVIEVPNHSSP-------S---------QLEVNVQRARKLLRQAER 63 (132)
T ss_pred CEEEecCCc-hhHHHHHHHHHHHhhcCCCeEEEEEEEecCCCCCc-------c---------hhHHHHHHHHHHHHHHHH
Confidence 599999995 5699999999998876 789999999986432211 0 011223567789999999
Q ss_pred HHHHhccceEEEEEecCCHHHHHHHHHHHhCCCEEEeccCCCCcchhhcCCcchhhhhhcCCCCceEEEEe
Q 003481 103 ICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFVN 173 (816)
Q Consensus 103 ~c~~~~v~~~~~v~e~~d~~~~Iv~~a~~~~id~lVmGs~g~~~~~R~~~gsVs~~V~~~ap~~C~V~vv~ 173 (816)
++.+.|++++..+..++++.++|+++++++++|+||||+++++.+.+.++||++++|+++++ |+|+||+
T Consensus 64 ~~~~~g~~~~~~~~~~~~~~~~I~~~a~~~~~dlIV~G~~~~~~~~~~~lGs~~~~v~~~~~--~pvlvv~ 132 (132)
T cd01988 64 IAASLGVPVHTIIRIDHDIASGILRTAKERQADLIIMGWHGSTSLRDRLFGGVIDQVLESAP--CDVAVVK 132 (132)
T ss_pred HhhhcCCceEEEEEecCCHHHHHHHHHHhcCCCEEEEecCCCCCccceecCchHHHHHhcCC--CCEEEeC
Confidence 99999999998887777899999999999999999999999999988999999999999999 9999984
|
Na+/H+ exchange proteins eject protons from cells, effectively eliminating excess acid from actively metabolising cells. Na+ /H+ exchange activity is also crucial for the regulation of cell volume, and for the reabsorption of NaCl across renal, intestinal, and other epithelia. These antiports exchange Na+ for H+ in an electroneutral manner, and this activity is carried out by a family of Na+ /H+ exchangers, or NHEs, which are known to be present in both prokaryotic and eukaryotic cells. These exchangers are highly-regulated (glyco)phosphoproteins, which, based on their primary structure, appear to contain 10-12 membrane-spanning regions (M) at the N-terminus and a large cytoplasmic region at the C-terminus. The transmembrane regions M3-M12 share identity wit h other members of the family. The M6 and M7 regions are highly conserved. Thus, this is thought to be the regio |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.6e-18 Score=185.35 Aligned_cols=177 Identities=24% Similarity=0.304 Sum_probs=137.3
Q ss_pred CccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccc
Q 003481 537 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 616 (816)
Q Consensus 537 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 616 (816)
.+|+.|++|...+|.++|.+.......+|...+.|+.|++.|+.| .+ .+|+|+||.||++..+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 478999999999999999877777778999999999999999999 44 899999999999999999999999999
Q ss_pred eeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHh-CCCCCCChHHHHHHhhcCccccccC
Q 003481 617 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILD 695 (816)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~d 695 (816)
..........+.....+...||..||+||.+.+..|+.|+||||||+||+||++ -..+|.-... ..-+..|.+...
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t-~~d~r~g~ip~~-- 480 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIAT-LTDIRDGIIPPE-- 480 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHh-hhhhhcCCCChH--
Confidence 887665533334445677889999999999999999999999999999999997 3333321111 111222222200
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCCh
Q 003481 696 PLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 728 (816)
Q Consensus 696 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~ 728 (816)
...++| .=..|+.+++.+.|.+||++.
T Consensus 481 -~~~d~p-----~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 481 -FLQDYP-----EEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred -HhhcCc-----HHHHHHHHhcCCCcccCchHH
Confidence 011222 335789999999999999443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=163.68 Aligned_cols=132 Identities=24% Similarity=0.392 Sum_probs=110.4
Q ss_pred ceeeeecceEEEEEEEcCeEEEEEEeccCCccc--------HHHHHHHHHHHhcCCCCceeeEecc--ccCCccceeecc
Q 003481 476 FKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQG--------QLEFQQEVRVLSKLQHPHLVTLLGA--CPEAWSLVYEYL 545 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~--------~~~~~~E~~il~~l~HpnIv~l~g~--~~~~~~lV~E~~ 545 (816)
+.||+|++|.||+|.+.|..|++|+........ ...+.+|+.++..+.|++|.....+ ..+..++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 469999999999999999999999876543211 2357789999999999988655544 356688999999
Q ss_pred CCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccccee
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 546 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 618 (816)
+|++|.+++.... + .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999885432 2 78899999999999999988 99999999999999 78999999998764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.4e-17 Score=190.39 Aligned_cols=213 Identities=22% Similarity=0.254 Sum_probs=145.2
Q ss_pred hcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccCCccceeeccC
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLP 546 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~lV~E~~~ 546 (816)
-++|..++.|..|+||.||..++. .+.+|+| +++.+.. +.+ ++....+| +.|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li----lRn---ilt~a~np-------------fvv----- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI----LRN---ILTFAGNP-------------FVV----- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh----hhc---cccccCCc-------------cee-----
Confidence 357889999999999999999876 6788884 3332211 001 22222333 333
Q ss_pred CCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCc-
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY- 625 (816)
Q Consensus 547 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~- 625 (816)
|+-...+... .+++.. ++.+++|||+.+ |+|||+||+|.+|+.=|++|+.|||+++........
T Consensus 136 -gDc~tllk~~---g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -GDCATLLKNI---GPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -chhhhhcccC---CCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 4444444322 234332 388999999988 999999999999999999999999999864321110
Q ss_pred --------CCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHH--HHHHhhcCccccccC
Q 003481 626 --------LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILD 695 (816)
Q Consensus 626 --------~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~~~~~~~~~d 695 (816)
..........+||+.|+|||++....|+..+|+|++|+|+||.+.|..||..... ....+....+ ...
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i-~wp- 278 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI-EWP- 278 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc-ccc-
Confidence 0011223466899999999999999999999999999999999999999964421 1111111100 000
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhccCCCCCCCCh
Q 003481 696 PLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 728 (816)
Q Consensus 696 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~ 728 (816)
+-......+..++|.+.|+.+|..|--..
T Consensus 279 ----E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 279 ----EEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred ----ccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 00122456889999999999999996544
|
|
| >PF00582 Usp: Universal stress protein family; InterPro: IPR006016 The universal stress protein UspA P28242 from SWISSPROT [] is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents | Back alignment and domain information |
|---|
Probab=99.68 E-value=4e-16 Score=147.50 Aligned_cols=137 Identities=18% Similarity=0.239 Sum_probs=102.0
Q ss_pred cEEEEEecCCcccchhhHHHHhhccCC-CCcEEEEEecCCCCCCCCCCCCCCCCcccHHHHHHHHHHHHHHHHHHHHHHH
Q 003481 23 EKVYVALGKCVEKGLSLLHWTLQRFGS-SREICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQKMKKLLDNYL 101 (816)
Q Consensus 23 ~~VlVavD~s~~~s~~Al~wal~~~~~-~~~v~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~ 101 (816)
++||||+|++. .+..|++||+..+.. ++.|++|||.++...... ............+..........
T Consensus 3 ~~Ilv~~d~~~-~~~~al~~a~~la~~~~~~i~~l~v~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~ 70 (140)
T PF00582_consen 3 KRILVAIDGSE-ESRRALRFALELAKRSGAEITLLHVIPPPPQYSF-----------SAAEDEESEEEAEEEEQARQAEA 70 (140)
T ss_dssp SEEEEEESSSH-HHHHHHHHHHHHHHHHTCEEEEEEEEESCHCHHH-----------HHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CEEEEEECCCH-HHHHHHHHHHHHHHhhCCeEEEEEeecccccccc-----------ccccccccccccchhhhhhhHHH
Confidence 69999999954 488999999998877 899999999985432211 00000000011011111111111
Q ss_pred HHHHHhccceEEEEEecCCHHHHHHHHHHHhCCCEEEeccCCCCcchhhcCCcchhhhhhcCCCCceEEEEe
Q 003481 102 RICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFVN 173 (816)
Q Consensus 102 ~~c~~~~v~~~~~v~e~~d~~~~Iv~~a~~~~id~lVmGs~g~~~~~R~~~gsVs~~V~~~ap~~C~V~vv~ 173 (816)
..+...+.......+..++++++|+++++++++|+||||+++++.+.+.++||++++|++++| |+|+||.
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~dliv~G~~~~~~~~~~~~gs~~~~l~~~~~--~pVlvv~ 140 (140)
T PF00582_consen 71 EEAEAEGGIVIEVVIESGDVADAIIEFAEEHNADLIVMGSRGRSGLERLLFGSVAEKLLRHAP--CPVLVVP 140 (140)
T ss_dssp HHHHHHTTSEEEEEEEESSHHHHHHHHHHHTTCSEEEEESSSTTSTTTSSSHHHHHHHHHHTS--SEEEEEE
T ss_pred HHHhhhccceeEEEEEeeccchhhhhccccccceeEEEeccCCCCccCCCcCCHHHHHHHcCC--CCEEEeC
Confidence 566667777777777788999999999999999999999999999999999999999999999 9999984
|
UspA enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae UspA [] reveals an alpha/beta fold similar to that of the Methanocaldococcus jannaschii (Methanococcus jannaschii) MJ0577 protein, which binds ATP [], though UspA lacks ATP-binding activity.; GO: 0006950 response to stress; PDB: 3DLO_C 3QTB_A 2PFS_A 3TNJ_A 1JMV_D 3FH0_B 3FDX_B 3AB7_A 3AB8_A 2GM3_F .... |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.2e-16 Score=162.28 Aligned_cols=129 Identities=25% Similarity=0.412 Sum_probs=105.8
Q ss_pred eeeeecceEEEEEEEcCeEEEEEEeccCCcc--------cHHHHHHHHHHHhcCCCCce--eeEeccccCCccceeeccC
Q 003481 477 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQ--------GQLEFQQEVRVLSKLQHPHL--VTLLGACPEAWSLVYEYLP 546 (816)
Q Consensus 477 ~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~--------~~~~~~~E~~il~~l~HpnI--v~l~g~~~~~~~lV~E~~~ 546 (816)
.||+|+||.||+|.+.|..|++|+....... ....+.+|+.++..++|+++ ..+++...+..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 3899999999999999999999996543211 12457789999999988754 4455555666799999999
Q ss_pred CCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceec
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 619 (816)
Q Consensus 547 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 619 (816)
|++|.+.+.... ..++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++|+|||++...
T Consensus 81 g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999998874321 178999999999999988 99999999999999 889999999987653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.6e-16 Score=165.61 Aligned_cols=142 Identities=19% Similarity=0.200 Sum_probs=110.2
Q ss_pred CCCccceeeeecceEEEEEE-E--cCeEEEEEEeccCCcc------------------------cHHHHHHHHHHHhcCC
Q 003481 471 NFSESFKVGQGGFGCVYKGE-M--LGRTVAIKMLYSHNMQ------------------------GQLEFQQEVRVLSKLQ 523 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~~~-~--~g~~vAiK~l~~~~~~------------------------~~~~~~~E~~il~~l~ 523 (816)
.|.+...||+|+||.||+|. . .|..||||++...... ....+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 37778899999999999998 3 4899999998754311 0123568999999997
Q ss_pred CC--ceeeEeccccCCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceE
Q 003481 524 HP--HLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNIL 601 (816)
Q Consensus 524 Hp--nIv~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NIL 601 (816)
+. .+.+++++ ...+|||||+++++|...+... ..+.......++.||+.+|.+||..+ .|+||||||+||+
T Consensus 109 ~~~i~~p~~~~~--~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW--RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe--cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEE
Confidence 53 34455543 3458999999998887755332 23455667899999999999999965 3999999999999
Q ss_pred ecCCCCeeEeecccceecc
Q 003481 602 LDSELSSKICDFGICRLVT 620 (816)
Q Consensus 602 l~~~~~vkL~DFGla~~~~ 620 (816)
++ ++.++|+|||.+....
T Consensus 182 i~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EE-CCCEEEEEChhhhccC
Confidence 99 8899999999987543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.8e-16 Score=182.71 Aligned_cols=142 Identities=25% Similarity=0.334 Sum_probs=114.5
Q ss_pred HHHHHHhcCCCccceeeeecceEEEEEEEcCeEEEEEEeccCCc--------ccHHHHHHHHHHHhcCCCCceeeEeccc
Q 003481 463 ADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNM--------QGQLEFQQEVRVLSKLQHPHLVTLLGAC 534 (816)
Q Consensus 463 ~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~--------~~~~~~~~E~~il~~l~HpnIv~l~g~~ 534 (816)
.........|...+.||+|+||.||+|.+.+..+++|+...... .....+.+|+.++..++|++++..+.++
T Consensus 326 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~ 405 (535)
T PRK09605 326 IKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYD 405 (535)
T ss_pred ccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEE
Confidence 33344455667788999999999999999877777765432211 1124588999999999999988765554
Q ss_pred --cCCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEee
Q 003481 535 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICD 612 (816)
Q Consensus 535 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~D 612 (816)
.+..++||||+++++|.+++. ....++.+++.+|.|||+.+ |+||||||+|||+ .++.++|+|
T Consensus 406 ~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liD 470 (535)
T PRK09605 406 VDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLID 470 (535)
T ss_pred EeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEe
Confidence 446889999999999999874 35678999999999999988 9999999999999 677999999
Q ss_pred cccceec
Q 003481 613 FGICRLV 619 (816)
Q Consensus 613 FGla~~~ 619 (816)
||+++..
T Consensus 471 FGla~~~ 477 (535)
T PRK09605 471 FGLGKYS 477 (535)
T ss_pred CcccccC
Confidence 9998753
|
|
| >PRK10116 universal stress protein UspC; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.7e-15 Score=145.33 Aligned_cols=135 Identities=13% Similarity=0.200 Sum_probs=101.9
Q ss_pred ccEEEEEecCCcccchhhHHHHhhccCC-CCcEEEEEecCCCCCCCCCCCCCCCCcccHHHHHHHHHHHHHHHHHHHHHH
Q 003481 22 GEKVYVALGKCVEKGLSLLHWTLQRFGS-SREICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQKMKKLLDNY 100 (816)
Q Consensus 22 ~~~VlVavD~s~~~s~~Al~wal~~~~~-~~~v~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 100 (816)
-++||||+|+|.. +..||++|++.+.. ++.++++||.+++..... + .....+.+.+...+..++.++.
T Consensus 3 ~~~ILv~~D~s~~-s~~al~~A~~lA~~~~a~l~ll~v~~~~~~~~~----~-----~~~~~~~~~~~~~~~~~~~l~~- 71 (142)
T PRK10116 3 YSNILVAVAVTPE-SQQLLAKAVSIARPVNGKISLITLASDPEMYNQ----F-----AAPMLEDLRSVMQEETQSFLDK- 71 (142)
T ss_pred CceEEEEccCCcc-hHHHHHHHHHHHHHhCCEEEEEEEccCcccchh----h-----hHHHHHHHHHHHHHHHHHHHHH-
Confidence 3699999999655 88999999998876 889999999875432111 1 1112223333333444445444
Q ss_pred HHHHHHhccceEEEEEecCCHHHHHHHHHHHhCCCEEEeccCCCCcchhhcCCcchhhhhhcCCCCceEEEEe
Q 003481 101 LRICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFVN 173 (816)
Q Consensus 101 ~~~c~~~~v~~~~~v~e~~d~~~~Iv~~a~~~~id~lVmGs~g~~~~~R~~~gsVs~~V~~~ap~~C~V~vv~ 173 (816)
++.+.|++....++..+++.++|+++|++.++|+||||+||++++.|.+ |||++|+++++ |+|+||.
T Consensus 72 --~~~~~~~~~~~~~~~~G~~~~~I~~~a~~~~~DLiV~g~~~~~~~~~~~--s~a~~v~~~~~--~pVLvv~ 138 (142)
T PRK10116 72 --LIQDADYPIEKTFIAYGELSEHILEVCRKHHFDLVICGNHNHSFFSRAS--CSAKRVIASSE--VDVLLVP 138 (142)
T ss_pred --HHHhcCCCeEEEEEecCCHHHHHHHHHHHhCCCEEEEcCCcchHHHHHH--HHHHHHHhcCC--CCEEEEe
Confidence 3566788776556666788999999999999999999999999999975 79999999999 9999995
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.65 E-value=7e-16 Score=156.86 Aligned_cols=143 Identities=23% Similarity=0.212 Sum_probs=111.0
Q ss_pred HHHHHhcCCCccceeeeecceEEEEEEEc-CeEEEEEEeccCCcc----------------------cHHHHHHHHHHHh
Q 003481 464 DLQTATCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQ----------------------GQLEFQQEVRVLS 520 (816)
Q Consensus 464 el~~~t~~f~~~~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~----------------------~~~~~~~E~~il~ 520 (816)
++......|...+.||.|+||.||++... |+.||||++...... ....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 33333344777889999999999999884 899999987653210 0113567899999
Q ss_pred cCCCC--ceeeEeccccCCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCC
Q 003481 521 KLQHP--HLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQ 598 (816)
Q Consensus 521 ~l~Hp--nIv~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~ 598 (816)
.+.|+ ++...++. ...++||||+++++|...... .....++.+++.++.++|..+ |+||||||+
T Consensus 89 ~l~~~~i~v~~~~~~--~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~ 154 (198)
T cd05144 89 ALYEEGFPVPKPIDW--NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEF 154 (198)
T ss_pred HHHHcCCCCCceeec--CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcc
Confidence 99877 44555543 346899999999999775421 235678899999999999977 999999999
Q ss_pred ceEecCCCCeeEeecccceecc
Q 003481 599 NILLDSELSSKICDFGICRLVT 620 (816)
Q Consensus 599 NILl~~~~~vkL~DFGla~~~~ 620 (816)
||+++.++.++|+|||++....
T Consensus 155 Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999986554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.2e-14 Score=158.12 Aligned_cols=144 Identities=12% Similarity=0.078 Sum_probs=112.3
Q ss_pred ccEEEEEecCCcccchhhHHHHhhccCC-CCcEEEEEecCCCCCCCCCCCCCCCCcccHHHHHHHHHHHHHHHHHHHHHH
Q 003481 22 GEKVYVALGKCVEKGLSLLHWTLQRFGS-SREICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQKMKKLLDNY 100 (816)
Q Consensus 22 ~~~VlVavD~s~~~s~~Al~wal~~~~~-~~~v~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 100 (816)
-++||||+|+|.. +..|++||+..+.. ++++++|||.++.... .. +.. ..+......+...+..++.++.+
T Consensus 3 ~~~ILv~~D~s~~-~~~al~~a~~lA~~~~a~l~ll~v~~~~~~~-~~-~~~-----~~~~~~~~~~~~~~~~~~~l~~~ 74 (305)
T PRK11175 3 YQNILVVIDPNQD-DQPALRRAVYLAQRNGGKITAFLPIYDFSYE-MT-TLL-----SPDEREAMRQGVISQRTAWIREQ 74 (305)
T ss_pred cceEEEEcCCCcc-ccHHHHHHHHHHHhcCCCEEEEEeccCchhh-hh-ccc-----chhHHHHHHHHHHHHHHHHHHHH
Confidence 4689999999555 88999999998876 7899999998643211 10 111 11111222222234556778888
Q ss_pred HHHHHHhccceEEEEEecCCHHHHHHHHHHHhCCCEEEeccCCCCcchhhcCCcchhhhhhcCCCCceEEEEeCC
Q 003481 101 LRICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFVNKG 175 (816)
Q Consensus 101 ~~~c~~~~v~~~~~v~e~~d~~~~Iv~~a~~~~id~lVmGs~g~~~~~R~~~gsVs~~V~~~ap~~C~V~vv~~g 175 (816)
...+...|++++..++..+++.++|+++|.++++|+||||++|.+++.+.++||++..|++++| |+|+||..+
T Consensus 75 ~~~~~~~~~~~~~~v~~~g~~~~~i~~~a~~~~~DLiV~G~~~~~~~~~~~~gs~~~~l~~~~~--~pvlvv~~~ 147 (305)
T PRK11175 75 AKPYLDAGIPIEIKVVWHNRPFEAIIQEVIAGGHDLVVKMTHQHDKLESVIFTPTDWHLLRKCP--CPVLMVKDQ 147 (305)
T ss_pred HHHHhhcCCceEEEEecCCCcHHHHHHHHHhcCCCEEEEeCCCCcHHHhhccChhHHHHHhcCC--CCEEEeccc
Confidence 8888888999998777667888999999999999999999999999999999999999999999 999999753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.4e-14 Score=138.94 Aligned_cols=133 Identities=23% Similarity=0.228 Sum_probs=112.4
Q ss_pred ccceeeeecceEEEEEEEcCeEEEEEEeccCCcccHHHHHHHHHHHhcCCC--CceeeEeccccC--CccceeeccCCCc
Q 003481 474 ESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH--PHLVTLLGACPE--AWSLVYEYLPNGS 549 (816)
Q Consensus 474 ~~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~H--pnIv~l~g~~~~--~~~lV~E~~~~gs 549 (816)
+.+.||.|+++.||++...+..+++|....... ...+..|+.++..++| .+++++++++.. ..+++|||++++.
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 346799999999999999888999999865443 4578899999999976 588888887754 6899999999887
Q ss_pred hhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccccee
Q 003481 550 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 550 L~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 618 (816)
+..+ +......++.+++.+|.+||.....+++|+||+|.||+++.++.++++|||.+..
T Consensus 80 ~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 7654 4466778899999999999997545699999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=8.5e-15 Score=147.16 Aligned_cols=136 Identities=23% Similarity=0.264 Sum_probs=97.1
Q ss_pred cceeeeecceEEEEEEEc-CeEEEEEEeccCCccc--HHH----------------------HHHHHHHHhcCCCCc--e
Q 003481 475 SFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQG--QLE----------------------FQQEVRVLSKLQHPH--L 527 (816)
Q Consensus 475 ~~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~~--~~~----------------------~~~E~~il~~l~Hpn--I 527 (816)
.+.||+|+||.||+|.+. +..||||++....... ... ...|...+.++.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 457999999999999887 8999999987543211 111 124555555554332 3
Q ss_pred eeEeccccCCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCceeeCCCCCCceEecCCC
Q 003481 528 VTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS-SKPEKIVHGDLKPQNILLDSEL 606 (816)
Q Consensus 528 v~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~ivHrDIkp~NILl~~~~ 606 (816)
.+.+++ ...++||||++++.+......... .. .....++.+++.++.++|. .+ |+|+||||+||+++ ++
T Consensus 82 ~~~~~~--~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL--NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec--CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CC
Confidence 444433 346899999999654322111110 11 5578899999999999999 77 99999999999999 89
Q ss_pred CeeEeecccceecc
Q 003481 607 SSKICDFGICRLVT 620 (816)
Q Consensus 607 ~vkL~DFGla~~~~ 620 (816)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999987554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd00293 USP_Like Usp: Universal stress protein family | Back alignment and domain information |
|---|
Probab=99.53 E-value=1e-13 Score=129.36 Aligned_cols=129 Identities=23% Similarity=0.355 Sum_probs=108.6
Q ss_pred EEEEEecCCcccchhhHHHHhhccCC-CCcEEEEEecCCCCCCCCCCCCCCCCcccHHHHHHHHHHHHHHHHHHHHHHHH
Q 003481 24 KVYVALGKCVEKGLSLLHWTLQRFGS-SREICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQKMKKLLDNYLR 102 (816)
Q Consensus 24 ~VlVavD~s~~~s~~Al~wal~~~~~-~~~v~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~ 102 (816)
+||||+|++.. +..+++||++.+.. +..|++|||.++....+. ........+.++.++.+..
T Consensus 1 ~ilv~i~~~~~-~~~~l~~a~~~a~~~~~~i~~l~v~~~~~~~~~----------------~~~~~~~~~~~~~l~~~~~ 63 (130)
T cd00293 1 RILVAVDGSEE-SERALRWAARLARRLGAELVLLHVVDPPPSSAA----------------ELAELLEEEARALLEALRE 63 (130)
T ss_pred CEEEEeCCCHH-HHHHHHHHHHHHHhcCCEEEEEEEecCCCCcch----------------hHHHHHHHHHHHHHHHHHH
Confidence 58999999554 88999999999887 899999999875432110 1223444677889999999
Q ss_pred HHHHhccceEEEEEecCCHHHHHHHHHHHhCCCEEEeccCCCCcchhhcCCcchhhhhhcCCCCceEEEE
Q 003481 103 ICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFV 172 (816)
Q Consensus 103 ~c~~~~v~~~~~v~e~~d~~~~Iv~~a~~~~id~lVmGs~g~~~~~R~~~gsVs~~V~~~ap~~C~V~vv 172 (816)
.|...|+++...+..+. ++++|++++++.++|+||||+++++.+.+.+.|+++.+++++++ |+|++|
T Consensus 64 ~~~~~~~~~~~~~~~~~-~~~~i~~~~~~~~~dlvvig~~~~~~~~~~~~~~~~~~ll~~~~--~pvliv 130 (130)
T cd00293 64 ALAEAGVKVETVVLEGD-PAEAILEAAEELGADLIVMGSRGRSGLRRLLLGSVAERVLRHAP--CPVLVV 130 (130)
T ss_pred HHhcCCCceEEEEecCC-CHHHHHHHHHHcCCCEEEEcCCCCCccceeeeccHHHHHHhCCC--CCEEeC
Confidence 99889999988877655 48999999999999999999999999999999999999999998 999985
|
The universal stress protein Usp is a small cytoplasmic bacterial protein whose expression is enhanced when the cell is exposed to stress agents. Usp enhances the rate of cell survival during prolonged exposure to such conditions, and may provide a general "stress endurance" activity. The crystal structure of Haemophilus influenzae Usp reveals an alpha/beta fold similar to that of the Methanococcus jannaschii MJ0577 protein, which binds ATP, athough Usp lacks ATP-binding activity. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.6e-14 Score=146.86 Aligned_cols=133 Identities=22% Similarity=0.226 Sum_probs=104.9
Q ss_pred cceee-eecceEEEEEEEcCeEEEEEEeccCCc-------------ccHHHHHHHHHHHhcCCCCce--eeEeccccC--
Q 003481 475 SFKVG-QGGFGCVYKGEMLGRTVAIKMLYSHNM-------------QGQLEFQQEVRVLSKLQHPHL--VTLLGACPE-- 536 (816)
Q Consensus 475 ~~~LG-~G~~g~Vy~~~~~g~~vAiK~l~~~~~-------------~~~~~~~~E~~il~~l~HpnI--v~l~g~~~~-- 536 (816)
...|| .||.|+||.+...+..++||.+..... .....+.+|+.++.+|+|++| +..++++..
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 35688 899999999999999999998854221 123457889999999998875 666665421
Q ss_pred ----CccceeeccCC-CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEe
Q 003481 537 ----AWSLVYEYLPN-GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKIC 611 (816)
Q Consensus 537 ----~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~ 611 (816)
..++|||+++| .+|.+++... +++.. .+.+|+.+|.+||+.+ |+||||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 13599999997 6898887542 34433 3678999999999988 9999999999999999999999
Q ss_pred eccccee
Q 003481 612 DFGICRL 618 (816)
Q Consensus 612 DFGla~~ 618 (816)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998754
|
|
| >PRK11175 universal stress protein UspE; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=8.4e-14 Score=151.42 Aligned_cols=141 Identities=12% Similarity=0.168 Sum_probs=98.4
Q ss_pred CccEEEEEecCCcccc------hhhHHHHhhccCC--CCcEEEEEecCCCCCCCCCCCCCCCCcccHHHHHHHHHHHHHH
Q 003481 21 GGEKVYVALGKCVEKG------LSLLHWTLQRFGS--SREICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQK 92 (816)
Q Consensus 21 ~~~~VlVavD~s~~~s------~~Al~wal~~~~~--~~~v~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (816)
..++||||+|+|.+.+ ..||++|++.+.. +..+++|||.++...... ...+. ...+ .+.+..++.
T Consensus 151 ~~~~Ilva~D~s~~~~~~~~~~~~al~~a~~la~~~~~a~l~ll~v~~~~~~~~~--~~~~~--~~~~---~~~~~~~~~ 223 (305)
T PRK11175 151 EGGKILVAVNVASEEPYHDALNEKLVEEAIDLAEQLNHAEVHLVNAYPVTPINIA--IELPE--FDPS---VYNDAIRGQ 223 (305)
T ss_pred CCCeEEEEeCCCCCccchhHHHHHHHHHHHHHHhhCcCCceEEEEEecCcchhcc--ccccc--cchh---hHHHHHHHH
Confidence 3579999999965532 5699999876542 578999999864332110 11110 0111 111111122
Q ss_pred HHHHHHHHHHHHHHhccceEEEEEecCCHHHHHHHHHHHhCCCEEEeccCCCCcchhhcCCcchhhhhhcCCCCceEEEE
Q 003481 93 MKKLLDNYLRICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFV 172 (816)
Q Consensus 93 ~~~ll~~~~~~c~~~~v~~~~~v~e~~d~~~~Iv~~a~~~~id~lVmGs~g~~~~~R~~~gsVs~~V~~~ap~~C~V~vv 172 (816)
..+ ....++.+.++..+...+..+++.++|+++|++.++|+||||++|++++.+.++||++++|++++| |+|+||
T Consensus 224 ~~~---~l~~~~~~~~~~~~~~~v~~G~~~~~I~~~a~~~~~DLIVmG~~~~~~~~~~llGS~a~~v~~~~~--~pVLvv 298 (305)
T PRK11175 224 HLL---AMKALRQKFGIDEEQTHVEEGLPEEVIPDLAEHLDAELVILGTVGRTGLSAAFLGNTAEHVIDHLN--CDLLAI 298 (305)
T ss_pred HHH---HHHHHHHHhCCChhheeeccCCHHHHHHHHHHHhCCCEEEECCCccCCCcceeecchHHHHHhcCC--CCEEEE
Confidence 222 334445556777654444556789999999999999999999999999999999999999999999 999999
Q ss_pred e
Q 003481 173 N 173 (816)
Q Consensus 173 ~ 173 (816)
+
T Consensus 299 ~ 299 (305)
T PRK11175 299 K 299 (305)
T ss_pred c
Confidence 6
|
|
| >COG0589 UspA Universal stress protein UspA and related nucleotide-binding proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=6e-13 Score=128.60 Aligned_cols=145 Identities=17% Similarity=0.168 Sum_probs=113.2
Q ss_pred ccEEEEEec-CCcccchhhHHHHhhccCC-CCcEEEEEecCCCCCCCCCCCCCCCCcccHHHHHHHHHHHHHHHHHHHHH
Q 003481 22 GEKVYVALG-KCVEKGLSLLHWTLQRFGS-SREICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQKMKKLLDN 99 (816)
Q Consensus 22 ~~~VlVavD-~s~~~s~~Al~wal~~~~~-~~~v~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 99 (816)
.++|++++| + ++.+..|+++|++.... +..+.++||.++............ .. .............++.++.
T Consensus 5 ~~~il~~~d~~-s~~~~~a~~~a~~~~~~~~~~~~~~~v~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~~~ 78 (154)
T COG0589 5 YKKILVAVDVG-SEAAEKALEEAVALAKRLGAPLILLVVIDPLEPTALVSVALA-DA----PIPLSEEELEEEAEELLAE 78 (154)
T ss_pred cceEEEEeCCC-CHHHHHHHHHHHHHHHhcCCeEEEEEEecccccccccccccc-cc----hhhhhHHHHHHHHHHHHHH
Confidence 479999999 8 55589999999998776 788889999975432222111100 00 0111223334677889999
Q ss_pred HHHHHHHhccce-EEEEEecCCHHHHHHHHHHHhCCCEEEeccCCCCcchhhcCCcchhhhhhcCCCCceEEEEeC
Q 003481 100 YLRICVEAEVKA-RIITTEADKIQKAIVQLMNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFVNK 174 (816)
Q Consensus 100 ~~~~c~~~~v~~-~~~v~e~~d~~~~Iv~~a~~~~id~lVmGs~g~~~~~R~~~gsVs~~V~~~ap~~C~V~vv~~ 174 (816)
..+...+.++.. +..+.+|.++...|++++.++++|+||||++|++++++.++|||+++|+++++ |+|+||..
T Consensus 79 ~~~~~~~~~~~~~~~~~~~g~~~~~~i~~~a~~~~adliV~G~~g~~~l~~~llGsvs~~v~~~~~--~pVlvv~~ 152 (154)
T COG0589 79 AKALAEAAGVPVVETEVVEGSPSAEEILELAEEEDADLIVVGSRGRSGLSRLLLGSVAEKVLRHAP--CPVLVVRS 152 (154)
T ss_pred HHHHHHHcCCCeeEEEEecCCCcHHHHHHHHHHhCCCEEEECCCCCccccceeeehhHHHHHhcCC--CCEEEEcc
Confidence 999999999995 77777777767999999999999999999999999999999999999999999 99999963
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=6.4e-15 Score=172.16 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=181.6
Q ss_pred cCCCccceeeeecceEEEEEEEc---CeEEEEEEeccCC--cccHHHHHHHHHHHhcCC-CCceeeEeccc--cCCccce
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQ-HPHLVTLLGAC--PEAWSLV 541 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~~~~~---g~~vAiK~l~~~~--~~~~~~~~~E~~il~~l~-HpnIv~l~g~~--~~~~~lV 541 (816)
..|.....||+|.|+.|-..... ...+|.|.+.... .........|..+-..+. |+|++.+++.. .+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45677778999999999877663 4557777665443 122233445777777776 99999999987 4458899
Q ss_pred eeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCceeeCCCCCCceEecCCC-CeeEeecccceec
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH-SSKPEKIVHGDLKPQNILLDSEL-SSKICDFGICRLV 619 (816)
Q Consensus 542 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~ivHrDIkp~NILl~~~~-~vkL~DFGla~~~ 619 (816)
++|..++++.+.+.... ....+....-.++.|+..+|.|+| ..+ +.|+||||+|.+++..+ .++++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999998883221 113444667789999999999999 766 99999999999999999 9999999999987
Q ss_pred cC-CCCcCCCccccCCCCC-CCCCCCcccccc-CCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCC
Q 003481 620 TE-DTLYLPSFHRSTAPKG-SFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDP 696 (816)
Q Consensus 620 ~~-~~~~~~~~~~~~~~~g-t~~Y~aPE~~~~-~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~ 696 (816)
.. .... .......| ++.|+|||...+ ....+..|+||.|+++.-+++|..|+....... +........
T Consensus 176 ~~~~g~~----~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-----~~~~~~~~~ 246 (601)
T KOG0590|consen 176 RNKNGAE----RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-----GRYSSWKSN 246 (601)
T ss_pred cccCCcc----eeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-----ccceeeccc
Confidence 76 3321 23345567 999999998877 456789999999999999999999996443321 111111111
Q ss_pred C---CCCCCHHHHHHHHHHHHHhhccCCCCCCCChH
Q 003481 697 L---AGDWPTFVARRLVDLGLQCCELYGRERPDITP 729 (816)
Q Consensus 697 ~---~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e 729 (816)
. .............+++.+++..+|..|.+..+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~ 282 (601)
T KOG0590|consen 247 KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEE 282 (601)
T ss_pred ccccccCccccCChhhhhcccccccCCchhcccccc
Confidence 1 01112235567888899999999999999984
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=2.6e-13 Score=140.06 Aligned_cols=207 Identities=23% Similarity=0.263 Sum_probs=142.3
Q ss_pred HHHHhcCCCCceeeEeccccCC-------ccceeeccCCCchhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 003481 516 VRVLSKLQHPHLVTLLGACPEA-------WSLVYEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKP 587 (816)
Q Consensus 516 ~~il~~l~HpnIv~l~g~~~~~-------~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~ 587 (816)
.+-|-++-|-|||+++.|+.+. ..++.|||..|+|..+|.+.. ....+......+|+.||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 3445567899999999888542 568999999999999998653 2345677777899999999999999988
Q ss_pred CceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHH
Q 003481 588 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQ 667 (816)
Q Consensus 588 ~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~e 667 (816)
++|+|+++..+.|++..+|-+|++--.-.. ..... ............+.++|.+||+=.....+.++|||+||+..++
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s-~h~s~-~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THPSV-NSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccc-cchhh-hhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 689999999999999999888875321111 11000 0001112234457889999998877778889999999999999
Q ss_pred HHhCCCCC-CChHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHH
Q 003481 668 LLTGRLPV-GLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 668 lltG~~Pf-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~L 735 (816)
|..|..-- .....+. ....+...+-.... ..-..++..|++..|..||+++.++.|.|
T Consensus 275 mailEiq~tnseS~~~---~ee~ia~~i~~len-------~lqr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 275 MAILEIQSTNSESKVE---VEENIANVIIGLEN-------GLQRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred HHHheeccCCCcceee---hhhhhhhheeeccC-------ccccCcCcccccCCCCCCcchhhhhcCce
Confidence 99876532 1111110 01111111110000 11235677899999999999997776654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.9e-12 Score=144.36 Aligned_cols=137 Identities=23% Similarity=0.290 Sum_probs=98.9
Q ss_pred ceeeeecceEEEEEEEc-CeEEEEEEeccCCccc----------------------------------------HHHHHH
Q 003481 476 FKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQG----------------------------------------QLEFQQ 514 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~~----------------------------------------~~~~~~ 514 (816)
..||.|++|.||+|++. |+.||||+.++..... .-.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999985 9999999986642110 002455
Q ss_pred HHHHHhcCC-----CCce--eeEeccccCCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHH-HHHHHhhcC
Q 003481 515 EVRVLSKLQ-----HPHL--VTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIAS-GLCFLHSSK 586 (816)
Q Consensus 515 E~~il~~l~-----HpnI--v~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-aL~yLH~~~ 586 (816)
|...+.+++ ++++ .+++..+....+|||||++|++|.+++..... .+ .+..++..++. .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 666665552 3332 23343334567999999999999987643211 12 23456666666 477889877
Q ss_pred CCceeeCCCCCCceEecCCCCeeEeecccceecc
Q 003481 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 620 (816)
Q Consensus 587 ~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 620 (816)
++|+|+||.||+++.++.++|+|||++..+.
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999987664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.5e-12 Score=125.05 Aligned_cols=130 Identities=20% Similarity=0.165 Sum_probs=100.2
Q ss_pred ceeeeecceEEEEEEEcCeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCce-eeEeccccCCccceeeccCCCchhhhh
Q 003481 476 FKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHL-VTLLGACPEAWSLVYEYLPNGSLQDRL 554 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~g~~~~~~~lV~E~~~~gsL~~~l 554 (816)
+.|+.|.++.||++...+..|++|+...... ....+..|+.++..+.+.++ .+++++..+..++||||++|.++....
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~~ 82 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTED 82 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcccccc
Confidence 4689999999999999999999999765432 22346789999998865554 456666555678999999998876530
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCceeeCCCCCCceEecCCCCeeEeeccccee
Q 003481 555 FRKSNVSPLLWKDRARIAAEIASGLCFLHSSK--PEKIVHGDLKPQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 555 ~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 618 (816)
. ....++.+++.+|..||..+ +..++|+|++|.||+++ ++.++|+|||.+..
T Consensus 83 --------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 83 --------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred --------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 0 11345778999999999987 23469999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=5.5e-12 Score=141.36 Aligned_cols=243 Identities=25% Similarity=0.246 Sum_probs=173.1
Q ss_pred CCCccceeee--ecceEEEEEEE--c--CeEEEEEEec--cCCcccHHHHHHHHHHHhcC-CCCceeeEeccccC--Ccc
Q 003481 471 NFSESFKVGQ--GGFGCVYKGEM--L--GRTVAIKMLY--SHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWS 539 (816)
Q Consensus 471 ~f~~~~~LG~--G~~g~Vy~~~~--~--g~~vAiK~l~--~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~ 539 (816)
.|.....+|. |.+|.||.+.. . +..+|+|.-+ .........=.+|+....++ .|+|.++.+..+.+ ..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556677999 99999999877 2 7789998732 22223333334566666666 49999998877754 356
Q ss_pred ceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCceeeCCCCCCceEecCC-CCeeEeecc
Q 003481 540 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIAS----GLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFG 614 (816)
Q Consensus 540 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----aL~yLH~~~~~~ivHrDIkp~NILl~~~-~~vkL~DFG 614 (816)
+-+|++ +.+|..+...... .++....+.++.+... ||.++|+.+ ++|-|+||.||++..+ ...+++|||
T Consensus 195 iqtE~~-~~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeccc-cchhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 666776 5788887765543 3555667777777777 999999988 9999999999999999 889999999
Q ss_pred cceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCCh-HHHHHHhhcCccccc
Q 003481 615 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLA-GEVRRAVSCGKLSSI 693 (816)
Q Consensus 615 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~-~~~~~~~~~~~~~~~ 693 (816)
+...+....... .+.......|..-|++||..+ +-++.+.|+|+||.++.+..+|..+.... ...|..+..+.+.
T Consensus 269 ~v~~i~~~~~~~-~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip-- 344 (524)
T KOG0601|consen 269 LVSKISDGNFSS-VFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP-- 344 (524)
T ss_pred eeEEccCCcccc-ceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc--
Confidence 999887765332 222234457888999999875 45889999999999999999987765321 1112222222111
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCCh
Q 003481 694 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 728 (816)
Q Consensus 694 ~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~ 728 (816)
.++-...+..+..++..+++.+|..|++..
T Consensus 345 -----~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q 374 (524)
T KOG0601|consen 345 -----LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQ 374 (524)
T ss_pred -----hhhhcCcchhhhhHHHHhcCcchhhhhHHH
Confidence 112222334566689999999999999887
|
|
| >PF04564 U-box: U-box domain; InterPro: IPR003613 Quality control of intracellular proteins is essential for cellular homeostasis | Back alignment and domain information |
|---|
Probab=99.21 E-value=6.8e-12 Score=105.31 Aligned_cols=71 Identities=45% Similarity=0.839 Sum_probs=62.8
Q ss_pred CCCccccchhhhhcCCCCccCCCccccccchhhhhccCCCCCCccccccCcCCCCCcHHHHHHHHHHHhhC
Q 003481 746 VPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDWLCKS 816 (816)
Q Consensus 746 ~p~~~~~pilqeim~dP~~~~dg~t~~~~~i~~~l~~g~~~sp~t~~~l~~~~l~pn~~lr~~~~~~~~~~ 816 (816)
+|..|.|||..++|.||.+.++|.+|+...|..|+..++.++|+|+..++..+|+||.+||++|++|+.++
T Consensus 1 iP~~f~CpIt~~lM~dPVi~~~G~tyer~~I~~~l~~~~~~~P~t~~~l~~~~l~pn~~Lk~~I~~~~~~~ 71 (73)
T PF04564_consen 1 IPDEFLCPITGELMRDPVILPSGHTYERSAIERWLEQNGGTDPFTRQPLSESDLIPNRALKSAIEEWCAEN 71 (73)
T ss_dssp SSGGGB-TTTSSB-SSEEEETTSEEEEHHHHHHHHCTTSSB-TTT-SB-SGGGSEE-HHHHHHHHHHHHHC
T ss_pred CCcccCCcCcCcHhhCceeCCcCCEEcHHHHHHHHHcCCCCCCCCCCcCCcccceECHHHHHHHHHHHHHc
Confidence 58899999999999999999999999999999999999999999999999999999999999999999875
|
Molecular chaperones recognise and contribute to the refolding of misfolded or unfolded proteins, whereas the ubiquitin-proteasome system mediates the degradation of such abnormal proteins. Ubiquitin-protein ligases (E3s) determine the substrate specificity for ubiquitylation and have been classified into HECT and RING-finger families. More recently, however, U-box proteins, which contain a domain (the U box) of about 70 amino acids that is conserved from yeast to humans, have been identified as a new type of E3 []. Members of the U-box family of proteins constitute a class of ubiquitin-protein ligases (E3s) distinct from the HECT-type and RING finger-containing E3 families []. Using yeast two-hybrid technology, all mammalian U-box proteins have been reported to interact with molecular chaperones or co-chaperones, including Hsp90, Hsp70, DnaJc7, EKN1, CRN, and VCP. This suggests that the function of U box-type E3s is to mediate the degradation of unfolded or misfolded proteins in conjunction with molecular chaperones as receptors that recognise such abnormal proteins [, ]. Unlike the RING finger domain, IPR001841 from INTERPRO, that is stabilised by Zn2+ ions coordinated by the cysteines and a histidine, the U-box scaffold is probably stabilised by a system of salt-bridges and hydrogen bonds. The charged and polar residues that participate in this network of bonds are more strongly conserved in the U-box proteins than in classic RING fingers, which supports their role in maintaining the stability of the U box. Thus, the U box appears to have evolved from a RING finger domain by appropriation of a new set of residues required to stabilise its structure, concomitant with the loss of the original, metal-chelating residues [].; GO: 0004842 ubiquitin-protein ligase activity, 0016567 protein ubiquitination, 0000151 ubiquitin ligase complex; PDB: 1T1H_A 2C2L_D 2C2V_V 1WGM_A 2KR4_A 3L1Z_B 3L1X_A 2KRE_A 3M63_A 2QIZ_A .... |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.4e-10 Score=110.80 Aligned_cols=135 Identities=16% Similarity=0.123 Sum_probs=98.0
Q ss_pred ceeeeecceEEEEEEEc--------CeEEEEEEeccCCc----------------------ccHHHHH----HHHHHHhc
Q 003481 476 FKVGQGGFGCVYKGEML--------GRTVAIKMLYSHNM----------------------QGQLEFQ----QEVRVLSK 521 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~--------g~~vAiK~l~~~~~----------------------~~~~~~~----~E~~il~~ 521 (816)
..||.|--+.||.|... +..+|||+.+.... .....+. +|+..|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999764 36899998753210 0012233 79999999
Q ss_pred CCC--CceeeEeccccCCccceeeccCCCchhh-hhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCceeeCCCCC
Q 003481 522 LQH--PHLVTLLGACPEAWSLVYEYLPNGSLQD-RLFRKSNVSPLLWKDRARIAAEIASGLCFL-HSSKPEKIVHGDLKP 597 (816)
Q Consensus 522 l~H--pnIv~l~g~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~ivHrDIkp 597 (816)
+.. -++.+++++ ...+|||||+.++.+.. .|.. ..++..+...+..+++.+|..| |..+ |||+||++
T Consensus 83 l~~~Gv~vP~pi~~--~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL--KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe--cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 843 455666654 56789999997654432 2211 1244456678889999999999 7877 99999999
Q ss_pred CceEecCCCCeeEeecccceecc
Q 003481 598 QNILLDSELSSKICDFGICRLVT 620 (816)
Q Consensus 598 ~NILl~~~~~vkL~DFGla~~~~ 620 (816)
.|||++ ++.+.|+|||.+....
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeCC
Confidence 999997 4689999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PRK12652 putative monovalent cation/H+ antiporter subunit E; Reviewed | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.1e-10 Score=122.89 Aligned_cols=102 Identities=12% Similarity=0.205 Sum_probs=78.5
Q ss_pred ccEEEEEecCCcccchhhHHHHhhccCC---CCcEEEEEecCCCCCCCCCCCCCCCCcccHHHHHHHHHHHHHHHHHHHH
Q 003481 22 GEKVYVALGKCVEKGLSLLHWTLQRFGS---SREICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQKMKKLLD 98 (816)
Q Consensus 22 ~~~VlVavD~s~~~s~~Al~wal~~~~~---~~~v~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~ 98 (816)
-+|||||||| |+.|++|+++|++.+.. +++|++|||.++...... . ....+..+++++
T Consensus 5 ykkILVavDG-Se~S~~Al~~AielA~~~g~~AeL~lL~Vv~~~~~~~~-------~-----------~~~~~~~eelle 65 (357)
T PRK12652 5 ANRLLVPVAD-SVTVRQTVAYAVESAEEAAETPTVHLVAAASGRAVDPE-------G-----------QDELAAAEELLE 65 (357)
T ss_pred cCeEEEEeCC-CHHHHHHHHHHHHHHHhcCCCCEEEEEEEecCcccccc-------h-----------hHHHHHHHHHHH
Confidence 4799999999 55599999999998865 379999999975322110 0 111244556777
Q ss_pred HHHHHHHH------hccceEEEEEec-------CCHHHHHHHHHHHhCCCEEEeccC
Q 003481 99 NYLRICVE------AEVKARIITTEA-------DKIQKAIVQLMNIHGIQKLVMGAF 142 (816)
Q Consensus 99 ~~~~~c~~------~~v~~~~~v~e~-------~d~~~~Iv~~a~~~~id~lVmGs~ 142 (816)
.+.+.+++ .||++++.++++ ++|++.|++||+++++|+||||-.
T Consensus 66 ~~~~~~~~~l~~~~~gV~ve~~vv~~~~~~~~~G~pae~Iv~~Aee~~aDLIVm~~~ 122 (357)
T PRK12652 66 RVEVWATEDLGDDASSVTIETALLGTDEYLFGPGDYAEVLIAYAEEHGIDRVVLDPE 122 (357)
T ss_pred HHHHHHHHhhhcccCCCceEEEEEeccccccCCCCHHHHHHHHHHHcCCCEEEECCC
Confidence 77777765 699999988764 689999999999999999999985
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.6e-09 Score=114.32 Aligned_cols=251 Identities=20% Similarity=0.271 Sum_probs=164.9
Q ss_pred ccceeeeecceEEEEEEEcCeEEEEEEeccCCcccHHHHHHHHHHHhcC-CCCceee--------EeccccCC-ccceee
Q 003481 474 ESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVT--------LLGACPEA-WSLVYE 543 (816)
Q Consensus 474 ~~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~--------l~g~~~~~-~~lV~E 543 (816)
....||+||-+.+|..-.-+..| .|++.......+.+. +..|... .||-+-. |+|--... ..++|.
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d~V-AKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRDQV-AKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCccccCCccceeeecchhhchh-heeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 35679999999999643333333 477766554433332 2333333 5664433 22222222 456777
Q ss_pred ccCCCc-hhhhhh---hcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceec
Q 003481 544 YLPNGS-LQDRLF---RKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 619 (816)
Q Consensus 544 ~~~~gs-L~~~l~---~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~ 619 (816)
.+.+.- ...++. +....+...|.-.++.+..++.+.+-||..| .+-+|++++|+|+.+++.+.|.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec
Confidence 776652 222221 2334567899999999999999999999998 899999999999999999999985443333
Q ss_pred cCCCCcCCCccccCCCCCCCCCCCccccc-----cCCCCcchhHhHHHHHHHHHHhC-CCCCCChHH-------HHHHhh
Q 003481 620 TEDTLYLPSFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTG-RLPVGLAGE-------VRRAVS 686 (816)
Q Consensus 620 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVwSlGviL~elltG-~~Pf~~~~~-------~~~~~~ 686 (816)
..+. .....+|...|.+||... +-.-+...|-|.||+++++|+.| ++||..... ....+.
T Consensus 168 ~ng~-------~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 168 ANGT-------LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred cCCc-------eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 2222 124567999999999654 33456789999999999999996 999963321 222344
Q ss_pred cCccccccC------CCCCCCCH-HHHHHHHHHHHHhhcc--CCCCCCCChHHHHHHHHHhh
Q 003481 687 CGKLSSILD------PLAGDWPT-FVARRLVDLGLQCCEL--YGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 687 ~~~~~~~~d------~~~~~~~~-~~~~~l~~Li~~cl~~--dP~~RPs~~e~l~~~Le~l~ 739 (816)
.|.+...-+ +....||- -.++.+..|..+|+.. ++.-||+.. ..+..|..+.
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~-aW~aAl~al~ 301 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK-AWVAALDALR 301 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH-HHHHHHHHHH
Confidence 444433222 22334443 3556788888999875 467899998 6666666553
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.09 E-value=3.2e-10 Score=130.37 Aligned_cols=143 Identities=17% Similarity=0.218 Sum_probs=92.9
Q ss_pred hcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCccc----------------------------------H---
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG----------------------------------Q--- 509 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~~~----------------------------------~--- 509 (816)
-..|.. ..||+|++|.||+|++. |+.||||++++..... .
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345665 68999999999999984 8999999997652100 0
Q ss_pred ---HHHHHHHHHHhcCC----CCcee---eEeccccCCccceeeccCCCchhhhh--hhcCC-CCCCCHHHHHHHHHHHH
Q 003481 510 ---LEFQQEVRVLSKLQ----HPHLV---TLLGACPEAWSLVYEYLPNGSLQDRL--FRKSN-VSPLLWKDRARIAAEIA 576 (816)
Q Consensus 510 ---~~~~~E~~il~~l~----HpnIv---~l~g~~~~~~~lV~E~~~~gsL~~~l--~~~~~-~~~l~~~~~~~i~~qia 576 (816)
-.|.+|...+.+++ +.+.+ ++|.-+....+|||||++|+.+.++- ...+. ...+....+..++.|+
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 12445555555552 33322 33333344578999999999998742 22110 0112222222333333
Q ss_pred HHHHHHhhcCCCceeeCCCCCCceEecCCC----CeeEeecccceeccCC
Q 003481 577 SGLCFLHSSKPEKIVHGDLKPQNILLDSEL----SSKICDFGICRLVTED 622 (816)
Q Consensus 577 ~aL~yLH~~~~~~ivHrDIkp~NILl~~~~----~vkL~DFGla~~~~~~ 622 (816)
...| ++|+|+||.||+++.++ .++++|||++..++..
T Consensus 277 ------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 277 ------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred ------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 3445 99999999999999888 9999999999887543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=6.7e-10 Score=125.69 Aligned_cols=162 Identities=20% Similarity=0.243 Sum_probs=120.8
Q ss_pred cCeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccC--CccceeeccCCCchhhhhhhcCCCCCCCHHHHH
Q 003481 492 LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRA 569 (816)
Q Consensus 492 ~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~ 569 (816)
.+.+|.|..++...........+-++.|+.++||||++++..+.. ..|||+|-+. .|..++.... -..+.
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~------~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG------KEEVC 107 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH------HHHHH
Confidence 377888888766555333446778889999999999999998855 4699999883 5676775433 35566
Q ss_pred HHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCcccccc
Q 003481 570 RIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649 (816)
Q Consensus 570 ~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~ 649 (816)
..+.||+.||.|||..+ .++|++|.-+.|+++..|..||++|-++........ ......--..|..|+.+..
T Consensus 108 ~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~------~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA------PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc------ccccchhhhcccChhhcCc
Confidence 77899999999999766 499999999999999999999999998765443221 0111122234667765432
Q ss_pred CCCCcchhHhHHHHHHHHHHhC
Q 003481 650 GVLTPKSDSYSFGLIILQLLTG 671 (816)
Q Consensus 650 ~~~s~ksDVwSlGviL~elltG 671 (816)
.. -..|.|.|||++++++.|
T Consensus 180 s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCc
Confidence 22 356999999999999999
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=7.3e-11 Score=138.43 Aligned_cols=249 Identities=21% Similarity=0.188 Sum_probs=172.8
Q ss_pred HhcCCCccceeeeecceEEEEEEEc--CeEEEEEEeccCCc---ccHHHHHHHHHHHhcCCCCceeeEecc--ccCCccc
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGA--CPEAWSL 540 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~--~~~~~~l 540 (816)
.-+.|.+.+-+-+|.++.++.+.-. |...++|+...... ........+-.++-..+||.++..... |....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3455667778889999999987654 44455554433221 112222333334334456777766554 4567899
Q ss_pred eeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceecc
Q 003481 541 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 620 (816)
Q Consensus 541 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 620 (816)
|++|+.+++|...|+... ..+..-....+..+..+++|||... +.|+|++|.|+|...+++.+++|||......
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999999887654 3444445566778899999999976 8999999999999999999999998443321
Q ss_pred CC---CCc-----------------CC-----CccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCC
Q 003481 621 ED---TLY-----------------LP-----SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 675 (816)
Q Consensus 621 ~~---~~~-----------------~~-----~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf 675 (816)
.- ... .. .........||+.|.+||...+......+|+|++|++++|.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 10 000 00 001234567999999999999999999999999999999999999999
Q ss_pred CChHH--HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCCh
Q 003481 676 GLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 728 (816)
Q Consensus 676 ~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~ 728 (816)
..... +...+..+ +......+...+....+++...+..+|.+|-.+.
T Consensus 1036 na~tpq~~f~ni~~~------~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNR------DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhhccccC------CCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 75433 21111111 1112233455667888999999999999998876
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.3e-09 Score=105.72 Aligned_cols=128 Identities=26% Similarity=0.390 Sum_probs=102.0
Q ss_pred eeeeecceEEEEEEEcCeEEEEEEeccCCcc--------cHHHHHHHHHHHhcCCC--CceeeEeccccCCccceeeccC
Q 003481 477 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQ--------GQLEFQQEVRVLSKLQH--PHLVTLLGACPEAWSLVYEYLP 546 (816)
Q Consensus 477 ~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~--------~~~~~~~E~~il~~l~H--pnIv~l~g~~~~~~~lV~E~~~ 546 (816)
.+++|+-+.+|.+.+.|.++++|.=.+..-. ......+|..+|.+++- -+...++.+.++...|+|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 5789999999999888888888864332211 12346789999998853 3445667777788899999999
Q ss_pred CCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeeccccee
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 547 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~ 618 (816)
|..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++|||++..
T Consensus 83 G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 83 GELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred ChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999888554 2567888999999999998 99999999999997764 99999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.6e-10 Score=128.01 Aligned_cols=248 Identities=22% Similarity=0.206 Sum_probs=173.4
Q ss_pred CcccCHHH-HHHHhcCCCccceeeeecceEEEEEEEc---CeEEEEEEeccCCcccHHH--HHHHHHHHhcC-CCCceee
Q 003481 457 SAEFSLAD-LQTATCNFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHNMQGQLE--FQQEVRVLSKL-QHPHLVT 529 (816)
Q Consensus 457 ~~~~~~~e-l~~~t~~f~~~~~LG~G~~g~Vy~~~~~---g~~vAiK~l~~~~~~~~~~--~~~E~~il~~l-~HpnIv~ 529 (816)
...|...+ ....+.+|.....||.|.|+.||..... +..|++|.+.........+ -..|+-+...+ .|.+++.
T Consensus 251 ~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 251 ANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred hheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCC
Confidence 34455555 5556678999999999999999987654 6789999876654333222 12455555555 5778887
Q ss_pred Eeccc--cCCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCC-C
Q 003481 530 LLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-L 606 (816)
Q Consensus 530 l~g~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~-~ 606 (816)
++..+ ....|+=.|||.++++...+... .-+....++++..|++.++.++|+.. ++|+|+||+||++..+ +
T Consensus 331 ~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~---~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~ 404 (524)
T KOG0601|consen 331 KNSSWSQLRQGYIPLEFCEGGSSSLRSVTS---QMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGF 404 (524)
T ss_pred CCCCccccccccCchhhhcCcchhhhhHHH---HhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchh
Confidence 66544 34578999999999887766322 23556778999999999999999977 9999999999999886 8
Q ss_pred CeeEeecccceeccCCCCcCCCccccCCCCCCCCC-CCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHh
Q 003481 607 SSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY-ADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV 685 (816)
Q Consensus 607 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y-~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~ 685 (816)
..+++|||++..+.-.. .....++..| .+|.......+..+.|+||||.-+.+.++|.+--..... +..+
T Consensus 405 ~~~~~~~~~~t~~~~~~--------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-~~~i 475 (524)
T KOG0601|consen 405 FSKLGDFGCWTRLAFSS--------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-SLTI 475 (524)
T ss_pred hhhccccccccccceec--------ccccccccccccchhhccccccccccccccccccccccccCcccCccccc-ceee
Confidence 89999999987532111 1222233344 355566667788999999999999999998754321111 1112
Q ss_pred hcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCCh
Q 003481 686 SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 728 (816)
Q Consensus 686 ~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~ 728 (816)
..|.+. ..+. ....+..+...+...++..||.+.
T Consensus 476 ~~~~~p--------~~~~-~~~~~q~~~kv~~~~~~~~~~l~~ 509 (524)
T KOG0601|consen 476 RSGDTP--------NLPG-LKLQLQVLLKVMINPDRKRRPSAV 509 (524)
T ss_pred eccccc--------CCCc-hHHhhhhhhhhhcCCccccchhhh
Confidence 222221 1222 236788888899999999999887
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.2e-09 Score=112.40 Aligned_cols=139 Identities=24% Similarity=0.338 Sum_probs=108.6
Q ss_pred ceeeeecceEEEEEEEcC-eEEEEEEeccCCc-ccHHHHHHHHHHHhcCCC--CceeeEeccccC-----CccceeeccC
Q 003481 476 FKVGQGGFGCVYKGEMLG-RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQH--PHLVTLLGACPE-----AWSLVYEYLP 546 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~g-~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~H--pnIv~l~g~~~~-----~~~lV~E~~~ 546 (816)
..||.|.++.||++...+ ..+++|....... .....+..|+.++..+.+ .++.+++.++.+ ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 468999999999998875 8999999765432 134468899999999965 345677777754 4589999999
Q ss_pred CCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK---------------------------------------- 586 (816)
Q Consensus 547 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~---------------------------------------- 586 (816)
|.++.+.+.. ..++..+...++.+++.+|.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988876532 24677788888899999999998531
Q ss_pred -------------CCceeeCCCCCCceEecC--CCCeeEeeccccee
Q 003481 587 -------------PEKIVHGDLKPQNILLDS--ELSSKICDFGICRL 618 (816)
Q Consensus 587 -------------~~~ivHrDIkp~NILl~~--~~~vkL~DFGla~~ 618 (816)
+..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 56689999997754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.9e-09 Score=101.25 Aligned_cols=141 Identities=24% Similarity=0.309 Sum_probs=103.6
Q ss_pred ccceeeeecceEEEEEEEcCeEEEEEEeccCCc--------ccHHHHHHHHHHHhcCCCCce--eeEeccccCCccceee
Q 003481 474 ESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNM--------QGQLEFQQEVRVLSKLQHPHL--VTLLGACPEAWSLVYE 543 (816)
Q Consensus 474 ~~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~--------~~~~~~~~E~~il~~l~HpnI--v~l~g~~~~~~~lV~E 543 (816)
....|-+|+-+.|+++.+.|+.+.||.-..... -...+..+|.++|.+++--.| .+++-+-.....|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 456789999999999999999999986432211 123457789999999853333 2233222456789999
Q ss_pred ccCC-CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCC---CeeEeeccccee
Q 003481 544 YLPN-GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL---SSKICDFGICRL 618 (816)
Q Consensus 544 ~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkL~DFGla~~ 618 (816)
|++| .++.+++........ .-.....++..|-..+.-||.++ |||+||..+||+|..++ .+.|+|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 9987 478888776543222 22333688999999999999998 99999999999996654 358999999754
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.85 E-value=4.9e-08 Score=107.42 Aligned_cols=207 Identities=22% Similarity=0.228 Sum_probs=144.0
Q ss_pred ceEEEEEEE--cCeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEecccc------CCccceeeccCCC-chhhh
Q 003481 483 FGCVYKGEM--LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP------EAWSLVYEYLPNG-SLQDR 553 (816)
Q Consensus 483 ~g~Vy~~~~--~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~------~~~~lV~E~~~~g-sL~~~ 553 (816)
..+.|++.. +|..|++|+++............-+++++++.|+|+|++..+|. ...+|||+|.++. +|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 457788876 49999999995444333322334578899999999999988763 2478999999875 78776
Q ss_pred hhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 554 LFRKSN------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 554 l~~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
-+.... ...+++..+|.++.|+..||.++|+.| +.-+-|.|.+||++.+..++|+..|+.-.+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 553321 234678899999999999999999998 88899999999999999999998887665543
Q ss_pred CCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCC
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 701 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~ 701 (816)
+.. +-+.. -.+-|.=.||.+++.|.||..--...+..... . ....
T Consensus 446 d~~--------------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s----~--------~~~I 490 (655)
T KOG3741|consen 446 DPT--------------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSS----H--------LTRI 490 (655)
T ss_pred CCC--------------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHH----H--------HHHh
Confidence 220 11111 23679999999999999996432111100000 0 0112
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCCh
Q 003481 702 PTFVARRLVDLGLQCCELYGRERPDIT 728 (816)
Q Consensus 702 ~~~~~~~l~~Li~~cl~~dP~~RPs~~ 728 (816)
...++.++.+++.-....++.+ -++.
T Consensus 491 ~~~yS~D~rn~v~yl~s~~~~~-ksI~ 516 (655)
T KOG3741|consen 491 TTTYSTDLRNVVEYLESLNFRE-KSIQ 516 (655)
T ss_pred hhhhhHHHHHHHHHHHhcCccc-ccHH
Confidence 3346667778888888877775 3444
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=1e-07 Score=101.07 Aligned_cols=136 Identities=17% Similarity=0.118 Sum_probs=97.5
Q ss_pred eeeecceEEEEEEEcCeEEEEEEeccCCcc-----------cHHHHHHHHHHHhcCCCCce--eeEeccc-------cCC
Q 003481 478 VGQGGFGCVYKGEMLGRTVAIKMLYSHNMQ-----------GQLEFQQEVRVLSKLQHPHL--VTLLGAC-------PEA 537 (816)
Q Consensus 478 LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~-----------~~~~~~~E~~il~~l~HpnI--v~l~g~~-------~~~ 537 (816)
+-......|+++.+.|+.|.||........ ....+.+|...+.+|..-+| ..++++. ...
T Consensus 30 v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~ 109 (268)
T PRK15123 30 FRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRT 109 (268)
T ss_pred EecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccce
Confidence 333344457788888999999977443311 11247789998888843222 2333332 123
Q ss_pred ccceeeccCCC-chhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecC-------CCCee
Q 003481 538 WSLVYEYLPNG-SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-------ELSSK 609 (816)
Q Consensus 538 ~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~-------~~~vk 609 (816)
.+||+|++++. +|.+++..... .+.+...+..++.+++..+.-||..| |+|+|+++.|||++. ++.+.
T Consensus 110 s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 110 SFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred eEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEE
Confidence 67999999886 89998854321 23455677899999999999999988 999999999999975 46799
Q ss_pred Eeecccce
Q 003481 610 ICDFGICR 617 (816)
Q Consensus 610 L~DFGla~ 617 (816)
|+||+.+.
T Consensus 186 LIDl~r~~ 193 (268)
T PRK15123 186 VIDLHRAQ 193 (268)
T ss_pred EEECCccc
Confidence 99999775
|
|
| >PRK10490 sensor protein KdpD; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.6e-07 Score=116.32 Aligned_cols=124 Identities=16% Similarity=0.180 Sum_probs=98.1
Q ss_pred CccEEEEEecCCcccchhhHHHHhhccCC-CCcEEEEEecCCCCCCCCCCCCCCCCcccHHHHHHHHHHHHHHHHHHHHH
Q 003481 21 GGEKVYVALGKCVEKGLSLLHWTLQRFGS-SREICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQKMKKLLDN 99 (816)
Q Consensus 21 ~~~~VlVavD~s~~~s~~Al~wal~~~~~-~~~v~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 99 (816)
..++|||+|+++.+ +.+.+++|.+.... ++.+++|||..+.... .. .+..+ -+..
T Consensus 249 ~~eriLV~v~~~~~-~~~lIr~~~rlA~~~~a~~~~l~V~~~~~~~------~~----------------~~~~~-~l~~ 304 (895)
T PRK10490 249 TRDAILLCIGHNTG-SEKLVRTAARLAARLGSVWHAVYVETPRLHR------LP----------------EKKRR-AILS 304 (895)
T ss_pred cCCeEEEEECCCcc-hHHHHHHHHHHHHhcCCCEEEEEEecCCcCc------CC----------------HHHHH-HHHH
Confidence 45789999999655 88899999998877 8999999999652110 00 01222 3344
Q ss_pred HHHHHHHhccceEEEEEecCCHHHHHHHHHHHhCCCEEEeccCCCCcchhhcCCcchhhhhhcCCCCceEEEEe
Q 003481 100 YLRICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFVN 173 (816)
Q Consensus 100 ~~~~c~~~~v~~~~~v~e~~d~~~~Iv~~a~~~~id~lVmGs~g~~~~~R~~~gsVs~~V~~~ap~~C~V~vv~ 173 (816)
+..+|++.|-++. ++.++|++++|++||.+++|+.||||.++++.+ .+.||+++.+++.++ .-.|+||.
T Consensus 305 ~~~lA~~lGa~~~--~~~~~dva~~i~~~A~~~~vt~IViG~s~~~~~--~~~~s~~~~l~r~~~-~idi~iv~ 373 (895)
T PRK10490 305 ALRLAQELGAETA--TLSDPAEEKAVLRYAREHNLGKIIIGRRASRRW--WRRESFADRLARLGP-DLDLVIVA 373 (895)
T ss_pred HHHHHHHcCCEEE--EEeCCCHHHHHHHHHHHhCCCEEEECCCCCCCC--ccCCCHHHHHHHhCC-CCCEEEEe
Confidence 4469999998844 557899999999999999999999999998876 557899999999998 56889985
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.3e-07 Score=94.60 Aligned_cols=125 Identities=26% Similarity=0.277 Sum_probs=81.5
Q ss_pred EEEEEEEc-CeEEEEEEeccCCc---------------------c-----cHHHHHHHHHHHhcCCCC--ceeeEecccc
Q 003481 485 CVYKGEML-GRTVAIKMLYSHNM---------------------Q-----GQLEFQQEVRVLSKLQHP--HLVTLLGACP 535 (816)
Q Consensus 485 ~Vy~~~~~-g~~vAiK~l~~~~~---------------------~-----~~~~~~~E~~il~~l~Hp--nIv~l~g~~~ 535 (816)
.||.|... |..||||+.+.... . ......+|.+.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 48999875 88999998754210 0 012356899999999765 45666644
Q ss_pred CCccceeeccC--CCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCceeeCCCCCCceEecCCCCeeEee
Q 003481 536 EAWSLVYEYLP--NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCF-LHSSKPEKIVHGDLKPQNILLDSELSSKICD 612 (816)
Q Consensus 536 ~~~~lV~E~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~y-LH~~~~~~ivHrDIkp~NILl~~~~~vkL~D 612 (816)
+..+|||||++ |..+..+. ... ++......++.+++..+.. +|..+ |+|+||.+.|||++.+ .+.|+|
T Consensus 79 ~~~~ivME~I~~~G~~~~~l~-~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 79 NRNVIVMEYIGEDGVPLPRLK-DVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ETTEEEEE--EETTEEGGCHH-HCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--
T ss_pred eCCEEEEEecCCCccchhhHH-hcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEe
Confidence 35689999998 55554433 221 1123456778888886665 56877 9999999999999887 999999
Q ss_pred cccceecc
Q 003481 613 FGICRLVT 620 (816)
Q Consensus 613 FGla~~~~ 620 (816)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=2e-08 Score=114.50 Aligned_cols=152 Identities=23% Similarity=0.381 Sum_probs=104.4
Q ss_pred HHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcC-CCc--cccCCCCCCCCCCCccccc
Q 003481 572 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL-PSF--HRSTAPKGSFPYADPEYHR 648 (816)
Q Consensus 572 ~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~--~~~~~~~gt~~Y~aPE~~~ 648 (816)
+.+++.||.|+|..- .+||++|.|++|.++.++..||+.|+++........+. ..+ .......-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345669999999975 59999999999999999999999999987665422111 000 0111223456799999999
Q ss_pred cCCCCcchhHhHHHHHHHHHHh-CCCCCCChHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCC
Q 003481 649 TGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDI 727 (816)
Q Consensus 649 ~~~~s~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~ 727 (816)
....++++|+|||||++|.+.. |+.-+...+.....-..+. ..+.....+...++.++.+-+.+++..++.-||++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~---~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~ 259 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN---LLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL 259 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc---ccccccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence 8888999999999999999995 5444432211111100000 11111223345667788889999999999999966
Q ss_pred h
Q 003481 728 T 728 (816)
Q Consensus 728 ~ 728 (816)
.
T Consensus 260 ~ 260 (700)
T KOG2137|consen 260 D 260 (700)
T ss_pred h
Confidence 5
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.55 E-value=8.7e-07 Score=89.37 Aligned_cols=152 Identities=20% Similarity=0.184 Sum_probs=111.3
Q ss_pred HHHHHHHhcCCCccceeeeecceEEEEEEEcCeEEEEEEeccC------CcccHHHHHHHHHHHhcCCCC--ceeeEecc
Q 003481 462 LADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSH------NMQGQLEFQQEVRVLSKLQHP--HLVTLLGA 533 (816)
Q Consensus 462 ~~el~~~t~~f~~~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~------~~~~~~~~~~E~~il~~l~Hp--nIv~l~g~ 533 (816)
|+.+-.....+-..-.-|+||.+.|+.-.+.|..+-+|.-... .+.+...|.+|+..|.+|..- ++.+.+ +
T Consensus 10 f~~~w~~~~~wve~pN~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f 88 (216)
T PRK09902 10 FNHWWATEGDWVEEPNYRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-F 88 (216)
T ss_pred HHHHHhCCCceecCCCcCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-e
Confidence 3333334444444444688999999999988888889975421 134667899999999999532 244444 3
Q ss_pred cc---C----CccceeeccCCC-chhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCC
Q 003481 534 CP---E----AWSLVYEYLPNG-SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE 605 (816)
Q Consensus 534 ~~---~----~~~lV~E~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~ 605 (816)
+. . ..+||+|-+.|- +|.+++.... ..+.+...+..++.+++.+|.-||..+ +.|+|+.+.|||++.+
T Consensus 89 ~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~ 164 (216)
T PRK09902 89 GEAVKIEGEWRALLVTEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTE 164 (216)
T ss_pred eeeeccCCceEEEEEEEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCC
Confidence 31 1 257999988643 8888875543 235567778899999999999999988 9999999999999866
Q ss_pred CC--eeEeeccccee
Q 003481 606 LS--SKICDFGICRL 618 (816)
Q Consensus 606 ~~--vkL~DFGla~~ 618 (816)
+. ++++||--++.
T Consensus 165 g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 165 GKAEAGFLDLEKSRR 179 (216)
T ss_pred CCeeEEEEEhhccch
Confidence 67 99999986654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=9.5e-07 Score=91.06 Aligned_cols=134 Identities=22% Similarity=0.217 Sum_probs=95.7
Q ss_pred CCccceeeeecceEEEEEEEc-CeEEEEEEeccCCcc----------------------cHHHHHHHHHHHhcCCCC--c
Q 003481 472 FSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQ----------------------GQLEFQQEVRVLSKLQHP--H 526 (816)
Q Consensus 472 f~~~~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~----------------------~~~~~~~E~~il~~l~Hp--n 526 (816)
..++.+||-|--+.||.|... |.++|||.-+..... ......+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456789999999999999997 999999975432110 122356899999998644 5
Q ss_pred eeeEeccccCCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCC
Q 003481 527 LVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL 606 (816)
Q Consensus 527 Iv~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~ 606 (816)
+.+.+++ +...+||||++|-.|...-. +-...-.|+..|+.-+.-+-..| |||+|+++-|||++.+|
T Consensus 173 VP~P~~~--nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg 239 (304)
T COG0478 173 VPKPIAW--NRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCcccc--ccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCC
Confidence 6665554 34579999999876655321 12223344555555555555656 99999999999999999
Q ss_pred CeeEeeccccee
Q 003481 607 SSKICDFGICRL 618 (816)
Q Consensus 607 ~vkL~DFGla~~ 618 (816)
.+.++||--+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999975543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.45 E-value=7.3e-07 Score=91.20 Aligned_cols=123 Identities=26% Similarity=0.304 Sum_probs=88.4
Q ss_pred EcCeEEEEEEeccCCc-------ccHHHHHHHHHHHhcCCCCc--eeeEeccccC------CccceeeccCCC-chhhhh
Q 003481 491 MLGRTVAIKMLYSHNM-------QGQLEFQQEVRVLSKLQHPH--LVTLLGACPE------AWSLVYEYLPNG-SLQDRL 554 (816)
Q Consensus 491 ~~g~~vAiK~l~~~~~-------~~~~~~~~E~~il~~l~Hpn--Iv~l~g~~~~------~~~lV~E~~~~g-sL~~~l 554 (816)
..++.+-+|.+..... -......+|...+.+|..-+ ....+++... ..+||+|++++. +|.+++
T Consensus 30 ~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~ 109 (206)
T PF06293_consen 30 LVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLL 109 (206)
T ss_pred ccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHH
Confidence 3356666665432211 23345778888888874332 3344444322 357999999885 899988
Q ss_pred hhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCC---CeeEeecccceec
Q 003481 555 FRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL---SSKICDFGICRLV 619 (816)
Q Consensus 555 ~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~---~vkL~DFGla~~~ 619 (816)
..... ++......++.+++..+.-||..+ |+|+|++|.|||++.+. .+.|+||+-++..
T Consensus 110 ~~~~~---~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 110 QQWEQ---LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred Hhhcc---cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 76432 444667899999999999999998 99999999999998886 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG2205 KdpD Osmosensitive K+ channel histidine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=3e-06 Score=98.31 Aligned_cols=131 Identities=18% Similarity=0.173 Sum_probs=106.3
Q ss_pred CccEEEEEecCCcccchhhHHHHhhccCC-CCcEEEEEecCCCCCCCCCCCCCCCCcccHHHHHHHHHHHHHHHHHHHHH
Q 003481 21 GGEKVYVALGKCVEKGLSLLHWTLQRFGS-SREICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQKMKKLLDN 99 (816)
Q Consensus 21 ~~~~VlVavD~s~~~s~~Al~wal~~~~~-~~~v~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 99 (816)
..++|+|+|+++.. +.+-++||-..... ++..++|||..|..... .++.+..+..
T Consensus 247 ~~e~ilvcI~~~~~-~e~liR~a~RlA~~~~a~~~av~v~~~~~~~~-----------------------~~~~~~~l~~ 302 (890)
T COG2205 247 ARERILVCISGSPG-SEKLIRRAARLASRLHAKWTAVYVETPELHRL-----------------------SEKEARRLHE 302 (890)
T ss_pred ccceEEEEECCCCc-hHHHHHHHHHHHHHhCCCeEEEEEeccccccc-----------------------cHHHHHHHHH
Confidence 34899999999666 77799999877766 78999999997533210 1344556777
Q ss_pred HHHHHHHhccceEEEEEecCCHHHHHHHHHHHhCCCEEEeccCCCCcchhhcCCcchhhhhhcCCCCceEEEEeCCcee
Q 003481 100 YLRICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFVNKGKHV 178 (816)
Q Consensus 100 ~~~~c~~~~v~~~~~v~e~~d~~~~Iv~~a~~~~id~lVmGs~g~~~~~R~~~gsVs~~V~~~ap~~C~V~vv~~g~~~ 178 (816)
...+|++-|-+.. ++.++|++++|++||..+++++||||-+.++.++|.+.||..+.++++++ ...|++|..+...
T Consensus 303 ~~~Lae~lGae~~--~l~~~dv~~~i~~ya~~~~~TkiViG~~~~~rw~~~~~~~l~~~L~~~~~-~idv~ii~~~~~~ 378 (890)
T COG2205 303 NLRLAEELGAEIV--TLYGGDVAKAIARYAREHNATKIVIGRSRRSRWRRLFKGSLADRLAREAP-GIDVHIVALDAPP 378 (890)
T ss_pred HHHHHHHhCCeEE--EEeCCcHHHHHHHHHHHcCCeeEEeCCCcchHHHHHhcccHHHHHHhcCC-CceEEEeeCCCCc
Confidence 8889998886554 45689999999999999999999999999999999999999999999998 5688888755444
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.5e-05 Score=78.48 Aligned_cols=106 Identities=25% Similarity=0.267 Sum_probs=84.5
Q ss_pred HHHHHHHhcCCC-CceeeEeccccCCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcee
Q 003481 513 QQEVRVLSKLQH-PHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591 (816)
Q Consensus 513 ~~E~~il~~l~H-pnIv~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iv 591 (816)
.+|.-+|..+++ +++.+++|+|. .++|.||...+++...-..-...-..+|..+.+|+.+++..+.+|+......+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG--~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~ 84 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG--RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY 84 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC--CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence 468888888865 69999999994 478999998776653211111112468999999999999999999986655688
Q ss_pred eCCCCCCceEecCCCCeeEeecccceecc
Q 003481 592 HGDLKPQNILLDSELSSKICDFGICRLVT 620 (816)
Q Consensus 592 HrDIkp~NILl~~~~~vkL~DFGla~~~~ 620 (816)
-.|++|+|+-++++|++|++|...+....
T Consensus 85 lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 85 LCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EeecchHHeEEeCCCcEEEEechhcchhH
Confidence 99999999999999999999998776543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.22 E-value=5.5e-06 Score=83.94 Aligned_cols=135 Identities=20% Similarity=0.193 Sum_probs=93.1
Q ss_pred HhcCCCccceeeeecceEEEEEEEcCeEEEEEEeccCCcccHHHH---------HHHHHHHhcCCC---CceeeEeccc-
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEF---------QQEVRVLSKLQH---PHLVTLLGAC- 534 (816)
Q Consensus 468 ~t~~f~~~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~~~~~---------~~E~~il~~l~H---pnIv~l~g~~- 534 (816)
..++|...+.+-......|.+-..+|..+++|..+......+..| .+.+..+.+++. ..++.++-+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 446788878888888888888888899999999876544332222 234444444432 2222222221
Q ss_pred ------cCCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCe
Q 003481 535 ------PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 608 (816)
Q Consensus 535 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~v 608 (816)
....+|||||++|..|.+... ++. .+...+..++.-||..| ++|+|++|.|++++.+ .+
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GI 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cE
Confidence 234568999999988877541 221 24566778899999988 9999999999999865 59
Q ss_pred eEeecccce
Q 003481 609 KICDFGICR 617 (816)
Q Consensus 609 kL~DFGla~ 617 (816)
+++||+..+
T Consensus 174 ~iID~~~k~ 182 (229)
T PF06176_consen 174 RIIDTQGKR 182 (229)
T ss_pred EEEECcccc
Confidence 999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.22 E-value=3e-06 Score=97.23 Aligned_cols=138 Identities=20% Similarity=0.273 Sum_probs=91.7
Q ss_pred ceeeeecceEEEEEEEc-CeEEEEEEeccCCccc----------------------------------------HHHHHH
Q 003481 476 FKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQG----------------------------------------QLEFQQ 514 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~~----------------------------------------~~~~~~ 514 (816)
..|+.++-|.||+|++. |+.||||+.++.-... .-.+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57999999999999998 9999999987642110 001345
Q ss_pred HHHHHhcCC-----CCce--eeEeccccCCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHH-HHHHhhcC
Q 003481 515 EVRVLSKLQ-----HPHL--VTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASG-LCFLHSSK 586 (816)
Q Consensus 515 E~~il~~l~-----HpnI--v~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~a-L~yLH~~~ 586 (816)
|...+.+++ .|++ .++|--+.....|+|||++|..+.+...-.. ..++-.. |+..++.+ +..+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~---ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKE---LAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHH---HHHHHHHHHHHHHHhcC
Confidence 555555542 3332 2333323456789999999999998753322 2244333 33333333 22222233
Q ss_pred CCceeeCCCCCCceEecCCCCeeEeecccceeccC
Q 003481 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 587 ~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~ 621 (816)
++|.|.+|.||+++.+|.+.+.|||+...+++
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999877654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.19 E-value=8.3e-06 Score=84.32 Aligned_cols=141 Identities=25% Similarity=0.268 Sum_probs=84.1
Q ss_pred ceeeeecceEEEEEEEcCeEEEEEEeccCCcccHHHHHHHHHHHhcCCCC--ceeeEecccc-----CCccceeeccCCC
Q 003481 476 FKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP--HLVTLLGACP-----EAWSLVYEYLPNG 548 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~Hp--nIv~l~g~~~-----~~~~lV~E~~~~g 548 (816)
+.|+.|..+.||+....+..+++|..... .....+..|..++..+... .+.+++.++. ...+++|++++|.
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 56899999999999998889999997554 3455677898888888432 3456665431 1257899999998
Q ss_pred chhh----------------hhh---hc-CCCCCCCHHHH---------HHH------------HHHHHH-HHHHHhhc-
Q 003481 549 SLQD----------------RLF---RK-SNVSPLLWKDR---------ARI------------AAEIAS-GLCFLHSS- 585 (816)
Q Consensus 549 sL~~----------------~l~---~~-~~~~~l~~~~~---------~~i------------~~qia~-aL~yLH~~- 585 (816)
.+.. .+. .. ....++.+... ... ...+.. .+..++..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 8777 111 11 01111111110 000 112222 33444432
Q ss_pred ---CCCceeeCCCCCCceEec-CCCCeeEeeccccee
Q 003481 586 ---KPEKIVHGDLKPQNILLD-SELSSKICDFGICRL 618 (816)
Q Consensus 586 ---~~~~ivHrDIkp~NILl~-~~~~vkL~DFGla~~ 618 (816)
.+..++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 345699999999999999 566667999987654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.1e-05 Score=83.79 Aligned_cols=137 Identities=14% Similarity=0.198 Sum_probs=80.8
Q ss_pred ceeeeecceEEEEEEEcCeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCc--eeeEeccc--cCCccceeeccCCCc-h
Q 003481 476 FKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPH--LVTLLGAC--PEAWSLVYEYLPNGS-L 550 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~g~~--~~~~~lV~E~~~~gs-L 550 (816)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-+ +.+.++++ .+...+||++++|.+ +
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~ 82 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF 82 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence 56999999999984 35677888876433 3345688999998885433 34555554 334678999998863 2
Q ss_pred hhhh---------------------hhcCCCCCCCHHHHHH-HHH----------HHHH-HHHHHhhc-CCCceeeCCCC
Q 003481 551 QDRL---------------------FRKSNVSPLLWKDRAR-IAA----------EIAS-GLCFLHSS-KPEKIVHGDLK 596 (816)
Q Consensus 551 ~~~l---------------------~~~~~~~~l~~~~~~~-i~~----------qia~-aL~yLH~~-~~~~ivHrDIk 596 (816)
...+ +... ........... +.. .+.. ...+|... .+..++|+|+.
T Consensus 83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~-~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 83 SRIISDNPSRLEEIAKIFAEMAKKLHSTK-CDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhcCCHHHHHHHHHHHHHHHHHHhCCC-CCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 1111 1100 01111111110 000 0111 12222211 12357899999
Q ss_pred CCceEecCCCCeeEeeccccee
Q 003481 597 PQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 597 p~NILl~~~~~vkL~DFGla~~ 618 (816)
|.||+++.++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999997653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >smart00504 Ubox Modified RING finger domain | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.4e-06 Score=70.92 Aligned_cols=62 Identities=50% Similarity=0.903 Sum_probs=59.1
Q ss_pred cccchhhhhcCCCCccCCCccccccchhhhhccCCCCCCccccccCcCCCCCcHHHHHHHHHH
Q 003481 750 FLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDW 812 (816)
Q Consensus 750 ~~~pilqeim~dP~~~~dg~t~~~~~i~~~l~~g~~~sp~t~~~l~~~~l~pn~~lr~~~~~~ 812 (816)
+.||+..++|.+|.+.+.|..|....|..|+.. +.++|+++..++..+++||.+||++|++|
T Consensus 2 ~~Cpi~~~~~~~Pv~~~~G~v~~~~~i~~~~~~-~~~cP~~~~~~~~~~l~~~~~l~~~i~~~ 63 (63)
T smart00504 2 FLCPISLEVMKDPVILPSGQTYERRAIEKWLLS-HGTDPVTGQPLTHEDLIPNLALKSAIQEW 63 (63)
T ss_pred cCCcCCCCcCCCCEECCCCCEEeHHHHHHHHHH-CCCCCCCcCCCChhhceeCHHHHHHHHhC
Confidence 568999999999999999999999999999988 78999999999999999999999999998
|
Modified RING finger domain, without the full complement of Zn2+-binding ligands. Probable involvement in E2-dependent ubiquitination. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.3e-05 Score=91.69 Aligned_cols=139 Identities=17% Similarity=0.192 Sum_probs=92.7
Q ss_pred ceeeeecceEEEEEEEc-CeEEEEEEeccCCccc-------------------------------------HHHHHHHHH
Q 003481 476 FKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQG-------------------------------------QLEFQQEVR 517 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~~-------------------------------------~~~~~~E~~ 517 (816)
..||.-+.|.||+|++. |..||||+-++.-... .-.|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 46899999999999997 8899999976542110 012445555
Q ss_pred HHhcC----CCCc------eeeEeccccCCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 003481 518 VLSKL----QHPH------LVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 587 (816)
Q Consensus 518 il~~l----~Hpn------Iv~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~ 587 (816)
-..++ .|-+ |.++|-.+.....|+||||+|..+.|.-.-.. ..++-..+..-+.++..-.-+-|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~~l~~~~~~qIf~~---- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPHDILNKLVEAYLEQIFKT---- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHHHHHHHHHHHHHHHHHhc----
Confidence 44433 3555 55666666667899999999998877543222 12444444433333322222333
Q ss_pred CceeeCCCCCCceEecC----CCCeeEeecccceeccC
Q 003481 588 EKIVHGDLKPQNILLDS----ELSSKICDFGICRLVTE 621 (816)
Q Consensus 588 ~~ivHrDIkp~NILl~~----~~~vkL~DFGla~~~~~ 621 (816)
|++|+|-+|.||+++. ++.+.+-|||+...+..
T Consensus 321 -GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 -GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred -CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3999999999999983 67899999999887654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.99 E-value=7.2e-05 Score=76.69 Aligned_cols=151 Identities=22% Similarity=0.239 Sum_probs=95.4
Q ss_pred CHHHHHHHhcCCCccce---eeeecceEEEEEEEc-CeEEEEEEeccCCccc-------------------HHH-----H
Q 003481 461 SLADLQTATCNFSESFK---VGQGGFGCVYKGEML-GRTVAIKMLYSHNMQG-------------------QLE-----F 512 (816)
Q Consensus 461 ~~~el~~~t~~f~~~~~---LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~~-------------------~~~-----~ 512 (816)
+...|....++..+... |+.|.-+.||+|... +..||+|++....... ... .
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 34444444444444444 556667789998764 8999999986543211 111 2
Q ss_pred HHHHHHHhcCC--CCceeeEeccccCCccceeeccCCCch-hhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCc
Q 003481 513 QQEVRVLSKLQ--HPHLVTLLGACPEAWSLVYEYLPNGSL-QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589 (816)
Q Consensus 513 ~~E~~il~~l~--HpnIv~l~g~~~~~~~lV~E~~~~gsL-~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ 589 (816)
..|+.-|.++. +-.+.+-+++. ...|||||+....+ .-.|.. .++...+...+..+++..+.-|-... +
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~--~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a--~ 187 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR--NNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEA--G 187 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec--CCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhc--C
Confidence 35666666663 22333334433 45799999955411 111211 11222356777888888888887733 3
Q ss_pred eeeCCCCCCceEecCCCCeeEeecccceecc
Q 003481 590 IVHGDLKPQNILLDSELSSKICDFGICRLVT 620 (816)
Q Consensus 590 ivHrDIkp~NILl~~~~~vkL~DFGla~~~~ 620 (816)
+||+||+.-|||+. ++.+.|+|||-|....
T Consensus 188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99999999999999 8899999999876554
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.94 E-value=5.6e-05 Score=79.34 Aligned_cols=137 Identities=18% Similarity=0.133 Sum_probs=82.5
Q ss_pred eeeecc-eEEEEEEEcCeEEEEEEeccCCcccHHHHHHHHHHHhcCC-CCceeeEeccccC--CccceeeccCCCchhhh
Q 003481 478 VGQGGF-GCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGACPE--AWSLVYEYLPNGSLQDR 553 (816)
Q Consensus 478 LG~G~~-g~Vy~~~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~--~~~lV~E~~~~gsL~~~ 553 (816)
|-.|.+ ..||+....+..+.+|+..... ...+.+|+.++..+. +--+.++++++.. ..++||++++|.+|...
T Consensus 6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred cCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 445555 7899998777788889875543 234667888888873 3445566776643 47899999999877643
Q ss_pred hh-------------------hcCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHHhhc----CC
Q 003481 554 LF-------------------RKSN-VSPLL--WKDRARIAA--------------------EIASGLCFLHSS----KP 587 (816)
Q Consensus 554 l~-------------------~~~~-~~~l~--~~~~~~i~~--------------------qia~aL~yLH~~----~~ 587 (816)
.. .... ..++. +...+.... .+...+..|-.. .+
T Consensus 83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 162 (244)
T cd05150 83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED 162 (244)
T ss_pred hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence 21 1000 00111 001110000 011112222111 12
Q ss_pred CceeeCCCCCCceEecCCCCeeEeecccce
Q 003481 588 EKIVHGDLKPQNILLDSELSSKICDFGICR 617 (816)
Q Consensus 588 ~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 617 (816)
..++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 459999999999999998778899998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=7.4e-05 Score=72.57 Aligned_cols=130 Identities=19% Similarity=0.206 Sum_probs=91.0
Q ss_pred CccceeeeecceEEEEEEEcCeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCceeeEeccccCCccceeeccCCCchhh
Q 003481 473 SESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQD 552 (816)
Q Consensus 473 ~~~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~lV~E~~~~gsL~~ 552 (816)
.....||+|.+|.||+|.+.|..+|+|+-+.++ ....+..|.++|..+.--++.+=+.++. ..++.|||+.|-.|.+
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg-~~~i~me~i~G~~L~~ 101 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG-EDFIRMEYIDGRPLGK 101 (201)
T ss_pred hhhhhhhcccccEEEEeeccCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec-hhhhhhhhhcCcchhh
Confidence 344569999999999999999999999876554 3456888999999987666644332222 2345599999888876
Q ss_pred hhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCC-CCceEecCCCCeeEeeccccee
Q 003481 553 RLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLK-PQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 553 ~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIk-p~NILl~~~~~vkL~DFGla~~ 618 (816)
.-... + .+-+..++..---|...| |-|+.|. |..++|..++.+.|+||..|+.
T Consensus 102 ~~~~~------~----rk~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 102 LEIGG------D----RKHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhcc------c----HHHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 54321 1 122334555544455555 9999985 6666666666999999998863
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.84 E-value=2.9e-06 Score=95.89 Aligned_cols=186 Identities=20% Similarity=0.147 Sum_probs=131.0
Q ss_pred hcCCCccceeeeecceEEEEEEEc-CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCc-eeeEecccc--CCccceeec
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPH-LVTLLGACP--EAWSLVYEY 544 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~g~~~--~~~~lV~E~ 544 (816)
|.-+...+.+++|+++.+|+.+.. .+....+.+... ....-++++|.+++||| .+..++-+. +...+++++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 333444456899999999998776 233334444322 34556889999999999 666666553 346789999
Q ss_pred cCCC-chhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccceeccCCC
Q 003481 545 LPNG-SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 545 ~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~ 623 (816)
+.++ +-........ ..+...+...+...-..+|++||+.. =+|+| ||+..+ +..++.||+....+....
T Consensus 316 ~s~~rs~~~~~~~se--~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSE--IALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hcCCccccccCChhh--Hhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence 9777 2222111110 11222334556777788999999964 48998 777755 689999999987776543
Q ss_pred CcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHHHHHHhCCCCCC
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVG 676 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL~elltG~~Pf~ 676 (816)
......+|+.++|||+...+.+..+.|+|++|+--.++--|-+|-.
T Consensus 386 -------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 -------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred -------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 3456779999999999999999999999999988778877877754
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.82 E-value=0.00016 Score=89.17 Aligned_cols=147 Identities=19% Similarity=0.275 Sum_probs=92.7
Q ss_pred cceeeeecceEEEEEEEcC----eEEEEEEeccCCc-ccHHHHHHHHHHHhcCC-CCce--eeEeccccC-----Cccce
Q 003481 475 SFKVGQGGFGCVYKGEMLG----RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQ-HPHL--VTLLGACPE-----AWSLV 541 (816)
Q Consensus 475 ~~~LG~G~~g~Vy~~~~~g----~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~-HpnI--v~l~g~~~~-----~~~lV 541 (816)
...|+.|.+..+|+....+ ..+++|+...... .....+.+|+.+|..+. |+++ .+++++|.+ ..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 4568999999999987763 4678887654322 23456889999999995 6665 777888754 47899
Q ss_pred eeccCCCchhhh-----------------------hhhcCC--------CCCCCH--HHHHHHH---------------H
Q 003481 542 YEYLPNGSLQDR-----------------------LFRKSN--------VSPLLW--KDRARIA---------------A 573 (816)
Q Consensus 542 ~E~~~~gsL~~~-----------------------l~~~~~--------~~~l~~--~~~~~i~---------------~ 573 (816)
|||++|..+.+. |+.... ..+..+ .++..|. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999988654321 111000 001111 1121111 1
Q ss_pred HHHHHHHHHhhcCCC--------ceeeCCCCCCceEecCC-CC-eeEeecccceeccC
Q 003481 574 EIASGLCFLHSSKPE--------KIVHGDLKPQNILLDSE-LS-SKICDFGICRLVTE 621 (816)
Q Consensus 574 qia~aL~yLH~~~~~--------~ivHrDIkp~NILl~~~-~~-vkL~DFGla~~~~~ 621 (816)
.+...+.+|..+-|. .+||+|+++.|||++.+ +. +-|.||.++..-.+
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdP 260 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQ 260 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCCh
Confidence 233446677554432 49999999999999853 33 57999998876543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00013 Score=76.10 Aligned_cols=71 Identities=18% Similarity=0.212 Sum_probs=45.5
Q ss_pred ceeeeecce-EEEEEEEcCeEEEEEEeccCCcccHHHHHHHHHHHhcCCCC---ceeeEeccccC-----CccceeeccC
Q 003481 476 FKVGQGGFG-CVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP---HLVTLLGACPE-----AWSLVYEYLP 546 (816)
Q Consensus 476 ~~LG~G~~g-~Vy~~~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~Hp---nIv~l~g~~~~-----~~~lV~E~~~ 546 (816)
..|+.||.. .||+. +..+++|..... .....+.+|..+|..+... .+.++++.... ..++||++++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 457877776 48875 346777875432 2344688899999887532 33444444322 2478999999
Q ss_pred CCchh
Q 003481 547 NGSLQ 551 (816)
Q Consensus 547 ~gsL~ 551 (816)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 97774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.72 E-value=8.9e-05 Score=78.50 Aligned_cols=138 Identities=18% Similarity=0.125 Sum_probs=80.6
Q ss_pred eeeecceEEEEEEEcCeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCce-eeEeccccCCccceeeccCCCchhhh---
Q 003481 478 VGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHL-VTLLGACPEAWSLVYEYLPNGSLQDR--- 553 (816)
Q Consensus 478 LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~g~~~~~~~lV~E~~~~gsL~~~--- 553 (816)
+..|-.+.+|+....+..+++|........-.....+|..++..+....+ .++++.+. .++||+|++|..+...
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~--~~~v~e~i~G~~~~~~~~~ 81 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE--HWLLVEWLEGEVITLDQFV 81 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC--CEEEEEeccCccccccccc
Confidence 55677889999887788899997654322211135678889988854333 34444443 4689999998766421
Q ss_pred --------------hhhcCC-CCCCCHHHH-HHHHHHH---------HHHHHHHhhc-----CCCceeeCCCCCCceEec
Q 003481 554 --------------LFRKSN-VSPLLWKDR-ARIAAEI---------ASGLCFLHSS-----KPEKIVHGDLKPQNILLD 603 (816)
Q Consensus 554 --------------l~~~~~-~~~l~~~~~-~~i~~qi---------a~aL~yLH~~-----~~~~ivHrDIkp~NILl~ 603 (816)
|+.... ..+++.... ..+..++ ...+..+-.. .+..++|+|+.|.||+++
T Consensus 82 ~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~ 161 (256)
T TIGR02721 82 ALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVT 161 (256)
T ss_pred CchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEe
Confidence 111110 112222211 1111111 1112222111 123589999999999999
Q ss_pred CCCCeeEeeccccee
Q 003481 604 SELSSKICDFGICRL 618 (816)
Q Consensus 604 ~~~~vkL~DFGla~~ 618 (816)
.++ +.|+||..|..
T Consensus 162 ~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 162 PQG-LKLIDWEYASD 175 (256)
T ss_pred CCC-CEEEeccccCc
Confidence 877 78999987754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd01984 AANH_like Adenine nucleotide alpha hydrolases superfamily including N type ATP PPases, ATP sulphurylases Universal Stress Response protein and electron transfer flavoprotein (ETF) | Back alignment and domain information |
|---|
Probab=97.68 E-value=9.6e-05 Score=64.11 Aligned_cols=84 Identities=19% Similarity=0.264 Sum_probs=69.0
Q ss_pred EEEEecCCcccchhhHHHHhhccCCCCcEEEEEecCCCCCCCCCCCCCCCCcccHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 003481 25 VYVALGKCVEKGLSLLHWTLQRFGSSREICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQKMKKLLDNYLRIC 104 (816)
Q Consensus 25 VlVavD~s~~~s~~Al~wal~~~~~~~~v~lvHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~~~c 104 (816)
|+||++|... |..++.||......+..++.+|+.
T Consensus 1 ilv~~sgg~d-S~~~l~~~~~~~~~~~~~~~~~~~--------------------------------------------- 34 (86)
T cd01984 1 ILVALSGGLD-SSVLLHLAKRLKSGGPEVVALVVV--------------------------------------------- 34 (86)
T ss_pred CEEEeeCCHH-HHHHHHHHHHHHhcCCCEEEEEeH---------------------------------------------
Confidence 6899999666 878999998875334567677665
Q ss_pred HHhccceEEEEEecCCHHHHHHHHHHHhCCCEEEeccCCCCcchhhcCC-cchhhhhhcCCCCceEEE
Q 003481 105 VEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAFPDNCMKVKMGS-RKASYAAKNAPMFCEIWF 171 (816)
Q Consensus 105 ~~~~v~~~~~v~e~~d~~~~Iv~~a~~~~id~lVmGs~g~~~~~R~~~g-sVs~~V~~~ap~~C~V~v 171 (816)
-..+.+.++++++++|.||+|+++.....+.++| +++.++++.++ |+|+.
T Consensus 35 ---------------~~~~~~~~~a~~~~~~~Iv~G~~~~d~~~~~~~~~~~~~~~~~~~~--~~vl~ 85 (86)
T cd01984 35 ---------------AFVRILKRLAAEEGADVIILGHNADDVAGRRLGASANVLVVIKGAG--IPVLT 85 (86)
T ss_pred ---------------HHHHHHHHHHHHcCCCEEEEcCCchhhhhhccCchhhhhhcccccC--CceeC
Confidence 3457788899999999999999999999988888 89999999999 88763
|
The domain forms a apha/beta/apha fold which binds to Adenosine nucleotide. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00034 Score=72.86 Aligned_cols=139 Identities=19% Similarity=0.288 Sum_probs=81.8
Q ss_pred ceeeeecceEEEEEEEc---CeEEEEEEeccCCcccHHHHHHHHHHHhcCCC-CceeeEeccccCCccceeeccCCCchh
Q 003481 476 FKVGQGGFGCVYKGEML---GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH-PHLVTLLGACPEAWSLVYEYLPNGSLQ 551 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~---g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~g~~~~~~~lV~E~~~~gsL~ 551 (816)
..|..|-...+|+.... +..|++|+....... .....+|+.++..+.. .-..++++.+. ..+||||++|.++.
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~~~l~e~i~G~~l~ 80 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ--NGLIYEFIPGRTLE 80 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC--CcEEEEeeCCCcCC
Confidence 45778888899998775 578999976543221 1223478888888843 33445555443 35899999987763
Q ss_pred hh-----------------hhhcCCC---------CCCCHHHHHHHHHH----------------------HHHHHHH--
Q 003481 552 DR-----------------LFRKSNV---------SPLLWKDRARIAAE----------------------IASGLCF-- 581 (816)
Q Consensus 552 ~~-----------------l~~~~~~---------~~l~~~~~~~i~~q----------------------ia~aL~y-- 581 (816)
.. |+..... ..-.|..+..+... +...+..
T Consensus 81 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~ 160 (235)
T cd05157 81 PEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWLK 160 (235)
T ss_pred HHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHHH
Confidence 21 1111110 11112222222111 1111111
Q ss_pred --Hhhc-CCCceeeCCCCCCceEecC-CCCeeEeecccce
Q 003481 582 --LHSS-KPEKIVHGDLKPQNILLDS-ELSSKICDFGICR 617 (816)
Q Consensus 582 --LH~~-~~~~ivHrDIkp~NILl~~-~~~vkL~DFGla~ 617 (816)
+-.. .+..++|+|+.|.|||++. ++.+.|+||..|.
T Consensus 161 ~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 161 ELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 2221 2346999999999999998 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00089 Score=74.87 Aligned_cols=74 Identities=15% Similarity=0.082 Sum_probs=55.1
Q ss_pred ceeeeecceEEEEEEEcC--eEEEEEEeccC------C-cccHHHHHHHHHHHhcCC---CCceeeEeccccCCccceee
Q 003481 476 FKVGQGGFGCVYKGEMLG--RTVAIKMLYSH------N-MQGQLEFQQEVRVLSKLQ---HPHLVTLLGACPEAWSLVYE 543 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~g--~~vAiK~l~~~------~-~~~~~~~~~E~~il~~l~---HpnIv~l~g~~~~~~~lV~E 543 (816)
+.||.|.+..||++...+ +.|+||.-.+. . .-....+..|.+.|..+. -.++.+++.+..+..++|||
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~~~lVME 111 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEELAVTVME 111 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCCCEEEEe
Confidence 468999999999999874 48999984321 1 224456778888888762 34677888887777899999
Q ss_pred ccCCCc
Q 003481 544 YLPNGS 549 (816)
Q Consensus 544 ~~~~gs 549 (816)
|+++..
T Consensus 112 ~L~~~~ 117 (401)
T PRK09550 112 DLSDHK 117 (401)
T ss_pred cCCCcc
Confidence 998743
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0007 Score=73.34 Aligned_cols=73 Identities=19% Similarity=0.050 Sum_probs=54.4
Q ss_pred ceeeeecceEEEEEEEcCeEEEEEEeccCCcccHHHHHHHHHHHhcCCC---CceeeEecccc-----CCccceeeccCC
Q 003481 476 FKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH---PHLVTLLGACP-----EAWSLVYEYLPN 547 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~H---pnIv~l~g~~~-----~~~~lV~E~~~~ 547 (816)
..||.|..+.||.....+..+.+|..+.. .....|..|...|..|.- -.+.+++++|. +..+||||++++
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGNPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCCEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 45999999999998876556777875331 123478899999988843 35777887763 347999999998
Q ss_pred Cch
Q 003481 548 GSL 550 (816)
Q Consensus 548 gsL 550 (816)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00052 Score=68.95 Aligned_cols=132 Identities=27% Similarity=0.382 Sum_probs=94.0
Q ss_pred cCcccCHHHHHHHhcCCCccceeeeecc-eEEEEEEEcCeEEEEEEecc---CCc-------c-----------cHHHHH
Q 003481 456 ESAEFSLADLQTATCNFSESFKVGQGGF-GCVYKGEMLGRTVAIKMLYS---HNM-------Q-----------GQLEFQ 513 (816)
Q Consensus 456 ~~~~~~~~el~~~t~~f~~~~~LG~G~~-g~Vy~~~~~g~~vAiK~l~~---~~~-------~-----------~~~~~~ 513 (816)
....|+. -+.+++..+.||.|.- |.||+++..|..+|||++.. ... . ...-|.
T Consensus 28 KL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~ 102 (207)
T PF13095_consen 28 KLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFN 102 (207)
T ss_pred CcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHH
Confidence 3445555 3378899999999999 99999999999999999422 111 0 012478
Q ss_pred HHHHHHhcCC---CCce--eeEeccc--c-CC-----------------ccceeeccCCCchhhhhhhcCCCCCCCHHHH
Q 003481 514 QEVRVLSKLQ---HPHL--VTLLGAC--P-EA-----------------WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDR 568 (816)
Q Consensus 514 ~E~~il~~l~---HpnI--v~l~g~~--~-~~-----------------~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~ 568 (816)
.|.+...+|+ +.++ |+.+||. . +. +.||.||++... .+.
T Consensus 103 ~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~---- 166 (207)
T PF13095_consen 103 CECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ---- 166 (207)
T ss_pred HHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----
Confidence 8999988884 4455 8999986 1 00 246777765532 111
Q ss_pred HHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecCCCCeeEeecccc
Q 003481 569 ARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 616 (816)
Q Consensus 569 ~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~~~~vkL~DFGla 616 (816)
..-+.+|.+-|..+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 167 ~~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 167 IRDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred hhHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 233567778889999988 999999999985 3589999864
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0009 Score=73.24 Aligned_cols=155 Identities=17% Similarity=0.225 Sum_probs=83.8
Q ss_pred cCHHHHHHHhcCCCc-----cceeeeecceEEEEEEEcCeEEEEEEeccCCcccHHHHHHHHHHHhcCC-----CCceee
Q 003481 460 FSLADLQTATCNFSE-----SFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-----HPHLVT 529 (816)
Q Consensus 460 ~~~~el~~~t~~f~~-----~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~-----HpnIv~ 529 (816)
++..++...-..|.. .+.|+.|....+|+....+..+++|++... ....+..|+.++..|. .|.++.
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~ 83 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQGEYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVA 83 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCCcEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCccee
Confidence 445555554445543 345667777899998877668999987521 2223334555555542 333332
Q ss_pred E-----eccccCCccceeeccCCCchhh-----------h---hhhcC-C-------CCCCCH-HHHHH-----------
Q 003481 530 L-----LGACPEAWSLVYEYLPNGSLQD-----------R---LFRKS-N-------VSPLLW-KDRAR----------- 570 (816)
Q Consensus 530 l-----~g~~~~~~~lV~E~~~~gsL~~-----------~---l~~~~-~-------~~~l~~-~~~~~----------- 570 (816)
- +....+..+++++|++|..+.. . |+... . ...+.| .....
T Consensus 84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (319)
T PRK05231 84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA 163 (319)
T ss_pred CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence 1 1112334689999999875421 1 11110 0 011112 22111
Q ss_pred -HHHH-HHHHHHHHhhc----CCCceeeCCCCCCceEecCCCCeeEeecccce
Q 003481 571 -IAAE-IASGLCFLHSS----KPEKIVHGDLKPQNILLDSELSSKICDFGICR 617 (816)
Q Consensus 571 -i~~q-ia~aL~yLH~~----~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 617 (816)
.+.+ +...+..+... -|.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 11122333211 24579999999999999976556899999764
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00045 Score=74.68 Aligned_cols=140 Identities=17% Similarity=0.178 Sum_probs=85.5
Q ss_pred cceeeeecceEEEEEEEcCeEEEEEEeccCCcccHHHHHHHHHHHhcCCCC--ceeeEeccc--------cCCccceeec
Q 003481 475 SFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP--HLVTLLGAC--------PEAWSLVYEY 544 (816)
Q Consensus 475 ~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~Hp--nIv~l~g~~--------~~~~~lV~E~ 544 (816)
...|..|....+|+....+..+++|+... .....+..|+.++..+.+. .+.+++... .+..++|++|
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 44577787889999887777899998764 2334566778887777432 244444322 2345789999
Q ss_pred cCCCchhh----h----------hhhcC-C-------CCCCCHHHHH----------HHHHHHHHHHHHHhh----cCCC
Q 003481 545 LPNGSLQD----R----------LFRKS-N-------VSPLLWKDRA----------RIAAEIASGLCFLHS----SKPE 588 (816)
Q Consensus 545 ~~~gsL~~----~----------l~~~~-~-------~~~l~~~~~~----------~i~~qia~aL~yLH~----~~~~ 588 (816)
++|..+.. . |+... . .....|.... .....+..++.++.. ..+.
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99877532 0 11100 0 0112232211 011223344555553 1234
Q ss_pred ceeeCCCCCCceEecCCCCeeEeecccce
Q 003481 589 KIVHGDLKPQNILLDSELSSKICDFGICR 617 (816)
Q Consensus 589 ~ivHrDIkp~NILl~~~~~vkL~DFGla~ 617 (816)
.++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 69999999999999988777899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0013 Score=66.42 Aligned_cols=129 Identities=22% Similarity=0.289 Sum_probs=86.6
Q ss_pred cceeeeecceEEEEEEEcCeEEEEEEeccCC----------------cccHHHHHHHHHHHhcCC------CCceeeEec
Q 003481 475 SFKVGQGGFGCVYKGEMLGRTVAIKMLYSHN----------------MQGQLEFQQEVRVLSKLQ------HPHLVTLLG 532 (816)
Q Consensus 475 ~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~----------------~~~~~~~~~E~~il~~l~------HpnIv~l~g 532 (816)
...||+|+.=.||.--. +....||+..... .....++.+|+.-...+. +.+|.+++|
T Consensus 6 ~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 45699999999996433 3456788887665 122445667777666665 889999999
Q ss_pred cccC--CccceeeccCC------CchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCceeeCCCCCCceEecC
Q 003481 533 ACPE--AWSLVYEYLPN------GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS 604 (816)
Q Consensus 533 ~~~~--~~~lV~E~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ivHrDIkp~NILl~~ 604 (816)
+... +..+|+|.+.+ -+|.+++... .++. . +...+-.-..||-.++ |+.+||+|.||++..
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVVQR 153 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEEEe
Confidence 9854 46788887643 2577777433 2443 3 3333444456777766 999999999999954
Q ss_pred C--C--CeeEee-ccc
Q 003481 605 E--L--SSKICD-FGI 615 (816)
Q Consensus 605 ~--~--~vkL~D-FGl 615 (816)
+ + .+.|+| ||.
T Consensus 154 ~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLGE 169 (199)
T ss_pred cCCCceEEEEEeCCCC
Confidence 3 2 477777 453
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0014 Score=71.37 Aligned_cols=141 Identities=16% Similarity=0.176 Sum_probs=81.8
Q ss_pred cceeeeecceEEEEEEEcCeEEEEEEeccCCcccHHHHHHHHHHHhcCCCC--ceeeEeccc--------cCCccceeec
Q 003481 475 SFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP--HLVTLLGAC--------PEAWSLVYEY 544 (816)
Q Consensus 475 ~~~LG~G~~g~Vy~~~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~Hp--nIv~l~g~~--------~~~~~lV~E~ 544 (816)
...++.|....+|+....+..+++|+..... ....+..|+.++..|... .+.+++... .+..+++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEeCCCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 3456677778999987766678899875432 223445667777666322 234444322 2336789999
Q ss_pred cCCCchhh--------------hhhhcCC-C-C-------CCCHHHHHH------------HHHHHHHHHHHHhh----c
Q 003481 545 LPNGSLQD--------------RLFRKSN-V-S-------PLLWKDRAR------------IAAEIASGLCFLHS----S 585 (816)
Q Consensus 545 ~~~gsL~~--------------~l~~~~~-~-~-------~l~~~~~~~------------i~~qia~aL~yLH~----~ 585 (816)
++|..+.. .++.... . . .-.|..... ....+...+.++.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 98865421 0111100 0 0 012221110 01123344555543 2
Q ss_pred CCCceeeCCCCCCceEecCCCCeeEeecccce
Q 003481 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICR 617 (816)
Q Consensus 586 ~~~~ivHrDIkp~NILl~~~~~vkL~DFGla~ 617 (816)
.+.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 24679999999999999988777899998763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG4642 consensus Chaperone-dependent E3 ubiquitin protein ligase (contains TPR repeats) [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.00014 Score=73.10 Aligned_cols=75 Identities=29% Similarity=0.546 Sum_probs=70.5
Q ss_pred ccCCCCCccccchhhhhcCCCCccCCCccccccchhhhhccCCCCCCccccccCcCCCCCcHHHHHHHHHHHhhC
Q 003481 742 EERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDWLCKS 816 (816)
Q Consensus 742 ~~~~~p~~~~~pilqeim~dP~~~~dg~t~~~~~i~~~l~~g~~~sp~t~~~l~~~~l~pn~~lr~~~~~~~~~~ 816 (816)
....+|.+..+.|..++|.+|.++++|.||+...|.+++.....+.|.|.-++...+++||.+|+.+|-.|+..|
T Consensus 204 k~rEvpd~lcgkIt~el~~~pvi~psgIty~ra~I~Ehl~rvghfdpvtr~~Lte~q~ipN~alkevIa~fl~~n 278 (284)
T KOG4642|consen 204 KKREVPDYLCGKITLELMREPVITPSGITYDRADIEEHLQRVGHFDPVTRWPLTEYQLIPNLALKEVIAAFLKEN 278 (284)
T ss_pred ccccccchhhhhhhHHhhcCCccCccccchhHHHHHHHHHHhccCCchhcccCCHHhhccchHHHHHHHHHHHhc
Confidence 346789999999999999999999999999999999999998999999999999999999999999999999764
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0012 Score=71.63 Aligned_cols=139 Identities=24% Similarity=0.339 Sum_probs=83.0
Q ss_pred ceeeeecceEEEEEEEc--------CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCc-eeeEeccccCCccceeeccC
Q 003481 476 FKVGQGGFGCVYKGEML--------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPH-LVTLLGACPEAWSLVYEYLP 546 (816)
Q Consensus 476 ~~LG~G~~g~Vy~~~~~--------g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~g~~~~~~~lV~E~~~ 546 (816)
+.|..|-...+|+.... +..+++|+..... .......+|..++..+...+ ..++++++.+ .+|++|++
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~--~~v~e~i~ 80 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN--GRIEEFIP 80 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC--CchhheeC
Confidence 34666777789988765 3789999975543 22234567888888884333 3455666643 46899998
Q ss_pred CCchhhh-----------------hhhcCCC--------CCCCHHHHHHH--------------------------HHHH
Q 003481 547 NGSLQDR-----------------LFRKSNV--------SPLLWKDRARI--------------------------AAEI 575 (816)
Q Consensus 547 ~gsL~~~-----------------l~~~~~~--------~~l~~~~~~~i--------------------------~~qi 575 (816)
|..+... |+..... .+.-|.....+ ...+
T Consensus 81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (302)
T cd05156 81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE 160 (302)
T ss_pred CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence 8776431 1111100 01111111111 1122
Q ss_pred HHHHHHHhh------cCCCceeeCCCCCCceEecCC----CCeeEeecccce
Q 003481 576 ASGLCFLHS------SKPEKIVHGDLKPQNILLDSE----LSSKICDFGICR 617 (816)
Q Consensus 576 a~aL~yLH~------~~~~~ivHrDIkp~NILl~~~----~~vkL~DFGla~ 617 (816)
...+.+|-. ..+..++|+|+.|.|||++.+ +.+.|+||..|.
T Consensus 161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 223344432 234569999999999999985 889999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00067 Score=82.28 Aligned_cols=197 Identities=20% Similarity=0.194 Sum_probs=135.5
Q ss_pred HHHHHHHhcCCCCceeeEeccccCC------ccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 003481 513 QQEVRVLSKLQHPHLVTLLGACPEA------WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586 (816)
Q Consensus 513 ~~E~~il~~l~HpnIv~l~g~~~~~------~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~ 586 (816)
.-|...+.++.|+|++.+++|.-+. ..+.-+++..-++...+.... .++....+.+..++..||.|+|+..
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 3567778888999999999886332 234567888888888776543 5777888899999999999999975
Q ss_pred CCceeeCCCCCC---ceEecCCCCeeEe--ecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCc--chhHh
Q 003481 587 PEKIVHGDLKPQ---NILLDSELSSKIC--DFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTP--KSDSY 659 (816)
Q Consensus 587 ~~~ivHrDIkp~---NILl~~~~~vkL~--DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~--ksDVw 659 (816)
..|.-+..+ +...+..+.+.++ ||+..+....... .....-+..|.+||......+.. ..|+|
T Consensus 307 ---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-------~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~ 376 (1351)
T KOG1035|consen 307 ---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-------SFSDLLAEIRNADEDLKENTAKKSRLTDLW 376 (1351)
T ss_pred ---cceeEEecccccccccCccceeecchhhhcccccCCCccc-------chhhcCccccccccccccccchhhhhhHHH
Confidence 555555444 4445566777777 9988877655432 12233455688888776555544 47999
Q ss_pred HHHHHHHHHHhCCCCCCChHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHhhccCCCCCCCChHHHHHHHHHh
Q 003481 660 SFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 660 SlGviL~elltG~~Pf~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~e~l~~~Le~l 738 (816)
.+|..+..+..|..+-...... ..+++. ... ..+.+...+|+..++++|++..+.+.+.+...
T Consensus 377 ~lgll~~~~~~~~~i~~~~~~~---------~~~l~~---~~~----~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 377 CLGLLLLQLSQGEDISEKSAVP---------VSLLDV---LST----SELLDALPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred HHHHHHhhhhhcCcccccccch---------hhhhcc---ccc----hhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence 9999999999988664321111 111111 011 15677888999999999999997776666543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.22 E-value=8.1e-05 Score=91.42 Aligned_cols=158 Identities=13% Similarity=-0.057 Sum_probs=118.4
Q ss_pred HHHHHHHhcCCCCceeeEecccc----CCccceeeccCCCchhhhhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 003481 513 QQEVRVLSKLQHPHLVTLLGACP----EAWSLVYEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKP 587 (816)
Q Consensus 513 ~~E~~il~~l~HpnIv~l~g~~~----~~~~lV~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~ 587 (816)
..|.+.++...|+++...+.-.+ ...+.+++|+.+|.+.+.|.+.. ..++++..-+.....+...+..-+|+...
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 34555666678999887665442 24688999999999999887653 33444444444444443666666665432
Q ss_pred --CceeeCCCCCCceEecCCCCeeEeecccceeccCCCCcCCCccccCCCCCCCCCCCccccccCCCCcchhHhHHHHHH
Q 003481 588 --EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLII 665 (816)
Q Consensus 588 --~~ivHrDIkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGviL 665 (816)
.-.+|+++|+-|.+|..+.++|++++|+.+...+... ......+++.|+.|++.+.-.++.++|+|..|+.+
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s------f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS------FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSL 1430 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCchHh------hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence 3478999999999999999999999999995444332 23556788899999999888899899999999999
Q ss_pred HHHHhCCCCCC
Q 003481 666 LQLLTGRLPVG 676 (816)
Q Consensus 666 ~elltG~~Pf~ 676 (816)
|.+.-|..+|-
T Consensus 1431 y~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1431 YLRSDGNAYFI 1441 (2724)
T ss_pred HHHhcccHHHH
Confidence 99999998873
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0045 Score=68.49 Aligned_cols=138 Identities=19% Similarity=0.250 Sum_probs=82.6
Q ss_pred eeeeecceEEEEEEEc------CeEEEEEEeccCCcccHHHHHHHHHHHhcCCCCce-eeEeccccCCccceeeccCCCc
Q 003481 477 KVGQGGFGCVYKGEML------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHL-VTLLGACPEAWSLVYEYLPNGS 549 (816)
Q Consensus 477 ~LG~G~~g~Vy~~~~~------g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnI-v~l~g~~~~~~~lV~E~~~~gs 549 (816)
.|-.|-...+|+.... +..|++|+......... .-.+|..++..+..-++ .++++.+.++ .|++|+++.+
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g--~v~efi~g~~ 119 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG--RVEEFIHART 119 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc--eEEEeeCCCC
Confidence 4555777889988753 36799998765432222 23578888888854444 4566766544 6899998777
Q ss_pred hhhh-----------------hhhcC---CCCCCCHHHHHHHHHHH-----------------HHHHHHH----hh-cCC
Q 003481 550 LQDR-----------------LFRKS---NVSPLLWKDRARIAAEI-----------------ASGLCFL----HS-SKP 587 (816)
Q Consensus 550 L~~~-----------------l~~~~---~~~~l~~~~~~~i~~qi-----------------a~aL~yL----H~-~~~ 587 (816)
|... ++... ......|..+.++..++ ...+..| .. ..+
T Consensus 120 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~ 199 (344)
T PLN02236 120 LSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQE 199 (344)
T ss_pred CCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCC
Confidence 6421 11111 01122344444443222 1112222 22 223
Q ss_pred CceeeCCCCCCceEecC-CCCeeEeecccce
Q 003481 588 EKIVHGDLKPQNILLDS-ELSSKICDFGICR 617 (816)
Q Consensus 588 ~~ivHrDIkp~NILl~~-~~~vkL~DFGla~ 617 (816)
..++|+|+++.|||++. ++.+.|+||..+.
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 45899999999999986 4689999998764
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.00092 Score=70.81 Aligned_cols=147 Identities=15% Similarity=0.183 Sum_probs=99.1
Q ss_pred cCHHHHHHHhcC---CCccceeeeecceEEEEEEEc-CeEEEEEEeccCCcc----------------------cHHHHH
Q 003481 460 FSLADLQTATCN---FSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQ----------------------GQLEFQ 513 (816)
Q Consensus 460 ~~~~el~~~t~~---f~~~~~LG~G~~g~Vy~~~~~-g~~vAiK~l~~~~~~----------------------~~~~~~ 513 (816)
+.+--|.+..++ ++.+++||-|.-+.||.+-+. |++.++|.-+..... ......
T Consensus 79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT 158 (465)
T ss_pred chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence 445555555544 678899999999999999887 999999964322110 011234
Q ss_pred HHHHHHhcCC-CC-ceeeEeccccCCccceeeccCCCchhhhhhhcCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCcee
Q 003481 514 QEVRVLSKLQ-HP-HLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591 (816)
Q Consensus 514 ~E~~il~~l~-Hp-nIv~l~g~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~iv 591 (816)
+|...|+.|. |. -+.+.++++ ..++|||++.+..|...-.-.. .-.+...+..-+--|-.+| +|
T Consensus 159 kEfafmkaL~e~gfpVPkpiD~~--RH~Vvmelv~g~Pl~~v~~v~d---------~~~ly~~lm~~Iv~la~~G---lI 224 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPIDHN--RHCVVMELVDGYPLRQVRHVED---------PPTLYDDLMGLIVRLANHG---LI 224 (465)
T ss_pred HHHHHHHHHHHcCCCCCCccccc--ceeeHHHhhcccceeeeeecCC---------hHHHHHHHHHHHHHHHHcC---ce
Confidence 6777777773 22 233444443 4579999999888866432111 2234445555566677777 99
Q ss_pred eCCCCCCceEecCCCCeeEeecccceecc
Q 003481 592 HGDLKPQNILLDSELSSKICDFGICRLVT 620 (816)
Q Consensus 592 HrDIkp~NILl~~~~~vkL~DFGla~~~~ 620 (816)
|+|..--||+++.++.++++||--+....
T Consensus 225 HgDFNEFNimv~dd~~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 225 HGDFNEFNIMVKDDDKIVVIDFPQMVSTS 253 (465)
T ss_pred ecccchheeEEecCCCEEEeechHhhccC
Confidence 99999999999999999999997654443
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 816 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-37 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-37 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-37 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-36 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-35 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-35 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 8e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-34 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-29 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-29 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 9e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-17 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-17 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 6e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-16 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-16 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-16 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-16 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-15 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-15 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-15 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 5e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 8e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 7e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-10 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-10 | ||
| 1t1h_A | 78 | Nmr Solution Structure Of The U Box Domain From Atp | 3e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 8e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 9e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 9e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 9e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 6e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 9e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 6e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 7e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1T1H|A Chain A, Nmr Solution Structure Of The U Box Domain From Atpub14, An Armadillo Repeat Containing Protein From Arabidopsis Thaliana Length = 78 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 296 bits (761), Expect = 3e-94
Identities = 107/291 (36%), Positives = 149/291 (51%), Gaps = 22/291 (7%)
Query: 460 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRV 518
L DL+ AT NF F +G G FG VYKG + G VA+K + QG EF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 519 LSKLQHPHLVTLLGACPEAWS--LVYEYLPNGSLQDRLFRKSN-VSPLLWKDRARIAAEI 575
LS +HPHLV+L+G C E L+Y+Y+ NG+L+ L+ + W+ R I
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 576 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAP 635
A GL +LH+ I+H D+K NILLD KI DFGI + TE H ST
Sbjct: 149 ARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELD----QTHLSTVV 201
Query: 636 KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV---------GLAGEVRRAVS 686
KG+ Y DPEY G LT KSD YSFG+++ ++L R + LA + +
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 687 CGKLSSILDP-LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736
G+L I+DP LA R+ D ++C L +RP + ++ +LE
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMG-DVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 9e-87
Identities = 99/302 (32%), Positives = 148/302 (49%), Gaps = 29/302 (9%)
Query: 460 FSLADLQTATCNFSESF------KVGQGGFGCVYKGEMLGRTVAIKMLYSHN----MQGQ 509
FS +L+ T NF E K+G+GGFG VYKG + TVA+K L + + +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 510 LEFQQEVRVLSKLQHPHLVTLLGACPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKD 567
+F QE++V++K QH +LV LLG + LVY Y+PNGSL DRL PL W
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 568 RARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627
R +IA A+G+ FLH +H D+K NILLD ++KI DFG+ R +
Sbjct: 135 RCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA---- 187
Query: 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE----VRR 683
++ G+ Y PE G +TPKSD YSFG+++L+++TG V E +
Sbjct: 188 QTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246
Query: 684 A----VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739
+ +D D + + + QC +RPDI + + L+++
Sbjct: 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIK-KVQQLLQEMT 305
Query: 740 VA 741
+
Sbjct: 306 AS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 6e-80
Identities = 109/302 (36%), Positives = 163/302 (53%), Gaps = 27/302 (8%)
Query: 460 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQG-QLEFQQEVR 517
FSL +LQ A+ NFS +G+GGFG VYKG + G VA+K L QG +L+FQ EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 518 VLSKLQHPHLVTLLGACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLL-WKDRARIAAE 574
++S H +L+ L G C LVY Y+ NGS+ L + P L W R RIA
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 575 IASGLCFLH-SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE-DTLYLPSFHRS 632
A GL +LH P KI+H D+K NILLD E + + DFG+ +L+ DT H +
Sbjct: 140 SARGLAYLHDHCDP-KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT------HVT 192
Query: 633 TAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV---GLAGE--------V 681
TA +G+ + PEY TG + K+D + +G+++L+L+TG+ LA + V
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 682 RRAVSCGKLSSILDP-LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740
+ + KL +++D L G++ +L+ + L C + ERP ++ +V+ LE +
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS-EVVRMLEGDGL 311
Query: 741 AE 742
AE
Sbjct: 312 AE 313
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 6e-62
Identities = 83/303 (27%), Positives = 130/303 (42%), Gaps = 30/303 (9%)
Query: 477 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE 536
VG+G FG V K + + VAIK + S + + F E+R LS++ HP++V L GAC
Sbjct: 15 VVGRGAFGVVCKAKWRAKDVAIKQIESESERK--AFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 537 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLK 596
LV EY GSL + L + + + G+ +LHS +P+ ++H DLK
Sbjct: 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132
Query: 597 PQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPK 655
P N+LL + + KICDFG + T KGS + PE + K
Sbjct: 133 PPNLLLVAGGTVLKICDFGTACDIQTHM---------TNNKGSAAWMAPEVFEGSNYSEK 183
Query: 656 SDSYSFGLIILQLLTGRLP----VGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVD 711
D +S+G+I+ +++T R P G A + AV G + + + +
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL--------IKNLPKPIES 235
Query: 712 LGLQCCELYGRERPDITPSLVKELEQLHVA-----EERPVPSFFLCPILQEIMHDPQVAA 766
L +C +RP + +VK + L E P P ++ +P V
Sbjct: 236 LMTRCWSKDPSQRPSME-EIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDF 294
Query: 767 DGF 769
F
Sbjct: 295 AEF 297
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 6e-61
Identities = 65/316 (20%), Positives = 114/316 (36%), Gaps = 39/316 (12%)
Query: 452 EDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLE 511
+ +L + +G FGCV+K ++L VA+K+ + Q +
Sbjct: 6 HHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSW-Q 64
Query: 512 FQQEVRVLSKLQHPHLVTLLGACPEA------WSLVYEYLPNGSLQDRLFRKSNVSPLLW 565
+ EV L ++H +++ +GA L+ + GSL D L + W
Sbjct: 65 NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSW 120
Query: 566 KDRARIAAEIASGLCFLHS--------SKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
+ IA +A GL +LH KP I H D+K +N+LL + L++ I DFG+
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKP-AISHRDIKSKNVLLKNNLTACIADFGLAL 179
Query: 618 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL-----TPKSDSYSFGLIILQLLTGR 672
S + G+ Y PE + + D Y+ GL++ +L +
Sbjct: 180 KFEAGK----SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 673 LPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 732
+ ++ P D V + L + +++
Sbjct: 236 TAADGPVDEYMLPFEEEIGQ--HPSLEDMQEVVVHKKKRP-----VLRDYWQKHAGMAML 288
Query: 733 KELEQL---HVAEERP 745
E + H AE R
Sbjct: 289 CETIEECWDHDAEARL 304
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 9e-59
Identities = 82/268 (30%), Positives = 130/268 (48%), Gaps = 21/268 (7%)
Query: 477 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLGAC 534
K+G G FG V++ E G VA+K+L + + EF +EV ++ +L+HP++V +GA
Sbjct: 44 KIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 535 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
P S+V EYL GSL L + L + R +A ++A G+ +LH+ P IVH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVH 162
Query: 593 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL 652
+LK N+L+D + + K+CDFG+ RL L S + G+ + PE R
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS------SKSAAGTPEWMAPEVLRDEPS 216
Query: 653 TPKSDSYSFGLIILQLLTGRLP-VGL-AGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 710
KSD YSFG+I+ +L T + P L +V AV + P + ++
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI-------PRNLNPQVA 269
Query: 711 DLGLQCCELYGRERPDITPSLVKELEQL 738
+ C +RP +++ L L
Sbjct: 270 AIIEGCWTNEPWKRPSFA-TIMDLLRPL 296
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 2e-55
Identities = 72/278 (25%), Positives = 119/278 (42%), Gaps = 36/278 (12%)
Query: 477 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQL----EFQQEVRVLSKLQHPHLVTLLG 532
+G GGFG VY+ +G VA+K + +QE ++ + L+HP+++ L G
Sbjct: 14 IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 533 AC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
C LV E+ G L L K + A +IA G+ +LH I
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 591 VHGDLKPQNILLDSELSS--------KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 642
+H DLK NIL+ ++ + KI DFG+ R T + G++ +
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT--------KMSAAGAYAWM 181
Query: 643 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP-VGL-AGEVRRAVSCGKLSSILDPLAGD 700
PE R + + SD +S+G+++ +LLTG +P G+ V V+ KL+ +
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI------ 235
Query: 701 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738
P+ L C RP T +++ +L +
Sbjct: 236 -PSTCPEPFAKLMEDCWNPDPHSRPSFT-NILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 1e-54
Identities = 82/283 (28%), Positives = 133/283 (46%), Gaps = 42/283 (14%)
Query: 477 KVGQGGFGCVYKGEMLGR--TVAIKMLYSHNMQGQL-------EFQQEVRVLSKLQHPHL 527
++G+GGFG V+KG ++ VAIK L + +G+ EFQ+EV ++S L HP++
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 528 VTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 587
V L G +V E++P G L RL K++ P+ W + R+ +IA G+ ++ + P
Sbjct: 86 VKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQNP 143
Query: 588 EKIVHGDLKPQNILLDS-----ELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 642
IVH DL+ NI L S + +K+ DFG+ + + G+F +
Sbjct: 144 -PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---------VSGLLGNFQWM 193
Query: 643 DPE--YHRTGVLTPKSDSYSFGLIILQLLTGRLP----VGLAGEVRRAVSCGKLS-SILD 695
PE T K+D+YSF +I+ +LTG P + + L +I
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI-- 251
Query: 696 PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738
P RL ++ C ++RP + +VKEL +L
Sbjct: 252 ------PEDCPPRLRNVIELCWSGDPKKRPHFS-YIVKELSEL 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-54
Identities = 77/271 (28%), Positives = 129/271 (47%), Gaps = 24/271 (8%)
Query: 477 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLGAC 534
++G G FG VYKG+ G VA+KML Q F+ EV VL K +H +++ +G
Sbjct: 31 RIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 535 -PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 593
++V ++ SL L ++ + K IA + A G+ +LH+ I+H
Sbjct: 90 TAPQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 594 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---YHRTG 650
DLK NI L + + KI DFG+ + + H+ GS + PE +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS----HQFEQLSGSILWMAPEVIRMQDSN 200
Query: 651 VLTPKSDSYSFGLIILQLLTGRLP---VGLAGEVRRAVSCGKLSSILDPLAGDWPTFVAR 707
+ +SD Y+FG+++ +L+TG+LP + ++ V G LS L + + P +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP----K 256
Query: 708 RLVDLGLQCCELYGRERPDITPSLVKELEQL 738
R+ L +C + ERP ++ E+E+L
Sbjct: 257 RMKRLMAECLKKKRDERPSFP-RILAEIEEL 286
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 185 bits (470), Expect = 2e-52
Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 31/237 (13%)
Query: 459 EFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRV 518
E + ++ N +G+G +G VYKG + R VA+K+ N Q F E +
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQ---NFINEKNI 58
Query: 519 --LSKLQHPHLVTLLGAC-------PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRA 569
+ ++H ++ + + LV EY PNGSL L + W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114
Query: 570 RIAAEIASGLCFLHSSKPE------KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623
R+A + GL +LH+ P I H DL +N+L+ ++ + I DFG+ +T +
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 624 LYLPSF--HRSTAPKGSFPYADPEY-------HRTGVLTPKSDSYSFGLIILQLLTG 671
L P + + + G+ Y PE + D Y+ GLI ++
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-51
Identities = 42/207 (20%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 477 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLGAC 534
K+ + G ++KG G + +K+L + + +F +E L HP+++ +LGAC
Sbjct: 17 KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 535 ----PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
+L+ ++P GSL + L + + + A ++A G+ FLH+ +P I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMARGMAFLHTLEP-LI 134
Query: 591 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---YH 647
L +++++D +++++I + +S + + PE
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKF-----------SFQSPGRMYAPAWVAPEALQKK 183
Query: 648 RTGVLTPKSDSYSFGLIILQLLTGRLP 674
+D +SF +++ +L+T +P
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-51
Identities = 63/277 (22%), Positives = 106/277 (38%), Gaps = 31/277 (11%)
Query: 477 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLGAC 534
+G+G FG VY G G VAI+++ F++EV + +H ++V +GAC
Sbjct: 40 LIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 535 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
P +++ +L + L +IA EI G+ +LH+ + I+H
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLHA---KGILH 153
Query: 593 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL 652
DLK +N+ D I DFG+ + + G + PE R
Sbjct: 154 KDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE-DKLRIQNGWLCHLAPEIIRQLSP 211
Query: 653 ---------TPKSDSYSFGLIILQLLTGRLP-VGL-AGEVRRAVSCGKLSSILDPLAGDW 701
+ SD ++ G I +L P A + + G ++
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS------- 264
Query: 702 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738
+ + + D+ L C ERP T L+ LE+L
Sbjct: 265 QIGMGKEISDILLFCWAFEQEERPTFT-KLMDMLEKL 300
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-50
Identities = 68/286 (23%), Positives = 119/286 (41%), Gaps = 24/286 (8%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
+G+G FG K G + +K L + + Q F +EV+V+ L+HP+++ +G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 535 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
+ + + EY+ G+L+ + KS S W R A +IASG+ +LHS I+H
Sbjct: 77 YKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIH 131
Query: 593 GDLKPQNILLDSELSSKICDFGICRLVTEDT--------LYLPSFHRSTAPKGSFPYADP 644
DL N L+ + + DFG+ RL+ ++ L P + G+ + P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 645 EYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTF 704
E K D +SFG+++ +++ + + P
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPP- 250
Query: 705 VARRLVDLGLQCCELYGRERPDITPSLVKELEQL--HVAEERPVPS 748
+ ++CC+L +RP L LE L H+A P+
Sbjct: 251 ---SFFPITVRCCDLDPEKRPS-FVKLEHWLETLRMHLAGHLPLGP 292
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-47
Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 28/225 (12%)
Query: 477 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRV--LSKLQHPHLVTLLGAC 534
VG+G +G V++G G VA+K+ S + + + +E + L+H +++ + +
Sbjct: 15 CVGKGRYGEVWRGSWQGENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIASD 71
Query: 535 ------PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 588
L+ Y GSL D L L RI IASGL LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 589 -----KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 643
I H DLK +NIL+ I D G+ + ++ T L + G+ Y
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDV--GNNPRVGTKRYMA 185
Query: 644 PE------YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR 682
PE + D ++FGL++ ++ + G+ + +
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-46
Identities = 55/223 (24%), Positives = 90/223 (40%), Gaps = 24/223 (10%)
Query: 477 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC-- 534
++G+G +G V+ G+ G VA+K+ ++ + E+ ++H +++ + A
Sbjct: 44 QIGKGRYGEVWMGKWRGEKVAVKVFFTTEEA-SWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 535 ----PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE-- 588
L+ +Y NGSL D L L K ++A SGLC LH+
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 589 ---KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 645
I H DLK +NIL+ + I D G+ DT G+ Y PE
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT--NEVDIPPNTRVGTKRYMPPE 216
Query: 646 ------YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR 682
+D YSFGLI+ ++ + G+ E +
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 7e-45
Identities = 54/226 (23%), Positives = 90/226 (39%), Gaps = 34/226 (15%)
Query: 477 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE 536
+G+G FG V++G+ G VA+K+ S + + E+ L+H +++ + A +
Sbjct: 49 SIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 537 A------WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE-- 588
LV +Y +GSL D L R + + ++A ASGL LH
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 589 ---KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 645
I H DLK +NIL+ + I D G+ D+ G+ Y PE
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR--HDSATDTIDIAPNHRVGTKRYMAPE 221
Query: 646 YHRTGVL-----------TPKSDSYSFGLIILQLLTGRLPVGLAGE 680
VL ++D Y+ GL+ ++ G+ +
Sbjct: 222 -----VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-39
Identities = 66/274 (24%), Positives = 116/274 (42%), Gaps = 32/274 (11%)
Query: 477 KVGQGGFGCVYKGEMLGRT--VAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTLLGA 533
++G+G FG V+ G + VA+K +F QE R+L + HP++V L+G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 534 CPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591
C + + V E + G L ++ + L K ++ + A+G+ +L S +
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 592 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY---ADPEYHR 648
H DL +N L+ + KI DFG+ R + ++ P A PE
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYA------ASGGLRQVPVKWTA-PEALN 288
Query: 649 TGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWPTFV 705
G + +SD +SFG+++ + + G P L+ + R V G L P
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG---RLPC-----PELC 340
Query: 706 ARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739
+ L QC +RP + ++ +EL+ +
Sbjct: 341 PDAVFRLMEQCWAYEPGQRPSFS-TIYQELQSIR 373
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 58/218 (26%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 533
+GQG V++G G AIK+ + + ++ +E VL KL H ++V L A
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-A 74
Query: 534 CPEAWS-----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 588
E + L+ E+ P GSL L SN L + + ++ G+ L
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---N 131
Query: 589 KIVHGDLKPQNILL----DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 644
IVH ++KP NI+ D + K+ DFG R + +D S + G+ Y P
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVSLY------GTEEYLHP 184
Query: 645 EYHRTGVL--------TPKSDSYSFGLIILQLLTGRLP 674
+ + VL D +S G+ TG LP
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-36
Identities = 78/219 (35%), Positives = 106/219 (48%), Gaps = 19/219 (8%)
Query: 477 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 535
K+GQG FG V+ G G T VAIK L M + F QE +V+ KL+H LV L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 536 EA-WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 594
E +V EY+ GSL D L + L +AA+IASG+ ++ VH D
Sbjct: 250 EEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 305
Query: 595 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEYHRTGVL 652
L+ NIL+ L K+ DFG+ RL+ ++ FP PE G
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAALYGRF 358
Query: 653 TPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 688
T KSD +SFG+++ +L T GR+P G+ EV V G
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
K+G GG VY E +L VAIK + + F++EV S+L H ++V+++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 532 --GACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
+ + LV EY+ +L + + PL +I G+ H +
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR--- 131
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK---GSFPYADPEY 646
IVH D+KPQNIL+DS + KI DFGI + ++E +L T G+ Y PE
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL--------TQTNHVLGTVQYFSPEQ 183
Query: 647 HRTGVLTPKSDSYSFGLIILQLLTGRLP 674
+ +D YS G+++ ++L G P
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-36
Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 21/221 (9%)
Query: 477 KVGQGGFGCVYKGEMLGRT--VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
K+G G +G VY+G + VA+K L M+ + EF +E V+ +++HP+LV LLG C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 535 PEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
+ E++ G+L D L R+ N + +A +I+S + +L + +H
Sbjct: 286 TREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIH 341
Query: 593 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEYHRTG 650
+L +N L+ K+ DFG+ RL+T DT Y FP PE
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAH------AGAKFPIKWTAPESLAYN 394
Query: 651 VLTPKSDSYSFGLIILQLLT-GRLPV-GLAG-EVRRAVSCG 688
+ KSD ++FG+++ ++ T G P G+ +V +
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 435
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 71/297 (23%), Positives = 113/297 (38%), Gaps = 33/297 (11%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
K+G+GGF V E L G A+K + H Q + E Q+E + HP+++ L+ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 535 PEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRA-RIAAEIASGLCFLHSSKP 587
L+ + G+L + + R + L +D+ + I GL +H+
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRS---TAPKGSFPYADP 644
+ H DLKP NILL E + D G A + + Y P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 645 E---YHRTGVLTPKSDSYSFGLIILQLLTGRLP---VGLAGEVRRAVSCGKLSSILDPLA 698
E V+ ++D +S G ++ ++ G P V G+ +LS P
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSP-- 270
Query: 699 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPVPSFFLCPIL 755
+ L L + +RP I P L+ +LE L + P P IL
Sbjct: 271 -----RHSSALWQLLNSMMTVDPHQRPHI-PLLLSQLEAL----QPPAPGQHTTQIL 317
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-35
Identities = 58/218 (26%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 533
+GQG V++G G AIK+ + + ++ +E VL KL H ++V L A
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-A 74
Query: 534 CPEAWS-----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 588
E + L+ E+ P GSL L SN L + + ++ G+ L
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---N 131
Query: 589 KIVHGDLKPQNILL----DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 644
IVH ++KP NI+ D + K+ DFG R + +D S + G+ Y P
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVSLY------GTEEYLHP 184
Query: 645 EYHRTGVL--------TPKSDSYSFGLIILQLLTGRLP 674
+ + VL D +S G+ TG LP
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-35
Identities = 78/219 (35%), Positives = 106/219 (48%), Gaps = 19/219 (8%)
Query: 477 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 535
K+GQG FG V+ G G T VAIK L M + F QE +V+ KL+H LV L
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 536 EA-WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 594
E +V EY+ GSL D L + L +AA+IASG+ ++ VH D
Sbjct: 333 EEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 388
Query: 595 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEYHRTGVL 652
L+ NIL+ L K+ DFG+ RL+ ++ FP PE G
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAALYGRF 441
Query: 653 TPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 688
T KSD +SFG+++ +L T GR+P G+ EV V G
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 71/311 (22%), Positives = 125/311 (40%), Gaps = 57/311 (18%)
Query: 477 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTL 530
++G+G FG V VA+K L + +F++E+ +L LQH ++V
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 531 LGACPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
G C A L+ EYLP GSL+D L + + + + ++I G+ +L +
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT-- 132
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YAD 643
++ +H DL +NIL+++E KI DFG+ +++ +D + + P G P YA
Sbjct: 133 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF----FKVKEP-GESPIFWYA- 185
Query: 644 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPT 703
PE + SD +SFG+++ +L T + + G+
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT------------YIEKSKSPPAEFMRMIGNDK- 232
Query: 704 FVARRLVDLGLQCCELYGR-------ERPDITPSLVKELEQL---HVAEERPVPSF-FLC 752
+ L RPD P + + + +R PSF L
Sbjct: 233 -------QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQR--PSFRDLA 283
Query: 753 PILQEIMHDPQ 763
+ +I +
Sbjct: 284 LRVDQIRDNMA 294
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 72/308 (23%), Positives = 120/308 (38%), Gaps = 69/308 (22%)
Query: 477 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVT 529
+G G FG VYKG + VAIK L E E V++ + +PH+
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 530 LLGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 588
LLG C L+ + +P G L D + + + + + +IA G+ +L +
Sbjct: 82 LLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL-EDR-- 136
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPE 645
++VH DL +N+L+ + KI DFG+ +L+ + A G P A E
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE------YHAEGGKVPIKWMA-LE 189
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWP 702
+ T +SD +S+G+ + +L+T G P G+ E+ + G+
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------------- 236
Query: 703 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL------HVAEERPVPSF-FLCPIL 755
RL +P I ++ + A+ R P F L
Sbjct: 237 -----RL-------------PQPPICT---IDVYMIMRKCWMIDADSR--PKFRELIIEF 273
Query: 756 QEIMHDPQ 763
++ DPQ
Sbjct: 274 SKMARDPQ 281
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 86/282 (30%), Positives = 125/282 (44%), Gaps = 33/282 (11%)
Query: 477 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 535
++G G FG V+ G G T VA+K L +M F E ++ +LQH LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 536 -EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 594
E ++ EY+ NGSL D L + + L +AA+IA G+ F+ +H D
Sbjct: 79 QEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 134
Query: 595 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY---ADPEYHRTGV 651
L+ NIL+ LS KI DFG+ RL+ ++ FP A PE G
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYT-------AREGAKFPIKWTA-PEAINYGT 186
Query: 652 LTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWPTFVARR 708
T KSD +SFG+++ +++T GR+P G+ EV + + G + P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---RMVR-----PDNCPEE 238
Query: 709 LVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE---RPVP 747
L L C + +RP L LE A E +P P
Sbjct: 239 LYQLMRLCWKERPEDRPTFD-YLRSVLEDFFTATEGQYQPQP 279
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 24/199 (12%)
Query: 477 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTL 530
++G+G FG V VA+K L + +F++E+ +L LQH ++V
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 531 LGAC----PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
G C L+ EYLP GSL+D L + + + + ++I G+ +L +
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT-- 163
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YAD 643
++ +H DL +NIL+++E KI DFG+ +++ +D Y ++ P G P YA
Sbjct: 164 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY----YKVKEP-GESPIFWYA- 216
Query: 644 PEYHRTGVLTPKSDSYSFG 662
PE + SD +SFG
Sbjct: 217 PESLTESKFSVASDVWSFG 235
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 5e-35
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 28/211 (13%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIK-MLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLG 532
++G+G F VYKG VA + + + + F++E +L LQHP++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 533 AC------PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
+ + LV E + +G+L+ L R + + + +I GL FLH+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR---SWCRQILKGLQFLHTRT 149
Query: 587 PEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--AD 643
P I+H DLK NI + S KI D G+ L + + P A
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGT-------PEFMA- 198
Query: 644 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
PE + D Y+FG+ +L++ T P
Sbjct: 199 PEMYEEKY-DESVDVYAFGMCMLEMATSEYP 228
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-35
Identities = 83/305 (27%), Positives = 131/305 (42%), Gaps = 46/305 (15%)
Query: 477 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTL 530
++G+G FG V VA+K L Q +FQ+E+++L L +V
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 531 LGACPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
G LV EYLP+G L+D L + + + L +++I G+ +L S
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS-- 145
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YAD 643
+ VH DL +NIL++SE KI DFG+ +L+ D Y + P G P YA
Sbjct: 146 -RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY----YVVREP-GQSPIFWYA- 198
Query: 644 PEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 702
PE + + +SD +SFG+++ +L T C + L + +
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKS------------CSPSAEFLRMMGCERD 246
Query: 703 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL---HVAEERPVPSF-FLCPILQEI 758
RL++L L+ E P P+ V EL +L ++R PSF L P L +
Sbjct: 247 VPALSRLLEL-LE--EGQRLPAPPACPAEVHELMKLCWAPSPQDR--PSFSALGPQLDML 301
Query: 759 MHDPQ 763
+
Sbjct: 302 WSGSR 306
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 72/301 (23%), Positives = 117/301 (38%), Gaps = 45/301 (14%)
Query: 477 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVT 529
+G+G FG V VA+K L + + + ++E+ +L L H ++V
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 530 LLGACPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 585
G C E L+ E+LP+GSL++ L N + + K + + A +I G+ +L S
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS- 144
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YA 642
+ VH DL +N+L++SE KI DFG+ + + D Y + P YA
Sbjct: 145 --RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY----YTVKDD-RDSPVFWYA 197
Query: 643 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 702
PE SD +SFG+ + +LLT + + L I G
Sbjct: 198 -PECLMQSKFYIASDVWSFGVTLHELLTY-------CDSDSSPMALFLKMIGPTH-GQMT 248
Query: 703 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL---HVAEERPVPSF-FLCPILQEI 758
+ G P P V +L + R SF L + +
Sbjct: 249 VTRLVNTLKEG------KRLPCPPNCPDEVYQLMRKCWEFQPSNR--TSFQNLIEGFEAL 300
Query: 759 M 759
+
Sbjct: 301 L 301
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 36/295 (12%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGA 533
+ +GGF VY+ + + GR A+K L S+ + QEV + KL HP++V A
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 534 CPEAWS---------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 584
L+ L G L + L + + PL +I + + +H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 585 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK------GS 638
KP I+H DLK +N+LL ++ + K+CDFG ++ Y S R + +
Sbjct: 155 QKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 639 FPYADPE---YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILD 695
Y PE + + K D ++ G I+ L + P + + GK S
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE--DGAKLRIVNGKYS---- 267
Query: 696 PLAGDWPTFVAR--RLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPVPS 748
P + L ++ ER I +V +L+++ A S
Sbjct: 268 -----IPPHDTQYTVFHSLIRAMLQVNPEERLSI-AEVVHQLQEIAAARNVNPKS 316
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 78/303 (25%), Positives = 124/303 (40%), Gaps = 53/303 (17%)
Query: 477 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVT 529
+G+G FG V VA+K L + ++QE+ +L L H H++
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 530 LLGACPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 585
G C +A + LV EY+P GSL+D L + ++ A +I G+ +LH+
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGL---AQLLLFAQQICEGMAYLHA- 152
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YA 642
+ +H DL +N+LLD++ KI DFG+ + V E Y +R G P YA
Sbjct: 153 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY----YRVRED-GDSPVFWYA 205
Query: 643 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 702
PE + SD +SFG+ + +LLT + ++ L I
Sbjct: 206 -PECLKEYKFYYASDVWSFGVTLYELLTH-------CDSSQSPPTKFLELIGIAQGQ-MT 256
Query: 703 TFVARRLVDLG--LQC---C--ELYG----------RERPDITPSLVKELEQLHVAEERP 745
L++ G L C E+Y RP +L+ L+ +H +
Sbjct: 257 VLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFE-NLIPILKTVHEKYQGQ 315
Query: 746 VPS 748
PS
Sbjct: 316 APS 318
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 64/271 (23%), Positives = 110/271 (40%), Gaps = 38/271 (14%)
Query: 477 KVGQGGFGCVYKGE-MLGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHP--HLVTLL 531
++G GG V++ + AIK + Q ++ E+ L+KLQ ++ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 532 GAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
+ +V E N L L +K ++ P +R + + +H
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQ---HG 128
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---- 645
IVH DLKP N L+ + K+ DFGI + DT S + + G+ Y PE
Sbjct: 129 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT---TSVVKDS-QVGTVNYMPPEAIKD 183
Query: 646 -------YHRTGVLTPKSDSYSFGLIILQLLTGRLP-VGLAGEVRRAVSCGKLSSILDP- 696
++PKSD +S G I+ + G+ P + ++ KL +I+DP
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------KLHAIIDPN 237
Query: 697 LAGDWPTFVARRLVDLGLQCCELYGRERPDI 727
++P + L D+ C + ++R I
Sbjct: 238 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 268
|
| >1t1h_A Gspef-atpub14, armadillo repeat containing protein; ubiquitin ligase, E3 ligase, U-BOX,; NMR {Arabidopsis thaliana} SCOP: g.44.1.2 Length = 78 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 2e-34
Identities = 28/68 (41%), Positives = 39/68 (57%)
Query: 746 VPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHAL 805
P +F CPI E+M DP + + G TYE +I+ WL+ G +T P + L H LTPN+ L
Sbjct: 5 FPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYVL 64
Query: 806 RHAIQDWL 813
+ I W
Sbjct: 65 KSLIALWC 72
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-34
Identities = 72/220 (32%), Positives = 110/220 (50%), Gaps = 21/220 (9%)
Query: 477 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 535
K+G G FG V+ T VA+K + +M F E V+ LQH LV L
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 536 -EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 594
E ++ E++ GSL D L + S +A+IA G+ F+ +H D
Sbjct: 254 KEPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRD 309
Query: 595 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FPY--ADPEYHRTGV 651
L+ NIL+ + L KI DFG+ R++ ++ Y TA +G+ FP PE G
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNE-Y-------TAREGAKFPIKWTAPEAINFGS 361
Query: 652 LTPKSDSYSFGLIILQLLT-GRLPV-GLAG-EVRRAVSCG 688
T KSD +SFG+++++++T GR+P G++ EV RA+ G
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 401
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 64/271 (23%), Positives = 110/271 (40%), Gaps = 38/271 (14%)
Query: 477 KVGQGGFGCVYKG-EMLGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHP--HLVTLL 531
++G GG V++ + AIK + Q ++ E+ L+KLQ ++ L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 532 GAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
+ +V E N L L +K ++ P +R + + +H
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQ---HG 147
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---- 645
IVH DLKP N L+ + K+ DFGI + DT S + + G+ Y PE
Sbjct: 148 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT---TSVVKDS-QVGTVNYMPPEAIKD 202
Query: 646 -------YHRTGVLTPKSDSYSFGLIILQLLTGRLP-VGLAGEVRRAVSCGKLSSILDP- 696
++PKSD +S G I+ + G+ P + ++ KL +I+DP
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------KLHAIIDPN 256
Query: 697 LAGDWPTFVARRLVDLGLQCCELYGRERPDI 727
++P + L D+ C + ++R I
Sbjct: 257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 287
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-34
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 477 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE 536
+G+G FG V G+ G VA+K + + F E V+++L+H +LV LLG E
Sbjct: 200 TIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 537 AWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 593
+Y EY+ GSL D L R S L + + ++ + +L VH
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHR 313
Query: 594 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEYHRTGV 651
DL +N+L+ + +K+ DFG+ + + G P PE R
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----------GKLPVKWTAPEALREKK 362
Query: 652 LTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 688
+ KSD +SFG+++ ++ + GR+P + +V V G
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 402
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 65/261 (24%), Positives = 108/261 (41%), Gaps = 39/261 (14%)
Query: 477 KVGQGGFGCVYKGEML-GRTVAIKM--LYSHNMQGQLEFQQEVRVLSKLQHP--HLVTLL 531
++G GG V++ + AIK L + Q ++ E+ L+KLQ ++ L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 532 GAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
+ +V E N L L +K ++ P +R + + +H
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQ---HG 175
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---- 645
IVH DLKP N L+ K+ DFGI + DT S + + G+ Y PE
Sbjct: 176 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDT---TSVVKDS-QVGAVNYMPPEAIKD 230
Query: 646 -------YHRTGVLTPKSDSYSFGLIILQLLTGRLP-VGLAGEVRRAVSCGKLSSILDP- 696
++PKSD +S G I+ + G+ P + ++ KL +I+DP
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------KLHAIIDPN 284
Query: 697 LAGDWPTFVARRLVDLGLQCC 717
++P + L D+ L+CC
Sbjct: 285 HEIEFPDIPEKDLQDV-LKCC 304
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 79/283 (27%), Positives = 123/283 (43%), Gaps = 34/283 (12%)
Query: 477 KVGQGGFGCVYKGEMLGR-----TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL 530
+G+G FG VY GE + + AIK L MQ F +E ++ L HP+++ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 531 LGACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 587
+G L + Y+ +G L F +S KD ++A G+ +L + +
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQ--FIRSPQRNPTVKDLISFGLQVARGMEYL-AEQ- 143
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADP 644
K VH DL +N +LD + K+ DFG+ R + + Y HR P A
Sbjct: 144 -KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR----HARLPVKWTA-L 197
Query: 645 EYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDW 701
E +T T KSD +SFG+++ +LLT G P + ++ ++ G+ L
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR---RLPQ----- 249
Query: 702 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER 744
P + L + QC E RP LV E+EQ+ A
Sbjct: 250 PEYCPDSLYQVMQQCWEADPAVRPTFR-VLVGEVEQIVSALLG 291
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-34
Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 30/276 (10%)
Query: 477 KVGQGGFGCVYKGEMLGRT--VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
K+G G +G VY+G + VA+K L M+ + EF +E V+ +++HP+LV LLG C
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 535 PEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
+ E++ G+L D L R+ N + +A +I+S + +L K +H
Sbjct: 79 TREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL-EKK--NFIH 134
Query: 593 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEYHRTG 650
DL +N L+ K+ DFG+ RL+T DT Y FP PE
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAH------AGAKFPIKWTAPESLAYN 187
Query: 651 VLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWPTFVAR 707
+ KSD ++FG+++ ++ T G P G+ +V + ++ P
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---RMER-----PEGCPE 239
Query: 708 RLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE 743
++ +L C + +RP + + E +
Sbjct: 240 KVYELMRACWQWNPSDRPSFA-EIHQAFETMFQESS 274
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-34
Identities = 75/275 (27%), Positives = 125/275 (45%), Gaps = 30/275 (10%)
Query: 477 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 535
++G G FG V G+ G+ VA+KM+ +M EF QE + + KL HP LV G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 536 EAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 593
+ + + V EY+ NG L + L +S+ L + ++ G+ FL S + +H
Sbjct: 74 KEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHR 128
Query: 594 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEYHRTGV 651
DL +N L+D +L K+ DFG+ R V +D ++ FP + PE
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-------SSVGTKFPVKWSAPEVFHYFK 181
Query: 652 LTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWPTFVARR 708
+ KSD ++FG+++ ++ + G++P EV VS G L P +
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH---RLYR-----PHLASDT 233
Query: 709 LVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE 743
+ + C +RP L+ +E L ++
Sbjct: 234 IYQIMYSCWHELPEKRPTFQ-QLLSSIEPLREKDK 267
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 477 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE 536
+G+G FG V G+ G VA+K + + F E V+++L+H +LV LLG E
Sbjct: 28 TIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 537 AWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 593
+Y EY+ GSL D L R S L + + ++ + +L VH
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL-EGN--NFVHR 141
Query: 594 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY---ADPEYHRTG 650
DL +N+L+ + +K+ DFG+ + + T G P A PE R
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASS-----------TQDTGKLPVKWTA-PEALREK 189
Query: 651 VLTPKSDSYSFGLIILQLLT-GRLP 674
+ KSD +SFG+++ ++ + GR+P
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTL- 530
VG+GG G VY+ E + R VA+K++ S + + Q+E R +LQ PH+V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 531 -LGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRA-RIAAEIASGLCFLHSSKPE 588
G + + L L R+ ++P RA I +I S L H++
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAP----PRAVAIVRQIGSALDAAHAAG-- 154
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK---GSFPYADPE 645
H D+KP+NIL+ ++ + + DFGI T++ L T G+ Y PE
Sbjct: 155 -ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL--------TQLGNTVGTLYYMAPE 205
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
T ++D Y+ ++ + LTG P
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
+G GG V+ R VA+K+L + + L F++E + + L HP +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 532 ------GACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 585
+V EY+ +L+D + + P+ K + A+ L F H +
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN 135
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 645
I+H D+KP NI++ + + K+ DFGI R + + S ++ A G+ Y PE
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG---NSVTQTAAVIGTAQYLSPE 189
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
R + +SD YS G ++ ++LTG P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 9e-34
Identities = 61/220 (27%), Positives = 104/220 (47%), Gaps = 21/220 (9%)
Query: 477 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC- 534
++G G FG V+ G L + VAIK + M + +F +E V+ KL HP LV L G C
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 535 -PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 593
LV E++ +G L D + ++ + + ++ G+ +L + ++H
Sbjct: 74 EQAPICLVTEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 128
Query: 594 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEYHRTGV 651
DL +N L+ K+ DFG+ R V +D ++ FP A PE
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-------SSTGTKFPVKWASPEVFSFSR 181
Query: 652 LTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 688
+ KSD +SFG+++ ++ + G++P + EV +S G
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 221
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 21/220 (9%)
Query: 477 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC- 534
++G G FG V G+ G+ VAIKM+ +M EF +E +V+ L H LV L G C
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 535 -PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 593
++ EY+ NG L + + + + + ++ + +L S ++ +H
Sbjct: 90 KQRPIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHR 144
Query: 594 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEYHRTGV 651
DL +N L++ + K+ DFG+ R V +D ++ FP + PE
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-------SSVGSKFPVRWSPPEVLMYSK 197
Query: 652 LTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 688
+ KSD ++FG+++ ++ + G++P E ++ G
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-33
Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 26/212 (12%)
Query: 479 GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGACP 535
G GGFG V + G VAIK E + E++++ KL HP++V+ P
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR-EVP 81
Query: 536 EAWS---------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
+ L EY G L+ L + N L + ++I+S L +LH ++
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141
Query: 587 PEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 643
I+H DLKP+NI+L KI D G + + + L F G+ Y
Sbjct: 142 ---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTEF------VGTLQYLA 191
Query: 644 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 675
PE T D +SFG + + +TG P
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 26/225 (11%)
Query: 477 KVGQGGFGCVYKGEMLGRT-----VAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTL 530
+G+G FG VY+G VA+K +F E ++ L HPH+V L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 531 LGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
+G E ++ E P G L L + N + L + +I + +L S
Sbjct: 79 IGIIEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 133
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEY 646
VH D+ +NIL+ S K+ DFG+ R + ++ Y A P + PE
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-------KASVTRLPIKWMS-PES 185
Query: 647 HRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 688
T SD + F + + ++L+ G+ P L +V + G
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG 230
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 71/281 (25%), Positives = 113/281 (40%), Gaps = 35/281 (12%)
Query: 477 KVGQGGFGCVYKGEMLGR-----TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTL 530
+G+G FG V++G + VAIK + +F QE + + HPH+V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 531 LGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
+G ++ E G L+ L + L A ++++ L +L SK +
Sbjct: 82 IGVITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL-ESK--R 136
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEY 646
VH D+ +N+L+ S K+ DFG+ R + + T Y A KG P A PE
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-------KASKGKLPIKWMA-PES 188
Query: 647 HRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWPT 703
T SD + FG+ + ++L G P G+ +V + G+ L P
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPM-----PP 240
Query: 704 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER 744
L L +C RP T L +L + E+
Sbjct: 241 NCPPTLYSLMTKCWAYDPSRRPRFT-ELKAQLSTILEEEKA 280
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 45/292 (15%)
Query: 477 KVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 529
++G+G FG V+ E VA+K L + + +FQ+E +L+ LQH H+V
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 530 LLGACPEA--WSLVYEYLPNGSLQDRL-------------FRKSNVSPLLWKDRARIAAE 574
G C + +V+EY+ +G L L + L IA++
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 575 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 634
IASG+ +L +S+ VH DL +N L+ + L KI DFG+ R V Y R
Sbjct: 142 IASGMVYL-ASQ--HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY-----RVGG 193
Query: 635 PKGSFP--YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGK 689
P + PE T +SD +SFG+I+ ++ T G+ P L+ EV ++ G+
Sbjct: 194 -HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 252
Query: 690 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVA 741
+L+ P + + D+ L C + ++R +I + K L L A
Sbjct: 253 ---VLER-----PRVCPKEVYDVMLGCWQREPQQRLNIK-EIYKILHALGKA 295
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 62/290 (21%), Positives = 114/290 (39%), Gaps = 42/290 (14%)
Query: 477 KVGQGGFGCVYKGEMLGR-----TVAIKML--YSHNMQGQLEFQQEVRVLSKLQHPHLVT 529
+G+G FG V +G + VA+K + + + + EF E + HP+++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 530 LLGAC----PEAWSLVY---EYLPNGSLQD--RLFR-KSNVSPLLWKDRARIAAEIASGL 579
LLG C + ++ G L R ++ + + + +IA G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 639
+L S++ +H DL +N +L +++ + DFG+ + + Y R
Sbjct: 161 EYL-SNR--NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY-----RQGR-IAKM 211
Query: 640 P---YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSI 693
P A E V T KSD ++FG+ + ++ T G P G+ E+ + G
Sbjct: 212 PVKWIA-IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR--- 267
Query: 694 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE 743
L P L ++ C +RP + L +LE+L +
Sbjct: 268 LKQ-----PEDCLDELYEIMYSCWRTDPLDRPTFS-VLRLQLEKLLESLP 311
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 72/294 (24%), Positives = 121/294 (41%), Gaps = 46/294 (15%)
Query: 477 KVGQGGFGCVYKGEMLGR-------TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 529
++G+G FG V+ E VA+K L + + +FQ+E +L+ LQH H+V
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 530 LLGACPEA--WSLVYEYLPNGSLQDRL------------FRKSNVSPLLWKDRARIAAEI 575
G C E +V+EY+ +G L L PL +A+++
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 576 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAP 635
A+G+ +L + VH DL +N L+ L KI DFG+ R + Y R
Sbjct: 168 AAGMVYL-AGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY-----RVGG- 218
Query: 636 KGSFP---YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGK 689
+ P PE T +SD +SFG+++ ++ T G+ P L+ E ++ G+
Sbjct: 219 RTMLPIRWMP-PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 277
Query: 690 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE 743
L+ P + + C + ++R I + L+ L A
Sbjct: 278 ---ELER-----PRACPPEVYAIMRGCWQREPQQRHSIK-DVHARLQALAQAPP 322
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-33
Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 39/215 (18%)
Query: 477 KVGQGGFGCVYKGEMLG-------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKL-QHPHL 527
+G G FG V + G TVA+KML S ++ + E++VLS L H ++
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 528 VTLLGAC--PEAWSLVYEYLPNGSLQDRL---------------FRKSNVSPLLWKDRAR 570
V LLGAC ++ EY G L + L + + L +D
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 571 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 630
+ ++A G+ FL +SK +H DL +NILL +KICDFG+ R + D+ Y+
Sbjct: 150 FSYQVAKGMAFL-ASK--NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK-- 204
Query: 631 RSTAPKGSFPY---ADPEYHRTGVLTPKSDSYSFG 662
P A PE V T +SD +S+G
Sbjct: 205 ----GNARLPVKWMA-PESIFNCVYTFESDVWSYG 234
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 38/223 (17%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 533
+G+GGFG V++ + + AIK + N + E +EV+ L+KL+HP +V A
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 534 CPEAWS--------------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 579
E + + + +L+D + + + I +IA +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT------LYLPSFHRST 633
FLHS + ++H DLKP NI + K+ DFG+ + +D +P++ R T
Sbjct: 132 EFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 634 APKGSFPYADPE------YHRTGVLTPKSDSYSFGLIILQLLT 670
G+ Y PE Y + K D +S GLI+ +LL
Sbjct: 189 GQVGTKLYMSPEQIHGNSY------SHKVDIFSLGLILFELLY 225
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 35/211 (16%)
Query: 477 KVGQGGFGCVYKGEMLG-------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKL-QHPHL 527
+G G FG V + G VA+KML + + + E++++S L QH ++
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 528 VTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNV-----------SPLLWKDRARIAAE 574
V LLGAC ++ EY G L + L RKS V S +D +++
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 575 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 634
+A G+ FL +SK +H D+ +N+LL + +KI DFG+ R + D+ Y+
Sbjct: 173 VAQGMAFL-ASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK------ 223
Query: 635 PKGSFPY---ADPEYHRTGVLTPKSDSYSFG 662
P A PE V T +SD +S+G
Sbjct: 224 GNARLPVKWMA-PESIFDCVYTVQSDVWSYG 253
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 26/226 (11%)
Query: 477 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVT 529
+G G FG VYKG + VAIK L E E V++ + +PH+
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 530 LLGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 588
LLG C L+ + +P G L D + + + + + +IA G+ +L
Sbjct: 82 LLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLED---R 136
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPE 645
++VH DL +N+L+ + KI DFG+ +L+ + A G P A E
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY------HAEGGKVPIKWMA-LE 189
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 688
+ T +SD +S+G+ + +L+T G P G+ E+ + G
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 60/228 (26%), Positives = 93/228 (40%), Gaps = 34/228 (14%)
Query: 471 NFSESFKVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLV 528
+F E +GQG FG V K + R AIK + + EV +L+ L H ++V
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNHQYVV 65
Query: 529 TLLGACPEAWS---------------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRA-RIA 572
A E + + EY NG+L D + ++ +D R+
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ---RDEYWRLF 122
Query: 573 AEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRS 632
+I L ++HS + I+H DLKP NI +D + KI DFG+ + V L ++
Sbjct: 123 RQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 633 TAPK--------GSFPYADPE-YHRTGVLTPKSDSYSFGLIILQLLTG 671
G+ Y E TG K D YS G+I +++
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 70/278 (25%), Positives = 122/278 (43%), Gaps = 34/278 (12%)
Query: 477 KVGQGGFGCVYKGEMLGR-----TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL 530
+G+G FGCVY G +L A+K L ++ +F E ++ HP++++L
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 531 LGACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 587
LG C + Y+ +G L++ F ++ KD ++A G+ +L +SK
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL-ASK- 147
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADP 644
K VH DL +N +LD + + K+ DFG+ R + + Y P A
Sbjct: 148 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT----GAKLPVKWMA-L 201
Query: 645 EYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDW 701
E +T T KSD +SFG+++ +L+T G P + ++ + G+ L
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR---LLQ----- 253
Query: 702 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739
P + L ++ L+C RP + LV + +
Sbjct: 254 PEYCPDPLYEVMLKCWHPKAEMRPSFS-ELVSRISAIF 290
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 78/320 (24%), Positives = 125/320 (39%), Gaps = 50/320 (15%)
Query: 477 KVGQGGFGCVYKGEMLGR------TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVT 529
+G G FG V+KG + V IK++ Q + + L H H+V
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 530 LLGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 588
LLG CP + LV +YLP GSL D + + + L + +IA G+ +L
Sbjct: 80 LLGLCPGSSLQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMYYLEE---H 134
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPE 645
+VH +L +N+LL S ++ DFG+ L+ D + P A E
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ------LLYSEAKTPIKWMA-LE 187
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWP 702
G T +SD +S+G+ + +L+T G P GL EV + G+ L P
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE---RLAQ-----P 239
Query: 703 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER---------------PVP 747
+ + ++C + RP L E ++ R P P
Sbjct: 240 QICTIDVYMVMVKCWMIDENIRPTFK-ELANEFTRMARDPPRYLVIKRESGPGIAPGPEP 298
Query: 748 SFFLCPILQEIMHDPQVAAD 767
L+E+ +P++ D
Sbjct: 299 HGLTNKKLEEVELEPELDLD 318
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 51/209 (24%), Positives = 89/209 (42%), Gaps = 17/209 (8%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLG 532
+G G +G K G+ + K L +M + EV +L +L+HP++V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 533 ACPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRA-RIAAEIASGLCFLHSSKP 587
+ + +V EY G L + + + L ++ R+ ++ L H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 588 E--KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 645
++H DLKP N+ LD + + K+ DFG+ R++ DT + +F G+ Y PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF------VGTPYYMSPE 186
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
KSD +S G ++ +L P
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >2f42_A STIP1 homology and U-box containing protein 1; chaperone; 2.50A {Danio rerio} PDB: 2c2v_S 2oxq_C Length = 179 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 4e-32
Identities = 24/139 (17%), Positives = 53/139 (38%), Gaps = 5/139 (3%)
Query: 680 EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL- 738
E R + + + + + + R+ + + ++++L
Sbjct: 32 EKRISQENELHAYLSKLILAEKERELDDRVKQSDDSQNGGDISKMKSKHDKYLMDMDELF 91
Query: 739 ----HVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRL 794
++R +P + I E+M +P + G TY+ K I + L+ P+T L
Sbjct: 92 SQVDEKRKKREIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPL 151
Query: 795 SHLHLTPNHALRHAIQDWL 813
+ L PN A++ I ++
Sbjct: 152 TQDQLIPNLAMKEVIDAFI 170
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 68/291 (23%), Positives = 117/291 (40%), Gaps = 43/291 (14%)
Query: 477 KVGQGGFGCVYKGEMLGR-----TVAIKMLYSHNMQGQ--LEFQQEVRVLSKLQHPHLVT 529
+G+G FG V + ++ VA+KML + + EF +E + + HPH+
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 530 LLGAC----PEAWS----LVYEYLPNGSLQD--RLFRKS-NVSPLLWKDRARIAAEIASG 578
L+G + ++ ++ +G L R N L + R +IA G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 579 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS 638
+ +L SS+ +H DL +N +L +++ + DFG+ R + Y R
Sbjct: 150 MEYL-SSR--NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY-----RQGC-ASK 200
Query: 639 FP---YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSS 692
P A E + T SD ++FG+ + +++T G+ P G+ E+ + G
Sbjct: 201 LPVKWLA-LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR-- 257
Query: 693 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE 743
L P + DL QC ++RP T L ELE +
Sbjct: 258 -LKQ-----PPECMEEVYDLMYQCWSADPKQRPSFT-CLRMELENILGHLS 301
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 72/305 (23%), Positives = 128/305 (41%), Gaps = 42/305 (13%)
Query: 477 KVGQGGFGCVYKGEMLGR-------TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLV 528
+G G FG VY+G++ G VA+K L + Q +L+F E ++SK H ++V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 529 TLLGACPEA--WSLVYEYLPNGSLQD----RLFRKSNVSPLLWKDRARIAAEIASGLCFL 582
+G ++ ++ E + G L+ R S S L D +A +IA G +L
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 583 HSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSF 639
+H D+ +N LL KI DFG+ R + + Y
Sbjct: 157 -EEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY------RKGGCAML 207
Query: 640 P--YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSIL 694
P + PE G+ T K+D++SFG+++ ++ + G +P + EV V+ G +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR---M 264
Query: 695 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE--RPVPSFFLC 752
DP P + + QC + +RP+ +++ +E +
Sbjct: 265 DP-----PKNCPGPVYRIMTQCWQHQPEDRPNFA-IILERIEYCTQDPDVINTALPIEYG 318
Query: 753 PILQE 757
P+++E
Sbjct: 319 PLVEE 323
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 8e-32
Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 38/214 (17%)
Query: 477 KVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHPHL 527
+G+G FG V + + G RTVA+KML + E+++L + H ++
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 528 VTLLGACPEA---WSLVYEYLPNGSLQDRL-------------FRKSNVSPLLWKDRARI 571
V LLGAC + ++ E+ G+L L L +
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 572 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 631
+ ++A G+ FL +S+ K +H DL +NILL + KICDFG+ R + +D Y
Sbjct: 154 SFQVAKGMEFL-ASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-----V 205
Query: 632 STAPKGSFPY---ADPEYHRTGVLTPKSDSYSFG 662
P A PE V T +SD +SFG
Sbjct: 206 RKG-DARLPLKWMA-PETIFDRVYTIQSDVWSFG 237
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-32
Identities = 72/281 (25%), Positives = 115/281 (40%), Gaps = 34/281 (12%)
Query: 477 KVGQGGFGCVYKGEMLGR-----TVAIKMLYSHNMQGQ-LEFQQEVRVLSKLQHPHLVTL 530
+G G G V G + VAIK L + + Q +F E ++ + HP+++ L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 531 LGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 588
G V EY+ NGSL F +++ + + +G+ +L S
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVGAGMRYL-SDL-- 170
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPE 645
VH DL +N+L+DS L K+ DFG+ R++ +D T G P A PE
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA-----YTTTGGKIPIRWTA-PE 224
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWP 702
+ SD +SFG+++ ++L G P + +V +V G L P
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY---RLPA-----P 276
Query: 703 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE 743
L L L C +RP + +V L+ L + E
Sbjct: 277 MGCPHALHQLMLDCWHKDRAQRPRFS-QIVSVLDALIRSPE 316
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 66/225 (29%), Positives = 108/225 (48%), Gaps = 25/225 (11%)
Query: 477 KVGQGGFGCVYKGEMLGR----TVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTL 530
++G G FG V KG + TVA+K+L + L E E V+ +L +P++V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 531 LGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
+G C E+W LV E G L L + +V K+ + +++ G+ +L
Sbjct: 84 IGICEAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYL-EES--N 137
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEY 646
VH DL +N+LL ++ +KI DFG+ + + D Y G +P YA PE
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-----KAQTHGKWPVKWYA-PEC 191
Query: 647 HRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 688
+ KSD +SFG+++ + + G+ P G+ G EV + G
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 63/220 (28%), Positives = 91/220 (41%), Gaps = 44/220 (20%)
Query: 477 KVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLV 528
+G+G FG V K TVA+KML + +L + E VL ++ HPH++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 529 TLLGAC--PEAWSLVYEYLPNGSLQDRL---------------------FRKSNVSPLLW 565
L GAC L+ EY GSL+ L + L
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 566 KDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625
D A +I+ G+ +L + K+VH DL +NIL+ KI DFG+ R V E+ Y
Sbjct: 150 GDLISFAWQISQGMQYL-AEM--KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 626 LPSFHRSTAPKGSFP---YADPEYHRTGVLTPKSDSYSFG 662
+ +G P A E + T +SD +SFG
Sbjct: 207 -----VKRS-QGRIPVKWMA-IESLFDHIYTTQSDVWSFG 239
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 23/224 (10%)
Query: 477 KVGQGGFGCVYKGEMLGRT----VAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTLL 531
++G G FG V +G R VAIK+L + E +E +++ +L +P++V L+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 532 GACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
G C EA LV E G L L + + A + +++ G+ +L K
Sbjct: 77 GVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL-EEK--NF 131
Query: 591 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEYH 647
VH DL +N+LL + +KI DFG+ + + D Y + G +P YA PE
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY-----TARSAGKWPLKWYA-PECI 185
Query: 648 RTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 688
+ +SD +S+G+ + + L+ G+ P + G EV + G
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 229
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 72/302 (23%), Positives = 126/302 (41%), Gaps = 51/302 (16%)
Query: 477 KVGQGGFGCVYKGEMLG---------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKL-QHP 525
+G+G FG V E +G TVA+KML + + E+ ++ + +H
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 526 HLVTLLGAC--PEAWSLVYEYLPNGSLQDRL-------------FRKSNVSPLLWKDRAR 570
+++ LLGAC ++ EY G+L++ L + + +KD
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 571 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 630
++A G+ +L +S+ K +H DL +N+L+ KI DFG+ R + Y
Sbjct: 162 CTYQLARGMEYL-ASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY----- 213
Query: 631 RSTAPKGSFPY---ADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRA 684
+ T G P A PE V T +SD +SFG+++ ++ T G P G+ E+ +
Sbjct: 214 KKTT-NGRLPVKWMA-PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 685 VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER 744
+ G +D P L + C +RP LV++L+++
Sbjct: 272 LKEGHR---MDK-----PANCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRILTLTTN 322
Query: 745 PV 746
Sbjct: 323 EE 324
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 477 KVGQGGFGCVYKGEMLGRT-----VAIKMLYSHNMQGQL---EFQQEVRVLSKLQHPHLV 528
K+G G FG V +GE + VA+K L + +F +EV + L H +L+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 529 TLLGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 587
L G +V E P GSL DRL + + L +R A ++A G+ +L S
Sbjct: 85 RLYGVVLTPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYLES--- 139
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGICRLV-TEDTLYLPSFHRSTAPKGSFP---YAD 643
++ +H DL +N+LL + KI DFG+ R + D Y P A
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY------VMQEHRKVPFAWCA- 192
Query: 644 PEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 674
PE +T + SD++ FG+ + ++ T G+ P
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-31
Identities = 71/305 (23%), Positives = 115/305 (37%), Gaps = 63/305 (20%)
Query: 477 KVGQGGFGCVYKGEMLGR-----TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTL 530
+G+G FG V++G + VAIK + +F QE + + HPH+V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 531 LGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
+G ++ E G L+ L + L A ++++ L +L SK +
Sbjct: 457 IGVITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL-ESK--R 511
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEY 646
VH D+ +N+L+ S K+ DFG+ R + + T Y A KG P A PE
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-------KASKGKLPIKWMA-PES 563
Query: 647 HRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWPT 703
T SD + FG+ + ++L G P G+ +V + G+
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------------- 609
Query: 704 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQL---HVAEERPVPSF-FLCPILQEIM 759
RL P P + L + R P F L L I+
Sbjct: 610 ----RL-------------PMPPNCPPTLYSLMTKCWAYDPSRR--PRFTELKAQLSTIL 650
Query: 760 HDPQV 764
+ ++
Sbjct: 651 EEEKL 655
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 30/206 (14%)
Query: 477 KVGQGGFGCVYKGEMLG-------RTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLV 528
++GQG FG VY+G G VAIK + + +M+ ++EF E V+ + H+V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 529 TLLGACPEA--WSLVYEYLPNGSLQD-------RLFRKSNVSPLLWKDRARIAAEIASGL 579
LLG + ++ E + G L+ + ++P ++A EIA G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 639
+L+++ K VH DL +N ++ + + KI DFG+ R + E Y R KG
Sbjct: 152 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-----RKGG-KGLL 202
Query: 640 PY---ADPEYHRTGVLTPKSDSYSFG 662
P + PE + GV T SD +SFG
Sbjct: 203 PVRWMS-PESLKDGVFTTYSDVWSFG 227
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 6e-31
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 479 GQGGFGCVYKGEML--GRTVAIKMLY-----SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
G+G FG VY +A+K+L+ ++ QL ++EV + S L+HP+++ L
Sbjct: 18 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL--RREVEIQSHLRHPNILRLY 75
Query: 532 G--ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPE 588
G L+ EY P G++ L + S R E+A+ L + HS +
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYITELANALSYCHS---K 128
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 648
+++H D+KP+N+LL S KI DFG ++ PS R+ G+ Y PE
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLC-GTLDYLPPEMIE 180
Query: 649 TGVLTPKSDSYSFGLIILQLLTGRLP 674
+ K D +S G++ + L G+ P
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 52/235 (22%), Positives = 88/235 (37%), Gaps = 38/235 (16%)
Query: 477 KVGQGGFGCVYKGEMLGR---------TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHL 527
+GQG F ++KG V +K+L + F + ++SKL H HL
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 528 VTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 585
V G C + LV E++ GSL + K N + + + +A ++A+ + FL
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDT--YLKKNKNCINILWKLEVAKQLAAAMHFL-EE 131
Query: 586 KPEKIVHGDLKPQNILLDSELSS--------KICDFGICRLVTEDTLY-LPSFHRSTAPK 636
++HG++ +NILL E K+ D GI V + P+
Sbjct: 132 N--TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI--PWVPPE 187
Query: 637 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 688
L +D +SFG + ++ + G P L +
Sbjct: 188 -CIEN-------PKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-31
Identities = 81/382 (21%), Positives = 151/382 (39%), Gaps = 38/382 (9%)
Query: 378 MRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRG 437
M + + RRR + + + S I +
Sbjct: 1 MSPIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGI--CSIEELSTSLYKKAGSENLYF 58
Query: 438 QAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGR--- 494
Q + L +L ++ + + + +F+E +G+G FGCVY G +L
Sbjct: 59 QGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGK 116
Query: 495 --TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVY---EYLPNG 548
A+K L ++ +F E ++ HP++++LLG C + Y+ +G
Sbjct: 117 KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 176
Query: 549 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 608
L++ F ++ KD ++A G+ FL +SK K VH DL +N +LD + +
Sbjct: 177 DLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL-ASK--KFVHRDLAARNCMLDEKFTV 231
Query: 609 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEYHRTGVLTPKSDSYSFGLII 665
K+ DFG+ R + + + +++ P A E +T T KSD +SFG+++
Sbjct: 232 KVADFGLARDMYDKE-FDSVHNKT---GAKLPVKWMA-LESLQTQKFTTKSDVWSFGVLL 286
Query: 666 LQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGR 722
+L+T G P + ++ + G+ L P + L ++ L+C
Sbjct: 287 WELMTRGAPPYPDVNTFDITVYLLQGRR---LLQ-----PEYCPDPLYEVMLKCWHPKAE 338
Query: 723 ERPDITPSLVKELEQLHVAEER 744
RP + LV + +
Sbjct: 339 MRPSFS-ELVSRISAIFSTFIG 359
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-31
Identities = 72/306 (23%), Positives = 129/306 (42%), Gaps = 44/306 (14%)
Query: 477 KVGQGGFGCVYKGEMLGR-------TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLV 528
+G G FG VY+G++ G VA+K L + Q +L+F E ++SK H ++V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 529 TLLGACPEA--WSLVYEYLPNGSLQDRLFRKS-----NVSPLLWKDRARIAAEIASGLCF 581
+G ++ ++ E + G L+ L R++ S L D +A +IA G +
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 582 LHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGS 638
L +H D+ +N LL KI DFG+ R + Y
Sbjct: 197 L-EEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY------RKGGCAM 247
Query: 639 FP--YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSI 693
P + PE G+ T K+D++SFG+++ ++ + G +P + EV V+ G
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR--- 304
Query: 694 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE--RPVPSFFL 751
+DP P + + QC + +RP+ +++ +E +
Sbjct: 305 MDP-----PKNCPGPVYRIMTQCWQHQPEDRPNFA-IILERIEYCTQDPDVINTALPIEY 358
Query: 752 CPILQE 757
P+++E
Sbjct: 359 GPLVEE 364
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 52/212 (24%), Positives = 85/212 (40%), Gaps = 37/212 (17%)
Query: 479 GQGGFGCVYKGEML--GRTVAIKMLY-----SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
G+GGF ++ A K++ + + ++ E+ + L H H+V
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKM--SMEISIHRSLAHQHVVGFH 81
Query: 532 GACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKP 587
G E V+ E SL + R+ ++ AR +I G +LH
Sbjct: 82 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEARYYLRQIVLGCQYLHR--- 133
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 647
+++H DLK N+ L+ +L KI DFG+ V D + G+ Y PE
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG----ERKKVLC--GTPNYIAPE-- 185
Query: 648 RTGVLT-----PKSDSYSFGLIILQLLTGRLP 674
VL+ + D +S G I+ LL G+ P
Sbjct: 186 ---VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-31
Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 44/220 (20%)
Query: 477 KVGQGGFGCVYKGEMLG-------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKL-QHPHL 527
+G G FG V G VA+KML + + E++++++L H ++
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 528 VTLLGAC--PEAWSLVYEYLPNGSLQD--------------------RLFRKSNVSPLLW 565
V LLGAC L++EY G L + RL + +++ L +
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 566 KDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625
+D A ++A G+ FL K VH DL +N+L+ KICDFG+ R + D+ Y
Sbjct: 172 EDLLCFAYQVAKGMEFL-EFK--SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 626 LPSFHRSTAPKGSFPY---ADPEYHRTGVLTPKSDSYSFG 662
+ P A PE G+ T KSD +S+G
Sbjct: 229 VVR------GNARLPVKWMA-PESLFEGIYTIKSDVWSYG 261
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-30
Identities = 50/216 (23%), Positives = 87/216 (40%), Gaps = 24/216 (11%)
Query: 471 NFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLV 528
+F +G G G + M R VA+K + +EV++L + +HP+++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSF---ADREVQLLRESDEHPNVI 81
Query: 529 TLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
+ + E +LQ+ + +K L + + + SGL LHS
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN 138
Query: 587 PEKIVHGDLKPQNILL-----DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 641
IVH DLKP NIL+ ++ + I DFG+C+ + SF R + G+ +
Sbjct: 139 ---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR---HSFSRRSGVPGTEGW 192
Query: 642 ADPEY---HRTGVLTPKSDSYSFGLIILQLLTGRLP 674
PE T D +S G + +++
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 75/306 (24%), Positives = 132/306 (43%), Gaps = 51/306 (16%)
Query: 477 KVGQGGFGCVYKGEMLG---------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHP 525
+G+G FG V E +G VA+KML S + L + E+ ++ + +H
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 526 HLVTLLGAC--PEAWSLVYEYLPNGSLQD--RLFRKSNV-----------SPLLWKDRAR 570
+++ LLGAC ++ EY G+L++ + R + L KD
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 571 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 630
A ++A G+ +L +SK K +H DL +N+L+ + KI DFG+ R + Y
Sbjct: 196 CAYQVARGMEYL-ASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY----- 247
Query: 631 RSTAPKGSFPY---ADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRA 684
+ T G P A PE + T +SD +SFG+++ ++ T G P G+ E+ +
Sbjct: 248 KKTT-NGRLPVKWMA-PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305
Query: 685 VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER 744
+ G +D P+ L + C +RP LV++L+++
Sbjct: 306 LKEGHR---MDK-----PSNCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRIVALTSN 356
Query: 745 PVPSFF 750
++
Sbjct: 357 QEMGYY 362
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 76/285 (26%), Positives = 127/285 (44%), Gaps = 39/285 (13%)
Query: 477 KVGQGGFGCVYKGEMLGRT------VAIKMLYSHNMQGQ-LEFQQEVRVLSKLQHPHLVT 529
+G G FG VYKG + + VAIK L + + Q ++F E ++ + H +++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 530 LLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 587
L G + + + EY+ NG+L F + + IA+G+ +L ++
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGMKYL-ANM- 166
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTED--TLYLPSFHRSTAPKGSFP---YA 642
VH DL +NIL++S L K+ DFG+ R++ +D Y T G P A
Sbjct: 167 -NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY-------TTSGGKIPIRWTA 218
Query: 643 DPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAG 699
PE T SD +SFG+++ +++T G P L+ EV +A++ G L
Sbjct: 219 -PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF---RLPT--- 271
Query: 700 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER 744
P + L +QC + RP +V L++L A +
Sbjct: 272 --PMDCPSAIYQLMMQCWQQERARRPKFA-DIVSILDKLIRAPDS 313
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 28/210 (13%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLG 532
K+G+G FG + GR IK + M + + E ++EV VL+ ++HP++V
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 533 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
+ E SL V +Y G L R+ +I L +H KI
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVHD---RKI 146
Query: 591 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE----- 645
+H D+K QNI L + + ++ DFGI R++ + G+ Y PE
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC------IGTPYYLSPEICENK 200
Query: 646 -YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
Y KSD ++ G ++ +L T +
Sbjct: 201 PY------NNKSDIWALGCVLYELCTLKHA 224
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 36/212 (16%)
Query: 477 KVGQGGFGCVYKGEMLGR-------TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLV 528
++G+ FG VYKG + G VAIK L + EF+ E + ++LQHP++V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 529 TLLGACPEA--WSLVYEYLPNGSLQDRL-------------FRKSNVSPLLWKDRARIAA 573
LLG + S+++ Y +G L + L ++ S L D + A
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 574 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 633
+IA+G+ +L SS +VH DL +N+L+ +L+ KI D G+ R V Y +
Sbjct: 136 QIAAGMEYL-SSH--HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY-----KLL 187
Query: 634 APKGSFP---YADPEYHRTGVLTPKSDSYSFG 662
P A PE G + SD +S+G
Sbjct: 188 G-NSLLPIRWMA-PEAIMYGKFSIDSDIWSYG 217
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 27/206 (13%)
Query: 479 GQGGFGCVYKGEML--GRTVAIKMLY-----SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
G+G FG VY +A+K+L+ ++ QL ++E+ + S L+HP+++ +
Sbjct: 23 GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQL--RREIEIQSHLRHPNILRMY 80
Query: 532 G--ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPE 588
+ L+ E+ P G L L + R+ E+A L + H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE----QRSATFMEELADALHYCHE---R 133
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 648
K++H D+KP+N+L+ + KI DFG PS R T G+ Y PE
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHA-------PSLRRRTMC-GTLDYLPPEMIE 185
Query: 649 TGVLTPKSDSYSFGLIILQLLTGRLP 674
K D + G++ + L G P
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-30
Identities = 64/226 (28%), Positives = 106/226 (46%), Gaps = 25/226 (11%)
Query: 477 KVGQGGFGCVYKGEMLGRT-----VAIKMLYSHNMQGQ-LEFQQEVRVLSKLQHPHLVTL 530
VG G FG V G + + VAIK L + Q +F E ++ + HP+++ L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 531 LGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 588
G ++ + V EY+ NGSL F + + + + IASG+ +L S
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL-SDM-- 166
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPE 645
VH DL +NIL++S L K+ DFG+ R++ +D T G P + PE
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA-----YTTRGGKIPIRWTS-PE 220
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 688
T SD +S+G+++ ++++ G P ++ +V +AV G
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 39/215 (18%)
Query: 477 KVGQGGFGCVYKGEMLG---------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHP 525
+G+G FG V E +G TVA+KML + L + E+ ++ + +H
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 526 HLVTLLGAC--PEAWSLVYEYLPNGSLQDRL-------------FRKSNVSPLLWKDRAR 570
+++ LLGAC ++ EY G+L++ L + + +KD
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 571 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 630
++A G+ +L +S+ K +H DL +N+L+ KI DFG+ R + Y
Sbjct: 208 CTYQLARGMEYL-ASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY----- 259
Query: 631 RSTAPKGSFPY---ADPEYHRTGVLTPKSDSYSFG 662
+ T G P A PE V T +SD +SFG
Sbjct: 260 KKTT-NGRLPVKWMA-PEALFDRVYTHQSDVWSFG 292
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 60/240 (25%), Positives = 100/240 (41%), Gaps = 35/240 (14%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
+G GGFG V+K + G+T IK + +N + ++EV+ L+KL H ++V G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCW 73
Query: 535 PEAWS------------------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIA 576
+ E+ G+L+ + K L + +I
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALELFEQIT 132
Query: 577 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 636
G+ ++HS +K+++ DLKP NI L KI DFG+ + D R+ + K
Sbjct: 133 KGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK------RTRS-K 182
Query: 637 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDP 696
G+ Y PE + + D Y+ GLI+ +LL + + G +S I D
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDK 242
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 53/212 (25%), Positives = 85/212 (40%), Gaps = 37/212 (17%)
Query: 479 GQGGFGCVYKGEML--GRTVAIKM-----LYSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
G+GGF ++ A K+ L + + ++ E+ + L H H+V
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKM--SMEISIHRSLAHQHVVGFH 107
Query: 532 GACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKP 587
G E V+ E SL + R+ ++ AR +I G +LH
Sbjct: 108 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEARYYLRQIVLGCQYLHR--- 159
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 647
+++H DLK N+ L+ +L KI DFG+ V D + G+ Y PE
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG----ERKKVLC--GTPNYIAPE-- 211
Query: 648 RTGVLT-----PKSDSYSFGLIILQLLTGRLP 674
VL+ + D +S G I+ LL G+ P
Sbjct: 212 ---VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-30
Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 23/225 (10%)
Query: 477 KVGQGGFGCVYKGEMLGRT----VAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTLL 531
++G G FG V +G R VAIK+L + E +E +++ +L +P++V L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 532 GAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
G C EA LV E G L L + + A + +++ G+ +L K
Sbjct: 403 GVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL-EEK--NF 457
Query: 591 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEYH 647
VH +L +N+LL + +KI DFG+ + + D Y + G +P YA PE
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY-----TARSAGKWPLKWYA-PECI 511
Query: 648 RTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGK 689
+ +SD +S+G+ + + L+ G+ P + G EV + GK
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 556
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 4e-30
Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 33/210 (15%)
Query: 477 KVGQGGFGCVYKGE---MLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL-- 530
+ GG G +Y + GR V +K L +S + + Q E + L+++ HP +V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 531 ------LGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 584
P + +V EY+ SL+ + L + EI L +LHS
Sbjct: 147 FVEHTDRHGDPVGY-IVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHS 200
Query: 585 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 644
+V+ DLKP+NI+L E K+ D G + G+ + P
Sbjct: 201 ---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY----------GTPGFQAP 246
Query: 645 EYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
E RTG T +D Y+ G + L
Sbjct: 247 EIVRTGP-TVATDIYTVGRTLAALTLDLPT 275
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 38/228 (16%), Positives = 84/228 (36%), Gaps = 48/228 (21%)
Query: 479 GQGGFGCVYKGEMLGRTVAIKMLY-------------------SHNMQGQLEFQQEVRVL 519
QG F + E + A+K + + E++++
Sbjct: 40 NQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFK--NELQII 97
Query: 520 SKLQHPHLVTLLGACPEAWS------LVYEYLPNGSLQDRL-----FRKSNVSPLLWKDR 568
+ +++ + +T + ++YEY+ N S+ K+ + +
Sbjct: 98 TDIKNEYCLTCE----GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 569 ARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 628
I + + ++H+ K I H D+KP NIL+D K+ DFG + + +
Sbjct: 154 KCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--- 208
Query: 629 FHRSTAPKGSFPYADPE--YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
+ +G++ + PE + + K D +S G+ + + +P
Sbjct: 209 ----GS-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 52/211 (24%), Positives = 83/211 (39%), Gaps = 33/211 (15%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
+VG+G FG V++ + G A+K + + +E+ + L P +V L GA
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAV 119
Query: 535 PEAWSL--VYEYLPNGSLQDRL-----FRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 587
E + E L GSL + + + GL +LH+
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA--------LYYLGQALEGLEYLHT--- 168
Query: 588 EKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADP 644
+I+HGD+K N+LL S+ + +CDFG + D L G+ A P
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI-PGT-ETHMA-P 225
Query: 645 E-YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
E K D +S ++L +L G P
Sbjct: 226 EVVMGKPC-DAKVDIWSSCCMMLHMLNGCHP 255
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 36/212 (16%)
Query: 479 GQGGFGCVYKGEML--GRTVAIKMLY-----SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
G+G F VY+ E + G VAIKM+ M +++ EV++ +L+HP ++ L
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQ--NEVKIHCQLKHPSILELY 77
Query: 532 GACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKP 587
E + VY E NG + L + ++ AR +I +G+ +LHS
Sbjct: 78 N-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKP---FSENEARHFMHQIITGMLYLHS--- 130
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 647
I+H DL N+LL ++ KI DFG+ + H + G+ Y PE
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH----EKHYTLC--GTPNYISPE-- 182
Query: 648 RTGVLT-----PKSDSYSFGLIILQLLTGRLP 674
+ T +SD +S G + LL GR P
Sbjct: 183 ---IATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 44/220 (20%)
Query: 477 KVGQGGFGCVYKGEMLG-------RTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLV 528
+G+G FG V++ G VA+KML + Q +FQ+E ++++ +P++V
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 529 TLLGACPEA--WSLVYEYLPNGSLQDRL---------------------FRKSNVSPLLW 565
LLG C L++EY+ G L + L PL
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 566 KDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625
++ IA ++A+G+ +L S + K VH DL +N L+ + KI DFG+ R + Y
Sbjct: 174 AEQLCIARQVAAGMAYL-SER--KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 626 LPSFHRSTAPKGSFP---YADPEYHRTGVLTPKSDSYSFG 662
++ + P PE T +SD +++G
Sbjct: 231 -----KADG-NDAIPIRWMP-PESIFYNRYTTESDVWAYG 263
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 37/216 (17%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLL 531
K+G+G F VY+ L G VA+K + ++ +E+ +L +L HP+++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 532 GACPEAWSL--VYEYLPNGSLQDRL--FRKSNVS---PLLWKDRARIAAEIASGLCFLHS 584
+ E L V E G L + F+K +WK ++ S L +HS
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK----YFVQLCSALEHMHS 154
Query: 585 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 644
+++H D+KP N+ + + K+ D G+ R + T S G+ Y P
Sbjct: 155 ---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL------VGTPYYMSP 205
Query: 645 E------YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
E Y KSD +S G ++ ++ + P
Sbjct: 206 ERIHENGY------NFKSDIWSLGCLLYEMAALQSP 235
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 36/211 (17%)
Query: 479 GQGGFGCVYKGE--MLGRTVAIKML----YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 532
G+G F V + GR VAIK++ + +L +EVR++ L HP++V L
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKL--FREVRIMKILNHPNIVKLFE 81
Query: 533 --ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPEK 589
+ L+ EY G + D L + AR +I S + + H ++
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKE----KEARSKFRQIVSAVQYCHQ---KR 134
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---- 645
IVH DLK +N+LLD++++ KI DFG T G+ PYA PE
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK----LDAFC---GAPPYAAPELFQG 187
Query: 646 --YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
Y G P+ D +S G+I+ L++G LP
Sbjct: 188 KKYD--G---PEVDVWSLGVILYTLVSGSLP 213
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 18/205 (8%)
Query: 478 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 535
+G+G +G VY G L +AIK + + + +E+ + L+H ++V LG+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 536 EAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 593
E + E +P GSL L K + +I GL +LH +IVH
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHR 146
Query: 594 DLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---YHRT 649
D+K N+L+++ KI DFG + + +F G+ Y PE
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF------TGTLQYMAPEIIDKGPR 200
Query: 650 GVLTPKSDSYSFGLIILQLLTGRLP 674
G +D +S G I+++ TG+ P
Sbjct: 201 GY-GKAADIWSLGCTIIEMATGKPP 224
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-28
Identities = 63/265 (23%), Positives = 100/265 (37%), Gaps = 40/265 (15%)
Query: 477 KVGQGGFGCV-YKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGAC 534
+G G G V ++G GR VA+K + E+++L++ HP+++ +
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNVIRYYCSE 78
Query: 535 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE----IASGLCFLHSSKPE 588
+ E N +LQD + K+ L + IASG+ LHS
Sbjct: 79 TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---L 134
Query: 589 KIVHGDLKPQNILLDSELSS-------------KICDFGICRLVTEDTLYLPSFHRSTAP 635
KI+H DLKPQNIL+ + I DFG+C+ + + P
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT--NLNNP 192
Query: 636 KGSFPYADPE-------YHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSC 687
G+ + PE LT D +S G + +L+ G+ P G +
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIR 252
Query: 688 GKLSSILDPLAGDWPTFVARRLVDL 712
G S LD + + DL
Sbjct: 253 GIFS--LDEMKCLHDRSLIAEATDL 275
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 56/216 (25%), Positives = 78/216 (36%), Gaps = 29/216 (13%)
Query: 472 FSESF----KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKL- 522
F +SF ++G G +G V+K GR A+K S + + EV K+
Sbjct: 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG 114
Query: 523 QHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSP--LLWKDRARIAAEIASG 578
QHP V L A E L E SLQ P +W +
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWG----YLRDTLLA 169
Query: 579 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS 638
L LHS +VH D+KP NI L K+ DFG+ + +G
Sbjct: 170 LAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA-------GEVQEGD 219
Query: 639 FPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
Y PE + +D +S GL IL++
Sbjct: 220 PRYMAPELLQGS-YGTAADVFSLGLTILEVACNMEL 254
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 65/211 (30%), Positives = 92/211 (43%), Gaps = 39/211 (18%)
Query: 477 KVGQGGFGCVYKGEMLG----RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHPHLVTL 530
+G+G FG V K + AIK + + + +F E+ VL KL HP+++ L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 531 LGACPEAWSL--VYEYLPNGSLQDRLFRKSNV--------------SPLLWKDRARIAAE 574
LGAC L EY P+G+L D L RKS V S L + AA+
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 575 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 634
+A G+ +L S K + +H DL +NIL+ +KI DFG+ R +
Sbjct: 151 VARGMDYL-SQK--QFIHRDLAARNILVGENYVAKIADFGLSR----GQEV----YVKKT 199
Query: 635 PKGSFPY---ADPEYHRTGVLTPKSDSYSFG 662
G P A E V T SD +S+G
Sbjct: 200 -MGRLPVRWMA-IESLNYSVYTTNSDVWSYG 228
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-28
Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 36/228 (15%)
Query: 465 LQTATCNFSESFKV----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE---FQQE 515
+Q +T FS+ +K G+G FG V + G+ A+K++ ++ + + +E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 516 VRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA 573
V++L +L HP+++ L + LV E G L D + + S D ARI
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE---VDAARIIR 133
Query: 574 EIASGLCFLHSSKPEKIVHGDLKPQNILLDS---ELSSKICDFGICRLVTEDTLYLPSFH 630
++ SG+ ++H KIVH DLKP+N+LL+S + + +I DFG+
Sbjct: 134 QVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-------K 183
Query: 631 RSTAPKGSFPYADPEYHRTGVL----TPKSDSYSFGLIILQLLTGRLP 674
+ G+ Y PE VL K D +S G+I+ LL+G P
Sbjct: 184 KMKDKIGTAYYIAPE-----VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 4e-28
Identities = 35/220 (15%), Positives = 65/220 (29%), Gaps = 29/220 (13%)
Query: 477 KVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 529
+G+G F VY+ + +K+ N Q + L +
Sbjct: 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMK 131
Query: 530 LLGAC--PEAWSLVYEYLPNGSLQDRL--FRKSNVSPLLWKDRARIAAEIASGLCFLHSS 585
A LV E G+L + + ++ + + A + + +H
Sbjct: 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC 191
Query: 586 KPEKIVHGDLKPQNILLDSELSS-----------KICDFGICRLVTEDTLYLPSFHRSTA 634
+ I+HGD+KP N +L + + D G D P TA
Sbjct: 192 E---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI----DMKLFPKGTIFTA 244
Query: 635 PKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
+ + E + D + + +L G
Sbjct: 245 KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 6e-28
Identities = 37/244 (15%), Positives = 70/244 (28%), Gaps = 60/244 (24%)
Query: 478 VGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQ--------- 523
+GQ + + G + + + Y + ++EV L L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 524 ----------------HPHLVTLLGACPEAWSLVY---EYLPNGSLQDRLF----RKSNV 560
++ + + W L +LQ S
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 561 SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 620
L+ R ++ ++ L LH +VH L+P +I+LD + F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 621 EDTLYLPSFHRSTAPKGSFPYADPEY----------HRTGVLTPKSDSYSFGLIILQLLT 670
+ +A PE H ++T D+++ GL I +
Sbjct: 263 ASAV----------SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 671 GRLP 674
LP
Sbjct: 313 ADLP 316
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 8e-28
Identities = 68/258 (26%), Positives = 103/258 (39%), Gaps = 41/258 (15%)
Query: 465 LQTATCNFSESFKV----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEV 516
+ + + SE ++ G G +G V AIK++ ++ + +EV
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 517 RVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE 574
VL L HP+++ L + LV E G L D + + + D A I +
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNE---VDAAVIIKQ 144
Query: 575 IASGLCFLHSSKPEKIVHGDLKPQNILLDS---ELSSKICDFGICRLVTEDTLYLPSFHR 631
+ SG+ +LH IVH DLKP+N+LL+S + KI DFG+ +
Sbjct: 145 VLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM------ 195
Query: 632 STAPKGSFPYADPEYHRTGVL----TPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAV 685
G+ Y PE VL K D +S G+I+ LL G P G E+ R V
Sbjct: 196 -KERLGTAYYIAPE-----VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV 249
Query: 686 SCGKLSSILDPLAGDWPT 703
GK + W
Sbjct: 250 EKGKYTFDSPE----WKN 263
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 37/212 (17%)
Query: 479 GQGGFGCVYKGE--MLGRTVAIKML-----YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
G G FG V GE + G VA+K+L S ++ G+++ +E++ L +HPH++ L
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHIIKLY 77
Query: 532 G--ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPE 588
+ P + +V EY+ G L D + + V AR + +I S + + H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHGRVEE----MEARRLFQQILSAVDYCHR---H 130
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE--- 645
+VH DLKP+N+LLD+ +++KI DFG+ ++++ S GS YA PE
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF----LRTSC---GSPNYAAPEVIS 183
Query: 646 ---YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
Y G P+ D +S G+I+ LL G LP
Sbjct: 184 GRLYA--G---PEVDIWSCGVILYALLCGTLP 210
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 31/235 (13%), Positives = 56/235 (23%), Gaps = 52/235 (22%)
Query: 479 GQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLLGA 533
G V+ A+K+ + E + ++L
Sbjct: 71 RVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDR 130
Query: 534 CPEAWS----------------------------LVYEYLPNGSLQDRL----FRKSNVS 561
L+ + L+ F
Sbjct: 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTLDFVYVFRG 189
Query: 562 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621
+ A++ L S + +VHG P N+ + + + D V
Sbjct: 190 DEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 622 DTLYLPSFHRSTAPKGSFPYADPEY--HRTGVLTPKSDSYSFGLIILQLLTGRLP 674
R A YA E+ T T +++ GL I ++ LP
Sbjct: 247 ---------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-27
Identities = 62/238 (26%), Positives = 98/238 (41%), Gaps = 46/238 (19%)
Query: 465 LQTATCNFSESFKV----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL-------- 510
++ ES+ G G +G V + AIK++
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 511 -----EFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPL 563
E E+ +L L HP+++ L + + LV E+ G L +++ +
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDE- 145
Query: 564 LWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS---ELSSKICDFGICRLVT 620
D A I +I SG+C+LH IVH D+KP+NILL++ L+ KI DFG+ +
Sbjct: 146 --CDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200
Query: 621 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL----TPKSDSYSFGLIILQLLTGRLP 674
+D ++ G+ Y PE VL K D +S G+I+ LL G P
Sbjct: 201 KD-------YKLRDRLGTAYYIAPE-----VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-26
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 31/211 (14%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ--LEFQQEVRVLSKLQHPHLVTLLG 532
+G+G FG V K + + A+K++ + + + +EV +L KL HP+++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 533 AC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
++ +V E G L D + ++ S D ARI ++ SG+ ++H I
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE---HDAARIIKQVFSGITYMHK---HNI 142
Query: 591 VHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 647
VH DLKP+NILL+S+ KI DFG+ ++ + G+ Y PE
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-------TKMKDRIGTAYYIAPE-- 193
Query: 648 RTGVL----TPKSDSYSFGLIILQLLTGRLP 674
VL K D +S G+I+ LL+G P
Sbjct: 194 ---VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 50/209 (23%), Positives = 84/209 (40%), Gaps = 29/209 (13%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
+G+G +G V A K + + ++ F+QE+ ++ L HP+++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 535 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
LV E G L +R+ K D ARI ++ S + + H + H
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRE---SDAARIMKDVLSAVAYCHK---LNVAH 129
Query: 593 GDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
DLKP+N L ++ K+ DFG+ + G+ Y P+
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-------RTKVGTPYYVSPQ---- 178
Query: 650 GVL----TPKSDSYSFGLIILQLLTGRLP 674
VL P+ D +S G+++ LL G P
Sbjct: 179 -VLEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 27/215 (12%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 533
+G G V VAIK + Q ++ +E++ +S+ HP++V+ +
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 534 ---CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWK--DRARIAA---EIASGLCFLHSS 585
E W LV + L GS+ D + D + IA E+ GL +LH
Sbjct: 82 FVVKDELW-LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK- 139
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF---PY- 641
+H D+K NILL + S +I DFG+ + + R T F P
Sbjct: 140 --NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT-----FVGTPCW 192
Query: 642 -ADPE-YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
A PE + K+D +SFG+ ++L TG P
Sbjct: 193 MA-PEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIK-MLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA 533
++G G G V+K G +A K + + + +E++VL + P++V GA
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 534 --CPEAWSLVYEYLPNGSLQDRLFRKSNVS-PLLWKDRARIAAEIASGLCFLHSSKPEKI 590
S+ E++ GSL L + + +L +++ + GL +L KI
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL----GKVSIAVIKGLTYLREKH--KI 153
Query: 591 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 650
+H D+KP NIL++S K+CDFG+ + + S S G+ Y PE +
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID------SMANSFV--GTRSYMSPERLQGT 205
Query: 651 VLTPKSDSYSFGLIILQLLTGRLP 674
+ +SD +S GL ++++ GR P
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 37/244 (15%), Positives = 68/244 (27%), Gaps = 61/244 (25%)
Query: 479 GQGGFGCVYKGE--MLGRTVAIKMLYS----------------------------HNMQG 508
GQ + G + + + Y +
Sbjct: 82 GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141
Query: 509 QLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVY---EYLPNGSLQDR---LFRKSNVSP 562
L F ++ Q ++ + + W L +LQ L S+
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201
Query: 563 LL-WKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621
L R ++ ++ L LH +VH L+P +I+LD + F
Sbjct: 202 SLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258
Query: 622 DTLYLPSFHRSTAPKGSFPYADPEY-----------HRTGVLTPKSDSYSFGLIILQLLT 670
+ S + PE R ++T D+++ GL+I +
Sbjct: 259 RVV----------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 671 GRLP 674
LP
Sbjct: 309 ADLP 312
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 35/211 (16%)
Query: 479 GQGGFGCVYKGE--MLGRTVAIKML-----YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
G G FG V G+ + G VA+K+L S ++ G++ +E++ L +HPH++ L
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKLFRHPHIIKLY 82
Query: 532 GACPEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHS 584
+ S +V EY+ G L D + + + +R + +I SG+ + H
Sbjct: 83 ----QVISTPSDIFMVMEYVSGGELFDYICKNGRLDE----KESRRLFQQILSGVDYCHR 134
Query: 585 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 644
+VH DLKP+N+LLD+ +++KI DFG+ ++++ S GS YA P
Sbjct: 135 ---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF----LRTSC---GSPNYAAP 184
Query: 645 E-YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
E P+ D +S G+I+ LL G LP
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 49/242 (20%), Positives = 85/242 (35%), Gaps = 61/242 (25%)
Query: 471 NFSESF----KVGQGGFGCVYKGEML--GRTVAIK--MLYSHNMQGQLEFQQEVRVLSKL 522
++ F K+G G FG V+K G AIK + +EV + L
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 523 -QHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDR-ARIAAEIASG 578
QH H+V A E + EY GSL D + + + + ++ G
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 579 LCFLHSSKPEKIVHGDLKPQNILLD-------------------SELSSKICDFGICRLV 619
L ++HS +VH D+KP NI + +++ KI D G +
Sbjct: 128 LRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 620 TE------DTLYLPSFHRSTAP---KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 670
+ D+ +L A + ++ + PK+D ++ L ++
Sbjct: 185 SSPQVEEGDSRFL-------ANEVLQENYTH-----------LPKADIFALALTVVCAAG 226
Query: 671 GR 672
Sbjct: 227 AE 228
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 46/216 (21%)
Query: 479 GQGGFGCVYKGE--MLGRTVAIKM-----LYSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
G+G FG V + VA+K L +M ++E +E+ L L+HPH++ L
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIKLY 75
Query: 532 GACPEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHS 584
+ + +V EY G L D + K ++ D R +I + + H
Sbjct: 76 ----DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTE----DEGRRFFQQIICAIEYCHR 126
Query: 585 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 644
KIVH DLKP+N+LLD L+ KI DFG+ ++T+ S GS YA P
Sbjct: 127 ---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF----LKTSC---GSPNYAAP 176
Query: 645 E------YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
E Y G P+ D +S G+++ +L GRLP
Sbjct: 177 EVINGKLYA--G---PEVDVWSCGIVLYVMLVGRLP 207
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 28/211 (13%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 533
K+G G FG V+ E G IK + Q +E + E+ VL L HP+++ +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 534 C--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLW-KDRARIAAEIASGLCFLHSSKPEKI 590
+V E G L +R+ L A + ++ + L + HS + +
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHV 145
Query: 591 VHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 647
VH DLKP+NIL KI DFG+ L D T G+ Y PE
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-------TNAAGTALYMAPE-- 196
Query: 648 RTGVL----TPKSDSYSFGLIILQLLTGRLP 674
V T K D +S G+++ LLTG LP
Sbjct: 197 ---VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 49/233 (21%), Positives = 97/233 (41%), Gaps = 22/233 (9%)
Query: 452 EDLPESAEFSLADLQTATCNFSESFKV----GQGGFGCVYKGE--MLGRTVAIKMLYSHN 505
++ ++ + + + + G G FG V++ GR K + +
Sbjct: 29 FYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY 88
Query: 506 MQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPL 563
+ + E+ ++++L HP L+ L A L+ E+L G L DR+ + +
Sbjct: 89 PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--M 146
Query: 564 LWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS--KICDFGICRLVTE 621
+ + GL +H IVH D+KP+NI+ +++ +S KI DFG+ +
Sbjct: 147 SEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203
Query: 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
D + + + +A PE + +D ++ G++ LL+G P
Sbjct: 204 DEIVKVTT-------ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 6e-25
Identities = 50/204 (24%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
++G G FG V++ G A K + + + + ++E++ +S L+HP LV L A
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 535 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
++YE++ G L +++ + N + + ++ GLC +H + VH
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHEN---NYVH 278
Query: 593 GDLKPQNILLDSELSS--KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 650
DLKP+NI+ ++ S+ K+ DFG+ + + G+ +A PE
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-------GTAEFAAPEVAEGK 331
Query: 651 VLTPKSDSYSFGLIILQLLTGRLP 674
+ +D +S G++ LL+G P
Sbjct: 332 PVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 69/229 (30%), Positives = 106/229 (46%), Gaps = 34/229 (14%)
Query: 461 SLADLQTATCNFSESF----KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQ 513
L +Q + E F K+G+G FG V+KG + VAIK++ + ++E Q
Sbjct: 9 GLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ 68
Query: 514 QEVRVLSKLQHPHLVTLLGA---CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR 570
QE+ VLS+ P++ G+ + W ++ EYL GS D L PL A
Sbjct: 69 QEITVLSQCDSPYVTKYYGSYLKDTKLW-IIMEYLGGGSALDLLEPG----PLDETQIAT 123
Query: 571 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 630
I EI GL +LHS EK +H D+K N+LL K+ DFG+ +T+
Sbjct: 124 ILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--------- 171
Query: 631 RSTAPKGSF---PY--ADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
+ + +F P+ A PE + K+D +S G+ ++L G P
Sbjct: 172 -TQIKRNTFVGTPFWMA-PEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2kre_A Ubiquitin conjugation factor E4 B; U-box domain, E3 ubiquitin ligase, E4 polyubiquitin chain EL factor, phosphoprotein, UBL conjugation pathway; NMR {Homo sapiens} PDB: 3l1x_A 3l1z_B Length = 100 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 8e-25
Identities = 21/89 (23%), Positives = 33/89 (37%), Gaps = 7/89 (7%)
Query: 731 LVKELEQLHVAEERP------VPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGR 784
+++E++ R P F P++ +M DP G + I L N
Sbjct: 5 FAEKVEEIVAKNARAEIDYSDAPDEFRDPLMDTLMTDPVRLPSGTIMDRSIILRHLLNSP 64
Query: 785 ETSPMTNLRLSHLHLTPNHALRHAIQDWL 813
T P L+ L P L+ IQ W+
Sbjct: 65 -TDPFNRQTLTESMLEPVPELKEQIQAWM 92
|
| >2kr4_A Ubiquitin conjugation factor E4 B; U-BOX, UFD2, ring, E3 ligase, UBL conjugation pathway; NMR {Mus musculus} Length = 85 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 9e-25
Identities = 19/73 (26%), Positives = 27/73 (36%), Gaps = 1/73 (1%)
Query: 741 AEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLT 800
+ P F P++ +M DP G + I L N T P L+ L
Sbjct: 6 IDYSDAPDEFRDPLMDTLMTDPVRLPSGTVMDRSIILRHLLNSP-TDPFNRQMLTESMLE 64
Query: 801 PNHALRHAIQDWL 813
P L+ IQ W+
Sbjct: 65 PVPELKEQIQAWM 77
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 31/211 (14%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE--FQQEVRVLSKLQHPHLVTLLG 532
+G+G FG V K + + A+K++ + + + +EV +L KL HP+++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 533 AC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
++ +V E G L D + ++ S D ARI ++ SG+ ++H I
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE---HDAARIIKQVFSGITYMHK---HNI 142
Query: 591 VHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 647
VH DLKP+NILL+S+ KI DFG+ ++T G+ Y PE
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-------KDRIGTAYYIAPE-- 193
Query: 648 RTGVL----TPKSDSYSFGLIILQLLTGRLP 674
VL K D +S G+I+ LL+G P
Sbjct: 194 ---VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 13/150 (8%)
Query: 472 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 529
++ K+GQG G VY + G+ VAI+ + + E+ V+ + ++P++V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 530 LLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
L + E W +V EYL GSL D + + A + E L FLHS
Sbjct: 82 YLDSYLVGDELW-VVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS-- 134
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGIC 616
+++H D+K NILL + S K+ DFG C
Sbjct: 135 -NQVIHRDIKSDNILLGMDGSVKLTDFGFC 163
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 15/152 (9%)
Query: 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHL 527
F K+G+G +G VYK G+ VAIK + ++ L+ +E+ ++ + PH+
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVESDLQEIIKEISIMQQCDSPHV 86
Query: 528 VTLLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 584
V G+ + W +V EY GS+ D + + L + A I GL +LH
Sbjct: 87 VKYYGSYFKNTDLW-IVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 585 SKPEKIVHGDLKPQNILLDSELSSKICDFGIC 616
+ +H D+K NILL++E +K+ DFG+
Sbjct: 144 ---MRKIHRDIKAGNILLNTEGHAKLADFGVA 172
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 45/216 (20%), Positives = 85/216 (39%), Gaps = 39/216 (18%)
Query: 479 GQGGFGCVYKGE--MLGRTVAIKML--------YSHNMQGQLEFQQEVRVLSKLQHPHLV 528
G G FG V+ + V +K + + E+ +LS+++H +++
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 529 TLLG--ACPEAWSLVYEYLPNGS-LQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHS 584
+L + LV E +G L + R + A I ++ S + +L
Sbjct: 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE----PLASYIFRQLVSAVGYLRL 148
Query: 585 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 644
+ I+H D+K +NI++ + + K+ DFG + L F+ G+ Y P
Sbjct: 149 ---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL----FYTFC---GTIEYCAP 198
Query: 645 EYHRTGVLT------PKSDSYSFGLIILQLLTGRLP 674
E VL P+ + +S G+ + L+ P
Sbjct: 199 E-----VLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 51/208 (24%), Positives = 85/208 (40%), Gaps = 28/208 (13%)
Query: 479 GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLG--A 533
G+G +G V + VA+K++ E ++E+ + L H ++V G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 534 CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPEKIVH 592
L EY G L DR+ + A+ ++ +G+ +LH I H
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHG---IGITH 128
Query: 593 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE------Y 646
D+KP+N+LLD + KI DFG+ + + G+ PY PE +
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMC--GTLPYVAPELLKRREF 184
Query: 647 HRTGVLTPKSDSYSFGLIILQLLTGRLP 674
H D +S G+++ +L G LP
Sbjct: 185 H--A---EPVDVWSCGIVLTAMLAGELP 207
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 45/219 (20%)
Query: 479 GQGGFGCVYKGEML--GRTVAIKML--------YSHNMQGQLEFQQEVRVLSKLQH--PH 526
G GGFG VY G + VAIK + ++ EV +L K+
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP--MEVVLLKKVSSGFSG 109
Query: 527 LVTLLG--ACPEAWSLVYEY-LPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFL 582
++ LL P+++ L+ E P L D + + + + AR ++ +
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE----ELARSFFWQVLEAVRHC 165
Query: 583 HSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 641
H+ ++H D+K +NIL+D K+ DFG L+ DT+Y G+ Y
Sbjct: 166 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDF-------DGTRVY 214
Query: 642 ADPE------YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
+ PE YH G + +S G+++ ++ G +P
Sbjct: 215 SPPEWIRYHRYH--G---RSAAVWSLGILLYDMVCGDIP 248
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 13/150 (8%)
Query: 472 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 529
K+G+G G V GR VA+KM+ Q + EV ++ QH ++V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 530 LLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
+ + E W ++ E+L G+L D + + L + A + + L +LH+
Sbjct: 107 MYKSYLVGEELW-VLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLHA-- 159
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGIC 616
+ ++H D+K +ILL + K+ DFG C
Sbjct: 160 -QGVIHRDIKSDSILLTLDGRVKLSDFGFC 188
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 37/214 (17%)
Query: 478 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM--QGQLEF-QQEVRVLSKLQHPHLVTLLG 532
+G+G F V + R AIK+L ++ + ++ + +E V+S+L HP V L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 533 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 589
+ L Y NG L + RK R AEI S L +LH +
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDE---TCTRFYTAEIVSALEYLHG---KG 150
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF---P-YADPE 645
I+H DLKP+NILL+ ++ +I DFG ++++ ++ A SF Y PE
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--------KQARANSFVGTAQYVSPE 202
Query: 646 YHRTGVLTPK-----SDSYSFGLIILQLLTGRLP 674
+LT K SD ++ G II QL+ G P
Sbjct: 203 -----LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 68/271 (25%), Positives = 108/271 (39%), Gaps = 24/271 (8%)
Query: 416 KQRIRRQKVEAVRWLERWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSES 475
Q R EA + + V+ A F + +
Sbjct: 29 DQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSF 88
Query: 476 FKV------GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHL 527
+ V G G FG V+K E G +A K++ + M+ + E + E+ V+++L H +L
Sbjct: 89 YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANL 148
Query: 528 VTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 585
+ L A LV EY+ G L DR+ +S L D +I G+ +H
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM 206
Query: 586 KPEKIVHGDLKPQNILLDSELSS--KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 643
I+H DLKP+NIL + + KI DFG+ R +F G+ +
Sbjct: 207 ---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-------GTPEFLA 256
Query: 644 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
PE ++ +D +S G+I LL+G P
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 25/207 (12%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA- 533
+G G F V+ + G+ A+K + + E+ VL K++H ++VTL
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 534 -CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
+ LV + + G L DR+ + + KD + + ++ S + +LH IVH
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTE---KDASLVIQQVLSAVKYLHE---NGIVH 129
Query: 593 GDLKPQNILL-----DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 647
DLKP+N+L +S++ I DFG+ ++ + + G+ Y PE
Sbjct: 130 RDLKPENLLYLTPEENSKI--MITDFGLSKMEQNGIM--------STACGTPGYVAPEVL 179
Query: 648 RTGVLTPKSDSYSFGLIILQLLTGRLP 674
+ D +S G+I LL G P
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 43/219 (19%)
Query: 479 GQGGFGCVYKGEML--GRTVAIKML------YSHNMQGQLEFQQEVRVLSKL----QHPH 526
G+GGFG V+ G L VAIK++ + + EV +L K+ HP
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG 99
Query: 527 LVTLLG--ACPEAWSLVYEY-LPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFL 582
++ LL E + LV E LP L D + K + +R ++ + +
Sbjct: 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGE----GPSRCFFGQVVAAIQHC 155
Query: 583 HSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 641
HS +VH D+K +NIL+D +K+ DFG L D Y G+ Y
Sbjct: 156 HSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGAL-LHDEPYTDF-------DGTRVY 204
Query: 642 ADPE------YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
+ PE YH + +S G+++ ++ G +P
Sbjct: 205 SPPEWISRHQYH--A---LPATVWSLGILLYDMVCGDIP 238
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 40/145 (27%), Positives = 73/145 (50%), Gaps = 11/145 (7%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
++G G FG VYK + G A K++ + + + ++ E+ +L+ HP++V LLGA
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 535 ---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591
+ W ++ E+ P G++ + L + ++ L FLHS ++I+
Sbjct: 86 YHDGKLW-IMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHS---KRII 139
Query: 592 HGDLKPQNILLDSELSSKICDFGIC 616
H DLK N+L+ E ++ DFG+
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 51/159 (32%), Positives = 77/159 (48%), Gaps = 22/159 (13%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKL-QHPHLVTLL 531
VG G +G VYKG + G+ AIK++ ++ G E +QE+ +L K H ++ T
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATYY 87
Query: 532 GA---------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 582
GA + W LV E+ GS+ D L + + + L + A I EI GL L
Sbjct: 88 GAFIKKNPPGMDDQLW-LVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 583 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621
H K++H D+K QN+LL K+ DFG+ +
Sbjct: 146 HQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 51/208 (24%), Positives = 85/208 (40%), Gaps = 28/208 (13%)
Query: 479 GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLG--A 533
G+G +G V + VA+K++ E ++E+ + L H ++V G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 534 CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPEKIVH 592
L EY G L DR+ + A+ ++ +G+ +LH I H
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHG---IGITH 128
Query: 593 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE------Y 646
D+KP+N+LLD + KI DFG+ + + G+ PY PE +
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMC--GTLPYVAPELLKRREF 184
Query: 647 HRTGVLTPKSDSYSFGLIILQLLTGRLP 674
H D +S G+++ +L G LP
Sbjct: 185 H--A---EPVDVWSCGIVLTAMLAGELP 207
|
| >1wgm_A Ubiquitin conjugation factor E4A; ubiquitinating enzyme, KIAA0126, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.44.1.2 Length = 98 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-23
Identities = 24/85 (28%), Positives = 33/85 (38%), Gaps = 2/85 (2%)
Query: 730 SLVKELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADG-FTYEGKAIRDWLENGRETSP 788
S L+Q FL PI+ +M DP V T + I L + +T P
Sbjct: 3 SGSSGLQQQEEETYADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLSD-QTDP 61
Query: 789 MTNLRLSHLHLTPNHALRHAIQDWL 813
L+ + PN L+ IQ WL
Sbjct: 62 FNRSPLTMDQIRPNTELKEKIQRWL 86
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 27/205 (13%), Positives = 49/205 (23%), Gaps = 48/205 (23%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
G ++ L R VA+ + E LS++ P + +L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 532 --GACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
+V E++ GSLQ+ + R +A+ H
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHR---AG 149
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
+ P + + + +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPAT-----------------MPD-------------- 178
Query: 650 GVLTPKSDSYSFGLIILQLLTGRLP 674
P+ D G + LL R P
Sbjct: 179 --ANPQDDIRGIGASLYALLVNRWP 201
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 31/224 (13%)
Query: 469 TCNFSESFKV----GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQL------EFQQEV 516
+ + + G G F V K G A K + + E ++EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 517 RVLSKLQHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE 574
+L ++ H +++TL L+ E + G L D L +K ++S ++ +
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIKQ 123
Query: 575 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLVTEDTLYLPSFH 630
I G+ +LH+ K I H DLKP+NI+L + K+ DFG+ + + + F
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF- 179
Query: 631 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
G+ + PE L ++D +S G+I LL+G P
Sbjct: 180 ------GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 53/237 (22%), Positives = 93/237 (39%), Gaps = 34/237 (14%)
Query: 459 EFSLADLQTATCNFSESFKV----GQGGFGCVYKGE--MLGRTVAIKML--------YSH 504
+ ++ D + + + G G G V + VAI+++ +
Sbjct: 120 DLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAR 179
Query: 505 NMQGQLEFQQEVRVLSKLQHPHLVTLLGAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPL 563
L + E+ +L KL HP ++ + E + +V E + G L D++ +
Sbjct: 180 EADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKE- 238
Query: 564 LWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS---ELSSKICDFGICRLVT 620
++ + +LH I+H DLKP+N+LL S + KI DFG +++
Sbjct: 239 --ATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293
Query: 621 EDTLYLPSFHRSTAPKGSFPYADPE---YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
E +L T G+ Y PE T D +S G+I+ L+G P
Sbjct: 294 ETSLM------RTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 42/219 (19%), Positives = 72/219 (32%), Gaps = 35/219 (15%)
Query: 477 KVGQG--GFGCVYKGEML--GRTVAIKM--LYSHNMQGQLEFQQEVRVLSKLQHPHLVTL 530
+G+G V G V ++ L + + + Q E+ V HP++V
Sbjct: 32 VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 531 LGA---CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLCFLHS 584
E W +V ++ GS +D L + + + IA + L ++H
Sbjct: 92 RATFIADNELW-VVTSFMAYGSAKD-LICTHFMDGM---NELAIAYILQGVLKALDYIHH 146
Query: 585 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--A 642
VH +K +IL+ + + + H +
Sbjct: 147 ---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 643 DPEYHRTGVLT-------PKSDSYSFGLIILQLLTGRLP 674
PE VL KSD YS G+ +L G +P
Sbjct: 204 -PE-----VLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 31/219 (14%)
Query: 471 NFSESFKV----GQGGFGCVYKGE--MLGRTVAIK------MLYSHNMQGQLEFQQEVRV 518
+ +++ G G F V K G+ A K + S + E ++EV +
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 519 LSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIA 576
L +++HP+++TL L+ E + G L D L K +++ + + +I
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE---DEATQFLKQIL 118
Query: 577 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLVTEDTLYLPSFHRS 632
G+ +LHS + I H DLKP+NI+L + K+ DFGI + + F
Sbjct: 119 DGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--- 172
Query: 633 TAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTG 671
G+ + PE L ++D +S G+I LL+G
Sbjct: 173 ----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 31/224 (13%)
Query: 469 TCNFSESFKV----GQGGFGCVYKGEML--GRTVAIK------MLYSHNMQGQLEFQQEV 516
N + + G G F V K G A K S + + ++EV
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 517 RVLSKLQHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE 574
+L ++QHP+++TL L+ E + G L D L K +++ ++ +
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQ 122
Query: 575 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLVTEDTLYLPSFH 630
I +G+ +LHS + I H DLKP+NI+L KI DFG+ + + F
Sbjct: 123 ILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF- 178
Query: 631 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
G+ + PE L ++D +S G+I LL+G P
Sbjct: 179 ------GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 4e-23
Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 469 TCNFSESFKV----GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQ--LEFQQEVRVLS 520
+ FS+++ V G+G F V + G A K++ + + + + ++E R+
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 521 KLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASG 578
KLQHP++V L + LV++ + G L + + + S D + +I
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE---ADASHCIQQILES 117
Query: 579 LCFLHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAP 635
+ + HS+ IVH +LKP+N+LL S+ K+ DFG+ V + A
Sbjct: 118 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-----EAWHGFA- 168
Query: 636 KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
G+ Y PE + + D ++ G+I+ LL G P
Sbjct: 169 -GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 59/233 (25%), Positives = 98/233 (42%), Gaps = 41/233 (17%)
Query: 468 ATCNFSESFKV----GQGGFGCVYKGE--MLGRTVAIKML---------YSHNMQGQLEF 512
+T F E+++ G+G V + + A+K++ + +
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 513 QQEVRVLSKL-QHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRA 569
+EV +L K+ HP+++ L + LV++ + G L D L K +S K+
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE---KETR 127
Query: 570 RIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL--- 626
+I + +C LH IVH DLKP+NILLD +++ K+ DFG +
Sbjct: 128 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 184
Query: 627 --PSFHRSTAP---KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
PS+ AP + S P Y + D +S G+I+ LL G P
Sbjct: 185 GTPSY---LAPEIIECSMNDNHPGY------GKEVDMWSTGVIMYTLLAGSPP 228
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 31/224 (13%)
Query: 469 TCNFSESFKV----GQGGFGCVYKGE--MLGRTVAIKML------YSHNMQGQLEFQQEV 516
+ + + G G F V K G A K + S + E ++EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 517 RVLSKLQHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE 574
+L ++ HP+++TL L+ E + G L D L +K ++S ++ +
Sbjct: 67 SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIKQ 123
Query: 575 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLVTEDTLYLPSFH 630
I G+ +LH+ K I H DLKP+NI+L + K+ DFG+ + + + F
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF- 179
Query: 631 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
G+ + PE L ++D +S G+I LL+G P
Sbjct: 180 ------GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 6e-23
Identities = 46/204 (22%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
+G+G FG V++ +T K + ++E+ +L+ +H +++ L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHLHESF 70
Query: 535 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
E +++E++ + +R+ + L ++ ++ L FLHS I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLHSHN---IGH 125
Query: 593 GDLKPQNILLDSELSS--KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 650
D++P+NI+ + SS KI +FG R + + F + Y PE H+
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-------TAPEYYAPEVHQHD 178
Query: 651 VLTPKSDSYSFGLIILQLLTGRLP 674
V++ +D +S G ++ LL+G P
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINP 202
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-23
Identities = 53/238 (22%), Positives = 89/238 (37%), Gaps = 62/238 (26%)
Query: 479 GQGGFGCVYKG--EMLGRTVAIKML----------------------------YSHNMQG 508
G+G +G V E A+K+L
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 509 QLEFQQEVRVLSKLQHPHLVTLLGACPEAWS--------LVYEYLPNGSLQDRLFRKSNV 560
Q+ QE+ +L KL HP++V L+ E +V+E + G + + K
Sbjct: 82 QVY--QEIAILKKLDHPNVVKLV----EVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-- 133
Query: 561 SPLLWKDRAR-IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 619
L +D+AR ++ G+ +LH +KI+H D+KP N+L+ + KI DFG+
Sbjct: 134 ---LSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 620 TEDTLYLPSFHRSTAPKGSFPYADPE---YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
L S G+ + PE R D ++ G+ + + G+ P
Sbjct: 188 KGSDALL-----SNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 49/228 (21%), Positives = 94/228 (41%), Gaps = 26/228 (11%)
Query: 464 DLQTATCNFSESFKV----GQGGFGCVYKGEML--GRTVAIKM-----LYSHNMQGQLEF 512
D+ F + +++ G+G F V + G+ A+K+ S +
Sbjct: 14 DMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDL 73
Query: 513 QQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLW-KDRA 569
++E + L+HPH+V LL +V+E++ L + ++++ + +
Sbjct: 74 KREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 133
Query: 570 RIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYL 626
+I L + H + I+H D+KP +LL S+ +S K+ FG+ + E L
Sbjct: 134 HYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA 190
Query: 627 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
G+ + PE + D + G+I+ LL+G LP
Sbjct: 191 ------GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 30/215 (13%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKML--------YSHNMQGQLEFQQEVRVLSKLQHPH 526
+G G G V + VAIK++ + L + E+ +L KL HP
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 527 LVTLLGAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 585
++ + E + +V E + G L D++ + ++ + +LH +
Sbjct: 77 IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKE---ATCKLYFYQMLLAVQYLHEN 133
Query: 586 KPEKIVHGDLKPQNILLDS---ELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 642
I+H DLKP+N+LL S + KI DFG +++ E S R+ G+ Y
Sbjct: 134 G---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-----SLMRTLC--GTPTYL 183
Query: 643 DPE---YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
PE T D +S G+I+ L+G P
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-22
Identities = 51/213 (23%), Positives = 95/213 (44%), Gaps = 35/213 (16%)
Query: 478 VGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEF-QQEVRVLSKLQHPHLVTLLG 532
+G+G FG V + + A+K + + ++ +E++++ L+HP LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 533 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 589
+ E +V + L G L+ L + + ++ ++ E+ L +L + ++
Sbjct: 83 SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK----EETVKLFICELVMALDYLQN---QR 135
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
I+H D+KP NILLD I DF I ++ +T + + G+ PY PE
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-ITTM------AGTKPYMAPE---- 184
Query: 650 GVLTPKS--------DSYSFGLIILQLLTGRLP 674
+ + + D +S G+ +LL GR P
Sbjct: 185 -MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-22
Identities = 54/229 (23%), Positives = 98/229 (42%), Gaps = 36/229 (15%)
Query: 465 LQTATC-NFSESFKV----GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE--FQQE 515
+ T TC F+E +++ G+G F V + + G+ A ++ + + + ++E
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 516 VRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA 573
R+ L+HP++V L + L+++ + G L + + + S D +
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE---ADASHCIQ 117
Query: 574 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFH 630
+I + H +VH +LKP+N+LL S+L K+ DFG+ V + F
Sbjct: 118 QILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF- 173
Query: 631 RSTAPKGSFPYADPEYHRTGVL-----TPKSDSYSFGLIILQLLTGRLP 674
G+ Y PE VL D ++ G+I+ LL G P
Sbjct: 174 -----AGTPGYLSPE-----VLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 54/230 (23%), Positives = 99/230 (43%), Gaps = 35/230 (15%)
Query: 469 TCNFSESFKV-----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSK 521
+ F + +++ G+G V L + A+K++ + +EV +L +
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 522 LQ-HPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASG 578
Q H +++ L+ + + LV+E + GS+ + ++ + + + + + ++AS
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNE---LEASVVVQDVASA 123
Query: 579 LCFLHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRS-TA 634
L FLH+ I H DLKP+NIL + KICDF + + + P
Sbjct: 124 LDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 635 PKGSFPYADPEYHRTGVL----------TPKSDSYSFGLIILQLLTGRLP 674
P GS Y PE V+ + D +S G+I+ LL+G P
Sbjct: 181 PCGSAEYMAPE-----VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIK-MLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLG 532
++G+G +G V K + G+ +A+K + + + + Q + ++ V+ + P++V G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 533 AC---PEAWSLVYEYLPNGSLQD--RLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 587
A + W + E + + S + + + +I L L +
Sbjct: 89 ALFREGDCW-ICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL- 145
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGIC-RLVTEDTLYLPSFHRSTAPKGSFPYADPE- 645
KI+H D+KP NILLD + K+CDFGI +LV D++ A G PY PE
Sbjct: 146 -KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSI----AKTRDA--GCRPYMAPER 196
Query: 646 ---YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
+SD +S G+ + +L TGR P
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 32/231 (13%)
Query: 457 SAEFSLADLQTATCNFSESFKVGQGGFGCVYKG--EMLGRTVAIK-MLYSHNMQGQLEFQ 513
S E DL+ ++G+G +G V K G+ +A+K + + N Q Q
Sbjct: 1 SMEVKADDLEPIM-------ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLL 53
Query: 514 QEVRV-LSKLQHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDR-- 568
++ + + + P VT GA + E + + SL D+ +++ +
Sbjct: 54 MDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSL-DKFYKQVIDKGQTIPEDIL 111
Query: 569 ARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC-RLVTEDTLYLP 627
+IA I L LHS ++H D+KP N+L+++ K+CDFGI LV D +
Sbjct: 112 GKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKD 167
Query: 628 SFHRSTAPKGSFPYADPE----YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
G PY PE + KSD +S G+ +++L R P
Sbjct: 168 ID------AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 4e-22
Identities = 49/151 (32%), Positives = 69/151 (45%), Gaps = 21/151 (13%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ------LEFQQEVRVLSKLQHPHLV 528
++G G FG VY + VAIK + + G+ + +EVR L KL+HP+ +
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKM---SYSGKQSNEKWQDIIKEVRFLQKLRHPNTI 117
Query: 529 TLLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 585
G AW LV EY GS D L + + PL + A + GL +LHS
Sbjct: 118 QYRGCYLREHTAW-LVMEYCL-GSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHS- 172
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGIC 616
++H D+K NILL K+ DFG
Sbjct: 173 --HNMIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-22
Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 35/210 (16%)
Query: 479 GQGGFGCVYKGE--MLGRTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVTL--LGA 533
G G FG + VA+K + + + Q+E+ L+HP++V +
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV--QREIINHRSLRHPNIVRFKEVIL 86
Query: 534 CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPEKIVH 592
P +++ EY G L +R+ S D AR ++ SG+ + HS +I H
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSE----DEARFFFQQLLSGVSYCHS---MQICH 139
Query: 593 GDLKPQNILLDSELSS--KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 650
DLK +N LLD + KICDFG + S +ST G+ Y PE
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQPKSTV--GTPAYIAPE----- 187
Query: 651 VLT------PKSDSYSFGLIILQLLTGRLP 674
VL +D +S G+ + +L G P
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 5e-22
Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 26/223 (11%)
Query: 465 LQTATCNFSESFKV----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE--FQQEV 516
+ A+ FS+++ V G+G F V + G A K++ + + + ++E
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 517 RVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE 574
R+ KLQHP++V L + LV++ + G L + + + S D + +
Sbjct: 80 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE---ADASHCIQQ 136
Query: 575 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHR 631
I + + HS+ IVH +LKP+N+LL S+ K+ DFG+ V + +
Sbjct: 137 ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW-----H 188
Query: 632 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
A G+ Y PE + + D ++ G+I+ LL G P
Sbjct: 189 GFA--GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 6e-22
Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 36/219 (16%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKML--------YSHNMQGQLEFQQEVRVLSKL-QHP 525
+G+G V + G A+K++ + + ++E +L ++ HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 526 HLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 583
H++TL+ + LV++ + G L D L K +S K+ I + + FLH
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE---KETRSIMRSLLEAVSFLH 217
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL-----PSFHRSTAP--- 635
+ IVH DLKP+NILLD + ++ DFG + P + AP
Sbjct: 218 A---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGY---LAPEIL 271
Query: 636 KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
K S P Y + D ++ G+I+ LL G P
Sbjct: 272 KCSMDETHPGY------GKEVDLWACGVILFTLLAGSPP 304
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-22
Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGA 533
+G+G F K + A+K++ Q+E+ L + HP++V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA---NTQKEITALKLCEGHPNIVKLHEV 74
Query: 534 C--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591
LV E L G L +R+ +K + S + + I ++ S + +H +V
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSE---TEASYIMRKLVSAVSHMHD---VGVV 128
Query: 592 HGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 648
H DLKP+N+L E + KI DFG RL D L P + YA PE
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL------KTPCFTLHYAAPE--- 179
Query: 649 TGVLT-----PKSDSYSFGLIILQLLTGRLP 674
+L D +S G+I+ +L+G++P
Sbjct: 180 --LLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 8e-22
Identities = 58/253 (22%), Positives = 92/253 (36%), Gaps = 65/253 (25%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKM-----LYSHNMQGQLEFQQEVRVLSKLQHPHLVT 529
+GQG +G V AIK+ + N + + EVR++ KL HP++
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 530 LLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLW---------------------- 565
L + LV E G L D+L + S
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 566 ---------------KDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS-- 608
K + I +I S L +LH+ + I H D+KP+N L + S
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEI 209
Query: 609 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSY-------SF 661
K+ DFG+ + + + A G+ + PE VL ++SY S
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKA--GTPYFVAPE-----VLNTTNESYGPKCDAWSA 262
Query: 662 GLIILQLLTGRLP 674
G+++ LL G +P
Sbjct: 263 GVLLHLLLMGAVP 275
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 47/215 (21%), Positives = 87/215 (40%), Gaps = 35/215 (16%)
Query: 479 GQGGFGCVYKGEML--GRTVAIKML------YSHNMQGQLEFQQEVRVLSKLQHPHLVTL 530
G+G +G V + A+K+L N + ++ +E+++L +L+H +++ L
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK--KEIQLLRRLRHKNVIQL 71
Query: 531 ----LGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
+ +V EY G + + ++ GL +LHS
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS-- 127
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE- 645
+ IVH D+KP N+LL + + KI G+ + + T+ +GS + PE
Sbjct: 128 -QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP---FAADDTCRTS-QGSPAFQPPEI 182
Query: 646 ------YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
+ G K D +S G+ + + TG P
Sbjct: 183 ANGLDTFS--G---FKVDIWSAGVTLYNITTGLYP 212
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 8e-22
Identities = 40/175 (22%), Positives = 70/175 (40%), Gaps = 11/175 (6%)
Query: 505 NMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSP 562
+ ++R + + V L L + +L+D + R+ ++
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 563 LLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622
I +IA + FLHS + ++H DLKP NI + K+ DFG+ + +D
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 623 T------LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTG 671
+P++ T G+ Y PE + K D +S GLI+ +LL
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 51/212 (24%), Positives = 87/212 (41%), Gaps = 29/212 (13%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIK-MLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLG 532
++G G G V+K G +A+K M S N + ++ V+ K P++V G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 533 AC---PEAWSLVYEYLPNGSLQDRLFRKSNVS-PLLWKDRARIAAEIASGLCFLHSSKPE 588
+ + + E + + + + + + +L ++ I L +L
Sbjct: 92 TFITNTDVF-IAMELMGTCAEKLKKRMQGPIPERIL----GKMTVAIVKALYYLKEKH-- 144
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGIC-RLVTEDTLYLPSFHRSTAPKGSFPYADPE-- 645
++H D+KP NILLD K+CDFGI RLV D G Y PE
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRS------AGCAAYMAPERI 196
Query: 646 ---YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
++D +S G+ +++L TG+ P
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 30/233 (12%)
Query: 455 PESAEFSLADLQTATCNFSESFKV----GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQG 508
S + S+ F+V G+G VY+ + + A+K+L +
Sbjct: 34 TASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK 93
Query: 509 QLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWK 566
+ E+ VL +L HP+++ L P SLV E + G L DR+ K S +
Sbjct: 94 IVR--TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSE---R 148
Query: 567 DRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL-----DSELSSKICDFGICRLVTE 621
D A +I + +LH + IVH DLKP+N+L D+ L KI DFG+ ++V
Sbjct: 149 DAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPL--KIADFGLSKIVEH 203
Query: 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
L G+ Y PE R P+ D +S G+I LL G P
Sbjct: 204 QVLM-------KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 4e-21
Identities = 57/241 (23%), Positives = 95/241 (39%), Gaps = 44/241 (18%)
Query: 456 ESAEFSLADLQTATCNFSESFKV-----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQG 508
E + ++ +++ G G G V + G+ A+K+LY
Sbjct: 10 SGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-- 67
Query: 509 QLEFQQEVRVLSKLQ-HPHLVTLLGACPEAWS------LVYEYLPNGSLQDRLFRKSNVS 561
+QEV + PH+V +L ++ E + G L R+ + +
Sbjct: 68 ---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD-Q 123
Query: 562 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRL 618
++ A I +I + + FLHS I H D+KP+N+L S+ K+ DFG +
Sbjct: 124 AFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180
Query: 619 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRL 673
T++ L P + Y PE VL P+ D +S G+I+ LL G
Sbjct: 181 TTQNAL--------QTPCYTPYYVAPE-----VLGPEKYDKSCDMWSLGVIMYILLCGFP 227
Query: 674 P 674
P
Sbjct: 228 P 228
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 5e-21
Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 24/210 (11%)
Query: 478 VGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLE-FQQEVRVLSKLQHPHLVTLLG 532
+G+G FG V ++ + A+K+L M + + F++E VL + TL
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 533 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 589
A LV +Y G L L S L ++ AR AE+ + +H
Sbjct: 142 AFQDDNNLYLVMDYYVGGDL---LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LH 195
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---- 645
VH D+KP NIL+D ++ DFG C + ED +S+ G+ Y PE
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-----QSSVAVGTPDYISPEILQA 250
Query: 646 -YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
G P+ D +S G+ + ++L G P
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-21
Identities = 52/228 (22%), Positives = 100/228 (43%), Gaps = 39/228 (17%)
Query: 465 LQTATCNFSESFKV----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRV 518
L + F++ ++V G G + + A+K++ + + + +E+ +
Sbjct: 13 LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID----KSKRDPTEEIEI 68
Query: 519 LSKL-QHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEI 575
L + QHP+++TL + +V E + G L D++ R+ S ++ + + I
Sbjct: 69 LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE---REASAVLFTI 125
Query: 576 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLVTEDTLYLPSFHR 631
+ +LH+ + +VH DLKP NIL E + +ICDFG + + + L
Sbjct: 126 TKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL----- 177
Query: 632 STAPKGSFPYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 674
P + + PE VL + D +S G+++ +LTG P
Sbjct: 178 -MTPCYTANFVAPE-----VLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 57/219 (26%), Positives = 84/219 (38%), Gaps = 26/219 (11%)
Query: 471 NFSESFKV-----GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQL--EFQQEVRVLSK 521
NF+ + + G+G F V + G+ A K L E E+ VL
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84
Query: 522 LQH-PHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASG 578
+ P ++ L L+ EY G + + + D R+ +I G
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEM-VSENDVIRLIKQILEG 143
Query: 579 LCFLHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAP 635
+ +LH + IVH DLKPQNILL S KI DFG+ R +
Sbjct: 144 VYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM------ 194
Query: 636 KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
G+ Y PE +T +D ++ G+I LLT P
Sbjct: 195 -GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-20
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 42/220 (19%)
Query: 476 FKV-GQGGFGCVYKGEM--LGRTVAIKML----------YSHNMQGQLEFQQEVRVLSKL 522
F+V G+GGFG V+ +M G+ A K L Y M E ++L+K+
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV-------EKKILAKV 242
Query: 523 QHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGL 579
+V+L A LV + G ++ ++ +P + RA A+I SGL
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 639
LH I++ DLKP+N+LLD + + +I D G+ + + G+
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY------AGTP 353
Query: 640 PYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 674
+ PE +L + D ++ G+ + +++ R P
Sbjct: 354 GFMAPE-----LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 57/212 (26%), Positives = 87/212 (41%), Gaps = 26/212 (12%)
Query: 478 VGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLE-FQQEVRVLSKLQHPHLVTLLG 532
+G+G F V +M G+ A+K++ +M +G++ F++E VL + L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 533 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 589
A LV EY G L L S + + AR AEI + +H
Sbjct: 129 AFQDENYLYLVMEYYVGGDL---LTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---LG 182
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
VH D+KP NILLD ++ DFG C + D RS G+ Y PE +
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-----RSLVAVGTPDYLSPEILQA 237
Query: 650 GVLTPKSDSY-------SFGLIILQLLTGRLP 674
P + SY + G+ ++ G+ P
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-19
Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 40/215 (18%)
Query: 478 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 532
+G+G FG V K + GR A+K+L + + E E RVL +HP L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 533 A--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHS 584
+ + V EY G L ++R+F + DRAR AEI S L +LHS
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRERVFSE---------DRARFYGAEIVSALDYLHS 266
Query: 585 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 644
K +V+ DLK +N++LD + KI DFG+C+ +D + +F G+ P
Sbjct: 267 EK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF------CGT-----P 313
Query: 645 EYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 674
EY VL D + G+++ +++ GRLP
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 2e-19
Identities = 52/156 (33%), Positives = 78/156 (50%), Gaps = 19/156 (12%)
Query: 478 VGQGGFGCVY----KGEMLGRTVAIKMLYSHNM--QGQLE-FQQEVRVLSKLQHPHLVTL 530
+G G FG V+ + GR A+K+L + Q+E E +LS + HP ++ +
Sbjct: 14 LGTGSFGRVHLIRSRHN--GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 531 LGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKP 587
G +A + + +Y+ G L L RKS P A+ AAE+ L +LHS
Sbjct: 72 WGTFQDAQQIFMIMDYIEGGELFSLL-RKSQRFP---NPVAKFYAAEVCLALEYLHS--- 124
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623
+ I++ DLKP+NILLD KI DFG + V + T
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 2e-19
Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 30/210 (14%)
Query: 478 VGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLG 532
+G+GGFG V ++ G+ A K L + +G+ E ++L K+ +V+L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 533 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 589
A +A LV + G L+ ++ + RA AAEI GL LH E+
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHR---ER 306
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
IV+ DLKP+NILLD +I D G+ V E G+ Y PE
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-------TIKGRVGTVGYMAPE---- 355
Query: 650 GVLTPKS-----DSYSFGLIILQLLTGRLP 674
V+ + D ++ G ++ +++ G+ P
Sbjct: 356 -VVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 5e-19
Identities = 58/232 (25%), Positives = 93/232 (40%), Gaps = 43/232 (18%)
Query: 465 LQTATCNFSESFKV-----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVR 517
LQ + +KV G G G V + A+KML Q + ++EV
Sbjct: 52 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVE 106
Query: 518 VLSKLQ-HPHLVTLLGACPEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR 570
+ + PH+V ++ ++ +V E L G L R+ + + ++ +
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASE 165
Query: 571 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLP 627
I I + +LHS I H D+KP+N+L S+ + K+ DFG + T
Sbjct: 166 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 220
Query: 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 674
T P + Y PE VL P+ D +S G+I+ LL G P
Sbjct: 221 -----TTPCYTPYYVAPE-----VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 48/217 (22%)
Query: 478 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM--QGQLE-FQQEVRVLSKLQHPHLVTLLG 532
+G G FG V K + G A+K+L + Q+E E R+L + P LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 533 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 589
+ + +L V EY+ G + L R S AR AA+I +LHS
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE----PHARFYAAQIVLTFEYLHS---LD 161
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL-------YLPSFHRSTAP-----KG 637
+++ DLKP+N+L+D + ++ DFG + V T L AP KG
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEAL-------APEIILSKG 214
Query: 638 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
+ V D ++ G++I ++ G P
Sbjct: 215 ---------YNKAV-----DWWALGVLIYEMAAGYPP 237
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 8e-19
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 49/220 (22%)
Query: 478 VGQGGFGCVY-----KGEMLGRTVAIKML-----YSHNMQGQLEFQQEVRVLSKLQHPHL 527
+GQG FG V+ G + A+K+L + ++ + E +L ++ HP +
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD---RVRTKMERDILVEVNHPFI 88
Query: 528 VTLLGA--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGL 579
V L A L+ ++L G L ++ +F + + + AE+A L
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE---------EDVKFYLAELALAL 139
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 639
LHS I++ DLKP+NILLD E K+ DFG+ + + SF G+
Sbjct: 140 DHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF------CGTV 190
Query: 640 PYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 674
Y PE V+ + D +SFG+++ ++LTG LP
Sbjct: 191 EYMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >2c2l_A CHIP, carboxy terminus of HSP70-interacting protein; chaperone, E3 ligase, ubiquitinylation, TPR, heat-shock protein complex; 3.3A {Mus musculus} SCOP: a.118.8.1 g.44.1.2 Length = 281 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 20/72 (27%), Positives = 37/72 (51%)
Query: 742 EERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTP 801
++R +P + I E+M +P + G TY+ K I + L+ +P+T L+ L P
Sbjct: 201 KKRDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIP 260
Query: 802 NHALRHAIQDWL 813
N A++ I ++
Sbjct: 261 NLAMKEVIDAFI 272
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 26/154 (16%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ---------EVRVLSKLQHP 525
VG+G +G V K GR VAIK E+++L +L+H
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKF-------LESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 526 HLVTLLGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 583
+LV LL C + W LV+E++ + ++ D L + + L ++ + +I +G+ F H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
S I+H D+KP+NIL+ K+CDFG R
Sbjct: 142 SHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 172
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 25/209 (11%)
Query: 478 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM--QGQLE-FQQEVRVLSKLQHPHLVTLLG 532
+G+G FG V + + + A+K+L M + F +E +++ P +V L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 533 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 589
A +V EY+P G L L +V AR AE+ L +HS
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPE----KWARFYTAEVVLALDAIHSMG--- 188
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---- 645
+H D+KP N+LLD K+ DFG C + ++ + R G+ Y PE
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-----RCDTAVGTPDYISPEVLKS 243
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
G + D +S G+ + ++L G P
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 55/222 (24%)
Query: 478 VGQGGFGCVYKGEM--LGRTVAIKML----------YSHNMQGQLEFQQEVRVLSKLQHP 525
+G+G FG V GR A+K+L +H + E RVL +HP
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-------ESRVLQNTRHP 65
Query: 526 HLVTLLGA--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIAS 577
L L A + V EY G L ++R+F + +RAR AEI S
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE---------ERARFYGAEIVS 116
Query: 578 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG 637
L +LHS +V+ D+K +N++LD + KI DFG+C+ D + +F G
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC------G 167
Query: 638 SFPYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 674
+ PEY VL D + G+++ +++ GRLP
Sbjct: 168 T-----PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 42/154 (27%), Positives = 64/154 (41%), Gaps = 26/154 (16%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ---------EVRVLSKLQHP 525
K+G+G +G V+K G+ VAIK E+R+L +L+HP
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKF-------LESEDDPVIKKIALREIRMLKQLKHP 62
Query: 526 HLVTLLGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 583
+LV LL LV+EY + ++ L + I + + F H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
+H D+KP+NIL+ K+CDFG R
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFAR 150
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 45/219 (20%)
Query: 478 VGQGGFGCVYKGEML-----GRTVAIKMLY-SHNMQGQLEFQQ---EVRVLSKLQHPHLV 528
+G+GG+G V++ + G+ A+K+L + ++ + E +L +++HP +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 529 TLLGA--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGLC 580
L+ A L+ EYL G L ++ +F + D A AEI+ L
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFME---------DTACFYLAEISMALG 135
Query: 581 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP 640
LH + I++ DLKP+NI+L+ + K+ DFG+C+ D +F G+
Sbjct: 136 HLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF------CGTIE 186
Query: 641 YADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 674
Y PE +L D +S G ++ +LTG P
Sbjct: 187 YMAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3m62_A Ubiquitin conjugation factor E4; armadillo-like repeats, UBL conjugation pathway, DNA damage, nucleus, phosphoprotein; HET: 1PE; 2.40A {Saccharomyces cerevisiae} PDB: 3m63_A* 2qiz_A 2qj0_A Length = 968 | Back alignment and structure |
|---|
Score = 89.8 bits (222), Expect = 2e-18
Identities = 22/82 (26%), Positives = 35/82 (42%), Gaps = 2/82 (2%)
Query: 733 KELEQLHVAEERPVPSFFLCPILQEIMHDPQV-AADGFTYEGKAIRDWLENGRETSPMTN 791
++ ++ E VP FL P++ IM DP + A + I+ L + T P
Sbjct: 875 RKADEEEDLEYGDVPDEFLDPLMYTIMKDPVILPASKMNIDRSTIKAHLLSDS-TDPFNR 933
Query: 792 LRLSHLHLTPNHALRHAIQDWL 813
+ L +TPN LR I +
Sbjct: 934 MPLKLEDVTPNEELRQKILCFK 955
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-18
Identities = 59/219 (26%), Positives = 90/219 (41%), Gaps = 38/219 (17%)
Query: 474 ESFKV-GQGGFGCVYKGEML--GRTVAIKMLYSH---NMQGQLEFQQEVRVLSKL---QH 524
++ G+GGFG VY G+ A+K L QG+ E +LS +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 525 PHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCF 581
P +V + A P+ S + + + G L L + S + R AAEI GL
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EADMRFYAAEIILGLEH 307
Query: 582 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 641
+H+ +V+ DLKP NILLD +I D G+ ++ + + G+ Y
Sbjct: 308 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--AS------VGTHGY 356
Query: 642 ADPEYHRTGVLTPKS------DSYSFGLIILQLLTGRLP 674
PE VL D +S G ++ +LL G P
Sbjct: 357 MAPE-----VLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 7e-18
Identities = 46/156 (29%), Positives = 77/156 (49%), Gaps = 29/156 (18%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ---------EVRVLSKLQHP 525
K+G+G +G VYK G VA+K + +L+ + E+ +L +L HP
Sbjct: 10 KIGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHP 62
Query: 526 HLVTLLGACPEAWS--LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRARIAAEIASGLCF 581
++V LL LV+E+L QD + S ++ + ++ GL F
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 582 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
HS + ++H DLKPQN+L+++E + K+ DFG+ R
Sbjct: 119 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 24/155 (15%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ--------EVRVLSKLQHPH 526
K+G G + VYKG G VA+K + +L+ ++ E+ ++ +L+H +
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEV-------KLDSEEGTPSTAIREISLMKELKHEN 64
Query: 527 LVTLLGACPEAWS--LVYEYLPN--GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 582
+V L LV+E++ N D + L ++ GL F
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 583 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
H +K I+H DLKPQN+L++ K+ DFG+ R
Sbjct: 125 HENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 4e-17
Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 27/154 (17%)
Query: 477 KVGQGGFGCVYKG-EMLGRTVAIKMLYSHNMQGQLEFQQ---------EVRVLSKLQHPH 526
K+G+G +G VYK G T A+K + +LE + E+ +L +L+H +
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKI-------RLEKEDEGIPSTTIREISILKELKHSN 61
Query: 527 LVTLLGACPEAWS--LVYEYLPNGSLQD-RLFRKSNVSPLLWKDRARIAAEIASGLCFLH 583
+V L LV+E+L QD + L ++ +G+ + H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
+ ++H DLKPQN+L++ E KI DFG+ R
Sbjct: 118 DRR---VLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 37/149 (24%), Positives = 63/149 (42%), Gaps = 21/149 (14%)
Query: 479 GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACP 535
G G G V + A+KML ++EV + + Q PH+V ++
Sbjct: 27 GLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDVYE 81
Query: 536 EAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
++ +V E L G L R+ + + ++ + I I + +LHS
Sbjct: 82 NLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHS---IN 137
Query: 590 IVHGDLKPQNILLDSELSS---KICDFGI 615
I H D+KP+N+L S+ + K+ DFG
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 23/154 (14%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ--------EVRVLSKLQHPH 526
+G+G F VYK + VAIK + + + E + E+++L +L HP+
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKI---KLGHRSEAKDGINRTALREIKLLQELSHPN 73
Query: 527 LVTLLGACPEAWS--LVYEYLPNGSLQD-RLFRKSNVSPLLWKDRARIAAEIASGLCFLH 583
++ LL A + LV++++ D + K N L GL +LH
Sbjct: 74 IIGLLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
I+H DLKP N+LLD K+ DFG+ +
Sbjct: 130 QHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 8e-17
Identities = 41/170 (24%), Positives = 73/170 (42%), Gaps = 38/170 (22%)
Query: 474 ESFKVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 529
E KVG+G +G VYK + + A+K + + + +E+ +L +L+HP++++
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVIS 82
Query: 530 LLGACPEAWS----LVYEYL-------------PNGSLQDRLFRKSNVSPLLWKDRARIA 572
L L+++Y + + + V LL+
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY------- 135
Query: 573 AEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRL 618
+I G+ +LH++ ++H DLKP NIL+ E KI D G RL
Sbjct: 136 -QILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 9e-17
Identities = 44/154 (28%), Positives = 77/154 (50%), Gaps = 27/154 (17%)
Query: 477 KVGQGGFGCVYKG-EMLGRTVAIKMLYSHNMQGQLEFQQ---------EVRVLSKLQHPH 526
KVG+G +G VYK + GR VA+K + +L+ + E+ +L +L HP+
Sbjct: 28 KVGEGTYGVVYKAKDSQGRIVALKRI-------RLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 527 LVTLLGACPEAWS--LVYEYLPNGSLQD-RLFRKSNVSPLLWKDRARIAAEIASGLCFLH 583
+V+L+ LV+E++ +D + N + L ++ G+ H
Sbjct: 81 IVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
+ I+H DLKPQN+L++S+ + K+ DFG+ R
Sbjct: 137 QHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 9e-17
Identities = 71/229 (31%), Positives = 98/229 (42%), Gaps = 68/229 (29%)
Query: 478 VGQGGFGCVY----KGEMLGRTVAIKML----------YSHNMQGQLEFQQEVRVLSK-L 522
+G+G FG V K E A+K+L H M E VL K +
Sbjct: 46 IGKGSFGKVLLARHKAE--EVFYAVKVLQKKAILKKKEEKHIMS-------ERNVLLKNV 96
Query: 523 QHPHLVTLLGA--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAE 574
+HP LV L + + V +Y+ G L ++R F + RAR AAE
Sbjct: 97 KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE---------PRARFYAAE 147
Query: 575 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 634
IAS L +LHS IV+ DLKP+NILLDS+ + DFG+C+ E ST
Sbjct: 148 IASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--------STT 196
Query: 635 PKGSF---P-YADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 674
+F P Y PE VL + D + G ++ ++L G P
Sbjct: 197 --STFCGTPEYLAPE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 1e-16
Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 28/155 (18%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQ---------EVRVLSKLQHP 525
K+G+G +G V+K + VA+K + +L+ E+ +L +L+H
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRV-------RLDDDDEGVPSSALREICLLKELKHK 61
Query: 526 HLVTLLGACPEAWS--LVYEYLPNGSLQD-RLFRKSNVSPLLWKDRARIAAEIASGLCFL 582
++V L LV+E+ QD + + S L + ++ GL F
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 583 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
HS ++H DLKPQN+L++ K+ +FG+ R
Sbjct: 118 HS---RNVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 67/221 (30%), Positives = 94/221 (42%), Gaps = 49/221 (22%)
Query: 477 KV-GQGGFGCV----YKGEMLGRTVAIKMLYSHNMQGQLEF---QQEVRVLSK-LQHPHL 527
K+ G+G FG V +K + AIK L + + E RVLS +HP L
Sbjct: 23 KMLGKGSFGKVFLAEFKKT--NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80
Query: 528 VTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHS 584
+ E V EYL G L + RA AAEI GL FLHS
Sbjct: 81 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD----LSRATFYAAEIILGLQFLHS 136
Query: 585 SKPEKIVHGDLKPQNILLDSELSSKICDFGICR--LVTEDTLYLPSFHRSTAPKGSF--- 639
+ IV+ DLK NILLD + KI DFG+C+ ++ + +F
Sbjct: 137 ---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN------------TFCGT 181
Query: 640 P-YADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 674
P Y PE +L + D +SFG+++ ++L G+ P
Sbjct: 182 PDYIAPE-----ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 27/154 (17%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ--------EVRVLSKLQHPH 526
K+G+G + VYKG+ VA+K + +LE ++ EV +L L+H +
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEI-------RLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 527 LVTLLGACPEAWS--LVYEYLPNGSLQD-RLFRKSNVSPLLWKDRARIAAEIASGLCFLH 583
+VTL S LV+EYL +D + + + + + ++ GL + H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
K ++H DLKPQN+L++ K+ DFG+ R
Sbjct: 118 RQK---VLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 62/223 (27%), Positives = 93/223 (41%), Gaps = 56/223 (25%)
Query: 478 VGQGGFGCVYKGEM--LGRTVAIKML----------YSHNMQGQLEFQQEVRVLSK-LQH 524
+G+G FG V E A+K+L M E RVL+ +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV-------EKRVLALPGKP 80
Query: 525 PHLVTLLGA--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIA 576
P L L + V EY+ G L Q F++ A AAEIA
Sbjct: 81 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE---------PHAVFYAAEIA 131
Query: 577 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 636
GL FL S + I++ DLK N++LDSE KI DFG+C+ D + +F
Sbjct: 132 IGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC------ 182
Query: 637 GSFPYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 674
G+ Y PE ++ + D ++FG+++ ++L G+ P
Sbjct: 183 GTPDYIAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 57/222 (25%)
Query: 478 VGQGGFGCVYKG--EMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQH------PH 526
+G+G FG V K + + VA+KM+ + Q E +R+L L+ +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEHLRKQDKDNTMN 160
Query: 527 LVTLLGA-------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 579
++ +L C + +E L + +L + L +K+ + A I L
Sbjct: 161 VIHMLENFTFRNHIC-----MTFELL-SMNLYE-LIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSS--KICDFG-ICRLVTEDTLYLPS-FHRSTAP 635
LH ++ I+H DLKP+NILL + S K+ DFG C Y+ S F+R+
Sbjct: 214 DALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRA--- 267
Query: 636 KGSFPYADPEYHRTGVL-----TPKSDSYSFGLIILQLLTGR 672
PE V+ D +S G I+ +LLTG
Sbjct: 268 --------PE-----VILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 63/223 (28%), Positives = 96/223 (43%), Gaps = 55/223 (24%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHP------ 525
+G+G FG V K VAIK++ + Q Q+E VR+L +
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE----VRLLELMNKHDTEMKY 116
Query: 526 HLVTLLGA-------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASG 578
++V L C LV+E L + +L D L R +N + + A ++ +
Sbjct: 117 YIVHLKRHFMFRNHLC-----LVFEML-SYNLYD-LLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 579 LCFLHSSKPEKIVHGDLKPQNILLDSELSS--KICDFGICRLVTED-TLYLPS-FHRSTA 634
L FL + + I+H DLKP+NILL + S KI DFG + + Y+ S F+RS
Sbjct: 170 LLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRS-- 226
Query: 635 PKGSFPYADPEYHRTGVL-----TPKSDSYSFGLIILQLLTGR 672
PE VL D +S G I++++ TG
Sbjct: 227 ---------PE-----VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 44/217 (20%)
Query: 478 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEF---QQEVRVLSK-LQHPHLVTLL 531
+G+G + V + R A+K++ + + Q E V + HP LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 532 GAC---PEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGLCFL 582
+C V EY+ G L + R + + AR +AEI+ L +L
Sbjct: 77 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE---------EHARFYSAEISLALNYL 126
Query: 583 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 642
H I++ DLK N+LLDSE K+ D+G+C+ +F G+ Y
Sbjct: 127 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC------GTPNYI 177
Query: 643 DPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 674
PE +L + D ++ G+++ +++ GR P
Sbjct: 178 APE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-16
Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 56/223 (25%)
Query: 478 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEF---QQEVRVLSK-LQHPHLVTLL 531
+G+G + V + R A++++ + + Q E V + HP LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 532 GAC---PEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGLCFL 582
+C V EY+ G L + R + + AR +AEI+ L +L
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE---------EHARFYSAEISLALNYL 169
Query: 583 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR--LVTEDTLYLPSFHRSTAPKGSF- 639
H I++ DLK N+LLDSE K+ D+G+C+ L DT +F
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS------------TFC 214
Query: 640 --P-YADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 674
P Y PE +L + D ++ G+++ +++ GR P
Sbjct: 215 GTPNYIAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 48/191 (25%), Positives = 81/191 (42%), Gaps = 44/191 (23%)
Query: 453 DLPESAEFSLADLQTATCNFSESF----KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNM 506
+ S++ + + + K+G+G +G VYK + TVAIK +
Sbjct: 13 EAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI----- 67
Query: 507 QGQLEFQQ---------EVRVLSKLQHPHLVTLLGACPEAWS--LVYEYLPN--GSLQDR 553
+LE ++ EV +L +LQH +++ L L++EY N D+
Sbjct: 68 --RLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDK 125
Query: 554 L--FRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS--- 608
+ L+ ++ +G+ F HS + +H DLKPQN+LL +S
Sbjct: 126 NPDVSMRVIKSFLY--------QLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETP 174
Query: 609 --KICDFGICR 617
KI DFG+ R
Sbjct: 175 VLKIGDFGLAR 185
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 6e-16
Identities = 50/153 (32%), Positives = 69/153 (45%), Gaps = 26/153 (16%)
Query: 478 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEF---QQEVRVLSK-LQHPHLVTLL 531
+G+G FG V + G A+K+L + + E R+LS HP L L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 532 GAC--PEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLH 583
P+ V E++ G L + R F + RAR AAEI S L FLH
Sbjct: 91 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE---------ARARFYAAEIISALMFLH 141
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 616
+ I++ DLK N+LLD E K+ DFG+C
Sbjct: 142 D---KGIIYRDLKLDNVLLDHEGHCKLADFGMC 171
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 8e-16
Identities = 54/226 (23%), Positives = 87/226 (38%), Gaps = 55/226 (24%)
Query: 478 VGQGGFGCVY-----KGEMLGRTVAIKMLYSHNMQGQLEFQQ----EVRVLSKLQH-PHL 527
+G G +G V+ G G+ A+K+L + + + + E +VL ++ P L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 528 VTLLGA--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGL 579
VTL A L+ +Y+ G L Q F + +I EI L
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE---------HEVQIYVGEIVLAL 172
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 639
LH I++ D+K +NILLDS + DFG+ + D A F
Sbjct: 173 EHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-------ETERA--YDF 220
Query: 640 ---P-YADPEYHRTGVLTPKSDSY-------SFGLIILQLLTGRLP 674
Y P+ ++ + S G+++ +LLTG P
Sbjct: 221 CGTIEYMAPD-----IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 42/165 (25%), Positives = 74/165 (44%), Gaps = 34/165 (20%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ-EVRVLSKLQHPHLVTLLGA 533
+G G FG VY+ ++ G VAIK + F+ E++++ KL H ++V L
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYF 115
Query: 534 CPEAWS--------LVYEYLPNGSLQD-----RLFRKSN--VSPLLWKDRARIAAEIASG 578
+ LV +Y+P + R + ++ + + K ++
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVK---LYMYQLFRS 168
Query: 579 LCFLHSSKPEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTED 622
L ++HS I H D+KPQN+LLD + + K+CDFG + +
Sbjct: 169 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.7 bits (196), Expect = 2e-15
Identities = 62/223 (27%), Positives = 93/223 (41%), Gaps = 56/223 (25%)
Query: 478 VGQGGFGCVYKGEM--LGRTVAIKML----------YSHNMQGQLEFQQEVRVLSK-LQH 524
+G+G FG V E A+K+L M E RVL+ +
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV-------EKRVLALPGKP 401
Query: 525 PHLVTLLGA--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIA 576
P L L + V EY+ G L Q F++ A AAEIA
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE---------PHAVFYAAEIA 452
Query: 577 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 636
GL FL S + I++ DLK N++LDSE KI DFG+C+ D + +F
Sbjct: 453 IGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC------ 503
Query: 637 GSFPYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 674
G+ Y PE ++ + D ++FG+++ ++L G+ P
Sbjct: 504 GTPDYIAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-15
Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 30/171 (17%)
Query: 470 CNFSESF----KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQ----EVRV 518
+ + ++G G +G VYK G VA+K + N G EV +
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 519 LSKLQ---HPHLVTLLGACPEAWS-------LVYEYLPNGSLQD--RLFRKSNVSPLLWK 566
L +L+ HP++V L+ C + + LV+E++ QD K+ L +
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAE 120
Query: 567 DRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
+ + GL FLH++ IVH DLKP+NIL+ S + K+ DFG+ R
Sbjct: 121 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 48/222 (21%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA- 533
GQG FG V G+ G +VAIK + E Q ++ L+ L HP++V L
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQLQSYF 88
Query: 534 CPEAWS--------LVYEYLPNGSLQD-----RLFRKSN--VSPLLWKDRARIAAEIASG 578
+V EY+P R + + P+L K ++
Sbjct: 89 YTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPPPILIK---VFLFQLIRS 141
Query: 579 LCFLHSSKPEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTED---TLYLPS-FHRST 633
+ LH + H D+KP N+L++ + K+CDFG + ++ Y+ S ++R
Sbjct: 142 IGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYR-- 198
Query: 634 APK---GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 672
AP+ G+ Y T D +S G I +++ G
Sbjct: 199 APELIFGNQHY-----------TTAVDIWSVGCIFAEMMLGE 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 34/171 (19%)
Query: 470 CNFSESF----KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-F----QQEVRV 518
C+ + K+GQG FG V+K G+ VA+K + M+ + E F +E+++
Sbjct: 13 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKI 69
Query: 519 LSKLQHPHLVTLLGACPEAWS----------LVYEYLPNGSLQD--RLFRKSNVSPLLWK 566
L L+H ++V L+ C S LV+++ D L V
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLV-KFTLS 124
Query: 567 DRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
+ R+ + +GL ++H +K I+H D+K N+L+ + K+ DFG+ R
Sbjct: 125 EIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 172
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 33/156 (21%)
Query: 477 KVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 535
+G G FG V++ +++ VAIK + +Q + +E++++ ++HP++V L
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 536 EAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE--------IASGL 579
LV EY+P + ++R S K + + + L
Sbjct: 103 SNGDKKDEVFLNLVLEYVP----ET-VYR---ASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSS-KICDFG 614
++HS I H D+KPQN+LLD K+ DFG
Sbjct: 155 AYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFG 187
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 5e-14
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 38/165 (23%)
Query: 477 KVGQGGFGCVYKG---EMLGRTVAIKMLYSHNMQGQLEFQQE------------VRVLSK 521
++G+G +G V+K + GR VA+K + +++ +E +R L
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRV-------RVQTGEEGMPLSTIREVAVLRHLET 70
Query: 522 LQHPHLVTLLGACPEAWS-------LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRARIA 572
+HP++V L C + + LV+E++ QD K + + +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMM 126
Query: 573 AEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
++ GL FLHS ++VH DLKPQNIL+ S K+ DFG+ R
Sbjct: 127 FQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 6e-14
Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 29/194 (14%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQQ----EVRVLSKLQHPHLVTL 530
+G G +G V + ++ R VAIK + + L + E+ +L++L H H+V +
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKI--LRVFEDLIDCKRILREIAILNRLNHDHVVKV 117
Query: 531 LG-ACPEAWS------LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRAR-IAAEIASGLC 580
L P+ +V E D +LFR L + + + + G+
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIAD----SDFKKLFRTPVY---LTELHIKTLLYNLLVGVK 170
Query: 581 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV-TEDTLYLPSFHRSTAPKGSF 639
++HS+ I+H DLKP N L++ + S K+CDFG+ R V + +
Sbjct: 171 YVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 640 PYADPEYHRTGVLT 653
+ LT
Sbjct: 228 VTFPHTKNLKRQLT 241
|
| >2yu4_A E3 SUMO-protein ligase NSE2; SP-ring domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 94 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 2e-13
Identities = 21/73 (28%), Positives = 32/73 (43%), Gaps = 9/73 (12%)
Query: 750 FLCPILQEIMHDP-QVAADGFTYEGKAIRDWLENGRETS-----PMT---NLRLSHLHLT 800
F CPI +E M P + G TYE AI +E+ ++ P + + L
Sbjct: 8 FTCPITKEEMKKPVKNKVCGHTYEEDAIVRMIESRQKRKKKAYCPQIGCSHTDIRKSDLI 67
Query: 801 PNHALRHAIQDWL 813
+ ALR AI++
Sbjct: 68 QDEALRRAIENHN 80
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 41/167 (24%), Positives = 61/167 (36%), Gaps = 27/167 (16%)
Query: 477 KVGQGGFGCVYKG-EMLGRTVAIKMLYSHNMQGQLE--FQQ---------EVRVLSKLQH 524
+ G +G V G + G VAIK +++ G+ E+R+L+ H
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 525 PHLVTLLGA-CPEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIA 576
P+++ L LV E + L + + + I
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVIS-PQHIQYFMYHIL 144
Query: 577 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623
GL LH + +VH DL P NILL ICDF + R T D
Sbjct: 145 LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 54/241 (22%), Positives = 93/241 (38%), Gaps = 45/241 (18%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQQ----EVRVLSKLQHPHLVTL 530
+G+G +G VY + + VAIK + + M L + E+ +L++L+ +++ L
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKSDYIIRL 90
Query: 531 LGAC-PEAWS------LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRAR-IAAEIASGLC 580
P+ +V E D +LF+ L ++ + I + G
Sbjct: 91 YDLIIPDDLLKFDELYIVLEIAD----SDLKKLFKTPIF---LTEEHIKTILYNLLLGEN 143
Query: 581 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP 640
F+H S I+H DLKP N LL+ + S K+CDFG+ R + + +
Sbjct: 144 FIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 641 YADPEYHRTG-VLT-----P----KSDSY-------SFGLIILQLLTGRLPVGLAGEVRR 683
+ + T V+T P ++Y S G I +LL R
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260
Query: 684 A 684
Sbjct: 261 P 261
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 6e-13
Identities = 50/231 (21%), Positives = 92/231 (39%), Gaps = 59/231 (25%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQ-------- 523
K+G G F V+ + + VA+K++ + + E +++L ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE----IKLLQRVNDADNTKED 81
Query: 524 ---HPHLVTLL------GACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE 574
H++ LL G +V+E L +L L +K + +I+ +
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLA-LIKKYEHRGIPLIYVKQISKQ 139
Query: 575 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS------KICDFGICRLVTED-TLYLP 627
+ GL ++H + I+H D+KP+N+L++ S KI D G E T +
Sbjct: 140 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197
Query: 628 S-FHRSTAPKGSFPYADPEYHRTGVL-----TPKSDSYSFGLIILQLLTGR 672
+ +RS PE VL +D +S +I +L+TG
Sbjct: 198 TREYRS-----------PE-----VLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 36/150 (24%), Positives = 54/150 (36%), Gaps = 22/150 (14%)
Query: 477 KVGQGGFGCVYKGEMLG-------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKL-QHPHL 527
+G+G FG V + + G RTVA+KML E+++L + H ++
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 528 VTLLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 584
V LLGAC ++ E+ G+L L R G F
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLST----------YLRSKRNEFVPYKTKGARFRQG 138
Query: 585 SKPEKIVHGDLKPQNILLDSELSSKICDFG 614
+ DLK + + S SS F
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFV 168
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 36/118 (30%), Positives = 55/118 (46%), Gaps = 14/118 (11%)
Query: 561 SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 620
L + + ++A G+ FL S K +H DL +NILL + KICDFG+ R +
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIY 244
Query: 621 EDTLYLPSFHRSTAPKGSFPY---ADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 674
+D Y P A PE V T +SD +SFG+++ ++ + G P
Sbjct: 245 KDPDY-----VRKG-DARLPLKWMA-PETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 8e-13
Identities = 36/166 (21%), Positives = 70/166 (42%), Gaps = 27/166 (16%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA 533
+G GG G V+ + VAIK + + + + E++++ +L H ++V +
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFEI 76
Query: 534 -CPEAWSLVYEYLPNGSLQD-------------RLFRKSNVSPLLWKDRAR-IAAEIASG 578
P L + L + + + + AR ++ G
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE----EHARLFMYQLLRG 132
Query: 579 LCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDT 623
L ++HS+ ++H DLKP N+ +++E L KI DFG+ R++
Sbjct: 133 LKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 9e-13
Identities = 37/158 (23%), Positives = 74/158 (46%), Gaps = 22/158 (13%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGA 533
K+G+G + V++ + V +K+L + + ++E+++L L+ P+++TL
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADI 99
Query: 534 CPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPE 588
+ S LV+E++ N + +L++ L R EI L + HS
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFK-QLYQT------LTDYDIRFYMYEILKALDYCHSMG-- 150
Query: 589 KIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLY 625
I+H D+KP N+++D E ++ D+G+ Y
Sbjct: 151 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 50/215 (23%), Positives = 93/215 (43%), Gaps = 44/215 (20%)
Query: 478 VGQGGFGCVYKG--EMLGRTVAIKMLY---SHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 532
+G G G V +L R VAIK L + + ++ E+ ++ + H ++++LL
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 128
Query: 533 ACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLH 583
+ LV E + +L ++ + L +R + ++ G+ LH
Sbjct: 129 VFTPQKTLEEFQDVYLVMELMDA-NLC-QVIQME-----LDHERMSYLLYQMLCGIKHLH 181
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED---TLYLPS-FHRSTAPK--G 637
S+ I+H DLKP NI++ S+ + KI DFG+ R T Y+ + ++R AP+
Sbjct: 182 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR--APEVIL 236
Query: 638 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 672
Y D +S G I+ +++ +
Sbjct: 237 GMGY-----------KENVDIWSVGCIMGEMVRHK 260
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 54/211 (25%), Positives = 86/211 (40%), Gaps = 25/211 (11%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH-PHLVTLL-- 531
K+G G FG +Y G + G VAIK+ QL E ++ +Q + T+
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWC 73
Query: 532 GACPEAWSLVYEYLPNG-SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
GA + +V E L G SL+D LF + L K +A ++ S + ++HS
Sbjct: 74 GAEGDYNVMVMELL--GPSLED-LFNFCSRKFSL-KTVLLLADQMISRIEYIHSK---NF 126
Query: 591 VHGDLKPQNILLDSELSSK---ICDFGICRLVTEDTLYLPSFHRSTAPKGSFP----YAD 643
+H D+KP N L+ I DFG+ + + + H + YA
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ---HIPYRENKNLTGTARYAS 183
Query: 644 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
H + + D S G +++ G LP
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.6 bits (164), Expect = 4e-12
Identities = 39/250 (15%), Positives = 66/250 (26%), Gaps = 61/250 (24%)
Query: 468 ATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHN--------MQGQLEFQQEVRVL 519
T K+G+G FG V++ VAIK++ + E E+ +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 520 SKLQ---------HPHLVTLL------GACPEAWSLVYEYLP--NGSLQDRLFRKSNVSP 562
+L + L G+ P +++ GS DR +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 563 LL--------------------WKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 602
+ I ++ + L + H DL N+LL
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE--ASLRFEHRDLHWGNVLL 195
Query: 603 DSELSSKICD-----------FGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 651
K+ G+ V+ L R D + TG
Sbjct: 196 KKTSLKKLHYTLNGKSSTIPSCGLQ--VSIIDYTLSRLERDGIVVFCDVSMDEDL-FTGD 252
Query: 652 LTPKSDSYSF 661
+ D Y
Sbjct: 253 GDYQFDIYRL 262
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 49/236 (20%), Positives = 85/236 (36%), Gaps = 55/236 (23%)
Query: 477 KVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP---- 525
+GQGGFGC+Y +M +K+ S N G L E++ + P
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN--GPLFT--ELKFYQRAAKPEQIQ 97
Query: 526 -----HLVTLLGACPEAWS------------LVYEYLPNG-SLQDRLFRKSNVSPLLWKD 567
+ LG S ++ + G LQ ++ + K
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQK-IYEANA-KRFSRKT 153
Query: 568 RARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI--CDFGICRLVTEDTLY 625
+++ I L ++H + VHGD+K N+LL+ + ++ D+G+ Y
Sbjct: 154 VLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY------RY 204
Query: 626 LPS---FHRSTAPKGSFP----YADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
P + PK + + H + + D G ++Q LTG LP
Sbjct: 205 CPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 51/215 (23%), Positives = 93/215 (43%), Gaps = 44/215 (20%)
Query: 478 VGQGGFGCVYKG--EMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 532
+G G G V +L R VAIK L + + + ++ E+ ++ + H +++ LL
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLN 91
Query: 533 ACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLH 583
S +V E + +L ++ + L +R + ++ G+ LH
Sbjct: 92 VFTPQKSLEEFQDVYIVMELMDA-NLC-QVIQME-----LDHERMSYLLYQMLCGIKHLH 144
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED---TLYLPS-FHRSTAPK--G 637
S+ I+H DLKP NI++ S+ + KI DFG+ R T Y+ + ++R AP+
Sbjct: 145 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR--APEVIL 199
Query: 638 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 672
Y D +S G I+ +++ G
Sbjct: 200 GMGY-----------KENVDIWSVGCIMGEMIKGG 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 49/218 (22%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
VG G +G V + G VAIK L + + + ++ E+ +L +QH +++ LL
Sbjct: 31 HVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLL 89
Query: 532 GACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFL 582
A S LV ++ LQ + S ++ + + ++ GL ++
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQT-DLQKIM--GLKFSE----EKIQYLVYQMLKGLKYI 142
Query: 583 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED-TLYLPSFHRST----APK- 636
HS+ +VH DLKP N+ ++ + KI DFG+ R + T Y+ T AP+
Sbjct: 143 HSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV-----VTRWYRAPEV 194
Query: 637 --GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 672
Y D +S G I+ ++LTG+
Sbjct: 195 ILSWMHY-----------NQTVDIWSVGCIMAEMLTGK 221
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 67.6 bits (164), Expect = 1e-11
Identities = 85/541 (15%), Positives = 159/541 (29%), Gaps = 163/541 (30%)
Query: 49 SSREICILHVHQPSPVIPT--LLGKLPASQASA------EVL--------SAFRAEERQK 92
S EI + + V T L L + Q EVL S + E+RQ
Sbjct: 47 SKEEIDHI-IMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQP 105
Query: 93 ---MKKLLDNYLRICVEAEVKA-----RIITTEADKIQKAIVQLMN-----IHGIQKLVM 139
+ ++ R+ + +V A R+ K+++A+++L I G +
Sbjct: 106 SMMTRMYIEQRDRLYNDNQVFAKYNVSRL--QPYLKLRQALLELRPAKNVLIDG-----V 158
Query: 140 GAFPDNCMKVKMGSRK---ASYAAKNAP----MFCEIWFVNKGK---------------- 176
GS K A + M +I+++N
Sbjct: 159 L-----------GSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLY 207
Query: 177 ---HVWTKEASESPNSFLPFCGAETRSAKMLRSRSLENCNGTSLFNPESILSRSATTLTH 233
WT + S N L + ++L+S+ ENC L +L
Sbjct: 208 QIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC----LL----VL--------- 250
Query: 234 VGITDWVQSDPVHMVFPSSPTISCSDMNLFSPRSSS----AGSGYMSEKRESTDSDSKVE 289
VQ+ F +SC L + R + + S +
Sbjct: 251 ----LNVQNAKAWNAF----NLSCK--ILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP 300
Query: 290 EDPLYVQHREVSIKAEELRNSA----------FAEFLRR--------KKLESEAMEAIGK 331
++ + + + + ++L AE +R K + + + I +
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIE 360
Query: 332 --VKAFESAYAREMH-----LRKEA---EDALQTTIQDQEKLKQEKAFVTQELHRTMRNV 381
+ E A R+M A L + + +K + V +LH+
Sbjct: 361 SSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLS--LIWFDVIKSDVMVVVNKLHKY---- 414
Query: 382 ALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRGQAGA 441
+L+ ++ E+T + I + + + + R V+ + + S
Sbjct: 415 SLVE-------KQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDD-LIP 466
Query: 442 ANYDG----FIG----LVEDLPESAEFS--LADLQTATCNFSESFKVGQGGFGCVYKGEM 491
D IG +E F D F E K+ G +
Sbjct: 467 PYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDF-----RFLEQ-KIRHDSTAWNASGSI 520
Query: 492 L 492
L
Sbjct: 521 L 521
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.1 bits (155), Expect = 2e-10
Identities = 99/616 (16%), Positives = 190/616 (30%), Gaps = 209/616 (33%)
Query: 335 FESAYAREMHL--RKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALLNSRAQEAN 392
FE+ E + + + F +++ +++ L
Sbjct: 9 FETG---EHQYQYKDILSVFEDAFVDN---------FDCKDVQDMPKSI-LSKEEIDHII 55
Query: 393 RRRDEATGELKLIQASIATLQQEKQRIRRQKVEAV-----RWL-ERWRSRGQAGAANYDG 446
+D +G L+L TL +++ + ++ VE V ++L ++ + +
Sbjct: 56 MSKDAVSGTLRLFW----TLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM 111
Query: 447 FIGLVEDLPESAE-FS---------LADLQTATCNFSESFKVG-QGGFGCVYKGEMLGRT 495
+I + L + F+ L+ A + V G G G+T
Sbjct: 112 YIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS-------GKT 164
Query: 496 V-AIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEA-----WSLVYEYLPN 547
A+ + S+ +Q +++F+ + + L C PE L+Y+ PN
Sbjct: 165 WVALDVCLSYKVQCKMDFK----I-------FWLNL-KNCNSPETVLEMLQKLLYQIDPN 212
Query: 548 GSLQDRLFRKSNVSPLL--WKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE 605
R SN+ + + R L SKP + L ++L +
Sbjct: 213 --WTSRSDHSSNIKLRIHSIQAELRR----------LLKSKPYENC---L----LVLLNV 253
Query: 606 LSSKICD-FGI-CR-LVT----EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDS 658
++K + F + C+ L+T + T +L + + H + LTP
Sbjct: 254 QNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLD---------HHSMTLTP---D 301
Query: 659 YSFGLI--ILQLLTGRLP----------VGLAGE-VR---------RAVSCGKLSSI--- 693
L+ L LP + + E +R + V+C KL++I
Sbjct: 302 EVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIES 361
Query: 694 -LDPLAGDWPTFVARRLVDLG------------LQCCELYGRERPDITPSLVKELEQLHV 740
L+ L P + L L ++ +V +L + +
Sbjct: 362 SLNVLE---PAEYRKMFDRLSVFPPSAHIPTILL--SLIWFDVIKSDVMVVVNKLHKYSL 416
Query: 741 AEERP------VPSFFL---CPILQEI-MHD-----------------PQVAADG--FTY 771
E++P +PS +L + E +H D +++
Sbjct: 417 VEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSH 476
Query: 772 EG---KAIR---------------DWLENG-RETSPMTNLRLSHL-----------HLTP 801
G K I +LE R S N S L ++
Sbjct: 477 IGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICD 536
Query: 802 NHALRH----AIQDWL 813
N AI D+L
Sbjct: 537 NDPKYERLVNAILDFL 552
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 52/251 (20%), Positives = 99/251 (39%), Gaps = 80/251 (31%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ-EVRVLSKLQHPHLVTLL-- 531
+G G FG V + + G+ A+K + ++ E+ ++ L H +++ L+
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHVNIIKLVDY 68
Query: 532 --------------------------------GACPEAWS------LVYEYLPNGSLQD- 552
+ S ++ EY+P+ +L
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKV 127
Query: 553 -RLFRKSN--VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS- 608
+ F +S + L ++ + F+HS I H D+KPQN+L++S+ ++
Sbjct: 128 LKSFIRSGRSIPMNLIS---IYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTL 181
Query: 609 KICDFGICRLVTED---TLYLPS-FHRSTAPK---GSFPYADPEYHRTGVLTPKSDSYSF 661
K+CDFG + + Y+ S F+R AP+ G+ Y TP D +S
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRFYR--APELMLGATEY-----------TPSIDLWSI 228
Query: 662 GLIILQLLTGR 672
G + +L+ G+
Sbjct: 229 GCVFGELILGK 239
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 30/190 (15%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIKMLY---SHNMQGQLEFQQEVRVLSKLQ-HPHLVTL 530
K+G+G +G V+K G VA+K ++ ++ Q F+ E+ +L++L H ++V L
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNL 74
Query: 531 LGAC-PEAWS---LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRAR-IAAEIASGLCFLH 583
L + LV++Y+ D + R + +L + + ++ + +LH
Sbjct: 75 LNVLRADNDRDVYLVFDYME----TDLHAVIR----ANILEPVHKQYVVYQLIKVIKYLH 126
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 643
S ++H D+KP NILL++E K+ DFG+ R + + P +
Sbjct: 127 SGG---LLHRDMKPSNILLNAECHVKVADFGLSR-----SFVNIRRVTNNIPLSINENTE 178
Query: 644 PEYHRTGVLT 653
+LT
Sbjct: 179 NFDDDQPILT 188
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 44/228 (19%), Positives = 83/228 (36%), Gaps = 42/228 (18%)
Query: 477 KVGQGGFGCVYKGEML--GRTVA---IKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
K+G GGFG +Y A +K+ Y N G L E++ ++ +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN--GPLFS--ELKFYQRVAKKDCIKKW 99
Query: 532 GACPEA---------WS------------LVYEYLPNG-SLQDRLFRKSNVSPLLWKDRA 569
+ S +V E L G LQ + ++
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKK--STVL 154
Query: 570 RIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI--CDFGICRLVTEDTLYLP 627
++ + L ++H ++ VHGD+K N+LL + ++ D+G+ + +
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 628 SFHRSTAP-KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
G+ + + H+ L+ +SD G +L+ L G+LP
Sbjct: 212 YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 44/226 (19%), Positives = 77/226 (34%), Gaps = 35/226 (15%)
Query: 477 KVGQGGFGCVYKGEML----------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPH 526
+ G +Y+ + ++K L + + + E R LQ
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 527 LVTLLGACPEA-----WS---------LVYEYLPNG-SLQDRLFRKSNVSPLLWKDRARI 571
L A LV L G SLQ S L + ++
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKHVLSERSVLQV 164
Query: 572 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI--CDFGICRLVTEDTLYLP-S 628
A + L FLH ++ VHG++ +NI +D E S++ +G ++
Sbjct: 165 ACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV 221
Query: 629 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
+ +G + + H+ + +SD S G +L+ L G LP
Sbjct: 222 EGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 26/160 (16%)
Query: 478 VGQGGFGCVYKG--EMLGRTVAIKML--YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA 533
+G+G +G V + VAIK + + H Q + E+++L + +H +++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 534 -CPEAWS------LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRAR-IAAEIASGLCFLH 583
+V + + D +L + ++S D +I GL ++H
Sbjct: 94 IRAPTIEQMKDVYIVQDLME----TDLYKLLKTQHLSN----DHICYFLYQILRGLKYIH 145
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623
S+ ++H DLKP N+LL++ KICDFG+ R+ D
Sbjct: 146 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 46/239 (19%), Positives = 82/239 (34%), Gaps = 73/239 (30%)
Query: 477 KVGQGGFGCVYK---GEMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHP----- 525
+G+G FG V + VA+K++ + +LE + VL K++
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKENK 81
Query: 526 -HLVTLLGA-------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIAS 577
V + C + +E L + + +++N P +A ++
Sbjct: 82 FLCVLMSDWFNFHGHMC-----IAFELL-GKNTFE-FLKENNFQPYPLPHVRHMAYQLCH 134
Query: 578 GLCFLHSSKPEKIVHGDLKPQNILLDSELSS-------------------KICDFGICRL 618
L FLH ++ + H DLKP+NIL + ++ DFG
Sbjct: 135 ALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191
Query: 619 VTED-TLYLPS-FHRSTAPKGSFPYADPEYHRTGVL----TPKSDSYSFGLIILQLLTG 671
E T + + +R PE +L D +S G I+ + G
Sbjct: 192 DHEHHTTIVATRHYRP-----------PE----VILELGWAQPCDVWSIGCILFEYYRG 235
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 8e-11
Identities = 47/226 (20%), Positives = 89/226 (39%), Gaps = 53/226 (23%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIKML--YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 532
+G+G +G V + G VAIK + + + + E+++L +H +++T+
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIFN 76
Query: 533 A-CPEAWS------LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRAR-IAAEIASGLCFL 582
P+++ ++ E + D R+ + +L D + + + L
Sbjct: 77 IQRPDSFENFNEVYIIQELMQ----TDLHRVIS----TQMLSDDHIQYFIYQTLRAVKVL 128
Query: 583 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST--------- 633
H S ++H DLKP N+L++S K+CDFG+ R++ E
Sbjct: 129 HGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 634 ----APK---GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 672
AP+ S Y + D +S G I+ +L R
Sbjct: 186 RWYRAPEVMLTSAKY-----------SRAMDVWSCGCILAELFLRR 220
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 52/244 (21%), Positives = 88/244 (36%), Gaps = 79/244 (32%)
Query: 477 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQH-----PH 526
K+G G FG V + A+K++ + ++E +L K+Q+ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDINNNN 97
Query: 527 LVTLLGA-------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 579
+V G C L++E L SL + + ++N + +D EI L
Sbjct: 98 IVKYHGKFMYYDHMC-----LIFEPL-GPSLYE-IITRNNYNGFHIEDIKLYCIEILKAL 150
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSS-------------------------KICDFG 614
+L + H DLKP+NILLD K+ DFG
Sbjct: 151 NYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207
Query: 615 ICRLVTED-TLYLPS-FHRSTAPKGSFPYADPEYHRTGVL-----TPKSDSYSFGLIILQ 667
++ + + +R+ PE V+ SD +SFG ++ +
Sbjct: 208 CATFKSDYHGSIINTRQYRA-----------PE-----VILNLGWDVSSDMWSFGCVLAE 251
Query: 668 LLTG 671
L TG
Sbjct: 252 LYTG 255
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 48/217 (22%)
Query: 478 VGQGGFGCVYK--GEMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 532
VG G +G V G VA+K L + + + ++ E+R+L ++H +++ LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 533 ACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLH 583
A S LV + L + + K L D + + +I GL ++H
Sbjct: 96 VFTPARSLEEFNDVYLVTHLMGA-DLNNIV--KCQK---LTDDHVQFLIYQILRGLKYIH 149
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED-TLYLPSFHRST----APK-- 636
S+ I+H DLKP N+ ++ + KI DFG+ R ++ T Y+ +T AP+
Sbjct: 150 SAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV-----ATRWYRAPEIM 201
Query: 637 -GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 672
Y D +S G I+ +LLTGR
Sbjct: 202 LNWMHY-----------NQTVDIWSVGCIMAELLTGR 227
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 25/211 (11%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLL-- 531
K+G G FG +Y G VAIK+ QL + E ++ LQ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWF 71
Query: 532 GACPEAWSLVYEYLPNG-SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
G + LV + L G SL+D LF + L K +A ++ + + F+HS +
Sbjct: 72 GVEGDYNVLVMDLL--GPSLED-LFNFCSRKLSL-KTVLMLADQMINRVEFVHS---KSF 124
Query: 591 VHGDLKPQNILLDSELSSK---ICDFGICRLVTEDTLYLPSFHRSTAPKGSFP----YAD 643
+H D+KP N L+ + I DFG+ + + + + H + YA
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ---HIPYRENKNLTGTARYAS 181
Query: 644 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
H + + D S G +++ L G LP
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 50/216 (23%), Positives = 89/216 (41%), Gaps = 46/216 (21%)
Query: 478 VGQGGFGCVYKG--EMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 532
VG G +G V G VAIK L + + + ++ E+R+L ++H +++ LL
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGLLD 91
Query: 533 ACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 584
+ LV ++ L + L + ++ GL ++H+
Sbjct: 92 VFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA 146
Query: 585 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED-TLYLPSFHRST----APK--- 636
+ I+H DLKP N+ ++ + KI DFG+ R + T Y+ T AP+
Sbjct: 147 AG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV-----VTRWYRAPEVIL 198
Query: 637 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 672
Y T D +S G I+ +++TG+
Sbjct: 199 NWMRY-----------TQTVDIWSVGCIMAEMITGK 223
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 2e-10
Identities = 52/239 (21%), Positives = 89/239 (37%), Gaps = 73/239 (30%)
Query: 477 KVGQGGFGCVYKG---EMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHP----- 525
+G+G FG V + + GR VA+K++ + + + E ++VL L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE----IQVLEHLNTTDPNST 76
Query: 526 -HLVTLLGA-------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIAS 577
V +L C +V+E L S D +++ P ++A +I
Sbjct: 77 FRCVQMLEWFEHHGHIC-----IVFELL-GLSTYD-FIKENGFLPFRLDHIRKMAYQICK 129
Query: 578 GLCFLHSSKPEKIVHGDLKPQNILLDSELSS-------------------KICDFGICRL 618
+ FLHS K+ H DLKP+NIL + K+ DFG
Sbjct: 130 SVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY 186
Query: 619 VTED-TLYLPS-FHRSTAPKGSFPYADPEYHRTGVL----TPKSDSYSFGLIILQLLTG 671
E + + + +R+ PE +L + D +S G I+++ G
Sbjct: 187 DDEHHSTLVSTRHYRA-----------PE----VILALGWSQPCDVWSIGCILIEYYLG 230
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 7e-10
Identities = 49/217 (22%), Positives = 83/217 (38%), Gaps = 35/217 (16%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH----PHLVTL 530
++G+G FG +++G + + VAIK + QL E R L P++
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIPNVYY- 73
Query: 531 LGACPEAWSLVYEYLPNG-SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
G LV + L G SL+D L + K A A ++ + + +H +
Sbjct: 74 FGQEGLHNVLVIDLL--GPSLED-LLDLCGRKFSV-KTVAMAAKQMLARVQSIHE---KS 126
Query: 590 IVHGDLKPQNILLDSELSSK-----ICDFGICRLVTEDTLYLPSFHRSTAPK-------G 637
+V+ D+KP N L+ S + DFG+ + Y + P G
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK------FYRDPVTKQHIPYREKKNLSG 180
Query: 638 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
+ Y H + + D + G + + L G LP
Sbjct: 181 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 54/217 (24%), Positives = 88/217 (40%), Gaps = 35/217 (16%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH----PHLVTL 530
K+G G FG + G+ L VAIK+ + QL E R +L P +
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVYYF 73
Query: 531 LGACPEAWSLVYEYLPNG-SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
G C + ++V E L G SL+D LF + + L K IA ++ S + ++HS +
Sbjct: 74 -GPCGKYNAMVLELL--GPSLED-LFDLCDRTFSL-KTVLMIAIQLISRMEYVHS---KN 125
Query: 590 IVHGDLKPQNILLDSELSSK-----ICDFGICRLVTEDTLYLPSF---HRSTAPKGSFP- 640
+++ D+KP+N L+ + I DF + + Y+ H S
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK------EYIDPETKKHIPYREHKSLTG 179
Query: 641 ---YADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
Y H + + D + G + + L G LP
Sbjct: 180 TARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 40/151 (26%), Positives = 63/151 (41%), Gaps = 33/151 (21%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-----HP---H 526
K+G G F V+ + VA+K++ S + E+R+L ++ P
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREM 102
Query: 527 LVTLLGA-----------CPEAWSLVYEYLPNG-SLQDRLFRKSNVSPLLWKDRARIAAE 574
+V LL C +V+E L G L KSN L +I +
Sbjct: 103 VVQLLDDFKISGVNGTHIC-----MVFEVL--GHHLLK-WIIKSNYQGLPLPCVKKIIQQ 154
Query: 575 IASGLCFLHSSKPEKIVHGDLKPQNILLDSE 605
+ GL +LH+ +I+H D+KP+NILL
Sbjct: 155 VLQGLDYLHTKC--RIIHTDIKPENILLSVN 183
|
| >2bay_A PRE-mRNA splicing factor PRP19; U-BOX, ubiquitin ligase, E3 ligase; 1.50A {Saccharomyces cerevisiae} SCOP: g.44.1.2 PDB: 1n87_A Length = 61 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-06
Identities = 11/55 (20%), Positives = 23/55 (41%), Gaps = 2/55 (3%)
Query: 748 SFFLCPILQEIMHDPQVA-ADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTP 801
S LC I ++ P ++ +E + ++++ P+TN LS +
Sbjct: 2 SHMLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKD-TGNDPITNEPLSIEEIVE 55
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 30/148 (20%), Positives = 54/148 (36%), Gaps = 14/148 (9%)
Query: 303 KAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYA----------REMHLRKEAEDA 352
+ +L E R+KL+ E + A GK+K E +E L +E
Sbjct: 956 QMLDLEEQLEEEEAARQKLQLEKVTADGKIKKMEDDILIMEDQNNKLTKERKLLEERVSD 1015
Query: 353 LQTTIQDQE----KLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQAS 408
L T + ++E L + K + + QE + + + GE +
Sbjct: 1016 LTTNLAEEEEKAKNLTKLKNKHESMISELEVRLKKEEKSRQELEKIKRKLEGESSDLHEQ 1075
Query: 409 IATLQQEKQRIRRQKVEAVRWLERWRSR 436
IA LQ + ++ Q + L+ +R
Sbjct: 1076 IAELQAQIAELKAQLAKKEEELQAALAR 1103
|
| >3htk_C E3 SUMO-protein ligase MMS21; SUMO E3 ligase, SPL-ring, ring, ATP-binding, chromosomal protein, coiled coil, DNA damage; 2.31A {Saccharomyces cerevisiae} Length = 267 | Back alignment and structure |
|---|
Score = 44.2 bits (103), Expect = 8e-05
Identities = 8/67 (11%), Positives = 22/67 (32%), Gaps = 4/67 (5%)
Query: 750 FLCPILQEIMHDPQVAAD-GFTYEGKAIRDWLENGRETS-PMT--NLRLSHLHLTPNHAL 805
CPI + P ++ ++ I+++L+ P + +S + +
Sbjct: 182 LTCPITCKPYEAPLISRKCNHVFDRDGIQNYLQGYTTRDCPQAACSQVVSMRDFVRDPIM 241
Query: 806 RHAIQDW 812
+
Sbjct: 242 ELRCKIA 248
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 7e-04
Identities = 19/171 (11%), Positives = 53/171 (30%), Gaps = 18/171 (10%)
Query: 277 EKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFE 336
K+ ++K+ + + I + + E + LE K+++
Sbjct: 919 YKKLHIGLENKIMQ-------LQRKIDEQNKEYKSLLE--KMNNLEITYSTETEKLRSDV 969
Query: 337 SAYAREM-------HLRKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALLNSRAQ 389
+ ++ + ++ + + EK + + + L S +
Sbjct: 970 ERLRMSEEEAKNATNRVLSLQEEIAKLRKELHQTQTEKKTIEEWADKYKHETEQLVSELK 1029
Query: 390 EANRRRDEATGEL--KLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRGQ 438
E N EL ++ + + ++++ + + L R R Q
Sbjct: 1030 EQNTLLKTEKEELNRRIHDQAKEITETMEKKLVEETKQLELDLNDERLRYQ 1080
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 816 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-62 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-55 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-54 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-53 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-53 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-51 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-51 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-50 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 6e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-49 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-47 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-46 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-39 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-31 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-19 | |
| d1t1ha_ | 78 | g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cre | 1e-18 | |
| d2c2la2 | 80 | g.44.1.2 (A:225-304) STIP1 homology and U box-cont | 8e-15 | |
| d1wgma_ | 98 | g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Hu | 3e-11 | |
| d1jm7a_ | 103 | g.44.1.1 (A:) brca1 RING domain {Human (Homo sapie | 2e-06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 2e-62
Identities = 75/271 (27%), Positives = 123/271 (45%), Gaps = 24/271 (8%)
Query: 477 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
++G G FG VYKG+ VA+KML Q F+ EV VL K +H +++ +G
Sbjct: 15 RIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 535 PEAW-SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 593
++V ++ SL L IA + A G+ +LH + I+H
Sbjct: 74 TAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 594 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT---G 650
DLK NI L +L+ KI DFG+ + + + H+ GS + PE R
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS----HQFEQLSGSILWMAPEVIRMQDKN 184
Query: 651 VLTPKSDSYSFGLIILQLLTGRLP---VGLAGEVRRAVSCGKLSSILDPLAGDWPTFVAR 707
+ +SD Y+FG+++ +L+TG+LP + ++ V G LS L + + P +
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP----K 240
Query: 708 RLVDLGLQCCELYGRERPDITPSLVKELEQL 738
+ L +C + ERP ++ +E L
Sbjct: 241 AMKRLMAECLKKKRDERPLFP-QILASIELL 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-55
Identities = 74/269 (27%), Positives = 111/269 (41%), Gaps = 18/269 (6%)
Query: 477 KVGQGGFGCVYKGEM-LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC- 534
++G G FG V+ G VA+K L +M F E ++ +LQH LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 535 PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 594
E ++ EY+ NGSL D L S + L +AA+IA G+ F+ +H D
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 134
Query: 595 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTP 654
L+ NIL+ LS KI DFG+ RL+ ++ + K + PE G T
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNE-----YTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 655 KSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGL 714
KSD +SFG+++ +++T + ++ P L L
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEV-----IQNLERGYRMVRPDNCPEELYQLMR 244
Query: 715 QCCELYGRERPDITPSLVKELEQLHVAEE 743
C + +RP L LE A E
Sbjct: 245 LCWKERPEDRPTFD-YLRSVLEDFFTATE 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 7e-55
Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 465 LQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSK 521
++ +F + ++G G G V+K G +A K+++ +E++VL +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 522 LQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 579
P++V GA S+ E++ GSL L + + + +++ + GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGL 117
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 639
+L KI+H D+KP NIL++S K+CDFG+ + + + + G+
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--------MANSFVGTR 167
Query: 640 PYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
Y PE + + +SD +S GL ++++ GR P
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (477), Expect = 8e-55
Identities = 62/265 (23%), Positives = 109/265 (41%), Gaps = 24/265 (9%)
Query: 477 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE 536
+G+G FG V G+ G VA+K + N F E V+++L+H +LV LLG E
Sbjct: 14 TIGKGEFGDVMLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 537 AWS---LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 593
+V EY+ GSL D L + S L + + ++ + +L VH
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHR 127
Query: 594 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLT 653
DL +N+L+ + +K+ DFG+ + + K + PE R +
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASSTQ---------DTGKLPVKWTAPEALREKKFS 178
Query: 654 PKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLG 713
KSD +SFG+++ ++ + ++ + + D P + ++
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----VPRVEKGYKMDAPDGCPPAVYEVM 233
Query: 714 LQCCELYGRERPDITPSLVKELEQL 738
C L RP L ++LE +
Sbjct: 234 KNCWHLDAAMRPSFL-QLREQLEHI 257
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 6e-54
Identities = 60/266 (22%), Positives = 110/266 (41%), Gaps = 22/266 (8%)
Query: 477 KVGQGGFGCVYKGEM-LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC- 534
++G G FG V G+ VAIKM+ + EF +E +V+ L H LV L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 535 -PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 593
++ EY+ NG L + L + + + ++ + +L ++ +H
Sbjct: 70 KQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE---SKQFLHR 124
Query: 594 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLT 653
DL +N L++ + K+ DFG+ R V +D + S K ++ PE +
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDE-----YTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 654 PKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDL 712
KSD ++FG+++ ++ + G++P I L P + ++ +
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMP--YERFTNSET----AEHIAQGLRLYRPHLASEKVYTI 233
Query: 713 GLQCCELYGRERPDITPSLVKELEQL 738
C ERP L+ + +
Sbjct: 234 MYSCWHEKADERPTFK-ILLSNILDV 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 1e-53
Identities = 63/265 (23%), Positives = 112/265 (42%), Gaps = 20/265 (7%)
Query: 477 KVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC- 534
++G G FG V+ G L VAIK + + +F +E V+ KL HP LV L G C
Sbjct: 12 EIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 535 -PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 593
LV+E++ +G L D L + + + + ++ G+ +L ++H
Sbjct: 71 EQAPICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYLEE---ACVIHR 125
Query: 594 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLT 653
DL +N L+ K+ DFG+ R V +D + ST K +A PE +
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQ-----YTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 654 PKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLG 713
KSD +SFG+++ ++ + + I P + + +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----VEDISTGFRLYKPRLASTHVYQIM 235
Query: 714 LQCCELYGRERPDITPSLVKELEQL 738
C + +RP + L+++L ++
Sbjct: 236 NHCWKERPEDRPAFS-RLLRQLAEI 259
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 185 bits (470), Expect = 2e-53
Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 31/297 (10%)
Query: 460 FSLADLQTATCNFSESF---------KVGQGGFGCVYKGEM-----LGRTVAIKMLYSHN 505
F+ D A F++ +G G FG V G + VAIK L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 506 MQGQL-EFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSP 562
+ Q +F E ++ + HP+++ L G ++ E++ NGSL F + N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQNDGQ 124
Query: 563 LLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622
+ IA+G+ +L VH DL +NIL++S L K+ DFG+ R + +D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEV 681
T P++ + K + PE + T SD +S+G+++ ++++ G P
Sbjct: 182 T-SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMT 238
Query: 682 RRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738
+ V +++I P L L L C + RP +V L+++
Sbjct: 239 NQDV----INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG-QIVNTLDKM 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 7e-53
Identities = 73/296 (24%), Positives = 129/296 (43%), Gaps = 24/296 (8%)
Query: 452 EDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNM 506
+L ++ + + + +F+E +G+G FGCVY G +L A+K L
Sbjct: 11 PELVQAVQHVVIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 68
Query: 507 QGQLE-FQQEVRVLSKLQHPHLVTLLGACPEAWS---LVYEYLPNGSLQDRLFRKSNVSP 562
G++ F E ++ HP++++LLG C + +V Y+ +G L++ F ++
Sbjct: 69 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHN 126
Query: 563 LLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622
KD ++A G+ FL +K VH DL +N +LD + + K+ DFG+ R + +
Sbjct: 127 PTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183
Query: 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR 682
S H T K + E +T T KSD +SFG+++ +L+T P
Sbjct: 184 EFD--SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 241
Query: 683 RAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738
+L P + L ++ L+C RP + LV + +
Sbjct: 242 DI-----TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFS-ELVSRISAI 291
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 9e-53
Identities = 69/272 (25%), Positives = 116/272 (42%), Gaps = 24/272 (8%)
Query: 474 ESFKVGQGGFGCVYKGEM----LGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHL 527
E ++G G FG V KG + +TVA+K+L + L E E V+ +L +P++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 528 VTLLGAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
V ++G C E+W LV E G L L + + K+ + +++ G+ +L
Sbjct: 71 VRMIGICEAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE--- 124
Query: 587 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 646
VH DL +N+LL ++ +KI DFG+ + + D Y + T K + PE
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY---YKAQTHGKWPVKWYAPEC 181
Query: 647 HRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 705
+ KSD +SFG+++ + + G+ P G V + + P
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSEV----TAMLEKGERMGCPAGC 235
Query: 706 ARRLVDLGLQCCELYGRERPDITPSLVKELEQ 737
R + DL C RP ++ L
Sbjct: 236 PREMYDLMNLCWTYDVENRPGFA-AVELRLRN 266
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 1e-52
Identities = 64/282 (22%), Positives = 115/282 (40%), Gaps = 22/282 (7%)
Query: 474 ESFKVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLV 528
++G G FG V +G VAIK+L + E +E +++ +L +P++V
Sbjct: 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 72
Query: 529 TLLGACPEA-WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 587
L+G C LV E G L L K + + A + +++ G+ +L
Sbjct: 73 RLIGVCQAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLE---E 127
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 647
+ VH DL +N+LL + +KI DFG+ + + D Y +A K + PE
Sbjct: 128 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY---TARSAGKWPLKWYAPECI 184
Query: 648 RTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVA 706
+ +SD +S+G+ + + L+ G+ P V ++ I + P
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQKP--YKKMKGPEV----MAFIEQGKRMECPPECP 238
Query: 707 RRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPVPS 748
L L C +RPD ++ + + + + V
Sbjct: 239 PELYALMSDCWIYKWEDRPDFL-TVEQRMRACYYSLASKVEG 279
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 6e-52
Identities = 62/294 (21%), Positives = 105/294 (35%), Gaps = 40/294 (13%)
Query: 477 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE 536
+G+G FG V++G+ G VA+K+ S + + E+ L+H +++ + A +
Sbjct: 10 SIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 537 AWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE-- 588
LV +Y +GSL D L R + + ++A ASGL LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 589 ---KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 645
I H DLK +NIL+ + I D G+ T + G+ Y PE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID--IAPNHRVGTKRYMAPE 182
Query: 646 YHRTGV------LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC------------ 687
+ ++D Y+ GL+ ++ G+ + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 688 -GKLSSILDPLAGDWPTF--VARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738
L P + R + + +C G R + K L QL
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL-RIKKTLSQL 295
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 180 bits (457), Expect = 1e-51
Identities = 64/267 (23%), Positives = 119/267 (44%), Gaps = 22/267 (8%)
Query: 477 KVGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
K+G G +G VY+G TVA+K L M+ + EF +E V+ +++HP+LV LLG C
Sbjct: 24 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 535 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
+ ++ E++ G+L D L + + +A +I+S + +L +H
Sbjct: 83 TREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIH 138
Query: 593 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL 652
DL +N L+ K+ DFG+ RL+T DT K + PE
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY-----TAHAGAKFPIKWTAPESLAYNKF 193
Query: 653 TPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDP-LAGDWPTFVARRLVD 711
+ KSD ++FG+++ ++ T + + ++ +L+ + P ++ +
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMS------PYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247
Query: 712 LGLQCCELYGRERPDITPSLVKELEQL 738
L C + +RP + + E +
Sbjct: 248 LMRACWQWNPSDRPSFA-EIHQAFETM 273
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-51
Identities = 83/271 (30%), Positives = 113/271 (41%), Gaps = 18/271 (6%)
Query: 477 KVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC- 534
K+GQG FG V+ G VAIK L M + F QE +V+ KL+H LV L
Sbjct: 24 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 82
Query: 535 PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 594
E +V EY+ GSL + L +AA+IASG+ ++ VH D
Sbjct: 83 EEPIYIVTEYMSKGSL-LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 138
Query: 595 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTP 654
L+ NIL+ L K+ DFG+ RL+ ++ + K + PE G T
Sbjct: 139 LRAANILVGENLVCKVADFGLARLIEDNE-----YTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 655 KSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGL 714
KSD +SFG+++ +L T G V R V L + P L DL
Sbjct: 194 KSDVWSFGILLTELTTKGRVP-YPGMVNREV----LDQVERGYRMPCPPECPESLHDLMC 248
Query: 715 QCCELYGRERPDITPSLVKELEQLHVAEERP 745
QC ERP L LE + E
Sbjct: 249 QCWRKEPEERPTFE-YLQAFLEDYFTSTEPQ 278
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 1e-50
Identities = 64/262 (24%), Positives = 104/262 (39%), Gaps = 28/262 (10%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLG 532
++G+G F VYKG VA L + + F++E +L LQHP++V
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 533 AC------PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
+ + LV E + +G+L+ L R + K +I GL FLH+
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 587 PEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 645
P I+H DLK NI + S KI D G+ L + A G+ + PE
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--------SFAKAVIGTPEFMAPE 183
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 705
+ D Y+FG+ +L++ T P + A +++S + P +
Sbjct: 184 MYE-EKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTSGVKPA--SFDKVA 238
Query: 706 ARRLVDLGLQCCELYGRERPDI 727
+ ++ C ER I
Sbjct: 239 IPEVKEIIEGCIRQNKDERYSI 260
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (446), Expect = 5e-50
Identities = 66/309 (21%), Positives = 118/309 (38%), Gaps = 44/309 (14%)
Query: 461 SLADLQTATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQL-EF 512
L L+ N +G+G FG V++ VA+KML +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 513 QQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKS------------ 558
Q+E ++++ +P++V LLG C + L++EY+ G L + L S
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 559 ---------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSK 609
PL ++ IA ++A+G+ +L K VH DL +N L+ + K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180
Query: 610 ICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLL 669
I DFG+ R + Y + PE T +SD +++G+++ ++
Sbjct: 181 IADFGLSRNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236
Query: 670 TGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITP 729
+ L + + D P L +L C +RP
Sbjct: 237 SYGLQPYYGMAHEEV-----IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFC- 290
Query: 730 SLVKELEQL 738
S+ + L+++
Sbjct: 291 SIHRILQRM 299
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 6e-50
Identities = 57/262 (21%), Positives = 102/262 (38%), Gaps = 23/262 (8%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLG 532
+G G +G K G+ + K L +M EV +L +L+HP++V
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 533 ACPEAWS----LVYEYLPNGSLQDRLFRKSNVS-PLLWKDRARIAAEIASGLCFLH--SS 585
+ + +V EY G L + + + L + R+ ++ L H S
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 645
++H DLKP N+ LD + + K+ DFG+ R++ DT + +F + Y PE
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG------TPYYMSPE 184
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 705
KSD +S G ++ +L P ++ + I + P
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAFSQKEL----AGKIREGKFRRIPYRY 238
Query: 706 ARRLVDLGLQCCELYGRERPDI 727
+ L ++ + L RP +
Sbjct: 239 SDELNEIITRMLNLKDYHRPSV 260
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-49
Identities = 55/260 (21%), Positives = 98/260 (37%), Gaps = 24/260 (9%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
++G G FG VYK + A K++ + + + ++ E+ +L+ HP++V LL A
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 535 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
++ E+ G++ + PL + + L +LH +K I+H
Sbjct: 79 YYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNK---IIH 133
Query: 593 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY-----H 647
DLK NIL + K+ DFG+ T R + G+ + PE
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTI------QRRDSFIGTPYWMAPEVVMCETS 187
Query: 648 RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVAR 707
+ K+D +S G+ ++++ P V S L P+ +
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPP--HHELNPMRVLLKIAKSEPPTL--AQPSRWSS 243
Query: 708 RLVDLGLQCCELYGRERPDI 727
D +C E R
Sbjct: 244 NFKDFLKKCLEKNVDARWTT 263
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 7e-49
Identities = 66/277 (23%), Positives = 115/277 (41%), Gaps = 23/277 (8%)
Query: 471 NFSESFKVGQGGFGCVYKGEM------LGRTVAIKMLYSHNMQGQL-EFQQEVRVLSKLQ 523
+ +G G FG VYKG + VAIK L + + Q +F E ++ +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 524 HPHLVTLLGACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCF 581
H +++ L G + ++ EY+ NG+L L K + IA+G+ +
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKY 125
Query: 582 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 641
L + VH DL +NIL++S L K+ DFG+ R++ +D + ++ K +
Sbjct: 126 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT---YTTSGGKIPIRW 179
Query: 642 ADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 701
PE T SD +SFG+++ +++T + +I D
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-----MKAINDGFRLPT 234
Query: 702 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738
P + L +QC + RP +V L++L
Sbjct: 235 PMDCPSAIYQLMMQCWQQERARRPKFA-DIVSILDKL 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 1e-48
Identities = 65/261 (24%), Positives = 110/261 (42%), Gaps = 32/261 (12%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLL 531
+G+G FG VY +A+K+L+ + + + ++EV + S L+HP+++ L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 532 GAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
G L+ EY P G++ L + S + A E+A+ L + HS +
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR--- 126
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
++H D+KP+N+LL S KI DFG R T G+ Y PE
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--------RRTTLCGTLDYLPPEMIEG 178
Query: 650 GVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPTFVAR 707
+ K D +S G++ + L G+ P E + +S + +P FV
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF---------TFPDFVTE 229
Query: 708 RLVDLGLQCCELYGRERPDIT 728
DL + + +RP +
Sbjct: 230 GARDLISRLLKHNPSQRPMLR 250
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 4e-48
Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 21/255 (8%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
K+GQG G VY + G+ VAI+ + + E+ V+ + ++P++V L +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 535 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
+ +V EYL GSL D + A + E L FLHS +++H
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECLQALEFLHS---NQVIH 139
Query: 593 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL 652
D+K NILL + S K+ DFG C +T + + + G+ + PE
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQ------SKRSTMVGTPYWMAPEVVTRKAY 193
Query: 653 TPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDL 712
PK D +S G++ ++++ G P E ++ L P ++ D
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP--YLNENPLRALYLIATNGTPEL--QNPEKLSAIFRDF 249
Query: 713 GLQCCELYGRERPDI 727
+C ++ +R
Sbjct: 250 LNRCLDMDVEKRGSA 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 6e-48
Identities = 68/272 (25%), Positives = 117/272 (43%), Gaps = 24/272 (8%)
Query: 477 KVGQGGFGCVYKGEML-----GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLV 528
K+G G FG V +GE +VA+K L + + +F +EV + L H +L+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 529 TLLGACPEAW-SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 587
L G +V E P GSL DRL + L +R A ++A G+ +L S
Sbjct: 75 RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLES--- 129
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 647
++ +H DL +N+LL + KI DFG+ R + ++ + K F + PE
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND---DHYVMQEHRKVPFAWCAPESL 186
Query: 648 RTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVA 706
+T + SD++ FG+ + ++ T G+ P + K + P
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-----EGERLPRPEDCP 241
Query: 707 RRLVDLGLQCCELYGRERPDITPSLVKELEQL 738
+ + ++ +QC +RP +L L +
Sbjct: 242 QDIYNVMVQCWAHKPEDRPTFV-ALRDFLLEA 272
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 8e-48
Identities = 71/288 (24%), Positives = 115/288 (39%), Gaps = 38/288 (13%)
Query: 477 KVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKL-QHPHL 527
+G G FG V + TVA+KML + E E++VLS L H ++
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 528 VTLLGAC--PEAWSLVYEYLPNGSLQDRLFRK---------------SNVSPLLWKDRAR 570
V LLGAC ++ EY G L + L RK + L +D
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 571 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 630
+ ++A G+ FL S + +H DL +NILL +KICDFG+ R + D+ ++
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS----NYV 202
Query: 631 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKL 690
+ + PE V T +SD +S+G+ + +L + V
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF----Y 258
Query: 691 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738
I + P + D+ C + +RP +V+ +E+
Sbjct: 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK-QIVQLIEKQ 305
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (429), Expect = 1e-47
Identities = 61/267 (22%), Positives = 97/267 (36%), Gaps = 31/267 (11%)
Query: 472 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ---LEFQQEVRVLSKLQHPH 526
FS+ ++G G FG VY + VAIK + Q + +EVR L KL+HP+
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 527 LVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 584
+ G LV EY + K PL + A + GL +LHS
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHS 133
Query: 585 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 644
++H D+K NILL K+ DFG ++ ++ G+ + P
Sbjct: 134 ---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV----------GTPYWMAP 180
Query: 645 EY---HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 701
E G K D +S G+ ++L + P L + + L
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSALYHIAQNESPALQ--- 235
Query: 702 PTFVARRLVDLGLQCCELYGRERPDIT 728
+ + C + ++RP
Sbjct: 236 SGHWSEYFRNFVDSCLQKIPQDRPTSE 262
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 170 bits (431), Expect = 2e-47
Identities = 56/257 (21%), Positives = 104/257 (40%), Gaps = 21/257 (8%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
++G G FG V++ G A K + + + + ++E++ +S L+HP LV L A
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 535 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
++YE++ G L +++ + N + + ++ GLC +H VH
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHE---NNYVH 147
Query: 593 GDLKPQNILLDSELSS--KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 650
DLKP+NI+ ++ S+ K+ DFG+ + G+ +A PE
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-------QSVKVTTGTAEFAAPEVAEGK 200
Query: 651 VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 710
+ +D +S G++ LL+G P GE S + + ++
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSP--FGGENDDETLRNVKSCDWNMDDSAFSG-ISEDGK 257
Query: 711 DLGLQCCELYGRERPDI 727
D + R I
Sbjct: 258 DFIRKLLLADPNTRMTI 274
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 3e-47
Identities = 68/291 (23%), Positives = 117/291 (40%), Gaps = 43/291 (14%)
Query: 477 KVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQGQLE-FQQEVRVLSKL-QHPHL 527
+G G FG V G VA+KML + E E++++++L H ++
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 528 VTLLGAC--PEAWSLVYEYLPNGSLQDRLFRK--------------------SNVSPLLW 565
V LLGAC L++EY G L + L K +++ L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 566 KDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625
+D A ++A G+ FL + VH DL +N+L+ KICDFG+ R + D+
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS-- 218
Query: 626 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV 685
++ + + PE G+ T KSD +S+G+++ ++ + + V
Sbjct: 219 --NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 276
Query: 686 SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736
I + D P + + + C R+RP +L L
Sbjct: 277 ----YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP-NLTSFLG 322
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 8e-47
Identities = 65/282 (23%), Positives = 118/282 (41%), Gaps = 25/282 (8%)
Query: 472 FSESFKVGQGGFGCVYK------GEMLGRTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQH 524
F + +G G FG VYK GE + VAIK L + + + E E V++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 525 PHLVTLLGACPEA-WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 583
PH+ LLG C + L+ + +P G L D + + + +IA G+ +L
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIG--SQYLLNWCVQIAKGMNYLE 128
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 643
++VH DL +N+L+ + KI DFG+ +L+ + + + K +
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE----EKEYHAEGGKVPIKWMA 181
Query: 644 PEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 702
E + T +SD +S+G+ + +L+T G P G + S + P
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD--GIPASEI----SSILEKGERLPQP 235
Query: 703 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER 744
+ + ++C + RP L+ E ++ +R
Sbjct: 236 PICTIDVYMIMVKCWMIDADSRPKFR-ELIIEFSKMARDPQR 276
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-46
Identities = 67/289 (23%), Positives = 112/289 (38%), Gaps = 37/289 (12%)
Query: 471 NFSESFKVGQGGFGCVYKGEMLG----RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QH 524
+ +G+G FG V K + AIK + + + +F E+ VL KL H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 525 PHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRK-------------SNVSPLLWKDRA 569
P+++ LLGAC L EY P+G+L D L + S S L +
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 570 RIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 629
AA++A G+ +L + +H DL +NIL+ +KI DFG+ R
Sbjct: 131 HFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV------ 181
Query: 630 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGK 689
+ T + + E V T SD +S+G+++ ++++
Sbjct: 182 -KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----- 235
Query: 690 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738
+ + P + DL QC ERP ++ L ++
Sbjct: 236 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA-QILVSLNRM 283
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 3e-46
Identities = 61/269 (22%), Positives = 108/269 (40%), Gaps = 23/269 (8%)
Query: 477 KVGQGGFGCVYKGEML-----GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTL 530
+G+G FG V++G + VAIK + E F QE + + HPH+V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 531 LGACPEAWS-LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
+G E ++ E G L+ F + L A ++++ L +L S ++
Sbjct: 74 IGVITENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLES---KR 128
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
VH D+ +N+L+ S K+ DFG+ R + + T +++++ K + PE
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-----YYKASKGKLPIKWMAPESINF 183
Query: 650 GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRL 709
T SD + FG+ + ++L + + + I + P L
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-----IGRIENGERLPMPPNCPPTL 238
Query: 710 VDLGLQCCELYGRERPDITPSLVKELEQL 738
L +C RP T L +L +
Sbjct: 239 YSLMTKCWAYDPSRRPRFT-ELKAQLSTI 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 4e-46
Identities = 69/297 (23%), Positives = 127/297 (42%), Gaps = 30/297 (10%)
Query: 471 NFSESFKVGQGGFGCVYKG-------EMLGRTVAIKMLY-SHNMQGQLEFQQEVRVLSKL 522
+ S ++GQG FG VY+G + VAIK + + +M+ ++EF E V+ +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 523 QHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLF-------RKSNVSPLLWKDRARIAA 573
H+V LLG + ++ E + G L+ L ++P ++A
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 574 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 633
EIA G+ +L+++K VH DL +N ++ + + KI DFG+ R + E Y +
Sbjct: 141 EIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGG 193
Query: 634 APKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSI 693
+ PE + GV T SD +SFG+++ ++ T + L +
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-----LRFV 248
Query: 694 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPVPSFF 750
++ D P L +L C + + RP ++ +++ R V ++
Sbjct: 249 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL-EIISSIKEEMEPGFREVSFYY 304
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 6e-46
Identities = 56/257 (21%), Positives = 94/257 (36%), Gaps = 20/257 (7%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 533
+G+G +G V VA+K++ E ++E+ + L H ++V G
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 534 C--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591
L EY G L DR+ + D R ++ +G+ +LH I
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG---IGIT 125
Query: 592 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG- 650
H D+KP+N+LLD + KI DFG+ + + G+ PY PE +
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNN----RERLLNKMCGTLPYVAPELLKRRE 181
Query: 651 VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 710
D +S G+++ +L G LP + + S K + +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP----WKKIDSAPL 237
Query: 711 DLGLQCCELYGRERPDI 727
L + R I
Sbjct: 238 ALLHKILVENPSARITI 254
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 162 bits (410), Expect = 2e-45
Identities = 65/274 (23%), Positives = 118/274 (43%), Gaps = 23/274 (8%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ---LEFQQEVRVLSKLQHPHLVTLL 531
+G GG V+ L R VA+K+L + + L F++E + + L HP +V +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 532 GACPEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 585
+V EY+ +L+D + + P+ K + A+ L F H +
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN 130
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 645
I+H D+KP NI++ + + K+ DFGI R + + S ++ A G+ Y PE
Sbjct: 131 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG---NSVTQTAAVIGTAQYLSPE 184
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 705
R + +SD YS G ++ ++LTG P G+ +V+ + P + +
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSVAYQHVREDPIPPSARHEG-L 241
Query: 706 ARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739
+ L + L+ R + +L ++H
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 8e-45
Identities = 67/270 (24%), Positives = 104/270 (38%), Gaps = 24/270 (8%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLL 531
+G+G F V L R AIK+L ++ +E V+S+L HP V L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 532 GAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
E Y NG L + + AEI S L +LH +
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHG---KG 128
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
I+H DLKP+NILL+ ++ +I DFG ++++ ++ R+ + G+ Y PE
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES----KQARANSFVGTAQYVSPELLTE 184
Query: 650 GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRL 709
SD ++ G II QL+ G P + I+ L D+P +
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLI----FQKIIK-LEYDFPEKFFPKA 237
Query: 710 VDLGLQCCELYGRERPDITPSLVKELEQLH 739
DL + L +R + H
Sbjct: 238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAH 267
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (407), Expect = 3e-44
Identities = 56/257 (21%), Positives = 105/257 (40%), Gaps = 21/257 (8%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
++G G FG V++ GR K + + + + E+ ++++L HP L+ L A
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 535 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
L+ E+L G L DR+ + + + + GL +H IVH
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEH---SIVH 150
Query: 593 GDLKPQNILLDSELSS--KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 650
D+KP+NI+ +++ +S KI DFG+ + D + + + +A PE
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-------TATAEFAAPEIVDRE 203
Query: 651 VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 710
+ +D ++ G++ LL+G P AGE + + + V+
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSP--FAGEDDLETLQNVKRCDWEFDEDAFSS-VSPEAK 260
Query: 711 DLGLQCCELYGRERPDI 727
D + R+R +
Sbjct: 261 DFIKNLLQKEPRKRLTV 277
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 5e-43
Identities = 49/258 (18%), Positives = 109/258 (42%), Gaps = 22/258 (8%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
+G+G FG V++ +T K + Q+ ++E+ +L+ +H +++ L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 535 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 592
E +++E++ + +R+ ++ L ++ ++ L FLHS I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHSHN---IGH 125
Query: 593 GDLKPQNILLDSELSS--KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 650
D++P+NI+ + SS KI +FG R + + + Y PE H+
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-------RLLFTAPEYYAPEVHQHD 178
Query: 651 VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 710
V++ +D +S G ++ LL+G P E + + +++ + ++ +
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINP--FLAETNQQIIENIMNAEYTFDEEAFKE-ISIEAM 235
Query: 711 DLGLQCCELYGRERPDIT 728
D + + R +
Sbjct: 236 DFVDRLLVKERKSRMTAS 253
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (391), Expect = 1e-42
Identities = 65/288 (22%), Positives = 122/288 (42%), Gaps = 39/288 (13%)
Query: 477 KVGQGGFGCVYKGEML---------GRTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHP 525
+G+G FG V E + VA+KML S + L + E+ ++ + +H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 526 HLVTLLGACPEAWS--LVYEYLPNGSLQDRLFRK-------------SNVSPLLWKDRAR 570
+++ LLGAC + ++ EY G+L++ L + + L KD
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 571 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 630
A ++A G+ +L S +K +H DL +N+L+ + KI DFG+ R + +
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID----YYK 192
Query: 631 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKL 690
++T + + PE + T +SD +SFG+++ ++ T V
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL--- 249
Query: 691 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738
+ + D P+ L + C +RP LV++L+++
Sbjct: 250 --LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRI 294
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (384), Expect = 2e-41
Identities = 60/260 (23%), Positives = 103/260 (39%), Gaps = 24/260 (9%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 533
+G G F V E + VAIK + ++G+ + E+ VL K++HP++V L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 534 C--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591
L+ + + G L DR+ K +D +R+ ++ + +LH IV
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHD---LGIV 129
Query: 592 HGDLKPQNILL---DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 648
H DLKP+N+L D + I DFG+ ++ ++ + G+ Y PE
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL-------STACGTPGYVAPEVLA 182
Query: 649 TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARR 708
+ D +S G+I LL G P E + L + + + W ++
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPP--FYDENDAKLFEQILKAEYEFDSPYWDD-ISDS 239
Query: 709 LVDLGLQCCELYGRERPDIT 728
D E +R
Sbjct: 240 AKDFIRHLMEKDPEKRFTCE 259
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 151 bits (383), Expect = 7e-41
Identities = 64/278 (23%), Positives = 111/278 (39%), Gaps = 29/278 (10%)
Query: 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ------LEFQQEVRVLSKL 522
+FS +G+GGFG VY G+ A+K L ++ + L + + ++S
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 523 QHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLC 580
P +V + A P+ S + + + G L L + D AAEI GL
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLE 121
Query: 581 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP 640
+H+ +V+ DLKP NILLD +I D G+ ++ + A G+
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--------KPHASVGTHG 170
Query: 641 YADPEYHRTGV-LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAG 699
Y PE + GV +D +S G ++ +LL G P + ++ + +A
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLTMAV 226
Query: 700 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 737
+ P + L L + R +E+++
Sbjct: 227 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 8e-41
Identities = 69/287 (24%), Positives = 116/287 (40%), Gaps = 37/287 (12%)
Query: 477 KVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQL-EFQQEVRVLSK-LQHPHL 527
+G+G FG V + + RTVA+KML + E+++L H ++
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 528 VTLLGACPEAWS---LVYEYLPNGSLQDRLFRKSNV-------------SPLLWKDRARI 571
V LLGAC + ++ E+ G+L L K N L +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 572 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 631
+ ++A G+ FL S K +H DL +NILL + KICDFG+ R + +D P + R
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PDYVR 192
Query: 632 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLS 691
+ + PE V T +SD +SFG+++ ++ + ++
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF----CR 248
Query: 692 SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738
+ + P + + L C +RP + LV+ L L
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS-ELVEHLGNL 294
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 148 bits (374), Expect = 2e-40
Identities = 60/280 (21%), Positives = 108/280 (38%), Gaps = 40/280 (14%)
Query: 472 FSESFKV----GQGGFGCVYKGEML--GRTVAIKML---------YSHNMQGQLEFQQEV 516
F E+++ G+G V + + A+K++ + + +EV
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 517 RVLSKLQ-HPHLVTLLGACPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA 573
+L K+ HP+++ L LV++ + G L D L K L K+ +I
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMR 117
Query: 574 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 633
+ +C LH IVH DLKP+NILLD +++ K+ DFG + +
Sbjct: 118 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-------EKLR 167
Query: 634 APKGSFPYADPEYHRTGVL------TPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC 687
G+ Y PE + + D +S G+I+ LL G P + +
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--FWHRKQMLMLR 225
Query: 688 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDI 727
+S + +W + + DL + + ++R
Sbjct: 226 MIMSGNYQFGSPEWDD-YSDTVKDLVSRFLVVQPQKRYTA 264
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 1e-39
Identities = 56/268 (20%), Positives = 99/268 (36%), Gaps = 14/268 (5%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 533
+G+G +G V VAIK + Q + +E+++L + +H +++ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 534 C--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591
P + YL + L++ L +I GL ++HS ++
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 131
Query: 592 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 651
H DLKP N+LL++ KICDFG+ R+ D T + Y PE
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLARVADPDH---DHTGFLTEYVATRWYRAPEIMLNSK 188
Query: 652 L-TPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 710
T D +S G I+ ++L+ R G+ L + P D + +
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNRPI--FPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 711 DLGLQCCELYGRERPDITPSLVKELEQL 738
+ L + P+ + L
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDL 274
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 147 bits (371), Expect = 1e-39
Identities = 64/268 (23%), Positives = 106/268 (39%), Gaps = 29/268 (10%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 531
+G G FG V+ GR A+K+L ++ E +LS + HP ++ +
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 532 GACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
G +A + + +Y+ G L L + AAE+ L +LHS +
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP---NPVAKFYAAEVCLALEYLHS---KD 124
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
I++ DLKP+NILLD KI DFG + V + + G+ Y PE T
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPD---------VTYTLCGTPDYIAPEVVST 175
Query: 650 GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRL 709
D +SFG++I ++L G P IL+ +P F +
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTP--FYDSNTMKT----YEKILNA-ELRFPPFFNEDV 228
Query: 710 VDLGLQCCELYGRERPDITPSLVKELEQ 737
DL + +R + ++++
Sbjct: 229 KDLLSRLITRDLSQRLGNLQNGTEDVKN 256
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-39
Identities = 67/265 (25%), Positives = 103/265 (38%), Gaps = 27/265 (10%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE---FQQEVRVLSK-LQHPHLVTL 530
+G+G FG V+ E + AIK L + + E RVLS +HP L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 531 LGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 588
E V EYL G L + AAEI GL FLHS +
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHS---K 122
Query: 589 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 648
IV+ DLK NILLD + KI DFG+C+ ++ G+ Y PE
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD------AKTNTFCGTPDYIAPEILL 176
Query: 649 TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARR 708
D +SFG+++ ++L G+ P +L + +P ++ +
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSP-------FHGQDEEELFHSIRMDNPFYPRWLEKE 229
Query: 709 LVDLGLQCCELYGRERPDITPSLVK 733
DL ++ +R + + +
Sbjct: 230 AKDLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 144 bits (363), Expect = 9e-39
Identities = 55/276 (19%), Positives = 98/276 (35%), Gaps = 27/276 (9%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
K+G G FG +Y G + G VAIK+ Q E ++ +Q + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 71
Query: 535 ---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591
+ +V E L F K +A ++ S + ++HS +
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFI 125
Query: 592 HGDLKPQNILLDSELSSKIC---DFGICRLVTEDTLYLPSF-HRSTAPKGSFPYADPEYH 647
H D+KP N L+ + DFG+ + + + + G+ YA H
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 648 RTGVLTPKSDSYSFGLIILQLLTGRLPVGL-----AGEVRRAVSCGKLSSILDPLAGDWP 702
+ + D S G +++ G LP + +S K+S+ ++ L +P
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245
Query: 703 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738
C L ++PD + L + L
Sbjct: 246 ----SEFATYLNFCRSLRFDDKPDYS-YLRQLFRNL 276
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-38
Identities = 49/215 (22%), Positives = 89/215 (41%), Gaps = 24/215 (11%)
Query: 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLV 528
+++++ +G G FG VY+ ++ G VAIK + +Q + +E++++ KL H ++V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 76
Query: 529 TLLGACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLC 580
L + LV +Y+P + L ++ L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 581 FLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 639
++HS I H D+KPQN+LLD + K+CDFG + + + +
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE------PNVSYICSRY 187
Query: 640 PYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
A T D +S G ++ +LL G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 140 bits (354), Expect = 1e-37
Identities = 48/278 (17%), Positives = 86/278 (30%), Gaps = 29/278 (10%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
++G+G FG +++G L + VAIK + + E R L + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 535 ---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591
LV + L K A A ++ + + +H +V
Sbjct: 70 GQEGLHNVLVIDLLGPSLED---LLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LV 123
Query: 592 HGDLKPQNILLDSELSS-----KICDFGICRLVTED-TLYLPSFHRSTAPKGSFPYADPE 645
+ D+KP N L+ S + DFG+ + + T + G+ Y
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLTGR-----LPVGLAGEVRRAVSCGKLSSILDPLAGD 700
H + + D + G + + L G L + + K S+ L L
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243
Query: 701 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738
+P L PD L ++
Sbjct: 244 FP----EEFYKYMHYARNLAFDATPDYD-YLQGLFSKV 276
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 69/286 (24%), Positives = 109/286 (38%), Gaps = 31/286 (10%)
Query: 477 KVGQGGFGCVYKGEML---GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKL---QHPHLV 528
++G+G +G V+K L GR VA+K + + L +EV VL L +HP++V
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 529 TLLGACPEAWS-------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCF 581
L C + + LV+E++ K + + + ++ GL F
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDMMFQLLRGLDF 131
Query: 582 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 641
LHS ++VH DLKPQNIL+ S K+ DFG+ R+ + T+ + Y
Sbjct: 132 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-------QMALTSVVVTLWY 181
Query: 642 ADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 701
PE D +S G I ++ + G L I P DW
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL--FRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 702 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL--HVAEERP 745
P VA + + + DI L + +R
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 285
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-37
Identities = 56/265 (21%), Positives = 98/265 (36%), Gaps = 31/265 (11%)
Query: 478 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGAC 534
+G G G V + A+KML Q + ++EV + + Q PH+V ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 535 PEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 588
++ +V E L G L R+ + + ++ + I I + +LHS
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN-- 131
Query: 589 KIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 645
I H D+KP+N+L S+ + K+ DFG + T + + Y PE
Sbjct: 132 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-------TPYYVAPE 183
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLTGRLPV--GLAGEVRRAVSCGKLSSILDPLAGDWPT 703
D +S G+I+ LL G P + + + +W
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 704 FVARRLVDLGLQCCELYGRERPDIT 728
V+ + L + +R IT
Sbjct: 244 -VSEEVKMLIRNLLKTEPTQRMTIT 267
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 2e-35
Identities = 60/265 (22%), Positives = 106/265 (40%), Gaps = 30/265 (11%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL------EFQQEVRVLSKLQHPHLV 528
++G G F V K G A K + + + ++EV +L ++QHP+++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 529 TLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 586
TL L+ E + G L D L K L ++ +I +G+ +LHS
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS-- 131
Query: 587 PEKIVHGDLKPQNILLDSE----LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 642
+I H DLKP+NI+L KI DFG+ + G+ +
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-------EFKNIFGTPEFV 183
Query: 643 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 702
PE L ++D +S G+I LL+G P G+ ++ +S++ ++
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASP--FLGDTKQET-LANVSAVNYEFEDEYF 240
Query: 703 TFVARRLVDLGLQCCELYGRERPDI 727
+ + D + ++R I
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTI 265
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 133 bits (334), Expect = 4e-35
Identities = 54/269 (20%), Positives = 99/269 (36%), Gaps = 20/269 (7%)
Query: 477 KVGQGGFGCVYKGEM-LGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLGA 533
K+G+G +G VYK + G T A+K + + +E+ +L +L+H ++V L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 534 CPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591
LV+E+L + + L ++ +G+ + H + ++
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR---VL 122
Query: 592 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 651
H DLKPQN+L++ E KI DFG+ R + + A +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL-----WYRAPDVLMGSKK 177
Query: 652 LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVD 711
+ D +S G I +++ G G + P + +WP D
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPL--FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 712 LGLQCCELYGRER--PDITPSLVKELEQL 738
E E + S + L ++
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKM 264
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 5e-35
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPH 526
NF + K+G+G +G VYK G VA+K + + +E+ +L +L HP+
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 527 LVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 584
+V LL LV+E+L + S ++ + ++ GL F HS
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 585 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 644
+++H DLKPQN+L+++E + K+ DFG+ R P + + A
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-----PVRTYTHEVVTLWYRAPE 172
Query: 645 EYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
+ D +S G I +++T R
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 5e-35
Identities = 67/274 (24%), Positives = 109/274 (39%), Gaps = 30/274 (10%)
Query: 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHP 525
+F +G+G FG V GR A+K+L + + E E RVL +HP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 526 HLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 583
L L A + V EY G L L R+ + AEI S L +LH
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLH 122
Query: 584 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 643
S +V+ D+K +N++LD + KI DFG+C+ D + +F G+ Y
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC------GTPEYLA 173
Query: 644 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAGDW 701
PE D + G+++ +++ GRLP + + ++ +
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---------RF 224
Query: 702 PTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735
P ++ L + ++R PS KE+
Sbjct: 225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 7e-35
Identities = 48/213 (22%), Positives = 88/213 (41%), Gaps = 23/213 (10%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLG 532
K+GQG FG V+K G+ VA+K + N + +E+++L L+H ++V L+
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 533 ACPEAWS----------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 582
C S LV+++ + + R+ + +GL ++
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYI 133
Query: 583 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 642
H KI+H D+K N+L+ + K+ DFG+ R + P+ + + + Y
Sbjct: 134 HR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV--VTLWYR 188
Query: 643 DPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLP 674
PE P D + G I+ ++ T
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 7e-35
Identities = 55/269 (20%), Positives = 92/269 (34%), Gaps = 24/269 (8%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-----FQQEVRVLSKLQHPHLVT 529
+G+G F VYK + VAIK + + + +E+++L +L HP+++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 530 LLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 587
LL A SLV++++ L GL +LH
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQ--- 118
Query: 588 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE-Y 646
I+H DLKP N+LLD K+ DFG+ + T + Y PE
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP------NRAYTHQVVTRWYRAPELL 172
Query: 647 HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVA 706
+ D ++ G I+ +LL L G+ ++ P WP +
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPF--LPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 707 RRLVDLGLQCCELYGRERPDITPSLVKEL 735
+ + +L
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDL 259
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 2e-34
Identities = 54/265 (20%), Positives = 95/265 (35%), Gaps = 40/265 (15%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE------FQQEVRVLSKLQHPH-- 526
+G GGFG VY G + VAIK + + E EV +L K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 527 LVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 584
++ LL P+++ L+ E + L + ++ + H+
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN 128
Query: 585 SKPEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 643
++H D+K +NIL+D K+ DFG L+ + T G+ Y+
Sbjct: 129 CG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD--------TVYTDFDGTRVYSP 177
Query: 644 PEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 702
PE+ R + +S G+++ ++ G +P E+ R +
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV-------------FFR 224
Query: 703 TFVARRLVDLGLQCCELYGRERPDI 727
V+ L C L +RP
Sbjct: 225 QRVSSECQHLIRWCLALRPSDRPTF 249
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 130 bits (327), Expect = 2e-33
Identities = 55/268 (20%), Positives = 102/268 (38%), Gaps = 29/268 (10%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLL 531
+G G FG V + G A+K+L + + E R+L + P LV L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 532 GACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
+ + +L V EY+ G + L R AA+I +LHS
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 590 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 649
+++ DLKP+N+L+D + ++ DFG + R+ G+ PE +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK---------RVKGRTWTLCGTPEALAPEIILS 212
Query: 650 GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRL 709
D ++ G++I ++ G P A ++ + +P+ + L
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPP-------FFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 710 VDLGLQCCELYGRERPDITPSLVKELEQ 737
DL ++ +R + V +++
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 4e-33
Identities = 42/204 (20%), Positives = 79/204 (38%), Gaps = 17/204 (8%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLG 532
K+G+G +G V+K + VA+K + + + +E+ +L +L+H ++V L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 533 ACPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 590
LV+E+ + ++ + ++ GL F H +
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCH---SRNV 122
Query: 591 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 650
+H DLKPQN+L++ K+ +FG+ R P S +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGI-----PVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 651 VLTPKSDSYSFGLIILQLLTGRLP 674
+ + D +S G I +L P
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRP 201
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 1e-31
Identities = 54/295 (18%), Positives = 99/295 (33%), Gaps = 34/295 (11%)
Query: 460 FSLADLQTATCNFSESFKV----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--E 511
F ++ ++ G G +G V G VAIK LY
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 512 FQQEVRVLSKLQHPHLVTLLGACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPL 563
+E+R+L ++H +++ LL + LV ++ G+ +L + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE---KL 118
Query: 564 LWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623
+ ++ GL ++H+ I+H DLKP N+ ++ + KI DFG+ R
Sbjct: 119 GEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-- 173
Query: 624 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR 683
+ + A T D +S G I+ +++TG+ G
Sbjct: 174 ------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL--FKGSDHL 225
Query: 684 AVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738
+ P A + + EL ++ I + L
Sbjct: 226 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNL 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 119 bits (298), Expect = 7e-30
Identities = 42/207 (20%), Positives = 84/207 (40%), Gaps = 28/207 (13%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGA 533
K+G+G + V++ + V +K+L + + ++E+++L L+ P+++TL
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADI 98
Query: 534 CPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 589
+ S LV+E++ N + L D EI L + HS
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---G 149
Query: 590 IVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 648
I+H D+KP N+++D E ++ D+G+ S + PE
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-------EYNVRVASRYFKGPELLV 202
Query: 649 T-GVLTPKSDSYSFGLIILQLLTGRLP 674
+ D +S G ++ ++ + P
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-29
Identities = 47/210 (22%), Positives = 80/210 (38%), Gaps = 28/210 (13%)
Query: 477 KVGQGGFGCVYKGE--MLGRTVAIKMLY--SHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 532
+G G G V +L R VAIK L N +E+ ++ + H ++++LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 533 ACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 584
+ LV E + Q + + + ++ G+ LHS
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLCGIKHLHS 137
Query: 585 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 644
I+H DLKP NI++ S+ + KI DFG+ R T + Y P
Sbjct: 138 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-------FMMTPYVVTRYYRAP 187
Query: 645 EYHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
E D +S G I+ +++ ++
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 7e-29
Identities = 49/209 (23%), Positives = 79/209 (37%), Gaps = 26/209 (12%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLG 532
VG G +G V G VA+K L +E+R+L ++H +++ LL
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 533 ACPEAWSL-------VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 585
A SL + +L L + + + L + +I GL ++HS
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHS- 139
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 645
I+H DLKP N+ ++ + KI DFG+ + + A
Sbjct: 140 --ADIIHRDLKPSNLAVNEDCELKILDFGLA--------RHTDDEMTGYVATRWYRAPEI 189
Query: 646 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 674
D +S G I+ +LLTGR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 1e-28
Identities = 64/273 (23%), Positives = 108/273 (39%), Gaps = 28/273 (10%)
Query: 477 KVGQGGFGCVYKGEML-----GRTVAIKML----YSHNMQGQLEFQQEVRVLSKLQH-PH 526
+G G +G V+ + G+ A+K+L + + E +VL ++ P
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 527 LVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 584
LVTL A L + +Y+ G L L ++ + EI L LH
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHK 147
Query: 585 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 644
I++ D+K +NILLDS + DFG+ + D R+ G+ Y P
Sbjct: 148 ---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-----ERAYDFCGTIEYMAP 199
Query: 645 EYHRTGV--LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 702
+ R G D +S G+++ +LLTG P + GE S ++S + +P
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRILKSEPPYP 256
Query: 703 TFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735
++ DL + ++R P E+
Sbjct: 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (262), Expect = 5e-25
Identities = 42/250 (16%), Positives = 89/250 (35%), Gaps = 26/250 (10%)
Query: 477 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 534
K+G G F V+ + + VA+K++ + + + E+++L ++
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADNTKEDSMG 78
Query: 535 ---------------PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 579
P +V + G L +K + +I+ ++ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 580 CFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS 638
++H I+H D+KP+N+L++ + I L + +
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS----IQT 192
Query: 639 FPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLA 698
Y PE +D +S +I +L+TG ++ I++ L
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL- 251
Query: 699 GDWPTFVARR 708
G+ P+++ R
Sbjct: 252 GELPSYLLRN 261
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 83.3 bits (205), Expect = 7e-19
Identities = 27/152 (17%), Positives = 45/152 (29%), Gaps = 19/152 (12%)
Query: 477 KVGQGGFGCVYKGEML-GRTVAIKML----------YSHNMQGQLEFQQEVRVLSKLQHP 525
+G+G V+ +K G L F ++ +
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 526 HLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 585
L L G Y + N L + L + + ++ + I + +
Sbjct: 67 ALQKLQGLAVPKV---YAWEGNAVLME-LIDAKELYRVRVENPDEVLDMILEEVAKFYH- 121
Query: 586 KPEKIVHGDLKPQNILLDSELSSKICDFGICR 617
IVHGDL N+L+ E I DF
Sbjct: 122 --RGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1t1ha_ g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 78 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: E3 ubiquitin ligase PUB14 species: Thale-cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 79.0 bits (194), Expect = 1e-18
Identities = 28/68 (41%), Positives = 39/68 (57%)
Query: 746 VPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHAL 805
P +F CPI E+M DP + + G TYE +I+ WL+ G +T P + L H LTPN+ L
Sbjct: 5 FPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYVL 64
Query: 806 RHAIQDWL 813
+ I W
Sbjct: 65 KSLIALWC 72
|
| >d2c2la2 g.44.1.2 (A:225-304) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 80 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: STIP1 homology and U box-containing protein 1, STUB1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 68.0 bits (165), Expect = 8e-15
Identities = 20/74 (27%), Positives = 38/74 (51%)
Query: 743 ERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPN 802
+R +P + I E+M +P + G TY+ K I + L+ +P+T L+ L PN
Sbjct: 1 KRDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPN 60
Query: 803 HALRHAIQDWLCKS 816
A++ I ++ ++
Sbjct: 61 LAMKEVIDAFISEN 74
|
| >d1wgma_ g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Human (Homo sapiens) [TaxId: 9606]} Length = 98 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Ubiquitin conjugation factor E4A species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.3 bits (140), Expect = 3e-11
Identities = 20/81 (24%), Positives = 29/81 (35%)
Query: 733 KELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNL 792
L+Q FL PI+ +M DP V ++ +T P
Sbjct: 6 SGLQQQEEETYADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLSDQTDPFNRS 65
Query: 793 RLSHLHLTPNHALRHAIQDWL 813
L+ + PN L+ IQ WL
Sbjct: 66 PLTMDQIRPNTELKEKIQRWL 86
|
| >d1jm7a_ g.44.1.1 (A:) brca1 RING domain {Human (Homo sapiens) [TaxId: 9606]} Length = 103 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: brca1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (105), Expect = 2e-06
Identities = 13/90 (14%), Positives = 32/90 (35%), Gaps = 6/90 (6%)
Query: 726 DITPSLVKELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLE--NG 783
D++ V+E++ + + CPI E++ +P + + L G
Sbjct: 2 DLSALRVEEVQNV----INAMQKILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKG 57
Query: 784 RETSPMTNLRLSHLHLTPNHALRHAIQDWL 813
P+ ++ L + +++ L
Sbjct: 58 PSQCPLCKNDITKRSLQESTRFSQLVEELL 87
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 816 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2gm3a1 | 171 | Putative ethylene-responsive protein AT3g01520/F4P | 99.92 | |
| d1mjha_ | 160 | "Hypothetical" protein MJ0577 {Archaeon Methanococ | 99.89 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d2z3va1 | 135 | Hypothetical protein TTHA0895 {Thermus thermophilu | 99.84 | |
| d1tq8a_ | 147 | Hypothetical protein Rv1636 {Mycobacterium tubercu | 99.82 | |
| d1jmva_ | 140 | Universal stress protein A, UspA {Haemophilus infl | 99.73 | |
| d1q77a_ | 138 | Hypothetical protein Aq_178 {Aquifex aeolicus [Tax | 99.66 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.64 | |
| d1wgma_ | 98 | Ubiquitin conjugation factor E4A {Human (Homo sapi | 98.63 | |
| d1t1ha_ | 78 | E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsi | 98.54 | |
| d2c2la2 | 80 | STIP1 homology and U box-containing protein 1, STU | 98.52 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.18 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.83 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.56 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.32 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.13 | |
| d1wy5a1 | 216 | TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId | 91.11 | |
| d2baya1 | 56 | Pre-mRNA splicing factor Prp19 {Baker's yeast (Sac | 90.04 | |
| d1jm7b_ | 97 | bard1 RING domain {Human (Homo sapiens) [TaxId: 96 | 82.24 | |
| d1ni5a1 | 227 | tRNA-Ile-lysidine synthetase, TilS, N-terminal dom | 82.11 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.24 Aligned_cols=257 Identities=29% Similarity=0.443 Sum_probs=208.9
Q ss_pred HCCCCCCCEEEEECCEEEEEEEECCEEEEEEEECCCCC--CCHHHHHHHHHHHHCCCCCCEEEEECCCCC-CCCCEEECC
Q ss_conf 23977564244206569999988590999999404883--137999999999743899840037210047-741124216
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYL 545 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~g~~~g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~ 545 (816)
.++|...+.||+|+||.||+|++.+ .||||+++.... .....|.+|+.++.+++|||||+++|++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~ 85 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC 85 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred CCCEEEEEEEEECCCCEEEEEEECC-EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCEEEEEEECC
T ss_conf 4518998898307885899999999-899999973469989999999999999847998786456797155899999658
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCCC
Q ss_conf 99961356410299998999999999999999999985169994460778899567547999068202651101478876
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~~~~~ 625 (816)
++|+|.+++.... ..+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+........
T Consensus 86 ~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 86 EGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEEECCCCCCC
T ss_conf 9988899985235--78999999999999999988875099---951614789979818997887500221333556776
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHCCCCCCCHH---HHHHHHHCCCCCCCCCCCCC
Q ss_conf 777555689998989889643335---988961037679999999992999999827---89998630963233578899
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRT---GVLTPKSDSYSFGLIILQLLTGRLPVGLAG---EVRRAVSCGKLSSILDPLAG 699 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~P~~~~~---~~~~~~~~~~~~~~~d~~~~ 699 (816)
.......||+.|+|||++.+ +.++.++|||||||+||||+||+.||.... .+...+..+.... ...
T Consensus 161 ----~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~ 232 (276)
T d1uwha_ 161 ----HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP----DLS 232 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCC----CGG
T ss_pred ----CCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC----CCH
T ss_conf ----312566557431799999505689999531516359999999978899899896999999996588898----600
Q ss_pred CCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 99989999999999995310889999974899999998310
Q 003481 700 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740 (816)
Q Consensus 700 ~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~l~~ 740 (816)
..+...+..+.+|+.+||..+|.+|||+. .++..|+.+..
T Consensus 233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~-~il~~Le~l~~ 272 (276)
T d1uwha_ 233 KVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLAR 272 (276)
T ss_dssp GSCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred HCCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 03655549999999997588976892999-99999999997
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=378.55 Aligned_cols=265 Identities=26% Similarity=0.414 Sum_probs=210.6
Q ss_pred CCHHHHHHHHCC---------CCCCCEEEEECCEEEEEEEEC--C---EEEEEEEECCCCCC-CHHHHHHHHHHHHCCCC
Q ss_conf 597889987239---------775642442065699999885--9---09999994048831-37999999999743899
Q 003481 460 FSLADLQTATCN---------FSESFKVGQGGFGCVYKGEML--G---RTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQH 524 (816)
Q Consensus 460 ~~~~~l~~at~~---------f~~~~~LG~G~~g~Vy~g~~~--g---~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~H 524 (816)
|+++++..++.+ |...+.||+|+||.||+|.+. + ..||||.+...... ....|.+|+.+|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHHHHCHHHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCC
T ss_conf 88798999996046220800427856980278829999999579978899999997844598999999999999985799
Q ss_pred CCEEEEECCCC--CCCCCEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf 84003721004--7741124216999613564102999989999999999999999999851699944607788995675
Q 003481 525 PHLVTLLGACP--EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 602 (816)
Q Consensus 525 pnIv~l~g~~~--~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILl 602 (816)
||||+++|+|. +..++||||+++|+|.+++.... ..++|..++.|+.|++.||.|||+.+ |+||||||+||||
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl 161 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILV 161 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CCCCCEEEEEEECCEEEEEEEECCCCCCEEEECCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEE
T ss_conf 888618999962887799997227985300210456--79999999999999999889885279---8357615044898
Q ss_pred CCCCCEEEEECCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCHHH-
Q ss_conf 47999068202651101478876777555689998989889643335988961037679999999992-9999998278-
Q 003481 603 DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE- 680 (816)
Q Consensus 603 d~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~P~~~~~~- 680 (816)
+.++.+||+|||+|+......... .........||+.|+|||++.++.++.++|||||||+||||+| |++||.....
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDP-TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp CTTCCEEECCC------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred CCCCCEEECCCCCCEECCCCCCCC-EEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH
T ss_conf 899919988844315756777765-3650256668830038788836997861214453578999986799999999999
Q ss_pred -HHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf -99986309632335788999998999999999999531088999997489999999831
Q 003481 681 -VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 681 -~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~l~ 739 (816)
+...+..+.. ...+...+..+.+|+.+||+.+|.+||++. .++..|+.+.
T Consensus 241 ~~~~~i~~~~~--------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~-ei~~~L~~~l 291 (299)
T d1jpaa_ 241 DVINAIEQDYR--------LPPPMDCPSALHQLMLDCWQKDRNHRPKFG-QIVNTLDKMI 291 (299)
T ss_dssp HHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHH-HHHHHHHHHH
T ss_pred HHHHHHHCCCC--------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 99999973788--------999742269999999997587976892999-9999999984
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.32 Aligned_cols=252 Identities=29% Similarity=0.419 Sum_probs=206.3
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC-CEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC-CCCCEEECCC
Q ss_conf 239775642442065699999885-90999999404883137999999999743899840037210047-7411242169
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLP 546 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~g~~~-g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~~ 546 (816)
.++|...+.||+|+||.||+|.+. +..||||++.... .....|.+|+.++.+++|||||+++|+|.+ ..++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEECC
T ss_conf 89938867981079828999999999999999986476-88899999999998679998857873104597699999578
Q ss_pred CCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCCCC
Q ss_conf 99613564102999989999999999999999999851699944607788995675479990682026511014788767
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626 (816)
Q Consensus 547 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~~~~~~ 626 (816)
+|+|.+++..... ..++|..+++|+.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+|+........
T Consensus 91 ~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~- 165 (272)
T d1qpca_ 91 NGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT- 165 (272)
T ss_dssp TCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-
T ss_pred CCCHHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCCC-
T ss_conf 9828888751478-98878899999999999999997489---546756422515620244042341014773588644-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCC-CCCCHH--HHHHHHHCCCCCCCCCCCCCCCCH
Q ss_conf 77555689998989889643335988961037679999999992999-999827--899986309632335788999998
Q 003481 627 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRL-PVGLAG--EVRRAVSCGKLSSILDPLAGDWPT 703 (816)
Q Consensus 627 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~-P~~~~~--~~~~~~~~~~~~~~~d~~~~~~~~ 703 (816)
......||+.|+|||++.++.++.++|||||||++|||+||.. |+.... .+...+..+.. ...|.
T Consensus 166 ----~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~--------~~~p~ 233 (272)
T d1qpca_ 166 ----AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR--------MVRPD 233 (272)
T ss_dssp ----CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------CCCCT
T ss_pred ----CCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC--------CCCCC
T ss_conf ----203567744445828983799982456452579999999689888888899999999970688--------88965
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 999999999999531088999997489999999831
Q 003481 704 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 704 ~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~l~ 739 (816)
..+..+.+|+.+||+.+|.+|||+. .+++.|+.+-
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~-ei~~~L~~~f 268 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFD-YLRSVLEDFF 268 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred CCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 5719999999997588976893999-9999861132
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.18 Aligned_cols=244 Identities=25% Similarity=0.387 Sum_probs=204.6
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCCCEEECC
Q ss_conf 39775642442065699999885--90999999404883137999999999743899840037210047--741124216
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 545 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 545 (816)
.+|...+.||+|+||.||+|... |..||||++..........+.+|+.++++++|||||++++++.+ ..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCCC
Q ss_conf 99961356410299998999999999999999999985169994460778899567547999068202651101478876
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~~~~~ 625 (816)
++|+|.+++... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC-
T ss_conf 798089886415----9999999999999999999999879---72267768886887899686425156413213666-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCHHHHHHH---HHCCCCCCCCCCCCCCCC
Q ss_conf 77755568999898988964333598896103767999999999299999982789998---630963233578899999
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VSCGKLSSILDPLAGDWP 702 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~~~~~~~~~---~~~~~~~~~~d~~~~~~~ 702 (816)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||......... ...+. . ....+
T Consensus 172 -----~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~------~~~~~ 239 (293)
T d1yhwa1 172 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-P------ELQNP 239 (293)
T ss_dssp -----CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-C------CCSSG
T ss_pred -----CCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC-C------CCCCC
T ss_conf -----44444447773682664479988012031372999998048899899799999999985799-9------88885
Q ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 8999999999999531088999997489999
Q 003481 703 TFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 703 ~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~ 733 (816)
...+..+.+|+.+||+.||.+||++.+.+.+
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 5379999999999866996689099999649
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.12 Aligned_cols=253 Identities=27% Similarity=0.416 Sum_probs=207.0
Q ss_pred CCCCCCC-EEEEECCEEEEEEEEC----CEEEEEEEECCCCCC-CHHHHHHHHHHHHCCCCCCEEEEECCCC-CCCCCEE
Q ss_conf 3977564-2442065699999885----909999994048831-3799999999974389984003721004-7741124
Q 003481 470 CNFSESF-KVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACP-EAWSLVY 542 (816)
Q Consensus 470 ~~f~~~~-~LG~G~~g~Vy~g~~~----g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~-~~~~lV~ 542 (816)
++|.... +||+|+||.||+|.+. +..||||+++..... ....|.+|+.++.+++|||||+++|+|. +..++||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm 87 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 87 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCEEEEEE
T ss_conf 47188784873060809999999608976899999988203978999999999999867998880686560368079999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCC
Q ss_conf 21699961356410299998999999999999999999985169994460778899567547999068202651101478
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~~ 622 (816)
||+++|+|.+++.... ..+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 88 E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp ECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EECCCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHHHHCCCCC
T ss_conf 8078996899752125--69999999999999999878998688---105767646604546885420331342115543
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCHH--HHHHHHHCCCCCCCCCCCCC
Q ss_conf 876777555689998989889643335988961037679999999992-999999827--89998630963233578899
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAG 699 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~P~~~~~--~~~~~~~~~~~~~~~d~~~~ 699 (816)
.... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||.... .+...+..+...
T Consensus 163 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~-------- 231 (285)
T d1u59a_ 163 DSYY---TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-------- 231 (285)
T ss_dssp SCEE---CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCC--------
T ss_pred CCCC---CCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC--------
T ss_conf 4321---13562113743358688727999954123220178999993899999997999999999818999--------
Q ss_pred CCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 9998999999999999531088999997489999999831
Q 003481 700 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 700 ~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~l~ 739 (816)
..|...+..+.+|+.+||+.+|.+||++. .+.+.|+.+.
T Consensus 232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~-~i~~~L~~~~ 270 (285)
T d1u59a_ 232 ECPPECPPELYALMSDCWIYKWEDRPDFL-TVEQRMRACY 270 (285)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 99976789999999997577976890999-9999999999
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.69 Aligned_cols=250 Identities=27% Similarity=0.470 Sum_probs=206.6
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC-CEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCC--CCCCCEEECCC
Q ss_conf 39775642442065699999885-9099999940488313799999999974389984003721004--77411242169
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLP 546 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~-g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~lV~E~~~ 546 (816)
++|...+.||+|+||.||+|.+. +..||||++.... ....+|.+|+.++.+++|||||+++|+|. +..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf 9958888982088829999998899999999987886-768999999999996689975653524315993379998369
Q ss_pred CCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCCCC
Q ss_conf 99613564102999989999999999999999999851699944607788995675479990682026511014788767
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626 (816)
Q Consensus 547 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~~~~~~ 626 (816)
+|+|.+++.... ..++|..++.|+.|+|.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCE-
T ss_conf 991899752013--47889999999999999877653164---310443153266668877686553210023688733-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCHH--HHHHHHHCCCCCCCCCCCCCCCCH
Q ss_conf 775556899989898896433359889610376799999999929-99999827--899986309632335788999998
Q 003481 627 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTG-RLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPT 703 (816)
Q Consensus 627 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG-~~P~~~~~--~~~~~~~~~~~~~~~d~~~~~~~~ 703 (816)
......||+.|+|||++.+..++.++|||||||++|||+|+ .+||.... .+...+..+.. ...|.
T Consensus 158 ----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~--------~~~p~ 225 (263)
T d1sm2a_ 158 ----SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR--------LYKPR 225 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC--------CCCCT
T ss_pred ----EECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC--------CCCCC
T ss_conf ----504300176667857860799984033210599999998789888778999999999980688--------89954
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 999999999999531088999997489999999831
Q 003481 704 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 704 ~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~l~ 739 (816)
..+..+.+|+.+||+.||.+||++. .+++.|+.+.
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~-~il~~L~~i~ 260 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFS-RLLRQLAEIA 260 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 3679999999997657976891999-9999999998
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.82 Aligned_cols=245 Identities=22% Similarity=0.302 Sum_probs=202.8
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCCCEEECC
Q ss_conf 39775642442065699999885--90999999404883137999999999743899840037210047--741124216
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 545 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 545 (816)
+.|...+.||+|+||.||+|.+. |..||+|++..........|.+|+.++++++|||||++++++.+ ..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCCC
Q ss_conf 99961356410299998999999999999999999985169994460778899567547999068202651101478876
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~~~~~ 625 (816)
++|+|.+++.... .++++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCCCCCC--
T ss_conf 9981889998628--99999999999999999999999889---8871407003148789998997161230357786--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC-----CCCCCCCHHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCC
Q ss_conf 77755568999898988964333-----59889610376799999999929999998278--999863096323357889
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLA 698 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~s~ksDVwSlGvil~elltG~~P~~~~~~--~~~~~~~~~~~~~~d~~~ 698 (816)
.......||+.|+|||++. ...|+.++|||||||++|||+||+.||..... +...+..+....
T Consensus 165 ----~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~------ 234 (288)
T d2jfla1 165 ----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT------ 234 (288)
T ss_dssp ----HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC------
T ss_pred ----CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCC------
T ss_conf ----4100102562647999983202578888806657878999999820889999989999999997079987------
Q ss_pred CCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf 999989999999999995310889999974899
Q 003481 699 GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 699 ~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l 731 (816)
...+...+..+.+|+.+||+.||.+|||+.+.+
T Consensus 235 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell 267 (288)
T d2jfla1 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLL 267 (288)
T ss_dssp CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 776566999999999997669966891999996
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=368.55 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=207.6
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCCCEEEC
Q ss_conf 239775642442065699999885--90999999404883137999999999743899840037210047--74112421
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 544 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 544 (816)
.++|...+.||+|+||.||+|.+. |..||||+++... ....+|.+|+.++.+++|||||+++|+|.+ ..++||||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEEC
T ss_conf 799398659820888089999999999699999977761-0399999999999867999882677527457854787631
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCC
Q ss_conf 69996135641029999899999999999999999998516999446077889956754799906820265110147887
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~~~~ 624 (816)
+++|+|.+++..... ..+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 95 ~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 95 MTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred CCCCCHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEECCCCCC
T ss_conf 467606777530355-41579999999999999788898789---30576045768998999289832445465378872
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCC-CH--HHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 6777555689998989889643335988961037679999999992999999-82--78999863096323357889999
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVG-LA--GEVRRAVSCGKLSSILDPLAGDW 701 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~-~~--~~~~~~~~~~~~~~~~d~~~~~~ 701 (816)
. ......|++.|+|||++.+..++.++|||||||++|||++|..|+. .. ..+...+..+.. ...
T Consensus 171 ~-----~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~--------~~~ 237 (287)
T d1opja_ 171 T-----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR--------MER 237 (287)
T ss_dssp E-----EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--------CCC
T ss_pred E-----EECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC--------CCC
T ss_conf 2-----103556654666927872799981043021789999998679988774259999999855888--------888
Q ss_pred CHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 98999999999999531088999997489999999831
Q 003481 702 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 702 ~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~l~ 739 (816)
|...+..+.+|+.+||+.||.+||++. .+.+.|+.+.
T Consensus 238 ~~~~~~~l~~li~~cl~~dP~~Rps~~-ei~~~L~~~~ 274 (287)
T d1opja_ 238 PEGCPEKVYELMRACWQWNPSDRPSFA-EIHQAFETMF 274 (287)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHTT
T ss_pred CCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 743309999999997577976893999-9999999998
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.38 Aligned_cols=245 Identities=28% Similarity=0.436 Sum_probs=201.6
Q ss_pred CEEEEECCEEEEEEEEC----CEEEEEEEECCCCCC--CHHHHHHHHHHHHCCCCCCEEEEECCCCC-CCCCEEECCCCC
Q ss_conf 42442065699999885----909999994048831--37999999999743899840037210047-741124216999
Q 003481 476 FKVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPNG 548 (816)
Q Consensus 476 ~~LG~G~~g~Vy~g~~~----g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~~~g 548 (816)
++||+|+||.||+|.+. +..||||+++..... ....|.+|+.++.+++|||||+++|+|.+ ..+|||||+++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEEEECCCCC
T ss_conf 78345878299999981697385999999880108989999999999999867998985277775059779999747889
Q ss_pred CHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCCCCCC
Q ss_conf 61356410299998999999999999999999985169994460778899567547999068202651101478876777
Q 003481 549 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 628 (816)
Q Consensus 549 sL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~~~~~~~~ 628 (816)
+|.+++.... .+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.......
T Consensus 93 ~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~-- 164 (277)
T d1xbba_ 93 PLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-- 164 (277)
T ss_dssp EHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE--
T ss_pred CHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCC--
T ss_conf 6899975225---7899999999999999976687479---5567776113102356751234134533134323443--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCHH--HHHHHHHCCCCCCCCCCCCCCCCHHH
Q ss_conf 555689998989889643335988961037679999999992-999999827--89998630963233578899999899
Q 003481 629 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPTFV 705 (816)
Q Consensus 629 ~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~P~~~~~--~~~~~~~~~~~~~~~d~~~~~~~~~~ 705 (816)
.......||+.|+|||++.+..++.++|||||||++|||+| |+.||.... .+...+..+.. ...|...
T Consensus 165 -~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~--------~~~p~~~ 235 (277)
T d1xbba_ 165 -KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER--------MGCPAGC 235 (277)
T ss_dssp -EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------CCCCTTC
T ss_pred -CCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--------CCCCCCC
T ss_conf -2244567784203916653799984344303403132896589999999899999999982899--------9998656
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 999999999953108899999748999999983
Q 003481 706 ARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 706 ~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~l 738 (816)
+..+.+|+.+||+.||.+||++. .+...|+..
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~-~i~~~L~~~ 267 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFA-AVELRLRNY 267 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHH-HHHHHHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHCH
T ss_conf 79999999997588976890989-999985288
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.49 Aligned_cols=245 Identities=22% Similarity=0.295 Sum_probs=199.2
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCC-CHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCCCEEEC
Q ss_conf 39775642442065699999885--909999994048831-37999999999743899840037210047--74112421
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 544 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 544 (816)
++|...+.||+|+||.||+|... |..||+|++...... ....+.+|+.++++++|||||++++++.+ ..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEEC
T ss_conf 46089989721748099999999999799999984566412799999999999857998884696540467436798864
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCC
Q ss_conf 69996135641029999899999999999999999998516999446077889956754799906820265110147887
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~~~~ 624 (816)
+++|+|.+++... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 85 ~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCCHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC
T ss_conf 5898089997537---99999999999999999999999759---83575468997887899879832314224046886
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHCCCCCCCHHHH---HHHHHCCCCCCCCCCCCCC
Q ss_conf 6777555689998989889643335988-96103767999999999299999982789---9986309632335788999
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRTGVL-TPKSDSYSFGLIILQLLTGRLPVGLAGEV---RRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~P~~~~~~~---~~~~~~~~~~~~~d~~~~~ 700 (816)
. ......+||+.|+|||++.+..+ +.++|||||||+||||+||++||...... ...+..... ...
T Consensus 159 ~----~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-------~~~ 227 (271)
T d1nvra_ 159 E----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-------YLN 227 (271)
T ss_dssp E----CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-------TST
T ss_pred C----CCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC-------CCC
T ss_conf 5----31113255747428728618999997101617379999998299788889859999999863888-------788
Q ss_pred CCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf 9989999999999995310889999974899
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l 731 (816)
.....+..+.+|+.+||+.||.+||++.+.+
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil 258 (271)
T d1nvra_ 228 PWKKIDSAPLALLHKILVENPSARITIPDIK 258 (271)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 6446999999999997679966890999996
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.66 Aligned_cols=255 Identities=27% Similarity=0.400 Sum_probs=206.0
Q ss_pred CCCCCCCEEEEECCEEEEEEEECC------EEEEEEEECCCCCC-CHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCCC
Q ss_conf 397756424420656999998859------09999994048831-37999999999743899840037210047--7411
Q 003481 470 CNFSESFKVGQGGFGCVYKGEMLG------RTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 540 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~g------~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~l 540 (816)
+.|...+.||+|+||.||+|.+.+ ..||||++...... ....|.+|+.++.+++|||||+++|+|.+ ..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf 99686159811779099999996899878799999998844596899999999999985689878323677833880389
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECC
Q ss_conf 24216999613564102999989999999999999999999851699944607788995675479990682026511014
Q 003481 541 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 620 (816)
Q Consensus 541 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~ 620 (816)
|+||+.+|+|.+.+.... ..++|..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEECCCCCCHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCCHHHCCC
T ss_conf 997213574022210234--54208999999999998541212123---4257656442788899849984551030035
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCC-CC--HHHHHHHHHCCCCCCCCCCC
Q ss_conf 7887677755568999898988964333598896103767999999999299999-98--27899986309632335788
Q 003481 621 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV-GL--AGEVRRAVSCGKLSSILDPL 697 (816)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~-~~--~~~~~~~~~~~~~~~~~d~~ 697 (816)
...... .......||+.|+|||++..+.++.++|||||||++|||+||..|+ .. ...+...+..+.
T Consensus 162 ~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-------- 230 (283)
T d1mqba_ 162 DDPEAT---YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-------- 230 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC--------
T ss_pred CCCCCC---EEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC--------
T ss_conf 787652---674267777343488887049999735563448989999967988655689999999986357--------
Q ss_pred CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 99999899999999999953108899999748999999983101
Q 003481 698 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVA 741 (816)
Q Consensus 698 ~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~l~~~ 741 (816)
....|...+..+.+|+.+||+.+|.+||++. .+++.|+.+...
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-eil~~L~~l~~~ 273 (283)
T d1mqba_ 231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFA-DIVSILDKLIRA 273 (283)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHH-HHHHHHHHHHHS
T ss_pred CCCCCHHHHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHHC
T ss_conf 8998504579999999997767976893999-999999998669
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=364.92 Aligned_cols=249 Identities=22% Similarity=0.349 Sum_probs=205.6
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCCCEEEC
Q ss_conf 239775642442065699999885--90999999404883137999999999743899840037210047--74112421
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 544 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 544 (816)
-++|.+.+.||+|+||.||+|... |..||||++..........+.+|+.+|.+++|||||++++++.+ ..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 65758988984076819999998899989999998452431699999999999867997999299999989999999985
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCEECCCC
Q ss_conf 69996135641029999899999999999999999998516999446077889956754--7999068202651101478
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD--SELSSKICDFGICRLVTED 622 (816)
Q Consensus 545 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld--~~~~~KL~DFGla~~~~~~ 622 (816)
+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC
T ss_conf 79988999997623--78999999999999999999997569---76000154673641688986999545210442565
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCCC
Q ss_conf 8767775556899989898896433359889610376799999999929999998278--99986309632335788999
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~~~~~--~~~~~~~~~~~~~~d~~~~~ 700 (816)
.. .....||+.|+|||++.+..++.++|||||||++|+|+||+.||..... ....+..+...- ...
T Consensus 180 ~~-------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-----~~~ 247 (350)
T d1koaa2 180 QS-------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM-----DDS 247 (350)
T ss_dssp SC-------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS-----CCG
T ss_pred CC-------CCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC-----CCC
T ss_conf 43-------200068624218899758998726765546599999985989989979999999998478898-----942
Q ss_pred CCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 9989999999999995310889999974899999
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~ 734 (816)
.....+..+.+|+.+||..||.+|||+.+.+.+.
T Consensus 248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp 281 (350)
T d1koaa2 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 281 (350)
T ss_dssp GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHST
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCC
T ss_conf 2358999999999997568966790899986291
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.83 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=203.2
Q ss_pred HHCCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCC-CHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCCCEE
Q ss_conf 7239775642442065699999885--909999994048831-37999999999743899840037210047--741124
Q 003481 468 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 468 at~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
..++|...++||+|+||.||+|... |..||+|+++..... ....+.+|+.+|.+++|||||+++++|.+ ..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 75688897897127780999999989996999999875409789999999999998679999994999999899999999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCC
Q ss_conf 2169996135641029999899999999999999999998516-999446077889956754799906820265110147
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS-KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 543 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~ 621 (816)
||+++|+|.+++.+.. .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 7679986899874249---99999999999999999999998599---97144577994687899899954877625678
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCHHHHHH--HHH---CCCCCC----
Q ss_conf 88767775556899989898896433359889610376799999999929999998278999--863---096323----
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVS---CGKLSS---- 692 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~~~~~~~~--~~~---~~~~~~---- 692 (816)
.. ....+||+.|+|||++.+..|+.++|||||||++|||+||+.||........ ... .+....
T Consensus 158 ~~--------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 158 SM--------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229 (322)
T ss_dssp HT--------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred CC--------CCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 86--------2111377141194687589989488899899999999988899899887899999988751775457742
Q ss_pred ---------------------------CCCCCCCCCC-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf ---------------------------3578899999-8999999999999531088999997489999999
Q 003481 693 ---------------------------ILDPLAGDWP-TFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 693 ---------------------------~~d~~~~~~~-~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~ 736 (816)
+........+ ...+..+.+|+.+||+.||.+|||+.+.+.+.+-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~ 301 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHH
T ss_conf 123332211112223541347788766502687667644489999999999868994679089999609864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.48 Aligned_cols=248 Identities=24% Similarity=0.344 Sum_probs=205.1
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCC--CHHHHHHHHHHHHCCCCCCEEEEECCCCC----CCCCE
Q ss_conf 39775642442065699999885--909999994048831--37999999999743899840037210047----74112
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLV 541 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~----~~~lV 541 (816)
++|...+.||+|+||.||+|+.. |..||+|.+...... ....|.+|+.++.+++|||||++++++.+ ..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 33799679830889199999999999799999987465797999999999999997789998248999991789989999
Q ss_pred EECCCCCCHHHHHHHCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCC--CCEEECCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf 42169996135641029-99989999999999999999999851699--9446077889956754799906820265110
Q 003481 542 YEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKP--EKIVHGDLKPQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 542 ~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~--~~iiHrDIkp~NILld~~~~~KL~DFGla~~ 618 (816)
|||+++|+|.+++.... ....+++..++.|+.|++.||.|||+.++ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEE
T ss_conf 95689993899998515457899999999999999999999997167788788586765425747888579800100032
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCC
Q ss_conf 14788767775556899989898896433359889610376799999999929999998278--9998630963233578
Q 003481 619 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDP 696 (816)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~~~~~--~~~~~~~~~~~~~~d~ 696 (816)
+..... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... +...+..+.+.
T Consensus 164 ~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~----- 232 (269)
T d2java1 164 LNHDTS------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR----- 232 (269)
T ss_dssp C-----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-----
T ss_pred CCCCCC------CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCC-----
T ss_conf 245777------556677882327999983999993898875278999980188998998999999999718998-----
Q ss_pred CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf 89999989999999999995310889999974899
Q 003481 697 LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 697 ~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l 731 (816)
..|...+..+.+|+.+||+.||.+||++.+.+
T Consensus 233 ---~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell 264 (269)
T d2java1 233 ---RIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264 (269)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf ---89743599999999997679955791899997
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.40 Aligned_cols=252 Identities=28% Similarity=0.451 Sum_probs=204.8
Q ss_pred HCCCCCCCEEEEECCEEEEEEEECC-------EEEEEEEECCCCC-CCHHHHHHHHHHHHCC-CCCCEEEEECCCCC--C
Q ss_conf 2397756424420656999998859-------0999999404883-1379999999997438-99840037210047--7
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--A 537 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~g~~~g-------~~vAiK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~ 537 (816)
.++|...+.||+|+||.||+|++.+ ..||+|.+..... .....|.+|+.++.++ +|||||+++|+|.+ .
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
T ss_conf 89939701983078819999998578855420499999966335878999999999999971589968687788862995
Q ss_pred CCCEEECCCCCCHHHHHHHCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCC
Q ss_conf 4112421699961356410299--------------------99899999999999999999998516999446077889
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSN--------------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKP 597 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~L~~~~~--------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp 597 (816)
.++||||+++|+|.++|..... ...+++..++.|+.|++.||.|||+.+ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCH
T ss_conf 899997279995999998625777510221000012220012577899999999999999999997399---05052703
Q ss_pred CCEEECCCCCEEEEECCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCC
Q ss_conf 9567547999068202651101478876777555689998989889643335988961037679999999992-999999
Q 003481 598 QNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVG 676 (816)
Q Consensus 598 ~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~P~~ 676 (816)
+|||++.++.+||+|||+|+........ .......||+.|+|||++.++.++.++|||||||+||||+| |++||.
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNY----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTS----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred HCCCCCCCCEEEEEECCCCCCCCCCCCE----EEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCC
T ss_conf 2144345982898514222204577861----562343578765783887279999633030003999999838999999
Q ss_pred CHH---HHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 827---899986309632335788999998999999999999531088999997489999999
Q 003481 677 LAG---EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 736 (816)
Q Consensus 677 ~~~---~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~ 736 (816)
... .+...+..+. ..+.|...+..+.+|+.+||+.+|.+|||+. .++..|.
T Consensus 269 ~~~~~~~~~~~~~~~~--------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~-ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGF--------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFP-NLTSFLG 322 (325)
T ss_dssp TCCCSHHHHHHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHH
T ss_pred CCCHHHHHHHHHHCCC--------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHH
T ss_conf 9898999999985699--------8998876789999999997588966893999-9999974
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=362.44 Aligned_cols=248 Identities=23% Similarity=0.336 Sum_probs=206.0
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCCCEEEC
Q ss_conf 239775642442065699999885--90999999404883137999999999743899840037210047--74112421
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 544 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 544 (816)
.++|.+.+.||+|+||.||+|... |..||||++..........+.+|+.+|.+++|||||++++++.+ ..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCEECCCC
Q ss_conf 69996135641029999899999999999999999998516999446077889956754--7999068202651101478
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD--SELSSKICDFGICRLVTED 622 (816)
Q Consensus 545 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld--~~~~~KL~DFGla~~~~~~ 622 (816)
+++|+|.+.+.... .++++..+..|+.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 108 ~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC
T ss_conf 89980888898638--99899999999999999999999779---26513144553113467884899525630343788
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCHHHH--HHHHHCCCCCCCCCCCCCC
Q ss_conf 87677755568999898988964333598896103767999999999299999982789--9986309632335788999
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~~~~~~--~~~~~~~~~~~~~d~~~~~ 700 (816)
.. .....||+.|+|||++.+..++.++|||||||++|+|+||+.||...... ...+..+... ....
T Consensus 183 ~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-----~~~~ 250 (352)
T d1koba_ 183 EI-------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-----FDED 250 (352)
T ss_dssp SC-------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-----CCSS
T ss_pred CC-------EEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC-----CCCC
T ss_conf 72-------01004764534899974799897633389899999999688998997999999999847889-----8930
Q ss_pred CCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 998999999999999531088999997489999
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~ 733 (816)
.+...+..+.+|+.+||+.||.+||++.+.+.+
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 024799999999999756996689189999609
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.31 Aligned_cols=252 Identities=25% Similarity=0.431 Sum_probs=207.3
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC--CE----EEEEEEECCCC-CCCHHHHHHHHHHHHCCCCCCEEEEECCCCC-CCCCE
Q ss_conf 39775642442065699999885--90----99999940488-3137999999999743899840037210047-74112
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GR----TVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLV 541 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~--g~----~vAiK~l~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV 541 (816)
.+|...+.||+|+||.||+|.+. |. .||+|.+.... ......|.+|+.++.+++|||||+++|+|.+ ..+++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEE
T ss_conf 99978319820899299999995899889899999996513497999999999999986799888158999961983699
Q ss_pred EECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCC
Q ss_conf 42169996135641029999899999999999999999998516999446077889956754799906820265110147
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 542 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~ 621 (816)
++|+.+|+|.+.+.... ..+++..+++|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 89 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEECCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCCCCEECCC
T ss_conf 98426874010111334--57999999999999999999998769---50476212031167998758602552223354
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCH--HHHHHHHHCCCCCCCCCCCC
Q ss_conf 8876777555689998989889643335988961037679999999992-99999982--78999863096323357889
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLA--GEVRRAVSCGKLSSILDPLA 698 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~P~~~~--~~~~~~~~~~~~~~~~d~~~ 698 (816)
.... .......||+.|+|||++.++.++.++|||||||++|||+| |.+||... ..+...+..+..
T Consensus 164 ~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~-------- 231 (317)
T d1xkka_ 164 EEKE----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-------- 231 (317)
T ss_dssp TCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC--------
T ss_pred CCCC----CCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--------
T ss_conf 4453----2236510586446708874699983565440799999999779999999998999999975998--------
Q ss_pred CCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 99998999999999999531088999997489999999831
Q 003481 699 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 699 ~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~l~ 739 (816)
...|...+..+.+|+.+||..+|.+||++. .++..|..+.
T Consensus 232 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~-eil~~l~~~~ 271 (317)
T d1xkka_ 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFR-ELIIEFSKMA 271 (317)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 999855689999999984789934691999-9999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=360.89 Aligned_cols=261 Identities=26% Similarity=0.451 Sum_probs=213.2
Q ss_pred HHHHHHHCCCCCCCEEEEECCEEEEEEEECC-------EEEEEEEECCCCCCC-HHHHHHHHHHHHCCCCCCEEEEECCC
Q ss_conf 8899872397756424420656999998859-------099999940488313-79999999997438998400372100
Q 003481 463 ADLQTATCNFSESFKVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQG-QLEFQQEVRVLSKLQHPHLVTLLGAC 534 (816)
Q Consensus 463 ~~l~~at~~f~~~~~LG~G~~g~Vy~g~~~g-------~~vAiK~l~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~g~~ 534 (816)
.+++...++|...+.||+|+||.||+|++.| ..||||+++...... ...|.+|+.++++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEE
T ss_conf 31138988938867982078839999998887657788299999988210857999999999999966899765524666
Q ss_pred CC--CCCCEEECCCCCCHHHHHHHCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEE
Q ss_conf 47--7411242169996135641029---------------------999899999999999999999998516999446
Q 003481 535 PE--AWSLVYEYLPNGSLQDRLFRKS---------------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 591 (816)
Q Consensus 535 ~~--~~~lV~E~~~~gsL~~~L~~~~---------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ii 591 (816)
.. ..++|+||+++|+|.+++.... ....+++..++.|+.|++.||.|||+.+ |+
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred CCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---EE
T ss_conf 059803899981589929999985275542100001110012103467889899999999999999855413578---68
Q ss_pred ECCCCCCCEEECCCCCEEEEECCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC
Q ss_conf 07788995675479990682026511014788767775556899989898896433359889610376799999999929
Q 003481 592 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTG 671 (816)
Q Consensus 592 HrDIkp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG 671 (816)
||||||+|||+|.++.+||+|||+|+........ .......||+.|+|||++....++.++|||||||++|||++|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~ 238 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB----C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred EEEECCCCEEECCCCCEEECCCHHHEECCCCCCC----CCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCC
T ss_conf 5488401168989992898331442113677641----115777767676798997268898056302523629999806
Q ss_pred C-CCCCCHHH--HHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 9-99998278--99986309632335788999998999999999999531088999997489999999831
Q 003481 672 R-LPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 672 ~-~P~~~~~~--~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~l~ 739 (816)
. +||..... +...+..+... ..|...+..+.+|+.+||+.+|++|||+. .+.+.|+++.
T Consensus 239 ~~~p~~~~~~~e~~~~v~~~~~~--------~~p~~~~~~~~~li~~cl~~~P~~RPt~~-ev~~~L~~i~ 300 (301)
T d1lufa_ 239 GLQPYYGMAHEEVIYYVRDGNIL--------ACPENCPLELYNLMRLCWSKLPADRPSFC-SIHRILQRMC 300 (301)
T ss_dssp TCCTTTTSCHHHHHHHHHTTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHTT
T ss_pred CCCCCCCCCHHHHHHHHHCCCCC--------CCCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHC
T ss_conf 89999998999999999739978--------88732529999999997488965793999-9999999842
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.40 Aligned_cols=242 Identities=27% Similarity=0.421 Sum_probs=203.5
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCC---CCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCCCEE
Q ss_conf 39775642442065699999885--9099999940488---3137999999999743899840037210047--741124
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++|...+.||+|+||.||+++.. |..||+|++.... ......+.+|+.++.+++|||||++++++.+ ..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCC
Q ss_conf 21699961356410299998999999999999999999985169994460778899567547999068202651101478
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~~ 622 (816)
||+++|+|.+++.... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EECCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEEEECCCC
T ss_conf 5047985898875048---9999999999999999999999889---465220234414668998711555633544888
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCCC
Q ss_conf 8767775556899989898896433359889610376799999999929999998278--99986309632335788999
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~~~~~--~~~~~~~~~~~~~~d~~~~~ 700 (816)
. .....||+.|+|||++.+..++.++|||||||+||||+||+.||..... ....+..+.. .
T Consensus 160 ~--------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~---------~ 222 (263)
T d2j4za1 160 R--------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF---------T 222 (263)
T ss_dssp C--------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCC---------C
T ss_pred C--------CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC---------C
T ss_conf 5--------2355788763499997589989314404675999998329999888999999999971899---------9
Q ss_pred CCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 9989999999999995310889999974899999
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~ 734 (816)
+|...+..+.+|+.+||+.||.+|||+.+.+.+.
T Consensus 223 ~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp 256 (263)
T d2j4za1 223 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 256 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCC
T ss_conf 9866899999999997647976890999997190
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.50 Aligned_cols=251 Identities=33% Similarity=0.422 Sum_probs=206.4
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC-CEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC-CCCCEEECCCC
Q ss_conf 39775642442065699999885-90999999404883137999999999743899840037210047-74112421699
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPN 547 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~-g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV~E~~~~ 547 (816)
++|.+...||+|+||.||+|.+. +..||||+++... .....|.+|+.++.+++|||||+++|+|.+ ..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEECCC
T ss_conf 9979846993079809999999999999999988044-888999999999986666788689999823975999994479
Q ss_pred CCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCCCCC
Q ss_conf 96135641029999899999999999999999998516999446077889956754799906820265110147887677
Q 003481 548 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 627 (816)
Q Consensus 548 gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~~~~~~~ 627 (816)
|+|..++..... ..++|..++.|+.+++.||.|||..+ |+||||||+|||++.++.+||+|||+++........
T Consensus 96 g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-- 169 (285)
T d1fmka3 96 GSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-- 169 (285)
T ss_dssp CBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCHHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCCE--
T ss_conf 943542000035-53059999999999999999875411---433531230799989992998442555425688733--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCC-CCHH--HHHHHHHCCCCCCCCCCCCCCCCHH
Q ss_conf 755568999898988964333598896103767999999999299999-9827--8999863096323357889999989
Q 003481 628 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV-GLAG--EVRRAVSCGKLSSILDPLAGDWPTF 704 (816)
Q Consensus 628 ~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~-~~~~--~~~~~~~~~~~~~~~d~~~~~~~~~ 704 (816)
......||+.|+|||++..+.++.++|||||||++|||+||..|+ .... .+...+..+.. ...+..
T Consensus 170 ---~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~--------~~~~~~ 238 (285)
T d1fmka3 170 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------MPCPPE 238 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------CCCCTT
T ss_pred ---EECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC--------CCCCCC
T ss_conf ---524545566545808983799891774132358999998689999988889999999982689--------999832
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 99999999999531088999997489999999831
Q 003481 705 VARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 705 ~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~l~ 739 (816)
.+..+.+|+.+||+.+|.+||++. .+...|+...
T Consensus 239 ~~~~l~~li~~cl~~dP~~Rps~~-~i~~~L~~~~ 272 (285)
T d1fmka3 239 CPESLHDLMCQCWRKEPEERPTFE-YLQAFLEDYF 272 (285)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHTTT
T ss_pred CCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 379999999997566975891999-9999876662
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.81 Aligned_cols=245 Identities=25% Similarity=0.425 Sum_probs=204.6
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC-CEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCCCEEECCC
Q ss_conf 39775642442065699999885-90999999404883137999999999743899840037210047--7411242169
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLP 546 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~-g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~~ 546 (816)
++|...++||+|+||.||+|++. +..||||+++.... ...+|.+|+.++.+++|||||+++|+|.+ ..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf 99799689820788399999988998999999874757-78999999999996689860158899850781699997048
Q ss_pred CCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCCCC
Q ss_conf 99613564102999989999999999999999999851699944607788995675479990682026511014788767
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626 (816)
Q Consensus 547 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~~~~~~ 626 (816)
+|+|.+++.... ..+++..+++|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCE-
T ss_conf 993888641024--67768999999999999999875468---434665413588769984798861442023578722-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCHHH--HHHHHHCCCCCCCCCCCCCCCCH
Q ss_conf 77555689998989889643335988961037679999999992-9999998278--99986309632335788999998
Q 003481 627 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPT 703 (816)
Q Consensus 627 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~P~~~~~~--~~~~~~~~~~~~~~d~~~~~~~~ 703 (816)
......||+.|+|||++....++.++|||||||++|||+| |+.||..... +...+..+.. ...|.
T Consensus 157 ----~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~--------~~~p~ 224 (258)
T d1k2pa_ 157 ----SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR--------LYRPH 224 (258)
T ss_dssp ----CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC--------CCCCT
T ss_pred ----EECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC--------CCCCC
T ss_conf ----524657887757807863799885210336432467397559999889999999999980797--------89965
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 999999999999531088999997489999
Q 003481 704 FVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 704 ~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~ 733 (816)
..+..+.+|+.+||+.+|.+||++.+.+.+
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHHHH
T ss_conf 465999999999766897689399999987
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.06 Aligned_cols=240 Identities=27% Similarity=0.387 Sum_probs=193.8
Q ss_pred CCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCC--CCHHHHHHHHHHHHCCCCCCEEEEECCCCC------CCCCEE
Q ss_conf 75642442065699999885--90999999404883--137999999999743899840037210047------741124
Q 003481 473 SESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE------AWSLVY 542 (816)
Q Consensus 473 ~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~~~lV~ 542 (816)
....+||+|+||.||+|.+. +..||+|.+..... .....|.+|+.++.+++|||||++++++.+ ..++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC-CCCCEEEEECCCCEECCC
Q ss_conf 2169996135641029999899999999999999999998516999446077889956754-799906820265110147
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD-SELSSKICDFGICRLVTE 621 (816)
Q Consensus 543 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld-~~~~~KL~DFGla~~~~~ 621 (816)
||+++|+|.+++.... .+++..+..|+.|++.||.|||+.+ .+|+||||||+|||++ .++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred ECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCEECCC
T ss_conf 5789894899975135---5469999999999999999999789-97996876743511667999889800576542368
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCHH---HHHHHHHCCCCCCCCCCCC
Q ss_conf 8876777555689998989889643335988961037679999999992999999827---8999863096323357889
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG---EVRRAVSCGKLSSILDPLA 698 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~~~~---~~~~~~~~~~~~~~~d~~~ 698 (816)
.. .....||+.|+|||++.+ .++.++|||||||++|||+||+.||.... .+...+..+....
T Consensus 168 ~~--------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~------ 232 (270)
T d1t4ha_ 168 SF--------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA------ 232 (270)
T ss_dssp TS--------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG------
T ss_pred CC--------CCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC------
T ss_conf 76--------677553813008988478-999867110079999999878899987655999999997389986------
Q ss_pred CCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf 9999899999999999953108899999748999
Q 003481 699 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 699 ~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~ 732 (816)
.++...+..+.+|+.+||+.||++|||+.+.+.
T Consensus 233 -~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 -SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -567557899999999976379758929999967
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.57 Aligned_cols=242 Identities=27% Similarity=0.368 Sum_probs=203.8
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCC---CCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCCCEE
Q ss_conf 39775642442065699999885--90999999404883---137999999999743899840037210047--741124
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++|...+.||+|+||.||+|... |..||||++..... .....+.+|+.++.+++|||||++++++.+ ..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCC
Q ss_conf 21699961356410299998999999999999999999985169994460778899567547999068202651101478
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~~ 622 (816)
||+++|+|.+++...+ .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCCEECCCC
T ss_conf 7048987777653159---9999999999999999997621650---884767741236688853886032102422567
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCCC
Q ss_conf 8767775556899989898896433359889610376799999999929999998278--99986309632335788999
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~~~~~--~~~~~~~~~~~~~~d~~~~~ 700 (816)
... .......||+.|+|||++.+..++.++|||||||+||||+||+.||...+. +...+..+.+ .
T Consensus 162 ~~~----~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~---------~ 228 (288)
T d1uu3a_ 162 SKQ----ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY---------D 228 (288)
T ss_dssp ------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC---------C
T ss_pred CCC----CCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC---------C
T ss_conf 764----333555677552584400268989666230456999998038899899599999999971899---------9
Q ss_pred CCHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 998999999999999531088999997489
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDITPS 730 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~ 730 (816)
+|...+..+.+|+.+||+.||.+|||+.+.
T Consensus 229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e~ 258 (288)
T d1uu3a_ 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEM 258 (288)
T ss_dssp CCTTCCHHHHHHHHTTSCSSGGGSTTSGGG
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 985479999999999855797689197897
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=360.75 Aligned_cols=246 Identities=23% Similarity=0.305 Sum_probs=202.6
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCC-CHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCCCEEE
Q ss_conf 239775642442065699999885--909999994048831-37999999999743899840037210047--7411242
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 543 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 543 (816)
.+.|...+.||+|+||.||+|... |..||||++...... ....+.+|+.++.+++|||||++++++.+ ..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 66669988994065839999999999989999998157731289999999999986799899919899998998889885
Q ss_pred CCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCEECC
Q ss_conf 169996135641029999899999999999999999998516999446077889956754---79990682026511014
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD---SELSSKICDFGICRLVT 620 (816)
Q Consensus 544 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld---~~~~~KL~DFGla~~~~ 620 (816)
|+++|+|.+++... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||+. .++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred CCCCCCHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCCEEEECC
T ss_conf 26898488865303---67887899999999999987524130---5568704630011046888249983154358725
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCC
Q ss_conf 788767775556899989898896433359889610376799999999929999998278--999863096323357889
Q 003481 621 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLA 698 (816)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~~~~~--~~~~~~~~~~~~~~d~~~ 698 (816)
... ......||+.|+|||++.+..++.++|||||||+||||+||+.||..... ....+..+...- .
T Consensus 162 ~~~-------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~ 229 (307)
T d1a06a_ 162 PGS-------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF-----D 229 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC-----C
T ss_pred CCC-------EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCC-----C
T ss_conf 897-------0440032842259188737999807873451599999985979999989999999986168777-----8
Q ss_pred CCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf 9999899999999999953108899999748999
Q 003481 699 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 699 ~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~ 732 (816)
...+...+..+.+|+.+||+.||.+||++.+.+.
T Consensus 230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 7666678999999999976089757918999862
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.99 Aligned_cols=237 Identities=26% Similarity=0.321 Sum_probs=201.2
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCC---CCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCCCEE
Q ss_conf 39775642442065699999885--9099999940488---3137999999999743899840037210047--741124
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++|.+.+.||+|+||.||+++.. |..||+|++.+.. ......+.+|+.+|++++|||||++++++.+ ..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCE
T ss_conf 74289889831768499999998999899999981565449799999999999998679998877876403564211100
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCC
Q ss_conf 21699961356410299998999999999999999999985169994460778899567547999068202651101478
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~~ 622 (816)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred ECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCCCCCCCCC
T ss_conf 0357986055553256---7759999999999965211343159---622464777847658998888205652003567
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCCC
Q ss_conf 8767775556899989898896433359889610376799999999929999998278--99986309632335788999
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~~~~~--~~~~~~~~~~~~~~d~~~~~ 700 (816)
.. .....+||+.|+|||++.+..|+.++|||||||++|||++|++||...+. +...+..+.+ .
T Consensus 159 ~~------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~---------~ 223 (337)
T d1o6la_ 159 GA------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---------R 223 (337)
T ss_dssp TC------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------C
T ss_pred CC------CCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC---------C
T ss_conf 86------20551008899666650489888333102230678899878999999699999999852899---------8
Q ss_pred CCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 998999999999999531088999997
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDI 727 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~Cl~~dp~~RPs~ 727 (816)
+|...+..+.+|+.+||+.||.+||+.
T Consensus 224 ~p~~~s~~~~dli~~~L~~dP~~R~~~ 250 (337)
T d1o6la_ 224 FPRTLSPEAKSLLAGLLKKDPKQRLGG 250 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCCCHHHHHHHHHHCCCCCHHHCCC
T ss_conf 986689999999986663893442256
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=359.07 Aligned_cols=243 Identities=25% Similarity=0.346 Sum_probs=197.6
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCCC---HHHHHHHHHHHHCCCCCCEEEEECCCCC--CCCCEE
Q ss_conf 39775642442065699999885--9099999940488313---7999999999743899840037210047--741124
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
..|...+.||+|+||.||+|+.. |..||||++....... ...|.+|+.++.+++|||||+++|++.+ ..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCC
Q ss_conf 21699961356410299998999999999999999999985169994460778899567547999068202651101478
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~~ 622 (816)
||+++|+|..++... .++++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EECCCCCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCCCCCCC-
T ss_conf 806999457899737---99999999999999999999998689---76667884217987999789844365334677-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHCCCCCCCHHHHH--HHHHCCCCCCCCCCC
Q ss_conf 876777555689998989889643335---988961037679999999992999999827899--986309632335788
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRT---GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPL 697 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~s~ksDVwSlGvil~elltG~~P~~~~~~~~--~~~~~~~~~~~~d~~ 697 (816)
.....||+.|+|||++.+ +.|+.++|||||||++|||++|+.||....... ..+..+..... .
T Consensus 168 ---------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~---~ 235 (309)
T d1u5ra_ 168 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL---Q 235 (309)
T ss_dssp ---------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---S
T ss_pred ---------CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC---C
T ss_conf ---------8731347663688998346788867214545589999999878899999799999999982899988---8
Q ss_pred CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 99999899999999999953108899999748999999
Q 003481 698 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 698 ~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L 735 (816)
+...+..+.+|+.+||+.||.+|||+.+.+.+.+
T Consensus 236 ----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~ 269 (309)
T d1u5ra_ 236 ----SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (309)
T ss_dssp ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred ----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHH
T ss_conf ----7888999999999977379657918999971997
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=350.80 Aligned_cols=238 Identities=26% Similarity=0.354 Sum_probs=199.6
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCC---CCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCCCEE
Q ss_conf 39775642442065699999885--9099999940488---3137999999999743899840037210047--741124
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++|.+.+.||+|+||.||+++.. |..||||++.... ......+.+|+.++++++|||||++++++.+ ..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCC
Q ss_conf 21699961356410299998999999999999999999985169994460778899567547999068202651101478
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~~ 622 (816)
||+++|+|...+.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EECCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCCEEECCC
T ss_conf 5037863223432222---1110079999999987655412476---770556810503868998898317521671245
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCCC
Q ss_conf 8767775556899989898896433359889610376799999999929999998278--99986309632335788999
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~~~~~--~~~~~~~~~~~~~~d~~~~~ 700 (816)
.....||+.|+|||++.+..|+.++|||||||+||+|+||+.||...+. +...+..+.. .
T Consensus 158 ---------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~---------~ 219 (316)
T d1fota_ 158 ---------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL---------R 219 (316)
T ss_dssp ---------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC---------C
T ss_pred ---------CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC---------C
T ss_conf ---------6434576343599998389998043046533368999759899999699999999970898---------8
Q ss_pred CCHHHHHHHHHHHHHHHCCCCCCCC-----CCHHHH
Q ss_conf 9989999999999995310889999-----974899
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERP-----DITPSL 731 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~Cl~~dp~~RP-----s~~~~l 731 (816)
+|...+..+.+++.+||..||.+|| ++.+.+
T Consensus 220 ~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il 255 (316)
T d1fota_ 220 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 255 (316)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred CCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHH
T ss_conf 997789999999999954499766643102199998
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.65 Aligned_cols=247 Identities=27% Similarity=0.437 Sum_probs=206.5
Q ss_pred CCCCCCCEEEEECCEEEEEEEECCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC---CCCCEEECCC
Q ss_conf 3977564244206569999988590999999404883137999999999743899840037210047---7411242169
Q 003481 470 CNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE---AWSLVYEYLP 546 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~lV~E~~~ 546 (816)
++|...+.||+|+||.||+|.+.|..||||+++... ....|.+|+.++++++|||||+++|+|.+ ..++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHEEEEEEEECCCCEEEEEEEECCEEEEEEEECCHH--HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECCC
T ss_conf 994885798207980899999999099999988577--799999999999867898985498788723892899996369
Q ss_pred CCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCCCC
Q ss_conf 99613564102999989999999999999999999851699944607788995675479990682026511014788767
Q 003481 547 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 626 (816)
Q Consensus 547 ~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~~~~~~ 626 (816)
+|+|.++|..... ..++|..+++|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 85 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCHHHHHHHCCC-CCCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEECCCCC---
T ss_conf 9989999874578-88899999999999985232113376---5536665676014689977632456003447877---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCHH--HHHHHHHCCCCCCCCCCCCCCCCH
Q ss_conf 77555689998989889643335988961037679999999992-999999827--899986309632335788999998
Q 003481 627 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPT 703 (816)
Q Consensus 627 ~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~P~~~~~--~~~~~~~~~~~~~~~d~~~~~~~~ 703 (816)
....+|+.|+|||++.++.+++++||||||+++|||+| |++||.... .+...+..+.. ...|.
T Consensus 158 ------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~--------~~~~~ 223 (262)
T d1byga_ 158 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------MDAPD 223 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC--------CCCCT
T ss_pred ------CCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--------CCCCC
T ss_conf ------6556664677817872798885887775799999999789999999999999999980899--------99976
Q ss_pred HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 9999999999995310889999974899999998310
Q 003481 704 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740 (816)
Q Consensus 704 ~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~l~~ 740 (816)
..+..+.+|+.+||+.||.+||++. .+.+.|+.+..
T Consensus 224 ~~~~~~~~li~~cl~~dP~~Rps~~-~l~~~L~~i~~ 259 (262)
T d1byga_ 224 GCPPAVYEVMKNCWHLDAAMRPSFL-QLREQLEHIKT 259 (262)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 5799999999997566976893999-99999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=351.25 Aligned_cols=239 Identities=23% Similarity=0.308 Sum_probs=200.3
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCC---CCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCCCEE
Q ss_conf 39775642442065699999885--90999999404883---137999999999743899840037210047--741124
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~ 542 (816)
++|...+.||+|+||.||++.+. |..||||++..... .....+.+|+.+|..++|||||++++++.+ ..++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCC
Q ss_conf 21699961356410299998999999999999999999985169994460778899567547999068202651101478
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 622 (816)
Q Consensus 543 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~~ 622 (816)
||+.+|+|.+++.... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEEEECCCC
T ss_conf 2334662266675158---9899999999999999899998599---861767999936077897886101033322566
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCCC
Q ss_conf 8767775556899989898896433359889610376799999999929999998278--99986309632335788999
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~~~~~--~~~~~~~~~~~~~~d~~~~~ 700 (816)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||..... ....+..+.. .
T Consensus 195 ---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~---------~ 256 (350)
T d1rdqe_ 195 ---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV---------R 256 (350)
T ss_dssp ---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------C
T ss_pred ---------CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC---------C
T ss_conf ---------6433676356788997179988533114500789999758899899599999999861798---------8
Q ss_pred CCHHHHHHHHHHHHHHHCCCCCCCC-----CCHHHHH
Q ss_conf 9989999999999995310889999-----9748999
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERP-----DITPSLV 732 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~Cl~~dp~~RP-----s~~~~l~ 732 (816)
.|...+..+.+|+.+||..||.+|+ ++.+.+.
T Consensus 257 ~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf 9766899999999998340998606553454999971
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=349.72 Aligned_cols=238 Identities=26% Similarity=0.322 Sum_probs=192.2
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCC---CCHHHHHH---HHHHHHCCCCCCEEEEECCCCC--CCC
Q ss_conf 39775642442065699999885--90999999404883---13799999---9999743899840037210047--741
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQ---EVRVLSKLQHPHLVTLLGACPE--AWS 539 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~---~~~~~~~~---E~~il~~l~HpnIv~l~g~~~~--~~~ 539 (816)
++|.+.+.||+|+||.||+|+.. |..||||++..... .....+.+ ++.++..++|||||++++++.+ ..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred CEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEC
Q ss_conf 12421699961356410299998999999999999999999985169994460778899567547999068202651101
Q 003481 540 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 619 (816)
Q Consensus 540 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~ 619 (816)
+||||+++|+|.++|.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEECCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEECEEEEC
T ss_conf 9999148983899987325---5327899999999999999999779---622044422167858896798220102333
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCC
Q ss_conf 478876777555689998989889643335-9889610376799999999929999998278--9998630963233578
Q 003481 620 TEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDP 696 (816)
Q Consensus 620 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~P~~~~~~--~~~~~~~~~~~~~~d~ 696 (816)
.... .....||+.|+|||++.. ..++.++|||||||+||||+||+.||..... ....... ...
T Consensus 158 ~~~~--------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~------~~~ 223 (364)
T d1omwa3 158 SKKK--------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM------TLT 223 (364)
T ss_dssp SSSC--------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH------SSS
T ss_pred CCCC--------CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH------CCC
T ss_conf 7886--------43311345542168760389998441046778999999859998888998999999986------046
Q ss_pred CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 8999998999999999999531088999997
Q 003481 697 LAGDWPTFVARRLVDLGLQCCELYGRERPDI 727 (816)
Q Consensus 697 ~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~ 727 (816)
....++...+..+.+|+.+||+.||.+||+.
T Consensus 224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~ 254 (364)
T d1omwa3 224 MAVELPDSFSPELRSLLEGLLQRDVNRRLGC 254 (364)
T ss_dssp CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTT
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCHHHHCCC
T ss_conf 8887887789999999999856698880887
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.48 Aligned_cols=250 Identities=27% Similarity=0.447 Sum_probs=201.2
Q ss_pred CCEEEEECCEEEEEEEECC-----EEEEEEEECCCCC-CCHHHHHHHHHHHHCCCCCCEEEEECCCCC---CCCCEEECC
Q ss_conf 6424420656999998859-----0999999404883-137999999999743899840037210047---741124216
Q 003481 475 SFKVGQGGFGCVYKGEMLG-----RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE---AWSLVYEYL 545 (816)
Q Consensus 475 ~~~LG~G~~g~Vy~g~~~g-----~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~---~~~lV~E~~ 545 (816)
.++||+|+||+||+|.+.. ..||||+++.... .....|.+|+.++++++|||||+++|+|.+ ..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCCC
Q ss_conf 99961356410299998999999999999999999985169994460778899567547999068202651101478876
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~~~~~ 625 (816)
++|+|.+++.... ..+++..+++++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ECCCHHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCC
T ss_conf 0674144210134--54048999999999887652003367---625776687576779998899106523225566555
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCHHH---HHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 7775556899989898896433359889610376799999999929999998278---9998630963233578899999
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE---VRRAVSCGKLSSILDPLAGDWP 702 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~~~~~---~~~~~~~~~~~~~~d~~~~~~~ 702 (816)
. ........||+.|+|||++..+.++.++||||||+++|||+||..||..... +...+..+.. ...|
T Consensus 187 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~--------~~~p 256 (311)
T d1r0pa_ 187 S--VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--------LLQP 256 (311)
T ss_dssp C--TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC--------CCCC
T ss_pred C--CEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--------CCCC
T ss_conf 3--10025655564556768874379997457466199999999789999888999999999980898--------8996
Q ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 89999999999995310889999974899999998310
Q 003481 703 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740 (816)
Q Consensus 703 ~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~l~~ 740 (816)
...+..+.+|+.+||+.||.+||++. ++++.|+.+..
T Consensus 257 ~~~~~~l~~li~~cl~~dP~~RPs~~-ei~~~L~~i~~ 293 (311)
T d1r0pa_ 257 EYCPDPLYEVMLKCWHPKAEMRPSFS-ELVSRISAIFS 293 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 44759999999997688976893999-99999999997
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.83 Aligned_cols=246 Identities=25% Similarity=0.317 Sum_probs=201.8
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCC------CCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CC
Q ss_conf 239775642442065699999885--90999999404883------137999999999743899840037210047--74
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM------QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AW 538 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~------~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~ 538 (816)
.++|...+.||+|+||.||+|+.. |..||||++..... .....|.+|+.+|.+++|||||++++++.+ ..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred CCEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CEEEEECC
Q ss_conf 11242169996135641029999899999999999999999998516999446077889956754799----90682026
Q 003481 539 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL----SSKICDFG 614 (816)
Q Consensus 539 ~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~----~~KL~DFG 614 (816)
++||||+++|+|.+++.... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEECCCCCCCCCHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCEEECCHH
T ss_conf 99998677864310010356---4215578999999999987666254---22113330127982589866646964334
Q ss_pred CCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCC
Q ss_conf 511014788767775556899989898896433359889610376799999999929999998278--999863096323
Q 003481 615 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSS 692 (816)
Q Consensus 615 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~~~~~--~~~~~~~~~~~~ 692 (816)
+|+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ....+..+...-
T Consensus 163 ~a~~~~~~~-------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1jksa_ 163 LAHKIDFGN-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235 (293)
T ss_dssp TCEECTTSC-------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC
T ss_pred HHHHCCCCC-------CCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC
T ss_conf 421057776-------3122477774309999818999976652214099999970889988999999999998168888
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf 3578899999899999999999953108899999748999
Q 003481 693 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 693 ~~d~~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~ 732 (816)
....+...+..+.+|+.+||+.||.+||++.+.+.
T Consensus 236 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 236 -----EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -----CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----CCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -----70104788999999999986389668919999961
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.60 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=207.0
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC-----CEEEEEEEECCCCCC-CHHHHHHHHHHHHCCCCCCEEEEECCCCC-CCCCE
Q ss_conf 239775642442065699999885-----909999994048831-37999999999743899840037210047-74112
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLV 541 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~g~~~-----g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~lV 541 (816)
.++|...+.||+|+||.||+|.+. +..||||.+...... ....|.+|+.++++++|||||+++|+|.+ ..++|
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv 85 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 85 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCEEEEE
T ss_conf 89969877993078829999999369964499999993656687999999999999986899998569889953747999
Q ss_pred EECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCC
Q ss_conf 42169996135641029999899999999999999999998516999446077889956754799906820265110147
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 542 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~ 621 (816)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEECCCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCHHHEECCC
T ss_conf 98406980776542247--89999999999999987752302267---44141026553206789678765034213367
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCHH--HHHHHHHCCCCCCCCCCCC
Q ss_conf 8876777555689998989889643335988961037679999999992-999999827--8999863096323357889
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLA 698 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~P~~~~~--~~~~~~~~~~~~~~~d~~~ 698 (816)
.... ......||+.|+|||++....++.++|||||||++|||+| |.+||.... .+...+..+...
T Consensus 161 ~~~~-----~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~------- 228 (273)
T d1mp8a_ 161 STYY-----KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------- 228 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-------
T ss_pred CCCE-----ECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC-------
T ss_conf 7623-----3054005831032667516998874524442478999982699998889999999999818999-------
Q ss_pred CCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 99998999999999999531088999997489999999831
Q 003481 699 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 699 ~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~l~ 739 (816)
..|...+..+.+|+.+||..||.+||++. .+...|+.+.
T Consensus 229 -~~~~~~~~~~~~li~~cl~~dp~~Rps~~-ei~~~L~~i~ 267 (273)
T d1mp8a_ 229 -PMPPNCPPTLYSLMTKCWAYDPSRRPRFT-ELKAQLSTIL 267 (273)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf -89877799999999997687976892999-9999999997
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.08 Aligned_cols=255 Identities=29% Similarity=0.437 Sum_probs=204.1
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC-------CEEEEEEEECCCCCC-CHHHHHHHHHHHHCC-CCCCEEEEECCCCC---
Q ss_conf 239775642442065699999885-------909999994048831-379999999997438-99840037210047---
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKL-QHPHLVTLLGACPE--- 536 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~g~~~-------g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--- 536 (816)
.++|...++||+|+||.||+|.+. ++.||||+++..... ....+..|..++.++ +|+|||.+++++.+
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCC
T ss_conf 79979844984167839999998677755578399999986001717899999999998861499849974115404797
Q ss_pred CCCCEEECCCCCCHHHHHHHCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC
Q ss_conf 74112421699961356410299-------------99899999999999999999998516999446077889956754
Q 003481 537 AWSLVYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD 603 (816)
Q Consensus 537 ~~~lV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld 603 (816)
..++||||+++|+|.++|..... ...+++..++.|+.|++.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred EEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEC
T ss_conf 579999845899299999853666665322202332146899999999999999999887379---71786773106577
Q ss_pred CCCCEEEEECCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCHH---
Q ss_conf 79990682026511014788767775556899989898896433359889610376799999999929-99999827---
Q 003481 604 SELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTG-RLPVGLAG--- 679 (816)
Q Consensus 604 ~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG-~~P~~~~~--- 679 (816)
.++.+||+|||+|+........ .......||+.|+|||++.++.++.++|||||||++|||+|| .+||....
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp GGGCEEECC------CCSCTTS----CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred CCCCEEECCCCCHHHCCCCCCC----CCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHH
T ss_conf 9982898457520011356652----224751667210203686468899663221367899999868899998999899
Q ss_pred HHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 899986309632335788999998999999999999531088999997489999999831
Q 003481 680 EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 680 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~l~ 739 (816)
.....+..+... ..|...+..+.+|+.+||+.||.+||++. .+++.|+.+.
T Consensus 245 ~~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-eil~~L~~il 295 (299)
T d1ywna1 245 EFCRRLKEGTRM--------RAPDYTTPEMYQTMLDCWHGEPSQRPTFS-ELVEHLGNLL 295 (299)
T ss_dssp HHHHHHHHTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred HHHHHHHCCCCC--------CCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 999999638988--------88865789999999997677966791999-9999997998
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=342.46 Aligned_cols=256 Identities=25% Similarity=0.381 Sum_probs=207.9
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCCC---HHHHHHHHHHHHCCCCCCEEEEECCCCC------C
Q ss_conf 239775642442065699999885--9099999940488313---7999999999743899840037210047------7
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQHPHLVTLLGACPE------A 537 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~~---~~~~~~E~~il~~l~HpnIv~l~g~~~~------~ 537 (816)
.++|.+.+.||+|+||.||+|... |+.||||++....... ...|.+|+.++..++|||||++++++.. .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred CCCEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCE
Q ss_conf 41124216999613564102999989999999999999999999851699944607788995675479990682026511
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~ 617 (816)
.++||||+++|+|.+++.... ++++..+..|+.|++.||.|||+.+ |+||||||+|||++.++..+|+|||++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEEHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEEHHHHHH
T ss_conf 999997788987101120358---9999999999999999999998579---5276346755665754320100344432
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCHHHHHH---HHHCCCCCCCC
Q ss_conf 014788767775556899989898896433359889610376799999999929999998278999---86309632335
Q 003481 618 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVSCGKLSSIL 694 (816)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~~~~~~~~---~~~~~~~~~~~ 694 (816)
........ ........||+.|+|||++.+..+++++|||||||++|||+||++||........ .+..+...
T Consensus 160 ~~~~~~~~---~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~--- 233 (277)
T d1o6ya_ 160 AIADSGNS---VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP--- 233 (277)
T ss_dssp ECC-------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC---
T ss_pred HHCCCCCC---CCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC---
T ss_conf 21235443---333464257624369999839999966320265289999976979989969999999998469999---
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 788999998999999999999531088999997489999999831
Q 003481 695 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 695 d~~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~l~ 739 (816)
+ .......+..+.+|+.+|+..||.+||+..+++.+.|.++.
T Consensus 234 -~--~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 -P--SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -G--GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -C--CHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf -7--10034789999999999866797677739999999999975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.22 Aligned_cols=252 Identities=28% Similarity=0.424 Sum_probs=204.8
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC--CE--EEEEEEECCCCC-CCHHHHHHHHHHHHCC-CCCCEEEEECCCCC--CCCCE
Q ss_conf 39775642442065699999885--90--999999404883-1379999999997438-99840037210047--74112
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GR--TVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLV 541 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~--g~--~vAiK~l~~~~~-~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~~~lV 541 (816)
++|...+.||+|+||.||+|.+. |. .||||++..... .....|.+|+.+|.++ +|||||+++|+|.+ ..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EECCCCCCHHHHHHHC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf 4216999613564102-------------999989999999999999999999851699944607788995675479990
Q 003481 542 YEYLPNGSLQDRLFRK-------------SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 608 (816)
Q Consensus 542 ~E~~~~gsL~~~L~~~-------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~ 608 (816)
|||+++|+|.++|... .....+++..+++++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCCE
T ss_conf 9802898699998640355555123101234578999999999999999987663089---5455505204898688763
Q ss_pred EEEECCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCC-CCCCCHH--HHHHHH
Q ss_conf 6820265110147887677755568999898988964333598896103767999999999299-9999827--899986
Q 003481 609 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR-LPVGLAG--EVRRAV 685 (816)
Q Consensus 609 KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~-~P~~~~~--~~~~~~ 685 (816)
||+|||+++...... ......||..|+|||.+..+.++.++|||||||++|||++|. +||.... .+...+
T Consensus 167 kl~DfG~a~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239 (309)
T ss_dssp EECCTTCEESSCEEC-------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred EECCCCCCCCCCCCC-------CCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
T ss_conf 874344322444223-------4553013775555387526999962215313889999983689999999999999999
Q ss_pred HCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 3096323357889999989999999999995310889999974899999998310
Q 003481 686 SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740 (816)
Q Consensus 686 ~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~l~~ 740 (816)
..+. ....|...+..+.+|+.+||+.||++||++. ++++.|+.+..
T Consensus 240 ~~~~--------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~-eil~~L~~i~~ 285 (309)
T d1fvra_ 240 PQGY--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFA-QILVSLNRMLE 285 (309)
T ss_dssp GGTC--------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred HHCC--------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 8268--------8888766789999999997678966894999-99999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.87 Aligned_cols=249 Identities=22% Similarity=0.265 Sum_probs=195.6
Q ss_pred CCCCCCC-EEEEECCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHCC-CCCCEEEEECCCCC------CCC
Q ss_conf 3977564-2442065699999885--909999994048831379999999997438-99840037210047------741
Q 003481 470 CNFSESF-KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE------AWS 539 (816)
Q Consensus 470 ~~f~~~~-~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~~------~~~ 539 (816)
++|.+.. .||+|+||.||+|... +..||||++.. ...+.+|+.++.++ +|||||++++++.+ ..+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEEE
T ss_conf 4879810796545486999999889998999999897-----47799999999986699997829899950346897899
Q ss_pred CEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEECCCC
Q ss_conf 12421699961356410299998999999999999999999985169994460778899567547---999068202651
Q 003481 540 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS---ELSSKICDFGIC 616 (816)
Q Consensus 540 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~---~~~~KL~DFGla 616 (816)
+|||||+||+|.++|..... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+|
T Consensus 86 ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCCHHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCEE
T ss_conf 99977899849999986278-77579999999999999999999769---864441002201135555663113545512
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCHHHH--HHHHHCCCCCCCC
Q ss_conf 10147887677755568999898988964333598896103767999999999299999982789--9986309632335
Q 003481 617 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSIL 694 (816)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~~~~~~--~~~~~~~~~~~~~ 694 (816)
+...... ......||+.|+|||++.+..|+.++|||||||+||+|+||+.||...... ...+.........
T Consensus 162 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~ 234 (335)
T d2ozaa1 162 KETTSHN-------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234 (335)
T ss_dssp EECCCCC-------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSS
T ss_pred EECCCCC-------CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHCCCC
T ss_conf 3336888-------643226775637927774898888888876451677886588998898877889999999853888
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 78899999899999999999953108899999748999999
Q 003481 695 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 695 d~~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L 735 (816)
+ .........+..+.+|+.+|++.||.+||++.+.+.+.+
T Consensus 235 ~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 274 (335)
T d2ozaa1 235 E-FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 274 (335)
T ss_dssp S-CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHH
T ss_pred C-CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf 8-898543469999999999975699657909999970987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.90 Aligned_cols=238 Identities=28% Similarity=0.359 Sum_probs=198.8
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCC---CCCHHHHHHHHHHHH-CCCCCCEEEEECCCCC--CCCCE
Q ss_conf 39775642442065699999885--9099999940488---313799999999974-3899840037210047--74112
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLS-KLQHPHLVTLLGACPE--AWSLV 541 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~---~~~~~~~~~E~~il~-~l~HpnIv~l~g~~~~--~~~lV 541 (816)
++|.+.+.||+|+||.||+|+.. |..||||++.+.. ......+..|..++. .++|||||++++++.+ ..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCC
Q ss_conf 42169996135641029999899999999999999999998516999446077889956754799906820265110147
Q 003481 542 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 621 (816)
Q Consensus 542 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~ 621 (816)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEECCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCHHHHCCC
T ss_conf 75037980899864047---8999999999999999999998689---34034765404444899630155530232356
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCC
Q ss_conf 88767775556899989898896433359889610376799999999929999998278--9998630963233578899
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAG 699 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~~~~~--~~~~~~~~~~~~~~d~~~~ 699 (816)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... +...+..+..
T Consensus 156 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~--------- 220 (320)
T d1xjda_ 156 GDA------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP--------- 220 (320)
T ss_dssp TTC------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred CCC------CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC---------
T ss_conf 653------34545787776899998279988323201122789898738899999899999999971899---------
Q ss_pred CCCHHHHHHHHHHHHHHHCCCCCCCCCCH
Q ss_conf 99989999999999995310889999974
Q 003481 700 DWPTFVARRLVDLGLQCCELYGRERPDIT 728 (816)
Q Consensus 700 ~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~ 728 (816)
.+|...+..+.+|+.+||..||.+||++.
T Consensus 221 ~~p~~~s~~~~dli~~~L~~dP~~R~s~~ 249 (320)
T d1xjda_ 221 FYPRWLEKEAKDLLVKLFVREPEKRLGVR 249 (320)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSBTTB
T ss_pred CCCCCCCHHHHHHHHHHCCCCCCCCCCHH
T ss_conf 89756799999999996544898783889
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.05 Aligned_cols=253 Identities=28% Similarity=0.448 Sum_probs=205.6
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC-------CEEEEEEEECCCCCC-CHHHHHHHHHHHHCCCCCCEEEEECCCC--CCCC
Q ss_conf 39775642442065699999885-------909999994048831-3799999999974389984003721004--7741
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWS 539 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~-------g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~g~~~--~~~~ 539 (816)
++|...++||+|+||.||+|.+. +..||||+++..... ....|.+|+.++.+++|||||+++|+|. +..+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEE
T ss_conf 99188359820788189999987864477896899999870128689999999999999769998841254784288106
Q ss_pred CEEECCCCCCHHHHHHHC-------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEE
Q ss_conf 124216999613564102-------9999899999999999999999998516999446077889956754799906820
Q 003481 540 LVYEYLPNGSLQDRLFRK-------SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICD 612 (816)
Q Consensus 540 lV~E~~~~gsL~~~L~~~-------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~D 612 (816)
+||||+++|+|.+++... .....+++..+.+|+.+++.||.|||..+ |+||||||+|||++.++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECCCCEEEEEE
T ss_conf 777604899889998750332113444688799999999999999999876479---65432867754035996499942
Q ss_pred CCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCHHH--HHHHHHCCC
Q ss_conf 26511014788767775556899989898896433359889610376799999999929-999998278--999863096
Q 003481 613 FGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTG-RLPVGLAGE--VRRAVSCGK 689 (816)
Q Consensus 613 FGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG-~~P~~~~~~--~~~~~~~~~ 689 (816)
||+|+........ .......||+.|+|||.+.+..++.++||||||+++|||+|| ++||..... +...+..+.
T Consensus 177 FGla~~~~~~~~~----~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~ 252 (308)
T d1p4oa_ 177 FGMTRDIYETDYY----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG 252 (308)
T ss_dssp TTCCCGGGGGGCE----EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC
T ss_pred CCCCEECCCCCCE----EECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC
T ss_conf 4542023577630----313402316323788887369988333444378999999968999999989999999998088
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 3233578899999899999999999953108899999748999999983
Q 003481 690 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 690 ~~~~~d~~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~l 738 (816)
.. ..|...+..+.+|+.+||+.+|.+||++. .++..|+..
T Consensus 253 ~~--------~~p~~~~~~l~~li~~cl~~~P~~RPs~~-~il~~L~~~ 292 (308)
T d1p4oa_ 253 LL--------DKPDNCPDMLFELMRMCWQYNPKMRPSFL-EIISSIKEE 292 (308)
T ss_dssp CC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHGGG
T ss_pred CC--------CCCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHH
T ss_conf 88--------88633539999999997577965893999-999997876
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.40 Aligned_cols=255 Identities=27% Similarity=0.452 Sum_probs=209.5
Q ss_pred CCCCCCCEEEEECCEEEEEEEECC---------EEEEEEEECCCCCC-CHHHHHHHHHHHHCC-CCCCEEEEECCCCC--
Q ss_conf 397756424420656999998859---------09999994048831-379999999997438-99840037210047--
Q 003481 470 CNFSESFKVGQGGFGCVYKGEMLG---------RTVAIKMLYSHNMQ-GQLEFQQEVRVLSKL-QHPHLVTLLGACPE-- 536 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~g---------~~vAiK~l~~~~~~-~~~~~~~E~~il~~l-~HpnIv~l~g~~~~-- 536 (816)
++|...+.||+|+||.||+|+..+ ..||||+++..... ...++.+|...+.++ +|||||+++|+|.+
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCCC
T ss_conf 99697009851678289999985787555667549999998811286889999999999998139996973465220188
Q ss_pred CCCCEEECCCCCCHHHHHHHCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC
Q ss_conf 74112421699961356410299-------------99899999999999999999998516999446077889956754
Q 003481 537 AWSLVYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD 603 (816)
Q Consensus 537 ~~~lV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld 603 (816)
..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred EEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCEEEC
T ss_conf 689999736999099999860677643222334574346799999999999999998766379---78630221022454
Q ss_pred CCCCEEEEECCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCHH--H
Q ss_conf 7999068202651101478876777555689998989889643335988961037679999999992-999999827--8
Q 003481 604 SELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--E 680 (816)
Q Consensus 604 ~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~P~~~~~--~ 680 (816)
.++.+||+|||+++........ .......||+.|+|||++.++.|+.++||||||+++|||+| |.+||.... .
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYY----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTT----CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred CCCCEEECCCHHHCCCCCCCCC----CCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHH
T ss_conf 7897676221110113555554----314667888466326675179888255547758888874017989899999999
Q ss_pred HHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 999863096323357889999989999999999995310889999974899999998310
Q 003481 681 VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740 (816)
Q Consensus 681 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~l~~ 740 (816)
+...+..+.. ...|...+..+.+|+.+||+.+|.+|||+. ++++.|+.+..
T Consensus 246 ~~~~i~~~~~--------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~-eil~~L~~i~a 296 (299)
T d1fgka_ 246 LFKLLKEGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRIVA 296 (299)
T ss_dssp HHHHHHTTCC--------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred HHHHHHCCCC--------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 9999972888--------898743529999999997667976793999-99999988860
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.71 Aligned_cols=258 Identities=26% Similarity=0.345 Sum_probs=198.1
Q ss_pred CCCCCCEEEEECCEEEEEEEECCEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC------CCCCEEEC
Q ss_conf 977564244206569999988590999999404883137999999999743899840037210047------74112421
Q 003481 471 NFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE------AWSLVYEY 544 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~g~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------~~~lV~E~ 544 (816)
+|...+.||+|+||.||+|+++|..||||++...... ...+..|+..+.+++|||||+++|+|.+ ..++||||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEEEECCCEEEEEEEECCEEEEEEEECCCCHH-HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEEEC
T ss_conf 8999889820788199999999989999998720046-799999999996279986832688998379860489999964
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCEEECCCCCCCEEECCCCCEEEEECCCCEEC
Q ss_conf 699961356410299998999999999999999999985169-----994460778899567547999068202651101
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK-----PEKIVHGDLKPQNILLDSELSSKICDFGICRLV 619 (816)
Q Consensus 545 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~ 619 (816)
+++|+|.++|... .++|..+++++.+++.||.|||... .++|+||||||+|||++.++.+||+|||+++..
T Consensus 83 ~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 83 HEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCC
T ss_conf 6698989998658----999899999999999999998876652046898661531731357868877688763866234
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCHHHHHHHHHHHHHHHCCCCCCCH---------------
Q ss_conf 4788767775556899989898896433359------8896103767999999999299999982---------------
Q 003481 620 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTG------VLTPKSDSYSFGLIILQLLTGRLPVGLA--------------- 678 (816)
Q Consensus 620 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~s~ksDVwSlGvil~elltG~~P~~~~--------------- 678 (816)
....... ........||+.|+|||++... .++.++|||||||+||||+||..||...
T Consensus 159 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 159 DSATDTI--DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp ETTTTEE--CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred CCCCCCE--ECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCC
T ss_conf 6777620--01355250354767822105654546777675012201599999996289988766311241012255643
Q ss_pred --HHHHHHHHCCCCCCCCCCCCC-CC-CHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf --789998630963233578899-99-989999999999995310889999974899999998310
Q 003481 679 --GEVRRAVSCGKLSSILDPLAG-DW-PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740 (816)
Q Consensus 679 --~~~~~~~~~~~~~~~~d~~~~-~~-~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~l~~ 740 (816)
.........+. +.|... .+ +......+.+|+.+||+.||.+||++. .+.+.|+.+..
T Consensus 237 ~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~-ei~~~L~~i~~ 297 (303)
T d1vjya_ 237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL-RIKKTLSQLSQ 297 (303)
T ss_dssp CHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred HHHHHHHHHHCCC----CCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 0999999875024----6888776557768999999999997606985895999-99999998888
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.58 Aligned_cols=252 Identities=27% Similarity=0.412 Sum_probs=204.0
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC---C--EEEEEEEECCCCC---CCHHHHHHHHHHHHCCCCCCEEEEECCCCC-CCCC
Q ss_conf 39775642442065699999885---9--0999999404883---137999999999743899840037210047-7411
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML---G--RTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSL 540 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~---g--~~vAiK~l~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~l 540 (816)
.+|...+.||+|+||.||+|.+. + ..||||++..... .....|.+|+.++.+++|||||+++|+|.+ ..++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCHHE
T ss_conf 89199789803888399999998899907999999998355579899999999999998689999878987774010011
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECC
Q ss_conf 24216999613564102999989999999999999999999851699944607788995675479990682026511014
Q 003481 541 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 620 (816)
Q Consensus 541 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~ 620 (816)
|+||+++|+|.+++.... .++++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECCCHHHHHCC
T ss_conf 465423861254442126--89999999999999999998752178---7520566888156556543325611555303
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCHHHHH--HHHHCCCCCCCCCCC
Q ss_conf 78876777555689998989889643335988961037679999999992-999999827899--986309632335788
Q 003481 621 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVR--RAVSCGKLSSILDPL 697 (816)
Q Consensus 621 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~P~~~~~~~~--~~~~~~~~~~~~d~~ 697 (816)
...... .......|++.|+|||++.+..++.++|||||||++|||+| |+.||....... ..+.....
T Consensus 163 ~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~------- 232 (273)
T d1u46a_ 163 QNDDHY---VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE------- 232 (273)
T ss_dssp C-CCEE---EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC-------
T ss_pred CCCCCC---EECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC-------
T ss_conf 588752---6547632573107999983799994215661489999999689999999699999999984799-------
Q ss_pred CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf 9999989999999999995310889999974899999998
Q 003481 698 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 737 (816)
Q Consensus 698 ~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~ 737 (816)
....+...+..+.+|+.+||+.||.+|||+. .+.+.|..
T Consensus 233 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~-ei~~~L~~ 271 (273)
T d1u46a_ 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV-ALRDFLLE 271 (273)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHH
T ss_conf 9998544539999999997688966792999-99999996
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.05 Aligned_cols=254 Identities=29% Similarity=0.417 Sum_probs=206.5
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC-------CEEEEEEEECCCCCC-CHHHHHHHHHHHHCC-CCCCEEEEECCCCC--C
Q ss_conf 239775642442065699999885-------909999994048831-379999999997438-99840037210047--7
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKL-QHPHLVTLLGACPE--A 537 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~g~~~-------g~~vAiK~l~~~~~~-~~~~~~~E~~il~~l-~HpnIv~l~g~~~~--~ 537 (816)
.++|...++||+|+||.||+|++. +..||||+++..... ....|.+|+.++.++ +|||||+++|+|.+ .
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf 89969854982068829999998066447788699999987424877999999999998762699988789989831997
Q ss_pred CCCEEECCCCCCHHHHHHHCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf 411242169996135641029---------------99989999999999999999999851699944607788995675
Q 003481 538 WSLVYEYLPNGSLQDRLFRKS---------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 602 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~L~~~~---------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILl 602 (816)
.++||||+++|+|.+++.... ....+++..++.|+.|++.||.|||+.+ ++||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCC
T ss_conf 8999973799879999985356654444453322233458899999999999999999887579---2666241021000
Q ss_pred CCCCCEEEEECCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-CCCCCCCH---
Q ss_conf 47999068202651101478876777555689998989889643335988961037679999999992-99999982---
Q 003481 603 DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLA--- 678 (816)
Q Consensus 603 d~~~~~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~ellt-G~~P~~~~--- 678 (816)
+.++.+||+|||+++........ .......||+.|+|||++..+.++.++|||||||++|||+| |.+||...
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNY----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTS----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred CCCCCCCCCCCCHHEECCCCCCC----EEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH
T ss_conf 02575210234010233678861----58620135968767788617999974001025899999985899887789989
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 789998630963233578899999899999999999953108899999748999999983
Q 003481 679 GEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 738 (816)
Q Consensus 679 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~l 738 (816)
..+...+..+... ..+...+..+.+|+.+||+.||.+||++. .+++.|+..
T Consensus 255 ~~~~~~i~~~~~~--------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~-~il~~L~~~ 305 (311)
T d1t46a_ 255 SKFYKMIKEGFRM--------LSPEHAPAEMYDIMKTCWDADPLKRPTFK-QIVQLIEKQ 305 (311)
T ss_dssp HHHHHHHHHTCCC--------CCCTTSCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHH
T ss_pred HHHHHHHHCCCCC--------CCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHH
T ss_conf 9999998668988--------98543659999999997577965792999-999999876
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.07 Aligned_cols=249 Identities=19% Similarity=0.276 Sum_probs=202.1
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCCCEEEC
Q ss_conf 239775642442065699999885--90999999404883137999999999743899840037210047--74112421
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 544 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 544 (816)
.++|.+.+.||+|+||.||+|... |..||+|+++.... ....+.+|+.+|.+++|||||++++++.+ ..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 0105887898317783999999989996999999757866-599999999999857997989098999889988999953
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEEECCCCEECCCC
Q ss_conf 699961356410299998999999999999999999985169994460778899567547--999068202651101478
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS--ELSSKICDFGICRLVTED 622 (816)
Q Consensus 545 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~--~~~~KL~DFGla~~~~~~ 622 (816)
+++|+|.+++.... ..+++.++..|+.|++.||.|||+.+ |+||||||+|||++. .+.+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCC
T ss_conf 89980889987538--99999999999999999999998769---97513554443443788518997644111003467
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCCC
Q ss_conf 8767775556899989898896433359889610376799999999929999998278--99986309632335788999
Q 003481 623 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 700 (816)
Q Consensus 623 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~~~~~--~~~~~~~~~~~~~~d~~~~~ 700 (816)
.. .....||+.|+|||.+.+..++.++|||||||++|+|++|+.||..... +...+..+...- + ..
T Consensus 158 ~~-------~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--~---~~ 225 (321)
T d1tkia_ 158 DN-------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF--D---EE 225 (321)
T ss_dssp CE-------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC--C---HH
T ss_pred CC-------CCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC--C---HH
T ss_conf 75-------321223322234021048777840113027999999982899999989999999998389998--8---02
Q ss_pred CCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 99899999999999953108899999748999999
Q 003481 701 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 735 (816)
Q Consensus 701 ~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L 735 (816)
.....+..+.+|+.+|+..||.+||++.+.+.+..
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 260 (321)
T d1tkia_ 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf 23678999999999986699668909999963996
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=335.61 Aligned_cols=244 Identities=25% Similarity=0.329 Sum_probs=200.7
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCCC---------HHHHHHHHHHHHCCC-CCCEEEEECCCCC-
Q ss_conf 39775642442065699999885--9099999940488313---------799999999974389-9840037210047-
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---------QLEFQQEVRVLSKLQ-HPHLVTLLGACPE- 536 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~~---------~~~~~~E~~il~~l~-HpnIv~l~g~~~~- 536 (816)
++|...+.||+|+||.||+++.. |..||||++....... ...+.+|+.++.+++ |||||++++++.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC
T ss_conf 63888528841768499999999999899999996244641147888999999999999999850799747997621467
Q ss_pred -CCCCEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf -7411242169996135641029999899999999999999999998516999446077889956754799906820265
Q 003481 537 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 615 (816)
Q Consensus 537 -~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGl 615 (816)
..+|||||+++|+|.++|.... ++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCEEEEEECCCCCHHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCHH
T ss_conf 60599997689866899998659---9999999999999999999998759---94323462548986899838712403
Q ss_pred CEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCHHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHC
Q ss_conf 1101478876777555689998989889643335------9889610376799999999929999998278--9998630
Q 003481 616 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT------GVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSC 687 (816)
Q Consensus 616 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~s~ksDVwSlGvil~elltG~~P~~~~~~--~~~~~~~ 687 (816)
++...... ......||+.|+|||++.+ ..++.++||||+||+||+|+||+.||..... ....+..
T Consensus 157 a~~~~~~~-------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~ 229 (277)
T d1phka_ 157 SCQLDPGE-------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229 (277)
T ss_dssp CEECCTTC-------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEECCCCC-------CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHHHHH
T ss_conf 16726887-------21345246788898886053445678899233185656023103228889889999999999981
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf 96323357889999989999999999995310889999974899
Q 003481 688 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 688 ~~~~~~~d~~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l 731 (816)
+...- ........+..+.+|+.+||+.+|.+||++.+++
T Consensus 230 ~~~~~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil 268 (277)
T d1phka_ 230 GNYQF-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268 (277)
T ss_dssp TCCCC-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred CCCCC-----CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 89888-----9854346899999999997658966891999997
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.48 Aligned_cols=247 Identities=23% Similarity=0.248 Sum_probs=191.0
Q ss_pred CCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCCC-----HHHHHHHHHHHHCCCCCCEEEEECCCCC--CCCCEEECC
Q ss_conf 642442065699999885--9099999940488313-----7999999999743899840037210047--741124216
Q 003481 475 SFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG-----QLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 545 (816)
Q Consensus 475 ~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~~-----~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~~ 545 (816)
.++||+|+||.||+|... |..||||++....... ...+.+|+.++.+++|||||++++++.+ ..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf 63851272829999999999969999998420212456799999999999998679999868985422587402204553
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCCC
Q ss_conf 99961356410299998999999999999999999985169994460778899567547999068202651101478876
Q 003481 546 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 625 (816)
Q Consensus 546 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~~~~~ 625 (816)
.++++...+... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp SEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred CCHHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC-
T ss_conf 450776554126---67789999999999999998863163---55035776258853778411465761000578755-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH--C--CC-----CCCCC-
Q ss_conf 7775556899989898896433359-889610376799999999929999998278999863--0--96-----32335-
Q 003481 626 LPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS--C--GK-----LSSIL- 694 (816)
Q Consensus 626 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~P~~~~~~~~~~~~--~--~~-----~~~~~- 694 (816)
......||+.|+|||++... .++.++|||||||++|||+||.+||........... . +. .....
T Consensus 156 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 156 -----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp -----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred -----CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHC
T ss_conf -----433020473336399972677888056436304289999859699999999999999998518997254521000
Q ss_pred --C----CCCCCCC-----HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf --7----8899999-----8999999999999531088999997489999
Q 003481 695 --D----PLAGDWP-----TFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 695 --d----~~~~~~~-----~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~ 733 (816)
. ......+ ...+..+.+|+.+|++.||++|||+.+.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 21344303478988678565689999999999763894569089999679
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.02 Aligned_cols=252 Identities=26% Similarity=0.331 Sum_probs=193.0
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC---CEEEEEEEECCCCCC--CHHHHHHHHHHHHCC---CCCCEEEEECCCC-----
Q ss_conf 239775642442065699999885---909999994048831--379999999997438---9984003721004-----
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKL---QHPHLVTLLGACP----- 535 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~g~~~---g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l---~HpnIv~l~g~~~----- 535 (816)
.++|...++||+|+||.||+|++. +..||||++...... ....+.+|+.++..+ +||||++++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred --CCCCCEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEC
Q ss_conf --774112421699961356410299998999999999999999999985169994460778899567547999068202
Q 003481 536 --EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 613 (816)
Q Consensus 536 --~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DF 613 (816)
...++++||+.+|++....... ...+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCEEEEEEEECCCCCHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCCEEECCH
T ss_conf 674699999740587144444303--789998999999999999999997588---983579862789858997542100
Q ss_pred CCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCHHHHHHHH---H-CCC
Q ss_conf 651101478876777555689998989889643335988961037679999999992999999827899986---3-096
Q 003481 614 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV---S-CGK 689 (816)
Q Consensus 614 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~~~~~~~~~~---~-~~~ 689 (816)
|+++...... ......||+.|+|||++.+..|+.++|||||||++|||+||++||.......... . .+.
T Consensus 161 g~~~~~~~~~-------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 161 GLARIYSFQM-------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp CSCCCCCGGG-------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred HHHHHHCCCC-------CCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCC
T ss_conf 0101100234-------577765485114831001798881110003289999998787998998989999999984079
Q ss_pred -----C-----------CCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf -----3-----------233578899999899999999999953108899999748999
Q 003481 690 -----L-----------SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 690 -----~-----------~~~~d~~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~ 732 (816)
+ ..........++...+..+.+|+.+||+.||.+|||+.+.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 96110532111103330223456454404458999999999987489667918999966
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.35 Aligned_cols=253 Identities=24% Similarity=0.324 Sum_probs=195.1
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCC--CCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCCCEEE
Q ss_conf 39775642442065699999885--90999999404883--137999999999743899840037210047--7411242
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 543 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 543 (816)
++|...++||+|+||.||+|... |..||+|++..... .....+.+|+.++.+++|||||++++++.+ ..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred CCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCC
Q ss_conf 16999613564102999989999999999999999999851699944607788995675479990682026511014788
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~~~ 623 (816)
|+.++ +.+.+.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~-~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEE-HHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ECCCC-HHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCEECCCCC
T ss_conf 23774-455544202-568888999999999999999865288---9921357114011346762103578613436886
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH----CCCCCCCCC---
Q ss_conf 7677755568999898988964333598-89610376799999999929999998278999863----096323357---
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTGV-LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGKLSSILD--- 695 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~P~~~~~~~~~~~~----~~~~~~~~d--- 695 (816)
. ......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+....... .+...+..-
T Consensus 157 ~------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 157 R------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp B------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred C------CCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCC
T ss_conf 4------1001036521541122136657774221033331342796687998988999999999983289833314442
Q ss_pred ----CCCCCC-----------CHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf ----889999-----------98999999999999531088999997489999
Q 003481 696 ----PLAGDW-----------PTFVARRLVDLGLQCCELYGRERPDITPSLVK 733 (816)
Q Consensus 696 ----~~~~~~-----------~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~ 733 (816)
.....+ ....+..+.+|+.+|+..||.+|||+.+.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 22421243454322220444166789999999999763995579189999678
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.05 Aligned_cols=250 Identities=24% Similarity=0.309 Sum_probs=190.5
Q ss_pred CCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--------CCCC
Q ss_conf 9775642442065699999885--90999999404883137999999999743899840037210047--------7411
Q 003481 471 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--------AWSL 540 (816)
Q Consensus 471 ~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--------~~~l 540 (816)
+|...++||+|+||+||+|++. |..||||++...... +.+|+.+|.+++|||||++++++.. ..+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH----HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 767516982176839999999999979999998816068----9999999986689898738789974476577318999
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCEEC
Q ss_conf 242169996135641029999899999999999999999998516999446077889956754799-9068202651101
Q 003481 541 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICDFGICRLV 619 (816)
Q Consensus 541 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~-~~KL~DFGla~~~ 619 (816)
||||+++|.+............+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf 9841688607888863103689999999999999999999998668---7645788603787358971167336605440
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH------------
Q ss_conf 478876777555689998989889643335-9889610376799999999929999998278999863------------
Q 003481 620 TEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS------------ 686 (816)
Q Consensus 620 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~P~~~~~~~~~~~~------------ 686 (816)
..... .....||+.|+|||.+.. ..++.++|||||||++|||++|++||...........
T Consensus 174 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 174 VRGEP-------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp CTTSC-------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCCCC-------CCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHH
T ss_conf 47765-------32002555556827764046888210002465277855028799898799999999999748981776
Q ss_pred -----CC----CCCCCCC-CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf -----09----6323357-889999989999999999995310889999974899999
Q 003481 687 -----CG----KLSSILD-PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 687 -----~~----~~~~~~d-~~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~ 734 (816)
.. .+..... +.........+..+.+|+.+||..||.+|||+.+.+.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 304 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 304 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf 5430621011035544567444431568999999999997658955792999996698
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=333.14 Aligned_cols=236 Identities=23% Similarity=0.354 Sum_probs=192.6
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCC------CHHHHHHHHHHHHCCC--CCCEEEEECCCCC--
Q ss_conf 239775642442065699999885--909999994048831------3799999999974389--9840037210047--
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ------GQLEFQQEVRVLSKLQ--HPHLVTLLGACPE-- 536 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~------~~~~~~~E~~il~~l~--HpnIv~l~g~~~~-- 536 (816)
.++|.+.+.||+|+||.||+|+.. |..||||++...... ....+.+|+.++.+++ |||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred CCCCEEECCCC-CCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-CCEEEEECC
Q ss_conf 74112421699-9613564102999989999999999999999999851699944607788995675479-990682026
Q 003481 537 AWSLVYEYLPN-GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFG 614 (816)
Q Consensus 537 ~~~lV~E~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~-~~~KL~DFG 614 (816)
..++||||+.+ +++.+++.... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.+ +.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEEECCCCCHHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEEEECCCC
T ss_conf 68999983368622899986158---9999999999999999999998779---75566761114774478848977546
Q ss_pred CCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 51101478876777555689998989889643335988-96103767999999999299999982789998630963233
Q 003481 615 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL-TPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSI 693 (816)
Q Consensus 615 la~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~ksDVwSlGvil~elltG~~P~~~~~~~~~~~~~~~~~~~ 693 (816)
+|+...... .+...||+.|+|||++.+..+ +.++|||||||++|||+||+.||.....+.. +..
T Consensus 157 ~a~~~~~~~--------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~----~~~--- 221 (273)
T d1xwsa_ 157 SGALLKDTV--------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR----GQV--- 221 (273)
T ss_dssp TCEECCSSC--------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH----CCC---
T ss_pred CCEECCCCC--------CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHHHHH----CCC---
T ss_conf 535324445--------56656587747999984899788653325540345367568899887367761----544---
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf 57889999989999999999995310889999974899
Q 003481 694 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 694 ~d~~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l 731 (816)
.++...+..+.+|+.+||..||.+|||+.+.+
T Consensus 222 ------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil 253 (273)
T d1xwsa_ 222 ------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 253 (273)
T ss_dssp ------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf ------77877999999999997608975893999985
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=327.83 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=196.0
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC-CEEEEEEEECCCCCC--CHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCCCEEEC
Q ss_conf 39775642442065699999885-909999994048831--37999999999743899840037210047--74112421
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 544 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~-g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E~ 544 (816)
++|...++||+|+||+||+|++. |..||||++...... ....+.+|+.+|++++|||||++++++.+ ..++++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCCC
Q ss_conf 69996135641029999899999999999999999998516999446077889956754799906820265110147887
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 624 (816)
Q Consensus 545 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~~~~ 624 (816)
+.++.+..+.... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EHHHHHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEECCCCCC
T ss_conf 0045678998604---77514456899999999999860574---88267877505686899787323664301146765
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH----CCC--------CC
Q ss_conf 6777555689998989889643335-9889610376799999999929999998278999863----096--------32
Q 003481 625 YLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGK--------LS 691 (816)
Q Consensus 625 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~P~~~~~~~~~~~~----~~~--------~~ 691 (816)
......|++.|+|||.+.. ..++.++|||||||++|||++|+.||........... .+. ..
T Consensus 156 ------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 156 ------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ------CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHH
T ss_conf ------41010243110137887178888841002111758999977979989889899999999863899711042123
Q ss_pred CC------CC---CC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf 33------57---88-99999899999999999953108899999748999
Q 003481 692 SI------LD---PL-AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 692 ~~------~d---~~-~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~ 732 (816)
.. .. +. ...+....+..+.+|+.+|++.||++|||+.+.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 332214333335676466651258999999999986689668909999856
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.37 Aligned_cols=249 Identities=23% Similarity=0.293 Sum_probs=195.0
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCC--CHHHHHHHHHHHHCCCCCCEEEEECCCCC--------
Q ss_conf 239775642442065699999885--909999994048831--37999999999743899840037210047--------
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE-------- 536 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------- 536 (816)
.++|...++||+|+||.||+|... |..||||++...... ....+.+|+.+|.+++|||||+++++|..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred CCCCEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 74112421699961356410299998999999999999999999985169994460778899567547999068202651
Q 003481 537 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 616 (816)
Q Consensus 537 ~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla 616 (816)
..++||||+ +++|...+.. ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEECC-CCCHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCCCCCCCE
T ss_conf 599998405-5218999874----02269999999999999999987378---764566851111210012211343102
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH----CCC--
Q ss_conf 101478876777555689998989889643335-9889610376799999999929999998278999863----096--
Q 003481 617 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGK-- 689 (816)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~ksDVwSlGvil~elltG~~P~~~~~~~~~~~~----~~~-- 689 (816)
+..... .+...||+.|+|||++.+ ..++.++|||||||++|+|++|++||........... .+.
T Consensus 169 ~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 169 RQADSE---------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239 (346)
T ss_dssp EECCSS---------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ECCCCC---------CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC
T ss_conf 206876---------31024553335889981787899650103003899999978699888976899999985037884
Q ss_pred ------------------CCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf ------------------323357889999989999999999995310889999974899999
Q 003481 690 ------------------LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 690 ------------------~~~~~d~~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~ 734 (816)
+...............+..+.+|+.+|+..||.+|||+.+++.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp 302 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 302 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf 888865300034433115786665566775568999999999997729955792999996396
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.07 Aligned_cols=256 Identities=21% Similarity=0.246 Sum_probs=196.3
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCC-CCHHHHHHHHHHHHCCCCCCEEEEECCCCCC------CC
Q ss_conf 239775642442065699999885--90999999404883-1379999999997438998400372100477------41
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPEA------WS 539 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~------~~ 539 (816)
+.+|...++||+|+||+||+|... |..||||++..... .....+.+|+.+|.+++||||+++++++... .+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 89859978994064809999999999949999998031095899999999999997689898858889950564554149
Q ss_pred CEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEEC
Q ss_conf 12421699961356410299998999999999999999999985169994460778899567547999068202651101
Q 003481 540 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 619 (816)
Q Consensus 540 lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~ 619 (816)
++++|+.+|+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEECCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 999962598656644058----9999999999999999999999789---867778764378879997787545705650
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHCC----CCC---
Q ss_conf 47887677755568999898988964333-5988961037679999999992999999827899986309----632---
Q 003481 620 TEDTLYLPSFHRSTAPKGSFPYADPEYHR-TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCG----KLS--- 691 (816)
Q Consensus 620 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~s~ksDVwSlGvil~elltG~~P~~~~~~~~~~~~~~----~~~--- 691 (816)
...... ........||+.|+|||++. ...++.++||||+||++|+|++|+.||............. ...
T Consensus 160 ~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDH---TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp CGGGCB---CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred CCCCCC---CEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH
T ss_conf 477764---10101102652000387860478887410100467013377669799788888999998765206997566
Q ss_pred ----------C--CCCCCCCCCC-----HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf ----------3--3578899999-----89999999999995310889999974899999
Q 003481 692 ----------S--ILDPLAGDWP-----TFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 692 ----------~--~~d~~~~~~~-----~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~ 734 (816)
. ...+.....+ ...+..+.+|+.+|+..||.+||++.+++.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hp 296 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 296 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf 423433222202446775577877783789999999999997648956790899986198
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.21 Aligned_cols=257 Identities=23% Similarity=0.316 Sum_probs=195.7
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCC--CCHHHHHHHHHHHHCCCCCCEEEEECCCCC---------
Q ss_conf 39775642442065699999885--90999999404883--137999999999743899840037210047---------
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--------- 536 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--------- 536 (816)
++|...++||+|+||+||+|++. |+.||||++..... .....+.+|+.+|.+++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCC
T ss_conf 79889999722748299999998999799999984222463789999999999998359996606765402465444457
Q ss_pred -CCCCEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf -7411242169996135641029999899999999999999999998516999446077889956754799906820265
Q 003481 537 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 615 (816)
Q Consensus 537 -~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGl 615 (816)
..++||||+.++.+...... ...++...+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEECCCCCCCCHHHHC---CCCCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCEEEEECCE
T ss_conf 638999853578741012220---344330899999999999998852299---88567672220366899687631350
Q ss_pred CEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH----CCCC
Q ss_conf 11014788767775556899989898896433359-889610376799999999929999998278999863----0963
Q 003481 616 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGKL 690 (816)
Q Consensus 616 a~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~P~~~~~~~~~~~~----~~~~ 690 (816)
++......... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||........... .+..
T Consensus 164 ~~~~~~~~~~~--~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 164 ARAFSLAKNSQ--PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp CEECCC-------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EEECCCCCCCC--CCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCC
T ss_conf 02235544432--1135660249787428997079998917870067864661744879989989999999999841899
Q ss_pred CCCCCC-------------C-CCCCCH-------HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 233578-------------8-999998-------9999999999995310889999974899999
Q 003481 691 SSILDP-------------L-AGDWPT-------FVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 691 ~~~~d~-------------~-~~~~~~-------~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~ 734 (816)
...... . ....+. .....+.+|+.+||+.||.+|||+.+.+.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp 306 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred CHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf 82553443203444332013344555033404445998999999998738965890999997495
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=324.20 Aligned_cols=258 Identities=22% Similarity=0.310 Sum_probs=195.9
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCCEEEEECCC---CCCCCCEEEC
Q ss_conf 39775642442065699999885--909999994048831379999999997438998400372100---4774112421
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC---PEAWSLVYEY 544 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~---~~~~~lV~E~ 544 (816)
++|...+.||+|+||.||+|++. |..||||++...... ..+..|+.++..++|+|+|.+++.| .+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC--HHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEE
T ss_conf 8899968985078809999999889989999997210058--88999999999703899601799999519877899987
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCEECCC
Q ss_conf 69996135641029999899999999999999999998516999446077889956754---799906820265110147
Q 003481 545 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD---SELSSKICDFGICRLVTE 621 (816)
Q Consensus 545 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld---~~~~~KL~DFGla~~~~~ 621 (816)
+ +|+|.+.+.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++ .+..+||+|||+|+....
T Consensus 85 ~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred C-CCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCC
T ss_conf 3-871333244306--88768999999999999999999799---44266787660643357776156504675134255
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCHHHHHHH-----HHCCCCCCCCC
Q ss_conf 887677-755568999898988964333598896103767999999999299999982789998-----63096323357
Q 003481 622 DTLYLP-SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA-----VSCGKLSSILD 695 (816)
Q Consensus 622 ~~~~~~-~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~~~~~~~~~-----~~~~~~~~~~d 695 (816)
...... .........||+.|+|||++.+..++.++|||||||++|||+||+.||......... ...........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred CCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCHH
T ss_conf 44554100013577678735329999918998983218861778999984987665530577999999852356789835
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 889999989999999999995310889999974899999998310
Q 003481 696 PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 740 (816)
Q Consensus 696 ~~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~l~~ 740 (816)
..... .+..+.+++..||..+|.+||++. .+.+.|+.+..
T Consensus 239 ~~~~~----~p~~~~~li~~cl~~~p~~RP~~~-~i~~~l~~~~~ 278 (299)
T d1ckia_ 239 VLCKG----YPSEFATYLNFCRSLRFDDKPDYS-YLRQLFRNLFH 278 (299)
T ss_dssp HHTTT----SCHHHHHHHHHHHHSCTTCCCCHH-HHHHHHHHHHH
T ss_pred HHCCC----CCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 75347----889999999998439955791999-99999999999
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.6e-45 Score=312.64 Aligned_cols=258 Identities=20% Similarity=0.252 Sum_probs=198.8
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHCCCC-CCEEEEECCCCC--CCCCEEE
Q ss_conf 239775642442065699999885--90999999404883137999999999743899-840037210047--7411242
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH-PHLVTLLGACPE--AWSLVYE 543 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~g~~~~--~~~lV~E 543 (816)
.++|.+.+.||+|+||.||+|++. |..||||++..... ...+.+|+.++..++| +|++.+++++.+ ..++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 9806997998417882999999988997999999750258--29999999999996489998779999601881179999
Q ss_pred CCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEEEECCCCEE
Q ss_conf 1699961356410299998999999999999999999985169994460778899567547-----99906820265110
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-----ELSSKICDFGICRL 618 (816)
Q Consensus 544 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~-----~~~~KL~DFGla~~ 618 (816)
|+ +|+|.+++.... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EC-CCCHHHHHHHHC--CCHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECCCCEEEE
T ss_conf 64-888799997520--31106899999999999999999779---6626677131523475434479568723660577
Q ss_pred CCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCHH-----HHHHHHHCCCCCC
Q ss_conf 14788767-77555689998989889643335988961037679999999992999999827-----8999863096323
Q 003481 619 VTEDTLYL-PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG-----EVRRAVSCGKLSS 692 (816)
Q Consensus 619 ~~~~~~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~~~~-----~~~~~~~~~~~~~ 692 (816)
........ ..........||+.|+|||++.+..++.++|||||||++|||+||+.||.... .....+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred CCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCC
T ss_conf 14676654111024676277510267989648888869998983199999986987678853021999999997056799
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 35788999998999999999999531088999997489999999831
Q 003481 693 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 739 (816)
Q Consensus 693 ~~d~~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~L~~l~ 739 (816)
......... +..+.+++..|+..+|.+||++. .+...|+.+.
T Consensus 236 ~~~~l~~~~----p~~l~~ii~~~~~~~~~~rP~y~-~l~~~l~~~~ 277 (293)
T d1csna_ 236 PLRELCAGF----PEEFYKYMHYARNLAFDATPDYD-YLQGLFSKVL 277 (293)
T ss_dssp CHHHHTTTS----CHHHHHHHHHHHHCCTTCCCCHH-HHHHHHHHHH
T ss_pred CHHHHCCCC----CHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHH
T ss_conf 958965799----89999999998439930085999-9999999999
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=319.60 Aligned_cols=249 Identities=21% Similarity=0.222 Sum_probs=196.5
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCC--CHHHHHHHHHHHHCCCCCCEEEEECCCC--------CC
Q ss_conf 39775642442065699999885--909999994048831--3799999999974389984003721004--------77
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACP--------EA 537 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~--------~~ 537 (816)
++|.+.++||+|+||+||+|.+. |..||||++...... ....+.+|+.++.+++|||||++++++. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf 77599889621758599999999999899999988233697999999999999986489876489989702564345762
Q ss_pred CCCEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCE
Q ss_conf 41124216999613564102999989999999999999999999851699944607788995675479990682026511
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~ 617 (816)
.|+||||+.++.+ +.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEEECCCHHHH-HHHH-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEECHHHHH
T ss_conf 6999841446778-7650-----38999999999999999998865221---1245677632113654431320102321
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCHHHHHHHH------------
Q ss_conf 01478876777555689998989889643335988961037679999999992999999827899986------------
Q 003481 618 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV------------ 685 (816)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~~~~~~~~~~------------ 685 (816)
...... ......||+.|+|||++.+..+++++||||+||++|+|++|+.||...+......
T Consensus 168 ~~~~~~-------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 168 TAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp --------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CCCCCC-------CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHH
T ss_conf 146665-------5332214655558133147777877433356625789865989988897788999999720589879
Q ss_pred ------------HCCCC-------C----CCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf ------------30963-------2----3357889999989999999999995310889999974899999
Q 003481 686 ------------SCGKL-------S----SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 686 ------------~~~~~-------~----~~~d~~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~ 734 (816)
..+.. . ....+.....+...+..+.+|+.+|+..||++|||+.+++.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hp 312 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCC
T ss_conf 998765667777641754356664212643335432101333799999999998769945790899996694
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.8e-45 Score=315.23 Aligned_cols=243 Identities=19% Similarity=0.289 Sum_probs=190.7
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHCCC-CCCEEEEECCCC----CCCCCEE
Q ss_conf 39775642442065699999885--9099999940488313799999999974389-984003721004----7741124
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGACP----EAWSLVY 542 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~----~~~~lV~ 542 (816)
++|.+.++||+|+||+||+|+.. |..||||+++.. ....+.+|+.+|.+++ ||||+++++++. ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 6718978983174819999998899979999998889---9999999999998515799876799999816877126888
Q ss_pred ECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCEECCC
Q ss_conf 2169996135641029999899999999999999999998516999446077889956754799-906820265110147
Q 003481 543 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICDFGICRLVTE 621 (816)
Q Consensus 543 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~-~~KL~DFGla~~~~~ 621 (816)
||+.+|+|.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EECCCCCHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCCCEECCC
T ss_conf 631798589974------68999999999999999998876433---443456441237748998366415654266468
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCHHHHH----------------HH
Q ss_conf 88767775556899989898896433359-88961037679999999992999999827899----------------98
Q 003481 622 DTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR----------------RA 684 (816)
Q Consensus 622 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~P~~~~~~~~----------------~~ 684 (816)
.. ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||....... ..
T Consensus 183 ~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 183 GQ-------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp TC-------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred CC-------CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHH
T ss_conf 87-------44432248642476102688888845232335455587604889998876018999999998788415555
Q ss_pred HHCCCC------CCCCCC---------CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf 630963------233578---------89999989999999999995310889999974899
Q 003481 685 VSCGKL------SSILDP---------LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 731 (816)
Q Consensus 685 ~~~~~~------~~~~d~---------~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l 731 (816)
...... ...... .........+..+.+|+.+|+..||.+|||+.+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L 317 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 54225444743000003334331121155211244899999999998669956890899996
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-44 Score=309.86 Aligned_cols=251 Identities=21% Similarity=0.232 Sum_probs=195.8
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCC--CHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCCCEEE
Q ss_conf 39775642442065699999885--909999994048831--37999999999743899840037210047--7411242
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 543 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~lV~E 543 (816)
++|...++||+|+||+||+|++. |..||||+++..... ....+.+|+.++..++|||||++++++.+ ..++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred CCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCEECCCCC
Q ss_conf 16999613564102999989999999999999999999851699944607788995675479990682026511014788
Q 003481 544 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 623 (816)
Q Consensus 544 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~~~~~~ 623 (816)
++.+++|..++... ..+++..+..++.|++.||.|||..+ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ECCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC
T ss_conf 02332221121235---65403678999999999987743399---8600146761211337826652046011046887
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCHHHHH---HHHH--CCCC-------
Q ss_conf 7677755568999898988964333598-8961037679999999992999999827899---9863--0963-------
Q 003481 624 LYLPSFHRSTAPKGSFPYADPEYHRTGV-LTPKSDSYSFGLIILQLLTGRLPVGLAGEVR---RAVS--CGKL------- 690 (816)
Q Consensus 624 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~ksDVwSlGvil~elltG~~P~~~~~~~~---~~~~--~~~~------- 690 (816)
. ......+++.|+|||++.... ++.++|||||||++|||++|+.||....... ..+. .+..
T Consensus 156 ~------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 156 R------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp S------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred C------CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf 5------1001034431014667506988880444026541889985189999889999999999986118997355134
Q ss_pred -CCCCC----------CCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
Q ss_conf -23357----------8899999899999999999953108899999748999
Q 003481 691 -SSILD----------PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 732 (816)
Q Consensus 691 -~~~~d----------~~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~ 732 (816)
....+ ......+...+..+.+|+.+|++.||++|||+.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 43222113344454431043306568999999999986499668909999964
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=315.64 Aligned_cols=243 Identities=26% Similarity=0.348 Sum_probs=193.1
Q ss_pred CCCCCCCEEEEECCEEEEEEEE-----CCEEEEEEEECCCCC----CCHHHHHHHHHHHHCCCC-CCEEEEECCCCC--C
Q ss_conf 3977564244206569999988-----590999999404883----137999999999743899-840037210047--7
Q 003481 470 CNFSESFKVGQGGFGCVYKGEM-----LGRTVAIKMLYSHNM----QGQLEFQQEVRVLSKLQH-PHLVTLLGACPE--A 537 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~-----~g~~vAiK~l~~~~~----~~~~~~~~E~~il~~l~H-pnIv~l~g~~~~--~ 537 (816)
++|...+.||+|+||.||+|.. +|..||||.+..... .....+.+|+.++.+++| |||+++++++.+ .
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred CCCEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCE
Q ss_conf 41124216999613564102999989999999999999999999851699944607788995675479990682026511
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~ 617 (816)
.++++||+.+|+|.+++.... .++......++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEEECCCCCHHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEEECCCHH
T ss_conf 001231234117999987304---5437888888999999998851499---8965477320124699988874132022
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCHHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCC
Q ss_conf 014788767775556899989898896433359--889610376799999999929999998278--9998630963233
Q 003481 618 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG--VLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSI 693 (816)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~ksDVwSlGvil~elltG~~P~~~~~~--~~~~~~~~~~~~~ 693 (816)
.+...... ......|++.|++||.+... .++.++|||||||+||+|+||+.||..... ....+..+...
T Consensus 178 ~~~~~~~~-----~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~-- 250 (322)
T d1vzoa_ 178 EFVADETE-----RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-- 250 (322)
T ss_dssp ECCGGGGG-----GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--
T ss_pred HHCCCCCC-----CCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCC--
T ss_conf 20344443-----22122233333106876057768871325177779999997689998888777799999983356--
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH
Q ss_conf 57889999989999999999995310889999974
Q 003481 694 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 728 (816)
Q Consensus 694 ~d~~~~~~~~~~~~~l~~Li~~Cl~~dp~~RPs~~ 728 (816)
....+|...+..+.+|+.+||..||.+||++.
T Consensus 251 ---~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~ 282 (322)
T d1vzoa_ 251 ---SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCG 282 (322)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSS
T ss_pred ---CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCCC
T ss_conf ---89988654799999999997445898819997
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=315.12 Aligned_cols=250 Identities=23% Similarity=0.264 Sum_probs=194.6
Q ss_pred HCCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCC--CHHHHHHHHHHHHCCCCCCEEEEECCCCC-------C
Q ss_conf 239775642442065699999885--909999994048831--37999999999743899840037210047-------7
Q 003481 469 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE-------A 537 (816)
Q Consensus 469 t~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~g~~~~-------~ 537 (816)
+++|...++||+|+||+||+|+.. |..||||++...... ....+.+|+.+|.+++|||||++++++.. .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred CCCEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEECCCCE
Q ss_conf 41124216999613564102999989999999999999999999851699944607788995675479990682026511
Q 003481 538 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 617 (816)
Q Consensus 538 ~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~ 617 (816)
.+++++|+.+|+|.+++.. ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEEEECCCCHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCHHC
T ss_conf 4999996258862320022----45309999999999999999997388---7651667763345543220013210001
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH----CCCCCC
Q ss_conf 014788767775556899989898896433359-889610376799999999929999998278999863----096323
Q 003481 618 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGKLSS 692 (816)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~ksDVwSlGvil~elltG~~P~~~~~~~~~~~~----~~~~~~ 692 (816)
.... ......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+....... .+....
T Consensus 170 ~~~~---------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 170 HTDD---------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240 (348)
T ss_dssp CCTG---------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred CCCC---------CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCH
T ss_conf 2575---------4444345435558355337756785512432058999997688997889889999999973079975
Q ss_pred -C------------CC--CCCCCC-----CHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf -3------------57--889999-----989999999999995310889999974899999
Q 003481 693 -I------------LD--PLAGDW-----PTFVARRLVDLGLQCCELYGRERPDITPSLVKE 734 (816)
Q Consensus 693 -~------------~d--~~~~~~-----~~~~~~~l~~Li~~Cl~~dp~~RPs~~~~l~~~ 734 (816)
. .. +..... ....+..+.+|+.+|+..||.+|||+.+++.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp 302 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 302 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf 77320010244544430355787555662678999999999997758834593899985599
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-41 Score=291.03 Aligned_cols=252 Identities=21% Similarity=0.260 Sum_probs=189.0
Q ss_pred CCCCCCCEEEEECCEEEEEEEEC--CEEEEEEEECCCCCCCHHHHHHHHHHHHCCC-----------CCCEEEEECCCCC
Q ss_conf 39775642442065699999885--9099999940488313799999999974389-----------9840037210047
Q 003481 470 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-----------HPHLVTLLGACPE 536 (816)
Q Consensus 470 ~~f~~~~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~-----------HpnIv~l~g~~~~ 536 (816)
++|.+.++||+|+||.||+|+.. |..||||+++.... ....+.+|+.++..++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 857998997507781899999999997999999834313-3689999999999840145555542276764789987631
Q ss_pred ----CCCCEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCC----
Q ss_conf ----741124216999613564102999989999999999999999999851-69994460778899567547999----
Q 003481 537 ----AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS-SKPEKIVHGDLKPQNILLDSELS---- 607 (816)
Q Consensus 537 ----~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDIkp~NILld~~~~---- 607 (816)
..++++.++..+..............+++..+..++.|++.||.|||+ .+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCCCCC
T ss_conf 2565202343200035420000012234678689999999999999888764058---6465677057056305765644
Q ss_pred --EEEEECCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCHHH-----
Q ss_conf --0682026511014788767775556899989898896433359889610376799999999929999998278-----
Q 003481 608 --SKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE----- 680 (816)
Q Consensus 608 --~KL~DFGla~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~ksDVwSlGvil~elltG~~P~~~~~~----- 680 (816)
+|++|||.+...... .....||+.|+|||++....++.++||||+||++++|++|+.||.....
T Consensus 169 ~~~kl~dfg~s~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~ 239 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH---------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239 (362)
T ss_dssp EEEEECCCTTCEETTBC---------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CEEEEEECCCCCCCCCC---------CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
T ss_conf 30567531442123445---------422366521057132146677764320123789999987889989875543210
Q ss_pred ----HHHH-HHCCC--------------------CCCCCCC-----------CCCCCCHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf ----9998-63096--------------------3233578-----------8999998999999999999531088999
Q 003481 681 ----VRRA-VSCGK--------------------LSSILDP-----------LAGDWPTFVARRLVDLGLQCCELYGRER 724 (816)
Q Consensus 681 ----~~~~-~~~~~--------------------~~~~~d~-----------~~~~~~~~~~~~l~~Li~~Cl~~dp~~R 724 (816)
.... ...|. ....+.. ....++...+..+.+|+.+|+..||.+|
T Consensus 240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 319 (362)
T d1q8ya_ 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 319 (362)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHC
T ss_conf 26899999998379987886245322000132012202432357764442100015674358999999999877994579
Q ss_pred CCCHHHHHHH
Q ss_conf 9974899999
Q 003481 725 PDITPSLVKE 734 (816)
Q Consensus 725 Ps~~~~l~~~ 734 (816)
||+.+++.+.
T Consensus 320 pta~e~L~Hp 329 (362)
T d1q8ya_ 320 ADAGGLVNHP 329 (362)
T ss_dssp BCHHHHHTCG
T ss_pred CCHHHHHCCC
T ss_conf 0899996693
|
| >d2gm3a1 c.26.2.4 (A:5-175) Putative ethylene-responsive protein AT3g01520/F4P13_7 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Putative ethylene-responsive protein AT3g01520/F4P13 7 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=99.92 E-value=2.1e-24 Score=176.25 Aligned_cols=149 Identities=19% Similarity=0.240 Sum_probs=121.4
Q ss_pred CEEEEEECCCC--------CCCHHHHHHHHHCCCC-CCC---EEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 38999824895--------1135468887300279-981---99999619999887778987877566899999999999
Q 003481 23 EKVYVALGKCV--------EKGLSLLHWTLQRFGS-SRE---ICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEER 90 (816)
Q Consensus 23 ~~VlVavD~~~--------~~s~~Al~wal~~~~~-~~~---i~liHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 90 (816)
.||+||||||+ ..|++||+||++++.. +++ ++++||.++...... .........+.+....+...
T Consensus 2 ~ki~vavd~s~~~~~~~~~~~S~~Al~wal~~~~~~~~~~~~L~~vhv~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 78 (171)
T d2gm3a1 2 TKVMVAVNASTIKDYPNPSISCKRAFEWTLEKIVRSNTSDFKILLLHVQVVDEDGFD---DVDSIYASPEDFRDMRQSNK 78 (171)
T ss_dssp EEEEEECCBCSSSCTTCBCHHHHHHHHHHHHHTTTTCTTSEEEEEEEEEC-------------CCCCSHHHHHHHTTSHH
T ss_pred CEEEEEECCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEECCCCCCCCC---CCCCCCCCHHHHHHHHHHHH
T ss_conf 889999769856677899999999999999999877999728999995456543434---44444567778999999999
Q ss_pred HHHHHHHHHHHHHHHHHCCCEEEEEEECCCHHHHHHHHHHHHCCCEEEECCCCCCCCHHHCCCCCHHHHHHCCCCCCEEE
Q ss_conf 99999999999999870660389998317888999999998098889963589994100038760134641099986599
Q 003481 91 QKMKKLLDNYLRICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIW 170 (816)
Q Consensus 91 ~~~~~ll~~~~~~c~~~~V~~~~~v~e~~d~~~~Ii~~i~~~~id~lVmGs~g~~~~~R~~~gsVs~~V~~~ap~~C~V~ 170 (816)
+.++++++.+...|...++.+++.+.+ ++++++|+++|++.++|+||||++|++.++|.++|||++||+++++ |+|+
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~v~~-G~~~~~I~~~a~~~~~dlIV~G~~g~~~~~~~~lGSv~~~vi~~~~--cpVl 155 (171)
T d2gm3a1 79 AKGLHLLEFFVNKCHEIGVGCEAWIKT-GDPKDVICQEVKRVRPDFLVVGSRGLGRFQKVFVGTVSAFCVKHAE--CPVM 155 (171)
T ss_dssp HHHHHHHHHHHHHHHHHTCEEEEEEEE-SCHHHHHHHHHHHHCCSEEEEEECCCC--------CHHHHHHHHCS--SCEE
T ss_pred HHHHHHHHHHHHHHHHCCCCEEEEEEE-CCHHHHHHHHHHHCCCCEEEECCCCCCCCCCCCCCCHHHHHHHCCC--CCEE
T ss_conf 999999999999988639944799982-7869999998764477579743677535455744869999983899--8989
Q ss_pred EEECCCE
Q ss_conf 9948933
Q 003481 171 FVNKGKH 177 (816)
Q Consensus 171 vv~kg~~ 177 (816)
||..+..
T Consensus 156 vV~~~~~ 162 (171)
T d2gm3a1 156 TIKRNAD 162 (171)
T ss_dssp EEECCGG
T ss_pred EEECCCC
T ss_conf 9968988
|
| >d1mjha_ c.26.2.4 (A:) "Hypothetical" protein MJ0577 {Archaeon Methanococcus jannaschii [TaxId: 2190]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: "Hypothetical" protein MJ0577 species: Archaeon Methanococcus jannaschii [TaxId: 2190]
Probab=99.89 E-value=2.1e-22 Score=162.99 Aligned_cols=150 Identities=13% Similarity=0.136 Sum_probs=120.8
Q ss_pred CEEEEEECCCCCCCHHHHHHHHHCCCC-CCCEEEEEECCCCCCCCCCCCC-----CCCCCCCHHHHHHHHHHHHHHHHHH
Q ss_conf 389998248951135468887300279-9819999961999988777898-----7877566899999999999999999
Q 003481 23 EKVYVALGKCVEKGLSLLHWTLQRFGS-SREICILHVHQPSPVIPTLLGK-----LPASQASAEVLSAFRAEERQKMKKL 96 (816)
Q Consensus 23 ~~VlVavD~~~~~s~~Al~wal~~~~~-~~~i~liHV~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~l 96 (816)
++||||||+ ++.|.+|++||++.+.. ++.|+++||.++.......... ........+....+.....+.+++.
T Consensus 4 ~~ILvavD~-s~~s~~al~~a~~la~~~~a~l~llhV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (160)
T d1mjha_ 4 KKILYPTDF-SETAEIALKHVKAFKTLKAEEVILLHVIDEREIKKRDIFSLLLGVAGLNKSVEEFENELKNKLTEEAKNK 82 (160)
T ss_dssp CEEEEECCS-CHHHHHHHHHHHHTCCSSCCEEEEEEEEEGGGTC-----------------CHHHHHHHHHHHHHHHHHH
T ss_pred CEEEEEECC-CHHHHHHHHHHHHHHHHCCCEEEEEEECCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_conf 829999879-9899999999999987539979999830566544333322224533222007889999999999999999
Q ss_pred HHHHHHHHHHHCCCEEEEEEECCCHHHHHHHHHHHHCCCEEEECCCCCCCCHHHCCCCCHHHHHHCCCCCCEEEEEECCC
Q ss_conf 99999999870660389998317888999999998098889963589994100038760134641099986599994893
Q 003481 97 LDNYLRICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFVNKGK 176 (816)
Q Consensus 97 l~~~~~~c~~~~V~~~~~v~e~~d~~~~Ii~~i~~~~id~lVmGs~g~~~~~R~~~gsVs~~V~~~ap~~C~V~vv~kg~ 176 (816)
++.+...|...|++++..+..| +++++|++++++.++|+||||+||++++++.++||++++|+++++ |||+||.+..
T Consensus 83 l~~~~~~~~~~gv~~~~~~~~G-~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~GS~a~~vl~~s~--~pVlvV~~~~ 159 (160)
T d1mjha_ 83 MENIKKELEDVGFKVKDIIVVG-IPHEEIVKIAEDEGVDIIIMGSHGKTNLKEILLGSVTENVIKKSN--KPVLVVKRKN 159 (160)
T ss_dssp HHHHHHHHHHTTCEEEEEEEEE-CHHHHHHHHHHHTTCSEEEEESCCSSCCTTCSSCHHHHHHHHHCC--SCEEEECCCC
T ss_pred HHHHHHHHHHCCCEEEEEEEEC-CHHHHHHHHHHCCCCCEEEECCCCCCCCCCCCCCCHHHHHHHCCC--CCEEEECCCC
T ss_conf 9999999876597699999945-589877665202422147761689986421410709999996299--9899982899
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=7.1e-23 Score=166.15 Aligned_cols=163 Identities=20% Similarity=0.156 Sum_probs=119.1
Q ss_pred CCCCEEEEECCEEEEEEEEC-CEEEEEEEECCCCCC------------------CHHHHHHHHHHHHCCCCCCEEEEECC
Q ss_conf 75642442065699999885-909999994048831------------------37999999999743899840037210
Q 003481 473 SESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQ------------------GQLEFQQEVRVLSKLQHPHLVTLLGA 533 (816)
Q Consensus 473 ~~~~~LG~G~~g~Vy~g~~~-g~~vAiK~l~~~~~~------------------~~~~~~~E~~il~~l~HpnIv~l~g~ 533 (816)
..+++||+|+||.||+|... |..||||+++..... ....+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred CCCCCCCEEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEC
Q ss_conf 04774112421699961356410299998999999999999999999985169994460778899567547999068202
Q 003481 534 CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 613 (816)
Q Consensus 534 ~~~~~~lV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDIkp~NILld~~~~~KL~DF 613 (816)
. ..+++|||++++.+.+ ++......++.+++.+|.|||..+ |+||||||+|||++.+ .++|+||
T Consensus 83 ~--~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 83 E--GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp E--TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCC
T ss_pred C--CCEEEEEEECCCCCCC----------HHHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEECC-CEEEEEC
T ss_conf 2--8889999504565420----------015789999999999999982688---8983689036114289-8999877
Q ss_pred CCCEECCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 651101478876777555689998989889------64333598896103767999999
Q 003481 614 GICRLVTEDTLYLPSFHRSTAPKGSFPYAD------PEYHRTGVLTPKSDSYSFGLIIL 666 (816)
Q Consensus 614 Gla~~~~~~~~~~~~~~~~~~~~gt~~Y~a------PE~~~~~~~s~ksDVwSlGvil~ 666 (816)
|+|......... .|.. .+++ ...|+.++|+||..--++
T Consensus 147 G~a~~~~~~~~~--------------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 147 PQSVEVGEEGWR--------------EILERDVRNIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TTCEETTSTTHH--------------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred CCCCCCCCCCCH--------------HHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHH
T ss_conf 884308998709--------------99987799999997-578998446899999874
|
| >d2z3va1 c.26.2.4 (A:2-136) Hypothetical protein TTHA0895 {Thermus thermophilus [TaxId: 274]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein TTHA0895 species: Thermus thermophilus [TaxId: 274]
Probab=99.84 E-value=1.6e-20 Score=150.51 Aligned_cols=133 Identities=13% Similarity=0.134 Sum_probs=103.6
Q ss_pred CEEEEEECCCCCCCHHHHHHHHHCCCC-CCCEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHH
Q ss_conf 389998248951135468887300279-9819999961999988777898787756689999999999999999999999
Q 003481 23 EKVYVALGKCVEKGLSLLHWTLQRFGS-SREICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQKMKKLLDNYL 101 (816)
Q Consensus 23 ~~VlVavD~~~~~s~~Al~wal~~~~~-~~~i~liHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~ 101 (816)
++||||||+ ++.|.+|++||++.+.. +++|+++||.++++.... . ...........+.+++.++.+
T Consensus 2 k~Ilv~~D~-s~~s~~a~~~a~~~a~~~~~~l~ll~V~~~~~~~~~--~---------~~~~~~~~~~~~~~~~~l~~~- 68 (135)
T d2z3va1 2 KTILLAYDG-SEHARRAAEVAKAEAEAHGARLIVVHAYEPVPDYLG--E---------PFFEEALRRRLERAEGVLEEA- 68 (135)
T ss_dssp CEEEEECCS-SHHHHHHHHHHHHHHHHHTCEEEEEEEECCCCTTCC--T---------THHHHHHHHHHHHHHHHHHHH-
T ss_pred CEEEEEECC-CHHHHHHHHHHHHHHHHCCCEEEEEEEECCCCCCCC--C---------CHHHHHHHHHHHHHHHHHHHH-
T ss_conf 989999789-989999999999999983999999997457754346--5---------026899999999999999999-
Q ss_pred HHHHHHCCCEEEEEEECCCHHHHHHHHHHHHCCCEEEECCCCCCCCHHHCCCCCHHHHHHCCCCCCEEEEE
Q ss_conf 99987066038999831788899999999809888996358999410003876013464109998659999
Q 003481 102 RICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFV 172 (816)
Q Consensus 102 ~~c~~~~V~~~~~v~e~~d~~~~Ii~~i~~~~id~lVmGs~g~~~~~R~~~gsVs~~V~~~ap~~C~V~vv 172 (816)
+...++.....++..+++.++|+++++++++|+||||+++++++.|.++||++++|+++++ |||++|
T Consensus 69 --~~~~~~~~~~~~~~~g~~~~~I~~~a~~~~~dliV~G~~~~~~~~~~~~Gs~~~~ll~~~~--~pVlvV 135 (135)
T d2z3va1 69 --RALTGVPKEDALLLEGVPAEAILQAARAEKADLIVMGTRGLGALGSLFLGSQSQRVVAEAP--CPVLLV 135 (135)
T ss_dssp --HHHHCCCGGGEEEEESCHHHHHHHHHHHTTCSEEEEESSCSSSCBCSSCBHHHHHHHHHCS--SCEEEE
T ss_pred --HHHCCCCEEEEEEECCCHHHHHHHHHHHHHEEEEEECCCCCCCCCCCCCCCHHHHHHHHCC--CCEEEC
T ss_conf --9866997289999827768999987520001157753679985210413709999997099--999959
|
| >d1tq8a_ c.26.2.4 (A:) Hypothetical protein Rv1636 {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Rv1636 species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.82 E-value=1.7e-19 Score=143.71 Aligned_cols=143 Identities=13% Similarity=0.106 Sum_probs=109.6
Q ss_pred CCCEEEEEECCCCCCCHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHH
Q ss_conf 96389998248951135468887300279981999996199998877789878775668999999999999999999999
Q 003481 21 GGEKVYVALGKCVEKGLSLLHWTLQRFGSSREICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQKMKKLLDNY 100 (816)
Q Consensus 21 ~~~~VlVavD~~~~~s~~Al~wal~~~~~~~~i~liHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 100 (816)
.-++|+||||+ +..|.+|++||++.+...+..+++|++.++.......... ..........+.+++.++.+
T Consensus 4 ~yk~ILv~vD~-s~~s~~al~~A~~la~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~l~~~ 74 (147)
T d1tq8a_ 4 AYKTVVVGTDG-SDSSMRAVDRAAQIAGADAKLIIASAYLPQHEDARAADIL--------KDESYKVTGTAPIYEILHDA 74 (147)
T ss_dssp CCCEEEEECCS-SHHHHHHHHHHHHHHTTTSEEEEEEECCC----------------------------CCTHHHHHHHH
T ss_pred CCCEEEEEECC-CHHHHHHHHHHHHHHHCCCCEEEEEEEECCCCCCCCCCCC--------HHHHHHHHHHHHHHHHHHHH
T ss_conf 78979999889-9899999999999986189879999994366654321100--------02468999999999999999
Q ss_pred HHHHHHHCCCEEEEEEECCCHHHHHHHHHHHHCCCEEEECCCCCCCCHHHCCCCCHHHHHHCCCCCCEEEEEEC
Q ss_conf 99998706603899983178889999999980988899635899941000387601346410999865999948
Q 003481 101 LRICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFVNK 174 (816)
Q Consensus 101 ~~~c~~~~V~~~~~v~e~~d~~~~Ii~~i~~~~id~lVmGs~g~~~~~R~~~gsVs~~V~~~ap~~C~V~vv~k 174 (816)
...+.+.++......+..+++++.|+++++++++|+||||+++++++.+.++||++++|+++++ |||+||+.
T Consensus 75 ~~~~~~~~~~~~~~~~~~G~~~~~i~~~a~~~~~dlIv~g~~~~~~~~~~l~Gs~~~~ll~~~~--~pVlvV~~ 146 (147)
T d1tq8a_ 75 KERAHNAGAKNVEERPIVGAPVDALVNLADEEKADLLVVGNVGLSTIAGRLLGSVPANVSRRAK--VDVLIVHT 146 (147)
T ss_dssp HHHHHTTTCCEEEEEEECSSHHHHHHHHHHHTTCSEEEEECCCCCSHHHHHTBBHHHHHHHHTT--CEEEEECC
T ss_pred HHHHHHCCCCCEEEEEEECCHHHHHHHHHHCCCEEEEEECCCCCCCCCCCCCCCHHHHHHHHCC--CCEEEEEC
T ss_conf 9999875997389999842769999876423513699855789986332502649999997089--98899946
|
| >d1jmva_ c.26.2.4 (A:) Universal stress protein A, UspA {Haemophilus influenzae [TaxId: 727]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Universal stress protein A, UspA species: Haemophilus influenzae [TaxId: 727]
Probab=99.73 E-value=2e-18 Score=136.60 Aligned_cols=135 Identities=13% Similarity=0.136 Sum_probs=101.9
Q ss_pred CEEEEEECCCCCCCHHHHHHHHHCCCC-CCCEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHH
Q ss_conf 389998248951135468887300279-9819999961999988777898787756689999999999999999999999
Q 003481 23 EKVYVALGKCVEKGLSLLHWTLQRFGS-SREICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQKMKKLLDNYL 101 (816)
Q Consensus 23 ~~VlVavD~~~~~s~~Al~wal~~~~~-~~~i~liHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~~ 101 (816)
++||||||++ ..|..|+.||+.++.. ++.|+++||.++++.... ... +......+ .+..++....+.
T Consensus 3 k~ILv~vD~s-~~s~~al~~A~~~a~~~~~~v~~lhv~~~~~~~~~--~~~------~~~~~~~~---~~~~~~~~~~~~ 70 (140)
T d1jmva_ 3 KHILVAVDLS-EESPILLKKAVGIAKRHDAKLSIIHVDVNFSDLYT--GLI------DVNMSSMQ---DRISTETQKALL 70 (140)
T ss_dssp SEEEEEECCS-TTHHHHHHHHHHHHHHHTCEEEEEEEEECCGGGCC--CCE------EHHHHHHT---TCCCCHHHHHHH
T ss_pred CEEEEEECCC-HHHHHHHHHHHHHHHHCCCEEEEEEEEEECCCCCC--CCC------CCCHHHHH---HHHHHHHHHHHH
T ss_conf 7099998799-89999999999999874990999999640442212--333------22358999---999999999999
Q ss_pred HHHHHHCCCEEEEEEECCCHHHHHHHHHHHHCCCEEEECCCCCCCCHHHCCCCCHHHHHHCCCCCCEEEEEEC
Q ss_conf 9998706603899983178889999999980988899635899941000387601346410999865999948
Q 003481 102 RICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFVNK 174 (816)
Q Consensus 102 ~~c~~~~V~~~~~v~e~~d~~~~Ii~~i~~~~id~lVmGs~g~~~~~R~~~gsVs~~V~~~ap~~C~V~vv~k 174 (816)
..+.+.++...+.++..++++++|+++++++++|+||||+||+++.. +||++++++++++ |||++|.-
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~I~~~a~~~~~dliV~G~~~~~~~~---lgs~~~~li~~~~--~pVliVp~ 138 (140)
T d1jmva_ 71 DLAESVDYPISEKLSGSGDLGQVLSDAIEQYDVDLLVTGHHQDFWSK---LMSSTRQVMNTIK--IDMLVVPL 138 (140)
T ss_dssp HHHHHSSSCCCCEEEEEECHHHHHHHHHHHTTCCEEEEEECCCCHHH---HHHHHHHHHTTCC--SEEEEEEC
T ss_pred HHHHHCCCCEEEEEEEECCHHHHHHHHHHHCHHHEEEECCCCCCCCC---CCCHHHHHHHCCC--CCEEEEEC
T ss_conf 99985588617999981688999998640031428884058999777---3539999986169--98999946
|
| >d1q77a_ c.26.2.4 (A:) Hypothetical protein Aq_178 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: Universal stress protein-like domain: Hypothetical protein Aq 178 species: Aquifex aeolicus [TaxId: 63363]
Probab=99.66 E-value=3e-17 Score=128.85 Aligned_cols=134 Identities=8% Similarity=0.080 Sum_probs=99.8
Q ss_pred CCEEEEEECCCCCCCHHHHHHHHHCCCC-CCCEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHH
Q ss_conf 6389998248951135468887300279-981999996199998877789878775668999999999999999999999
Q 003481 22 GEKVYVALGKCVEKGLSLLHWTLQRFGS-SREICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQKMKKLLDNY 100 (816)
Q Consensus 22 ~~~VlVavD~~~~~s~~Al~wal~~~~~-~~~i~liHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~ 100 (816)
-++||||+|+ |+.|.+||+||++.+.. ++.++++||.++............... .. ...+...+.+++.++.+
T Consensus 4 mk~ILv~~D~-S~~s~~al~~A~~~a~~~~a~l~llhv~~~~~~~~~~~~~~~~~~-~~----~~~e~~~~~~~~~l~~~ 77 (138)
T d1q77a_ 4 MKVLLVLTDA-YSDCEKAITYAVNFSEKLGAELDILAVLEDVYNLERANVTFGLPF-PP----EIKEESKKRIERRLREV 77 (138)
T ss_dssp CEEEEEEEST-TCCCHHHHHHHHHHHTTTCCEEEEEEECHHHHHHHHHHHHHCCCC-CT----HHHHHHHHHHHHHHHHH
T ss_pred CCEEEEEEEC-CHHHHHHHHHHHHHHHHCCCEEEEEEECCCCCCCCCCCCCCCCCH-HH----HHHHHHHHHCCCCCHHH
T ss_conf 8999999959-999999999999965440543899997367433321023322210-13----45656543111200222
Q ss_pred HHHHHHHCCCEEEEEEECCCHHHHHHHHHHHHCCCEEEECCCCCCCCHHHCCCCCHHHHHHCCCCCCEEEEEE
Q ss_conf 9999870660389998317888999999998098889963589994100038760134641099986599994
Q 003481 101 LRICVEAEVKARIITTEADKIQKAIVQLMNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFVN 173 (816)
Q Consensus 101 ~~~c~~~~V~~~~~v~e~~d~~~~Ii~~i~~~~id~lVmGs~g~~~~~R~~~gsVs~~V~~~ap~~C~V~vv~ 173 (816)
...+...++.++..+.+ +++++.|+++|+++++|+||||+||.++++|.++|+ . |+++||+
T Consensus 78 ~~~~~~~~~~~~~~v~~-G~~~~~I~~~a~~~~~DLIV~Gs~g~~~l~r~l~g~---------~--~~~livk 138 (138)
T d1q77a_ 78 WEKLTGSTEIPGVEYRI-GPLSEEVKKFVEGKGYELVVWACYPSAYLCKVIDGL---------N--LASLIVK 138 (138)
T ss_dssp HHHHHSCCCCCCEEEEC-SCHHHHHHHHHTTSCCSEEEECSCCGGGTHHHHHHS---------S--SEEEECC
T ss_pred CCCCCCCCEEEEEEEEC-CHHHHHHHHHHHHCCCCEEEEECCCCCHHHHHHCCC---------C--CCEEEEC
T ss_conf 01122232147986402-304788887666426999999569976789985599---------9--8879869
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.64 E-value=2.3e-07 Score=63.32 Aligned_cols=147 Identities=16% Similarity=0.090 Sum_probs=94.2
Q ss_pred HHHHHHCCCCCCCEEEEECCEEEEEEEECCEEEEEEEECCCCCCCHHHHHHHHHHHHCCC-CCCEEEEECCCC--CCCCC
Q ss_conf 899872397756424420656999998859099999940488313799999999974389-984003721004--77411
Q 003481 464 DLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGACP--EAWSL 540 (816)
Q Consensus 464 ~l~~at~~f~~~~~LG~G~~g~Vy~g~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~--~~~~l 540 (816)
++...-..|......+.++.+.||+....+..+.+|+...........+.+|...+..+. +-.+.+++.++. +..++
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHHHHCEEEEECCCCCCCCCEEEEEECCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEE
T ss_conf 99975135279976789987718999908986999984887653255699999999987606998728999750896499
Q ss_pred EEECCCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC----------------------------------
Q ss_conf 2421699961356410299998999999999999999999985169----------------------------------
Q 003481 541 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK---------------------------------- 586 (816)
Q Consensus 541 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~---------------------------------- 586 (816)
||+++++.++.+..... . ....++.+++..|..||+..
T Consensus 88 v~~~l~G~~~~~~~~~~-----~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 88 LMSEADGVLCSEEYEDE-----Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHTTTC-----S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred EEEECCCCCCCCCCCCC-----C---CHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 99860433435433440-----2---699999989999999855684214357644656555778998776555543033
Q ss_pred ----------------------CCCEEECCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf ----------------------99446077889956754799906820265110
Q 003481 587 ----------------------PEKIVHGDLKPQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 587 ----------------------~~~iiHrDIkp~NILld~~~~~KL~DFGla~~ 618 (816)
+..++|+|+.|.|||++.+..+-|.||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 232005799999999844986781789860047642364996599960231441
|
| >d1wgma_ g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Ubiquitin conjugation factor E4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.63 E-value=1.4e-08 Score=71.42 Aligned_cols=72 Identities=29% Similarity=0.459 Sum_probs=66.1
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCCCCC-CCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 88887444510121017988668985-33310044552059878886445567678987289999999997519
Q 003481 744 RPVPSFFLCPILQEIMHDPQVAADGF-TYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDWLCKS 816 (816)
Q Consensus 744 ~~~p~~~l~pilqei~~dP~~~~~g~-~~~~~~i~~~l~~g~~~sp~t~~~~~~~~l~Pn~alr~~~~~~~~~~ 816 (816)
...|..|.|||..++|.+|++.+.+. +|+...|..|+.. ..++|.++..+...+|+||.+||.+|++|+.++
T Consensus 17 ~~~P~~f~CPI~~~lm~dPV~~~~~~~ty~r~~I~~~l~~-~~~~P~~~~~l~~~~L~pN~~Lr~~I~~~~~~~ 89 (98)
T d1wgma_ 17 ADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLS-DQTDPFNRSPLTMDQIRPNTELKEKIQRWLAER 89 (98)
T ss_dssp CSCCTTTBCTTTCSBCSSEEECTTTCCEEEHHHHHHHTTT-SCBCTTTCSBCCTTTSEECHHHHHHHHHHHHHS
T ss_pred CCCCHHHCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHCCHHHHHHHHHHHHHHH
T ss_conf 5990774886734688777762355320149999999870-687665556664011201399999999999999
|
| >d1t1ha_ g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: E3 ubiquitin ligase PUB14 species: Thale-cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=98.54 E-value=1.9e-08 Score=70.42 Aligned_cols=73 Identities=38% Similarity=0.732 Sum_probs=69.2
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 8888744451012101798866898533310044552059878886445567678987289999999997519
Q 003481 744 RPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDWLCKS 816 (816)
Q Consensus 744 ~~~p~~~l~pilqei~~dP~~~~~g~~~~~~~i~~~l~~g~~~sp~t~~~~~~~~l~Pn~alr~~~~~~~~~~ 816 (816)
+.+|..|.||+-.++|.+|.+.+.|.+|....|..|+..+...+|.++..+...+++||++||++|++|+.+|
T Consensus 3 peiP~~l~CpIc~~~m~dPV~~~cgh~fc~~ci~~~~~~~~~~cP~~~~~l~~~~l~pN~~L~~~I~~~~~~~ 75 (78)
T d1t1ha_ 3 PEFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYVLKSLIALWCESN 75 (78)
T ss_dssp CCCSSSSSCTTTSCCCSSEEEETTTEEEEHHHHHHHHTTTCCBCTTTCCBCSSCCCEECTTTHHHHHHHHHHS
T ss_pred CCCCCCCCCCCCCCHHHCCEECCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
T ss_conf 9899627991718121083372677743399999999988887886556377565624699999999999995
|
| >d2c2la2 g.44.1.2 (A:225-304) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: STIP1 homology and U box-containing protein 1, STUB1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.52 E-value=3.6e-08 Score=68.60 Aligned_cols=73 Identities=27% Similarity=0.546 Sum_probs=69.0
Q ss_pred CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 8888744451012101798866898533310044552059878886445567678987289999999997519
Q 003481 744 RPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDWLCKS 816 (816)
Q Consensus 744 ~~~p~~~l~pilqei~~dP~~~~~g~~~~~~~i~~~l~~g~~~sp~t~~~~~~~~l~Pn~alr~~~~~~~~~~ 816 (816)
+.+|..+.||+-.++|.+|.+.+.|.+|....|..|+..+..++|.++..++..+++||.+||++|++|+++|
T Consensus 2 ~eiP~~l~CpIc~~l~~dPv~~~cGhtfc~~ci~~~l~~~~~~cP~c~~~l~~~~l~pN~~L~~~I~~~l~~~ 74 (80)
T d2c2la2 2 RDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLAMKEVIDAFISEN 74 (80)
T ss_dssp CCCCSTTBCTTTCSBCSSEEECSSCCEEETTHHHHHHHHTCSSCTTTCCCCCGGGCEECHHHHHHHHHHHTTC
T ss_pred CCCCCCCCCCCCCCHHHHHCCCCCCCEECHHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHC
T ss_conf 9897001185837323403305886856388999998637765787566654235551999999999999987
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.18 E-value=2.8e-05 Score=49.47 Aligned_cols=75 Identities=16% Similarity=0.069 Sum_probs=50.3
Q ss_pred CEEEEECCEEEEEEEEC--CEEEEEEEECCC------C-CCCHHHHHHHHHHHHCCC---CCCEEEEECCCCCCCCCEEE
Q ss_conf 42442065699999885--909999994048------8-313799999999974389---98400372100477411242
Q 003481 476 FKVGQGGFGCVYKGEML--GRTVAIKMLYSH------N-MQGQLEFQQEVRVLSKLQ---HPHLVTLLGACPEAWSLVYE 543 (816)
Q Consensus 476 ~~LG~G~~g~Vy~g~~~--g~~vAiK~l~~~------~-~~~~~~~~~E~~il~~l~---HpnIv~l~g~~~~~~~lV~E 543 (816)
..||.|....||+.... +..+.+|.-... . .....+...|...|..+. ...++++++++.+...+|||
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~~~lvmE 111 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVME 111 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEEC
T ss_pred EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEECCCCCEEEEE
T ss_conf 98079852768999957998489996177130346777888778999999999986505798855289985988779871
Q ss_pred CCCCCCH
Q ss_conf 1699961
Q 003481 544 YLPNGSL 550 (816)
Q Consensus 544 ~~~~gsL 550 (816)
++++..+
T Consensus 112 ~L~~~~~ 118 (392)
T d2pula1 112 DLSHLKI 118 (392)
T ss_dssp CCTTSEE
T ss_pred CCCCCCC
T ss_conf 3577653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.83 E-value=4.7e-05 Score=47.96 Aligned_cols=128 Identities=21% Similarity=0.183 Sum_probs=77.0
Q ss_pred EEEEECC-EEEEEEEEC-CEEEEEEEECCCCCCCHHHHHHHHHHHHCCC--CCCEEEEECCCC--CCCCCEEECCCCCCH
Q ss_conf 2442065-699999885-9099999940488313799999999974389--984003721004--774112421699961
Q 003481 477 KVGQGGF-GCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ--HPHLVTLLGACP--EAWSLVYEYLPNGSL 550 (816)
Q Consensus 477 ~LG~G~~-g~Vy~g~~~-g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~--HpnIv~l~g~~~--~~~~lV~E~~~~gsL 550 (816)
.+..|.. +.||+.... +..+.+|........ .+..|...+..+. .-.+.++++++. +..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCCHH---HHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 767865477589999389878999958966776---89999999999986599988613222456615999874413554
Q ss_pred HHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--------------------------------------------
Q ss_conf 356410299998999999999999999999985169--------------------------------------------
Q 003481 551 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK-------------------------------------------- 586 (816)
Q Consensus 551 ~~~L~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-------------------------------------------- 586 (816)
.+.. +. ...++.+++..|.-||...
T Consensus 94 ~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred CCCC--------CC---HHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHH
T ss_conf 3221--------26---899999999999987368854488755412468899999987541101134011213799999
Q ss_pred -----------CCCEEECCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf -----------99446077889956754799906820265110
Q 003481 587 -----------PEKIVHGDLKPQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 587 -----------~~~iiHrDIkp~NILld~~~~~KL~DFGla~~ 618 (816)
+..++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 9998718765795678678887635773796589998533265
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.56 E-value=0.00062 Score=40.51 Aligned_cols=157 Identities=11% Similarity=0.076 Sum_probs=78.1
Q ss_pred CCHHHHHHHHCCCCCCCEE-----EEECCEEEEEEEECCEEEEEEEECCCCCCCHHHHHHHHHHHHCCC-----CCCEEE
Q ss_conf 5978899872397756424-----420656999998859099999940488313799999999974389-----984003
Q 003481 460 FSLADLQTATCNFSESFKV-----GQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-----HPHLVT 529 (816)
Q Consensus 460 ~~~~~l~~at~~f~~~~~L-----G~G~~g~Vy~g~~~g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~-----HpnIv~ 529 (816)
.+.+++.....+|..+... ..|---+.|.....+..+++|++....... ++..++.++..|. -|..+.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~~~--~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKN--DLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC---CC--HHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCCHH--HHHHHHHHHHHHHHCCCCCCCCCE
T ss_conf 899999999986799985685237888526738999789728999807899988--999999998754302555455641
Q ss_pred EE-CC----CCCCCCCEEECCCCCCHHH--------------HHHHCC-------CCCCCCH-----------------H
Q ss_conf 72-10----0477411242169996135--------------641029-------9998999-----------------9
Q 003481 530 LL-GA----CPEAWSLVYEYLPNGSLQD--------------RLFRKS-------NVSPLLW-----------------K 566 (816)
Q Consensus 530 l~-g~----~~~~~~lV~E~~~~gsL~~--------------~L~~~~-------~~~~l~~-----------------~ 566 (816)
.. |. .......++.++.+..... .++... ......+ .
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCH
T ss_conf 04897621341255024531146553332046788888998764544432024531011101200245677776531141
Q ss_pred HHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf 999999999999999851-6999446077889956754799906820265110
Q 003481 567 DRARIAAEIASGLCFLHS-SKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 567 ~~~~i~~~ia~aL~yLH~-~~~~~iiHrDIkp~NILld~~~~~KL~DFGla~~ 618 (816)
.....+......+.-... .-+.++||+|+.++||+++.+...-|.||+.+..
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 27999999987642048554545033378636564020454126742221236
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.32 E-value=0.0019 Score=37.36 Aligned_cols=72 Identities=14% Similarity=0.235 Sum_probs=47.5
Q ss_pred CEEEEECCEEEEEEEEC---------CEEEEEEEECCCCCCCHHHHHHHHHHHHCCC-CCCEEEEECCCCCCCCCEEECC
Q ss_conf 42442065699999885---------9099999940488313799999999974389-9840037210047741124216
Q 003481 476 FKVGQGGFGCVYKGEML---------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGACPEAWSLVYEYL 545 (816)
Q Consensus 476 ~~LG~G~~g~Vy~g~~~---------g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~~~~lV~E~~ 545 (816)
..|+.|-.-.+|+.... ...|.+++.- . ........+|..++..+. +.-..++++++.+ .+|++|+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--g~I~efi 123 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG--GRLEEYI 123 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--EEEECCC
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-C-CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC--CEEEEEE
T ss_conf 991785334348999688775445789817999659-9-61165899999999999757999808998189--5699973
Q ss_pred CCCCHH
Q ss_conf 999613
Q 003481 546 PNGSLQ 551 (816)
Q Consensus 546 ~~gsL~ 551 (816)
++.+|.
T Consensus 124 ~g~~l~ 129 (395)
T d1nw1a_ 124 PSRPLS 129 (395)
T ss_dssp CEEECC
T ss_pred CCCCCC
T ss_conf 455488
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.13 E-value=0.0064 Score=33.80 Aligned_cols=133 Identities=13% Similarity=0.118 Sum_probs=70.8
Q ss_pred CEEEEEEEEC-CEEEEEEEECCCCCCCHHHHHHHHHHHHCCCCCC--EEEEECCC-------CCCCCCEEECCCCCCHHH
Q ss_conf 5699999885-9099999940488313799999999974389984--00372100-------477411242169996135
Q 003481 483 FGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPH--LVTLLGAC-------PEAWSLVYEYLPNGSLQD 552 (816)
Q Consensus 483 ~g~Vy~g~~~-g~~vAiK~l~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~l~g~~-------~~~~~lV~E~~~~gsL~~ 552 (816)
--.||+.... |..|++|+..+... ...++..|...+..|.... ++..+... .+..+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred CCEEEEEECCCCCEEEEEEECCCCC-CHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCC
T ss_conf 2026999838999799998478778-899999999999999855998787520689805665347999986527768899
Q ss_pred --------------HHHHC----C--CCCCCCHH----------------------HHHHHHHHHHHHHHHH-HHCCCCC
Q ss_conf --------------64102----9--99989999----------------------9999999999999998-5169994
Q 003481 553 --------------RLFRK----S--NVSPLLWK----------------------DRARIAAEIASGLCFL-HSSKPEK 589 (816)
Q Consensus 553 --------------~L~~~----~--~~~~l~~~----------------------~~~~i~~~ia~aL~yL-H~~~~~~ 589 (816)
.++.. . ....+++. .....+..+...+.-+ ....+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCE
T ss_conf 99999999899999988630357865567789788766568999874769988989999999999999998454568712
Q ss_pred EEECCCCCCCEEECCCCCEEEEECCCCEE
Q ss_conf 46077889956754799906820265110
Q 003481 590 IVHGDLKPQNILLDSELSSKICDFGICRL 618 (816)
Q Consensus 590 iiHrDIkp~NILld~~~~~KL~DFGla~~ 618 (816)
+||+|+.+.|||++.+ ..+.||+-|..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred EECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 0247888042878389--35886520146
|
| >d1wy5a1 c.26.2.5 (A:1-216) TilS-like protein Aq_1887 {Aquifex aeolicus [TaxId: 63363]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: TilS-like protein Aq 1887 species: Aquifex aeolicus [TaxId: 63363]
Probab=91.11 E-value=0.32 Score=22.54 Aligned_cols=96 Identities=14% Similarity=0.249 Sum_probs=59.9
Q ss_pred CCCCEEEEEECCCCCCCHHHHHHHHHCCCC--C-CCEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q ss_conf 996389998248951135468887300279--9-8199999619999887778987877566899999999999999999
Q 003481 20 GGGEKVYVALGKCVEKGLSLLHWTLQRFGS--S-REICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQKMKKL 96 (816)
Q Consensus 20 ~~~~~VlVavD~~~~~s~~Al~wal~~~~~--~-~~i~liHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 96 (816)
.++++|+||+-|-.. |. ||-+.+-.+.. + ..+.++||-.- . . . ....-
T Consensus 22 ~~~~kv~Va~SGG~D-S~-~Ll~lL~~~~~~~~~~~i~~~~vdh~---~----r--~------------------~s~~~ 72 (216)
T d1wy5a1 22 SGERRVLIAFSGGVD-SV-VLTDVLLKLKNYFSLKEVALAHFNHM---L----R--E------------------SAERD 72 (216)
T ss_dssp SSCCEEEEECCSSHH-HH-HHHHHHHHSTTTTTCSEEEEEEEECC---S----S--T------------------HHHHH
T ss_pred CCCCEEEEEECCCHH-HH-HHHHHHHHHHHHCCCCCEEEEEEECC---C----C--C------------------CHHHH
T ss_conf 899869999678599-99-99999999987668770888875112---3----4--1------------------03321
Q ss_pred HHHHHHHHHHHCCCEEEEEEECC--------CH--------HHHHHHHHHHHCCCEEEECCCCC
Q ss_conf 99999999870660389998317--------88--------89999999980988899635899
Q 003481 97 LDNYLRICVEAEVKARIITTEAD--------KI--------QKAIVQLMNIHGIQKLVMGAFPD 144 (816)
Q Consensus 97 l~~~~~~c~~~~V~~~~~v~e~~--------d~--------~~~Ii~~i~~~~id~lVmGs~g~ 144 (816)
.+....+|...+|.+...-+... .. ...+.+++.+++++.|++|.+..
T Consensus 73 ~~~~~~~~~~l~i~~~i~~~~~~~~~~~~~~~~~~~~R~~Ry~~l~~~a~~~~~~~ia~GH~~d 136 (216)
T d1wy5a1 73 EEFCKEFAKERNMKIFVGKEDVRAFAKENRMSLEEAGRFLRYKFLKEILESEGFDCIATAHHLN 136 (216)
T ss_dssp HHHHHHHHHHHTCCEEEEECCHHHHHHHTTCCHHHHHHHHHHHHHHHHHHHTTCSEEECCCCHH
T ss_pred HHHHHHHHHHHHHHHHHHCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEECC
T ss_conf 3478999986200010210210111137764457879999988764111122312157652024
|
| >d2baya1 g.44.1.2 (A:1-56) Pre-mRNA splicing factor Prp19 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Pre-mRNA splicing factor Prp19 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=90.04 E-value=0.029 Score=29.43 Aligned_cols=51 Identities=20% Similarity=0.380 Sum_probs=46.1
Q ss_pred CCCHHHHHCCCCCCC-CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 451012101798866-8985333100445520598788864455676789872
Q 003481 751 LCPILQEIMHDPQVA-ADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPN 802 (816)
Q Consensus 751 l~pilqei~~dP~~~-~~g~~~~~~~i~~~l~~g~~~sp~t~~~~~~~~l~Pn 802 (816)
.|++-.+++.+|... ..|+.|....|..|+.. +.++|+++..++..+|+|.
T Consensus 2 ~C~Ic~~~~~~Pv~~~~cGh~fc~~cI~~~l~~-~~~CP~c~~~l~~~dLipi 53 (56)
T d2baya1 2 LCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKD-TGNDPITNEPLSIEEIVEI 53 (56)
T ss_dssp CCTTTCSCCSSEEEETTTTEEEEHHHHHHHHHH-HSBCTTTCCBCCGGGCEEC
T ss_pred CCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCCCCHHHCEEC
T ss_conf 993678568865745789984559999998760-3679854781887753647
|
| >d1jm7b_ g.44.1.1 (B:) bard1 RING domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: bard1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.24 E-value=1 Score=19.25 Aligned_cols=83 Identities=16% Similarity=0.156 Sum_probs=62.0
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHCCCCCCC-CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC
Q ss_conf 8899999748999999983101568888744451012101798866-898533310044552059878886445567678
Q 003481 720 YGRERPDITPSLVKELEQLHVAEERPVPSFFLCPILQEIMHDPQVA-ADGFTYEGKAIRDWLENGRETSPMTNLRLSHLH 798 (816)
Q Consensus 720 dp~~RPs~~~~l~~~L~~l~~~~~~~~p~~~l~pilqei~~dP~~~-~~g~~~~~~~i~~~l~~g~~~sp~t~~~~~~~~ 798 (816)
+|..+-.+. .....|+.+.. .+.|++=.+.+.+|... .=|++|-...|..|+.+ .+|.-+..+...+
T Consensus 2 ~p~~~~~~~-~~~~~l~~l~~--------~l~C~IC~~~~~~pv~~~~CgH~fC~~Ci~~~~~~---~CP~Cr~~~~~~~ 69 (97)
T d1jm7b_ 2 EPDGRGAWA-HSRAALDRLEK--------LLRCSRCTNILREPVCLGGCEHIFCSNCVSDCIGT---GCPVCYTPAWIQD 69 (97)
T ss_dssp CSSTTCCCH-HHHHHHHHHHH--------TTSCSSSCSCCSSCBCCCSSSCCBCTTTGGGGTTT---BCSSSCCBCSCSS
T ss_pred CCCCCCCCH-HHHHHHHHHHH--------CCCCCCCCCHHHCCCEECCCCCCHHHHHHHHHHHC---CCCCCCCCCCHHH
T ss_conf 988666507-67999996212--------28992587221127465889993029999999853---6662278676551
Q ss_pred CCCCHHHHHHHHHHHH
Q ss_conf 9872899999999975
Q 003481 799 LTPNHALRHAIQDWLC 814 (816)
Q Consensus 799 l~Pn~alr~~~~~~~~ 814 (816)
+.||.+|++.++.+..
T Consensus 70 l~~n~~l~~lv~~~~~ 85 (97)
T d1jm7b_ 70 LKINRQLDSMIQLCSK 85 (97)
T ss_dssp CCCCHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHH
T ss_conf 8605899999999999
|
| >d1ni5a1 c.26.2.5 (A:0-226) tRNA-Ile-lysidine synthetase, TilS, N-terminal domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Adenine nucleotide alpha hydrolase-like superfamily: Adenine nucleotide alpha hydrolases-like family: PP-loop ATPase domain: tRNA-Ile-lysidine synthetase, TilS, N-terminal domain species: Escherichia coli [TaxId: 562]
Probab=82.11 E-value=0.97 Score=19.33 Aligned_cols=96 Identities=14% Similarity=0.105 Sum_probs=51.5
Q ss_pred CCCCEEEEEECCCCCCCHHHHHHHHHCCCC--CCCEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q ss_conf 996389998248951135468887300279--981999996199998877789878775668999999999999999999
Q 003481 20 GGGEKVYVALGKCVEKGLSLLHWTLQRFGS--SREICILHVHQPSPVIPTLLGKLPASQASAEVLSAFRAEERQKMKKLL 97 (816)
Q Consensus 20 ~~~~~VlVavD~~~~~s~~Al~wal~~~~~--~~~i~liHV~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll 97 (816)
...++|+||+-|-.. |...+....+.... +..++++||-+-.. + ......
T Consensus 11 ~~~kkvlva~SGG~D-S~~Ll~ll~~~~~~~~~~~l~~~~vdh~~r---------~------------------~s~~~~ 62 (227)
T d1ni5a1 11 LTSRQILVAFSGGLD-STVLLHQLVQWRTENPGVALRAIHVHHGLS---------A------------------NADAWV 62 (227)
T ss_dssp TTCSEEEEECCSBHH-HHHHHHHHHHHHTTSTTCEEEEEEECCSCC---------S------------------SHHHHH
T ss_pred CCCCCEEEEECCCHH-HHHHHHHHHHHHHHCCCCEEEEEEECCCCC---------C------------------CHHHHH
T ss_conf 889968999638499-999999999998758895699998678987---------5------------------214458
Q ss_pred HHHHHHHHHHCCCEEEEEEECCCHHH----------HHHHHHHHHCCCEEEECCCC
Q ss_conf 99999998706603899983178889----------99999998098889963589
Q 003481 98 DNYLRICVEAEVKARIITTEADKIQK----------AIVQLMNIHGIQKLVMGAFP 143 (816)
Q Consensus 98 ~~~~~~c~~~~V~~~~~v~e~~d~~~----------~Ii~~i~~~~id~lVmGs~g 143 (816)
+....+|.+.+|.....-........ .........+.+.|++|.+.
T Consensus 63 ~~~~~~~~~~~i~~~i~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~i~~gH~~ 118 (227)
T d1ni5a1 63 THCENVCQQWQVPLVVERVQLAQEGLGIEAQARQARYQAFARTLLPGEVLVTAQHL 118 (227)
T ss_dssp HHHHHHHHHTTCCEEEECCCCCCSSSTTTTHHHHHHHHHHHHTCCTTEEEECCCCH
T ss_pred HHHHHHHHHCCCCCEEEECCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_conf 99999975415763266313333443036689999999888775203899999888
|